Ecr 2016 Final Programme.pdf

FINAL PROGRAMME

TIMETABLE

Sunday, March 6

Saturday, March 5

Friday, March 4

Thursday, March 3

Wednesday, March 2

08:30 09:00 09:30 10:00 New Horizons Session NH 1 E³ - ECR Academy E³ 121 E³ - ECR Master Class E³ 126

10:30 11:00 11:30 12:00

12:15 13:00 13:30 14:00

E³ - ECR Academy E³ 221

E³ - The Beauty of Basic Knowledge E³ 24A, E³ 25A

Scientific Sessions (200)

Clinical Trials in Radiology 1

Satellite Symposium SY 1a

Satellite Symposia SY 1b, SY 2, SY 3, SY 4

Refresher Courses (100) EuroSafe Imaging Session 1

1

New Horizons Session NH 5 Professional Challenges Session PC 5 Special Focus Session SF 5 State of the Art Symposium SA 5 E³ - ECR Academies E³ 522, E³ 521, E³ 519 E³ - ECR Master Class E³ 526 Refresher Courses (500) Joint Course: ESR and RSNA MC 528 E³ - Rising Stars Programme Basic Session 1

Wilhelm Conrad Röntgen Honorary Lecture Andrea G. Rockall; UK

E³ - ECR Academies E³ 621, E³ 622 Joint Course: ESR and RSNA MC 628

E³ - The Beauty of Basic Knowledge E³ 24B, E³ 25B

Scientific Sessions (600)

Clinical Trials in Radiology 2

E³ - Rising Stars Programme Basic Session 2

Satellite Symposia SY 5, SY 6, SY 7, SY 8, SY 9, SY 10, SY 11, SY 12

5

6 ESR meets the Nordic Countries

Professional Challenges Sessions PC 9a, PC 9b Special Focus Sessions SF 9a, SF 9b, SF 9c E³ - ECR Academies E³ 922, E³ 921, E³ 920, E³ 919

E³ - ECR Academies E³ 1022, E³ 1021 EFOMP Workshop EF 2

9

Special Focus Sessions SF 13a, SF 13b, SF 13c, SF 13d E³ - ECR Academies E³ 1321, E³ 1318 E³ - European Diploma Prep Session E³ 1323

Josef Lissner Honorary Lecture Valérie Vilgrain; FR

MIR @ ECR Session MIR 1

E³ - Rising Stars Programme Student Session 4

EFOMP Workshop EF 1

RTF Quiz

E³ - The Beauty of Basic Knowledge E³ 24C, E³ 25C

Scientific Sessions (1000)

Refresher Courses (900) E³ - Rising Stars Programme Student Session 3

2

10 ESR meets Japan

Satellite Symposia SY 13, SY 14, SY 15, SY 16, SY 17, SY 18, SY 19, SY 20

Sven-Ivar Seldinger Honorary Lecture Staffan Holmin; SE

Refresher Courses (1300)

E³ - ECR Academy E³ 1421 E³ - European Diploma Prep Session E³ 1423 Refresher Course RC 1405

ESR Patient Advisory Group ESR-PAG 1

Scientific Sessions (1400)

EIBIR Session 3

E³ - Rising Stars Programme Basic Session 4

ESR Patient Advisory Group ESR-PAG 2

Satellite Symposia SY 26, SY 27, SY 28, SY 29, SY 30

13

Special Focus Sessions SF 17a, SF 17b Professional Challenges Session PC 17 State of the Art Symposium SA 17 E³ - ECR Academy E³ 1721 E³ - ECR Master Classes E³ 1726a, E³ 1726b, E³ 1726c, E³ 1726d Refresher Courses (1700) EIBIR Session 4 Joint Session: ESR and ESHI E³ - Rising Stars Programme Basic Session 6

17

RTF Highlighted Lectures E³ - Rising Stars Programme Basic Session 5

14

ESR meets Colombia Professional Challenges Session PC 18 E³ - ECR Master Class E³ 1826 E³ - European Diploma Prep Session E³ 1823

E³ - The Beauty of Basic Knowledge E³ 24D, E³ 25D Junior Image Interpretation Quiz

E³ - The Beauty of Basic Knowledge E³ 24E, E³ 25E E³ - Rising Stars Programme Case-Based Diagnosis Training

Scientific Sessions (1800)

18

The Voice of EPOS • in the EPOS™ Arena Wednesday – Saturday: hourly between 09:00 and 17:00 • Sunday: hourly between 09:00 and 13:00 2

ECR 2016 | Final Programme

www.myESR.org

TIMETABLE

E³ - ECR Academies E³ 721, E³ 722

Refresher Courses (400)

4

EuroSafe Imaging Session 2 Satellite Symposium SY 1d

Professional Challenges Sessions PC 8a, PC 8b Special Focus Sessions SF 8a, SF 8b, SF 8c, SF 8d Multidisciplinary Session MS 8 E³ - ECR Academies E³ 822, E³ 821, E³ 819

Scientific Sessions (700) EIBIR Session 1 ESOR Session Joint Course: ESR and RSNA MC 728

Refresher Courses (800) Joint Session: American College of Radiology Session

E³ - Rising Stars Programme Student Session 1

7

EFRS meets Sweden

8

ESR Working Group on Ultrasound Joint Course: ESR and RSNA MC 828 E³ - Rising Stars Programme Student Session 2

EIBIR Session 2

Professional Challenges Sessions PC 12a, PC 12b E³ - ECR Academies E³ 1221, E³ 1220, E³ 1218 E³ - ECR Master Classes E³ 1226a, E³ 1226b, E³ 1226c

Joint Session: ESR and ESMRMB

Refresher Courses (1200)

Satellite Symposia SY 21, SY 22, SY 23, SY 24, SY 25

MIR @ ECR Session MIR 3

Image Interpretation Quiz MIR @ ECR Session MIR 2

11

EuroSafe Imaging Session 3

12

Joint Session: ESR and EANM EDiR talk E³ - Rising Stars Programme Basic Session 3

Special Focus Session SF 15 State of the Art Symposium SA 15 E³ - ECR Academies E³ 1521, E³ 1520, E³ 1518 E³ - ECR Master Class E³ 1526 E³ - European Diploma Prep Session E³ 1523

Special Focus Session SF 16 Multidisciplinary Sessions MS 16a, MS 16b E³ - ECR Academies E³ 1621, E³ 1620, E³ 1618 E³ - ECR Master Class E³ 1626 E³ - European Diploma Prep Session E³ 1623

Refresher Courses (1500)

Refresher Courses (1600)

Joint Session: ESR and ERS E³ - Rising Stars Programme Student Final Session

15

EuroSafe Imaging Session 4 Joint Session: ESR and ESTRO Joint Session: ESR, EFSUMB and ESPR

16

Thursday, March 3

3

Presentation of Honorary Members: Ronald L. Arenson; US Hassen A. Gharbi; TN Qiyong Guo; CN

Wednesday, March 2

Opening Ceremony

New Horizons Session NH 4 E³ - ECR Academy E³ 419 E³ - ECR Master Classes E³ 426a, E³ 426b Pros & Cons Session PS 427

Satellite Symposium SY 1c

17:45 18:00 18:30 19:00

Friday, March 4

Scientific Sessions (300)

16:00 16:30 17:00 17:30

Saturday, March 5

14:00 14:30 15:00 15:30

Scientific Sessions (1900) E³ - Rising Stars Programme Case-Based Diagnosis Training

19 www.myESR.org

Sunday, March 6

E³ - European Diploma Prep Session E³ 1923

Final Programme | ECR 2016

3

28TH EUROPEAN CONGRESS OF RADIOLOGY CONGRESS VENUE

CONGRESS LANGUAGE

Austria Center Vienna Bruno Kreisky Platz 1 1220 Vienna, Austria

English

ONSITE OPENING HOURS Registration Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . Thursday, March 3 to Saturday, March 5. . . Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . .

12:00–18:00 07:00–18:00 07:30–18:00 07:30–16:00

Preview Centre Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00 Wednesday, March 2 to Saturday, March 5. . . 07:30–18:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00 EPOS™ – Scientific Exhibition Wednesday, March 2 to Saturday, March 5. . 08:00–18:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 08:00–15:30

Technical Exhibition EXPO Halls and EXPO Foyer D Thursday, March 3 to Saturday, March 5. . . 10:00–17:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00 First Level (Gallery) Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . 14:00–17:00 Thursday, March 3 to Saturday, March 5. . . 10:00–17:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 10:00–16:00 Travel Service Tuesday, March 1 . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00 Wednesday, March 2 to Saturday, March 5. . . 07:30–18:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . 07:30–15:00 Press Office & Business Centre Wednesday, March 2 to Sunday, March 6. . 08:00–18:00

SESSIONS IN JOINT SPONSORSHIP WITH CIRSE

Cardiovascular and Interventional Radiological Society of Europe

EFOMP

European Federation of Organisations for Medical Physics

EFRS

European Federation of Radiographer Societies

ESCR

European Society of Cardiac Radiology

ESER

European Society of Emergency Radiology

ESGAR

European Society of Gastrointestinal and Abdominal Radiology

ESHNR

European Society of Head and Neck Radiology

ESMOFIR European Society of Molecular and Functional Imaging in Radiology ESNR

European Society of Neuroradiology

ESOI

European Society of Oncologic Imaging

ESPR

European Society of Paediatric Radiology

ESSR

European Society of Musculoskeletal Radiology

ESTI

European Society of Thoracic Imaging

ESUR

European Society of Urogenital Radiology

EUSOBI

European Society of Breast Imaging

EuSoMII

European Society of Medical Imaging Informatics

4

ECR 2016 | Final Programme

www.myESR.org

General Information

INFORMATION FROM A–Z

TABLE OF CONTENTS Forewords by the ESR President. . . . . . . . . . . . . . . . . . . . . . . . . . 6 by the ECR 2016 Congress President. . . . . . . . . . . . 8 General Information Information from A to Z . . . . . . . . . . . . . . . . . . . . . . CME at ECR 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . Headline Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . (Junior) Image Interpretation Quizzes. . . . . . . . . . EPOS™ – Scientific Exhibition . . . . . . . . . . . . . . . . . Green Meeting. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Free Publications. . . . . . . . . . . . . . . . . . . . . . . . . . . . . ECR 2016 welcomes its industry partners. . . . . . ESR Journals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Underground Map . . . . . . . . . . . . . . . . . . . . . . . . . .

12 22 24 27 28 31 31 33 35 37

Floor Plans. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 ESR Dignitaries Honorary Member Ronald L. Arenson. . . . . . . . . 50 Honorary Member Hassen A. Gharbi . . . . . . . . . . . 51 Honorary Member Qiyong Guo. . . . . . . . . . . . . . . . 52 Gold Medallist Gabriel P. Krestin. . . . . . . . . . . . . . . 53 Gold Medallist Claude Manelfe. . . . . . . . . . . . . . . . 54 Gold Medallist Peter Vock. . . . . . . . . . . . . . . . . . . . 55 Honorary Lecturer Staffan Holmin . . . . . . . . . . . . . 56 Honorary Lecturer Andrea G. Rockall . . . . . . . . . . 57 Honorary Lecturer Valérie Vilgrain. . . . . . . . . . . . . 58 Committees ESR Executive Council . . . . . . . . . . . . . . . . . . . . . . 60 Congress Committee. . . . . . . . . . . . . . . . . . . . . . . . . 61 Programme Planning Committee . . . . . . . . . . . . . . 61 Scientific Subcommittees. . . . . . . . . . . . . . . . . . . . . 62 Topic Coordinators . . . . . . . . . . . . . . . . . . . . . . . . . . 65 Programme Overviews Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . . Thursday, March 3 . . . . . . . . . . . . . . . . . . . . . . . . . . Friday, March 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Saturday, March 5 . . . . . . . . . . . . . . . . . . . . . . . . . . Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

www.myESR.org

68 70 72 74 76

Scientific Programme ESR/EFRS meets Sessions. . . . . . . . . . . . . . . . . . . 81 New Horizons Sessions. . . . . . . . . . . . . . . . . . . . . . . 83 State of the Art Symposia . . . . . . . . . . . . . . . . . . . . 85 Special Focus Sessions . . . . . . . . . . . . . . . . . . . . . . 87 Professional Challenges Sessions . . . . . . . . . . . . . 91 Multidisciplinary Sessions. . . . . . . . . . . . . . . . . . . . . 95 European Excellence in Education (E3) . . . . . . . . 97 Rising Stars Programme. . . . . . . . . . . . . . . . . . . 99 European Diploma Prep Sessions. . . . . . . . . . . 105 The Beauty of Basic Knowledge . . . . . . . . . . 107 ECR Academies . . . . . . . . . . . . . . . . . . . . . . . . . 109 ECR Master Classes . . . . . . . . . . . . . . . . . . . . . . . 115 Mini Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119 Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . . 121 The Voice of EPOS. . . . . . . . . . . . . . . . . . . . . . . . . 123 Refresher Courses / Scientific Sessions. . . . . . . 143 Abdominal and Gastrointestinal. . . . . . . . . . . 144 Breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146 Cardiac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147 Chest. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148 Computer Applications. . . . . . . . . . . . . . . . . . . . 150 Molecular Imaging . . . . . . . . . . . . . . . . . . . . . . . 150 Genitourinary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151 Head and Neck . . . . . . . . . . . . . . . . . . . . . . . . . . 152 Interventional Radiology. . . . . . . . . . . . . . . . . . 153 Musculoskeletal. . . . . . . . . . . . . . . . . . . . . . . . . . 155 Neuro. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156 Paediatric. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158 Physics in Radiology . . . . . . . . . . . . . . . . . . . . . 159 Radiographers. . . . . . . . . . . . . . . . . . . . . . . . . . . 160 Vascular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162 Oncologic Imaging . . . . . . . . . . . . . . . . . . . . . . . 163 Emergency Radiology. . . . . . . . . . . . . . . . . . . . . 164 Joint Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165 Industry Programme Satellite Symposia. . . . . . . . . . . . . . . . . . . . . . . . . . 177 Industry Workshops. . . . . . . . . . . . . . . . . . . . . . . . . 181

Final Programme | ECR 2016

5

Forewords

FOREWORD BY THE ESR PRESIDENT

DEAR COLLEAGUES,

It gives me great pleasure to welcome you to the European

ties together various previous endeavours in the field of

Congress of Radiology (ECR) 2016. As president of the

imaging biomarkers and personalised imaging, including

European Society of Radiology (ESR), it is very satisfying

close collaboration with the ESR-EORTC and QIBA™.

to see the culmination of all the hard work and dedication that has gone into preparing this event, which is always the

On a similar note, I am pleased to say that the ESR has

biggest highlight of the society’s year.

recently signed a memorandum of understanding with the Biobanking and BioMolecular resources Research Infra-

The ECR is so much more than a scientific meeting; beyond

structure – European Research Infrastructure Consortium

the regular programme that forms its basis, there are an

(BBMRI-ERIC) with the aim of raising the profile of imaging

ever-increasing number of special sessions and side events

biobanks and ultimately establishing a European imaging

that tie in with the ESR’s ongoing activities. More and more,

biobank infrastructure. Endeavours such as this and the

the ECR is becoming not only a marker of the current state

EIBALL are vital groundwork for ensuring we can make the

of our discipline, via its scientific content, but also a reflec-

most of future developments in medical imaging.

tion of the ESR’s progress, as so many of the achievements from throughout the prior twelve months are represented

The EuroSafe Imaging campaign, the ESR’s own initia-

here in one way or another. Naturally, this congress is not

tive to promote quality and safety in medical imaging, will

just where we, as individuals, come to discover the latest

also be well represented at the congress. The campaign is

in our field; it is also where we, as a society, celebrate and

continually growing in scope and this year that is clearly

look back on the steps we have taken over the last year.

reflected in the ECR programme, with not only four dedicated EuroSafe Imaging sessions, but six other sessions

Some of our proudest recent moments have come in the

and workshops centred on various subjects. One of those

field of research. In particular, the European Institute for

topics is clinical decision support (CDS), a major issue on

Biomedical Imaging Research (EIBIR), of which the ESR

the ESR’s agenda over the last year, during which we have

is the majority owner, saw remarkable success in 2015. Four

launched a CDS platform (the ESR iGuide), as well as our

Horizon 2020 projects benefiting from EIBIR’s proposal

own basis patient safety standards and the ESR Clinical

preparation services and expertise had grant agreements

Audit Tool. Such services are an important part of the ESR’s

signed, meaning EIBIR is now involved in 25% of all projects

strategy going forward, as part of a larger commitment to

funded under the imaging-specific call. Considering the suc-

providing professional support for the radiological family.

cess rate for Horizon 2020 proposals has been generally low, this is a real credit to the expertise we have at our disposal

The provision of qualifications is yet another form of sup-

in this arena. This success story will form part of one of

port we offer to radiologists, and one of the most notable

the four EIBIR sessions at this congress, and EIBIR will also

non-programme aspects of recent ECRs is the hosting

feature in an additional session introducing the European

of examinations for the European Diploma in Radiology

Imaging Biomarkers Alliance (EIBALL), a new body that

(EDiR). This will be the sixth ECR at which an EDiR exam

6

ECR 2016 | Final Programme

www.myESR.org

Forewords

FOREWORD BY THE ESR PRESIDENT

has been held and this year it will serve as a platform for the introduction of a change in format. The European Board of Radiology (EBR) has been actively reviewing the examination process with the aim of making sure the exam remains as accurate a test of candidates’ ability as possible. The result of this is that a new ‘skills examination’ will be tested at ECR 2016, developed from what used to be known as the oral part of the exam. I would like to wish everyone taking the exam, which will include the EDiR’s 1000th candidate, the very best of luck! Another educational service that is fundamentally tied in with the ECR is the Electronic Poster Online System, better

Prof. Luis Donoso Bach is Director of the Diagnostic Imaging Department of the Hospital Clínic of the University of Barcelona, Spain. He is also the Executive Director of the UDIAT Diagnostic Centre at the Health Corporation Parc Taulí.

known to most of us as EPOS™. The online database serves as a learning resource all year round, but the posters it

programme will match the recent standard and see just as

contains are of course all submitted for the congress. This

broad a range of the radiological family joining us in Vienna.

year, EPOS has a new side to it, as submitters have been able to apply to present their posters in person, under the

Finally, I would like to express my thanks to Prof. Katrine

heading The Voice of EPOS. I hope many of you will take the

Riklund for masterminding a fantastic programme for ECR

oportunity to attend these presentations, which will bring

2016, along with all members of the Congress Programme

a valuable new dimension to the usual EPOS experience.

Planning Committee, the Chairs and members of the Scientific Subcommittees, the Subspecialty Societies and, of

One of the outcomes of this expansion of EPOS may very

course, the wonderful team at the ESR office. I hope each

well be that some submitters who may usually stay at home

one of you will enjoy the experience, and the amazing city

during the ECR might make their first trip to Vienna, and

of Vienna, to the very fullest.

this of course would be a wonderful bonus. By adding more and more flavours to our congress, we hope to cater for every taste in the radiological spectrum. One of the largest growing areas of the ECR in that respect is the programme for radiographers. We are delighted that the numbers of radiographers and radiological technicians visiting the congress have been consistently high over recent years, thanks

Luis Donoso Bach

largely to the close involvement of the European Federation

ESR President

of Radiographer Societies. I am positive that this year’s

www.myESR.org

Final Programme | ECR 2016

7

Forewords

FOREWORD BY THE ECR PRESIDENT

DEAR FRIENDS, DEAR COLLEAGUES,

during last year’s ECR. Even if we are in a transition period, with an increased use of digital communication and online participation, a huge number of people still take part on-site in Vienna, and I hope you will continue to do so. Another good example of our progress is that, even as time is passing by, we are getting younger. Between 2008 and 2015 the average age of attendees has fallen from 47 to 42 years. At ECR 2016 you will have the chance to find out a lot about interesting medical imaging in the ‘ESR meets’ sessions, such as breast radiology in the Nordic countries, state-ofthe-art radiology in Japan, and the transition from practice to reality in Colombia. You are all invited to these sessions; they are not intended exclusively for attendees from the presenting countries, but for everyone else to discover

Prof. Katrine Riklund is a radiologist who is also licensed in nuclear medicine at Umeå University Hospital, Sweden. She is deputy head of the department of radiation sciences and director of the medical school at Umeå University.

something new. Radiology will also meet nuclear medicine in a session on hybrid imaging and during ECR 2016 you can also witness the launch of the new European Society for Hybrid Medical Imaging (ESHI) by visiting the ESHI booth in the entrance hall, where you can pick plenty of information about the new society. For ECR 2016, the new format introduced to the educational

I am very proud and greatly honoured to welcome you to

programme last year will remain, which means you will find

the European Congress of Radiology (ECR) 2016. During

sessions with the right level of complexity wherever you

the last 20 years I have seen the congress evolve and grow,

are in your professional development. To guide you, the

and every year I love being at this wonderful event. The

sessions are marked with the knowledge level they are

first impression when arriving in the entrance hall is always

intended for. Also this year, candidates will once again be

fabulous and the feeling of being welcome is always strong

sitting examinations for the European Diploma in Radiology

for me, and I hope all of you will feel the same. To meet you

(EDiR) during the congress. Interest in the EDiR has been

all in the entrance hall, in lecture rooms, and in the technical

increasing every year and I am pleased to say this particular

exhibition, strengthens my confidence of the importance

examination was fully booked a long time in advance.

of keeping face-to-face meetings. The number of friends and colleagues attending the ECR has increased year by

This year’s poster shows you a combination of the phe-

year and we ended up with more than 25,000 attendees

nomena we have up north, close to the Arctic Circle; the

8

ECR 2016 | Final Programme

www.myESR.org

Forewords

FOREWORD BY THE ECR PRESIDENT

northern lights and the midnight sun, but something is

radiology beyond our comfort zones, just because our field

wrong. They do not show up simultaneously, not even at

is so amazing!

Kebnekajse, which is the mountain on the poster. So the poster is a hybrid of both summer and winter, and hybrid is

This ECR is the result of almost one and a half years of work

a theme that is repeated throughout ECR 2016. These phe-

from hundreds of people who have contributed to creat-

nomena are mixed with small objects symbolising people,

ing this wonderful congress, and I am so thankful to have

or molecules, or whatever you would like them to be, and

the opportunity to be part of this enormous preparation

if you look at the movies you can see them all moving, in

team. The enthusiasm and devotion of all collaborators is

some way connected to each other. The ECR 2015 theme

the basis for creating a congress which delivers both the

‘radiology without borders’ is more relevant than ever for

basics and the front line in imaging. I would like to offer my

most of us and I hope we still can meet at ECR 2016 with-

most sincere thanks to the fantastic efforts of the Congress

out borders even if the situation in Europe has changed

Programme Planning Committee, the Chairs and members

dramatically during recent months. The ECR is one of the

of the Scientific Subcommittees, the Subspecialty Societies

greatest radiological events in the world, with participants

and, of course, the dedicated and professional support of

from more than 120 countries, which means you will meet

ESR office staff. Progression demands change and, when

friends and colleagues from almost every part of the world.

ECR 2016 comes to a close, I will be the last ‘ECR Congress President’. In the coming year we are moving forward with

ECR 2016 will keep up the good reputation of a programme

a re-organisation of the European Society of Radiology

woven from high quality teaching and scientific sessions,

(ESR) leadership structure, and the ECR will become the

as well as posters. A new feature this year is the Voice of

responsibility of the new combined ESR/ECR President.

EPOS, which consists of poster sessions with short oral presentations in the EPOSTM area. Interest in this new idea

Finally, I would like to warmly welcome you to ECR 2016,

has been great, leading to an all-time high in EPOS abstract

and hope you enjoy the congress, meet friends, make new

submissions, with 2,989 abstracts submitted. The Voice of

contacts in your network, and take the opportunity to enjoy

EPOS sessions will be held not only in organ-based topic

the social events of the congress and also of Vienna.

groups, but also in several different languages, adding a useful new dimension to the congress. I am also happy to announce that submission of Clinical Trials in Radiology abstracts has increased substantially compared to last year, so I also encourage you to come and listen to the presentations based on these ongoing

Katrine Riklund

trials. I know that sessions with basic radiology are very

ECR 2016 Congress President

much appreciated, but I have a wish that, this year, all of us will challenge ourselves by taking some time to explore

www.myESR.org

Final Programme | ECR 2016

9

PROUDLY PRESENTS

JUAN DIEGO FLÓREZ

AN EXCLUSIVE PERFORMANCE AT THE

© Juan Diego Flórez 2014

ECR 2016 OPENING CEREMONY WEDNESDAY, MARCH 2 17:45–19:00, ROOM A

GENERAL INFORMATION

General Information

INFORMATION FROM A–Z ARTS & CULTURE

BOOKSTORE

Delegates are encouraged to visit the Arts & Culture Desk

This year, for the third time, the ECR is offering delegates an

in the entrance hall for information on Vienna’s cultural

outstanding service. The Viennese bookstore Buchkontor

events such as exclusive opera performances, delightful

will open a special ECR bookstore in the entrance hall of

concerts, and the fascinating exhibitions in Vienna’s most

the congress venue. Browse through a wide range of books,

important and remarkable museums. Pick up your personal

from guidebooks on Vienna’s best sights to cookbooks full

Arts & Culture Brochure at this counter to find descriptions

of delicious Austrian recipes. For the more discerning reader,

of all cultural places.

there will also be a range of Austrian literature so you can take some of the country’s history and culture home with

BADGES

you. The Buchkontor staff look forward to welcoming you

For organisational and security reasons, badges must be

and helping you find that page-turner.

worn at the congress venue. Access to the different areas will

Buchkontor’s ECR Bookstore, entrance hall.

only be granted upon presentation of an appropriate badge. BROADCAST ZONES

Lost or Forgotten Badges

The ECR features specific Broadcast Zones, where you can

In the case of loss, a replacement badge will only be provided

listen to sessions and view the corresponding presentation

on full payment of the applicable onsite registration fee.

material in a relaxed atmosphere when the actual lecture

Forgotten badges will be replaced against a deposit of the

rooms are overcrowded. Broadcast Zones are located

full onsite fee.

In the Austria Center Vienna next to Room B and C (2nd level), Rooms O and N (1st level), and Room K (lower

BOOK OF ABSTRACTS

In keeping with the ESR’s commitment to environmental sustainability, and due to demand from its members, the Book of Abstracts is only available online.

level) In the M Building next to Rooms M4 and M5 See Floor Plans on pages 40–48.

All abstracts can be accessed at www.i3-journal.org/articles.

BUSINESS CENTRE

You can also create your own personal Book of Abstracts with

The Press Office & Business Centre, located on the entrance

the help of the popular ECR Interactive Programme Planner

level, offers copy facilities for a small charge.

on our new platform ECR Online (ecronline.myESR.org).

Opening hours:

Abstracts of EPOS™ presentations no longer appear in the

Wednesday, March 2 to Sunday, March 6. . . . 08:00–18:00

Book of Abstracts. Each full EPOS™ presentation can instead be cited by a Digital Object Identifier (DOI), which appears

CAFÉS & RESTAURANTS

with the presentation at www.myESR.org/epos.

If you are looking for an ideal meeting point, or if you just want to take a short break, try one of the various foyer cafés and restaurants. They are situated throughout the whole congress venue and on all levels of the building, offering a variety of tasty hot and cold snacks. Please see the ‘coffee-cup’ signs on the Floor Plans on pages 40–48 of this programme to locate the various foyer cafés. CASE-BASED DIAGNOSIS TRAINING

Please refer to the E3 – Rising Stars Programme and see pages 99–104.

12

ECR 2016 | Final Programme

www.myESR.org

General Information

INFORMATION FROM A–Z CASES OF THE DAY

CLINICAL TRIALS IN RADIOLOGY

From Wednesday to Saturday, five Cases of the Day cover-

For the second time, at ECR 2016, Clinical Trials in Radiol-

ing different sections of radiology are shown on computer

ogy (CTiR) sessions are taking place. The CTiR sessions are

stations in the EPOS™ classroom on the 1 level. Participants

comprised of presentations on recent trials which are very

are invited to submit their diagnoses. The winners will be

likely to have an impact on clinical practice.

announced on the ESR website.

Session places are allocated on a first-come, first-served

We would like to acknowledge the contribution of the fol-

basis. Please refer to page 167 for the programme of the

lowing authors to the Cases of the Day:

sessions.

Wednesday:

CME ACCREDITATION SYSTEM

Case 1: M.-A. Weber; Germany

The ESR is happy to provide you with a fully digital CME

st

Case 2: S. Liddy, O. Buckley; Ireland Case 3: S. Hanquinet, M. Laurent; Switzerland Case 4: J. Avsenik, K. Surlan Popovič; Slovenia Case 5: V. Di Paola, R. Pozzi Mucelli; Italy Thursday: Case 1: G.M. Magnano, M.B. Damasio; Italy Case 2: G. Chassagnon, M.-P. Revel; France Case 3: Ž. Snoj, J. Regvat, V. Salapura; Slovenia Case 4: F. Iafrate, M. Santoni, C. Cavallini, S. Pontone; Italy

acquisition system for ECR 2016. Please note that we no longer provide printed CME stickers. Evaluation and CME acquisition will be possible via » The official ECR app, ECR 2016, available via the App Store (iOS) and Google play (Android) » More than 130 laptops in the ECR Online & EPOS Lounge located on the 1st level » The registration counters on the entrance level from Friday, March 4, 13:00 onwards

Case 5: E. Loney; United Kingdom

» The CME & evaluation terminals located on the 1st level

Friday:

Please note that evaluation of the sessions is only possible

Case 1: A. Alcalá-Galiano; Spain Case 2: L. Oleaga Zufiría; Spain Case 3: R. Woitek, T.H. Helbich, H. Ringl, C.J. Herold; Austria Case 4: I. Shrainer, I. Arkhipova, V. Sinitsyn, E. Zorin, N. Ermakov; Russian Federation Case 5: M. Claudon; France Saturday: Case 1: A.C. Tsili, G.V. Mouka, A.A. Ntorkou, D. Giannakis, S. Stavrou, M.I. Argyropoulou; Greece Case 2: J.A. Gonzalez-Nieto, J. Vizuete del Rio; Spain Case 3: J. Babar, S. Karia; United Kingdom Case 4: P. Martín, A. Ramos, E. Salvador; Spain Case 5: E. Vachev, G. Kirova, V. Traykov, E. Ruskova, B. Penev, G. Kuninski; Bulgaria CHURCHES AND RELIGIOUS COMMUNITIES IN VIENNA

Vienna is a multi-denominational, multi-cultural city. We will be pleased to provide you with information on local religious communities and places of worship at the Travel Service Desk.

March 2–7, 2016. CME credits will only be awarded if » You are logged into https://eval.webges.com/ecr2016 with your username (last name) and Personal ID (printed on your badge) » You have fully completed the electronic questionnaire for each session See pages 22–23. COAT CHECK

The coat check services are located on the entrance level, in Foyers E and F, as well as on the lower level next to Room D1. COMMUNICATION AREAS

If you are looking for the perfect place to meet and talk with friends or just to relax and browse through ECR Today, ECR 2016 offers areas perfectly equipped for communication and recreation; the ESR Welcome Lounge right in the middle of the entrance hall, and the Rising Stars & RTF Lounge on the lower level, which welcomes all students, residents and trainees.

www.myESR.org

Final Programme | ECR 2016

13

General Information

INFORMATION FROM A–Z CONFIRMATION OF PAYMENT AND ATTENDANCE

ECR 2016 SMARTPHONE APP

Congress-related confirmation will be available during and

The ECR 2016 App gives iPhone, iPad and Android users a

after the congress from the ESR website (www.myESR.org)

new way to experience the congress. The app is packed with

via the MyUserArea (login with your last name and your

features, including general congress information, scientific

Personal ID as printed on your badge).

and educational programme details, top news stories from ECR Today, full abstracts, and even floor plans of the Austria

CONGRESS LANGUAGE

Center. Please make sure you have Bluetooth enabled, as

English

the app supports iBeacons™ technology. You can download

CONGRESS VENUE

Austria Center Vienna Bruno Kreisky Platz 1 1220 Vienna, Austria Phone: (+43 1) 533 40 64–0 To reach the ACV by public transport from the city centre (Stephansplatz) take the U1 underground line (red line, direction Leopoldau). Get off at Kaisermühlen/Vienna International Centre and take the exit marked Donau-City-Straße. Travelling time: approximately eight minutes. ‘ECR ONLINE’ (PREVIOUSLY ‘ECR LIVE’)

After last year’s success, the ESR is once again providing a live streaming service for ECR 2016, under its new name ECR Online, in an effort to bring the ECR to everyone. All ECR sessions are being broadcast live via the ESR website, with Facebook and Twitter options integrated into the web interface to provide a fully interactive experience. ECR Online is kindly supported by Bayer HealthCare and GE Healthcare. Link: ecronline.myESR.org ECR ONLINE & EPOS™ LOUNGE

The ECR Online & EPOS™ Lounge has 130 computer terminals where delegates can watch ECR sessions either live or on demand. Enjoy the Lounge’s relaxing atmosphere while you catch up with the congress sessions. ECR TODAY

ECR Today, the popular daily newspaper of the congress, is published from Wednesday to Sunday and distributed in

the ECR 2016 App from iTunes/Google Play. EFOMP (European Federation of Organisations for Medical Physics) WORKSHOP

This workshop is the 18th in the series of EFOMP Workshops on new technology in diagnostic radiology. This year’s workshop is entitled ‘Radiation protection for the female patient and female medical staff’. It has been organised by EFOMP in collaboration with the ESR to address the current and future technological requirements for radiology imaging equipment (please refer to page 169). ‘EFRS MEETS’ SESSION

After the enormous success at previous ECRs, which reflected the good relations between the ESR and the European Federation of Radiographer Societies (EFRS), the EFRS is again hosting a dedicated session. ‘EFRS meets Sweden’ underlines the essential role of radiographers in medical imaging. Please refer to page 82 for the programme of the session. EIBIR BOOTH

Visit the EIBIR Booth in the entrance hall for the most recent news on the European Institute for Biomedical Imaging Research and to celebrate ten years of EIBIR. EMERGENCY INFORMATION/FIRST AID

For fire, medical or police assistance, please contact ACV Information or the nearest available ECR or ACV staff member. A medical specialist trained in emergency medicine will be present for the duration of the congress. See Red Cross sign on the Floor Plan page 41.

the entrance hall of the congress venue and in the entrance area of the Technical Exhibition. In addition, all issues are available online at www.myESR.org

14

ECR 2016 | Final Programme

www.myESR.org

General Information

INFORMATION FROM A–Z EPOS™ – SCIENTIFIC EXHIBITION

EUROPEAN EXCELLENCE IN EDUCATION (E3)

The ECR 2016 electronic scientific exhibition is open

The E3 programme emphasises the importance of lifelong

Wednesday to Saturday from 08:00 to 18:00, and Sunday

learning. It covers the entire range of educational issues,

from 08:00 to 15:30. EPOS™ can be accessed via the 130

from undergraduate medical education to subspecialised

workstations in the ECR Online & EPOS™ Lounge, which is

continuing professional development. For the second time

located on the 1st level.

at ECR 2016, the E3 programme is structured according to

Make sure to attend the new The Voice of EPOS sessions,

the different levels defined by the ESR European Training

where the authors of the best posters will present those in

Curriculum for Radiology.

moderated poster sessions.

The E3 programme consists of the following five branches,

See pages 28–29.

which reflect the different levels of education in radiology, as well as the different stages of an individual’s professional

‘ESR MEETS’ SESSIONS

career:

The purpose of ‘ESR meets’ is to forge closer ties between

Rising Stars Programme, European Diploma Prep Sessions,

the ESR and its guest societies. The guest nations of this year’s ECR are the Colombia, Japan and the Nordic Countries, as a tribute to the home of ECR Congress President Katrine Riklund from Sweden. There are dedicated sessions for the radiological communities of these nations to demonstrate the excellence of radiology in their countries. Places at these sessions are allocated on a first-come, firstserved basis. Please refer to pages 81–82 for the programme

The Beauty of Basic Knowledge, ECR Academies, ECR Master Classes. The Rising Stars Programme is designed especially for residents, students, radiographers and trainee radiographers. It consists of Basic Sessions, Student Sessions, Case-Based Diagnosis Training, and the Radiology Trainees Forum Programme including the RTF Highlighted Lectures and the

of the sessions.

RTF Quiz.

ESR WELCOME LOUNGE

The European Diploma Prep Sessions aim to prepare pro-

Visit the ESR Welcome Lounge in the entrance hall! Whether you are looking for an ideal meeting point or just want to take a short break – the ESR Welcome Lounge will suit your needs. Free wireless LAN is provided for your convenience. Watch out for artistic performances from the ‘ESR meets’ countries during the lunch breaks. EUROPEAN BOARD OF RADIOLOGY (EBR)

Visit the EBR Booth in the entrance hall to learn all about the European Diploma in Radiology (EDiR), how to apply, and where and when the next exams will take place. www.myEBR.org EUROPEAN DIPLOMA IN RADIOLOGY (EDIR)

spective candidates for the European Diploma in Radiology (EDiR). They are also suitable for residents who want an overview of the various topics relevant to imaging and for those preparing for their national board examinations. The content of the programme reflects Level I European Training Curriculum for Radiology (ETC) learning objectives across a two-year cycle. The sessions are held in close cooperation with the European Board of Radiology (EBR). Each of the six sessions is led by three lecturers and moderated by one chairman. The Beauty of Basic Knowledge programmes focus on knowledge essential to the daily practice of radiology. The format of these sessions reflects the tradition of conven-

An examination for the European Diploma in Radiology

tional teaching sessions, in which experienced teachers

is being held at ECR 2016. The electronic-based written

share their insights into a topic of particular relevance with

examination takes place on Tuesday, March 1, in the ECR

a group of attendees.

Online & EPOS™ Lounge on the 1st level, whereas the case-

Each Beauty of Basic Knowledge session consists of a

based oral examinations take place Wednesday, March 2 in

45-minute lecture or two 25-minute lectures held by one or

various rooms on the entrance level in the M Building (see

two speakers plus 10–15 minutes for discussion. The teaching

Floor Plan M Building on page 46).

format is usually case-based with some interaction with

Success in the examination certifies a standard of radi-

the attendees. The content of the sessions is mostly tied to

ological knowledge deemed appropriate by the ESR for

the Level I and Level II European Training Curriculum (ETC)

independent practise in general radiology.

learning objectives. The Beauty of Basic Knowledge sessions

www.myEBR.org

are suited to residents and board-certified radiologists who

www.myESR.org

Final Programme | ECR 2016

15

General Information

INFORMATION FROM A–Z want to refresh their knowledge in basic topics of imaging

EUROSAFE IMAGING

and image-guided therapy.

EuroSafe Imaging is the ESR’s latest initiative in radiation

The programmes will be concluded with a self-assessment

protection. It aims to promote the safe and appropriate

test, published on the platform ‘ESR Education on Demand’.

use of medical imaging in Europe and around the world.

ECR delegates can access the platform and the self-assess-

Please view the EuroSafe Imaging Poster Exhibition on a

ment tests through the work stations in the ECR Online & EPOS™ Lounge (1st level).

dedicated screen in the ECR Online & EPOS™ Lounge on the 1st level, with submissions from all over Europe. And

The ECR Academies consist of a series of four to six ses-

stop by the EuroSafe Imaging Booth in the entrance hall to learn all about this important initiative.

sions relevant to a particular area of radiology. This may be a classic organ-based field or a technically oriented area of another field related to radiology, such as management. Each ECR Academy spans several days, in which the different facets of the area in question are covered by experts in the field. An ECR Academy is a coherent course in which the different sessions complement one another in order to reflect the entirety of the field. The ECR Academies are particularly suited to general radiologists or radiologists with a subspecialisation. All programmes (apart from Interactive Teaching Sessions) will be concluded with a self-assessment test, published on the platform ‘ESR Education on Demand’. ECR delegates can access the platform and the self-assessment tests through the work stations in the ECR Online & EPOS™ Lounge (1st level).

EXPO HALLS & EXPO FOYER D

Opening hours: Thursday, March 3 to Saturday, March 5. . . . . . 10:00–17:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00 Visit the additional technical exhibition area on the 1st level of the congress venue: First Level (Gallery) Opening hours: Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00 Thursday, March 3 to Saturday, March 5. . . . . . 10:00–17:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . .

10:00–16:00

FREE PUBLICATIONS

The ESR again presents the ‘Free Publications’ Booth on the

The ECR Master Classes focus on continuous professional development and lifelong learning. The classes are designed for subspecialised radiologists seeking cutting-edge information in their particular fields of interest. They are held by experts in the field and reflect state-of-the-art knowledge,

1st level, integrated into the ECR Online & EPOS™ Lounge. Pick up free copies of radiology journals and magazines (see page 31). FUTURE MEETINGS DESK

as well as emerging trends.

This area – located in the ECR Online & EPOS™ Lounge on the

The ECR Master Classes are offered in cooperation with

1stlevel – offers you an overview of future meetings in the

each of the following subspecialty societies:

field of radiology and related disciplines, from all over the

CIRSE (one on vascular and one on interventional radiology),

world. Feel free to contribute flyers and posters to promote

ESCR, ESER, ESGAR, ESHNR, ESMOFIR, ESNR, ESOI, ESPR,

your own meetings and courses.

ESSR, ESTI, ESUR, EUSOBI. HEADLINE SESSIONS ‘EUROPEAN RADIOLOGY’

For details on the Honorary Lectures by Staffan Holmin,

European Radiology is Europe’s number one journal in gen-

Andrea G. Rockall and Valérie Vilgrain see page 25.

eral radiology. And it celebrates its 25 anniversary this year! th

See page 35.

‘INSIGHTS INTO IMAGING’

Insights into Imaging is the ESR’s online journal for educaEUROPEAN SCHOOL OF RADIOLOGY (ESOR) BOOTH

tion and guidelines. It is open access and PubMed indexed.

Visit the ESOR Booth in the entrance hall for the latest news

See page 35.

on the European School of Radiology. In addition, there is an ESOR Info Desk in the Rising Stars & RTF Lounge.

16

ECR 2016 | Final Programme

www.myESR.org

General Information

INFORMATION FROM A–Z INDUSTRY WORKSHOPS

MEETING ROOMS

At ECR 2016 there are various Industry Workshops sched-

Meeting rooms at ECR 2016 are to be found here:

uled, organised by Bayer HealthCare, Fujifilm Europe, GE Healthcare, Hologic, Mammotome and Toshiba Medical

In the Austria Center Vienna

Systems. Please note that Industry Workshops are no longer

1st level:

CME-accredited.

2nd level: Meeting Rooms 2.11, 2.12, 2.34, 2.41, 2.42, 2.44,

See separate booklet for details.

Meeting Rooms 1.85, 1.86 2.95

3 level: rd

Meeting Room 3.32

INTERACTIVE PROGRAMME PLANNER

The ESR is again proud to present this popular interactive tool for ECR 2016. The IPP provides a convenient way to explore and customise the congress programme online, in both traditional browser and mobile device versions.

In the adjoining M Building (only available from Wednesday, March 2, to Saturday, March 5) Entrance level: Meeting Rooms M6, M7, M8, M10, M21, M22, M23, M24, M25, M26, M27, M29, M30, M32,

Featuring various search and browse functions for sessions

M33, M34.

as well as posters, the IPP also includes a ‘basket’ option, which enables users to collate items from the programme to create their own personal calendar and even print a personalised Book of Abstracts. The IPP is integrated into the new platform ECR Online.

You will find them marked on the Floor Plans (see pages 40–48). Please contact the Info Service Desk at the entrance to

Link: ecronline.myESR.org

the M Building for onsite booking of meeting rooms; from

(JUNIOR) IMAGE INTERPRETATION QUIZ

Desk at the right end of the registration desks.

The Image Interpretation Quizzes are two traditional highlights of every ECR. This year’s themes are ‘Imaging with the Stars’ and ‘Millennials showdown: the next generation

Saturday onwards please contact the Meeting Room Service

MEMBERSHIP

For membership application and renewal, please go to the

of radiology’ (see page 27).

membership desk in the entrance hall.

LIABILITY

MINI COURSE

The ESR and the Austria Center Vienna are free from all

ECR 2016 features again the joint course of the ESR and

liabilities that may arise from the delegates’ and presenters’

RSNA (Radiological Society of North America), which will

participation in ECR 2016 and its activities.

this year focus again on ‘Emergency Radiology’.

LOST & FOUND

assessment.

Lost and found articles may be picked up or handed in at the ACV Information Desk located in the entrance area. MEDITATION & PRAYER ZONE

The Meditation & Prayer Zone is located on the lower level next to Room K. You will find it marked on the Floor Plan.

The sessions will be interactive with electronic voting/self Places for all courses are allocated on a first-come, firstserved basis. Please refer to pages 119–120 for the course’s programme. MIR @ ECR

After last year’s success, the ESR Subcommittee on Management in Radiology has again organised special sessions at the ECR on communication and improving quality and safety, taking place on Friday, March 4, 12:15– 17:30 in Room D2. See pages 169–171.

www.myESR.org

Final Programme | ECR 2016

17

General Information

INFORMATION FROM A–Z MULTIDISCIPLINARY SESSIONS

PREVIEW CENTRE

The concept of these sessions is to promote a multidisci-

Speakers are reminded to check in at the cSlide Preview

plinary approach to detection and treatment, integrating

Centre’s welcome desk at least three hours prior to their

radiologists and other clinicians to share their expertise.

scheduled presentation, even if they have already uploaded

The topics that are covered this year are: pancreatic cancer,

their presentation prior to the conference. Three speaker

uterine myomas and sports injuries.

registration workstations will be at the speakers’ disposal,

Please refer to pages 95–96 for the programme of the

and an additional workstation for last-minute changes and

sessions.

uploads is available. Onsite presentation upload procedure:

NEW HORIZONS SESSIONS

The aim of the New Horizons Sessions is to provide practitioners with an overview of the new developments in a specific area of practice e.g. specialty, technique, or disease. These developments may become routine within a few years, or may indicate a new direction for research and clinical application. There are three New Horizons Sessions at ECR 2016, entitled ‘New frontiers in imaging of vascular wall and plaque’, ‘Big data: why should radiologists care?’ and ‘Imaging beyond morphology’. Session places are allocated on a first-come, first-served basis. Please refer to pages 83–84 for the programme of the sessions. OPENING CEREMONY

The ECR 2016 Opening Ceremony will take place Wednesday, March 2, 17:45–19:00 in Room A. ESR Honorary Membership will be awarded to Ronald L. Arenson, Hassen A. Gharbi and Qiyong Guo. See page 10. PRESS

The ECR 2016 Opening Press Conference takes place on Wednesday, March 2, at 09:30 at the Austria Center Vienna, Room 1.85, 1st level. For press accreditation, please contact the Press Office & Business Centre on the entrance level. To obtain a press badge, you must present an international press ID or a confirmation letter from the relevant medium. Delegates and exhibitors may display their press kits in the Press Office & Business Centre. There are also several publicly available computer terminals as well as workspace and plug points for you to work with your personal laptop. Opening hours: Wednesday, March 2 to Sunday, March 6. . . . 08:00–18:00

» Check in at the cSlide Preview Centre Welcome Desk to receive your login details and the title of your presentation » Log into an available computer and upload your presentation » Presentations can be checked in presenter mode and edited onsite The Preview Centre is located on the 1st level, next to the ECR Online & EPOS™ Lounge. Opening hours: Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00 Wednesday, March 2 to Saturday, March 5. . . . 07:30–18:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00 Please note that only digital material will be accepted for oral presentations. Presenters may submit their presentation material, with their login details, prior to the congress. All material must be in English and be provided on CD-ROM, DVD or USB devices. All presentations will be transferred to the session rooms electronically. The material remains the property of the speakers. PROFESSIONAL CHALLENGES SESSIONS

These sessions are intended to communicate and exchange issues on radiological training and education, research networking, radiological management and professional developments. This year’s topics are ‘Personalised radiology: myth or reality?’, ‘Clinical decision support (CDS)’, ‘An introduction to European Imaging Biomarkers Alliance (EIBALL)’, ‘Biobanks meet imaging’, ‘Radiology ten years from now: where will it be?’, ‘Comprehensive cardiothoracic radiology: the way to go?’, ‘How to become the undergraduate teacher you always wanted to be’, ‘European variation in imaging: focus on technology’ and ‘Monitoring safety and quality’. Places are allocated on a first-come, first-served basis. Please refer to pages 91–93 for the sessions’ programme.

18

ECR 2016 | Final Programme

www.myESR.org

General Information

INFORMATION FROM A–Z PUBLIC TRANSPORT

REFRESHER COURSES

Tickets for public transportation are available online at

73 Refresher Courses have been organised by the various

shop.wienerlinien.at or at any underground station.

scientific subcommittees for ECR 2016. Based on the topic

Underground map; see page 37.

of the session, some refresher courses are presented in an ‘integrated’ format with an organised panel discussion,

PUBLISHERS ROW (1ST LEVEL) & PARTNER PUBLISHERS (ENTRANCE LEVEL)

similar to Special Focus Sessions.

Opening hours:

Please refer to pages 143–164 for the programme of the

Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00

sessions.

Places are allocated on a first-come, first-served basis.

Thursday, March 3 to Saturday, March 5. . . . . . 10:00–17:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–16:00

REGISTRATION OPENING HOURS

Browse through a wide range of scientific publications

Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00

displayed by the most important publishers in the field of medicine. RADIOLOGY TRAINEES FORUM (RTF)

The RTF promotes and coordinates the efforts of radiology

Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . 07:00–18:00 Thursday, March 3. . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00 Friday, March 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00 Saturday, March 5. . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00

trainees at a European level in order to improve the progress of radiology and related sciences. One of the RTF’s most

RESTAURANT RESERVATIONS

important goals is to provide an equal level of radiological

Our staff at the Dining & Shopping Desk in the entrance

knowledge and skills for radiology trainees all over Europe. Highlighted Lectures organised by the RTF will be given on Saturday, March 5, 10:30–12:00 in Room O (see page 159). The RTF General Assembly takes place on Thursday, March 3, 09:00–10:30, in Meeting Room 2.95 (1st level). For more detailed information please visit the RTF Meeting Point in the Rising Stars & RTF Lounge on the lower level. Don’t miss the Meet & Greet Sessions with ESR President Luis Donoso Bach (Thursday, March 3, 15:40–16:00) and ECR 2016 Congress President Katrine Riklund (Thursday, March 3, 16:00–16:20) in the Rising Stars & RTF Lounge. And join us at the RTF Quiz with Quizmaster José Cáceres on Thursday, March 3, 12:30–13:30 in Room Z. RECORDING / PHOTOGRAPHY

Video or audio recording of presentations is not allowed without the speaker’s/exhibitor’s and ECR’s prior permission. Flash photography is not permitted during presentations. Interviews must take place outside the lecture room. For queries, please contact the ESR Press Office.

hall will be pleased to recommend places to eat close to your hotel or near a certain theatre, and will be happy to reserve a table for you. RISING STARS LOUNGE / RESIDENTS & STUDENTS LOUNGE

The Rising Stars Lounge for residents and students is located on the lower level. In the lounge you will find information on the European School of Radiology, the European Diploma of Radiology and the Radiology Trainees Forum. Don’t miss the Meet & Greet Sessions with ESR President Luis Donoso Bach (Thursday, March 3, 15:40–16:00) and ECR 2016 Congress President Katrine Riklund (Thursday, March 3, 16:00–16:20). RISING STARS PROGRAMME

The E³ – Rising Stars Programme is part of the E³ – European Excellence in Education programme. See pages 99–104. SATELLITE SYMPOSIA

Industrial Satellite Symposia are presented by international companies. Please note that Satellite Symposia are no longer CME-accredited. Places are allocated on a first-come, firstserved basis. See separate booklet for details.

www.myESR.org

Final Programme | ECR 2016

19

General Information

INFORMATION FROM A–Z SCIENTIFIC PRESENTATION AWARDS

SOCIETY BOOTHS

The authors of the best scientific papers and scientific/

More than 50 national and international radiological soci-

educational exhibits will be presented with a certificate and

eties present their meetings and societies in the society

given free ECR 2017 registration.

booths area, which is located on the entrance level, next to

Scientific Papers: The award will be assigned to the best

the registration desks and the coat checks.

paper presentation of each topic based on the evaluation by session moderators and subcommittee members. Selection

SPECIAL ASSISTANCE

criteria comprise quality of presentation, scientific content

Delegates with special needs may park on the lower level

and overall impression of the performance. The award winners will be informed after the congress and will be published on the ESR website. Scientific/educational exhibits: See page 29 (Scientific Exhibition Awards). SCIENTIFIC SESSIONS

Accepted papers for oral presentation are presented in the Scientific Sessions. Places are allocated on a first-come, first-served basis. Please refer to pages 143–164 for the programme of the sessions.

with direct elevator access to the ACV. All lecture rooms are accessible by wheelchair. SPECIAL FOCUS SESSIONS

Special Focus Sessions deal with a topic at the cutting edge of development and clinical application. The topics of these sessions are presented so as to promote debate and to give an in-depth analysis. The chairman introduces each aspect of the topic and the panellists then discuss their different perspectives and opinions. The audience is also given the opportunity to discuss their ideas with the lecturers. Places are allocated on a first-come, first-served basis. Please refer to pages 87–90 for the programme of the sessions.

SECURITY / SAFETY

The safety of all congress attendees is of utmost importance

STATE OF THE ART SYMPOSIA

to the European Society of Radiology. The Austria Center

These sessions are intended to inform the audience about

Vienna and the ESR have taken security precautions to ensure the maximum possible safety for all ECR participants. Please inform our staff, especially our room attendants, immediately if security problems occur. The ESR reserves the right to check your identification upon admission to the congress centre and/or inside the building. You may be asked at any time to present adequate proof of identity by showing your passport, driver’s licence, national or military identification, or student ID, all with photograph and signature. SMOKING

Smoking is not permitted inside the Austria Center Vienna. The ECR is a non-smoking congress. Outside the building, we kindly ask you to use the ashtrays provided. Please note that smoking is prohibited in front of the main entrance. SOCIAL MEDIA

the ‘real state of the art’ of a given subject. Each of the lecturers is an expert on the topic as a whole or on some specific aspect of the topic, which will be the subject of the respective session. The presentations are followed by a discussion conducted by the panellists, led by the chairman. Places are allocated on a first-come, first-served basis. Please refer to page 85–86 for the programme of the sessions. STUDENTS’ SESSIONS

At ECR 2016, students have again the chance to present their own abstracts in front of a huge audience. The submitters of the best 32 abstracts have been invited to Vienna to present their work in dedicated sessions. See page 102–103. TAXI

There is a taxi stand outside the main entrance.

The official congress hashtag for Twitter and Instagram is #ECR2016.

20

ECR 2016 | Final Programme

www.myESR.org

General Information

INFORMATION FROM A–Z TECHNICAL EXHIBITION

Opening hours: Expo Halls & Expo Foyer D Thursday, March 3 to Saturday, March 5. . . . . . 10:00–17:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00 First Level (Gallery) Opening hours: Wednesday, March 2 . . . . . . . . . . . . . . . . . . . . . . . 14:00–17:00 Thursday, March 3 to Saturday, March 5. . . . . . 10:00–17:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–16:00 Detailed information on the Technical Exhibition can be found in the ‘Industry Programme & On-Show Guide’. TRAVEL SERVICE

The ESR and ECR are proud to offer their delegates services that should facilitate their travel arrangements and make their stay in Vienna as pleasant as possible. The ESR’s Travel Service Desk is located in the entrance hall of the Austria Center Vienna. Next to it you can find the ECR’s official travel agency Mondial. Opening hours: Tuesday, March 1. . . . . . . . . . . . . . . . . . . . . . . . . . . 12:00–18:00 Wednesday, March 2 to Saturday, March 5. . . . 07:30–18:00 Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–15:00 WIRELESS LAN

Free wireless LAN access is available throughout the congress venue and all lecture rooms. The name of the public WiFi is ‘ECR’.

www.myESR.org

Final Programme | ECR 2016

21

General Information

CME AT ECR 2016 GENERAL INFORMATION

CME ACQUISITION PROCEDURE

Each ECR delegate has access to confirmation of all activi-

The ESR is happy to provide you with a fully digital CME

ties attended (CME confirmation and record of attendance).

acquisition system for ECR 2016. Please note that we no

The event has been accredited by the UEMS/EACCME and

longer provide printed CME stickers. Not only will we save

it is possible to claim a maximum of 28 CME points for

tons of paper and become an even greener and more sus-

attendance of scientific sessions at the ECR. Please note

tainable meeting, but the system provides a lot more flex-

that this number may differ from the maximum number of

ibility to delegates in regard to evaluating sessions and

credits your national jurisdiction approves for your contin-

obtaining CME credits. At ECR 2016, you will have several

uous medical education.

opportunities to complete the electronic questionnaires for each session.

The Österreichische Ärztekammer (Austrian Medical Chamber) has granted a maximum of 40 DFP (Diplom-Fortbildungs-Programm der Österreichischen Akademie der Ärzte) credits for ECR 2016. USA

Evaluation and CME acquisition will be possible via » The official ECR app, ECR 2016, available via the App Store (iOS) and Google play (Android) » More than 130 laptops in the ECR Online & EPOS Lounge located on the first level

Following the agreement on the mutual recognition of credits between the AMA (American Medical Association) and the UEMS-EACCME, American physicians attending an event in Europe will have their credits converted to AMA PRA Category 1 in the USA.

» The registration counters on the entrance level from Friday, March 4, 13:00 onwards » The CME & Evaluation terminals located on the first level Please note that evaluation of the sessions is only possible March 2–7, 2016.

Worldwide CME points claimed at the ECR are accepted by the majority

CME credits will only be awarded if

of national CME authorities worldwide, which have manda-

» You are logged into https://eval.webges.com/ecr2016 with

tory CME for their physicians. Please consult your national jurisdiction for the maximum number of CME points they will approve following your attendance at ECR 2016.

your username and PID (printed on your badge) » You have fully completed the electronic questionnaire for each session The combined participation and evaluation questionnaire is of great value to the organising committee when selecting topics for future ECRs. Evaluation forms differ depending on the type of scientific event.

22

ECR 2016 | Final Programme

www.myESR.org

General Information

CME AT ECR 2016 GUIDANCE

CME CONFIRMATION

Confirmation of participation in the scientific programme

Every participant will be able to view and print their own

may be obtained as follows:

personal record of attendance via the internet in the MyUs-

Scientific Sessions 1. Attend the session. 2. Log in to https://eval.webges.com/ecr2016 or use the ECR 2016 app to evaluate the session. 3. Fill out this form completely during or after the session. If you do not have a smartphone, tablet or laptop with you, please visit one of the locations mentioned above and evaluate the session(s) you visited on one of the CME & Evaluation terminals there.

erArea on the condition that the above procedures have been carried out. This service will be available from two weeks after the congress via the MyUserArea on the ESR website (www.myESR.org). Please note that your Personal ID, which is printed on your badge, is required for login. The printout of your record should be submitted to your national jurisdiction (usually responsible for accreditation) for approval of your CME points. Please note that the

Scientific Exhibition

record of attendance will be issued only to the participant.

1. Enter EPOS™ (Electronic Presentation Online System) on

It will not be supplied to any accreditation agency or other

one of the 130 laptops in the ECR Online & EPOS™ Lounge and view posters. 2. Log in to https://eval.webges.com/ecr2016 or use the ECR 2016 app to evaluate the session. 3. Fill out this form completely after visiting the electronic scientific exhibition.

organisation. Although participants may partially attend multiple concurrent sessions, the total number of hours printed at the end of the list limits the credit to the equivalent of a single session during that time slot.

A maximum of 3 hours of attendance at the scientific

For further information, please contact ECR CME Support at

exhibition will be listed if the participant has completed

[email protected].

and submitted the online evaluation form.

www.myESR.org

Final Programme | ECR 2016

23

HEADLINE SESSIONS

24

OPENING CEREMONY Wednesday, March 2, 17:45–19:00, Room A Luis Donoso Bach; Barcelona/ES ESR President Katrine Riklund; Umeå/SE ECR 2016 Congress President Presentation of Honorary Membership Ronald L. Arenson; San Francisco, CA/US Hassen A. Gharbi; Tunis/TN Qiyong Guo; Shenyang/CN

WILHELM CONRAD RÖNTGEN HONORARY LECTURE (HL 1)

Imaging the invisible killer: towards personalisation of ovarian cancer care Thursday, March 3, 12:15–12:45, Room A Andrea G. Rockall; London/UK

JOSEF LISSNER HONORARY LECTURE (HL 2)

Liver imaging: where do we stand now? Friday, March 4, 12:15–12:45, Room A Valérie Vilgrain; Clichy/FR

SVEN-IVAR SELDINGER HONORARY LECTURE (HL 3)

Imaging and micronavigation: time to redraw the map? Saturday, March 5, 12:15–12:45, Room A Staffan Holmin; Stockholm/SE

IMAGE INTERPRETATION QUIZ Imaging with the stars

Friday, March 4, 14:00–15:30, Room A Moderator: A.G. Rockall; London/UK

JUNIOR IMAGE INTERPRETATION QUIZ

Millennials showdown: the next generation of radiology Saturday, March 5, 12:55–13:55, Room A Moderator: F. Arnberg; Stockholm/SE

25

General Information

10 YEARS OF EIBIR €63,000,000

research funding secured with EIBIR support

VISIT OUR BOOTH IN THE MAIN ENTRANCE HALL

www.eibir.org 26

ECR 2016 | Final Programme

www.myESR.org

General Information

(JUNIOR) IMAGE INTERPRETATION QUIZZES The Image Interpretation sessions, two traditional highlights of every ECR, provide both education and entertainment. Two panels of distinguished radiologists will share their knowledge and diagnosis strategies with you. The slogan for this year’s ‘senior’ quiz is ‘Imaging with the stars’. Radiologists will challenge each other in an enjoyable and exciting competition where they will face some tricky cases. In the ‘junior’ quiz, with its theme ‘Millennials showdown: the next generation of radiology’, the panellists will compete with each other in teams. While solving a variety of cases, the moderator will guarantee a scientifically challenging and entertaining session. Both quizzes will be interactive with the use of an electronic voting system via one’s own device (smartphone, tablet or laptop) at no costs.

4

March

Friday, March 4, 14:00–15:30, Room A Image Interpretation Quiz (IIQ) Imaging with the stars Moderator: A.G. Rockall; London/UK » Team 1: N. Grenier; Bordeaux/FR M. Vernooij; Rotterdam/NL M. Gardarsdottir; Reykjavik/IS S.A. Taylor; London/UK » Team 2: I. Thomassin-Naggara; Paris/FR H.R. Jäger; London/UK A.R. Larici; Rome/IT T.K. Helmberger; Munich/DE

5

March

Saturday, March 5, 12:55–13:55, Room A Junior Image Interpretation Quiz (JIIQ) Millennials showdown: the next generation of radiology Moderator: F. Arnberg; Stockholm/SE » Team 1: C. Toxopeus; Amsterdam/NL A. Gupta; London/UK » Team 2: F.G. Meinel; Munich/DE D. Penha; Lisbon/PT » Team 3: J.A. Prat-Matifoll; Barcelona/ES O. Urbán; Szeged/HU » Team 4: B. Fejér; Budapest/HU S. Belkacem; Monaco/MC

www.myESR.org

Final Programme | ECR 2016

27

General Information

EPOS™ – SCIENTIFIC EXHIBITION OPENING HOURS

WHAT’S AVAILABLE IN THE ECR ONLINE & EPOSTM LOUNGE?

Wednesday, March 2 to Saturday, March 5. . . 08:00–18:00

» Over 2,000 new scientific and educational exhibits and

Sunday, March 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 08:00–15:30

scientific paper presentations » The new feature ‘The Voice of EPOS’ with 350 oral poster presentations

The staff of the EPOS™ Service Desk will be glad to assist you during these times.

» Access to ECR Online and ECR on Demand » 20 new Cases-of-the-Day (five new cases each day) » eLearning including self assessment modules on ECR

LOCATION

2016 courses

ECR Online & EPOS™ Lounge, 1 level st

» EURORAD – Europe’s largest radiological case database

ESR THANKS ALL REVIEWERS

We cordially thank the members of the Scientific Exhibition Committee (see p. XX) and the EPOS™ Reviewers who reviewed abstracts and graded electronic posters in the past months, establishing the basis for presenting the awards.

(in alphabetical order) A Jose Acosta Batlle; Madrid/ES

C Cem Calli; Izmir/TR

Johannes Heverhagen; Bern/CH

Emel Ada; Izmir/TR

Davide Caramella; Pisa/IT

Jérome Hodel; Paris/FR

Helen C. Addley; Cambridge/UK

Nelson M.G. Caserta; Campinas/BR

Philip Hodnett; Dooradoyle/IE

Angel Alberich-Bayarri; Valencia/ES

Francesca Coppola; Bologna/IT I Anna Maria Ierardi; Marsala/IT

Efthymia Alexopoulou; Athens/GR Hatem Alkadhi; Zurich/CH

D John Damilakis; Iraklion/GR J Alan Jackson; Manchester/UK

Maria Chiara Ambrosetti; Verona/IT

Adelard I. B. De Backer; Ghent/BE

Takatoshi Aoki; Kitakyushu/JP

Pim De Graaf; Amsterdam/NL

Jarl A. Jakobsen; Oslo/NO

Paraskevi Argyropoulou;

Albert de Roos; Leiden/NL

Laura Jimenez-Juan; Toronto, ON/CA

Alexandroupolis/GR Irina Arkhipova; Moscow/RU

Savas Deftereos; Alexandroupolis/GR Stefan Delorme; Heidelberg/DE

Loukas G. Astrakas; Ioannina/GR B Mojisola Balogun; Birmingham/UK Nuria Bargalló Alabart; Barcelona/ES

K Nektarios Kalyvas; Athens/GR Aikaterini Kanavaki; Geneva/CH

E Olle Ekberg; Malmö/SE

Panagiotis Kapetas; Vienna/AT Georgios Kapsas; Alexandroupolis/GR

F Eduardo F.C. Fleury; Sao Paulo/BR

Ara Kassarjian; Majadahonda, Madrid/ES

Irene Bargellini; Pisa/IT

Anastasia Fotiadou; Huntingdon/UK

Caroline Keyzer; Brussels/BE

Antonio Barile; L’Aquila/IT

Ferdinand Frauscher; Innsbruck/AT

Daniela Kienzl-Palma; Vienna/AT

Tommaso V. Bartolotta; Palermo/IT

Susan Freeman; Cambridge/UK

Friedrich Knollmann; Sacramento, CA/US

Antonio Basile; Catania/IT Gorka Bastarrika; Toronto, ON/CA

Paraskevi Kosta; Ioannina/GR G Matthew T.G. Gaskarth; Cambridge/UK

Elmar Kotter; Freiburg/DE

Tobias Baumann; Freiburg/DE

Jonn-Terje Geitung; Norbyhagen/NO

Karl-Friedrich Kreitner; Mainz/DE

Radu Baz; Constanta/RO

Abraham Ghiatas; Ekali-Athens/GR

Miltiadis Krokidis; Cambridge/UK

Kunwar S.S. Bhatia; Hong Kong/CN

Anastasia Glantzouni; Ioannina/GR

Vasiliki Bizimi; Athens/GR

Sofia Gourtsoyianni; London/UK

Johan G. Blickman; Rochester, NY/US

Ali Guermazi; Boston, MA/US

Einat Blumfield; New York, NY/US Alessandro Bozzao; Rome/IT Florian M. Buck; Langnau am Albis/CH

28

Birgitta Hansson; Stockholm/SE

Fabrizio Calliada; Pavia/IT

ECR 2016 | Final Programme

L Andrea Laghi; Latina/IT Andrea Lakatos; Miskolc/HU Marc Lemmerling; Beervelde/BE

H Danisia Haba; Iasi/RO Andreas Hansch; Jena/DE

Eva Llopis; Alzira-Valencia/ES Roberto Llorens; Valencia/ES

www.myESR.org

General Information

EPOS™ – SCIENTIFIC EXHIBITION SCIENTIFIC EXHIBITION AWARDS

ATTENDANCE AND EVALUATION

A jury of European radiologists has judged all scientific and

Confirmation of participation in the Scientific Exhibition

educational exhibits with regard to their scientific content,

may be obtained as follows:

educational value, originality and visual impression. Taking

1. Enter EPOS™ (Electronic Presentation Online System) on

advantage of EPOS™, the rating was carried out online,

one of the 132 laptops in the ECR Online & EPOS™ Lounge

prior to the congress, enabling a detailed and considered assessment. On this basis, the Scientific Exhibition Commit-

and view posters. 2. Log in to https://eval.webges.com/ecr2016 or use the ECR

tee has awarded the best posters with Magna Cum Laude, Cum Laude and Certificate of Merits.

2016 app to evaluate the session. 3. Fill out this form completely after visiting the electronic

Awardees can pick up their certificates at the EPOS™ Service

scientific exhibition.

Desk. Each of the Magna Cum Laude awardees will also be granted free ECR 2017 registration. Awarded posters are flagged in EPOS™ and will be published on the ESR website and on myESR.org/epos

Elizabeth Loney; Darlington/UK

Tadeusz J. Popiela; Krakow/PL

Ioana Gabriela Lupescu; Bucharest/RO

Panos K. Prassopoulos; Alexandroupolis/GR

M Andreas Mahnken; Marburg/DE

T Denis Tack; Braine-L’Alleud/BE Adele Taibbi; Palermo/IT Stephen Taylor; Mons/BE

Lorenzo Preda; Milan/IT

Stuart A. Taylor; London/UK

Lorenzo Mannelli; New York, NY/US

Davide Prezzi; London/UK

Gail Thornbury; Belfast/UK

Celso Matos; Lisbon/PT

Stefan Puig; Vienna/AT

Michael Toepker; Vienna/AT

Josephine McHugo; Birmingham/UK Elena Mershina; Moscow/RU

Michael Torkzad; Milford/UK Q Emilio Quaia; Trieste/IT

Manabu Minami; Ibaraki/JP

R Christopher Riedl; New York, NY/US

Saeed Mirsadraee; Edinburgh/UK

Soraya Robinson; Vienna/AT

Penelope L. Moyle; Cambridge/UK

Janeth Romero; Boston, MA/US

Valdair F. Muglia; Ribeirao Preto/BR

Alejandro Rovira-Canellas; Barcelona/ES

N Stephanie Nougaret; St Clement

Ioannis A. Tsalafoutas; Athens/GR Dimitrios K. Tsetis; Iraklion/GR

Peter Mildenberger; Mainz/DE

Reinhard Rzanny; Jena/DE

de Riviere/FR

Athina Tsili; Ioannina/GR U Sara Upponi; Cambridge/UK V Edwin J. Van Beek; Edinburgh/UK Will J.M. van der Putten; Galway/IE Berit Verbist; Leiden/NL

S Roberto Sanz-Requena; Valencia/ES O Amaka Offiah; Sheffield/UK

Christoph Schaeffeler; Chur/CH

W Matthew G. Wallis; Cambridge/UK

Anastasia Oikonomou; Toronto, ON/CA

Martina Scharitzer; Vienna/AT

Dag Wormanns; Berlin/DE

Yumiko Oishi Tanaka; Tsukuba/JP

Karl Schürmann; Aachen/DE

Klaus Wörtler; Munich/DE

Mihaela Onu; Bucharest/RO

Teik Choon See; Cambridge/UK

Ximena Wortsman; Santiago/CL

Nisha Sharma; Leeds/UK

Petra Wunderlich; Radebeul/DE

P Leo Pallwein-Prettner; Linz/AT

Ashley Shaw; Cambridge/UK

Miguel Palm; Maastricht/NL

Martin J. Shelly; Dublin/IE

Valeria Panebianco; Rome/IT

Paul Sijens; Groningen/NL

Gerald Pärtan; Vienna/AT

Gustavo N. Simao; Ribeirao Preto/BR

Annie Paterson; Belfast/UK

Stephan Skornitzke; Heidelberg/DE

Luis J. Pina Insausti; Pamplona/ES

Wolfram Stiller; Heidelberg/DE

Katja Pinker-Domenig; Vienna/AT

Misa Sumi; Nagasaki/JP

www.myESR.org

X Vasilis Xydis; Ioannina/GR Z Giulia Zamboni; Verona/IT Anastasia Zikou; Ioannina/GR

Final Programme | ECR 2016

29

WATCH MORE THAN 1,500 LECTURES ONLINE LIVE OR ON DEMAND Plan and personalise your ECR 2016 experience with the Interactive Programme Planner Free live video and social media stream ONE PLATFORM FOR ALL ecronline.myESR.org

POWERED BY

General Information

GREEN MEETING

FREE PUBLICATIONS

Let’s keep our congress green

Broaden your horizons with Free Publications at ECR 2016

The ECR 2016 will be a green meeting designed to meet

The Free Publications initiative will run for the 10th consec-

environmental sustainability criteria set by the ‘Federal

utive year after attracting increasing levels of attention at

Ministry of Agriculture, Forestry, Environment and Water

ECR 2015. The Free Publications booth will be located on

Management’ (Austria’s national eco-friendly certificate).

the first level of the ACV within the Preview Area (next to the EPOS™ Lounge). The booth will be richly stocked

We encourage our employees, partners and customers to

with a galaxy of fascinating reading material from many of

adopt practices that promote awareness of environmental

our associated organisations and publishing houses from

conservation and sustainable use and we endeavour to

around the world, such as Globetech, Diagnostic Imaging

adhere to these principles throughout our entire enterprise.

and European Hospital.

Here are some ways you can contribute to our goal of

About 20 publishers will provide more than 30 different

becoming a green meeting:

titles for this initiative, ranging from copies of the ESR’s

» If possible, please choose an environmentally friendly form

flagship journals European Radiology and Insights into Imag-

of transport like public transport or car sharing

ing, to issues from as far afield as South America. It is a

» Please follow your hotel’s eco-friendly advice (e.g. chang-

rare chance to learn from so many diverse medical imaging

ing towels and bed sheets only when necessary) and

communities from around the globe, so we encourage you

please switch off all lights and electronic devices when

to make the very best of the opportunity.

leaving your hotel room » Please choose drinks served in glass, food served on reus-

We are of course grateful for the enthusiasm of our friends

able dishes and avoid cans, plastic bottles and products

in the publishing industry for making the Free Publications

in disposable packaging

initiative possible, and allowing us to provide ECR par-

» Please dispose of your waste (PET, glass, paper, residual waste, metal) by using the separate bins in your hotel and

ticipants with the chance to pick up some literature and broaden their medical imaging horizons.

at the congress venue. » Please use online registration and non-printed media instead of paper » Please return your badge to the info point after the con-

FREE PUBLICATIONS BOOTH:

1st level, within the ECR Online & EPOS™ Lounge.

gress has ended

We’re not saying it’ll be easy, but we know that it’ll be worth it. Thank you for your support!

www.myESR.org

Final Programme | ECR 2016

31

General Information

32

ECR 2016 | Final Programme

www.myESR.org

General Information

ECR 2016 WELCOMES ITS INDUSTRY PARTNERS The ESR welcomes its Supporting Members The ESR gives a warm welcome to all its existing and newly

The companies contribute with their active involvement

joined supporting membership companies.

to the success of the society and its congress with their

As the ECR puts a special focus on innovation and keeping

continuous support for the cause of radiology in Europe.

up to date with recent developments in the field, a close cooperation with the industry leaders is indispensable.

ESR Supporting Members:

4-STAR:

3-STAR:

Agfa HealthCare

HealthCare

Bayer HealthCare

Mindray TeraRecon

Bracco Carestream Health Esaote

2-STAR:

Fujifilm Europe

Alpinion Medical Systems

GE Healthcare

Paramed Medical Systems

Guerbet

Shimadzu Europa

Hitachi Medical Systems Europe

Swissray Medical

Philips

Varian Medical Systems

Samsung

Vinno Technology

Siemens Healthcare Toshiba Medical Systems Europe ‘ESR MEETS’ COUNTRIES

Each year the ECR places a special focus on its ‘ESR meets’ countries – in 2016 namely the Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Japan and Colombia – with particular emphasis on their scientific and technological developments. The ESR, industry companies and the national societies work closely together to highlight these countries.

Thank you for your involvement! www.myESR.org

Final Programme | ECR 2016

33

General Information

INFORMATION FROM A–Z

LET’S CELEBRATE YEARS OF

Top radiologists read more than just images www.european-radiology.org

34

ECR 2016 | Final Programme

www.myESR.org

General Information

JOURNALS EUROPEAN RADIOLOGY

INSIGHTS INTO IMAGING

European Radiology at your fingertips!

The clearest insights … for all to see!

Carry Europe’s leading radiology journal with you wherever

Insights into Imaging is the ESR journal for education and

you go – with the European Radiology App – download

strategies in radiology. Besides excellent review articles,

the app from iTunes or via the QR code below.

it publishes articles on professional issues, several official documents and political statements.

This year marks the 25th anniversary of European Radiology, the official journal of the ESR and official organ of numerous

Insights into Imaging is an Open Access journal on the

subspecialty organisations. It acts as a flagship, publishing

Springer­Open platform – therefore all articles published are

original scientific papers in the radiological field with an

freely available. As benefit for ESR members, ESR covers

Impact Factor of 4.014 for 2014.

the Article Processing Charges for all its active members!

Full access to the online version of European Radiology is

Links to the journals

included in the ESR membership fee.

www.european-radiology.org

ESR members can also arrange subscriptions for the printed

www.i3-journal.org

version at special rates in the MyUserArea (www.myESR. org/MyUserArea under ‘MyJournals’). Don’t miss another issue of the special cover illustrations (on all printed issues in 2016), and subscribe to the printed version now.

www.myESR.org

Final Programme | ECR 2016

35

www.myESR.org A

Park & Ride

Ticket Sales

Infopoints

Customer Service Centre (U3 Erdberg)

Vienna International Busterminal

Underground Line (U-Bahn) Commuter Train (S-Bahn) City Airport Train Urban Train (Lokalbahn)

ECR STOP: Kaisermühlen / Vienna Int. Centre

General Information

UNDERGROUND MAP

C V

Final Programme | ECR 2016

37

© Wiener Linien, August 2013

Floor Plans

– LEVEL BUILDING

FLOOR PLANS

www.myESR.org

Final Programme | ECR 2016

39

LOUNGE AREA

6+ 7

ECR 2016 | Final Programme re sto ok Bo

Austrian Airlines

EXPO X5

MAIN ENTRANCE

Info

ESR WELCOME LOUNGE

o xp - E nd W es a ’ MA rvic itors on Se hib trati Exegis R

C CH OA EC T K1

EXPO X4

5 1-

D AN E ICE TR FF EN S O SS C S E E PR USIN B

= CASH DISPENSER / ATM

10

44

= SOCIETY BOOTHS

8-

22 - 30

ESR MEETS

35

N IO AT TR GIS RE

E1

Room

Room

E2 21 12 -

CONGRESS OFFICE

Room

45 +4 6

RE GIS TR AT IO N

47 -

F2

F1

Room

MOBILE UNIT

uil din g

M10

M21 M22 M23

All Rooms on this level, with the exception of Room M1 and the EDiR Zone - are Meeting Rooms.

EDiR EXAMINATION AREA

M34 M33 M32

M24

M25

Reservations

M6

M29 M30

Restaurant

M1

M27

M8

M26

M7

INTERNET CORNER

M Building 0 - ENTRANCE LEVEL

Arts & Culture

Mondial

MB

Industry Workshop Room 0.93

TOSHIBA

Travel Service

50 +5 1

TO / FROM UNDERGROUND

49

Scanning Suite

PHILIPS AT 2 CO CK E CH

Ch ec k-i n

31 - 34

CM Ea sy

56

40 52 -

ACV 0 - ENTRANCE LEVEL Floor Plans

0 – ENTRANCE LEVEL ACV + M BUILDING

n k-i ec Ch

sy Ea CM

www.myESR.org

Floor Plans

0 – ENTRANCE LEVEL ACV

ACV 0 - ENTRANCE LEVEL

PHILIPS

CONGRESS OFFICE

Room

Room

56

F1

31 - 34

22 - 30

Room

E2

AT 2 CO CK E CH

Room

21

44

12 -

5

F2

35

1-

E1

52 -

C CH OA EC T K1

Scanning Suite

Industry Workshop Room 0.93

7

RE GI ST RA TIO N

10

o xp - E nd W es a ’ MA rvic itorsion Se hib trat Exegis R

n k-i ec Ch

D AN E ICE TR FF EN SO SC ES ES PR USIN B

sy Ea CM

ESR WELCOME LOUNGE

Info

Austrian Airlines

47 -

49

45 +4 6

CM Ea sy

re sto ok Bo

Ch ec k-i n

8-

50 +5 1

6+

ESR MEETS N TIO RA ST GI RE

TOSHIBA

MB

uil din g

Mondial Travel Service Arts & Culture

= SOCIETY BOOTHS

Restaurant

= CASH DISPENSER / ATM

Reservations

MAIN ENTRANCE

MOBILE UNIT

TO / FROM UNDERGROUND

EXPO X4

EXPO X5

LOUNGE AREA

www.myESR.org

Final Programme | ECR 2016

41

Floor Plans

1 – FIRST LEVEL ACV

ACV 1 - FIRST LEVEL

Meeting Room 1.85 EVALUATION & CME TERMINALS

BAYER

Meeting Room 1.86

Industry Workshop Room 1.61-62

Room

Room

O

N

EXPO GALLERY

MAMMOTOME Industry Workshop Room 1.98

Room

L8

Room

STUDIO 2016

HOLOGIC

PREVIEW CENTRE

Industry Workshop Room L7

ECR ONLINE & EPOSTM LOUNGE FREE PUBLICATIONS & FUTURE MEETINGS

42

ECR 2016 | Final Programme

EPOSTM ARENA

www.myESR.org

Floor Plans

ACV 2 - SECOND LEVEL

OERG Lounge

2 – SECOND LEVEL ACV

ESGAR Lounge

ESUR

E ON TZ AS DC OA BR

BR OA DC AS TZ ON E

2.83

Room

Room

C

B

Meeting Room 2.44

Meeting Room 2.95

Room

2.96

A

Rooms 2.41 + 2.42

2.97 2.98

Meeting Room 2.34 Meeting Room 2.11

Meeting Room 2.12 2.13 2.14

Room

Z

RESTAURANT

www.myESR.org

2.17

Final Programme | ECR 2016

43

Floor Plans

3 – THIRD LEVEL ACV

ACV 3 - THIRD LEVEL

OF FIC ES 3.4 3– 3.6 6

7 3.9 7– 3.7 ES FIC OF

PRESIDENTS’ OFFICE

OF FIC ES

3.1 2– 3.1 5

ES FIC 4 OF +3.3 3 3.3

Meeting Room 3.32 Past Presidents Circle

44

ECR 2016 | Final Programme

www.myESR.org

Floor Plans

-2 – LOWER LEVEL ACV

ACV -2 - LOWER LEVEL

MEDITATION & PRAYER ZONE

HOLOGIC

Industry Workshop Room -2.83 / -2.84

FUJIFILM

GE

Industry Workshop Room -2.61-62

Room

Room

G

K

CO AT CH EC K

CKK 3 CHEEC H

T C COTA A

CO

T AS DC OA E BR ZON

RE ST AU RA NT

Industry Workshop Room -2.85 / -2.86

RISING STARS & RTF LOUNGE

4

Room

D1

EX TO PO X1

Room

D2 EXPO FOYER D

VIRTUAL SKYDIVE

TO EXPO X1 - X3

EXPO X1 EXPO X2 EXPO X3

www.myESR.org

Final Programme | ECR 2016

45

Floor Plans

0 – ENTRANCE LEVEL M BUILDING

M Building 0 - ENTRANCE LEVEL

INTERNET CORNER

AC V

EN TR A LE NCE VE L

M7

M8

M1

M29 M30 M27 M26 M25 M24

M6 M34 M33 M32

M21 M22 M23

M10

EDiR EXAMINATION AREA All Rooms on this level, with the exception of Room M1 and the EDiR Zone - are Meeting Rooms.

46

ECR 2016 | Final Programme

www.myESR.org

Floor Plans

1 – FIRST LEVEL M BUILDING

BROADCAST ZONE

M Building 1 - FIRST LEVEL

M2 M4 M3

www.myESR.org

Final Programme | ECR 2016

47

Floor Plans

2 – SECOND LEVEL M BUILDING

BROADCAST ZONE

M Building 2 - SECOND LEVEL

M5

48

ECR 2016 | Final Programme

www.myESR.org

General Information

INFORMATION FROM A–Z

ESR DIGNITARIES

www.myESR.org

Final Programme | ECR 2016

49

ESR Dignitaries

HONORARY MEMBERS

Ronald L. Arenson San Francisco, CA/US Honorary Member

His research interest is informatics in radiology. He has also patented new techniques in interventional radiology. One of his achievements was the development of a catheter that can be steered in a magnetic field, enabling interventionists to reach further into smaller blood vessels. In 2001, he and fellow researchers filed a patent on the invention, which was selected for presentation at a national fair on technology. Although he now dedicates most of his time to being an administrator and mentor, he is still involved in the development of novel information system applications. Prof. Arenson has authored or co-authored more than 110 peer-reviewed scientific articles, four book chapters, three books and numerous exhibits, abstracts and editorials. He has also served on the editorial boards of several journals, including

In recognition of his pioneering work in radiology and commitment to the advancement of medical imaging, Professor Ronald L. Arenson from San Francisco, United States, will be awarded Honorary Membership of the European Society of Radiology at ECR 2016.

Radiology and Journal of the American College of Radiology. He has served on several committees of numerous medical societies and organisations, such as the American College of Medical Informatics (ACMI), the Association of University Radiologists (AUR), the Academy of Radiology Research (ARR) and the American College of Radiology (ACR). He was also a founding member of the Radiology Information System Consortium, now the Society for Imaging Informatics in Medicine (SIIM).

Ronald L. Arenson is the Alexander R. Margulis Distinguished Professor and chair of the department of radiology and bio-

Prof. Arenson holds fellowships in the ACR, ACMI and SIIM, and is

medical imaging at the University of California, San Francisco,

past-president of the AUR, ARR and the Society of Chairmen of

where he has worked since 1992. He is the immediate past

Academic Radiology Departments (SCARD). In addition he has

president of the Radiological Society of North America (RSNA).

served on the United States’ National Advisory Council of the National Institute of Biomedical Imaging and Bioengineering of

Prof. Arenson received his medical degree in 1970 from New York

the National Institutes of Health, and the NIH Council of Councils.

Medical College in New York and completed his diagnostic radi-

Prof. Arenson has received numerous honours throughout his

ology residency at Massachusetts General Hospital in Boston.

long career, including the Alumni Medal of Honor from New York Medical College in 2001 and a gold medal from AUR in 2013.

He began his academic career in 1976 at the University of Pennsylvania, where he successively became associate chair-

At ECR 2016, he will receive Honorary Membership of the

man of clinical services in radiology, director of administrative

European Society of Radiology.

services, and interim vice provost for information systems and computing for the campus.

50

ECR 2016 | Final Programme

www.myESR.org

ESR Dignitaries

HONORARY MEMBERS

Hassen A. Gharbi Tunis/TN Honorary Member

Hassen A. Gharbi is a professor of radiology and medical biophysics from Tunis, Tunisia. He was head of the department of radiology at Tunis Children’s Hospital and head of the medical biophysics department at Tunis Medical School. He is the immediate past president of the World Federation for Ultrasound in Medicine and Biology (WFUMB) and the African Society of Radiology (ASR). He obtained his medical degree in 1966 from Paris Medical School, where he subsequently specialised in radiology, aeronautic medicine, medical informatics and medical biophysics. He completed a PhD in optic physiology at the Orsay Science Faculty in Paris, and two decades later graduated in Management of Radiation Accidents from Oak Ridge Associated Universities, Tennessee, USA. Prof. Gharbi worked as an assistant professor at the biophysics department of Paris Medical School between 1966 and 1970, before being appointed vice dean of Tunis Medical School in 1971. In 1970 he created the first paediatric radiology department in North Africa at Tunis Children’s Hospital, which he later headed. Prof. Gharbi is the founder and the first president of the Mediterranean and African Society of Ultrasound (MASU) and also

In recognition of his contribution to the development of paediatric radiology in Africa and his dedication to strengthening ties between African and European radiologists, Professor Hassen A. Gharbi from Tunis, Tunisia, will be awarded Honorary Membership of the European Society of Radiology at ECR 2016.

founded the Tunisian National Centre of Radiation Protection, serving as its director between 1971 and 1989. classification of the hydatid cyst appearance published in RadiBetween 1975 and 1985 he was president of the Radiological

ology in 1981 is still used around the world.

Tunisian Commission of the Ministry of Public Health, to which he also acted as adviser on radiology, paediatric radiology, bio-

He has authored or co-authored more than 20 books on pae-

medical engineering, radiation protection, training and hospital

diatric radiology, and tropical and infectious diseases (hydatid

equipment planning.

diseases), and has published more than 130 articles in national

He has served the World Health Organization as an expert in

and international journals. He also sits on the editorial boards

radiology, radioprotection and paediatric radiology since 1993.

of several international journals.

Prof. Gharbi is retired but is still involved in several teaching

Prof. Gharbi has received many awards recognising his contri-

programmes, mainly to promote the good use of ultrasound

butions to the promotion of radiology in developing countries,

in developing countries around the world.

mainly in Africa.

His other main interest was imaging of hydatid diseases and

At ECR 2016, he will receive Honorary Membership of the

the study of their epidemiology and treatment. His ultrasound

European Society of Radiology.

www.myESR.org

Final Programme | ECR 2016

51

ESR Dignitaries

HONORARY MEMBERS

Qiyong Guo

Shenyang/CN Honorary Member His research interests relate to abdominal imaging, especially of the liver and biliary tract. He is also an interventional radiologist, with particular interests in non-vascular interventional radiology and tumour diagnosis and treatment, and has published more than 150 papers. His main activities are hospital management, diagnostic imaging consultancy, and guidance for graduate and PHD students. He has mentored more than 100 graduate students and PhD doctors. Prof. Guo is chief editor of the China Clinical Medical Imaging Journal and Contemporary Hospital Management. He is also in charge of more than ten projects at all levels of academic research, including national natural science funds. He is chief editor of three specialised textbooks including Interventional

In recognition of his contributions to the advancement of abdominal imaging and his efforts in strengthening ties between Asian and European radiologists, Professor Qiyong Guo from Shenyang, China, will be awarded Honorary Membership of the European Society of Radiology at ECR 2016.

Radiology and chief editor of several specialised monographs such as Practical Radiology. He is president of the Chinese Association of Radiologists and chairman of medical imaging for the China Hospitals Association. He is also an executive member of the Asian Oceanian Society of Radiology (AOSR), and a former president of the Chinese Society of Radiology and the Asian Society of Abdominal Radiology (ASAR). In recognition of his work, he has been awarded numerous dis-

Qiyong Guo is a professor of radiology and chairman of the

tinctions throughout his career, including honorary membership

radiology department at Shengjing Hospital, China Medical

of the Russian Society of Radiology in 2009, the Japan Society

University (CMU). He is also president of Shengjing Hospital,

of Radiology in 2011 and the German Society of Radiology in

vice president of CMU, and dean of the radiology faculty.

2013. Last but not least, he received the Gold Medal of ASAR in 2015.

Prof. Guo graduated from CMU in 1983 and started working as a radiologist in Shengjing Hospital. He finished his medical studies

At ECR 2016, Prof. Guo will receive Honorary Membership of

in Japan, at Nara Medical University, where he specialised in

the European Society of Radiology.

abdominal imaging and interventional radiology and majored in liver research between 1988 and 1993. In 1993 he returned to Shengjing Hospital, where he took on his current positions.

52

ECR 2016 | Final Programme

www.myESR.org

ESR Dignitaries

GOLD MEDALLISTS

Gabriel P. Krestin Rotterdam/NL Gold Medallist

Gabriel P. Krestin is full professor of radiology and chairman of the Department of Radiology and Nuclear Medicine at Erasmus MC, University Medical Centre Rotterdam, the Netherlands. He graduated in medicine from the University of Cologne in Germany, where he completed his residency in radiology in 1988. After undertaking fellowship training in abdominal imaging and MRI, Prof. Krestin completed a PhD on experimental and clinical applications of fast gradient-echo MR imaging in the abdomen, in 1990, at the same university. He was subsequently appointed as a radiologist and head of the MRI centre at Zürich University Hospital, Switzerland, where he later became associate professor of radiology and head of the clinical radiology service. He also served as acting chairman of the diagnostic radiology department before he moved into his present position in the Netherlands. He was a permanent visiting professor at Stanford University Medical School from 1998 to 2009, and the Couch-Kerley Traveling Professor to the Royal College of Radiologists in the UK. Prof. Krestin has authored more than 390 original articles and 90 book chapters, and is the editor of seven books, some of which

In recognition of his pioneering work in abdominal and molecular imaging, and his commitment to the development and harmonisation of radiology in Europe, Professor Gabriel P. Krestin from Rotterdam, the Netherlands, will be awarded the Gold Medal of the European Society of Radiology at ECR 2016.

have been translated into several languages. His main areas of research are imaging of abdominal organs and cardio-vascular diseases, molecular imaging and population imaging. His research has been supported by numerous grants from Euro-

Prof. Krestin currently serves on the editorial and advisory

pean and national research organisations, charities and industry.

boards of several international journals including MagMa, Investigative Radiology, and Abdominal Radiology, and has been a

Prof. Krestin has extensive experience in leadership, manage-

member of the editorial boards of Radiology and European

ment and strategic planning. He is the founder of Management

Radiology.

in Radiology (MIR) and founder and current Scientific Director of the European Institute for Biomedical Imaging Research

He has been awarded many distinctions for his work, including

(EIBIR). He is also a member of numerous scientific advisory

the Albers Schönberg Medal of the German Society of Radiol-

boards for companies, European organisations, and universities.

ogy and the Schinz Medal of the Swiss Society of Radiology. Furthermore he has been awarded honorary membership of

Prof. Krestin recently served as president of the ESR and of the

numerous national radiology societies and of the ESMRMB.

International Society for Strategic Studies in Radiology. He is also the past president of the European Society for Magnetic

At ECR 2016, he will receive the Gold Medal of the European

Resonance in Medicine and Biology.

Society of Radiology.

www.myESR.org

Final Programme | ECR 2016

53

ESR Dignitaries

GOLD MEDALLISTS

Claude Manelfe Toulouse/FR Gold Medallist

Prof. Manelfe is a founding member, former president and secretary general of the French Society of Neuroradiology, as well as a former president of the European Society of Neuroradiology (1998 to 2000). He also served as Secretary General and President of the International Society of Radiology from 2002 to 2008. He was a visiting professor at the University of California, San Francisco in 1981–1982, and at the University of British Columbia, Vancouver in 1982. He has published more than 235 publications in neurology, neurosurgery, neuroradiology, and diagnostic and interventional neuroradiology. Seventy of his articles have been devoted to MR, mainly to the field of neuroimaging. He also served as Editor in Chief of Neuroradiology from 1993 to 2004.

In recognition of his service to the discipline, French neuroradiologist Professor Claude Manelfe from Toulouse, France, will be awarded the Gold Medal of the European Society of Radiology at ECR 2016.

He retired from his activities eight years ago but is still working part time in a general hospital. Prof. Manelfe has been awarded many distinctions over his long career, including the Gold Medal of Toulouse Faculty of Medicine and the scientific prize of the European Society of Neuroradiology for his medical thesis on vascular supply of the

Claude Manelfe is professor emeritus at Paul Sabatier University

human spinal dura mater. He was also laureate of the Medical

in Toulouse, France. He was professor and chairman of diag-

Research Foundation for his work on therapeutic endovascular

nostic radiology at Paul Sabatier University for thirty years,

occlusions. His achievements have been recognised with various

and head of the diagnostic and therapeutic neuroradiology

honours, including the Schinz medal of the Swiss Society of

department at Purpan University Hospital in Toulouse.

Radiology, fellowship of the American College of Radiology, and honorary membership of the American Society of Neuro-

In 1969, Prof. Manelfe received his medical degree from Toulouse

radiology, the Radiological Society of North America, and the

University, where he subsequently completed fellowships in

European Society of Neuroradiology.

neurology and radiology, and a specialisation in neuropsychiatry. At ECR 2016, he will receive the Gold Medal of the European His main interests were interventional neuroradiology and end-

Society of Radiology.

ovascular occlusions at the beginning of the 1970s, and MRI and imaging of the spine and spinal cord later.

54

ECR 2016 | Final Programme

www.myESR.org

ESR Dignitaries

GOLD MEDALLISTS

Peter Vock Bern/CH Gold Medallist

Peter Vock is professor emeritus at the University of Bern and senior consultant radiologist at Bern University Hospital (Inselspital) in Bern, Switzerland. He chaired the Institute of Radiology of Bern University from 1989 to 2012. In 1973 he obtained his medical degree from the University of Bern, and subsequently did a residency in radiation oncology, radiology and nuclear medicine at Inselspital, where he started working as a radiologist after his board certification in 1980. Before that, he also completed a residency in internal medicine at Tiefenauspital in Bern. Between 1982 and 1983, he was a visiting research associate in chest imaging at the department of radiology, Duke University Medical Center, Durham, NC, USA. Prof. Vock’s research interests focus on chest imaging, CT and particularly radiation protection. He has dedicated much of his work to radiation protection on an institutional, professional, national and international level, serving as a member of the Swiss Federal Commission of Radiation Protection for more than twelve years and chairing the commission’s medical subcommittee for six years. He was also responsible for radiation protection within the Swiss Society of Radiology and currently serves as

In recognition of his lifelong commitment to the field of radiology, Professor Peter Vock from Bern, Switzerland, will be awarded the Gold Medal of the European Society of Radiology (ESR) at ECR 2016.

chairman of the ESR’s Radiation Protection Subcommittee. Prof. Vock has also represented the ESR in different radiation protection projects, such as the European Medical ALARA Network (EMAN), Medical Radiation Protection Education and Training (MEDRAPET) and European Diagnostic Reference Levels for Paediatric Imaging (PiDRL). Prof. Vock is Deputy Editor of European Radiology and a member of the Steering Committee of the EuroSafe Imaging campaign. He has been attending the ECR ever since its creation in the early 1990s. At ECR 2016, Prof. Vock will receive the Gold Medal of the European Society of Radiology.

www.myESR.org

Final Programme | ECR 2016

55

ESR Dignitaries

HONORARY LECTURERS

Staffan Holmin Stockholm/SE Honorary Lecturer

Prof. Holmin leads the research group in neuroradiology at Karolinska Institutet, working on clinical and experimental projects in stroke management and endovascular technique development, and is responsible for the imaging research facilities in the planning of the new Karolinska Hospital. After graduating with a medical degree from Karolinska Institutet in 1995, Prof. Holmin obtained his doctoral degree in 1997 and his physician certification from the same institution in 1999. In 2006 he did a post-doc and fellowship training at Bicêtre Hospital in Paris, France, under the supervision of Professor Pierre Lasjaunias. In 2005 he passed the Swedish and European specialist neurosurgery examinations and two years later the Swedish specialist neuroradiology examination.

In recognition of his significant expertise in the field of neurointervention and his great achievements in research, Professor Staffan Holmin from Stockholm, Sweden, has been invited to give the Sven-Ivar Seldinger Honorary Lecture ‘Imaging and micronavigation – time to redraw the map?’ at ECR 2016.

Prof. Holmin is the main inventor of an endovascular device for transvasal passage (Extroducer), a project he developed together with Karolinska Institutet Innovations AB between 2008 and 2014. The project resulted in granted patents in USA, Japan and Europe. He has been responsible for human and animal imaging facilities in the research building of the New Karolinska Hospital since March 2013. He is the Karolinska Institutet’s representative for neuroradiology in the preparation for the New Karolinska Hospi-

Staffan Holmin is the Söderberg professor of clinical neuroim-

tal. He is the principal investigator and co-principal investigator

aging at Karolinska Institutet. He is also a consultant in end-

for a number of different national and international research

ovascular neurointervention and vice chairman of the neu-

projects, and is currently developing additional new applications

roradiology department at Karolinska University Hospital in

for endovascular techniques.

Stockholm, Sweden. At ECR 2016, Prof. Holmin will present the Sven-Ivar Seldinger Honorary Lecture, titled ‘Imaging and micronavigation – time to redraw the map?’

56

ECR 2016 | Final Programme

www.myESR.org

ESR Dignitaries

HONORARY LECTURERS

Andrea G. Rockall London/UK Honorary Lecturer

Andrea G. Rockall is Consultant Radiologist at the Royal Marsden Hospital and Visiting Professor of Radiology at Imperial College London, UK. She graduated in neuroanatomy at King’s College London in 1987 and received her medical degree from King’s College Hospital Medical School in 1990. She was awarded the Royal College of Radiologists’ (RCR) Rohan Williams Medal, the gold medal award for the FRCR examination, in 1997. She chose radiology as a career because of the central role imaging plays in the diagnostic pathway. After completing her training in internal medicine, she started working as a registrar in radiology at St. Mary’s Hospital and then as a senior registrar in radiology at University College London Hospitals. In 2000, she was appointed Senior Lecturer and Consultant Radiologist at St. Bartholomew’s Hospital London, a position she held for twelve years. During that time, she was appointed Honorary Professor of Cancer Imaging at Bart’s Cancer Institute, Queen Mary University London, before taking up her current position. Prof. Rockall is currently chief investigator on three national multi-centre studies: the MAPPING study, which is evaluating diffusion weighted imaging, FDG and F-ethyl-choline PET/CT in nodal staging in cervix and endometrial cancer (funded by Cancer Research

In recognition of her major contributions to oncologic radiology and her dedication to the advancement of the field in Europe and beyond, Professor Andrea G. Rockall from London, United Kingdom, has been invited to give the Wilhelm Conrad Röntgen Honorary Lecture ‘Imaging the invisible killer: towards personalisation of ovarian cancer care’.

UK); the MALIBO study, which is developing machine learning in whole body MRI for detection of metastatic disease (funded by National Institute for Health Research – NIHR); and the MROC study,

In addition, she serves on several committees, including the

which is evaluating multi-parametric MRI in determining treatment

European Society of Gynaecologic Oncology’s quality standards

planning and staging of ovarian cancer (also funded by NIHR).

in ovarian cancer surgery committee, the RSNA Programme Committee and the ACR O-RADS steering committee. She has

Prof. Rockall has authored or co-authored more than 100 pub-

also served as Chair of the ESR Statutes and Rules Subcommit-

lications in peer-reviewed journals, three books and numerous

tee and as a member of the ESR Membership Subcommittee.

book chapters. Prof. Rockall has received many distinctions for her work, includShe was president of the International Cancer Imaging Society

ing the Outstanding Teacher Award from the International

for 2015 and is a council member of the British Gynaecologic

Society for Magnetic Resonance in Medicine in 2014.

Cancer Society. She is also currently a member of the RCR Steering Group for Cancer Imaging and Reporting, and she

At ECR 2016, Prof. Rockall will present the Wilhelm Conrad

chairs the Female Pelvic Imaging Working Group for the Euro-

Röntgen Honorary Lecture, titled ‘Imaging the invisible killer:

pean Society of Urogenital Radiology.

towards personalisation of ovarian cancer care’.

www.myESR.org

Final Programme | ECR 2016

57

ESR Dignitaries

HONORARY LECTURERS

Valérie Vilgrain Clichy/FR Honorary Lecturer

University Hospital, an institution well known for its expertise and outstanding clinicians in abdominal diseases. She subspecialised in the gastrointestinal tract, with a special focus on liver, biliary and pancreatic diseases, an area that still fascinates her to this day. Her major research interests are diagnostic and interventional imaging of the liver, pancreas and bile ducts, focusing on multidetector CT, MRI, contrast-enhanced ultrasound and functional imaging. In addition, Prof. Vilgrain is involved in several on-going research projects, and she is the principal investigator of the SARAH trial, which aims to compare SorAfenib, the reference treatment of advanced hepatocellular carcinoma (HCC), against radioembolisation. She is also involved in a combined academic/company

In recognition of her contribution to abdominal imaging and commitment to the advancement of radiology, Professor Valérie Vilgrain from Clichy, France, has been invited to give the Josef Lissner Honorary Lecture, titled ‘Liver imaging: where do we stand now?’ at ECR 2016.

project on HCC, which aims to develop imaging solutions for better patient management. She has authored or co-authored 332 articles original articles, mainly on abdominal imaging, and co-edited 30 books on abdominal imaging. Prof. Vilgrain holds membership of many societies, including the European Society of Radiology (ESR), the Radiological Society of North America (RSNA) and the European Society

Valérie Vilgrain is chair of the radiology department at Beaujon

of Gastrointestinal and Abdominal Radiology (ESGAR).

University Hospital in Clichy and full professor of radiology at Paris Diderot University – Paris 7, France.

She has served as vice-chairperson of the French Radiological Society and chairperson of the Education Programme Com-

She obtained her medical degree from René Descartes Univer-

mittee for the society’s annual meeting. She serves on several

sity in Paris in 1985. She then did a residency in internal medicine,

committees for the European Congress of Radiology and chairs

neurology and radiology at Paris University.

the RSNA Regional Committee for Europe.

Prof. Vilgrain chose to subspecialise in chest and abdominal

At ECR 2016, Prof. Vilgrain will present the Josef Lissner Hon-

diseases, and completed a fellowship in radiology at Beaujon

orary Lecture, titled ‘Liver imaging: where do we stand now?’

58

ECR 2016 | Final Programme

www.myESR.org

COMMITTEES

www.myESR.org

Final Programme | ECR 2016

59

General Information

ESR EXECUTIVE COUNCIL BOARD OF DIRECTORS President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Luis Donoso Bach; Barcelona/ES 1st Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Paul M. Parizel; Antwerp/BE 2nd Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bernd Hamm; Berlin/DE Past President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lorenzo Bonomo; Rome/IT

COMMITTEE CHAIRS Communication and External Affairs Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Boris Brkljačić; Zagreb/HR ECR 2016 Congress Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Katrine Riklund; Umeå/SE ECR 2017 Programme Planning Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Paul M. Parizel; Antwerp/BE Education Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Laura Oleaga; Barcelona/ES Finance and Internal Affairs Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Michael Fuchsjäger; Graz/AT National Societies Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deniz Akata; Ankara/TR Publications Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lorenzo E. Derchi; Genoa/IT Quality; Safety and Standards Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Jane Adam; London/UK Research Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hans-Ulrich Kauczor; Heidelberg/DE Subspecialties and Allied Sciences Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Catherine M. Owens; London/UK

NON-VOTING Director of the European School of Radiology (ESOR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nicholas Gourtsoyiannis; Athens/GR Executive Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Peter Baierl; Vienna/AT

60

ECR 2016 | Final Programme

www.myESR.org

ECR 2016 Committees

CONGRESS COMMITTEE Chairperson (Congress President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Riklund; Umeå/SE ESR President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Donoso Bach; Barcelona/ES ESR 1st Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.M. Parizel; Antwerp/BE ESR Executive Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Baierl; Vienna/AT Chairperson of the Finance and Internal Affairs Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.H. Fuchsjäger; Graz/AT Chairperson of the Publications Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.E. Derchi; Genoa/IT

PROGRAMME PLANNING COMMITTEE POSTGRADUATE EDUCATIONAL PROGRAMME

E³ – RISING STARS PROGRAMME

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . H.-U. Kauczor; Heidelberg/DE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL

Members: . . . . . . . . . . . . . . . . . . . . . . . . . R.G.H. Beets-Tan; Maastricht/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Camps Herrero; Valencia/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H.B. Eggesbø; Oslo/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.J. Grainger; Leeds/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Haliloglu; Ankara/TR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D.R. Kool; Nijmegen/NL

CASES OF THE DAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Vilar; Valencia/ES EFOMP REPRESENTATIVE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Torresin; Milan/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Malamateniou; London/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R. Pozzi-Mucelli; Verona/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Puech; Lille/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D.K. Tsetis; Iraklion/GR SCIENTIFIC PAPERS Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Brkljačić; Zagreb/HR Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.E. Andersen; Odense/DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Arkhipova; Moscow/RU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.-Y. Marcy; Ollioules/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A.C. Offiah; Sheffield/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.P. Parkar; Bergen/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H.-P. Schlemmer; Heidelberg/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Zackrisson; Malmö/SE EPOS EDITOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.I. Argyropoulou; Ioannina/GR E³ – EUROPEAN EXCELLENCE IN EDUCATION

ESMRMB REPRESENTATIVE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E.R. Danielsen; Copenhagen/DK IMAGE INTERPRETATION QUIZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A.G. Rockall; London/UK JUNIOR IMAGE INTERPRETATION QUIZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .F. Arnberg; Stockholm/SE EVALUATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.H. Fuchsjäger; Graz/AT ESR EDUCATION COMMITTEE CHAIRPERSON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Oleaga Zufiría: Barcelona/ES E-LEARNING EDITORS

E³ – ECR ACADEMIES:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Maas; Amsterdam/NL

Modern imaging in Colorectal Cancer . L.K. Blomqvist; Stockholm/SE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Barter; Cambridge/UK

Neuroradiology: from Morphology to Function . P.M. Parizel; Antwerp/BE Modern Cardiac Imaging . . . . . . . . . . . . . . . . . . V.E. Sinitsyn; Moscow/RU Diagnostic Urogenital Radiology . . . . . . . . . . . . H.C. Thoeny; Berne/CH Interactive Teaching Sessions . . . . . . . . . . . . . . . . M.G. Mack; Munich/DE

ESR QUALITY, SAFETY AND STANDARDS COMMITTEE CHAIRPERSON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E.J. Adam; London/UK ESR PUBLICATIONS COMMITTEE CHAIRPERSON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.E. Derchi, Genoa/IT ESR SUBSPECIALTIES AND ALLIED SCIENCES COMMITTEE CHAIRPERSON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Owens; London/UK

www.myESR.org

Final Programme | ECR 2016

61

ECR 2016 Committees

SCIENTIFIC SUBCOMMITTEES ABDOMINAL AND GASTROINTESTINAL

CARDIAC

The ESR would like to thank ESGAR for their cooperation on this subcommittee

The ESR would like to thank the ESCR for their cooperation on this subcommittee

Chairpersons: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.A. Bali; Brussels/BE

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . F. Cademartiri; Rotterdam/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Laghi; Latina/IT Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Croisille; Saint-Etienne/FR Abdominal Viscera

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Donato; Coimbra/PT

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.R. Ayuso; Barcelona/ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Kallifatidis; Thessaloniki/GR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Blachar; Tel Aviv/IL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G.I. Kirova-Nedialkova; Sofia/BG

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Hatzidakis; Iraklion/GR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Loewe; Vienna/AT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.A. Jackson; Plymouth/UK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K. Nikolaou; Tübingen/DE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Karcaaltincaba; Ankara/TR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.J. Perea; Barcelona/ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.C. Lauenstein; Essen/DE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Roditi; Glasgow/UK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Lewin-Zeitoun; Villejuif/FR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.D. Rud; St. Petersburg/RU

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Manfredi; Verona/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Stolzmann; Zurich/CH

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Maniatis; Aabenraa/DK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Urbanczyk-Zawadzka; Krakow/PL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Phoa; Amsterdam/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.M.A. van Ooijen; Groningen/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Staunton; Cork/IE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J. Venancio; Lisbon/PT

CHEST The ESR would like to thank ESTI for their cooperation on this subcommittee

GI Tract Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Aasen; Oslo/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Cappendijk; ‘s Hertogenbosch/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Hoeffel; Reims/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Kölblinger; Ried im Innkreis/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U. Korman; Istanbul/TR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Laniado; Dresden/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Maksimović; Belgrade/RS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Ramalho; Almada/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J. Rimola; Barcelona/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Terraz; Geneva/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.J.M. Tolan; Leeds/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Weninger; Arvika/SE BREAST The ESR would like to thank EUSOBI for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . C.S. Balleyguier; Villejuif/FR Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Bernathova; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Borbely; Budapest/HU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E.J. Cornford; Nottingham/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E.M. Fallenberg; Berlin/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K. Kinkel; Chêne-Bougeries/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Panizza; Milan/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.M. Pijnappel; Utrecht/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.J. Pina Insausti; Pamplona/ES

62

ECR 2016 | Final Programme

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.-P. Revel; Paris/FR Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Bakon; Warsaw/PL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Buckley; Dublin/IE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Devaraj; London/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Frauenfelder; Zurich/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Hartmann; Rotterdam/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Karabulut; Denizli/TR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Mershina; Moscow/RU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Persson; Linköping/SE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Regier; Hamburg/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Sverzellati; Parma/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Tack; Baudour/BE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Vilar; Valencia/ES COMPUTER APPLICATIONS The ESR would like to thank EuSoMII for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Regge; Turin/IT Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Bricault; Grenoble/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. de Bruijne; Rotterdam/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Kotter; Freiburg/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Morozov; Moscow/RU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Pokieser; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Salvador; Barcelona/ES

www.myESR.org

ECR 2016 Committees

SCIENTIFIC SUBCOMMITTEES MOLECULAR IMAGING

INTERVENTIONAL RADIOLOGY

The ESR would like to thank ESMOFIR for their cooperation on this subcommittee

The ESR would like to thank CIRSE for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X. Montet; Geneva/CH

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Filippiadis; Athens/GR

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Cyran; Munich/DE

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L. Crocetti; Pisa/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. de Jong; Rotterdam/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Denys; Lausanne/CH

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Fanti; Bologna/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Dimopoulou; Uppsala/SE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L. Fournier; Paris/FR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Georgiades; Nicosia/CY

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.H. Helbich; Vienna/AT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.K. Helmberger; Munich/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . W. Jaschke; Innsbruck/AT

GENITOURINARY

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. McDermott; Cork/IE

The ESR would like to thank ESUR for their cooperation on this subcommittee

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G.J. Munneke; London/UK

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Forstner; Salzburg/AT Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.D. Alt; Düsseldorf/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. De Visschere; Ghent/BE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Donati; Zurich/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.L. Lobo; Lisbon/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Nicolau; Barcelona/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Nikolic; Novi Sad/RS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Pellerin; Paris/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Peynircioglu; Ankara/TR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.A.A.J. van den Bosch; Utrecht/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Wojtaszek; Warsaw/PL MUSCULOSKELETAL The ESR would like to thank the ESSR for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Maas; Amsterdam/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Rørvik; Bergen/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Rouvière; Lyon/FR

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Alcalá-Galiano; Madrid/ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Studniarek; Gdansk/PL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Andreisek; Zurich/CH

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.R. Torkzad; Milford/UK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Barile; L’Aquila/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Tsili; Ioannina/GR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Cyteval; Montpellier/FR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Valentino; Udine/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E.E. Drakonaki; Iraklion/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I.-M. Noebauer-Huhmann; Vienna/AT

HEAD AND NECK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.P. Parkar; Bergen/NO

The ESR would like to thank the ESHNR for their cooperation on this subcommittee

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Robinson; Leeds/UK

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Kohler; Sion/CH Members: . . . . . . . . . . . . . . . . . . . . . . . . J. Frühwald-Pallamar; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D. Haba; Iasi/RO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Koltowska; Wroclaw/PL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Lell; Erlangen/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Lo Casto; Palermo/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Loney; Darlington/UK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Shahabpour; Brussels/BE . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Vasilevska Nikodinovska; Skopje/MK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Vieira; Porto/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.-A. Weber; Heidelberg/DE NEURO The ESR would like to thank the ESNR for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.A. Yousry; London/UK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Steens; Nijmegen/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.-A. Varoquaux; Marseille/FR

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Calli; Izmir/TR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Dörfler; Erlangen/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Due-TØnnessen; Oslo/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Gerevini; Milan/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.A. Lucic; Sremska Kamenica/RS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Pierot; Reims/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Ramos; Madrid/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B.F. Schuknecht; Zurich/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Surlan Popovič; Ljubljana/SI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L. van den Hauwe; Antwerp/BE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.P. Wattjes; Amsterdam/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Zlatareva; Sofia/BG

www.myESR.org

Final Programme | ECR 2016

63

ECR 2016 Committees

SCIENTIFIC SUBCOMMITTEES PAEDIATRIC

VASCULAR

The ESR would like to thank the ESPR for their cooperation on this subcommittee

The ESR would like to thank CIRSE for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Raissaki; Iraklion/GR

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.P. Lawler; Dublin/IE

Members: . . . . . . . . . . . . . . . . .S. Franchi-Abella; Le Kremlin-Bicêtre/FR

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Brisbois; Liège/BE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Hanquinet; Geneva/CH

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Burrel; Barcelona/ES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.D. Humphries; London/UK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Engelke; Göttingen/DE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Kljucevsek; Ljubljana/SI

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.N.M. Lohle; Tilburg/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G.M. Magnano; Genoa/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Melchiorre; Milan/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .H.-J. Mentzel; Jena/DE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Pfammatter; Zurich/CH

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.A.J. Nievelstein; Utrecht/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Uberoi; Oxford/UK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Sorantin; Graz/AT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Vilares Morgado; Porto/PT

PHYSICS IN RADIOLOGY

ONCOLOGIC IMAGING

The ESR would like to thank EFOMP for their cooperation on this subcommittee

The ESR would like to thank ESOI for their cooperation on this subcommittee

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Beyer; Vienna/AT

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V.J. Goh; London/UK

Member: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.J. Caruana; Msida/MT

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Coenegrachts; Bruges/BE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Damilakis; Iraklion/GR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.J. Fütterer; Nijmegen/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .V. Gershan; Skopje/MK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Johnston; Dublin/IE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Gilligan; Dublin/IE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I.G. Lupescu; Bucharest/RO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Kachelrieß; Heidelberg/DE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . P.K. Prassopoulos; Alexandroupoli/GR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.J. Lurie; Aberdeen/UK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.E. Sundin; Stockholm/SE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Trianni; Udine/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G. Zamboni; Verona/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Zanca; Leuven/BE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C.J. Zech; Basle/CH

RADIOGRAPHERS

EMERGENCY RADIOLOGY

The ESR would like to thank the EFRS for their cooperation on this subcommittee

The ESR would like to thank ESER for their cooperation on this subcommittee

Chairpersons: . . . . . . . . . . . . . . . . . . . I.M. Björkman-Burtscher; Lund/SE

Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Alkadhi; Zurich/CH

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Malamateniou; London/UK Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .J.M. Artigas; Zaragoza/ES Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Bezzina; Msida/MT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Basilico; Chieti/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.J. Foley; Dublin/IE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F.H. Berger; Amsterdam/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Mekiš; Ljubljana/SI

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.B. Dormagen; Oslo/NO

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Precht; Odense/DK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Eklof; Uppsala/SE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Santos; Coimbra/PT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Ilves; Tartu/EE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .V. Syrgiamiotis; Athens/GR

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Schouman-Claeys; Paris/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Wirth; Munich/DE

64

ECR 2016 | Final Programme

www.myESR.org

ECR 2016 Committees

ECR 2016 TOPIC COORDINATORS E³ – EUROPEAN EXCELLENCE IN EDUCATION

MINI COURSE

E³ – Rising Stars Programme:

Joint Course of ESR and RSNA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL Case-Based Diagnosis Training . . . . . . . . . . . . K.M. Friedrich; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Robinson; Vienna/AT

(Radiological Society of North America): Emergency Radiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U. Linsenmaier; Munich/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Palkó; Szeged/HU

E³ – European Diploma Prep Sessions: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Ertl-Wagner; Munich/DE E³ – The Beauty of Basic Knowledge: Breast Imaging . . . . . . . . . . . . . . . . . . . . . J. Camps Herrero; Valencia/ES Chest Imaging . . . . . . . . . . . . . . . . . . . N. Howarth; Chêne-Bougeries/CH E³ – ECR Academies: Modern imaging in Colorectal Cancer . L.K. Blomqvist; Stockholm/SE Neuroradiology: from Morphology to Function . . . . . . . . . . . . . P.M. Parizel; Antwerp/BE Modern Cardiac Imaging . . . . . . . . . . . . . . . . . . V.E. Sinitsyn; Moscow/RU Diagnostic Urogenital Radiology . . . . . . . . . . . . H.C. Thoeny; Berne/CH Interactive Teaching Sessions . . . . . . . . . . . . . . . . M.G. Mack; Munich/DE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Smits; Rotterdam/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.J. Zagoria; San Francisco, CA/US MULTIDISCIPLINARY SESSIONS Sports injuries: diagnosis and management . . . . . . . . . . . . . . . . . . M. Padrón; Madrid/ES Pancreatic cancer: radiological diagnosis and treatment . . . L. Grenacher; Heidelberg/DE Uterine myomas: radiological diagnosis and treatment . . . . . . . . . A.-M. Belli; London/UK PROS AND CONS SESSION Risks and benefits of reporting incidental findings . . . . . . . . S. Weckbach; Heidelberg/DE

E³ – Master Classes: Abdominal and Gastrointestinal (ESGAR) . . . . . . . . . . . . . . . . M.A. Bali; Brussels/BE, A. Laghi; Latina/IT Breast (EUSOBI) . . . . . . . . . . . . . . . . . . . . . . C.S. Balleyguier; Villejuif/FR

CLINICAL TRIALS IN RADIOLOGY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE

Cardiac (ESCR) . . . . . . . . . . . . . . . . . . . . . F. Cademartiri; Rotterdam/NL Chest (ESTI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.-P. Revel; Paris/FR Molecular Imaging (ESMOFIR) . . . . . . . . . . . . . . . X. Montet; Geneva/CH Genitourinary (ESUR) . . . . . . . . . . . . . . . . . . . . R. Forstner; Salzburg/AT Head and Neck (ESHNR) . . . . . . . . . . . . . . . . . . . . . . . R. Kohler; Sion/CH Interventional Radiology (CIRSE) . . . . . . . . . . D. Filippiadis; Athens/GR Musculoskeletal (ESSR) . . . . . . . . . . . . . . . . . . . M. Maas; Amsterdam/NL Neuro (ESNR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . T.A. Yousry; London/UK Paediatric (ESPR) . . . . . . . . . . . . . . . . . . . . . . . . . M. Raissaki; Iraklion/GR Vascular (CIRSE) . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.P. Lawler; Dublin/IE Oncologic Imaging (ESOI) . . . . . . . . . . . . . . . . . . . . V.J. Goh; London/UK Emergency Radiology (ESER) . . . . . . . . . . . . . . . . H. Alkadhi; Zurich/CH

www.myESR.org

Final Programme | ECR 2016

65

Programme Overviews

Title

PROGRAMME OVERVIEWS

www.myESR.org

Final Programme | ECR 2016

67

Programme Overviews

WEDNESDAY, MARCH 2 Room/ Time

08:3009:00 09:0009:30 09:3010:00

A 2nd Level (ACV)

E³ 121 E³ - ECR Academies: Interactive Teaching Session Head ‘and neck cancer after treatment: what you need to know

B 2nd Level (ACV)

C 2nd Level (ACV)

Z 2nd Level (ACV)

RC 101 GI Tract Assessing inflammation and fibrosis in Crohn’s disease

O 1st Level (ACV)

NH 1 New Horizons Session New frontiers in imaging of vascular wall and plaque

N 1st Level (ACV)

Studio 2016 1st Level (ACV)

RC 105 Computer Applications Daily use of mobile devices in radiology

L8 1st Level (ACV)

L2 1st Level (ACV)

EuroSafe Imaging Session 1 Low-dose research in medical radiation protection

E1 Entrance Level (ACV)

E2 Entrance Level (ACV)

F1 Entrance Level (ACV)

RC 110 Musculoskeletal The elbow: a comprehensive approach

F2 Entrance Level (ACV)

RC 102 Breast Breast ultrasound 2016

D1 Lower Level (ACV)

RC 104 Chest Pneumonia

Programme Overviews

Programme Overviews

WEDNESDAY, MARCH 2

WEDNESDAY, MARCH 2

D2 Lower Level (ACV)

RC 113 Physics in Radiology Single-dualmulti-energy CT

G Lower Level

K Lower Level

(ACV)

(ACV)

RC 111 Neuro Toxic brain disorders

11:0011:30 11:3012:00

E³ 221 E³ - ECR Academies: Interactive Teaching Session Unexpected findings on brain MRI

SS 201a Abdominal Viscera Pancreas and bile ducts

SS 202 Breast Breast biopsy

SS 206 Molecular Imaging PET/CT and MR in oncology

SS 201b Gastrointestinal Tract A guided tour through the GI tract

SS 203a Cardiac Cardiomyopathies (1)

13:0013:30

E³ 24A E³ - The Beauty of Basic Knowledge: Breast Imaging Breast ultrasound: a primer

SY 2 Satellite Symposium*

SY 3 Satellite Symposium*

SY 1a Joint Satellite Symposium*

SY 1b Joint Satellite Symposium*

SS 215 Vascular Vasculopathy: form and function

SS 210 Musculoskeletal Trauma and inflammation

SS 211a Neuro Paediatric and epilepsy

SS 216a Oncologic Imaging Hepatocellular cancer: characterisation, response and recurrence

SS 213 Physics in Radiology CT imaging: effects of body size and use of iterative reconstruction

SS 204 Chest Pulmonary vessels and perfusion

SS 209 Interventional Radiology Ablation outside the liver

SS 214 Radiographers Radiographers’ education: the curriculum

09:0009:30

SS 207 Genitourinary Technical advances

VoE 4 The Voice of EPOS™ Cardiac

13:3014:00 14:0014:30 14:3015:00 15:0015:30

SS 301a Abdominal Viscera Liver metastases: detection, characterisation and treatment response assessment

SS 302 Breast Breast innovation, biomarkers

SS 305 Computer Applications Developing tools for clinical workflow management

SS 301b Gastrointestinal Tract Colon

SS 303a Cardiac Cardiomyopathies (2)

SY 1c Joint Satellite Symposium*

SS 315 Vascular Peripheral arteries: imaging and therapy

SS 310 Musculoskeletal Ultrasound

SS 311a Neuro Cerebral tumours (1)

SS 316 Oncologic Imaging Dealing with metastatic disease

SS 313 Physics in Radiology Radiation risk assessment and awareness”

SS 304 Chest Lung MRI

SS 309 Interventional Radiology Musculoskeletal

SS 314 Radiographers CT parameters: juggling or struggling?

SS 307 Genitourinary Prostate cancer: targeted biopsy and beyond

VoE 5 The Voice of EPOS™ French

16:3017:00

E³ 426a E³ - ECR Master Class A tour around cholangiopathies

VoE 6 The Voice of EPOS™ Arabic

NH 4 New Horizons Session Big data: why should radiologists care?

RC 412 Paediatric Chest imaging in paediatrics

RC 408 Head and Neck Head and neck imaging: don’t sell your ultrasound yet!

RC 410 Musculoskeletal Bone trauma in the axial skeleton: patterns of injury and how I describe them

SY 1d Joint Satellite Symposium*

17:0017:30

EuroSafe Imaging Session 2 EuroSafe Imaging Alliance & Campaign what is new?

17:45–19:00 Room A: Opening Ceremony / Presentation of Honorary Members

ECR 2016 | Final Programme

RC 402 Breast Radiopathological correlation: more important than you thought

RC 404 Chest Pulmonary embolism - persistent controversies

RC 413 Physics in Radiology Artefacts and pitfalls in tomography

E³ 419 E³ 426b E³ - ECR E³ - ECR Academies: Master Class NeuroradiolMR-targeted ogy: focal therapies from Morfor prostate phology to cancer Function Functional MRI of the brain opens new horizons

RC 106 Molecular Imaging Molecular imaging: what can we quantify?

M3 1st Level

VoE 7 The Voice of EPOS™ Chest

M4 1st Level

M5 2nd Level

(M Building)

(M Building)

(M Building)

RC 109 Interventional Radiology Image fusion for imageguided interventions

RC 117 Emergency Radiology Abdominal trauma: does it bleed, will it start bleeding or is something else leaking?

E³ 126 E³ - ECR Master Class Cardiac CT and new interventions

Room/ Time

08:3009:00 09:0009:30 09:3010:00 10:0010:30

SS 208 Head and Neck Orbits and olfaction

SS 212 Paediatric Brain and neck

SS 203b Cardiac The evolving role of cardiac CT

SS 216b Oncologic Imaging Advanced imaging methods (2)

SS 211b Neuro Gadolinium deposition and trauma

10:3011:00 11:0011:30

11:3012:00

11:3012:00

12:0012:30

12:0012:30

12:3013:00

12:3013:00

13:0013:30

13:0013:30

13:3014:00

13:3014:00

14:0014:30

SS 308 Head and Neck Salivary glands, neck, parathyroid

SS 312 Paediatric Thorax and musculoskeletal

SS 303b Cardiac CT perfusion

SS 311b Neuro Dementia

SS 311c Neuro Neurovascular interventions (1)

14:0014:30 14:3015:00

15:0015:30

15:0015:30

15:3016:00

15:3016:00

16:0016:30 16:3017:00 17:0017:30

RC 415 Vascular Basic principles of varicose vein diagnosis and endovascular treatment

RC 403 RC 409 Cardiac Interventional Imaging of Radiology cardiac valves: Basic new trends principles of percutaneous tumour ablation

RC 417 Emergency Radiology ‘Special patients’ in the emergency room: when and how to image them?

PS 427 Pros & Cons Session Risks and benefits of reporting incidental findings

16:0016:30 16:3017:00 17:0017:30

Technical Exhibition: EXPO First Level (Gallery): 14:00–17:00

Registration: Tuesday, March 1: 12:00–18:00 / Wednesday, March 2: 07:00–18:00

68

RC 416 Oncologic Imaging Evaluating lymph node involvement: an impossible task?

11:0011:30

14:3015:00

15:3016:00 16:0016:30

(M Building)

M2 1st Level

(M Building)

10:0010:30 10:3011:00

VoE 2 The Voice of EPOS™ Breast

CTiR 1 E³ 25A E³ - The Beauty Clinical Trials of Basic in Radiology Knowledge: Chest Imaging Useful signs in chest radiology

M1 Entrance Level

09:3010:00

VoE 3 The Voice of EPOS™ Italian SY 4 Satellite Symposium*

Room/ Time

08:3009:00

VoE 1 The Voice of EPOS™ Abdominal/GI

12:0012:30 12:3013:00

(EPOS™ Arena)

RC 107 Genitourinary Pitfalls in gynaecologic oncologic imaging: how to avoid them and minimise risks

10:0010:30 10:3011:00

ECR Online & EPOS™ Lounge

* Not CME accredited

www.myESR.org

www.myESR.org

EPOS™ – Scientific Exhibition: 08:00–18:00

Final Programme | ECR 2016

69

www.myESR.org

Programme Overviews

TODAY’S HIGHLIGHTS Wednesday, March 2 Room A OPENING CEREMONY 17:45–19:00 Prof. Donoso & Prof. Riklund officially open ECR 2016 Presentation of Honorary Members Musical Entertainment by Martin Grubinger Room O NH 1 08:30–10:00

New frontiers in imaging of vascular wall and plaque

Room L8 EuroSafe Imaging Session 1 08:30–10:00 Low-dose research in medical radiation protection Room D2 12:30–13:30

CTiR 1 Clinical Trials in Radiology

Room C 16:00–17:30

NH 4

Big data: why should radiologists care?

THURSDAY, MARCH 3 Room/ Time 08:3009:00 09:0009:30 09:3010:00

(ACV)

E³ 521 E³ - ECR Academies: Interactive Teaching Session Integrating diagnostic tools in breast imaging

B 2nd Level

C 2nd Level

(ACV)

RC 501 Abdominal Viscera The many faces of benign liver lesions

(ACV)

Z 2nd Level (ACV)

SF 5 Special Focus Session Taking imaging to the cloud

O 1st Level (ACV)

RC 512 Paediatric Imaging of foetus and infant

N 1st Level (ACV)

RC 508 Head and Neck Pathways for tumour spread

Studio 2016 1st Level (ACV)

PC 5 Professional Challenges Session Personalised radiology: myth or reality?

L8 1st Level (ACV)

L2 1st Level (ACV)

NH 5 New Horizons Session Imaging beyond morphology

E1 Entrance Level

E2 Entrance Level

F1 Entrance Level

RC 510 Musculoskeletal Inflammatory arthritis: beyond the radiograph

SA 5 State of the Art Symposium Abdominal diffusionweighted imaging (DWI): an update

RC 516 Oncologic Imaging A multidisciplinary approach to prostate cancer: can we make a difference?

(ACV)

(ACV)

(ACV)

F2 Entrance Level (ACV)

D1 Lower Level (ACV)

RC 504 Chest HRCT patterns in chest radiology: back to basics and beyond

Programme Overviews

THURSDAY, MARCH 3

THURSDAY, MARCH 3

D2 Lower Level (ACV)

RC 513 Physics in Radiology How to assess and communicate examination risks to patients and referring physicians?

G Lower Level

K Lower Level

(ACV)

(ACV)

E³ - Rising E³ 519 Stars E³ - ECR Programme Academies: Neuroradiol­ Basic 1: ogy: from Neuroradiology: Morphology Brain to Function Advanced imaging techniques in brain tumours

10:3011:00 11:0011:30 11:3012:00 12:0012:30 12:3013:00 13:0013:30

Room E2 16:00–17:30

13:3014:00 14:0014:30 14:3015:00

ECR Online & EPOS™ Lounge

(EPOS™ Arena)

E³ 621 E³ - ECR Academies: Interactive Teaching Session Cardiac CT: from stenosis assessment to risk stratification

HL 1 Headline Session

E³ 721 E³ - ECR Academies: Interactive Teaching Session Cardiac imaging

SS 601a Abdominal Viscera Chronic liver disease and primary liver tumours

SS 602a Breast Breast MRI: new sequences and applications

E³ 24B E³ - The Beauty of Basic Knowledge: Breast Imaging Cracking the mystery of needles and gauges

SS 701a Abdominal Viscera Functional imaging of liver and spleen

SS 605 Computer Applications Image processing techniques (1)

RTF Quiz Radiology Trainees Forum

SS 702 Breast Breast MRIDWI (1)

SS 715 Vascular Endovascular therapies: what’s new?

SS 601b Gastrointestinal Tract Multimodality imaging of Crohn’s disease

SY 5 Satellite Symposium*

SS 701b Gastrointestinal Tract Advanced imaging of the oesophagus and stomach

15:0015:30

SS 603 Cardiac Evolving techniques

SY 6 Satellite Symposium*

ESOR Session Advancing clinical practice: role of education

SS 607a Genitourinary Female pelvis

SS 615 Vascular Optimising vascular imaging techniques

SS 611 Neuro Cerebrovascular disease (1)

SS 616 Oncologic Imaging Advanced imaging methods (1)

SS 617 Emergency Radiology Cardiothoracic emergencies

E³ - Rising Stars Programme Student Session 1: Breast

SS 710 Musculoskeletal Muscles

SS 602b Breast Breast ultrasound

SS 609 Interventional Radiology Non-vascular techniques in the abdomen

E³ 25B CTiR 2 E³ - The Beauty Clinical Trials of Basic in Radiology Knowledge: Chest Imaging How to avoid misdiagnosis on the chest x-ray

SY 8 Satellite Symposium*

SY 7 Satellite Symposium*

EIBIR Session 1 Joint VPHPRISM/ ASSURE Session - from screening to therapy: innovative breast care concepts

SS 610a Musculoskeletal Body composition

SS 711 Neuro Cerebrovascular disease (2)

SS 716 Oncologic Imaging Whole body imaging

SS 713 Physics in Radiology Innovations in radiology

SS 704 Chest Lung cancer

SS 717 Emergency Radiology Trauma of the brain and body

SS 610b Musculoskeletal Cartilage assessment

E³ - Rising Stars Programme Basic 2: Head and neck imaging

VoE 8 The Voice of EPOS™ Head and Neck

VoE 10 The Voice of EPOS™ Genitourinary

SY 9 Satellite Symposium*

SS 707 Genitourinary Prostate cancer: routine and novel MRI techniques

VoE 13 The Voice of EPOS™ Nordic

16:3017:00 17:0017:30

E³ 821 E³ - ECR Academies: Interactive Teaching Session Evaluation of patients with lung emphysema

RC 801 GI Tract CT colonography today

SF 8a Special Focus Session Common mistakes in breast imaging

ESR Working Group on Ultrasound Minimising the risk of transmitting infections through ultrasound: is current practice sufficient?

PC 8a RC 808 Professional Head and Challenges Neck Session Paediatric: how we do Clinical head and neck decision imaging in support (CDS) children

VoE 14 The Voice of EPOS™ Russian

E³ - Rising Stars Programme Student Session 2: Neuro

RC 810 Musculoskeletal Sports injuries to the knee: improving my report

MS 8 Multidisciplinary Session Pancreatic cancer: radiological diagnosis and treatment

Registration: 07:30–18:00

ECR 2016 | Final Programme

SF 8b Special Focus Session Assessing myocardium at-risk with MRI

SF 8c Special Focus Session Imaging in obesity

SF 8d E³ 819 Special Focus E³ - ECR Session Academies: Neuroradiol­ CT radiation ogy: from dose Morphology optimisation: to Function are we doing Cerebral blood enough? flow quantification

ACR Session Delivering higher value care in radiology: how to make it work in clinical practice perspectives from the American College of Radiology

E³ 526 E³ - ECR Master Class Perfusion imaging

VoE 15 The Voice of EPOS™ Abdominal/GI

M3 1st Level

M4 1st Level

M5 2nd Level

(M Building)

(M Building)

(M Building)

RC 503 Cardiac Novel ways to assess myocardial tissue

RC 509 Interventional Radiology Imaging and endovascular treatment of pulmonary embolism

MC 528 Joint Course of ESR and RSNA: Emergency Radiology Abdominal emergencies

E³ 522 E³ - ECR Academies: Diagnostic Urogenital Radiology Retroperitoneum and adrenals

10:0010:30

11:0011:30

Room/ Time 08:3009:00 09:0009:30 09:3010:00 10:0010:30

SS 608 SS 607b Head and Genitourinary Neck New frontiers: Pre- and urolithiasis post-operative and renal imaging in function oncology

SS 604 Chest Spectral CT, advanced CT analysis and emphysema

MC 628 Joint Course of ESR and RSNA: Emergency Radiology Chest emergencies

E³ 622 E³ - ECR Academies: Diagnostic Urogenital Radiology Kidney

10:3011:00 11:0011:30

11:3012:00

11:3012:00

12:0012:30

12:0012:30 SY 11 Satellite Symposium*

SY 12 Satellite Symposium*

12:3013:00

13:0013:30

13:0013:30

13:3014:00

13:3014:00

14:0014:30

SS 708 Head and Neck Temporal bone

SS 701c SS 703 Abdominal Cardiac Viscera Epidemiology, Advances in CT prognosis and trials

MC 728 Joint Course of ESR and RSNA: Emergency Radiology CNS emergencies

E³ 722 E³ - ECR Academies: Diagnostic Urogenital Radiology Emergencies

14:0014:30 14:3015:00

15:0015:30

15:0015:30

15:3016:00

15:3016:00

16:0016:30 16:3017:00 17:0017:30

RC 815 Vascular Carotid artery disease: so what’s new?

RC 803 Cardiac Imaging of heart failure

RC 809 Interventional Radiology Current trends in transarterial chemoembolisation (TACE) and radioembolisation for HCC

MC 828 Joint Course of ESR and RSNA: Emergency Radiology General principles: paediatric and ENT emergencies

E³ 822 E³ - ECR Academies: Diagnostic Urogenital Radiology Upper and lower urinary tract

16:0016:30 16:3017:00 17:0017:30

Technical Exhibition: EXPO First Level (Gallery): 10:00–17:00

EPOS™ – Scientific Exhibition: 08:00–18:00

70

PC 8b Professional Challenges Session An introduction to European Imaging Biomarker Alliance (EIBALL)

(M Building)

M2 1st Level

(M Building)

09:3010:00

14:3015:00

15:3016:00 16:0016:30

M1 Entrance Level

12:3013:00 VoE 12 The Voice of EPOS™ Oncology

SS 714 Radiographers Quality issues in ultrasound and CT

09:0009:30

10:3011:00

VoE 11 The Voice of EPOS™ Chinese SY 10 Satellite Symposium*

Room/ Time 08:3009:00

VoE 9 The Voice of EPOS™ Emergency

10:0010:30

Room M 5 PS 427 Risks and benefits of reporting 16:00–17:30 incidental findings EuroSafe Imaging Session 2 EuroSafe Imaging Alliance & Campaign - what is new?

A 2nd Level

Programme Overviews

* Not CME accredited

www.myESR.org

www.myESR.org

Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00

Final Programme | ECR 2016

71

www.myESR.org

Programme Overviews

TODAY’S HIGHLIGHTS Thursday, March 3 Room A WILHELM CONRAD RÖNTGEN 12:15–12:45 HONORARY LECTURE Imaging the invisible killer: towards personalisation of ovarian cancer care Andrea G. Rockall; London/UK

FRIDAY, MARCH 4 Room/ Time

E³ 921 E³ - ECR Academies: Interactive Teaching 09:00Session Diagnostic 09:30 evaluation of bone tumours

Abdominal diffusion-weighted imaging (DWI): an update

11:0011:30

Studio 2016 PC 5 08:30–10:00

Personalised radiology: myth or reality?

11:3012:00

RTF Quiz

Studio 2016 PC 8a Clinical Decision Support (CDS) 16:00–17:30 Room F1 PC 8b An introduction to European Imaging 16:00–17:30 Biomarkers Alliance (EIBALL) Room E2 MS 8 16:00–17:30

Pancreatic cancer: radiological diagnosis and treatment

Room O ESR Working Group on Ultrasound 16:00–17:30  Minimising the risk of transmitting infections through ultrasound: is current practice sufficient?

(ACV)

C 2nd Level (ACV)

Z 2nd Level (ACV)

RC 901 Abdominal Viscera Hepatocellular tumours

O 1st Level (ACV)

RC 912 Paediatric Hepatobiliary imaging in children

N 1st Level (ACV)

E³ 920 E³ - ECR Academies: Modern Cardiac Imaging How to quantify the haemodynamic significance of coronary stenosis

Studio 2016 1st Level (ACV)

PC 9a Professional Challenges Session Biobanks meet imaging

L8 1st Level (ACV)

L2 1st Level (ACV)

E³ - Rising Stars Programme Student Session 3: Abdominal and Gastrointestinal

E1 Entrance Level (ACV)

PC 9b Professional Challenges Session Radiology ten years from now: where will it be?

E2 Entrance Level (ACV)

F1 Entrance Level (ACV)

F2 Entrance Level (ACV)

D1 Lower Level (ACV)

SF 9c RC 916 SF 9a RC 904 Special Focus Oncologic Special Focus Chest Session Imaging Session Low dose Brain hyDiffusionBreast and no-dose persignals weighted density: how chest imaging: after repeated imaging (DWI) not to be opportunities gadolinium in oncology: confused? and limitations administrahow I do it tions

D2 Lower Level (ACV)

RC 914 Radiographers State-of-theart breast imaging

Programme Overviews

FRIDAY, MARCH 4

FRIDAY, MARCH 4

G Lower Level

K Lower Level

(ACV)

(ACV)

EF 1 E³ 919 EFOMP E³ - ECR Workshop: Academies: Radiation Neuroradiol­ Protection for ogy: from the female Morphology patient and to Function female mediFunctional cal staff imaging of the Breast imaging modalities spine and radiation dose

10:3011:00

12:0012:30 12:3013:00

ECR Online & EPOS™ Lounge

(EPOS™ Arena)

E³ 1021 E³ - ECR Academies: Interactive Teaching Session Emergency radiology I

EM 1 ESR meets the Nordic Countries Mammography in Nordic countries: screening and new developments

SS 1002 Breast Breast MRIDWI (2) and various MRI applications

SS 1015 Vascular Thoracic aorta: novel imaging and interventions

SS 1001a Gastrointestinal Tract Rectal cancer: staging and restaging

SS 1003 Cardiac CT of the coronary arteries

SS 1011a Neuro Neurovascular interventions (2)

E³ - Rising Stars Programme Student Session 4: Student Projects

SS 1010a Musculoskeletal Oncology

SS 1011b Neuro Cerebrovascular disease (3)

SS 1016 Oncologic Imaging Prostate and renal tract cancers: advanced detection methods

SS 1001b Abdominal Viscera Hepatocellular carcinoma: evaluation of therapeutic response

SS 1004 Chest Imaging methods: something old, something new

HL 2

Headline Session

13:0013:30

E³ 24C E³ - The Beauty of Basic Knowledge: Breast Imaging Breast cancer staging: why and how

SY 13 Satellite Symposium*

SY 14 Satellite Symposium*

SY 15 Satellite Symposium*

SY 16 Satellite Symposium*

SY 17 E³ 25C Joint Satellite E³ - The Beauty Symposium* of Basic Knowledge: Chest Imaging Reporting chest radiology made easy

SS 1009 Interventional Radiology Liver ablation

MIR @ ECR Session 1 Communication in radiology

SS 1014 Radiographers High dose antidotes

EF 2 EFOMP Workshop: Radiation Protection for the female patient and female medical staff Pregnancy and lactation

VoE 16 The Voice of EPOS™ Head and Neck

VoE 18 The Voice of EPOS™ Musculoskeletal

SY 18 Satellite Symposium*

14:3015:00

IIQ Image Interpretation Quiz Imaging with the stars

15:0015:30

EM 4 EFRS meets Sweden The professional role of Swedish radiographers in medical imaging

SY 21 Satellite Symposium*

SY 22 Satellite Symposium*

SY 23 Satellite Symposium*

EIBIR Session 2 MITIGATE: What does it take to perform clinical trials in interventional radiology?

VoE 20 The Voice of EPOS™ Neuro

MIR @ ECR Session 2 Improving quality and safety in radiology

SY 24 Satellite Symposium*

VoE 21 The Voice of EPOS™ Spanish

VoE 22 The Voice of EPOS™ Japanese

15:3016:00 16:0016:30 16:3017:00 17:0017:30

E³ 1221 E³ - ECR Academies: Interactive Teaching Session Use of staging and classification systems

Joint Session of the ESR and the EANM Hybrid imaging: radiology and nuclear medicine

E³ 1218 E³ - ECR Academies: Modern Imaging in Colorectal Cancer Rectal cancer: update on organ saving treatments

EDiR talk What you should know about the EDiR

RC 1212 Paediatric Key issues in paediatric imaging

E³ 1220 E³ - ECR Academies: Modern Cardiac Imaging Essentials of modern imaging in cardiac diseases

RC 1207 Genitourinary MRI for gynaecologic imaging: how I do it

EIBIR Session 3 Gateway to European funding for research projects

RC 1210 Musculoskeletal Systemic disease: what to look for in the musculoskeletal system

Registration: 07:30–18:00

ECR 2016 | Final Programme

PC 12a Professional Challenges Session Comprehensive cardiothoracic radiology: the way to go?

RC 1204 Chest Occupational lung diseases: the known and the less known

MIR @ ECR Session 3 Improving radiology departments

RC 1211 Neuro Cerebrovascular disease

E³ - Rising Stars Programme Basic 3: Interventional radiology: tumour ablation

(M Building)

RC 906 Molecular Imaging Preclinical imaging as a driver for translational research: how I do it

M2 1st Level

VoE 23 The Voice of EPOS™ Genitourinary

M3 1st Level

M4 1st Level

M5 2nd Level

(M Building)

(M Building)

(M Building)

(M Building)

RC 915 Vascular Fixing a leaky EVAR

SF 9b Special Focus Session Imaging in the presence of orthopaedic hardware

RC 917 Emergency Radiology Acute pain: your friend and enemy in emergency radiology

E³ 922 E³ - ECR Academies: Diagnostic Urogenital Radiology Gynaecology

08:3009:00 09:0009:30 09:3010:00

10:0010:30

11:0011:30

Room/ Time

10:0010:30 SS 1008 Head and Neck Maxillofacial imaging

SS 1012 Paediatric Abdominal and foetal imaging

SS 1006 Molecular Imaging Advanced hybrid imaging in oncology

SS 1010b Musculoskeletal Hip and shoulder

E³ 1022 E³ - ECR Academies: Diagnostic Urogenital Radiology Prostate

10:3011:00 11:0011:30

11:3012:00

11:3012:00

12:0012:30

12:0012:30 SY 20 Satellite Symposium*

12:3013:00

13:0013:30

13:0013:30

13:3014:00

13:3014:00 SY 25 Satellite Symposium*

14:0014:30

Joint Session of the ESR and ESMRMB Cardiac MRI

14:0014:30

14:3015:00

14:3015:00

15:0015:30

15:0015:30

15:3016:00

15:3016:00

16:0016:30 16:3017:00 17:0017:30

EuroSafe Imaging Session 3 Joint Session of the ESR and HERCA: the new EUBSS Directive - a step forward to patient safety

E³ 1226a E³ - ECR Master Class Interventional radiology for deep venous thrombosis (DVT): ready for prime time?

E³ 1226b E³ - ECR Master Class Expanding horizons in paediatric imaging

E³ 1226c E³ - ECR Master Class Whole body CT in trauma patients

PC 12b Professional Challenges Session How to become the undergraduate teacher you always wanted to be

16:0016:30 16:3017:00 17:0017:30

Technical Exhibition: EXPO First Level (Gallery): 10:00–17:00

EPOS™ – Scientific Exhibition: 08:00–18:00

72

RC 1216 Oncologic Imaging New insights in bone tumour imaging

09:3010:00

M1 Entrance Level

12:3013:00

13:3014:00 14:0014:30

09:0009:30

10:3011:00

VoE 19 The Voice of EPOS™ Turkish SY 19 Satellite Symposium*

Room/ Time 08:3009:00

VoE 17 The Voice of EPOS™ Interventional

10:0010:30

Room E2 SA 5 08:30–10:00

Room Z 12:30–13:30

B 2nd Level

09:3010:00

Imaging beyond morphology

CTiR 2 Clinical Trials in Radiology

(ACV)

08:3009:00

Room L8 NH 5 08:30–10:00

Room D2 12:30–13:30

A 2nd Level

Programme Overviews

* Not CME accredited

www.myESR.org

www.myESR.org

Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00

Final Programme | ECR 2016

73

www.myESR.org

Programme Overviews

TODAY’S HIGHLIGHTS Friday, March 4 Room A 12:15–12:45

JOSEF LISSNER HONORARY LECTURE Liver imaging: where do we stand now? Valérie Vilgrain; Clichy/FR

Studio 2016 PC 9a Biobanks meet imaging 08:30–10:00 Room E1 PC 9b Radiology ten years from now: 08:30–10:00 where will it be? Room B EM1 ESR meets the Nordic Countries 10:30–12:00  Mammography in Nordic countries: screening and new developments Room B EM 5 EFRS meets Sweden (European 14:00–15:30 Federation of Radiographer Societies) The professional role of Swedish radiographers in medical imaging Room A IIQ 14:00–15:30

IMAGE INTERPRETATION QUIZ Imaging with the stars

Room F2 PC 12a Comprehensive cardiothoracic 16:00–17:30 radiology: the way to go?

SATURDAY, MARCH 5 Room/ Time 08:3009:00 09:0009:30 09:3010:00

A 2nd Level (ACV)

E³ 1321 E³ - ECR Academies: Interactive Teaching Session MR imaging in sports medicine I

B 2nd Level

C 2nd Level

(ACV)

(ACV)

RC 1301 Abdominal Viscera IgG4-related disease: what is it and what do I need to know?

E³ 1318 E³ - ECR Academies: Modern Imaging in Colorectal Cancer Colon cancer: staging and restaging of local disease

Z 2nd Level (ACV)

SF 13a Special Focus Session MR/PET: role in oncology

O 1st Level (ACV)

RC 1312 Paediatric Imaging children with cancer

N 1st Level (ACV)

Studio 2016 1st Level (ACV)

L8 1st Level (ACV)

L2 1st Level (ACV)

RC 1308 RC 1307 ESR-PAG 1 Head and Genitourinary ESR Patient Neck Lessons I Advisory Group Pitfalls in learned from Patient-centred interpretation mistakes in care in clinical of kidney and radiology: do head and neck adrenal we really put disease imaging our patients first?

E1 Entrance Level

E2 Entrance Level

F1 Entrance Level

F2 Entrance Level

SF 13b Special Focus Session Cholangiocarcinoma: an update

SF 13c Special Focus Session Non-alcoholic fatty liver disease (NAFLD)

E³ 1323 E³ - European Diploma Prep Session Cardiac and vascular

RC 1302 Breast Tailoring breast cancer screening to risk level

(ACV)

(ACV)

(ACV)

(ACV)

D1 Lower Level (ACV)

Programme Overviews

Programme Overviews

SATURDAY, MARCH 5

SATURDAY, MARCH 5

D2 Lower Level (ACV)

SF 13d RC 1314 Special Focus RadiograSession phers Severe trauma Enhancing patients: research in myths, radiography: a realities and change future of culture

G Lower Level

K Lower Level

(ACV)

(ACV)

RC 1311 Neuro Reporting the degenerative lumbar spine

E³ - Rising Stars Programme Basic 4: Musculoskeletal: trauma

11:0011:30

E³ 1421 E³ - ECR Academies: Interactive Teaching Session Skull base lesions

EM 2 ESR meets Japan State-of-theart radiology

SS 1402a Breast Screening

SS 1406 Molecular Imaging Advanced experimental imaging

TF 1 Radiology Trainees Forum Highlighted Lectures

RC 1405 Computer Applications Will the good old PACS disappear?

11:3012:00 12:0012:30 12:3013:00

Headline Session

E³ 24D E³ - The Beauty of Basic Knowledge: Breast Imaging Ductal carcinoma in situ (DCIS): small tumour but big problem

SY 26 Satellite Symposium*

13:3014:00 14:0014:30

Room B Joint Session of the ESR and the 16:00–17:30 EANM (European Association of Nuclear Medicine) Hybrid imaging: radiology and nuclear medicine

14:3015:00 15:0015:30

SS 1407 ESR-PAG 2 Genitourinary ESR Patient MultiAdvisory Group parametric MR Mind the gap of prostate data-sharing cancer: an for better update patient outcomes the key issues for patients and the radiology community

SS 1410 Musculoskeletal Applications in CT and MR: something old, something new

SS 1411a Neuro Cerebrovascular disease (4)

E³ 1423 E³ - European Diploma Prep Session Head and neck

SS 1401 Abdominal Viscera Advances in abdominal MRI

SS 1404 SS 1409 Chest Interventional Chest CT dose Radiology reduction Intra-arterial therapies in the liver

SS 1414 Radiographers Safety and patient care in medical imaging

E³ - Rising Stars Programme Basic 5: Neuroradiology: spine

VoE 24 The Voice of EPOS™ Neuro

E³ 1521 E³ - ECR Academies: Interactive Teaching Session Genitourinary and gastrointestinal radiology

SF 15 Special Focus Session Head and neck radiology: from symptoms to diagnosis

E³ 1518 E³ - ECR Academies: Modern Imaging in Colorectal Cancer Colorectal cancer: synchronous and metachronous metastases

SY 27 Satellite Symposium*

EIBIR Session 4 The VPHDARE@IT Project: delivering a clinical decision support platform for earlier dementia diagnosis

E³ 1526 E³ - ECR Master Class Fire and ice outside the liver

SY 28 Satellite Symposium*

E³ 1520 E³ - ECR Academies: Modern Cardiac Imaging Myocardial characterisation: established modalities vs new ones

E³ - Rising Stars Programme Student Final Session

VoE 26 The Voice of EPOS™ Paediatric

RC 1510 SA 15 MusculoState of skeletal the Art Shoulder MRI: Symposium mastering Endovascular technique and abdominal making my reaneurysm port relevant repair (EVAR): where do we stand now?

E³ 1523 E³ - European Diploma Prep Session Gynaecological and obstetrics

RC 1502 Breast Update on BI-RADS

RC 1504 Chest Mediastinal disease revisited

SY 30 Satellite Symposium* VoE 28 The Voice of EPOS™ Musculoskeletal

RC 1514 Radiographers Innovative education in medical imaging

RC 1511 Neuro White spots in the brain

RC 1513 Physics in Radiology IT tools for dose tracking and workflow optimisation

VoE 29 The Voice of EPOS™ Korean

16:3017:00 17:0017:30

E³ 1621 E³ - ECR Academies: Interactive Teaching Session Emergency radiology II

RC 1601 Abdominal Viscera The spleen: the forgotten organ

E³ 1618 E³ - ECR Academies: Modern Imaging in Colorectal Cancer Rectal cancer: staging and restaging local disease

Joint Session of the ESR and ESTRO MRI and MR/PET in radiation treatment planning challenges and opportunities

Joint Session of the ESR, EFSUMB and ESPR Contrast enhanced ultrasound (CEUS) in paediatrics

E³ 1620 E³ - ECR Academies: Modern Cardiac Imaging Cardiac imaging: to new horizons

MS 16a Multidisciplinary Session Uterine myomas: radiological diagnosis and treatment

EuroSafe Imaging Session 4 You too can definitely do audits

MS 16b SF 16 Multidiscipli- Special Focus nary Session Session Sports injuries: Prostate MRI: diagnosis increasing and need? management

Registration: 07:30–18:00

ECR 2016 | Final Programme

M3 1st Level

(M Building)

M4 1st Level

(M Building)

VoE 30 The Voice of EPOS™ Portuguese

E³ 1623 E³ - European Diploma Prep Session Interventional

RC 1602 Breast Tomosynthesis: the new mammography

E³ 1626 E³ - ECR Master Class Less common infiltrative lung diseases

RC 1614 Radiographers Safety issues in medical imaging

RC 1611 Neuro Update on endovascular stroke treatment: a medical breakthrough?

RC 1613 Physics in Radiology MR: artefacts and devices

VoE 31 The Voice of EPOS™ Interventional

M5 2nd Level

(M Building)

Room/ Time

09:0009:30

09:0009:30

09:3010:00

09:3010:00

10:0010:30

10:0010:30

11:0011:30

SS 1408 Head and Neck Thyroid nodules

SS 1416 Oncologic Imaging Pelvic and breast cancer

SS 1415 Vascular Pulmonary vasculature: new and improved

SS 1411b Neuro Cerebral tumours (2)

SS 1402b Breast Contrastspectral mammography and MRI update in background parenchymal enhancement

10:3011:00 11:0011:30 11:3012:00

12:0012:30

12:0012:30

12:3013:00

12:3013:00

13:0013:30

13:0013:30

13:3014:00

13:3014:00

14:0014:30

SS 1503 Cardiac Interventional applications

SS 1501 Abdominal Viscera Liver fibrosis: imaging assessment

SS 1515 Vascular New observations in visceral imaging and therapy

SS 1511 Neuro Multiple sclerosis

SS 1502 Breast Breast density: an update

14:0014:30 14:3015:00

15:0015:30

15:0015:30

15:3016:00

15:3016:00

16:0016:30

16:0016:30

16:3017:00

16:3017:00

17:0017:30

17:0017:30

Technical Exhibition: EXPO First Level (Gallery): 10:00–17:00

EPOS™ – Scientific Exhibition: 08:00–18:00

74

(M Building)

M2 1st Level

(M Building)

08:3009:00

14:3015:00

15:3016:00 16:0016:30

M1 Entrance Level

08:3009:00

10:3011:00

VoE 27 The Voice of EPOS™ German

E³ 25D E³ - The Beauty of Basic Knowledge: Chest Imaging Measurements in chest radiology

SY 29 Satellite Symposium*

Joint Session of the ESR and ERS Imaging of airways: what the respirologist needs to know

Room/ Time

11:3012:00

HL 3

13:0013:30

Room M 5 PC 12b How to become the undergraduate 16:00–17:30 teacher you always wanted to be

(EPOS™ Arena)

VoE 25 The Voice of EPOS™ Breast

10:0010:30 10:3011:00

ECR Online & EPOS™ Lounge

* Not CME accredited

www.myESR.org

www.myESR.org

Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00

Final Programme | ECR 2016

75

www.myESR.org

Programme Overviews

TODAY’S HIGHLIGHTS Saturday, March 5

SUNDAY, MARCH 6 Room/ Time

E³ 1721 E³ - ECR Academies: Interactive Teaching 09:00Session 09:30 MR imaging in sports medicine II

09:3010:00

Room B EM 3 10:30–12:00

ESR meets Japan State-of-the-art radiology

10:3011:00

Room A JIIQ 12:55–13:55

JUNIOR IMAGE INTERPRETATION QUIZ Millennials showdown: the next generation of radiology

Studio 2016 Joint Session of the ESR and ERS 14:00–15:30 (European Respiratory Society) Imaging of airways: what the respirologist needs to know Studio 2016 MS 16a Uterine myomas: radiological 16:00–17:30 diagnosis and treatment Room E1 MS 16b Sports injuries: 16:00–17:30 diagnosis and management Room Z Joint Session of the ESR and ESTRO 16:00–17:30 (European Society for Radiotherapy and Oncology) MRI and MR/PET in radiation treatment planning – challenges and opportunities Room O Joint Session of the ESR, EFSUMB 16:00–17:30 (European Federation of Societies for Ultrasound in Medicine and Biology) and ESPR (European Society of Paediatric Radiology) Contrast enhanced ultrasound (CEUS) in paediatrics

(ACV)

08:3009:00

Room A SVEN-IVAR SELDINGER 12:15–12:45 HONORARY LECTURE  Imaging and micronavigation: time to redraw the map? Staffan Holmin; Stockholm/SE

Room E2 SA 15 Endovascular abdominal aneurysm 14:00–15:30 repair (EVAR): where do we stand now?

A 2nd Level

B 2nd Level

C 2nd Level

(ACV)

RC 1701 Abdominal Viscera Differential diagnosis in pancreatic imaging

(ACV)

Z 2nd Level (ACV)

O 1st Level (ACV)

N 1st Level (ACV)

Studio 2016 1st Level (ACV)

L8 1st Level (ACV)

L2 1st Level (ACV)

RC 1707 PC 17 E³ 1726a Genitourinary Professional E³ - ECR Prostate Challenges Master Class Characterisaimaging: how Session tion of salivary I do it European gland masses variation in imaging: focus on technology

Joint Session of the ESR and ESHI Medical hybrid imaging

E1 Entrance Level

E2 Entrance Level

SA 17 State of the Art Symposium Emergency imaging of the pregnant patient

SF 17a Special Focus Session Neuro imaging in paediatrics

(ACV)

(ACV)

F1 Entrance Level (ACV)

F2 Entrance Level (ACV)

D1 Lower Level (ACV)

SF 17b E³ 1726b E³ 1726c E³ - ECR Special Focus E³ - ECR Master Class Session Master Class Challenging Actionable Personalised questions for pulmonary medicine breast imagnodules: in oncology: ing in 2016: what can breast density, should we rely on size only? imaging offer? how to solve the non-mass enigma, new developments in breast MRI

D2 Lower Level (ACV)

RC 1714 Radiographers The magic of excellent images

Programme Overviews

Programme Overviews

SUNDAY, MARCH 6

NOTES

G Lower Level

K Lower Level

(ACV)

(ACV)

E³ 1726d E³ - ECR Master Class Imaging in dementia

E³ - Rising Stars Programme Basic 6: Thoracic emergencies

E³ 1826 E³ - ECR Master Class MSK and intervention

EM 3 ESR meets Colombia From practice to reality: how we do it

SS 1802 Breast Digital breast tomosynthesis: an update

SS 1805 Computer Applications Image processing techniques (2)

PC 18 Professional Challenges Session Monitoring safety and quality

SS 1803 Cardiac MR (1)

SS 1816 Oncologic Imaging Gastrointestinal cancer: prediction and assessment of therapeutic response

SS 1815 Vascular Abdominal aortic and other aneurysms

SS 1810 Musculoskeletal Ligaments, tendons and joints

SS 1811 Neuro Spine

E³ 1823 E³ - European Diploma Prep Session Paediatric

SS 1813 Physics in Radiology Practical radiation risk management

SS 1804 Chest COPD and infiltrative lung diseases

SS 1809 Interventional Radiology Peri- and postprocedural imaging

SS 1814 Radiographers Getting the radiation dose as low as possible

SS 1807 Genitourinary Tumours of the urinary tract and adrenals

E³ 24E E³ - The Beauty of Basic Knowledge: Breast Imaging High-risk lesions: solving the dilemma

13:0013:30

SS 1902a Breast Multiparametric breast MRI, PET

SS 1901a Abdominal Viscera Benign and malignant pancreatic diseases

SS 1902b Breast Preoperative imaging, neoadjuvant chemotherapy, imaging of the axilla

SS 1905 Computer Applications Quality control and safety issues in radiology

SS 1901b Abdominal Viscera Abdominal surgery: the added value of radiology

SS 1903 Cardiac MR (2)

09:0009:30

10:0010:30 10:3011:00

VoE 34 The Voice of EPOS™ Cardiac

VoE 35 The Voice of EPOS™ Chest

E³ 25E E³ - The Beauty of Basic Knowledge: Chest Imaging Dose optimisation made easy in computed tomography of the chest

ESR General Assembly

13:3014:00

14:3015:00

VoE 32 The Voice of EPOS™ Vascular

11:0011:30 11:3012:00

12:0012:30 12:3013:00

Room/ Time 08:3009:00

VoE 33 The Voice of EPOS™ Oncology

11:3012:00

14:0014:30

(EPOS™ Arena)

09:3010:00

10:0010:30

11:0011:30

ECR Online & EPOS™ Lounge

SS 1916 SS 1907 Oncologic Genitourinary Imaging Imaging of the Assessment reproductive and prediction system of treatment response

15:0015:30

CBDT E³ - Rising Stars Programme Case-Based Diagnosis Training Part 1 13:00–14:00 ––––– Cased-Based Training Interlude 14:00–14:30 ––––– Case-Based Diagnosis Training Part 2 14:30–15:30

12:0012:30 12:3013:00 13:0013:30 13:3014:00

SS 1911 Neuro Movement disorders and neurodegenerative diseases

E³ 1923 E³ - European Diploma Prep Session Urogenital

SS 1913 Physics in Radiology Physics of dual-energy CT and breast imaging

SS 1904 Chest Computerbased quantification and texture analysis

SS 1909 Interventional Radiology Endovascular

SS 1914 Radiographers How to improve image quality in MRI and mammography

14:0014:30 14:3015:00 15:0015:30

15:3016:00

15:3016:00

16:0016:30

16:0016:30

16:3017:00

16:3017:00

17:0017:30

17:0017:30

Registration: 07:30–16:00

Technical Exhibition: EXPO First Level (Gallery): 10:00–16:00

EPOS™ – Scientific Exhibition: 08:00–15:30

76

ECR 2016 | Final Programme

Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–14:00

www.myESR.org

www.myESR.org

Final Programme | ECR 2016

77

www.myESR.org

TODAY’S HIGHLIGHTS

New eLearning Platform

Sunday, March 6 Room E1 SA 17 08:30–10:00

Emergency imaging of the pregnant patient

Room O PC 17 08:30–10:00

European variation in imaging: focus on technology

Room F1 E3 1726b Personalised medicine in oncology: 08:30–10:00 what can imaging offer? Room C Joint Session of the ESR and ESHI 08:30–10:00 (European Society for Hybrid Medical Imaging) Medical hybrid imaging Room B EM 4 10:30–12:00

ESR meets Colombia From practice to reality: how we do it

Room O PC 18 10:30–12:00

Monitoring safety and quality

Room E1 CBDT 13:00–15:30

Case-Based Diagnosis Training Special programme for residents and general radiologists

EDUCATION ON DEMAND learn.myESR.org

SCIENTIFIC PROGRAMME Please note that sessions are marked with a logo to indicate their classification according to the European Training Curriculum. First three years of training Fourth and fifth years of training (general radiologist standard) Subspecialty training standard

ESR/EFRS meets Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81 New Horizons Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 State of the Art Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 Special Focus Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87 Professional Challenges Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91 Multidisciplinary Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95 European Excellence in Education (E3) . . . . . . . . . . . . . . . . . . . . . . . . . . . 97 Rising Stars Programme. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99 European Diploma Prep Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105 The Beauty of Basic Knowledge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107 ECR Academies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109 ECR Master Classes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115 Mini Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119 Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121 The Voice of EPOS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 Refresher Courses / Scientific Sessions. . . . . . . . . . . . . . . . . . . . . . . . . . . 143

79

80

ESR/EFRS MEETS SESSIONS

Once again, the ESR will welcome a number of guest countries to the ECR as part of the ‘ESR meets’ programme. The national radiological societies of Colombia, Japan, and the Nordic countries, will present their most recent scientific developments in joint sessions with the ESR, and try to strengthen links between professionals from different countries and disciplines. The European Federation of Radiographer Societies (EFRS) will also host its own ‘meets’ session for radiographers, in conjunction with representatives of the Swedish Society of Radiographers. Both the ESR and the EFRS warmly welcome these societies and hope to see ECR delegates attend the sessions in large numbers.

81

Programme by Session Type

ESR/EFRS MEETS SESSIONS 4

March

Friday, March 4, 10:30–12:00, Room B ESR meets the Nordic Countries EM 1 Mammography in Nordic countries: screening and new developments

5

March

Presiding: K. Riklund; Umea/SE H. Honda; Fukuoka/JP

Presiding: K. Riklund; Umea/SE M. Gardarsdottir; Reykjavik/IS G. Hagen; Oslo/NO K.R. Nielsen; Copenhagen/DK H. Ståhlbrandt; Eksjö/SE R.L. Vanninen; Kuopio/FI

» Welcome by the ESR President L. Donoso Bach; Barcelona/ES » Introduction: Radiology today in Japan [A-570] H. Honda; Fukuoka/JP » State-of-the-art of neuroimaging [A-571] S. Aoki; Tokyo/JP

» Welcome by the ESR President L. Donoso Bach; Barcelona/ES

» Interlude: Radiologist’s intermission: refreshing photo-stream on our beautiful country (I) [A-572] Y. Miki; Osaka/JP

» Introduction [A-384] H. Ståhlbrandt; Eksjö/SE » Mammography screening in Denmark: implementation and results [A-385] I. Vejborg; Copenhagen/DK

» Advanced liver imaging: improving treatment decisions [A-573] T. Murakami; Osaka/JP

» Performing MRI preoperatively in all breast cancer patients in Iceland: is it worthwhile? [A-386] M. Gardarsdottir; Reykjavik/IS

» Interlude: Radiologist’s intermission: refreshing photo-stream on our beautiful country (II) [A-574] T. Taoka; Nagoya/JP

» Breast density, risk for breast cancer and how to personalise screening: what are the future breast imaging modalities? [A-387] S. Zackrisson; Malmö/SE

» Diagnostic imaging of thymic tumours [A-575] N. Tomiyama; Osaka/JP

» Interval cancers in population-based screening programmes [A-388] S.R. Hoff; Aalesund/NO » New developments in MRI and MR image analysis of breast cancer [A-389] J. Hakumäki; Kuopio/FI

4

March

Friday, March 4, 14:00–15:30, Room B EFRS meets Sweden (European Federation of Radiographer Societies) EM 4 The professional role of Swedish radiographers in medical imaging Presiding: H  .H. Hjemly; Oslo/NO K. Hillergård; Jönköping/SE » Introduction [A-405, A-406] H.H. Hjemly; Oslo/NO K. Hillergård; Jönköping/SE » The Swedish radiographer as a professional [A-407] B.T. Andersson; Lund/SE » Implementation of a caring approach within the Swedish radiography programme [A-408] M. Lundén; Gothenburg/SE » Implementation of a research process and quality improvement within the Swedish radiography programme [A-409] K. Fridell; Stockholm/SE

Saturday, March 5, 10:30–12:00, Room B ESR meets Japan EM 2 State-of-the-art radiology

» Panel discussion: Always be a pioneer: state-of-the-art technologies from Japan

6

March

Sunday, March 6, 10:30–12:00, Room B ESR meets Colombia EM 3 From practice to reality: how we do it Presiding: K. Riklund; Umea/SE F.G. Lubinus; Bucaramanga/CO » Welcome by the ESR President L. Donoso Bach; Barcelona/ES » Introduction [A-779] F.G. Lubinus; Bucaramanga/CO » The law of radiology in Colombia: how we arrived to it [A-780] R. Restrepo; Medellin/CO » Interlude: The history of radiology in Colombia » Percutaneous biopsies: how do I do it? [A-781] F. Uriza; Bogota/CO » Interlude: Colombia, magical realism » Minor interventional procedures in tropical diseases [A-782] A. Morillo; Bogota/CO » Panel discussion: Minimally-invasive procedures: is there a place for the non-interventional radiologists?

» Cultural highlights [A-410] G. Örnberg; Umeå/SE » Panel discussion

82

ECR 2016 | Final Programme

www.myESR.org

NEW HORIZONS SESSIONS

The New Horizons Sessions aim to provide practitioners with an overview of the new developments in a specific area of practice, whether it is a subspecialty, a particular technique, or certain diseases. These developments may become routine within a few years, or may indicate a new direction for research and clinical application. Each session is 90 minutes long and features an introduction from a chairman, followed by three or four brief presentations on different aspects of the main subject, and concluded by a panel discussion that will hopefully answer some critical questions. Places are allocated on a first-come, first-served basis.

83

Programme by Session Type

NEW HORIZONS SESSIONS 2

March

Wednesday, March 2, 08:30–10:00, Room O NH 1 New frontiers in imaging of vascular wall and plaque » Chairman’s introduction: How to use the tools? [A-007] C. Loewe; Vienna/AT » Molecular imaging for MR [A-008] M.R. Makowski; Berlin/DE » New insights using nuclear and hybrid imaging [A-009] J. Knuuti; Turku/FI » Ultrasound elastography: how useful can it be? [A-010] N. Liasis; Athens/GR » New options with CT [A-011] A. Persson; Linköping/SE

3

March

Thursday, March 3, 08:30–10:00, Room L8 NH 5 Imaging beyond morphology » Chairman’s introduction [A-149] O. Clément; Paris/FR » MRI fingerprinting: the future? [A-150] S. Trattnig; Vienna/AT » Receptor-targeted multimodal imaging [A-151] M. de Jong; Rotterdam/NL » Radiomics [A-152] L.S. Fournier; Paris/FR » Panel discussion: Imaging biomarkers: a key role for radiologists in the future?

» Panel discussion: Predictive role of imaging in the evolution of atherosclerosis: where do we stand?

2

March

Wednesday, March 2, 16:00–17:30, Room C NH 4 Big data: why should radiologists care? » Chairman’s introduction [A-065] M. Dewey; Berlin/DE » Big data: big science [A-066] G. Zanetti; Pula/IT » Big data: big business [A-067] B.J. Hillman; Charlottesville, VA/US » Big data: what’s in it for the patient? [A-068] M.M. Hunink; Rotterdam/NL » Panel discussion: How to make best use of big data?

84

ECR 2016 | Final Programme

www.myESR.org

STATE OF THE ART SYMPOSIA

These sessions will inform the audience about the ‘real state of the art’ of a given subject. Each of the lecturers is an expert on the given topic as a whole or on a specific aspect of the topic. The 90-minute sessions are chaired by a moderator who will introduce three to four speakers addressing various issues within wider subjects such as anatomical regions, specific diseases, or particular techniques. The presentations will be followed by a discussion conducted by the panellists, led by the chairman. Places are allocated on a first-come, first-served basis.

85

Programme by Session Type

STATE OF THE ART SYMPOSIA 3

March

Thursday, March 3, 08:30–10:00, Room E2 SA 5 Abdominal diffusion-weighted imaging (DWI): an update

» Chairman’s introduction [A-743] R. Basilico; Chieti/IT

» Technical advances: the many faces of DWI [A-158] N. Papanikolaou; Iraklion/GR

» Polytrauma: US, CT or MR [A-744] A. Palkó; Szeged/HU

» Biliary ducts and pancreas: main advantages in clinical practice [A-159] C. Matos; Lisbon/PT

» Pulmonary embolism: CT or scintigraphy? [A-745] M.-P. Revel; Paris/FR

» Panel discussion: Should we do it qualitative or quantitatively?

5

Sunday, March 6, 08:30–10:00, Room E1 SA 17 Emergency imaging of the pregnant patient

» Chairman’s introduction [A-157] L. Martí-Bonmatí; Valencia/ES

» Small bowel: main advantages in clinical practice [A-160] S.A. Taylor; London/UK

March

6

March

Saturday, March 5, 14:00–15:30, Room E2 SA 15 Endovascular abdominal aneurysm repair (EVAR): where do we stand now?

» MRI and contrast media: what are the risks for the foetus? [A-746] M. Wozniak; Lublin/PL » Ionising radiation: when should we be concerned? [A-747] J. Damilakis; Iraklion/GR » Panel discussion with sample cases presentation: Emergency in pregnancy: what is best for the mother and baby?

» Chairman’s introduction [A-631] T. Rand; Vienna/AT » Endovascular versus open surgical repair: what do we know so far? [A-632] D.K. Tsetis; Iraklion/GR » The role of imaging in preoperative planning and follow-up [A-633] F. Rengier; Heidelberg/DE » Implantation techniques and long-term results [A-634] R. Uberoi; Oxford/UK » Imaging and treatment of endoleaks [A-635] M. Gschwendtner; Linz/AT » Panel discussion: The key role of the radiologist in endovascular abdominal aortic aneurysm repair

86

ECR 2016 | Final Programme

www.myESR.org

SPECIAL FOCUS SESSIONS

The concept of a Special Focus Session is to deal with a topic at the cutting edge of development and clinical application. A traditional approach is inappropriate for such a session, which should reflect the lecturers’ forthright personal views on a developing subject. The topics of these sessions should be presented in such a way as to promote debate and give an in-depth analysis. The chairman will introduce each aspect of the topic and the panellists will then discuss their different perspectives and opinions. The audience will have the opportunity to discuss their ideas with the lecturers. Session length: 90 minutes; three to four speakers. Places are allocated on a first-come, first-served basis.

87

Programme by Session Type

SPECIAL FOCUS SESSIONS 3

March

Thursday, March 3, 08:30–10:00, Room C SF 5 Taking imaging to the cloud

3

March

» Chairman’s introduction [A-134] J. Reponen; Raahe/FI

» Chairman’s introduction [A-278] S. Lee; Manchester/UK

» How does it work? [A-135] J. Fernandez-Bayó; Sabadell/ES

» Epidemiology and current trends in obesity [A-279] N. Finer; London/UK

» What are the benefits? [A-136] E.R. Ranschaert; ‘s-Hertogenbosch/NL

» Fat quantification and advanced body composition assessment using MRI [A-280] O. Dahlqvist Leinhard; Linkoping/SE

» What are the applications of cloud in radiology? [A-137] O. Ratib; Geneva/CH

» Imaging of modern surgical procedures and their complications [A-281] M. Rengo; Latina/IT

» Panel discussion: Will cloud computing be the future of image storage?

3

March

Thursday, March 3, 16:00–17:30, Room C SF 8a Common mistakes in breast imaging » Chairman’s introduction [A-243] G. Forrai; Budapest/HU

» Is there a role for bariatric embolisation in the treatment of the obese patient? [A-282] C. Weiss; Baltimore, MD/US » Panel discussion: How best to manage obesity and its implications on the radiology department

3

March

» Common mistakes in mammography [A-244] E.J. Cornford; Nottingham/UK

3

Thursday, March 3, 16:00–17:30, Room D2 SF 8d CT radiation dose optimisation: are we doing enough?

» Common mistakes in second-look ultrasound after MRI [A-245] P.A.T. Baltzer; Vienna/AT

» Chairmen’s introduction [A-283, A-284] I.M. Björkman-Burtscher; Lund/SE C. Malamateniou; London/UK

» Common mistakes in breast MRI [A-246] F. Pediconi; Rome/IT

» CT radiation dose optimisation: what has been achieved so far? [A-285] J. Santos; Coimbra/PT

» Panel discussion: How to avoid common mistakes in breast imaging?

March

Thursday, March 3, 16:00–17:30, Room D1 SF 8c Imaging in obesity

» Dose reduction techniques in paediatric CT: from A to Z [A-286] E. Sorantin; Graz/AT » Challenges and opportunities in CT dose optimisation: what can we do in the future? [A-287] S.J. Foley; Dublin/IE

Thursday, March 3, 16:00–17:30, Room F2 SF 8b Assessing myocardium at-risk with MRI » Chairman’s introduction [A-274] M. Gardarsdottir; Reykjavik/IS » T2 imaging [A-275] M. Gutberlet; Leipzig/DE » Late gadolinium enhancement [A-276] S. Kozerke; Zurich/CH » Prognostic value of area-at-risk assessment by T2 and late enhancement imaging [A-277] A. de Roos; Leiden/NL » Panel discussion: How do we best assess at-risk myocardium and how do we best get the correct information across?

» Panel discussion: What are the suggested priorities and actions for CT dose optimisation?

4

March

Friday, March 4, 08:30–10:00, Room F2 SF 9a Breast density: how not to be confused? » Chairman’s introduction [A-343] E. Azavedo; Stockholm/SE » The mammographic dense breast [A-344] F.J. Gilbert; Cambridge/UK » The ultrasound dense breast [A-345] L.J. Pina Insausti; Pamplona/ES » The MRI dense breast [A-346] P.A.T. Baltzer; Vienna/AT » Panel discussion: How to overcome the dense breast in screening?

88

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

SPECIAL FOCUS SESSIONS 4

March

Friday, March 4, 08:30–10:00, Room M 3 SF 9b Imaging in the presence of orthopaedic hardware

5

March

» Chairman’s introduction [A-514] G. Cook; London/UK

» Chairman’s introduction [A-371] M. Zanetti; Zurich/CH

» Principles and possibilities of MR/PET [A-515] A. Kjaer; Copenhagen/DK

» Optimising CT for imaging metalwork [A-372] M.-A. Weber; Heidelberg/DE

» MR/PET: imaging head and neck cancer [A-516] S. Bisdas; London/UK

» What problems do metalwork cause for MRI and how can we solve them? [A-373] J.V. Dehem; Ypres/BE

» MR/PET: imaging prostate cancer [A-517] A.J. Beer; Ulm/DE

» Imaging prosthetic joint infection: traditionally problematic, but do we have the answers now? [A-374] F. Kainberger; Vienna/AT » Panel discussion: What is the imaging modality of choice after plain films in the presence of orthopaedic hardware?

4

March

Saturday, March 5, 08:30–10:00, Room Z SF 13a MR/PET: role in oncology

» MR/PET: imaging of GI cancer [A-518] V.J. Goh; London/UK » Panel discussion: Which clinical indications have enough evidence for routine MR/PET rather than PET/CT?

5

March

Friday, March 4, 08:30–10:00, Room E2 SF 9c Brain hypersignals after repeated gadolinium administrations

Saturday, March 5, 08:30–10:00, Room E1 SF 13b Cholangiocarcinoma: an update » Chairman’s introduction [A-535] R. Manfredi; Verona/IT » Classification of cholangiocellular carcinoma (CCC) [A-536] C. Cantwell; Dublin/IE

» Chairman’s introduction [A-334] V. Runge; Berne/CH » Chemistry of Gd chelates and fundamentals in toxicity [A-335] S. Aime; Turin/IT

» Imaging in mass-forming intrahepatic (IH) type [A-537] F. Caseiro-Alves; Coimbra/PT » Diagnostic assessment of periductal/infiltrating and intraductal-growing types: the view of the diagnostic radiologist [A-538] R. Kloeckner; Mainz/DE

» Recent literature review [A-336] A. Radbruch; Heidelberg/DE » Hypersignals in the brain: which clinical impact [A-337] T. Yousry; London/UK

» Diagnostic assessment of periductal/infiltrating and intraductal-growing types: the view of the interventional radiologist [A-539] S. Terraz; Geneva/CH

» Recent FDA and EMA undertakings in the matter [A-338] O. Clément; Paris/FR » Panel discussion: Gadolinium injections: should we change our practice?

» Therapeutic role of interventional radiology in unresectable patients [A-540] G. Carrafiello; Varese/IT » Panel discussion: Can we improve diagnosis and treatment of cholangiocarcinoma?

5

March

Saturday, March 5, 08:30–10:00, Room E2 SF 13c Non-alcoholic fatty liver disease (NAFLD) » Chairman’s introduction: Defining the clinical problem [A-541] C. Bartolozzi; Pisa/IT » Imaging in diagnosing and quantifying liver fat [A-542] V. Vilgrain; Clichy/FR » Imaging in diagnosing and staging liver fibrosis [A-543] L. Martí-Bonmatí; Valencia/ES » Early detection of HCC [A-544] T. Denecke; Berlin/DE » Panel discussion: How to manage the surveillance of the population at risk

www.myESR.org

Final Programme | ECR 2016

89

Programme by Session Type

SPECIAL FOCUS SESSIONS 5

March

Saturday, March 5, 08:30–10:00, Room D1 SF 13d Severe trauma patients: myths, realities and future

6

March

» Chairman’s introduction [A-748] A. Rossi; Genoa/IT

» Chairman’s introduction [A-552] M. Stajgis; Poznan/PL

» Imaging of metabolic disorders in children [A-749] B. Ertl-Wagner; Munich/DE

» ‘When time is gold’: whole-body CT in polytrauma patients [A-553] S. Wirth; Munich/DE

» Imaging in paediatric epilepsy [A-750] T.A.G.M. Huisman; Baltimore, MD/US

» Where is the proper place for fast FAST (focused assessment with sonography for trauma)? [A-554] H. Alkadhi; Zurich/CH » Missed lesions in trauma patients: the Damocles’ sword [A-555] R. Basilico; Chieti/IT » Geriatric trauma: what is different? [A-556] E. Dick; London/UK » Panel discussion: How is the role of the radiologist changing in the management of trauma patients?

5 March

Saturday, March 5, 14:00–15:30, Room B SF 15 Head and neck radiology: from symptoms to diagnosis » Chairman’s introduction [A-608] B. Verbist; Leiden/NL » Tinnitus [A-609] M.M. Lemmerling; Ghent/BE » Stuffy and runny nose [A-610] S. Colley; Birmingham/UK » Sore throat [A-611] D. Farina; Brescia/IT

Sunday, March 6, 08:30–10:00, Room E2 SF 17a Neuro imaging in paediatrics

» Imaging headache in children [A-751] E. Vázquez; Barcelona/ES » Panel discussion: Can we do without CT in paediatric neuroimaging?

6

March

Sunday, March 6, 08:30–10:00, Room D1 SF 17b Actionable pulmonary nodules: should we rely on size only? » Chairman’s introduction [A-758] L. Bonomo; Rome/IT » Limitations of nodule measurements [A-759] A.R. Larici; Rome/IT » Shape and density: predictors of subtypes and mutations in NSCLC? [A-760] O.L. Sedlaczek; Heidelberg/DE » Proliferation tracers and not only [A-761] R. Boellaard; Amsterdam/NL » How necessary is clinical data? [A-762] A.A. Bankier; Boston, MA/US » Panel discussion: How to define an actionable nodule in daily practice?

» Lumps of the infrahyoid neck [A-612] M.G. Mack; Munich/DE » Panel discussion: To what extent do symptoms guide your imaging approach and interpretation?

5

March

Saturday, March 5, 16:00–17:30, Room E2 SF 16 Prostate MRI: increasing need? » Chairman’s introduction [A-694] J.C. Vilanova; Girona/ES » MRI before the first prostate biopsy: has the time come? [A-695] B. Hamm; Berlin/DE » The role of prostate MRI in active surveillance [A-696] A.R. Padhani; London/UK » Is prostate MRI accurate enough for focal treatment planning? [A-697] V. Panebianco; Rome/IT » Panel discussion: Does the use of MRI improve the outcome in prostate cancer?

90

ECR 2016 | Final Programme

www.myESR.org

PROFESSIONAL CHALLENGES SESSIONS

The idea of these sessions is to communicate and exchange information on professional issues related to radiology, such as training and education, research networking, radiological management and professional developments. 90-minute sessions; introduction by one or two chairmen; three to four lecturers; panel discussion. Places are allocated on a first-come, first-served basis.

91

Programme by Session Type

PROFESSIONAL CHALLENGES SESSIONS 3

March

Thursday, March 3, 08:30–10:00, Studio 2016 PC 5 Personalised radiology: myth or reality?

3

March

» Chairman’s introduction [A-144] C.J. Herold; Vienna/AT

» Chairman’s introduction [A-269] P.M. Parizel; Antwerp/BE

» Personalised imaging in practice: a myth? [A-145] F.J. Gilbert; Cambridge/UK

» EIBALL and its mission [A-270] S. Trattnig; Vienna/AT

» Personalised imaging and standardised protocols: a contradiction? [A-146] S.O. Schönberg; Mannheim/DE

» The potential role of EIBALL for EORTC multicentre trials [A-271] Y. Liu; Brussels/BE

» En route to personalised imaging: the role of multidisciplinary conferences [A-147] J.A. Verschakelen; Leuven/BE

» The organisational role of EIBIR in EIBALL [A-272] V. Vilgrain; Clichy/FR » Imaging biomarker development for EIBALL by subspecialty societies [A-273] K. Nikolaou; Tübingen/DE

» From personalised to precision imaging: impact on clinical practise [A-148] G.P. Krestin; Rotterdam/NL

» Panel discussion: What is the role of EIBALL now and in the future?

» Panel discussion: How to enhance personalised radiology in clinical routine

3 March

Thursday, March 3, 16:00–17:30, Room F1 PC 8b An introduction to European Imaging Biomarkers Alliance (EIBALL)

Thursday, March 3, 16:00–17:30, Studio 2016 PC 8a Clinical decision support (CDS) » Chairman’s introduction [A-255] L. Donoso Bach; Barcelona/ES » What is a clinical decision support system? [A-256] F. Sardanelli; San Donato Milanese/IT » Imaging referral guidelines in Europe [A-257] M.G.M. Hunink; Rotterdam/NL » An effective clinical decision support system [A-258] G. Boland; Boston, MA/US » Cost-effectiveness of clinical decision support [A-259] P. Mildenberger; Mainz/DE » Panel discussion: Is CDS really adding value to healthcare in addition to radiation safety? This session is part of the EuroSafe Imaging campaign.

4

March

Friday, March 4, 08:30–10:00, Studio 2016 PC 9a Biobanks meet imaging Moderators: E. Neri; Pisa/IT M. Pasterk; Graz/AT » How does Biobanking and BioMolecular resource Research Infrastructur - European Research Infrastructure Consortium (BBMRI-ERIC) work? [A-324] J.-E. Litton; Graz/AT » Patient rights: data overprotection? [A-325] M.T. Mayrhofer; Graz/AT » What is the difference between a PACS and a clinical bank of radiological images? [A-326] A. van der Lugt; Rotterdam/NL » Population-based cohort biobanks: accessing large European prospective cohorts through the biobanking infrastructure BBMRI large prospective cohorts (LPC) [A-327] O. Törnwall; Graz/AT » Population-based cohort: image banks [A-328] F. Bamberg; Tübingen/DE » What are ontologies? [A-329] B. Gibaud; Rennes/FR

92

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

PROFESSIONAL CHALLENGES SESSIONS 4

March

Friday, March 4, 08:30–10:00, Room E1 PC 9b Radiology ten years from now: where will it be?

6

March

» Chairman’s introduction [A-330] C.D. Becker; Geneva/CH

» Chairman’s introduction [A-731] G. Frija; Paris/FR

» Expanding radiology with new multidisciplinary competencies [A-331] J.A. Reekers; Amsterdam/NL

» PACS and eHealth [A-732] D. Caramella; Pisa/IT » Reporting and communication [A-733] O. Ratib; Geneva/CH

» Potential synergies between radiology and pathology [A-332] R.H. Oyen; Leuven/BE

» Procedure codes and lexica in radiology for supporting workflow improvements [A-734] P. Mildenberger; Mainz/DE

» The beauty of general radiology [A-333] G.H. Mostbeck; Vienna/AT

» Equipment and innovation [A-735] B. Brkljačić; Zagreb/HR

» Panel discussion: What are the leadership challenges for the next decade?

4

March

Friday, March 4, 16:00–17:30, Room F2 PC 12a Comprehensive cardiothoracic radiology: the way to go?

6

March

Sunday, March 6, 10:30–12:00, Room O PC 18 Monitoring safety and quality » Chairmen’s introduction [A-783, A-784] G. Frija; Paris/FR A. Torresin; Milan/IT

» Challenges and opportunities [A-466] A. de Roos; Leiden/NL

» Experience of total management of quality and safety [A-785] L. Oleaga Zufiría; Barcelona/ES

» Perspectives from cardiac imaging [A-468] J. Bremerich; Basle/CH » Panel discussion: How to best increase our impact on this interdisciplinary field?

4

» Panel discussion: What is the European vision on imaging technology?

» Chairman’s introduction: A perspective from both worlds: cardiac and thoracic imaging [A-465] E.J.R. van Beek; Edinburgh/UK

» Perspectives from thoracic imaging [A-467] M. Rémy-Jardin; Lille/FR

March

Sunday, March 6, 08:30–10:00, Room O PC 17 European variation in imaging: focus on technology

Friday, March 4, 16:00–17:30, Room M 5 PC 12b How to become the undergraduate teacher you always wanted to be

» Dose monitoring systems in CT [A-786] D. Caramella; Pisa/IT » Experience from a group of imaging centres [A-787] A. Palkó; Szeged/HU » Dose monitoring systems in interventional radiology [A-788] A. England; Salford/UK » Panel discussion: What are the bottlenecks in safety and quality management? This session is part of the EuroSafe Imaging campaign.

» Chairmen’s introduction [A-499, A-500] S.J. Golding; Oxford/UK M. Maas; Amsterdam/NL » The undergraduate curriculum: how to get the balance right [A-501] B. Ertl-Wagner; Munich/DE » Teaching methods’ top tips: how you can capture and maintain your students’ attention [A-502] C. Nyhsen; Sunderland/UK » Online resources: how to find the best case material and tutorials for your medical students [A-503] P. Pokieser; Vienna/AT » Using social media for undergraduate education: this generation’s communication [A-504] N. Pyatigorskaya; Paris/FR » Panel discussion: Teaching the undergraduate: in what ways is this similar to teaching radiology to other groups and in what ways does it differ?

= Interactive session with electronic voting/self assessment

www.myESR.org

Final Programme | ECR 2016

93

Activities 2016

Education in partnership

myESR.org/esor

Visiting Schools Visiting Seminars ESOR Courses for EDiR Scholarship Programmes Fellowship Programmes Visiting Professorship Programmes Online Courses Tutorials

MULTIDISCIPLINARY SESSIONS

The concept of these sessions is to promote a multidisciplinary approach to detection and treatment, integrating radiologists and other clinicians to share their expertise. Places are allocated on a first-come, first-served basis.

95

Programme by Session Type

MULTIDISCIPLINARY SESSIONS 3

March

Thursday, March 3, 16:00–17:30, Room E2 MS 8 Pancreatic cancer: radiological diagnosis and treatment » Chairman’s introduction [A-264] L. Grenacher; Munich/DE » Surgical oncological management [A-265] J. Werner; Munich/DE » Medical oncological management [A-266] D. Jäger; Heidelberg/DE » Radiology oncological management [A-267] L. Grenacher; Munich/DE » Radiation oncological management [A-268] F. Sterzing; Heidelberg/DE » Multidisciplinary case presentation and discussion

5

March

Saturday, March 5, 16:00–17:30, Studio 2016 MS 16a Uterine myomas: radiological diagnosis and treatment » Chairman’s introduction [A-681] A.-M. Belli; London/UK » Imaging of fibroids [A-682] R. Das; London/UK » Epidemiology, clinical presentation and non radiological therapeutic options for the treatment of fibroids [A-683] I. Manyonda; London/UK » Radiological treatments for fibroids [A-684] A.-M. Belli; London/UK » Multidisciplinary case discussion

5

March

Saturday, March 5, 16:00–17:30, Room E1 MS 16b Sports injuries: diagnosis and management » Chairman’s introduction [A-689] M. Padrón; Madrid/ES » What does the radiologist offer? [A-690] C. Faletti; Turin/IT » How I face a sport injury: the sport physician’s approach [A-691] J.-M. Alonso; Doha/QA » The physiotherapist’s view [A-692] A. Zerolo; Madrid/ES » The surgeon’s perspective [A-693] M. Leyes; Madrid/ES » Multidisciplinary case presentation and discussion: Which practice help and which hinder the team approach to managing the injured athlete? How can we improve on this?

96

ECR 2016 | Final Programme

www.myESR.org

EUROPEAN EXCELLENCE IN EDUCATION (E³)

The E³ programme emphasises the importance of lifelong learning. It covers the entire range of educational issues, from undergraduate medical education to subspecialised continuing professional development. For the second time at ECR 2016, the E³ programme is structured according to the different levels defined by the European Training Curriculum for Radiology. The E³ programme consists of the following five branches, which reflect the different levels of education in radiology, as well as the different stages of an individual’s professional career: Rising Stars Programme European Diploma Prep Sessions The Beauty of Basic Knowledge ECR Academies ECR Master Classes

97

European Board of Radiology

Take the European Diploma in Radiology

EDiR YOUR PASSPORT TO A BETTER CAREER Next Exam: July 1, 2016 (Barcelona, Spain)

First EDiR with the new examination structure! www.myEBR.org [email protected]

E3 RISING STARS PROGRAMME

The Rising Stars Programme is designed especially for residents, students, radiographers and trainee radiographers. It consists of Basic Sessions, Student Sessions, Case-Based Diagnosis Training sessions, and the Radiology Trainees Forum Programme including the RTF Highlighted Lectures and the RTF Quiz.

99

ESR Learning Centre Passeig de Gràcia, 86, planta 8 08008 Barcelona Spain www.esrlearningcentre.com

HOST YOUR COURSE, SEMINAR OR WORKSHOP IN AN ESR LEARNING CENTRE For more information including rates, please contact [email protected]

ESR Learning Centre Neutorgasse 9 1010 Vienna Austria www.esrlearningcentre.com

Programme by Session Type

E3 – RISING STARS PROGRAMME BASIC SESSIONS Special sessions suitable for residents, students, radiographers and radiographers-in-training

3

March

3

March

4

March

Thursday, March 3, 08:30–10:00, Room K Basic Session 1: Neuroradiology: brain

5

March

Saturday, March 5, 08:30–10:00, Room K Basic Session 4: Musculoskeletal: trauma

» White matter disorders [A-174] A. Rovira-Cañellas; Barcelona/ES

» Shoulder [A-562] M. Zanetti; Zurich/CH

» Tumours [A-175] J. Walecki; Warsaw/PL

» Knee [A-563] K. Verstraete; Ghent/BE

» Stroke [A-176] E.T. Tali; Ankara/TR

» Ankle [A-564] J. Kramer; Linz/AT

Thursday, March 3, 10:30–12:00, Room K Basic Session 2: Head and neck imaging

5

March

Saturday, March 5, 10:30–12:00, Room K Basic Session 5: Neuroradiology: spine

» Orbit [A-202] P.C. Maly Sundgren; Lund/SE

» Anatomy and congenital disorders [A-593] A. Rossi; Genoa/IT

» Ear [A-203] B. Verbist; Leiden/NL

» Tumours [A-594] M.M. Thurnher; Vienna/AT

» Sinuses [A-204] R. Maroldi; Brescia/IT

» Degenerative disease of the spine [A-595] M. Sasiadek; Wroclaw/PL

Friday, March 4, 16:00–17:30, Room K Basic Session 3: Interventional radiology: tumour ablation

6

March

Sunday, March 6, 08:30–10:00, Room K Basic Session 6: Thoracic emergencies

» Kidney [A-477] K. Katsanos; London/UK

» Vascular [A-768] R. Morgan; London/UK

» Liver [A-478] L. Crocetti; Pisa/IT

» Pulmonary [A-769] C.M. Schaefer-Prokop; Amersfoort/NL

» Bones [A-479] A. Gangi; Strasbourg/FR

» Cardiac [A-770] C. Loewe; Vienna/AT

www.myESR.org

Final Programme | ECR 2016

101

Programme by Session Type

E3 – RISING STARS PROGRAMME STUDENT SESSIONS Students will present their work

3

March

Thursday, March 3, 14:00–15:30, Room L8 Student Session 1: Breast

Thursday, March 3, 16:00–17:30, Room L8 Student Session 2: Neuro

» Magnetic resonance spectroscopy and its potential to identify neoadjuvant chemotherapy non-responders in triple negative breast cancer patients M.A. Chiorean; Cluj-Napoca/RO

» Altered brain activation in cortical-subcortical and pyramydal white matter stroke patients during hand motion: functional MRI study O. Omelchenko; Kyiv/UA

» What’s lurking in the corner? Extra-mammary findings on breast MRI, frequency and relevance R. Hayden; Dublin/IE

» Diffusion tensor imaging as a potential biomarker in prognosticating neurocognitive outcome in mild traumatic brain injury: evidence of altered structural connectivity V. Veeramuthu; Kuala Lumpur/MY

» The challenge of breast imaging in young: when to proceed to biopsy? A. Hatw; Cairo/EG » Results of quality control of three digital breast tomosynthesis systems in the clinical environment A. Rodriguez Ruiz; Madrid/ES » Incidentally detected enhancing lesions found in preoperative breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves classification accuracy O.H. Arponen; Kuopio/FI » Background parenchymal enhancement and breast density on preoperative breast MRI: correlation with tumour characteristics and size estimation M. Pizzato; Turin/IT » Is a one-year follow-up an efficient method for better management of MRI BI-RADS® 3 lesions? C. Ziadé; Bordeaux/FR » Stereotactic vacuum-assisted breast biopsy: comparison between 11- and 8-gauge needles I. Ruggirello; Florence/IT

102

3

March

ECR 2016 | Final Programme

» Diagnostic accuracy of MR imaging techniques for treatment response assessment in patients with high grade glioma: a systematic review and meta-analysis B.R.J. van Dijken; Winsum/NL » Osseous pseudoprogression in vertebral bodies treated with stereotactic radiosurgery C. Beaman; TX/US » CSF flow quantification by MRI: a diagnostic tool in normal pressure hydrocephalus J. Shanks; Uppsala/SE » Alcohol consumption during adolescence is associated with reduced volumes of anterior cingulate cortex and insula N. Heikkinen; Kuopio/FI » Cerebellum enlargement in 4-6-month-old infants at high familial risk of autism spectrum disorders I. Pote; London/UK » Do genetic effects really influence frequent anatomic variations of intra- and extracranial arteries? B. Forgo; Budapest/HU

www.myESR.org

Programme by Session Type

E3 – RISING STARS PROGRAMME STUDENT SESSIONS Students will present their work

4

March

Friday, March 4, 08:30–10:00, Room L8 Student Session 3: Abdominal and Gastrointestinal

4

March

» Abdominal tumours beyond the classical framework A.S. Yancheva; Varna/BG

Friday, March 4, 10:30–12:00, Room L8 Student Session 4: Student Projects » Flipping our learning: a blended story about alternative methods to improve study skills among medical students T.I. Adam; Cluj-Napoca/RO

» Multiparametric magnetic resonance in the assessment of the normal pancreas N. Gennaro; Perugia/IT

» Sharing my passion for neuroradiology through a workshop for medical students interested in neurosurgery S. Abu Arif; Cluj-Napoca/RO

» Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI S. Matoori; Zurich/CH

» A new educational project in Radiology: the concept of cross-sectional knowledge F. Serpi; Milan/IT

» Detection of appendicitis using 99mTcantigranulocyte antibodies J. Petrovic; Belgarde/RS

» Involving medical students in the Breast Unit: a university project aiming healthcare quality and educational achievements M. Morellá; Murcia/ES

» Transarterial drug-eluting beads chemoembolization for patients with liver tumours, single center experience R. Skumbiņš; Riga/LV

» Beyond images: a radiology educational platform for medical students M. Saftencu; Cluj-Napoca/RO

» Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient for discriminating recurrence from scar-tissue S. Grosu; Freiburg/DE

» The H.E.A.R.T. Project: a students’ approach on providing support for personal and professional development of European medical students S. Curcean; Agnita/RO

» Measurement of interstitial volume to assess abdominal organ amyloid burden using quantitative equilibrium contrast enhanced CT S. Sivarajan; London/UK

» A review of thyroid sonographic features and international guidelines: ability to differentiate benign and malignant nodules A. Weir; Limerick/IE

» Measuring two target lesions: how representative are selected target lesions of all liver metastases? F.O. Hofmann; Munich/DE

» Internship dissertation: comparative study of integrative neural networks implemented in modal and tonal auditory stimulation of brain with functional MRI of activation and diffusion tensor J.-B. Billaud; Villejuif/FR

5

March

Saturday, March 5, 14:00–15:30, Room L8 Student Final Session Programme to be announced

www.myESR.org

Final Programme | ECR 2016

103

Programme by Session Type

E3 – RISING STARS PROGRAMME RADIOLOGY TRAINEES FORUM PROGRAMME 3

March

Thursday, March 3, 12:30–13:30, Room Z RTF Quiz

CASE-BASED DIAGNOSIS TRAINING Special programme for residents and general radiologists

6

March

Moderator: J. Cáceres; Barcelona/ES

5

March

Sunday, March 6, 13:00–14:00, Room E1 CBDT I Case-Based Diagnosis Training - Part I  Moderators: K.M. Friedrich; Vienna/AT S. Robinson; Vienna/AT

Saturday, March 5, 10:30–12:00, Room O  TF Highlighted Lectures R

» Liver [A-796] L. Martí-Bonmatí; Valencia/ES » Neuro [A-797] D. Prayer; Vienna/AT

Moderators: M. Basta-Nikolic; Novi Sad/RS D. Berritto; Naples/IT

» Maxillofacial [A-798] S. Robinson; Vienna/AT

» Imaging of prostate cancer [A-576] S. Stojanovic; Novi Sad/RS

» Musculoskeletal [A-799] F. Kainberger; Vienna/AT

» Rectal cancer: tips for a better staging [A-577] L. Curvo-Semedo; Coimbra/PT

» Breast [A-800] M.H. Fuchsjäger; Graz/AT

» Intestinal ischaemia: key points for the radiologist [A-578] R. Grassi; Naples/IT

6

March

Sunday, March 6, 14:00–14:30, Room E1 Interlude: Know your calcifications! [A-801, A-802] W. Drahanowsky; Vienna/AT S. Robinson; Vienna/AT

6

March

Sunday, March 6, 14:30–15:30, Room E1 CBDT II Case-Based Diagnosis Training - Part II  Moderators: K.M. Friedrich; Vienna/AT S. Robinson; Vienna/AT » Head and neck [A-807] C. Czerny; Vienna/AT » Chest [A-808] H. Prosch; Vienna/AT » Spine [A-809] K.M. Friedrich; Vienna/AT » Gastrointestinal [A-810] W. Schima; Vienna/AT » Genitourinary [A-811] M. Toepker; Vienna/AT

= Interactive session with electronic voting/self assessment

104

ECR 2016 | Final Programme

www.myESR.org

E3 EUROPEAN DIPLOMA PREP SESSIONS

The European Diploma Prep Sessions aim to prepare prospective candidates for the European Diploma in Radiology (EDiR). They are also suitable for residents who want an overview of the various topics relevant to imaging and for those preparing for their national board examinations. The content of the programme reflects Level I European Training Curriculum (ETC) learning objectives across a two-year cycle. The sessions are held in close cooperation with the European Board of Radiology (EBR). Each of the six sessions is led by three lecturers and moderated by one chairman.

105

Programme by Session Type

E3 – EUROPEAN DIPLOMA PREP SESSIONS 5

March

Saturday, March 5, 08:30–10:00, Room F1 E³ 1323 Cardiac and vascular

Sunday, March 6, 10:30–12:00, Room F1 E³ 1823 Paediatric

» Chairman’s introduction [A-545] R. Vliegenthart; Groningen/NL

» Chairman’s introduction [A-789] V. Donoghue; Dublin/IE

A. Cardiovascular imaging: the basics [A-546] M. Gutberlet; Leipzig/DE

A. Paediatric neuro imaging [A-790] M.I. Argyropoulou; Ioannina/GR

B. Cardiovascular imaging: valves, endocardium and aorta [A-547] C. Loewe; Vienna/AT

B. Paediatric chest imaging [A-791] C. Owens; London/UK

C. Cardiovascular imaging: myocardium and pericardium [A-548] J. Bogaert; Leuven/BE

5 March

6

March

C. Paediatric abdominal imaging [A-792] S.G.F. Robben; Maastricht/NL

6

March

Saturday, March 5, 10:30–12:00, Room F1 E³ 1423 Head and neck

Sunday, March 6, 14:00–15:30, Room F1 E³ 1923 Urogenital » Chairman’s introduction [A-803] D. Akata; Ankara/TR

» Chairman’s introduction [A-589] M.G. Mack; Munich/DE

A. Renal and adrenal imaging [A-804] L.E. Derchi; Genoa/IT

A. Temporal bone and skull base [A-590] A. Trojanowska; Lublin/PL

B. Imaging of the ureter and bladder [A-805] J.-M. Correas; Paris/FR

B. Nose, paranasal sinuses and nasopharynx [A-591] C. Czerny; Vienna/AT

C. Prostate imaging [A-806] H.C. Thoeny; Berne/CH

C. Oral cavity, oro- and hypopharynx and larynx [A-592] M. Becker; Geneva/CH

5

March

Saturday, March 5, 14:00–15:30, Room F1 E³ 1523 Gynaecological and obstetrics » Chairman’s introduction [A-636] C.D. Alt; Düsseldorf/DE A. Imaging of the uterus [A-637] R.A. Kubik-Huch; Baden/CH B. Disorders of the adnexa [A-638] E. Sala; New York, NY/US C. Fundamentals of foetal imaging [A-639] D. Prayer; Vienna/AT

5

March

Saturday, March 5, 16:00–17:30, Room F1 E³ 1623 Interventional » Chairman’s introduction [A-698] M. Szczerbo-Trojanowska; Lublin/PL A. Basic principles of angiography and image-guided interventions [A-699] T.K. Helmberger; Munich/DE B. Interventions of the hepatobiliary system [A-700] J.I. Bilbao; Pamplona/ES C. Vascular interventions [A-701] J.A. Reekers; Amsterdam/NL

106

ECR 2016 | Final Programme

www.myESR.org

E3 THE BEAUTY OF BASIC KNOWLEDGE

The Beauty of Basic Knowledge programmes focus on knowledge essential to the daily practice of radiology. The format of these sessions reflects the tradition of conventional teaching sessions, in which experienced teachers share their insights into a topic of particular relevance with a group of attendees. A Beauty of Basic Knowledge session either consists of 45-minute lectures held by one or two speakers (plus 10–15 minutes of discussion per lecture), or two 25-minute lectures and a general discussion. The teaching format is usually case-based, and features some interaction with the attendees. The content of the sessions is mostly tied to the Level I and Level II European Training Curriculum (ETC) learning objectives. The Beauty of Basic Knowledge sessions are suited to residents and board-certified radiologists who want to refresh their knowledge of basic topics in imaging and image-guided therapy.

107

Programme by Session Type

E3 – THE BEAUTY OF BASIC KNOWLEDGE BREAST IMAGING

CHEST IMAGING

The programme will be concluded with a self-assessment test, published on ‘ESR Education on Demand’.

The programme will be concluded with a self-assessment test, published on ‘ESR Education on Demand’.

Moderator: J. Camps Herrero; Valencia/ES

Moderator: N. Howarth; Chêne-Bougeries/CH

2

March

Wednesday, March 2, 12:30–13:30, Room B E³ 24A Breast ultrasound: a primer [A-058]

3 March

4

March

5 March

6

3

March

R.M. Pijnappel; Utrecht/NL

K. Kinkel; Chêne-Bougeries/CH

B. Non neoplastic lesions [A-215] A.R. Larici; Rome/IT

4

Saturday, March 5, 12:30–13:30, Room B E³ 24D Ductal carcinoma in situ (DCIS): small tumour but big problem [A-597]



Friday, March 4, 12:30–13:30, Room D1 E³ 25C Reporting chest radiology made easy A. Interstitial lung disease: 5 golden rules [A-403] S.R. Desai; London/UK B. Pleural disease [A-404] C. Beigelman; Lausanne/CH

G. Forrai; Budapest/HU

Sunday, March 6, 12:30–13:30, Room B E³ 24E High-risk lesions: solving the dilemma [A-793]

Thursday, March 3, 12:30–13:30, Room D1 E³ 25B How to avoid misdiagnosis on the chest x-ray A. Neoplastic lesions [A-214] J. Vlahos; London/UK

March



March

B. Mediastinum and chest wall [A-060] J. Cáceres; Barcelona/ES

Friday, March 4, 12:30–13:30, Room B E³ 24C Breast cancer staging: why and how [A-402]

Wednesday, March 2, 12:30–13:30, Room D1 E³ 25A Useful signs in chest radiology A. Lung parenchyma [A-059] G.R. Ferretti; Grenoble/FR

A. Tardivon; Paris/FR

Thursday, March 3, 12:30–13:30, Room B E³ 24B Cracking the mystery of needles and gauges [A-213]

2

March

5

March

Saturday, March 5, 12:30–13:30, Room D1 E³ 25D Measurements in chest radiology

A. Linda; Udine/IT A. Heart and great vessels: how, why, when? [A-598] G. Fassa-Ashrafpoor; Chêne-Bougeries/CH B. Lung nodules: is volume better than size? [A-599] M. Prokop; Nijmegen/NL

6

March

Sunday, March 6, 12:30–13:30, Room D1 E³ 25E Dose optimisation made easy in computed tomography of the chest A. Dose descriptors [A-794] D. Tack; Baudour/BE B. CT angiography and CT of lung disease [A-795] X. Montet; Geneva/CH

108

ECR 2016 | Final Programme

www.myESR.org

E3 ECR ACADEMIES

The ECR Academies consist of a series of four to six sessions relevant to a particular area of radiology. This may be a classic organ-based field or a technically oriented area of another field related to radiology, such as management. Each ECR Academy spans several days, in which the different facets of the area in question are covered by experts in the field. An ECR Academy is a coherent course in which the different sessions complement one another in order to reflect the entirety of the field. The ECR Academies are particularly suited to general radiologists or radiologists with a subspecialisation.

109

Programme by Session Type

E3 – ECR ACADEMIES MODERN IMAGING IN COLORECTAL CANCER

NEURORADIOLOGY: FROM MORPHOLOGY TO FUNCTION

The programme will be concluded with a self-assessment test, published on ‘ESR Education on Demand’.

The programme will be concluded with a self-assessment test, published on ‘ESR Education on Demand’.

4

March

Friday, March 4, 16:00–17:30, Room C E³ 1218 Rectal cancer: update on organ saving treatments

2

March

» Chairman’s introduction [A-106] T.A. Yousry; London/UK A. No function without structure: challenges in diffusion MRI and fiber tractography for clinical research [A-107] A. Leemans; Utrecht/NL B. Clinical utility of fMRI for pre-operative brain mapping [A-108] H. Urbach; Freiburg/DE C. Introduction to resting state fMRI and functional connectomics [A-109] L. Nyberg; Umea/SE

Moderator: L.K. Blomqvist; Stockholm/SE A. The surgical perspective [A-431] G.L. Beets; Amsterdam/NL B. The oncological perspective [A-432] V. Valentini; Rome/IT C. The radiological perspective [A-433] R.G.H. Beets-Tan; Amsterdam/NL

5

March

Saturday, March 5, 08:30–10:00, Room C E³ 1318 Colon cancer: staging and restaging of local disease

3

March

Moderator: P. Lefere; Roeselare/BE A. Computed tomography for staging [A-511] E. Rollven; Stockholm/SE

C. Assessment of vasculature prior to laparoscopic resection [A-513] A. Laghi; Latina/IT

5

Saturday, March 5, 14:00–15:30, Room C E³ 1518 Colorectal cancer: synchronous and metachronous metastases

3

March

Moderator: T.K. Helmberger; Munich/DE

B. Optimal diagnostic algorithm [A-614] A. Ba-Ssalamah; Vienna/AT C. PET/CT vs MR/PET: which and when? [A-615] P. Veit-Haibach; Zurich/CH

5

Saturday, March 5, 16:00–17:30, Room C E³ 1618 Rectal cancer: staging and restaging local disease Moderator: D.-M. Koh; Sutton/UK A. Transrectal ultrasonography [A-664] J.E.R. Waage; Hillerød/DK B. Emerging MR-techniques [A-665] D.M. Lambregts; Amsterdam/NL C. Multiparametric assessment of treatment response [A-666] N. Papanikolaou; Iraklion/GR

110

ECR 2016 | Final Programme

Thursday, March 3, 16:00–17:30, Room G E³ 819 Cerebral blood flow quantification » Chairman’s introduction [A-291] T. van der Zijden; Edegem/BE A. Functional imaging of cerebral perfusion [A-292] A. Krainik; Grenoble/FR B. Cerebral blood flow measurements with arterial spin-labelling [A-293] X. Golay; London/UK C. Cerebrovascular reserve imaging and the consequences of neurovascular uncoupling [A-294] D. Mikulis; Toronto, ON/CA

A. Clinical management: what needs to be improved? [A-613] T. Holm; Stockholm/SE

March

Thursday, March 3, 08:30–10:00, Room G E³ 519 Advanced imaging techniques in brain tumours » Chairman’s introduction [A-177] P.C. Maly Sundgren; Lund/SE A. Clinical utility of perfusion imaging for differentiating brain tumours [A-178] I.N. Pronin; Moscow/RU B. Hybrid imaging with MRI/PET of brain tumours [A-179] N.L. Albert; Munich/DE C. Assessment of brain tumour perfusion and abnormal vascular structure using arterial spin-labelling [A-180] P. Hales; London/UK

B. Imaging for restaging after neoadjuvant treatment [A-512] M. Maas; Maastricht/NL

March

Wednesday, March 2, 16:00–17:30, Room G E³ 419 Functional MRI of the brain opens new horizons

4

March

Friday, March 4, 08:30–10:00, Room G E³ 919 Functional imaging of the spine » Chairman’s introduction [A-359] M. Muto; Naples/IT A. Measuring CSF flow: technique and clinical usefulness [A-360] B. Ertl-Wagner; Munich/DE B. Diffusion tensor imaging of the spinal cord in the assessment of intramedullary changes [A-361] M. Sasiadek; Wroclaw/PL C. Functional and quantitative MRI of symptomatic stenoses of the lumbar spine [A-362] K. Eberhardt; Werneck/DE

www.myESR.org

Programme by Session Type

E3 – ECR ACADEMIES MODERN CARDIAC IMAGING The programme will be concluded with a self-assessment test, published on ‘ESR Education on Demand’.

4

March

Friday, March 4, 08:30–10:00, Room N E³ 920 How to quantify the haemodynamic significance of coronary stenosis

5

March

Moderator: C. Loewe; Vienna/AT

Moderator: J. Bremerich; Basle/CH

A. CT-angiography: new tools (TAFE, TAG, CT-FFR) [A-321] G. Pontone; Milan/IT

A. Hybrid systems in the assessment of myocardial perfusion and viability [A-620] D.V. Ryzhkova; St. Petersburg/RU

B. Myocardial perfusion: what can be done with MR and CT [A-322] R. Vliegenthart; Groningen/NL

B. T1 and T2-mapping: new items in the radiology toolbox [A-621] P. Croisille; Saint-Etienne/FR

C. New players on the field: SPECT/CT, PET/CT, MR/PET [A-323] S.G. Nekolla; Munich/DE

4

March

Friday, March 4, 16:00–17:30, Room N E³ 1220 Essentials of modern imaging in cardiac diseases Moderator: G.I. Kirova-Nedialkova; Sofia/BG A. Major challenges in diagnostic imaging of cardiac diseases [A-447] M. Oudkerk; Groningen/NL B. Backbone of cardiac imaging: CT and MRI [A-448] M. Gutberlet; Leipzig/DE C. Hybrid systems for cardiac applications: essentials [A-449] J. Knuuti; Turku/FI

www.myESR.org

Saturday, March 5, 14:00–15:30, Room N E³ 1520 Myocardial characterisation: established modalities vs new ones

C. Cardiac spectroscopy: is it ready for clinical practice? [A-622] M. Beer; Ulm/DE

5

March

Saturday, March 5, 16:00–17:30, Room N E³ 1620 Cardiac imaging: to new horizons Moderator: E. Mousseaux; Paris/FR A. New approaches for coronary atherosclerotic plaque characterisation [A-678] E.J.R. van Beek; Edinburgh/UK B. Imaging of microvascular disease [A-679] R. Manka; Zurich/CH C. Tracking of stem cells in cardiac repair: role of MR and hybrid imaging [A-680] L. Natale; Rome/IT

Final Programme | ECR 2016

111

Programme by Session Type

E3 – ECR ACADEMIES DIAGNOSTIC UROGENITAL RADIOLOGY The programme will be concluded with a self-assessment test, published on ‘ESR Education on Demand’.

3

March

Thursday, March 3, 08:30–10:00, Room M 5 E³ 522 Retroperitoneum and adrenals

3

March

Moderator: J. Venancio; Lisbon/PT

Moderator: V. Logager; Copenhagen/DK

A. Anatomy and imaging techniques of the retroperitoneum [A-197] F.M. Danza; Rome/IT

A. CTU and MRU of the upper urinary tract [A-309] N.C. Cowan; Portsmouth/UK B. Imaging of kidney and ureter [A-310] M.A. Cova; Trieste/IT

B. Differential diagnoses of retroperitoneal masses [A-198] M.-F. Bellin; Le Kremlin-Bicêtre/FR C. Differential diagnoses of adrenal lesions [A-199] G. Heinz-Peer; St. Pölten/AT

3

March

C. Imaging of bladder and urethra [A-311] J. Lopes Dias; Lisbon/PT

4

March

Thursday, March 3, 10:30–12:00, Room M 5 E³ 622 Kidney

A. MR imaging techniques and normal anatomy of the female pelvis [A-379] C.S. Balleyguier; Villejuif/FR

A. Differential diagnoses of cystic renal masses [A-209] M. Claudon; Vandoeuvre-les-Nancy/FR

B. Staging of cervical cancer [A-380] R. Forstner; Salzburg/AT

B. Differential diagnoses of solid renal masses [A-210] R.H. Oyen; Leuven/BE

C. Differential diagnoses of adnexal masses [A-381] S. Swift; Leeds/UK

C. Acute and chronic renal infection [A-211] N. Grenier; Bordeaux/FR

Thursday, March 3, 14:00–15:30, Room M 5 E³ 722 Emergencies Moderator: M.M. Otero-García; Vigo/ES A. Male pelvis emergencies [A-234] M. Bertolotto; Trieste/IT B. Gynaecological emergencies [A-235] R.A. Kubik-Huch; Baden/CH C. Imaging of obstetric and puerperal emergencies [A-236] M. Weston; Leeds/UK

Friday, March 4, 08:30–10:00, Room M 5 E³ 922 Gynaecology Moderator: T.M. Cunha; Lisbon/PT

Moderator: H.C. Thoeny; Berne/CH

3 March

Thursday, March 3, 16:00–17:30, Room M 5 E³ 822 Upper and lower urinary tract

4

March

Friday, March 4, 10:30–12:00, Room M 5 E³ 1022 Prostate Moderator: J.J. Fütterer; Nijmegen/NL A. Ultrasound of the prostate [A-394] T. Fischer; Berlin/DE B. Multiparametric MRI of the prostate [A-395] G.M. Villeirs; Ghent/BE C. Staging of prostate cancer [A-396] A.R. Padhani; London/UK

= Interactive session with electronic voting/self assessment

112

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

E3 – ECR ACADEMIES INTERACTIVE TEACHING SESSIONS

2

March

Wednesday, March 2, 08:30–10:00, Room A E³ 121 Head and neck cancer after treatment: what you need to know

3

March

A. Imaging after surgical treatment [A-001] M. Lell; Erlangen/DE

A. Pretherapeutic evaluation of lung emphysema [A-237] C.P. Heussel; Heidelberg/DE

B. Imaging after radiotherapy/chemotherapy [A-002] G. Madani; London/UK

2

March

Wednesday, March 2, 10:30–12:00, Room A E³ 221 Unexpected findings on brain MRI

B. Diagnostic work-up after treatment of lung emphysema [A-238] N. Sverzellati; Parma/IT

4

March

A. Large ventricles: normal or abnormal? [A-056] S. Langner; Greifswald/DE

3

B. Pseudotumours: mimic bone tumours [A-313] F.M.H.M. Vanhoenacker; Antwerp/BE

Thursday, March 3, 08:30–10:00, Room A E³ 521 Integrating diagnostic tools in breast imaging

4

March

A. Multimodality breast imaging [A-128] K. Kinkel; Chêne-Bougeries/CH

3

Thursday, March 3, 10:30–12:00, Room A E³ 621 Cardiac CT: from stenosis assessment to risk stratification A. CT in stable chest pain [A-200] R. Marano; Rome/IT B. Cardiac CT in the emergency room [A-201] G. Feuchtner; Innsbruck/AT

3

March

Friday, March 4, 10:30–12:00, Room A E³ 1021 Emergency radiology I A. Abdominal vascular emergencies [A-382] A. Palkó; Szeged/HU

B. Multiparametric breast MRI [A-129] J. Camps Herrero; Valencia/ES

March

Friday, March 4, 08:30–10:00, Room A E³ 921 Diagnostic evaluation of bone tumours A. Bone tumours: benign or malignant? [A-312] H.-J. van der Woude; Amsterdam/NL

B. Incidental lesions on a brain MRI [A-057] E.T. Tali; Ankara/TR

March

Thursday, March 3, 16:00–17:30, Room A E³ 821 Evaluation of patients with lung emphysema

B. Chest trauma [A-383] J.D. Dodd; Dublin/IE

4

March

Friday, March 4, 16:00–17:30, Room A E³ 1221 Use of staging and classification systems A. RECIST 1.1 training [A-423] A. Graser; Munich/DE B. Gastrointestinal-abdominal masses [A-424] A. Ba-Ssalamah; Vienna/AT

Thursday, March 3, 14:00–15:30, Room A E³ 721 Cardiac imaging A. Patterns of delayed enhancement [A-216] P. Hunold; Lübeck/DE B. Cardiomyopathies: from diagnosis to prognosis [A-217] A. Jacquier; Marseille/FR

= Interactive session with electronic voting/self assessment

www.myESR.org

Final Programme | ECR 2016

113

Programme by Session Type

E3 – ECR ACADEMIES INTERACTIVE TEACHING SESSIONS

5

March

Saturday, March 5, 08:30–10:00, Room A E³ 1321 MR imaging in sports medicine I A. Muscle injury in sports [A-505] M.G. Mack; Munich/DE B. Knee trauma [A-506] M.O. De Maeseneer; Brussels/BE

5

March

6

March

Sunday, March 6, 08:30–10:00, Room A E³ 1721 MR imaging in sports medicine II A. Sports injuries of the ankle [A-719] P. Robinson; Leeds/UK B. Shoulder injury [A-720] M. Zanetti; Zurich/CH

Saturday, March 5, 10:30–12:00, Room A E³ 1421 Skull base lesions A. Imaging of the cavernous sinus and the anterior skull base [A-568] D. Farina; Brescia/IT B. Imaging of the central skull base [A-569] D.-A. Varoquaux; Marseille/FR

5

March

Saturday, March 5, 14:00–15:30, Room A E³ 1521 Genitourinary and gastrointestinal radiology A. Prostate MRI using PI-RADS [A-606] H.C. Thoeny; Berne/CH B. New aspects of renal tumours [A-607] N. Grenier; Bordeaux/FR

5

March

Saturday, March 5, 16:00–17:30, Room A E³ 1621 Emergency radiology II A. Brain trauma [A-658] M. Smits; Rotterdam/NL B. Peripheral vascular injury [A-659] J. Ferda; Plzen/CZ

= Interactive session with electronic voting/self assessment

114

ECR 2016 | Final Programme

www.myESR.org

E3 ECR MASTER CLASSES

The ECR Master Classes focus on continuous professional development and lifelong learning. The classes are designed for subspecialised radiologists seeking cutting-edge information in their particular fields of interest. They are held by experts in the field and reflect state-ofthe-art knowledge, as well as emerging trends. ECR Master Classes are offered in cooperation with each of the following subspecialty societies: CIRSE (one on vascular and one on interventional radiology), ESCR, ESER, ESGAR, ESHNR, ESMOFIR, ESNR, ESOI, ESPR, ESSR, ESTI, ESUR, EUSOBI.

115

Programme by Session Type

E3 – ECR MASTER CLASSES 2

March

Wednesday, March 2, 08:30–10:00, Room M 5 Cardiac E³ 126 Cardiac CT and new interventions

3

March

» Chairman’s introduction [A-052] A. Jankauskas; Kaunas/LT

» Chairman’s introduction [A-181] X. Montet; Geneva/CH

A. CT before and after transcatheter aortic valve interventions (TAVI) [A-053] J.-N. Dacher; Rouen/FR

A. Perfusion imaging: how I do it - by CT and/or by MRI? [A-182] C.C. Cyran; Munich/DE

B. CT before and after transcatheter mitral valve interventions (TMVI) [A-054] P. Blanke; Vancouver, BC/CA

B. Liver perfusion [A-183] V.J. Goh; London/UK C. Lung perfusion [A-184] M. Rémy-Jardin; Lille/FR

C. CT before and after electrophysiology interventions [A-055] R. Salgado; Antwerp/BE

D. Cerebral perfusion [A-185] H.R. Jäger; London/UK

» Discussion: How can CT best facilitate cardiac interventions?

2

March

Wednesday, March 2, 16:00–17:30, Room B Abdominal and Gastrointestinal E³ 426a A tour around cholangiopathies

» Panel discussion: The pros and cons of perfusion imaging

4

March

» Chairman’s introduction [A-061] C. Matos; Lisbon/PT A. Clinical scenarios [A-062] M. Arvanitaki; Brussels/BE

A. Imaging of DVT [A-490] P. Haage; Wuppertal/DE B. Declotting in the emergency room: why not? [A-491] R. de Graaf; Maastricht/NL

C. Treatment: which and when [A-064] E. Jonas; Stockholm/SE

C. Filter indications 2016: new oral anticoagulants and other developments [A-492] M.J. Lee; Dublin/IE

» Multidisciplinary panel discussion

2

Wednesday, March 2, 16:00–17:30, Room K Genitourinary E³ 426b MR-targeted focal therapies for prostate cancer » Chairman’s introduction: the rationale for focal therapy [A-101] F. Cornud; Paris/FR A. The role of multiparametric MR in the planning phase of focal therapy [A-102] V. Panebianco; Rome/IT B. MR-targeted high intensity focused ultrasound [A-103] M.C. Roethke; Heidelberg/DE

Friday, March 4, 16:00–17:30, Room M 2 Vascular E³ 1226a Interventional radiology for deep venous thrombosis (DVT): ready for prime time? Moderator: J.I. Bilbao; Pamplona/ES

B. Which imaging modalities? [A-063] J.M. Lee; Seoul/KR

March

Thursday, March 3, 08:30–10:00, Room M 1 Molecular Imaging E³ 526 Perfusion imaging

4

March

Friday, March 4, 16:00–17:30, Room M 3 Paediatric E³ 1226b Expanding horizons in paediatric imaging Moderator: S. Franchi-Abella; Le Kremlin-Bicêtre/FR A. Elastography in paediatrics [A-493] M. Anooshiravani-Dumont; Geneva/CH B. Diffusion-weighted imaging: toy or solution? [A-494] P.D. Humphries; London/UK C. Contrast-enhanced ultrasound in children [A-495] D. Kljucevsek; Ljubljana/SI

C. MR-guided cryoablation and focal laser therapy [A-104] J.J. Fütterer; Nijmegen/NL D. MR-targeted intensity-modulated radiotherapy with focal boost [A-105] V. Fonteyne; Gent/BE » Panel discussion: What are the challenges in providing focal treatment in prostate cancer?

= Interactive session with electronic voting/self assessment

116

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

E3 – ECR MASTER CLASSES 4

March

Friday, March 4, 16:00–17:30, Room M 4 Emergency Radiology E³ 1226c Whole body CT in trauma patients

6

March

Moderator: H. Alkadhi; Zurich/CH

5

March

A. Improving the triage: which patients should undergo whole-body CT (WBCT)? [A-496] D.R. Kool; Nijmegen/NL

Moderator: A. Trojanowska; Lublin/PL

B. How can we improve our WBCT protocol? [A-497] B. Leidner; Ekerö/SE

B. CT, MR/PET and PET/CT [A-737] N.J.M. Freling; Amsterdam/NL

C. Optimising the value of radiologists in trauma care [A-498] K.H. Nieboer; Brussels/BE

C. MRI diffusion and perfusion [A-738] S. Espinoza-Boireau; Paris/FR

Saturday, March 5, 14:00–15:30, Room O Interventional Radiology E³ 1526 Fire and ice outside the liver

A. Ultrasound [A-736] C.Z. Karaman; Aydin/TR

6

March

» Chairman’s introduction [A-616] M. Bezzi; Rome/IT

A. Personalised medicine in oncology: hope or reality? [A-752] E.E. Voest; Amsterdam/NL

B. Renal ablation: update and level of evidence [A-618] C.M. Sommer; Heidelberg/DE

B. Radiogenomics: can this assist personalised medicine? [A-753] V.J. Goh; London/UK

C. Bone and soft tissues ablation: update and level of evidence [A-619] A. Gangi; Strasbourg/FR

C. Hybrid MRI/PET: the next step in personalised cancer care? [A-754] A. Kjaer; Copenhagen/DK

» Panel discussion: How to strengthen the role of ablation beyond the liver in everyday clinical practice and how to prove the value of what we do

5

Saturday, March 5, 16:00–17:30, Room D1 Chest E³ 1626 Less common infiltrative lung diseases Moderator: M. Regier; Hamburg/DE A. Pleuroparenchymal fibro elastosis [A-705] A. Devaraj; London/UK B. Alveolar proteinosis [A-706] W.F.M. De Wever; Leuven/BE C. Lymphangioleiomyomatosis [A-707] A. Oikonomou; Toronto, ON/CA

Sunday, March 6, 08:30–10:00, Room F1 Oncologic Imaging E³ 1726b Personalised medicine in oncology: what can imaging offer? Moderator: R.G.H. Beets-Tan; Amsterdam/NL

A. Lung ablation: update and level of evidence [A-617] W. Prevoo; Amsterdam/NL

March

Sunday, March 6, 08:30–10:00, Room N Head and Neck E³ 1726a Characterisation of salivary gland masses

» Panel discussion: Can imaging facilitate a personalised medicine approach in oncology?

6

March

Sunday, March 6, 08:30–10:00, Room F2 Breast E³ 1726c Challenging questions for breast imaging in 2016: breast density, how to solve the non-mass enigma, new developments in breast MRI Moderator: R.M. Mann; Nijmegen/NL A. Breast density: what the breast radiologist needs to know [A-755] S.J. Vinnicombe; Dundee/UK B. How can we manage the non-mass breast (enigma) pattern? [A-756] F. Pediconi; Rome/IT C. New developments in breast MRI [A-757] L. Umutlu; Essen/DE

www.myESR.org

Final Programme | ECR 2016

117

Programme by Session Type

E3 – ECR MASTER CLASSES 6

March

Sunday, March 6, 08:30–10:00, Room G Neuro E³ 1726d Imaging in dementia Moderator: D. van Westen; Lund/SE A. The neurochemistry of the Alzheimer’s continuum [A-771] S. Engelborghs; Antwerp/BE B. MR contribution to diagnosis and differential diagnosis [A-772] F. Barkhof; London/UK, Amsterdam/NL C. PET imaging in dementia [A-773] K. Herholz; Manchester/UK

6

March

Sunday, March 6, 10:30–12:00, Room A Musculoskeletal E³ 1826 MSK and intervention » Chairman’s introduction [A-774] A. Gangi; Strasbourg/FR A. How to biopsy soft tissue and bone tumours [A-775] G.K.O. Åström; Uppsala/SE B. Lower back pain: what can I do? [A-776] D.J. Wilson; Oxford/UK C. Injectables - steroids and platelet-rich plasma (PRP): how and when? [A-777] M.J.C.M. Rutten; ‘s-Hertogenbosch/NL D. Painful solitary bone lesions: what is the most appropriate approach? [A-778] F. Arrigoni; L’Aquila/IT

= Interactive session with electronic voting/self assessment

118

ECR 2016 | Final Programme

www.myESR.org

MINI COURSE

The Joint Course of the ESR and RSNA (Radiological Society of North America) focuses on emergency radiology. Places are allocated on a first-come, first-served basis. Please note that you can only take part in electronic voting via your own device (smartphone, tablet, laptop) by connecting to the WiFi network of the lecture room you are in. Once connected, you will be automatically directed to the voting website. No app required.

119

Programme by Session Type

MINI COURSE JOINT COURSE OF THE ESR AND RSNA (RADIOLOGICAL SOCIETY OF NORTH AMERICA): EMERGENCY RADIOLOGY 3

March

Thursday, March 3, 08:30–10:00, Room M 4 MC 528 Abdominal emergencies

3

March

Moderators: A. Palkó; Szeged/HU R.J. Zagoria; San Francisco, CA/US

Moderators: A. Palkó; Szeged/HU R.J. Zagoria; San Francisco, CA/US

A. Abdominal injuries [A-193] A. Palkó; Szeged/HU

A. CNS trauma and neurovascular injury [A-230] H.A. Rowley; Madison, WI/US

B. The enemy within: non-traumatic abdominal emergencies [A-194] R.J. Zagoria; San Francisco, CA/US

B. CNS non-traumatic emergencies [A-231] M. Smits; Rotterdam/NL C. Interactive case discussion [A-232, A-233] H.A. Rowley; Madison, WI/US M. Smits; Rotterdam/NL

C. Interactive case discussion [A-195, A-196] A. Palkó; Szeged/HU R.J. Zagoria; San Francisco, CA/US

3

March

Thursday, March 3, 14:00–15:30, Room M 4 MC 728 CNS emergencies

Thursday, March 3, 10:30–12:00, Room M 4 MC 628 Chest emergencies

3

March

Thursday, March 3, 16:00–17:30, Room M 4 MC 828 General principles: paediatric and ENT emergencies

Moderators: A. Palkó; Szeged/HU R.J. Zagoria; San Francisco, CA/US

Moderators: A. Palkó; Szeged/HU R.J. Zagoria; San Francisco, CA/US

A. Thoracic injuries [A-205] J.A. Soto; Boston, MA/US

A. Imaging of polytrauma patients [A-306] U. Linsenmaier; Munich/DE

B. Non-traumatic thoracic emergencies [A-206] C.M. Schaefer-Prokop; Amersfoort/NL

B. Challenges of imaging paediatric abdominal emergencies [A-307] C.J. Sivit; Cleveland, OH/US

C. Interactive case discussion [A-207, A-208] J.A. Soto; Boston, MA/US C.M. Schaefer-Prokop; Amersfoort/NL

C. Imaging in ENT emergencies [A-308] D. Nunez; New Haven, CT/US

= Interactive session with electronic voting/self assessment

120

ECR 2016 | Final Programme

www.myESR.org

PROS & CONS SESSION The Pros & Cons Session will examine the controversial topic: ‘Risks and benefits of reporting incidental findings’ The session will be split into one interactive and one non-interactive part.

2

March

Wednesday, March 2, 16:00–17:30, Room M 5 PS 427 Risks and benefits of reporting incidental findings Moderator: S. Weckbach; Heidelberg/DE Teaser: J. Sellors; London/UK A. Good reasons to ignore incidental findings [A-124] L. Berlin; Skokie, IL/US B. Good reasons to report incidental findings [A-125] A. van der Lugt; Rotterdam/NL » Questions and answers [A-126, A-127] S. Weckbach; Heidelberg/DE J. Sellors; London/UK

= Partly interactive session with electronic voting/self assessment

www.myESR.org

Final Programme | ECR 2016

121

EPOS™ SCIENTIFIC EXHIBITION More than 2,000 new scientific and educational exhibits and scientific paper presentations EURORAD Learn from more than 5,500 case reports EUROSAFE IMAGING POSTER EXHIBITION The ESR’s latest initiative in radiation protection with submissions from all over Europe

ECR ONLINE & EPOSTM LOUNGE

WEDNESDAY, MARCH 2 TO SATURDAY, MARCH 5: 08:00–18:00 SUNDAY, MARCH 6: 08:00–15:30

TRADEMARK OF

THE VOICE OF EPOS

ECR 2016 proudly presents The Voice of EPOS, a unique opportunity for a direct scientific exchange between poster authors and their audience. Located in the ECR Online & EPOS Lounge, the EPOS™ Arena will offer a stage for the best posters submitted for ECR 2016, presented by their authors in moderated poster sessions. In addition to sessions comprising organ-based topics, there will be foreign language sessions to provide a platform for an international and multilingual scientific community. All presentations will also be broadcast online via the ECR Online streaming service. Sessions will be held at the following times in the EPOS™ Arena.

123

Programme by Session Type

THE VOICE OF EPOS 2

March

Wednesday, March 2, 10:00–11:00 VoE 1 Abdominal/GI

Wednesday, March 2, 11:00–12:00 VoE 2 Breast

Moderator: M. Torkzad; Milford/UK

Moderator: L.J. Pina Insausti; Pamplona/ES

» Assessment of kidney iron accumulation as a cause of renal dysfunction in patients with sickle cell disease (SCD) using MRI- R2* relaxometry (C-0940) S. Keller; Hamburg/DE

» Descriptors of malignant non-mass enhancement of breast MRI: their correlation to clinical prognostic factors (C-0226) Y. Machida; Chuo City, Tokyo/JP

» Educating medical students and junior doctors through an ‘abdominopelvic imaging’ multimedia radiology application (C-1122) C. Ní Leidhin; Dublin/IE

» Shear-wave elastography for the differential diagnosis of breast papillary lesions (C-0339) W.K. Lee; Seoul/KR

» Characterisation of liver nodules with Gd-EOBDTPA-enhanced MRI and contrast-enhanced ultrasound (CEUS) in a transgenic mouse model of hepatocellular carcinoma (C-1187) P. Marra; Milano/IT » Transjugular intrahepatic portosystemic shunt (TIPS) – what radiologists should know (C-1508) E. Nagaya; Sao Paulo/BR » Can magnetic resonance enterocolonography reflect the presence of partial mucosal healing in patients with Crohn’s disease? (C-1853) Y. Kitazume; Tokyo/JP » Contrast enhanced ultrasonography is safe in paediatric patients: a 10-year retrospective study (C-2070) A. Torres; Stockholm/SE » Abdominal wall lesions: a pictorial review (C-2181) K. Nam; Seoul/KR » MRI in the evaluation of pancreatic tumour treated with irreversible electroporation (IRE) (C-2196) M. Studniarek; Gdansk/PL » Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI (C-2342) S. Matoori; Salzburg/AT » Acute gastro-intestinal bleeding (AGB), diagnostic and interventional management: a preliminary retrospective single centre experience (C-2372) E. Puglielli; Teramo/IT

124

2

March

ECR 2016 | Final Programme

» Quantitative shear wave elastography in the evaluation of breast cancer metastatic axillary lymph nodes (C-0494) V.V. Kapustin; Moscow Oblast/RU » Radar imaging of breast lesions – a clinical evaluation and comparison (C-0521) M. Shere; Bristol/UK » Dual-energy contrast enhanced spectral mammography. One step beyond BI-RADS score, by adding the power of iodinated contrast media (C-0756) C. Gkali; Athens/GR » Radiation-induced angiosarcoma of the breast – a 15-year retrospective review (C-1143) I.P. Alves; Funchal/PT » Liponecrosis after autologous lipofilling: Which is the best imaging modality for evaluating it? (C-1224) A. Jarre; Valencia/ES » Invasive breast cancer in young Korean women under 35 years of age: clinical, radiological, and histopathological characteristics (C-1591) S. Lee; Seoul/KR » Prognostic importance of SWE on breast cancer: lysyl oxidase gene study (C-2150) Y.K. Kayadibi; Istanbul/TR » Comparison of full-field digital mammography (FFDM) with synthesised 2D mammography and digital breast tomosynthesis (DBT) in Chinese women (C-2332) H.Y.L. Sinn; Hong Kong/HK

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 2

March

Wednesday, March 2, 12:00–13:00 VoE 3 Italian

2

March

Wednesday, March 2, 13:00–14:00 VoE 4 Cardiac

Moderator: I. Bargellini; Pisa/IT

Moderator: A. Alberich-Bayarri; Valencia/ES

» Accuracy of integrated imaging techniques in paediatric airway diseases (C-0729) N. Stagnaro; Genova/IT

» Size of hypertrophic myocardium or myocardial fibrosis by LGE and cine in patients with hypertrophic cardiomyopathy: correlation with the New York Heart Function Assessment (NYHA) (C-0037) J. Zhao; Chongqing/CN

» Role of interventional radiology in the treatment of pancreatitis complications (C-1029) F. Corvino; Naples/IT » MRI patterns of brain toxicity in children (C-1297) M.C. Rossi Espagnet; Rome/IT » Clinical, functional and imaging results after one year from intrarticular injection of platelet rich plasma (PRP) versus hyaluronic acid (HA) in patients with osteoarthritis of the knee (OA) (C-1699) S. Quarchioni; Teramo/IT

» CT perfusion imaging of the myocardium vs. coronary CT angiography for the assessment of hemodynamic relevant coronary artery stenosis (C-0066) A.S. Straeter; Munich/DE » T1 mapping of the myocardium: what a resident needs to know (C-0385) F.M. Caballeros; Pamplona/ES

» Unexplained chronic cough (UCC) in children: can chest computed tomography (CCT) help in making a diagnosis? What about radiation exposure? (C-2027) M. Cellina; Milan/IT

» The relationship between coronary artery stenosis using non-invasive computed tomography coronary angiography and invasive fractional flow reserve in patients with ischemic heart disease (C-0615) I. Anan; Tokyo/JP

» MR thermometry: ex-vivo model assessment using three fast T1-weighted sequences during laser ablation procedures (C-2042) F. Giurazza; Rome/IT

» Radiologic and clinicopathologic findings of eosinophilic heart diseases: assessment with cardiac MRI and MDCT (C-1326) J.Y. Yoo; Seoul/KR

» Role of STIR and T2-weighted TSE MR sequences for recognising occult inflammatory breast cancer (C-2152) M. Moschetta; Bari/IT

» Diagnostic, therapeutic and economic implications of FFRCT-adoption in the non-invasive assessment of CAD: a retrospective study (C-1518) K. De Smet; Oostduinkerke/BE

» Digital breast tomosynthesis-guided biopsy: preliminary experience (C-2207) F. Pipan; Udine/IT

» Everything you need to know about congenital anomalies involving the coronary sinus on CT (C-1534) A. Goienetxea Murgiondo; Donostia/ES

» A new MR follow-up algorithm for a proper management of ‘small’ adrenal adenomas (AA) (C-2245) R. Faletti; Turin/IT

» Take a look at the heart: Role of cardiovascular CT and MRI in cardioembolic stroke (C-1788) A. Ugarte; San Sebastian/ES » The impact of alcohol intake on the presence of coronary artery disease (C-2212) D. Danicska; Budapest/HU » Inferior insertion points delayed enhancement and right ventricular dilation in patients with congenital heart disease (C-2357) P.M. Cannao; San Donato Milanese/IT

www.myESR.org

Final Programme | ECR 2016

125

Programme by Session Type

THE VOICE OF EPOS 2

March

Wednesday, March 2, 14:00–15:00 VoE 5 French

2

March

Wednesday, March 2, 15:00–16:00 VoE 6 Arabic

Moderator: S. Nougaret; St. Clement de Riviere/FR

Moderator: T. El-Diasty; Mansoura/EG

» Imaging of the complications of middle ear surgery: how do I keep my favourite surgeon away from jail? (C-0658) A. Venkatasamy; Strasbourg/FR

» Value of subtracted magnetic resonance images in diagnosis of different non vascular lesions of the body (C-0039) A.M. Abougabal; Alexandria/EG

» Selective arterial embolisation of renal tumour in a hybrid operating room at the same time as laparoscopic partial nephrectomy: a new approach in renal surgery (C-0905) L. Besnier; Angers/FR

» Detection of uterine vascular malformations using 4D-CT angiography: initial experience (C-0553) A.M.H. El-Sharkawy; Tanta/EG

» Updated prostate imaging reporting and data system (PI-RADS) 2.0 versus 1.0: detection accuracy of prostate clinically significant and insignificant cancer (C-1203) S. Peslerbe; Angers/FR

» MRI defecography signs in obstructed defecation (C-1906) M. A. Alkubeyyer; Riyadh/SA

» Automatic detection of prostate cancer using quantitative perfusion parameters in contrastenhanced ultrasound (C-1798) M. Skendi; Paris/FR » 320-row CT transcatheter aortic valve implantation planning using a single reduced contrast media bolus injection: a prospective study on 50 patients (C-2034) M. Ohana; Strasbourg/FR » Assesment of comparative accuracies of ultrasound and fluoroscopic steroid injections into the subacromial bursa (C-2068) S. Charlon; Paris/FR » Greater occipital nerve MR tractography: feasibility and anatomical considerations (C-2088) A. Kastler; Grenoble/FR » Post-traumatic neuroma after surgery of the carpal tunnel: MRI study (C-2291) J.-L. Drapé; Paris/FR » Radiation dose and acquisition time for CT transaortic valve implantation (TAVI) planning examinations with new-generation 256 multi-detector CT (MDCT) (C-2376) L. Macron; Saint-Denis/FR

» Imaging appearances of stromal fibrosis (C-1134) L. Nassar; Beirut/LB

» Meningeal thickening in MRI: from signs to etiologies (C-1979) A. Hssine; Soussa/TN » Endovascular treatment of distal basilar artery aneurysms (C-2019) M. Zaitoun; Zagazig/EG » Radiology reports evaluation by University of Rochester Medical Center (URMC) emergency department (ED) (C-2102) W.A. Abdellatif; Zagazig/EG » Utility of intra-arterial cone beam CT angiography in detection of intracranial micro-arteriovenous malformations (C-2304) A. Elmokadem; Mansoura/EG » Image defined risk factors using MDCT: are they a good predictor of surgical outcomes in abdominal neuroblastoma regardless of the disease stage? (C-0413) O. Kamal; Asyut/EG » RENAL nephrometry score value in approach and outcomes of partial nephrectomy (C-1395) H.S. Gaber; Mansoura/EG

» Brain cysts (C-2385) A. Krainik; Grenoble/FR

126

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 2

March

Wednesday, March 2, 16:00–17:00 VoE 7 Chest

3

March

Thursday, March 3, 09:00–10:00 VoE 8 Head and Neck

Moderator: M. Toepker; Vienna/AT

Moderator: E. Ada; Izmir/TR

» Assessment of primary pulmonary malignancy: comparison of CT and MR imaging with radial 3D T1-weighted gradient echo and radial 3D ultrashort TE sequences at 3.0 Tesla using a high-density coil (C-0582) H. Lee; Wonju/KR

» A pilot feasibility study of 99mTc-EC-DG SPECT/ CT imaging in the treatment response evaluation in patients with locally advanced head and neck cancer  (C-0200) C.W. Westin; Chicago, IL/US

» A type of future virtual 3D microscope and its 3D image printing to make realized magnified model of the peripheral lung, based on micro CT of the lung specimen (C-0716) H. Natori; Sapporo/JP » CT lung subtraction for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension (C-0926) T. Kariyasu; Tokyo/JP » 80 kV low contrast volume CT pulmonary angiography for the diagnosis of acute pulmonary embolism: improving patient safety (C-1152) J. Bell; Bradford/UK » MR imaging of mediastinal tumours (C-1156) A. Matos; Lisbon/PT » Lung sonography; a valuable contributor in the NICU (C-1323) E. Manoli; Marousi/GR » The use of hyperpolarised xenon (HP 129Xe-MRI) for assessing collateral ventilation (C-1541) M. Chen; Oxford/UK

» Salivary gland tumours: a pictorial review (C-0317) A.R. Ramírez; Madrid/ES » “Necrotic lymphadenopathy” in the neck: how many diagnostic keys do you have? (C-0411) J.S. Kim; Seoul/KR » Thyroid FNA guidelines; a comparison of the six internationally recognised guidelines (C-0441) A. Weir; Limerick/IE » Usability of exposure dose reduction using volume scan in the auditory-ossicle CT scan (C-0653) K. Nagamoto; Fukuoka/JP » Compliance of British thyroid ultrasound «U» guidelines - are we all speaking the “Unified” thyroid language? (C-1158) S. Singh; Leeds/UK » Are we requesting PET-CT scans in line with current guidance at the Edinburgh Cancer Centre in the diagnostic work-up of head and neck cancers? (C-1272) A. Vibhakar; Edinburgh/UK » Parathyroid glands: so small but yet so big (C-1520) M. Pérez Dávila; Madrid/ES

» MDCT signs of acute thoracic compartment syndrome (TCS): a pictorial review (C-1757) C. Liguori; Naples/IT

» Retropharyngeal calcific tendinitis of the musculus longus colli tendon - a clinical mimicker (C-1744) E.C. Schubert; Munich/DE

» Individualised CTPA injection protocol optimises contrast use and increases arterial attenuation (C-2235) H.-J. Raatschen; Hannover/DE

» Labyrinthine hemorrhage detected on magnetic resonance image as a cause of sudden profound sensorineural hearing loss (C-1837) D.-W. Park; Guri-si/KR

» CT-guided needle biopsy of lung lesions: is there the possibility of reducing the dose? (C-2317) G. Coppola; Rome/IT

www.myESR.org

Final Programme | ECR 2016

127

Programme by Session Type

THE VOICE OF EPOS 3

March

Thursday, March 3, 10:00–11:00 VoE 9 Emergency

3

March

Thursday, March 3, 11:00–12:00 VoE 10 Genitourinary

Moderator: S. Nougaret; St. Clement de Riviere/FR

Moderator: N. Caserta; Campinas/BR

» Traumatic adrenal hematoma: clinical and imaging findings (C-0193) A.S. Kahraman; Malatya/TR

» Vesical artery embolization in hemorragic cystitis in children, a case series of 3 patients (C-0380) D. Barnés Navarro; Montornés del Vallés/ES

» Magnetic resonance imaging evaluation of spinal cord injury with out radiographic abnormality (SCIWORA). (C-0640) D. Rajgopal; Manglore/IN

» Multifocal renal solid tumours: radiological approach (C-0781) M.Á. Corral de la Calle; Ávila/ES

» Major trauma CTs: how reliable are trainee radiologists reports? (C-0822) E. Lagha; London/UK

» Preliminary results of prostate artery embolisation as final treatment in selected BPH patients (C-0888) F. Imani; Rotterdam/NL

» Radiologic patterns of hepatic injuries following cardiopulmonary resuscitation (C-0941) A. Dixit; St. John’s/CA

» Imaging findings of various uterine and extrauterine leiomyomas with unusual appearance or location (C-0915) R. Dosho; Tokyo/JP

» Pearls and pitfalls in the diagnosis of ectopic pregnancy (C-1251) S. Ramanathan; Doha/QA

» Postpartum period: uncommon emergent complications (C-0922) M. Certo; Santo Tirso/PT

» Brain attack: imaging of non traumatic neuro emergencies, what radiologists should know (C-1563) R. Gautam; Manila/PH

» Comparison of ADC of normal uterine zones between postmenopausal and reproductive age women   (C-1267) A. Tsili; Ioannina/GR

» CT pulmonary angiography in pregnancy: to do or not to do? Role of minimally invasive CTPA (C-2058) A. Lemos; Milan/IT » Reliability and time effectivity of an assisted bone reading software for the analysis of CT trauma cases (C-2280) S.M. Anton; Lübeck/DE » MDCT signs accuracy in detection of acute perforated appendicitis (C-2354) P. P. Saturnino; Naples/IT

» Technical pitfalls in prostate MRI - insights into eliminating artifacts in your prostate protocol (C-1392) M. Czarniecki; Warsaw/PL » Differentiation of adrenal nodular hyperplasia and lipid-poor adenoma by clinical manifestation and advance virtual monoenergetic technique on CT (C-2047) W. Shu xian; Zhengzhou/CN » Diffusion magnetic resonance in cervical carcinoma: the role of ADC in the evaluation of treatment response (C-2114) G.M. Barelli; Rome/IT » Value of MRI features of acute adnexal torsion in pregnant women (C-2216) D. Kang; Dong-gu, Ulsan/KR

128

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 3

March

Thursday, March 3, 12:00–13:00 VoE 11 Chinese

3

March

Thursday, March 3, 13:00–14:00 VoE 12 Oncology

Moderator: V. Chong; Singapore/SG

Moderator: O. Tanaka; Tsukuba/JP

» Resting-state functional magnetic resonance imaging study on amplitude of low-frequency fluctuate of somatoform disorder (C-0137) L. Wei; Chongqing/CN

» Increased incidence of pancreatic cancer in hepatocellular carcinoma cohort (C-0038) W. Gonoi; Tokyo/JP

» Quantitative spectral CT evaluation of kidney tumours with the stretched-exponential nonlinear regression analysis model (C-0256) X. Yang; Shenyang/CN » Safety and efficacy of high-dose adenosine stress cardiac MR   (C-0718) Y.Y. Kwong; Hong Kong/CN » The experimental study of diffusion kurtosis imaging combined with dynamic contrast-enhanced magnetic resonance imaging in the prediction of posttraumatic epilepsy (C-0971) W. Li; Shanghai/CN » Differentiation of angiomyolipoma with minimal fat and common non-clear cell renal cell carcinoma on MDCT (C-1104) X. Li; Tianjin/CN » The combination of shear wave elastography and contrast-enhanced ultrasound for diagnosing breast lesions: a mutiple logistic regression analysis (C-1371) H. Wu; Chengdu/CN » Dynamic functional connectivity patterns of the subgenual anterior cingulate cortex in patients with refractory and nonrefractory major depressive disorders (C-2173) B. Cheng; Chengdu/CN » Cortico-striatal connectivity in drug-naive patients with obsessive-compulsive disorder (C-2349) X. Hu; Chengdu/CN

» A web-based and user friendly planning tool to predict outcome for percutaneous cryoablation of renal tumours including validation of the simulation model (C-0451) J.J. Futterer; Nijmegen/NL » Dual energy CT quantification of lipiodol deposition after transarterial chemoembolization in patients with hepatocellular carcinoma (C-0608) Y. Yoshiyasu; Nagoya/JP » Y90-radioembolization of hypovascular liver lesions: role of cone-beam CT (C-0698) A. Grigolini; Pisa/IT » Response assessment of response to treatment in the cancer patient: a tutorial for the radiologist (C-0755) A. Nunziata; Ercolano/IT » Dose modulation in low dose lung cancer screening: how low can we go? (C-0920) N. Verma; Gainesville, FL/US » Comparative analysis of multi-parametric positron emission tomography, diffusion weighted imaging and diffusion tensor imaging values in lung adenocarcinoma patients (C-1249) S. Lucic; Sremska Kamenica, Novi Sad/RS » Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen (C-1544) M. Silva; Parma/IT » Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer (C-2122) K.L.M. Michielsen; Leuven/BE » Five year follow up of indeterminate pulmonary nodules in osteosarcoma patients: how do they behave? (C-2190) M. Iqbal; Lahore/PK

www.myESR.org

Final Programme | ECR 2016

129

Programme by Session Type

THE VOICE OF EPOS 3

March

Thursday, March 3, 14:00–15:00 VoE 13 Nordic

3

March

Thursday, March 3, 15:00–16:00 VoE 14 Russian

Moderator: M. Torkzad; Milford/UK

Moderator: I. Arkhipova; Moscow/RU

» Assessment of effective dose in a series of CT of the knees, time to revise the guidelines? (C-0205) J.M.E. Torsvik; Bergen/NO

» Assessment of dynamic pelvic floor MRI (MRdefecography) (C-0069) K.S. Petrov; Moscow/RU

» Magnetic resonance imaging of hyperacute tissue injury and regional cerebral blood flow in clinically relevant ischemic stroke model in the rat (C-0320) P. Little; Stockholm/SE

» Cervical spine MRI in Hirayama disease: practical aspects (C-0189) E.I. Kremneva; Moscow/RU

» Measuring mammographic density: comparing a fully automated volumetric assessment versus European radiologists’ qualitative classification (C-0383) H. Sartor; Malmö/SE » MRI changes after the implantation of percutaneous interspinous device Aperius in spinal stenosis a retrospective cohort study (C-0469) W. Witwit; Gothenburg/SE » Dynamic contrast enhanced computed tomography: effects of non rigid motion correction on image quality and reproducibility (C-0564) K.R. Brow; Glostrup/DK » PGMI score of baseline mammograms before interval cancers in a population-based screening programme (C-0675) R. Gullien; Oslo/NO » Emerging role of functional brain MRI in low-grade glioma surgery (C-0873) A. Friismose; Odense/DK » Protocol for evaluation of radiologist’s active role in the diagnostic assessment of patients with vague symptoms suspected of serious illness that can be cancer  (C-1687) N. Lapitskaya; Silkeborg/DK » Semi-automatic quantification of exocrine pancreatic function by secretin-stimulated MRI in chronic pancreatitis and healthy subjects (C-1921) A. Madzak; Aalborg/DK

» Ultrasound diagnostics simulators for students and residents: implementation experience (C-0239) D. Venidiktova; Smolensk/RU » Opposed phase (out-of-phase) imaging. Resident guide   (C-0472) T. Movsisyan; Moscow/RU » Proton MR spectroscopy of ischemic rat brain: dynamic changes of metabolites in infarct zone in deferent normalisations (C-0518) D. Namestnikova; Moscow/RU » Evaluation of the radiation-induced brain injury: MRI follow-up study (C-0707) Z. Savintseva; Saint-Petersburg/RU » Localization of Broca’s and Wernicke’s areas with resting state fMRI (C-1673) E. Pechenkova; Moscow/RU » The comparison between coronary CT angiography and intravascular ultrasound for assessment of coronary plaque components in patients with acute coronary syndrome (C-1696) M. Shabanova; Moscow/RU » Brain CT-perfusion: correlation between completeness of the circle of Willis and haemodynamic changes in cases of not-acute atherosclerotic occlusion of main brachiocephalic arteries (C-2366) A. Vishnevskaia; Moscow/RU

» The natural history of non-resected intraductal papillary mucinous neoplasms (IPMN) of the pancreas: a single institution experience (C-2387) N. Kartalis; Stockholm/SE

130

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 3

March

Thursday, March 3, 16:00–17:00 VoE 15 Abdominal/GI

4

March

Friday, March 4, 09:00–10:00 VoE 16 Head and Neck

Moderator: I. Arkhipova; Moscow/RU

Moderator: K. Bhatia; Hong Kong/CN

» Radiofrequency ablation following transarterial chemoembolization for patients with BCLC B, C stage hepatocellular carcinoma (C-0067) T. Jianfei; lishui/CN

» Correlation between sonographic features and nuclear morphometric parameters in parotid gland tumours (C-0079) D. Obad Kovacevic; Zagreb/HR

» Peritoneal cavity anatomy in CT peritoneography: a comprehensive description (C-0401) J. Calvo Blanco; Oviedo/ES

» Nodular (N) and non-nodular (non-N) configuration of subacute granulomatous thyroiditis (SAT): characteristics and interval change (IC) using followup (FU) ultrasonography (US) (C-0129) Y.J. Lee; Busan/KR

» Part II - Video animation of anomalies of rotation of gut (C-0580) M.D. Rahalkar; Pune/IN » The role of MRCP in a hospital with a 24/7 experienced ultrasound service: when is MRCP indispensable and when could it be avoided? (C-0789) V. Moustakas; Rodos/GR » Imaging of ALPPS procedure: what the radiologist should know (C-0818) M. Zerial; Udine/IT » Reproducibility of relative liver enhancement (C-0836) K.A. Schelz; Kogarah/AU » Evaluation of the scan timing for CT during arterial portography using two different bolus tracking methods (C-0856) A.Chiba; Sapporo, Hokkaido/JP » Primary solid tumours of the liver: a pictorial review (C-1424) P. Brown; Leeds/UK » Linitis plastica of the rectum: an unusual type of rectal cancer (C-1723) D.M. Angulo; Palma de Mallorca/ES

» Head and neck manifestation of aarcoidosis: a pictorial review of findings at CT and MR (C-0253) J. Rogers; Knoxville, TN/US » Ultrasound for the diagnosis of carotidynia (C-0261) M.A. Abrahamy; Zerifin/IL » Differential diagnosis of non-traumatic lesions of the scalp: a pictorial review (C-0284) R. Morcillo; Toledo/ES » Cystic fibrosis sinus score (CFSS) for the evaluation of the paranasal sinuses complications of cystic fibrosis using cone beam CT (C-2007) M.C. Firetto; Milan/IT » Thyroglossal duct cyst: imaging characteristics and clinical correlation (C-2132) I.H. Lee; Daejeon/KR » Evaluation of shear wave elastography with transverse and longitudinal scans: differentiation between benign and malignant thyroid nodules (C-2383) Y.J. Choi; Seoul/KR

» Predictive value of the target appearance on the hepatobiliary phase of GD-EOB-DTPA MRI in the patients of breast cancer hepatic metastasis: the first step for the personalised radiology (C-2030) H.J. Lee; Seoul/KR

www.myESR.org

Final Programme | ECR 2016

131

Programme by Session Type

THE VOICE OF EPOS 4

March

Friday, March 4, 10:00–11:00 VoE 17 Interventional

4

March

Friday, March 4, 11:00–12:00 VoE 18 Musculoskeletal

Moderator: I. Bargellini; Pisa/IT

Moderator: E. Llopis; Alzira-Valencia/ES

» Out of sight, out of mind? A three point plan to optimize IVC filter follow-up (C-0231) C. C. Logan; Dublin/IE

» Tarsal tunnel syndrome: evaluation on MRI (C-0022) Y. Kobashi; Chiba/JP

» Liver regeneration: comparison of portal vein embolization versus radio-frequency-assisted liver partition with portal vein ligation (RALPP) (C-0471) M. Tsakok; London/UK » Minimally invasive treatment of osteoid osteoma (OO): MR guided focused ultrasound surgery (MRgFUS) and radiofrequency thermal ablation (RFA) (C-0473) F. Arrigoni; L’Aquila/IT

» Dynamic MRI scan in osteosarcoma and Ewing sarcoma (C-0295) O. M. Albtoush; Vienna/AT » An optimal protocol for full-spine radiography (C-0649) C. Ernst; Brussels/BE » Scaphoid imaging with digital tomosynthesis as an adjunct to radiography: a single department’s experience (C-1036) B. Gibney; Dublin/IE

» The use of fluoroscopy and ultrasound guidance in placement of peritoneal dialysis catheter (C-0911) A.M.K. Abdel Aal; Birmingham, AL/US

» Anatomy and non-traumatic pathology of the atlantoaxial joint (C-1260) G. Retnasingam; Leicester/UK

» Evaluation of sclerotherapy for the treatment of infected postoperative lymphocele (C-1013) S.H. Kang; Seongnam-si/KR

» The diagnostic challenge of groin pain in adults: review of imaging modalities and differential diagnoses (C-1291) A. Zaidi; Ariana/TN

» Key points of successful percutaneous ethanol sclerotherapy (PEST) procedure – long term results of PEST treatments in patients with symptomatic liver and splenic cysts (C-1553) A. Kollár; Budapest/HU » Variant hepatic arterial anatomy and extra-hepatic arterial supply in hepatocellular carcinoma (HCC) and colorectal metastases: impact on transarterial chemoembolization (TACE) planning and technique (C-1686) S. Aquilina; Msida/MT » Correlation of peak skin dose with geometrical and dosimetric parameters from interventional procedures (C-1835) N. Fitousi; Leuven/BE » A new classification of stent graft-induced distal complications (SIDCs) after repair with stainless steel-based device for aortic dissection (C-2062) Y. Xue; Beijing/CN

» Radiographic signs predicting rotator cuff tears (C-1443) J.J. van der Reijden; Deventer/NL » MR imaging in the post-therapeutic/post-surgical follow-up of malignant musculoskeletal neoplasms: pearls and pitfalls (C-1781) N.S. Sideri; Chaidari/GR » Cyclops lesions do not worsen clinical outcome two years after anterior cruciate ligament surgery (C-2026) L. Facchetti; San Francisco, CA/US » Radiation dose of lumbar spine CT: analysis and comparison between different modes of acquisition in two European imaging centers (C-2386) A. Papachristodoulou; Thessaloniki/GR

» Checklist use in radiology: an Australia-wide crosssectional study (C-2209) C. Mandel; Melbourne/AU

132

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 4

March

Friday, March 4, 12:00–13:00 VoE 19 Turkish

4

March

Friday, March 4, 13:00–14:00 VoE 20 Neuro

Moderator: C. Calli; Izmir/TR

Moderator: E. Ada; Izmir/TR

» Value of dynamic MR imaging using the Ktrans technique for assessment of native kidneys in preemptive renal transplantation (C-0033) R. Sade; Erzurum/TR

» T2*-weighted perfusion MRI imaging biomarkers obtained at the peritumoural area of high-grade gliomas relate to patients survival (C-0599) L. Marti-Bonmati; Valencia/ES

» Evaluation of bone marrow via diffusion-weighted imaging in adult patients with acute leukemia (C-0062) A. Kocyigit; Denizli/TR

» Hypertrophic olivar degeneration: review of literature and presentation of a 7 case series (C-0728) J.P. Martínez Barbero; Jaen/ES

» The view from the mastoid fontanel of the neonatal brain (C-0974) F.C. Sarioglu; Izmir/TR

» 3D arterial spin labelling: as a part of routine MRI brain protocols (C-0792) M. R. Verma; Mumbai/IN

» MRI findings in paediatric acquired brown syndrome with various etiological factors (C-0983) C.Z. Karaman; Aydin/TR

» High resolution MRI of the intracranial arterial wall: utility and imaging findings in a variety of disease states (C-0878) S. Power; Toronto, ON/CA

» Decreased bilateral insula volume and widespread white matter dysintegrity in schizophrenia (C-1033) A. Onay; Istanbul/TR

» Diffusion tensor imaging of spinal cord as an emerging tool in neuroradiology (C-1049) K. Agawane; Mumbai/IN

» Efficiency and utility of strain elastography in the diagnosis and staging of acute appendicitis in patients in paediatric age group (C-1103) H. Arslan; Van/TR

» Gender related peculiarities of amygdala deactivation during movements (C-1342) O. Omelchenko; Kyiv/UA

» Extraarticular lateral ankle impingement (C-1282) C. Cevikol; Antalya/TR » Evaluation of optic nerve head biomechanical properties in pseudoexfoliation glaucoma with realtime ultrasound elastography (C-1412) Ö. Ünal; Ankara/TR » Rhabdomyosarcoma everywhere: differential diagnosis on imaging (C-1675) A. Güneş; Ankara/TR » Evaluation of iron accumulation in choroid plexus in patients with beta-thalassaemia major by using susceptibility weighted imaging (SWI) (C-2254) E. Üre; Istanbul/TR

www.myESR.org

» Middle cerebral artery anatomy: do you know yours? (C-1360) D.P. Mitchell; Dublin/IE » Ultra-high field MRI of the substantia nigra in patients with atypical parkinsonisms (C-1366) D. Frosini; Pisa/IT » Intrinsic brain abnormalities in drug-naive patients with obsessive-compulsive disorder: a resting-state functional MRI study (C-2361) X. Hu; Chengdu/CN » Diffusion MR imaging using multi-band EPI in brain: basics and its clinical application (C-0595) M. Hori; Tokyo/JP

Final Programme | ECR 2016

133

Programme by Session Type

THE VOICE OF EPOS 4

March

Friday, March 4, 14:00–15:00 VoE 21 Spanish

4

March

Friday, March 4, 15:00–16:00 VoE 22 Japanese

Moderator: A. Alberich-Bayarri; Valencia/ES

Moderator: Y.O. Tanaka; Tsukuba/JP

» Multi-task paradigm in functional magnetic resonance imaging (fMRI) (C-0011) A. Granados; Cali/CO

» Proposal of quantitative identification method of a small-type OSL dosimeter: conditions that the dosimeter is not identified in the medical image (C-0010) K. Takegami; Tokushima/JP

» Diagnostic errors: understanding the concepts through spine examples (C-0444) R. Mirón Mombiela; Valencia/ES » Prognostic value of early diffusion weighted MRI in full-term newborns with hypoxic ischemic encephalopathy (C-0795) E.-M. Heursen; Cádiz/ES » Ultrasound of the lumbar spine: what should the radiologist know to perform interventional spine procedures? Technique, normal anatomy, and anatomic variant with radiologic correlation (C-1327) M. Squarcia; Barcelona/ES

» Comparison of shear wave velocity measurement using VTQ and VTIQ: phantom and cervical lymph node studies (C-0290) R. Kishimoto; Chiba/JP » Evaluation of energy dependence of nanoDot optically stimulated luminescence (OSL) dosimeter using characteristic x-ray induced by medical x-ray equipment (C-0338) T. Okazaki; Tsukuba, Ibaraki/JP

» Imaging findings of paediatric intestinal, liverintestinal, and multivisceral transplantation (C-1358) M. Parrón; Madrid/ES

» Imaging of pulmonary nontuberculous mycobacterial infection: variations, sequential changes, and differential diagnoses (C-0584) S. Noguchi; Tenri/JP

» Detection of bone metastases through diffusionweighted whole-body imaging with background body signal suppression (DWIBS) (C-1601) H. Barragán-Campos; Queretaro/MX

» Image quality evaluation of turbo-spin echo diffusion weighted image (TSE-DWI): a phantom study (C-0631) T. Yoshida; Shizuoka/JP

» Retained surgical sponge in chest and abdomen: CT imaging appearance and complications (C-1614) S. Ramirez; Medellin/CO

» Evaluation of myocardial fibrosis using T1 mapping in dilated cardiomyopathy (DCM) compared with endomyocardial biopsy (EMB) (C-0651) Y. Morita; Suita, Osaka/JP

» Post-treatment imaging in primary and secondary brain tumours: a diagnostic challenge (C-1672) D.D.J. De la Rosa Porras; Madrid/ES » Aorto-caval space: a forgotten retroperitoneal space (C-1925) C. Varela Ubilla; Santiago/CL » MRI: the technique of choice in the study of pleomorphic adenoma (C-2211) B. Brea Alvarez; Majadahonda/ES

» Consideration of reliability in the diagnosis of acute ischemic cerebrovascular disorders about MRI in iPad air (C-1280) H. Hattori; Toyoake/JP » Research and development of tumour response observation system for dose-volume delivery guided particle therapy (TROS-DGPT) (C-1362) T. Nishio; Hiroshima/JP » Development of activity pencil beam algorithm using measured distribution data of positron emitter nuclei generated by target nuclear fragmentation reaction for innovative proton therapy (C-1364) A. Nishio-Miyatake; Yokohama/JP » A predictive factor of delayed neurological sequelae following carbon monoxide intoxication (C-1695) Y. Kubo; Tokyo/JP

134

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 4

March

Friday, March 4, 16:00–17:00 VoE 23 Genitourinary

5

March

Saturday, March 5, 09:00–10:00 VoE 24 Neuro

Moderator: V.F. Muglia; Ribeirao Preto/BR

Moderator: Moderator: C. Calli; Izmir/TR

» Postsurgical complications of the urinary diversion after radical cystectomy (C-0678) B. Garcia Martinez; Santander/ES

» Incidence, risk factors and clinical significance of contrast staining areas after mechanical thrombectomy in patients with acute ischaemic stroke (C-1082) M. Rusina; Trnava/SK

» MRI of benign and malignant lesions of prostate (C-0964) A. Bangaragiri; Singapore/SG » Emergency imaging of acute abdomen of gynecologic origin: spectrum of MDCT findings (C-1213) V.S. Teran Pareja; Madrid/ES » Benign mimics of gynecologic malignancies (C-1523) D. Ballah; San Francisco, CA/US » MRI findings of placental invasion without placental previa (C-1594) S. Kitai; Tokyo/JP » Contribution of magnetic resonance imaging of pelvic floor to de novo stress urinary incontinence post vaginal delivery (C-2180) N. Li; Tianjin/CN

» Grey-white matter ratio of the brain: a candidate marker for the duration of the terminal phase based on post-mortem CT-scans (C-1141) P.A.M. Hofman; Maastricht/NL » Extra-axial hyperdense lesions in head CT scan without contrast: systematic guide of differential diagnosis (C-1273) A. Pacheco; Valencia/ES » Stroke imaging – time is brain (C-1743) R. Rege; Mumbai/IN » Fiber tractography of the brachial plexus in patients with avulsion trauma (C-1851) M. Amelin; Novosibirsk/RU

» Low dose multidetector CT for the initial detection of urolithiasis: a local clinical audit (C-2239) Y.A.R.M. Selim; Nizwa/OM

» Understanding microstructure of the brain with advanced diffusion tensor imaging and comparing with pathological findings (C-1967) K. Sato; Tokyo/JP

» Radiologic percutaneous interventions for ureter disease (C-0966) H. Lee; Anyang/KR

» The outcome of fMRI language mapping is affected by patient fatigue (C-2314) M. Kiss; Budapest/HU

» Prostate cancer: correlation of intravoxel incoherent motion MR parameters with Gleason score (C-0918) D.M. Yang; Seoul/KR

» Comparison of quantitative susceptibility mapping at 1.5- and 3.0-Tesla (C-2355) O. Solyanik; Hanover/DE » Neuroimaging of the sciatic nerve high division causing Piriformis syndrome (C-2379) S.A. Jengojan; Vienna/AT » Stent-retriever thrombectomy of small caliber intracranial vessels using pREset LITE - safety and efficacy (C-2381) W. Kurre; Stuttgart/DE

www.myESR.org

Final Programme | ECR 2016

135

Programme by Session Type

THE VOICE OF EPOS 5

March

Saturday, March 5, 10:00–11:00 VoE 25 Breast

5

March

Saturday, March 5, 11:00–12:00 VoE 26 Paediatric

Moderator: E. Fleury; Sao Paulo/BR

Moderator: M. Argyropoulou; Ioannina/GR

» Real-time elastography: impact of strain ratio on diagnostic performance of solid breast lesions (C-0731) K. Bojanic; Osijek/HR

» Gastro-intestinal anomalies in infants with congenital diaphragmatic hernia: prenatal diagnosis and postnatal complications (C-0372) K. Minkner; Neuchâtel/CH

» Importance of anatomopathological-imaging correlations for the validation of a breast biopsy results (C-1182) A. Jalaguier-Coudray; Marseille/FR

» Which serum biochemical markers could predict radiologic metabolic bone disease in preterm infants? (C-0890) J.W. Park; Daejeon/KR

» MRI in high cancer-risk patients with BIRADS-3 lesions: is short-interval follow-up the answer? (C-1211) G. Bar On; Beer Yaakov/IL

» CT and MRI imaging features of paediatric rhabdomyosarcomas (RMS) (C-1441) L. A. Fowkes; London/UK

» Health-related quality of life, anxiety and depression in women related to mammography in Greece (C-1325) A. Zisakis; Athens/GR » The European Commission Initiative on Breast Cancer (ECIBC) and the development of the person-centered new European guidelines (C-1470) A. Uluturk Tekin; Varese/IT » Reduction mammoplasty: what radiologists should know (C-1558) S. Plaza Loma; Valladolid/ES » Is there a place for dual-energy contrast enhanced digital mammography in daily practice? (C-1746) I. Garkalne; Merchtem/BE » The accuracy of MRI in evaluating residual tumour size and complete response post neoadjuvant chemotherapy in patients with non metastatic breast cancer (C-1869) H.A. Fleming; Cork/IE

» Imaging evaluation of the thyroid gland in children: what radiologists should know (C-1616) B.F. Corgosinho; São Paulo/BR » Assessment of the quality of portable x-ray examinations at a level 3 neonatal intensive care unit (NICU) (C-1769) J. Deakin; London/UK » The role of diffusion tensor imaging (DTI) in developmental brain anomalies in pediatric age group of Egyptian patients (C-2097) D.H.F.H. Haroun; Cairo/EG » Patient size and radiation dose: a grid too far? (C-2129) J. Shur; London/UK » Serial flow-sensitive 4D MRI in paediatric patients with Marfan syndrome for early risk stratification of progressive aortic disease (C-2156) J. Geiger; Zurich/CH

» Can breast cancer biopsy influence sentinel lymph node status? (C-2149) R. Rella; Rome/IT » Quantitative 1HMR spectroscopy as a predictive biomarker of pathological complete response during neoadjuvant chemotherapy for localy advanced breast cancer: results from early response assessement (C-2382) S. Drisis; Brussels/BE

136

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 5

March

Saturday, March 5, 12:00–13:00 VoE 27 German

5

March

Saturday, March 5, 13:00–14:00 VoE 28 Musculoskeletal

Moderator: S. Delorme; Heidelberg/DE

Moderator: A. Guermazi; Boston, MA/US

» A web-based and user friendly planning tool to predict outcome for percutaneous microwave ablation of liver tumours including validation of the simulation model (C-0241) C. Schnedl; Graz/AT

» Referring physicians’ experiences of outsourcing radiological examinations (C-0447) P. Tavakol Olofsson; Stockholm/SE

» Flip-angle and compliance assessment of the median nerve as diagnostic tools in CTS? (C-0439) L. Gruber; Innsbruck/AT » Development of an analogue decision aid for mammographic mass lesions based on a naive Bayes network (C-0704) M. Benndorf; Freiburg/DE » Radial volumetric interpolated breath-hold examination of the liver: clinical impact of selfgated 3D isotropic contrast-enhanced late-phase MR imaging (C-1032) J. Weiß; Tübingen/DE

» Fat suppression techniques for MR imaging of the musculoskeletal system (C-0585) C. Tsiotsios; Haidari/GR » Beyond ulcers and osteomyelitis: imaging of less common musculoskeletal complications in diabetes (C-0775) A. Rao; Bangalore/IN » Clinical evaluation of a new x-ray imaging system based on Talbot-Lau interferometry: comparison of patients with RA to healthy volunteers (C-0953) J. Tanaka; Iruma-County/JP » Calcific tendonitis affecting the linea aspera: a case series and systematic narrative review (C-1310) S.B.L. Low; Norwich/UK

» MRI-derived regional biventricular function in patients with chronic thromboembolic pulmonary hypertension (CTEPH) before and after pulmonary endarterectomy (PEA) (C-1677) S. K. Maschke; Hanover/DE

» Diagnostic benefit of susceptibility weighted magnetic resonance imaging for the assessment of subacromial spur formation causing subacromial impingement syndrome (SAIS) (C-2039) D. Nörenberg; Munich/DE

» Cloud-based teleoncology system for interactive evaluation of new software tools through common web browsers and its application to multi-disciplinary treatment planning (C-1829) J. Woetzel; Bremen/DE

» “Fat brook” of posteromedial popliteal fossa: pathologic correlation between cadaver and MR imaging (C-2172) Y. Song; Seoul/KR

» Breast cancer detection and tumour characteristics differ in BRCA1 and BRCA2 mutation carriers (C-2131) J. Knaudt; Mannheim/DE

» Can we predict fracture in pathologic altered bone of the proximal femur using only plain radiographs? (C-2194) M. Simunovic; Zagreb/HR

» Flow velocity determination by magnetic particle imaging: phantom validation and in vivo measurements in a mouse model (C-2215) M. Kaul; Hamburg/DE

» Low-energy laser therapy efficacy assessment by MRI in patients with herniated intravertebral discs (C-2281) A. Tkachev; Volgograd/RU

» In vivo visualisation of tumour-mediated immune remodelling in premetastatic tissue - target-specific imaging of S100A8/A9 reveals premetastatic niche establishment (C-2334) M. Eisenblatter; Münster/DE

» Predicting poor outcome from simple ankle injuries (C-2371) S. Bullock; Oxford/UK

www.myESR.org

Final Programme | ECR 2016

137

Programme by Session Type

THE VOICE OF EPOS 5

March

Saturday, March 5, 14:00–15:00 VoE 29 Korean

5

March

Saturday, March 5, 15:00–16:00 VoE 30 Portuguese

Moderator: J.M. Goo; Seoul/KR

Moderator: V.F. Muglia; Ribeirao Preto/BR

» Adenovirus pneumonia: thin-section CT findings in 104 immunocompetent patients (C-0224) C. Park; Daejeon/KR

» CT role in distinguishing GIST from non-GIST mesenchymal gastric tumours (C-0686) N. Almeida Costa; Porto/PT

» Abnormalities in intrahepatic periportal space: multimodality imaging findings (C-0541) J.Y. Oh; Busan/KR

» Borderline breast lesions: Correlation between imaging, epidemiology and histology - 7 years of experience (C-1121) G.G.N. Mello; São Paulo/BR

» Guideline for repeat imaging studies: nationwide result of pilot project for application of the guideline (C-0544) S.E. Jung; Seoul/KR » Role of CT in siting and post procedural following of central venous catheter: anatomical review and strategy for preventing complication (C-0952) E.-J. Kang; Busan/KR » Corrosive esophageal cancer: esophagographic and computed tomography (CT) findings (C-1154) S.Y. Noh; Seoul/KR » Distinct pattern of recurrence of lung mucinous adenocarcinoma after surgical resection: implication for postoperative surveillance strategy (C-1697) D.H. Lee; Daegu/KR » Ankle after Brostrom operation: MR imaging findings in individuals without lateral instability - a pilot study (C-2171) J. Yi; Bucheon-si/KR » Reproducibility and diagnostic performance of shear wave elastography in evaluating breast solid mass (C-2176) H.S. Shin; Seoul/KR » Fluoroscopic-guided artificial pneumoperitoneum formation for the management of air leak after pulmonary resection (C-2299) H.Y. Choi; Seoul/KR

» Do not fall on your knees - recognizing common and uncommon pitfalls that may simulate meniscal tears (C-1146) P. Musa Aguiar; São Paulo/BR » Prognostic value of baseline MRI in glioblastoma multiforme patients:  a survival analysis of morphological, volumetric and diffusion MRI predictors (C-1179) D.J. Pereira; Coimbra/PT » Breast fibromatosis: the great pretender (C-1238) C. Salvador; Lisbon/PT » The role of ultrasonography with colour Doppler in the acute scrotum (C-1509) A.L. Amado Costa; Lisbon/PT » The immediate effect of sildenafil on right ventricular function in patients with heart failure measured by cardiac magnetic resonance: a randomized controlled trial (C-1586) S.M. Borges; Salvador/BR » Imaging findings after breast implant removal (C-1888) E. Francolin; São Paulo/BR » Radioprotection in paediatric CT examinations: application of a dose reduction protocol (C-2363) B.P.M. Morgado; Vila Real de Santo António/PT

» Evaluation of the antiperistaltic effect of intravenous butylscopolamine in pediatric magnetic resonance enterography (C-2368) S. Jang; Seoul/KR

138

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 5

March

Saturday, March 5, 16:00–17:00 VoE 31 Interventional

6

March

Sunday, March 6, 09:00–10:00 VoE 32 Vascular

Moderator: A. Basile; Catania/IT

Moderator: I. Bargellini; Pisa/IT

» Evidence-based levels, guidelines and recommendations in interventional spine treatments according to clinical diagnoses (C-0324) H. Brat; Sion/CH

» Anomalies and normal variants of the intracranial arteries: proposed workflow for classification and significance (C-0199) A. Hakim; Bern/CH

» Percutaneous embolization in pelvic congestive syndrome. Does it really improve symptoms? (C-0708) M.D. Ferrer-Puchol; Alzira/ES

» Anomalous pulmonary venous connection: the journey from theory to practice (C-1245) C. Schiau; Cluj-Napoca/RO

» Creating a larger zone of safety versus “livin’ on the edge”-a review of rare complications of microwave ablation (C-0712) Y. Zhang; Valhalla, NY/US » Preoperative thrombus volume predicts sac enlargement after EVAR (C-1419) R. Müller-Wille; Regensburg/DE » Percutaneous transhepatic intraductal biopsy in biliary stricture differentiation (C-2029) D. Frantsev; Moscow/RU » Comparison of lesion conspicuity between conventional ultrasonography and Sonazoid contrast enhanced ultrasonography as pretreatment evaluation for percutaneous radiofrequency ablation of small hepatocellular carcinomas (C-2112) J.W. Seo; Goyang/KR » Safety and survival in the management of complicated tunneled and non-tunneled catheters: a comparison of over-the-wire catheter exchange and catheter removal and replacement (C-2120) Y. Yim; Seoul/KR » Radiation exposure to interventional radiologists during endovascular procedures (C-2124) A.M.H. Sailer; Maastricht/NL » Transarterial embolisation of type II endoleaks after EVAR with the use the embolic polymer Onyx (C-2146) M. Wojtaszek; Warsaw/PL

www.myESR.org

» All clogged up: spectrum of venous thrombosis in the abdomen and pelvis (C-1597) E. Zalaquett; Santiago/CL » MRI assessment of vascular age: principles, techniques and applications (C-1909) M.N. Sicaja; Zagreb/HR » Isolated cortical vein thrombosis: a review of imaging features and diagnostic pitfall (C-1975) K.H. Lee; Deajeon/KR » Dual source dual energy CT: optimising performance of routine contrast enhanced chest CT for detection of pulmonary embolus (C-2054) D. Caruso; Rome/IT » Distinguishing high-flow from low-flow vascular malformations using maximum intensity projection images in dynamic magnetic resonance angiography (C-2297) N.K. Majewska; Poznan/PL » Comparison imaging findings in patients with internal carotid artery dissection and vertebral artery dissection (C-2340) M. Dreval; Moscow/RU » Dynamic CT angiography in native kidneys using a multiphase CT protocol - potential of significant reduction of contrast medium (C-2389) A. Helck; Munich/DE

Final Programme | ECR 2016

139

Programme by Session Type

THE VOICE OF EPOS 6

March

Sunday, March 6, 10:00–11:00 VoE 33 Oncology

Sunday, March 6, 11:00–12:00 VoE 34 Cardiac

Moderator: S. Delorme; Heidelberg/DE

Moderator: E. Mershina; Moscow/RU

» Pain palliation in metastatic bone disease: interventional radiology is a “key player” among equals (C-1299) D.K. Filippiadis; Marousi, Athens/GR

» Syntax score in patients with high computed tomography coronary calcium score (C-0243) M. Hegde; Bengaluru/IN

» PET/CT in diagnosis of synchronous and metachronous tumours (C-1528) D. Zlatareva; Sofia/BG » Elastofibroma dorsi: diagnosis and follow-up (C-1640) M. Bartocci; Rome/IT » The copycat - an illustrative review of benign entities that may mimic malignancy from head to toe (C-1719) C. Azzopardi; Birkirkara/MT » Compare multiparametric 3TMRI to clinical parameters to characterise single lesion of prostate cancer, using three different scores: Likert scale, PIRADS v1 and v2 (C-2157) L. Zantedeschi; Verona/IT » Diffusion weighted MRI; can it help in differentiation of abdomino-pelvic lymphadenopathy; comparative study (C-2266) M. Essam; Cairo/EG » Impact of structuring a computed tomography (CT) report on radiological practice and clinicians’ perception: a study on lymphoma patients (C-2271) R. Girometti; Udine/IT » Increased reproducibility of semiautomatic 3D-segmentation over 2D-measurements for quantification of specific iodine uptake of hepatic colorectal metastases in dual-energy CT (C-2308) K.S. Winter; Munich/DE » Increased abdominal visceral adiposity is associated with unsuspected pulmonary embolism in hospitalised patients with malignant digestive tract tumours (C-2325) L. Lin; Guangzhou/CN

140

6

March

ECR 2016 | Final Programme

» Assessment of left ventricular dissipative energy loss by vector flow mapping in end stage senal disease patients (C-0670) Y. Zhong; Chengdu/CN » Feasibility of low-concentration iodinated contrast medium with lower-tube-voltage dual-source CT aortography using iterative reconstruction: comparison with automatic exposure control CT aortography (C-0702) D.M. Choo; Daejeon/KR » Vessel flexibility index as a potential new marker for cardio-vascular disease - a pilot study (C-1535) E. Nagy; Graz/AT » Dynamic CT cardiac perfusion protocol at 70 kV: impact on radiation and contrast agent dose (C-2073) N. Buls; Brussels/BE » Relation between left atrial appendage morphology and left atrial volume in patients with atrial fibrillation (C-2082) R. Faletti; Turin/IT » Rationale and design of the PERFECTION (C-2083) G. Pontone; Milan/IT » Occult coronary artery disease in asymptomatic patients: utility of coronary computed tomography angiography as a screening tool (C-2164) L. Patriarca; L’Aquila/IT » Determination of scan delay time in coronary CT angiography: utility of ECG gated bolus tracking technique (C-2221) J. Chang; Seoul/KR » Peri-aortic fluid after surgery of the ascending aorta: range of normal findings on early postoperative CT (C-2331) S. Boccalini; Genova/IT

www.myESR.org

Programme by Session Type

THE VOICE OF EPOS 6

March

Sunday, March 6, 12:00–13:00 VoE 35 Chest Moderator: M. Toepker; Vienna/AT » Value of expiratory chest x-rays in diagnosing pneumothorax (C-0314) M. Imran; Middlesborough/UK » Mixed convolution kernel in thoracic computed tomography images (C-0875) J. Neubauer; Freiburg/DE » Pulmonary imaging in ANCA-associated vasculitides (C-1473) M. Affes; Ariana/TN » Complications of tuberculous mediastinal lymphadenitis in HIV-positive patients: CT findings (C-1525) I. Sokolina; Moscow/RU » A quantitative CT analysis in the evaluation of lymph node involvement of pulmonary tuberculosis and sarcoidosis (C-1721) H. Choi; Seoul/KR » A novel classification system for thoracic gallstones (C-2155) A.J.S. Lott; Tromso/NO » Influence of computed tomography dose reduction and iterative reconstruction on computer-aided detection of pulmonary nodules (C-2186) R. W. van Hamersvelt; Utrecht/NL » Influence of arterial input function placement on CT lung dynamic perfusion maps (C-2229) N.S. Paul; Toronto, ON/CA » Subclinical pulmonary tuberculosis and airway obstruction: correlation of HRCT findings with pulmonary function test and immunologic diagnostic test of tuberculosis (C-2327) D.H. Lee; Ansan/KR » When fat is good news: lipoid pneumonia, an overlooked differential diagnosis (C-2384) A.L. Popirtac; Paris/FR

www.myESR.org

Final Programme | ECR 2016

141

Programme by Session Type

THE VOICE OF EPOS

myESR.org/RisingStars facebook.com/ESRRisingStars

ECR STUDENT REGISTRATION FOR ONLY € 50 Students and radiographers-in-training under the age of 30, without any academic degree, can register for just € 50. SIX BASIC SESSIONS Renowned professors from all over Europe give basic lectures. STUDENT SESSIONS The submitting authors of the best 32 abstracts have been invited to the ECR to present their work, with their accommodation and travel expenses paid by the European Society of Radiology. 142

ECR 2016 | Final Programme

www.myESR.org

REFRESHER COURSES & SCIENTIFIC SESSIONS

Refresher Courses, as the name suggests, aim to refresh knowledge, reviewing and updating the more basic subjects for those who have not kept up to speed with certain developments, or who just need a reminder – something of interest not only to young radiologists but also experienced doctors. The length of each course is 90 minutes (classic Refresher Course: three parts of 30 minutes each, including the introduction and time for discussion; integrated Refresher Course: three parts of 23 minutes each, leaving enough time for the introduction by the chairpersons and the panel discussion). The course will be given by two or three lecturers and led by one or two moderator(s) on a defined subject of clinical imaging, imaging technique, interventional radiology and related subjects. Accepted papers for oral presentation are presented in the Scientific Sessions. Places are allocated on a first-come, first-served basis. The authors of the best scientific papers will be presented with a certificate and given free ECR 2017 registration. The award will be assigned to the best paper presentation of each topic based on the evaluation by session moderators and subcommittee members. Selection criteria comprise quality of presentation, scientific content and overall impression of the performance. The award winners will be informed after the congress and will be published on the ESR website.

143

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Abdominal and Gastrointestinal 2

March

Wednesday, March 2, 08:30–10:00, Room B RC 101 Assessing inflammation and fibrosis in Crohn’s disease

3

March

» Chairman’s introduction [A-003] A. Laghi; Latina/IT

» Chairman’s introduction [A-130] M. Karcaaltincaba; Ankara/TR

A. Is sonography (CEUS and elastography) the right tool? [A-004] E. Quaia; Trieste/IT

A. Vascular [A-131] F. Caseiro-Alves; Coimbra/PT B. Cystic-Biliary [A-132] G. Brancatelli; Palermo/IT

B. Is there space for MDCT (spectral imaging, iodine map)? [A-005] J. Podgorska; Warsaw/PL

C. Hepatocellular [A-133] R.L. Baron; Chicago, IL/US

C. Will MRI (DWI and perfusion) solve the problem? [A-006] S.A. Taylor; London/UK » Panel discussion: How do I approach a case in my routine clinical practice?

2

March

» Panel discussion: How do I manage an incidental and potentially benign liver lesion?

3

March

Wednesday, March 2, 10:30–12:00, Room B SS 201a Pancreas and bile ducts Moderators: B.I. Choi; Seoul/KR G. Zamboni; Verona/IT

Moderators: D.E. Malone; Dublin/IE P. Rodríguez; Madrid/ES

3

March

Wednesday, March 2, 10:30–12:00, Room O SS 201b A guided tour through the GI tract

Moderators: S. Gourtsoyianni; London/UK

Moderators: K. Skrobisz-Balandowska; Gdansk/PL

C. Hoeffel; Reims/FR

B.E. Van Beers; Clichy/FR

2

Wednesday, March 2, 14:00–15:30, Room B SS 301a Liver metastases: detection, characterisation and treatment response assessment

3

March

2

March

Moderators: P. Leander; Malmö/SE A. Wibmer; Vienna/AT

3

March

Wednesday, March 2, 14:00–15:30, Room O SS 301b Colon

Thursday, March 3, 14:00–15:30, Room O SS 701b Advanced imaging of the oesophagus and stomach [B-0623 – B-0633]

[K-06, B-0238 – B-0247] Moderators: R. Maksimović; Belgrade/RS T. Mang; Vienna/AT

Thursday, March 3, 14:00–15:30, Room B SS 701a Functional imaging of liver and spleen [B-0591 – B-0601]

[K-05, B-0206 – B-0215] Moderators: E. Kasatkina; Heidelberg/DE A.M. Riddell; London/UK

Thursday, March 3, 10:30–12:00, Room O SS 601b Multimodality imaging of Crohn’s disease [B-0441 – B-0451]

[B-0035– B-0044]

March

Thursday, March 3, 10:30–12:00, Room B SS 601a Chronic liver disease and primary liver tumours [B-0408 – B-0417]

[B-0001 – B-0011]

2 March

Thursday, March 3, 08:30–10:00, Room B RC 501 The many faces of benign liver lesions

Moderators: O. Ekberg; Malmö/SE M.A. Mazzei; Siena/IT

3

March

Thursday, March 3, 14:00–15:30, Room M 2 SS 701c Advances in CT [B-0729 – B-0739] Moderators: E. Akchurina; Moscow/RU H. Ringl; Vienna/AT This session is part of the EuroSafe Imaging campaign.

144

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Abdominal and Gastrointestinal 3

March

Thursday, March 3, 16:00–17:30, Room B RC 801 CT colonography today

5

March

Saturday, March 5, 10:30–12:00, Room F2 SS 1401 Advances in abdominal MRI [B-0974 – B-0984]

» Chairman’s introduction [A-239] M. Hellström; Gothenburg/SE A. How I perform it [A-240] P. Lefere; Roeselare/BE B. How I interpret it [A-241] T. Mang; Vienna/AT

Moderators: K. Coenegrachts; Bruges/BE A.J. van der Molen; Leiden/NL

5

March

C. Screening with CTC [A-242] D. Regge; Turin/IT

[B-1083 – B-1093]

» Panel discussion: Challenging cases from clinical practice

4

March

Friday, March 4, 08:30–10:00, Room B RC 901 Hepatocellular tumours

Moderators: F. Caseiro-Alves; Coimbra/PT S.K. Venkatesh; Rochester, MN/US

5

March

» Chairman’s introduction [A-314] C. Bartolozzi; Pisa/IT

A. Acute and chronic splenic disease [A-661] G. Zamboni; Verona/IT

B. HCC staging: what is new in imaging and can predict prognosis [A-316] C. Ayuso; Barcelona/ES

B. The incidental splenic lesion [A-662] M. Laniado; Dresden/DE

C. Equivocal nodules in cirrhotic patient: how to solve the puzzle [A-317] Y. Menu; Paris/FR

C. Malignant lesions [A-663] S. Gourtsoyianni; London/UK » Panel discussion: How to manage incidental findings in clinical routine practice

» Panel discussion: Impact of imaging on classification and differentiation of hepatocellular lesions

4

Friday, March 4, 10:30–12:00, Room O SS 1001a Rectal cancer: staging and restaging

6

March

[K-20, B-0773 – B-0782]

4

A. Pancreatic cancer or pancreatitis [A-722] R. Manfredi; Verona/IT

Friday, March 4, 10:30–12:00, Room F2 SS 1001b Hepatocellular carcinoma: evaluation of therapeutic response

B. Cystic tumours vs pseudocysts [A-723] M.A. Bali; Brussels/BE C. Incidental findings [A-724] C. Stoupis; Männedorf/CH

[B-0835 – B-0845]

» Panel discussion: How do we manage difficult cases and incidental findings?

Moderators: D. Akata; Ankara/TR L. Crocetti; Pisa/IT

5 March

Saturday, March 5, 08:30–10:00, Room B RC 1301 IgG4-related disease: what is it and what do I need to know? » Chairman’s introduction [A-507] S.A. Jackson; Plymouth/UK A. Pancreatic manifestations [A-508] R. Pozzi-Mucelli; Verona/IT B. Hepatobiliary manifestations [A-509] M. Ronot; Clichy/FR C. Systemic manifestations [A-510] G. Morana; Treviso/IT » Panel discussion: Tips and tricks in clinical practice

www.myESR.org

Sunday, March 6, 08:30–10:00, Room B RC 1701 Differential diagnosis in pancreatic imaging » Chairman’s introduction [A-721] B. Marincek; Cleveland, OH/US

Moderators: L. Curvo-Semedo; Coimbra/PT A. Plumb; London/UK

March

Saturday, March 5, 16:00–17:30, Room B RC 1601 The spleen: the forgotten organ » Chairman’s introduction [A-660] L.H. Ros Mendoza; Zaragoza/ES

A. The revised adenoma classification [A-315] C.J. Zech; Basle/CH

March

Saturday, March 5, 14:00–15:30, Room M 2 SS 1501 Liver fibrosis: imaging assessment

6

March

Sunday, March 6, 14:00–15:30, Room B SS 1901a Benign and malignant pancreatic diseases [K-33, B-1263 – B-1272] Moderators: J.M. Lee; Seoul/KR M. Spirovski; Sremska Kamenica/RS

6

March

Sunday, March 6, 14:00–15:30, Room O SS 1901b Abdominal surgery: the added value of radiology [B-1295 – B-1304] Moderators: I. Dudás; Budapest/HU D. Vorwerk; Ingolstadt/DE

Final Programme | ECR 2016

145

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Breast 2

March

Wednesday, March 2, 08:30–10:00, Room F2 RC 102 Breast ultrasound 2016

3

March

[B-0602 – B-0612]

Moderator: A. Athanasiou; Athens/GR

Moderators: F. Pediconi; Rome/IT F. Thibault; Paris/FR

A. Evidence for screening in dense breasts [A-024] V. Girardi; Brescia/IT B. Elastosonography: true advances or false hope? [A-025] C.S. Balleyguier; Villejuif/FR C. Nodal staging of breast cancer: still needed? [A-026] F. Kilburn-Toppin; Cambridge/UK

2

March

4

March

Moderators: S. Allen; Sutton/UK V. Girardi, Brescia/IT

2

Moderators: M. Di Matteo; Rome/IT S.H. Heywang-Köbrunner, Munich/DE

5

March

Wednesday, March 2, 14:00–15:30, Room C SS 302 Breast innovation, biomarkers

A. Calculating, using and improving individual risk estimates [A-549] S.W. Duffy; London/UK

Moderators: C.S. Balleyguier; Villejuif/FR M.H. Fuchsjäger; Graz/AT

2

Wednesday, March 2, 16:00–17:30, Room F2 RC 402 Radio-pathological correlation: more important than you thought

B. Intermediate risk: the grey zone [A-550] S.H. Heywang-Köbrunner; Munich/DE C. High risk: MRI alone? [A-551] F. Sardanelli; San Donato Milanese/IT

5

March

Moderators: S. Perez Rodrigo; Madrid/ES R.M. Pijnappel; Utrecht/NL

A. Pre-treatment planning [A-090] C.K. Kuhl; Aachen/DE

C. The breast radiologist sitting down with the pathologist [A-092] T. Tot; Falun/SE

5

March

» Panel discussion: How to enhance the interaction between radiologists and pathologists?

3 March

Thursday, March 3, 10:30–12:00, Room C SS 602a Breast MRI: new sequences and applications [B-0419 – B-0429]

3

March

Saturday, March 5, 10:30–12:00, Room C SS 1402a Screening [B-0920 – B-0930]

» Chairman’s introduction [A-089] F.J. Gilbert; Cambridge/UK

B. Intra-operative specimen evaluation [A-091] J. Camps Herrero; Valencia/ES

Saturday, March 5, 08:30–10:00, Room F2 RC 1302 Tailoring breast cancer screening to risk level Moderator: R.M. Pijnappel; Utrecht/NL

[B-0216 – B-0226]

March

Friday, March 4, 10:30–12:00, Room C SS 1002 Breast MRI-DWI (2) and various MRI applications [B-0751 – B-0761]

Wednesday, March 2, 10:30–12:00, Room C SS 202 Breast biopsy [B-0012 – B-0022]

March

Thursday, March 3, 14:00–15:30, Room C SS 702 Breast MRI-DWI (1)

Saturday, March 5, 10:30–12:00, Room M 5 SS 1402b Contrast-spectral mammography and MRI update in background parenchymal enhancement [B-1061 – B-1071] Moderators: M. Bernathova; Vienna/AT L.J. Pina Insausti; Pamplona/ES

5

March

Saturday, March 5, 14:00–15:30, Room F2 RC 1502 Update on BI-RADS

Moderators: A. Sever; Maidstone/UK I. Thomassin-Naggara; Paris/FR

Moderator: G. Esen; Istanbul/TR

Thursday, March 3, 10:30–12:00, Room D1 SS 602b Breast ultrasound

B. Ultrasound [A-641] A. Evans; Dundee/UK

[K-12, B-0526 – B-0535]

A. Mammography [A-640] U. Bick; Berlin/DE

C. MRI [A-642] M.H. Fuchsjäger; Graz/AT

Moderators: B. Brkljačić; Zagreb/HR A. Domingo; Tarragona/ES

146

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Breast 5

March

Saturday, March 5, 14:00–15:30, Room M 5 SS 1502 Breast density: an update

Cardiac 2

March

[B-1116 – B-1126]

[B-0045 – B-0055] Moderators: F. Bamberg; Tübingen/DE R. Dore; Pavia/IT

Moderators: I. Baglio, Verona/IT R. Schulz-Wendtland; Erlangen/DE

5

March

Saturday, March 5, 16:00–17:30, Room F2 RC 1602 Tomosynthesis: the new mammography

2

March

Moderators: F. Cademartiri; Rotterdam/NL G. Feuchtner; Innsbruck/AT

A. Should we abandon 2D mammography? [A-702] S. Zackrisson; Malmö/SE

2

March

6

Sunday, March 6, 10:30–12:00, Room C SS 1802 Digital breast tomosynthesis: an update [K-27, B-1127 – B-1136]

Moderators: J. Broncano; Cordoba/ES A. de Roos; Leiden/NL

2

March

6

Sunday, March 6, 14:00–15:30, Room A SS 1902a Multiparametric breast MRI, PET [K-34, B-1253 – B-1262]

Moderators: R. Fischbach; Hamburg/DE M. Francone; Rome/IT

2

March

Moderators: E.M. Fallenberg; Berlin/DE G. Forrai; Budapest/HU

6

March

Wednesday, March 2, 14:00–15:30, Room M 3 SS 303b CT perfusion [B-0376 – B-0386]

Moderators: T. Knogler; Vienna/AT A. Selim; Cairo/EG

March

Wednesday, March 2, 14:00–15:30, Room N SS 303a Cardiomyopathies (2) [B-0248 – B-0258]

C. The future of mammography: my predictions [A-704] E.M. Fallenberg; Berlin/DE

March

Wednesday, March 2, 10:30–12:00, Room M 3 SS 203b The evolving role of cardiac CT [K-01, B-0174 – B-0183]

Moderator: D. Bernardi; Trento/IT

B. Clinical validation and results in the last 5 years: where do we stand? [A-703] P. Skaane; Oslo/NO

Wednesday, March 2, 10:30–12:00, Room N SS 203a Cardiomyopathies (1)

Wednesday, March 2, 16:00–17:30, Room M 2 RC 403 Imaging of cardiac valves: new trends Moderator: G. Roditi; Glasgow/UK A. Echocardiography remains the reference technique [A-113] F. Knebel; Berlin/DE

Sunday, March 6, 14:00–15:30, Room C SS 1902b Preoperative imaging, neoadjuvant chemotherapy, imaging of the axilla

B. MRI is the best comprehensive approach [A-114] M. Francone; Rome/IT

[B-1273 – B-1283]

C. Does CT have a role in diagnosing valvular disease? [A-115] G. Feuchtner; Innsbruck/AT

Moderators: C. Dromain; Villejuif/FR P. Panizza; Milan/IT

3

March

Thursday, March 3, 08:30–10:00, Room M 2 RC 503 Novel ways to assess myocardial tissue Moderator: G. Bastarrika; Pamplona/ES A. T1 mapping: technical considerations [A-186] M.R. Makowski; Berlin/DE B. T2 mapping: technical considerations [A-187] C. Tessa; Lido di Camaiore/IT C. Clinical use of T1 and T2 mapping [A-188] A. de Roos; Leiden/NL

www.myESR.org

Final Programme | ECR 2016

147

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Cardiac 3

March

Chest

Thursday, March 3, 10:30–12:00, Room N SS 603 Evolving techniques

2

March

Wednesday, March 2, 08:30–10:00, Room D1 RC 104 Pneumonia

[B-0452 – B-0462] » Chairman’s introduction [A-027] I.E. Tyurin; Moscow/RU

Moderators: A.J.B.S. Madureira; Porto/PT M. Meyer; Mannheim/DE

3

March

A. Community-acquired pneumonia [A-028] I. Hartmann; Rotterdam/NL B. Tuberculosis [A-029] E. Castañer; Sabadell/ES

Thursday, March 3, 14:00–15:30, Room M 3 SS 703 Epidemiology, prognosis and trials

C. Fungal pneumonia in immunocompromised hosts [A-030] J. Mayer; Heidelberg/DE

[B-0740 – B-0750] Moderators: C. Colantoni; Milan/IT K. Gruszczynska; Katowice/PL

3

March

Thursday, March 3, 16:00–17:30, Room M 2 RC 803 Imaging of heart failure

» Panel discussion: What is the role of radiologists in the diagnosis and management of lung infections?

2

March

[B-0109 – B-0119]

» Chairman’s introduction [A-298] C. Loewe; Vienna/AT A. Current ESC and AHA guidelines: how to choose imaging techniques in heart failure patients? [A-299] J.T. Ortiz-Pérez; Barcelona/ES B. Differentiating the causes for heart failure: is MRI the indisputable gold standard? [A-300] T. Leiner; Utrecht/NL

Moderators: E.E.J.G. Coche; Brussels/BE J. Dinkel; Munich/DE

2

March

Moderators: P. Ciet; Rotterdam/NL W.F.M. De Wever; Leuven/BE

» Panel discussion: What is the preferred comprehensive imaging test in heart failure?

4

Friday, March 4, 10:30–12:00, Room N SS 1003 CT of the coronary arteries [K-21, B-0783 – B-0792] Moderators: D. Brisbois; Liège/BE J.M. Kerl; Darmstadt/DE

5

March

Saturday, March 5, 14:00–15:30, Room M 1 SS 1503 Interventional applications [B-1072 – B-1082] Moderators: D. Maintz; Cologne/DE E. Pershina; Moscow/RU

6

March

Wednesday, March 2, 14:00–15:30, Room D1 SS 304 Lung MRI [B-0312 – B-0322]

C. SPECT as an alternative imaging technique [A-301] F. Caobelli; Hannover/DE

March

Wednesday, March 2, 10:30–12:00, Room D1 SS 204 Pulmonary vessels and perfusion

2

March

Wednesday, March 2, 16:00–17:30, Room D1 RC 404 Pulmonary embolism persistent controversies » Chairman’s introduction [A-093] M. Rémy-Jardin; Lille/FR A. Subsegmental PE, incidental PE: diagnosis and management [A-094] C.M. Schaefer-Prokop; Amersfoort/NL B. CT not available, contraindicated, or inconclusive: what to do? [A-095] E.J.R. van Beek; Edinburgh/UK C. Can we predict outcome from imaging? [A-096] B. Ghaye; Brussels/BE » Panel discussion: How to optimise patient management?

Sunday, March 6, 10:30–12:00, Room N SS 1803 MR (1) [B-1148 – B-1158] Moderators: A. Jacquier; Marseille/FR K. Pagonidis; Iraklion/GR

6

March

Sunday, March 6, 14:00–15:30, Room N SS 1903 MR (2) [B-1305 – B-1315] Moderators: A. Esposito; Milan/IT C. Herzog; Munich/DE

148

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Chest 3

March

Thursday, March 3, 08:30–10:00, Room D1 RC 504 HRCT - patterns in chest radiology: back to basics and beyond

4

March

» Chairman’s introduction [A-165] H. Prosch; Vienna/AT

» Chairman’s introduction [A-469] N. Karabulut; Denizli/TR

A. Secondary pulmonary lobule anatomy: essential to tackle with the nodular pattern [A-166] T. Frauenfelder; Zurich/CH

A. Silicosis and coal workers’ pneumoconiosis [A-470] K. Marten-Engelke; Göttingen/DE B. Asbestos-related disease [A-471] S.J. Copley; London/UK

B. Linear and reticular pattern [A-167] F. Molinari; Lille/FR

C. Hypersensitivity pneumonitis [A-472] P.-Y. Brillet; Bobigny/FR

C. Ground glass opacities (GGO) and consolidation [A-168] J. Vogel-Claussen; Hannover/DE » Panel discussion: Is it always easy to detect a pattern? Tips for success

3

March

» Panel discussion: What are the key findings for diagnosing occupational lung diseases?

5

March

Thursday, March 3, 10:30–12:00, Room M 3 SS 604 Spectral CT, advanced CT analysis and emphysema Moderators: F. Molinari; Lille/FR M. Silva; Parma/IT

3

This session is part of the EuroSafe Imaging campaign.

5

March

A. The crucial role of chest x-ray: mediastinal lines and stripes [A-643] E.E.J.G. Coche; Brussels/BE

Moderators: G. Aviram; Tel Aviv/IL E. Jon; Vitoria/ES

Friday, March 4, 08:30–10:00, Room D1 RC 904 Low dose and no-dose chest imaging: opportunities and limitations

B. Mediastinal masses: role of CT [A-644] M. Occhipinti; Rome/IT C. A new look at the mediastinum: role of MRI and PET/CT [A-645] F.L. Giesel; Heidelberg/DE

6

March

Moderator: A.P. Parkar; Bergen/NO

C. US [A-349] F. Gleeson; Oxford/UK

4

March

Friday, March 4, 10:30–12:00, Room D1 SS 1004 Imaging methods: something old, something new

Sunday, March 6, 10:30–12:00, Room D1 SS 1804 COPD and infiltrative lung diseases [K-28, B-1211 – B-1220]

A. Low-dose CT [A-347] O. Buckley; Dublin/IE B. MRI [A-348] J. Dinkel; Munich/DE

Saturday, March 5, 14:00–15:30, Room D1 RC 1504 Mediastinal disease revisited Moderator: A. Persson; Linköping/SE

Thursday, March 3, 14:00–15:30, Room D1 SS 704 Lung cancer [K-16, B-0676 – B-0685]

4 March

Saturday, March 5, 10:30–12:00, Room D1 SS 1404 Chest CT dose reduction [K-25, B-0985 – B-0994] Moderators: T. Henzler; Mannheim/DE D. Tack; Baudour/BE

[B-0580 – B-0590]

March

Friday, March 4, 16:00–17:30, Room D1 RC 1204 Occupational lung diseases: the known and the less known

Moderators: D. Kienzl-Palma; Vienna/AT A. Oikonomou; Toronto, ON/CA

6

March

Sunday, March 6, 14:00–15:30, Room D1 SS 1904 Computer-based quantification and texture analysis [B-1358 – B-1368] Moderators: R. Cesar; Golnik/SI M. Regier; Hamburg/DE

[B-0846 – B-0856] Moderators: E.J. Stern; Seattle, WA/US M. Toepker; Vienna/AT

www.myESR.org

Final Programme | ECR 2016

149

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Computer Applications 2

March

Wednesday, March 2, 08:30–10:00, Room N RC 105 Daily use of mobile devices in radiology

Molecular Imaging 2

March

» Chairman’s introduction [A-012] O. Ratib; Geneva/CH

Moderator: T.H. Helbich; Vienna/AT A. Advanced MRI techniques [A-042] C.A. Cuénod; Paris/FR

A. What did mobile devices change in radiology education? [A-013] E. Kotter; Freiburg/DE

B. Advanced PET imaging techniques [A-043] T. Beyer; Vienna/AT

B. Is it appropriate to read a study on a smartphone or a tablet? [A-014] E. Neri; Pisa/IT C. Security and ethical issues of mobile device technology [A-015] E.R. Ranschaert; ‘s-Hertogenbosch/NL » Panel discussion: Will mobile technology overcome stationary technology in radiology?

2 March

[B-0227 – B-0237]

3

March

C. Clinical applications of quantitative hybrid imaging in oncology [A-044] L. Umutlu; Essen/DE

2

March

Moderators: S. Chatziioannou; Athens/GR E. Lopci; Rozzano/IT

4

March

Thursday, March 3, 10:30–12:00, Room Z SS 605 Image processing techniques (1) Moderators: S. Bickelhaupt; Heidelberg/DE M. de Bruijne; Rotterdam/NL

5

A. Preclinical MR/PET imaging of cancer [A-364] C. Kuntner-Hannes; Seibersdorf/AT

Saturday, March 5, 10:30–12:00, Room N RC 1405 Will the good old PACS disappear?

B. What about nano-technology? [A-365] F.M.A. Kiessling; Aachen/DE

» Chairman’s introduction [A-579] D. Regge; Turin/IT

D. View of the radiographer [A-367] R. Harris; London/UK

A. It’s time for PACS replacement: how-to guide, recommendations and pitfalls [A-580] S. Morozov; Moscow/RU

» Panel discussion: How to set-up an attractive programme

B. Enterprise-based vendor-neutral archiving: is this the future of PACS? [A-581] J. Fernandez-Bayó; Sabadell/ES

C. View of the young researcher [A-366] D. Berritto; Acerra/IT

4

March

C. Does PACS into the cloud means PACS evaporates? [A-582] J. Schillebeeckx; Knokke/BE

6

Sunday, March 6, 10:30–12:00, Room Z SS 1805 Image processing techniques (2) [B-1137 – B-1147] Moderators: A. Alberich-Bayarri; Valencia/ES U. Bick; Berlin/DE

6

March

Sunday, March 6, 14:00–15:30, Room Z SS 1905 Quality control and  safety issues in radiology

Friday, March 4, 10:30–12:00, Room M 3 SS 1006 Advanced hybrid imaging in oncology [K-22, B-0899 – B-0908] Moderators: A.M. Herneth; Vienna/AT N.N.

» Panel discussion: How will increased interconnection affect radiologist’s day-to-day life? March

Friday, March 4, 08:30–10:00, Room M 1 RC 906 Preclinical imaging as a driver for translational research: how I do it » Chairman’s introduction [A-363] J. Hodler; Zurich/CH

[B-0430 – B-0440]

March

Wednesday, March 2, 10:30–12:00, Room Z SS 206 PET/CT and MR in oncology [B-0023 – B-0033]

Wednesday, March 2, 14:00–15:30, Room Z SS 305 Developing tools for clinical workflow management Moderators: L. Faggioni; Pisa/IT B. Gibaud; Rennes/FR

Wednesday, March 2, 08:30–10:00, Room M 1 RC 106 Molecular imaging: what can we quantify?

5

March

Saturday, March 5, 10:30–12:00, Room Z SS 1406 Advanced experimental imaging [B-0931 – B-0941] Moderators: S. Walker-Samuel; London/UK B. Wängler; Mannheim/DE

[K-35, B-1284 – B-1293] Moderators: R. Salvador; Barcelona/ES P.M.A. van Ooijen; Groningen/NL This session is part of the EuroSafe Imaging campaign.

150

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Genitourinary 2

March

Wednesday, March 2, 08:30–10:00, Room K RC 107 Pitfalls in gynaecologic oncologic imaging: how to avoid them and minimise risks

4

March

» Chairman’s introduction [A-450] C.D. Alt; Düsseldorf/DE

» Chairman’s introduction [A-035] E. Sala; New York, NY/US

2 March

Friday, March 4, 16:00–17:30, Studio 2016 RC 1207 MRI for gynaecologic imaging: how I do it

A. Mistakes in assessment of cervical cancer [A-036] K. Downey; London/UK

A. Basics of patient preparation and T2W-imaging [A-451] N.M. deSouza; Sutton/UK

B. Mistakes in assessment of endometrial cancer [A-037] T.M. Cunha; Lisbon/PT

B. Contrast agents [A-452] R.A. Kubik-Huch; Baden/CH

C. Mistakes in assessment of ovarian masses [A-038] I. Thomassin-Naggara; Paris/FR

C. Diffusion and ADC [A-453] E. Sala; New York, NY/US

» Panel discussion: How can we improve interdisciplinary communication and avoid misunderstanding in our reports?

» Panel discussion: Multiparametric MRI of the female pelvis - should it replace tailored protocols?

5

March

Wednesday, March 2, 10:30–12:00, Room K SS 207 Technical advances

Saturday, March 5, 08:30–10:00, Studio 2016 RC 1307 Lessons I learned from mistakes in kidney and adrenal imaging

[B-0131 – B-0141] » Chairman’s introduction [A-525] S.M. Dudea; Cluj-Napoca/RO

Moderators: U.G. Mueller-Lisse; Munich/DE R. Turkay; Istanbul/TR

2

March

A. Renal cancer [A-526] T. Bäuerle; Erlangen/DE B. PET/CT in nephrourology [A-527] P.A.T. Baltzer; Vienna/AT

Wednesday, March 2, 14:00–15:30, Room K SS 307 Prostate cancer: targeted biopsy and beyond

C. Common mistakes in tumour percutaneous radiofrequency ablation [A-528] J.-M. Correas; Paris/FR

[B-0334 – B-0344]

» Panel discussion: How to manage small lesions of the kidneys incidentally detected in abdominal imaging

Moderators: K. Downey; London/UK M. Meissnitzer; Salzburg/AT

3

March

Thursday, March 3, 10:30–12:00, Studio 2016 SS 607a Female pelvis [K-13, B-0463 – B-0472] Moderators: O. Nikolic; Novi Sad/RS K. Pyra; Lublin/PL

3

March

5

March

Saturday, March 5, 10:30–12:00, Studio 2016 SS 1407 Multi-parametric MR of prostate cancer: an update [K-26, B-0942 – B-0951] Moderators: D. Junker; Innsbruck/AT J.C. Vilanova; Girona/ES

Thursday, March 3, 10:30–12:00, Room M 2 SS 607b New frontiers: urolithiasis and renal function [B-0569 – B-0579] Moderators: M.-F. Bellin; Le Kremlin-Bicêtre/FR J. Lopes Dias; Lisbon/PT

3

March

Thursday, March 3, 14:00–15:30, Room K SS 707 Prostate cancer: routine and novel MRI techniques [B-0697 – B-0707] Moderators: D. Bonekamp; Hirschberg/DE N.C. Cowan; Portsmouth/UK

www.myESR.org

Final Programme | ECR 2016

151

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Genitourinary 6

March

Sunday, March 6, 08:30–10:00, Studio 2016 RC 1707 Prostate imaging: how I do it

Head and Neck 2

March

Wednesday, March 2, 10:30–12:00, Room M 1 SS 208 Orbits and olfaction [K-02, B-0153 – B-0162]

» Chairman’s introduction [A-739] H.-P. Schlemmer; Heidelberg/DE A. Detection and assessment of aggressiveness [A-740] P. Puech; Lille/FR B. Image-guided biopsy and staging [A-741] J.J. Fütterer; Nijmegen/NL

Moderators: L.S. Politi; Worcester, MA/US T. Rodt; Hannover/DE

2

March

C. Role of imaging in active surveillance and detection of recurrence [A-742] V. Logager; Copenhagen/DK » Panel discussion: Multiparametric MRI: what are the challenges and strategies to solve these?

6 March

[B-0355 – B-0365] Moderators: G. Conte; Milan/IT C. Czerny; Vienna/AT

2

March

Sunday, March 6, 10:30–12:00, Room K SS 1807 Tumours of the urinary tract and adrenals

A. Salivary gland imaging with ultrasound [A-072] S. Colley; Birmingham/UK

Moderators: G. Heinz-Peer; St. Pölten/AT R. Huzjan Korunić; Zagreb/HR

6

Sunday, March 6, 14:00–15:30, Room L8 SS 1907 Imaging of the reproductive system [B-1326 – B-1335]

B. Masses of the soft parts of the neck [A-073] S. Robinson; Vienna/AT C. Lymph nodes: differential diagnosis and fine-needle aspiration [A-074] R. Maroldi; Brescia/IT

3

March

Moderators: G. Masselli; Rome/IT K.B. Puzakov; Moscow/RU

Wednesday, March 2, 16:00–17:30, Room N RC 408 Head and neck imaging: don’t sell your ultrasound yet! Moderator: D.-A. Varoquaux; Marseille/FR

[B-1232 – B-1242]

March

Wednesday, March 2, 14:00–15:30, Room M 1 SS 308 Salivary glands, neck, parathyroid

Thursday, March 3, 08:30–10:00, Room N RC 508 Pathways for tumour spread Moderator: R. Hermans; Leuven/BE A. Pathways for oral cavity and oropharynx tumour spread [A-141] A. Borges; Lisbon/PT B. Pathways for nasopharyngeal tumour spread including perineural spread [A-142] V. Chong; Singapore/SG C. Pathway for laryngeal and hypopharyngeal tumour spread [A-143] R. Kohler; Sion/CH

3

March

Thursday, March 3, 10:30–12:00, Room M 1 SS 608 Pre- and post-operative imaging in oncology [B-0558 – B-0568] Moderators: A. Borges; Lisbon/PT S. Steens; Nijmegen/NL

3

March

Thursday, March 3, 14:00–15:30, Room M 1 SS 708 Temporal bone [K-17, B-0719 – B-0728] Moderators: S. Kösling; Halle a.d. Saale/DE K. Markiet; Gdansk/PL

152

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Head and Neck 3

March

Thursday, March 3, 16:00–17:30, Room N RC 808 Paediatric: how we do head and neck imaging in children

Interventional Radiology 2

March

Moderator: N.J.M. Freling; Amsterdam/NL

» Chairman’s introduction [A-045] A. Adam; London/UK

A. Temporal bone [A-252] B. De Foer; Antwerp/BE

4 March

B. Oral, paranasal sinuses and orbit [A-253] M. Lell; Erlangen/DE

A. Cone-beam CT in vascular and non-vascular interventional procedures [A-046] T.F. Jakobs; Munich/DE

C. Cysts and lumps in the neck [A-254] A. Ailianou; Geneva/CH

B. US image fusion [A-047] G.H. Mostbeck; Vienna/AT C. How can we improve targeting in image-guided interventions: stereotaxis, robotics and advanced techniques [A-048] L.A. Solbiati; Rozzano/IT

Friday, March 4, 10:30–12:00, Room M 1 SS 1008 Maxillofacial imaging

» Panel discussion: Practical and economic issues in using high-end guidance for interventional radiology

[B-0877 – B-0887] Moderators: N.I. Traykova; Plovdiv/BG G. Widmann; Innsbruck/AT

2

March

5

March

Wednesday, March 2, 08:30–10:00, Room M 3 RC 109 Image fusion for image-guided interventions

Saturday, March 5, 08:30–10:00, Room N RC 1308 Pitfalls in interpretation of head and neck disease

Wednesday, March 2, 10:30–12:00, Room D2 SS 209 Ablation outside the liver [B-0120 – B-0130] Moderators: G. Carrafiello; Varese/IT M. Tsitskari; Athens/GR

Moderator: J. Frühwald-Pallamar; Vienna/AT A. Anatomical variants without clinical consequence [A-522] F.A. Pameijer; Utrecht/NL

2

March

B. Anatomical variants posing surgical risks [A-523] D. Farina; Brescia/IT

[B-0323 – B-0333] Moderators: A. Diamantopoulos; London/UK S. Marcia; Cagliari/IT

C. Distinct head and neck disease or systemic disease? [A-524] B.F. Schuknecht; Zurich/CH

5 March

2

March

Saturday, March 5, 10:30–12:00, Room M 1 SS 1408 Thyroid nodules [B-1017 – B-1027] Moderators: K.S.S. Bhatia; Shatin/HK R.K. Lingam; London/UK

Wednesday, March 2, 14:00–15:30, Room D2 SS 309 Musculoskeletal

Wednesday, March 2, 16:00–17:30, Room M 3 RC 409 Basic principles of percutaneous tumour ablation » Chairman’s introduction [A-116] T. de Baère; Villejuif/FR A. Thermal ablation with RF [A-117] F. Orsi; Milan/IT B. Microwave ablation: what is the difference? [A-118] P.L. Pereira; Heilbronn/DE C. Cryoablation: ice can be better than heat [A-119] D.J. Breen; Southampton/UK D. Irreversible electroporation: principles, technique and clinical applications [A-120] A. Nilsson; Uppsala/SE » Panel discussion: Selection of ablation modalities: operator’s preference or evidence-based?

www.myESR.org

Final Programme | ECR 2016

153

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Interventional Radiology 3

March

Thursday, March 3, 08:30–10:00, Room M 3 RC 509 Imaging and endovascular treatment of pulmonary embolism

4

March

[B-0857 – B-0865] Moderators: T. Albrecht; Berlin/DE J. Garnon; Strasbourg/FR

» Chairman’s introduction [A-189] B. Peynircioglu; Ankara/TR A. Imaging algorithm for pulmonary embolism [A-190] B. Ghaye; Brussels/BE B. What is new in the recently published guidelines for pulmonary embolism treatment? [A-191] R. Uberoi; Oxford/UK

5

March

3

March

6

March

Sunday, March 6, 10:30–12:00, Room D2 SS 1809 Peri- and postprocedural imaging [B-1222 – B-1231]

Moderators: O. Akhan; Ankara/TR D. Kuhelj; Ljubljana/SI

3

Moderators: R.F. Dondelinger; Liège/BE C. Schmid-Tannwald; Munich/DE

Thursday, March 3, 10:30–12:00, Room D2 SS 609 Non-vascular techniques in the abdomen [B-0536 – B-0546]

March

Saturday, March 5, 10:30–12:00, Room D2 SS 1409 Intra-arterial therapies in the liver [B-0995 – B-1005]

C. Updates on the endovascular treatment of massive and submassive pulmonary embolism [A-192] S.C. Spiliopoulos; Patras/GR » Panel discussion: Appropriate diagnosis and risk stratification in the management of acute massive and acute sub-massive pulmonary embolism

Friday, March 4, 10:30–12:00, Room D2 SS 1009 Liver ablation

Thursday, March 3, 16:00–17:30, Room M 3 RC 809 Current trends in transarterial chemoembolisation (TACE) and radioembolisation for HCC

Moderators: A. Bharadwaz; Aarhus/DK A.D. Kelekis; Athens/GR

6

March

Sunday, March 6, 14:00–15:30, Room D2 SS 1909 Endovascular [K-36, B-1369 – B-1378] Moderators: V. Bérczi; Budapest/HU M. Krokidis; Cambridge/UK

» Chairman’s introduction [A-302] A. Denys; Lausanne/CH A. Imaging in therapy planning and follow-up [A-303] L. Crocetti; Pisa/IT B. TACE and TAE for HCC: new agents, new schedules, new combinations [A-304] K. Malagari; Athens/GR C. Radioembolisation: critical appraisal of techniques and guidelines for treatment [A-305] J.I. Bilbao; Pamplona/ES » Panel discussion: The intermediate HCC patient: how can we stratify patients and allocate them to different therapies?

154

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Musculoskeletal 2

March

Wednesday, March 2, 08:30–10:00, Room E1 RC 110 The elbow: a comprehensive approach

3

March

» Chairman’s introduction [A-020] A. Alcalá-Galiano; Madrid/ES

» Chairman’s introduction [A-153] M. Reijnierse; Leiden/NL

A. The tendons: anatomy, pathology and intervention [A-021] P. Peetrons; Brussels/BE

A. Rheumatoid arthritis: what does MRI show and how do I do it? [A-154] I. Sudoł-Szopińska; Warsaw/PL

B. Ligament injury and instability: what to look for and what to say [A-022] M.C. De Jonge; Amsterdam/NL

B. The axial skeleton in spondyloarthritis: conventional radiograph to MRI [A-155] R. Campbell; Liverpool/UK

C. Nerve entrapment at the elbow [A-023] L.M. Sconfienza; San Donato Milanese/IT

C. Ultrasound in inflammatory arthritis: what does it show and what does it mean? [A-156] A. Klauser; Innsbruck/AT

» Panel discussion: US, CT, conventional MR, high field MR: what to choose when?

2

March

Wednesday, March 2, 10:30–12:00, Room E1 SS 210 Trauma and inflammation [K-03, B-0067 – B-0076]

» Panel discussion: How practical is it for radiologists to support ultrasound and MRI for clinical rheumatology? Is it something the rheumatologists should undertake themselves?

3

March

Moderators: R. Hemke; Amsterdam/NL I.-M. Noebauer-Huhmann; Vienna/AT

2 March

Wednesday, March 2, 14:00–15:30, Room E1 SS 310 Ultrasound [B-0270 – B-0280]

Wednesday, March 2, 16:00–17:30, Room E1 RC 410 Bone trauma in the axial skeleton: patterns of injury and how I describe them

Moderators: G. Guglielmi; Andria/IT A.S. Issever; Berlin/DE

3

March

Moderators: E.H.G. Oei; Rotterdam/NL S. Trattnig; Vienna/AT

3

March

Thursday, March 3, 14:00–15:30, Room E1 SS 710 Muscles [B-0634 – B-0644] Moderators: J. Oudeman; Amsterdam/NL D.J. Wilson; Oxford/UK

A. Thoracic and lumbar spine [A-075] V.N. Cassar-Pullicino; Oswestry/UK

C. Acetabulum [A-077] A. Kassarjian; Majadahonda/ES

Thursday, March 3, 10:30–12:00, Room G SS 610b Cartilage assessment [B-0547 – B-0557]

Moderator: D. Spira; Heidelberg/DE

B. Pelvis [A-076] K. Verstraete; Ghent/BE

Thursday, March 3, 10:30–12:00, Room E1 SS 610a Body composition [B-0484 – B-0494]

Moderators: P. Peetrons; Brussels/BE L.M. Sconfienza; San Donato Milanese/IT

2 March

Thursday, March 3, 08:30–10:00, Room E1 RC 510 Inflammatory arthritis: beyond the radiograph

3

March

Thursday, March 3, 16:00–17:30, Room E1 RC 810 Sports injuries to the knee: improving my report » Chairman’s introduction [A-260] V. Vasilevska Nikodinovska; Skopje/MK A. Reporting meniscal tears: pitfalls and how I avoid them [A-261] G. Andreisek; Zurich/CH B. The collateral ligaments and posterolateral corner: what are they, why do they matter and how do I assess them? [A-262] U. Aydingoz; Ankara/TR C. Imaging the reconstructed ACL in athletes: how to assess and what to report [A-263] A.P. Parkar; Bergen/NO » Panel discussion: How will the patient and clinician be most helped by our report, and is there a role for structured reporting?

www.myESR.org

Final Programme | ECR 2016

155

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Musculoskeletal 4

March

Friday, March 4, 10:30–12:00, Room E1 SS 1010a Oncology

Neuro 2

March

[K-24, B-0804 – B-0812]

Moderator: P. Due-Tønnessen; Oslo/NO

Moderators: S. Boudabbous; Geneva/CH K. Wörtler; Munich/DE

4 March

A. Alcohol-related changes in the brain [A-039] M. Knauth; Goettingen/DE B. Recreational drugs and occupational hazards [A-040] L. Reneman; Amsterdam/NL

Friday, March 4, 10:30–12:00, Room M 4 SS 1010b Hip and shoulder

C. Treatment-induced effects on the brain parenchyma [A-041] J. Alvarez-Linera; Madrid/ES

[B-0909 – B-0918] Moderators: S.E. Anderson; Baden/CH T. Geith; Munich/DE

4

March

2

March

A. Imaging the diabetic foot [A-458] J. Kramer; Linz/AT

Moderators: N. Bargalló; Barcelona/ES I. Koerte; Munich/DE

2

March

B. MSK manifestations of non-malignant haematological disease [A-459] A.H. Karantanas; Iraklion/GR C. MSK manifestations of renal disease [A-460] G. Guglielmi; Andria/IT

5 March

Moderators: H. Hanelore; Cluj-Napoca/RO A. Rovira-Cañellas; Barcelona/ES

2

Saturday, March 5, 10:30–12:00, Room E1 SS 1410 Applications in CT and MR: something old, something new

5

Moderators: A. Falini; Milan/IT F.P. Kuhn; Zurich/CH

2

March

A. The normal MRI: techniques and anatomy [A-628] E. Llopis; Valencia/ES

Moderators: N. Pyatigorskaya; Paris/FR M.A. van Buchem; Leiden/NL

2

March

» Panel discussion: How are the indications for MR arthography in the shoulder changing?

6

March

Sunday, March 6, 10:30–12:00, Room E1 SS 1810 Ligaments, tendons and joints

Wednesday, March 2, 14:00–15:30, Room M 5 SS 311c Neurovascular interventions (1) [K-08, B-0398 – B-0407]

B. Rotator cuff tears: what are they and what do they look like? [A-629] K.-F. Kreitner; Mainz/DE C. Patterns of instability: what does the MRI show? [A-630] A.J. Grainger; Leeds/UK

Wednesday, March 2, 14:00–15:30, Room M 4 SS 311b Dementia [B-0387 – B-0397]

Saturday, March 5, 14:00–15:30, Room E1 RC 1510 Shoulder MRI: mastering technique and making my report relevant » Chairman’s introduction [A-627] M. Maas; Amsterdam/NL

Wednesday, March 2, 14:00–15:30, Room E2 SS 311a Cerebral tumours (1) [K-07, B-0281 – B-0290]

[B-0952 – B-0962]

March

Wednesday, March 2, 10:30–12:00, Room M 5 SS 211b Gadolinium deposition and trauma [B-0195 – B-0205]

March

Moderators: A. Cotten; Lille/FR J. Fereirra, Lisbon/PT

Wednesday, March 2, 10:30–12:00, Room E2 SS 211a Paediatric and epilepsy [B-0077 – B-0087]

Friday, March 4, 16:00–17:30, Room E1 RC 1210 Systemic disease: what to look for in the musculoskeletal system Moderator: A. Cotten; Lille/FR

Wednesday, March 2, 08:30–10:00, Room G RC 111 Toxic brain disorders

Moderators: A. Biondi; Besançon/FR H.P. Schemuth; Essen/DE

3

March

Thursday, March 3, 10:30–12:00, Room E2 SS 611 Cerebrovascular disease (1) [K-14, B-0495 – B-0504] Moderators: K.M. Thierfelder; Munich/DE P. Vilela; Almada/PT

[K-29, B-1180 – B-1189] Moderators: A.H. Karantanas; Iraklion/GR A. Sachs; Vienna/AT

156

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Neuro 3

March

Thursday, March 3, 14:00–15:30, Room E2 SS 711 Cerebrovascular disease (2)

5

March

[B-0645 – B-0654]

[B-1050 – B-1060]

Moderators: U. Lamot; Ljubljana/SI Z. Merhemic; Sarajevo/BA

4

March

Friday, March 4, 10:30–12:00, Studio 2016 SS 1011a Neurovascular interventions (2)

Moderators: J.H. Gillard; Cambridge/UK S. Looby; Dublin/IE

5

March

[B-0793 – B-0803]

4

A. White spots and blots in the brain: what are they? [A-655] T.A. Yousry; London/UK B. How can I improve my reporting of T2-hyperintense lesions? [A-656] A. Rovira-Cañellas; Barcelona/ES

Friday, March 4, 10:30–12:00, Room E2 SS 1011b Cerebrovascular disease (3) [B-0813 – B-0823] Moderators: M. Buruian; Targu-Mures/RO T. Rostovtseva; St. Petersburg/RU

4 March

C. Is there a need for quantitative reporting of white matter lesions? [A-657] F. Barkhof; London/UK, Amsterdam/NL

5

March

Friday, March 4, 16:00–17:30, Room G RC 1211 Cerebrovascular disease

Moderators: K.-O. Løvblad; Geneva/CH R. Woitek; Vienna/AT

5

March

B. Detecting microhaemorrhages: why are they important? What are they? Should we use GRE T2* or SWI or both? [A-481] H.R. Jäger; London/UK

5

March

Moderator: S. Rohde; Dortmund/DE A. A critical appraisal of the current literature [A-716] W. van Zwam; Maastricht/NL

Saturday, March 5, 08:30–10:00, Room G RC 1311 Reporting the degenerative lumbar spine

C. Endovascular stroke treatment: ethical and economical concerns [A-718] K.-O. Løvblad; Geneva/CH

A. Disc nomenclature: how I make my report [A-565] J. Rankine; Leeds/UK

B. Which techniques can we use to reopen an occluded cerebral blood vessel? [A-717] T. van der Zijden; Edegem/BE

6

March

C. What to say and not to say in your report [A-567] M.M. Thurnher; Vienna/AT

Moderators: S. Morozova; Moscow/RU J. Van Goethem; Antwerp/BE

6

March

Saturday, March 5, 10:30–12:00, Room E2 SS 1411a Cerebrovascular disease (4) [B-0963 – B-0973] Moderators: D. Bos; Rotterdam/NL C. Calli; Izmir/TR

www.myESR.org

Sunday, March 6, 10:30–12:00, Room E2 SS 1811 Spine [K-30, B-1190 – B-1199]

B. Don’t forget the facet joints and posterior elements [A-566] L. van den Hauwe; Antwerp/BE

5

Saturday, March 5, 16:00–17:30, Room G RC 1611 Update on endovascular stroke treatment: a medical breakthrough?

C. Cerebral perfusion studies in cerebrovascular disease: techniques, indications and applications [A-482] P.M. Parizel; Antwerp/BE

Moderator: D. Zlatareva; Sofia/BG

March

Saturday, March 5, 14:00–15:30, Room M 4 SS 1511 Multiple sclerosis [B-1105 – B-1115]

Moderator: M. Vernooij; Rotterdam/NL A. Vascular distribution territories: arterial and venous [A-480] A. Dörfler; Erlangen/DE

Saturday, March 5, 14:00–15:30, Room G RC 1511 White spots in the brain Moderator: E.T. Tali; Ankara/TR

Moderators: T. Kau; Klagenfurt/AT S. Haller; Geneva/CH

March

Saturday, March 5, 10:30–12:00, Room M 4 SS 1411b Cerebral tumours (2)

Sunday, March 6, 14:00–15:30, Room E2 SS 1911 Movement disorders and neurodegenerative diseases [B-1337 – B-1347] Moderators: L. Haider; Vienna/AT S. Lehéricy; Paris/FR

Final Programme | ECR 2016

157

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Paediatric 2

March

Wednesday, March 2, 10:30–12:00, Room M 2 SS 212 Brain and neck

4

March

[B-0163 – B-0173]

[B-0888 – B-0898]

Moderators: P. Gulino; Florence/IT D. Prayer; Vienna/AT

2

March

Wednesday, March 2, 14:00–15:30, Room M 2 SS 312 Thorax and musculoskeletal

Moderators: G. Kasprian; Vienna/AT G. Papaioannou; Athens/GR

4

March

[K-09, B-0366 – B-0375] Moderators: C. Balassy; Vienna/AT Z. Yazici; Bursa/TR

2 March

A. Key issues in the x-ray department [A-444] E. Sorantin; Graz/AT B. Dose reduction and image quality in paediatric CT [A-445] R.A.J. Nievelstein; Utrecht/NL

Moderator: W. Hirsch; Leipzig/DE

C. Patient compliance and motion-free protocols in general paediatric MRI [A-446] G.K. Schneider; Homburg a.d. Saar/DE

A. Congenital anomalies of the chest [A-069] M. Haliloglu; Ankara/TR B. Lung infection and its complications [A-070] M.L. Lobo; Lisbon/PT

3

March

Thursday, March 3, 08:30–10:00, Room O RC 512 Imaging of foetus and infant Moderator: A.M. Taylor; London/UK A. Foetal neuro imaging [A-138] A. Rossi; Genoa/IT B. Foetal body imaging [A-139] F.E. Avni; Lille/FR C. Neonatal urinary tract imaging [A-140] M. Riccabona; Graz/AT

4

March

Friday, March 4, 16:00–17:30, Room O RC 1212 Key issues in paediatric imaging » Chairman’s introduction [A-443] J. Portelli; Msida/MT

Wednesday, March 2, 16:00–17:30, Room O RC 412 Chest imaging in paediatrics

C. Imaging interstitial lung disease in children: update 2016 [A-071] M.P. García-Peña; Barcelona/ES

Friday, March 4, 10:30–12:00, Room M 2 SS 1012 Abdominal and foetal imaging

» Panel discussion: What are the essentials in education and training for paediatric imaging?

5

March

Saturday, March 5, 08:30–10:00, Room O RC 1312 Imaging children with cancer Moderator: P. Tomà; Rome/IT A. Imaging of abdominal masses at diagnosis: clues for benignity vs malignancy [A-519] A.M.J.B. Smets; Amsterdam/NL B. From whole body MRI to MR/PET [A-520] J. Schäfer; Tübingen/DE C. Imaging of complications of therapy [A-521] K. McHugh; London/UK

Friday, March 4, 08:30–10:00, Room O RC 912 Hepatobiliary imaging in children Moderator: M. Raissaki; Iraklion/GR A. Imaging of liver masses [A-318] H. Woodley; Leeds/UK B. Imaging of biliary disorders [A-319] S.G.F. Robben; Maastricht/NL C. Intervention in the hepatobiliary system [A-320] S. Franchi-Abella; Le Kremlin-Bicêtre/FR

158

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Physics in Radiology 2

March

Wednesday, March 2, 08:30–10:00, Room D2 RC 113 Single-dual-multi-energy CT

3

March

» Chairman’s introduction [A-031] J. Damilakis; Iraklion/GR A. Basics of diagnostic dual energy CT [A-032] T. Klinder; Hamburg/DE

» Chairman’s introduction [A-169] A. Torresin; Milan/IT

B. Photon counting detector technology for diagnostic CT [A-033] M. Danielsson; Stockholm/SE

A. Radiation risk: a patient’s perspective [A-170] E. Briers; Hasselt/BE B. Radiation risks for patients and staff [A-171] P. Gilligan; Dublin/IE

C. Do we really need multi-energy CT? [A-034] S.T. Schindera; Basle/CH

C. Risk in MRI [A-172] R. Peeters; Leuven/BE

» Panel discussion: How many energies do we need in CT?

2

March

Thursday, March 3, 08:30–10:00, Room D2 RC 513 How to assess and communicate examination risks to patients and referring physicians?

D. Communicating risks to patients and the public [A-173] N. Leitgeb; Graz/AT » Panel discussion: How real are the risks and how do we communicate them?

Wednesday, March 2, 10:30–12:00, Room F2 SS 213 CT imaging: effects of body size and use of iterative reconstruction [K-04, B-0099 – B-0108] Moderators: B.M. Gramer; Munich/DE A. Jahnen; Esch-sur-Alzette/LU

This session is part of the EuroSafe Imaging campaign.

3

March

Thursday, March 3, 14:00–15:30, Room F2 SS 713 Innovations in radiology [B-0665 – B-0675]

2

March

Wednesday, March 2, 14:00–15:30, Room F2 SS 313 Radiation risk assessment  and awareness [K-10, B-0302 – B-0311] Moderators: N. Buls; Brussels/BE O. Ciraj-Bjelac; Belgrade/RS This session is part of the EuroSafe Imaging campaign.

2

March

Wednesday, March 2, 16:00–17:30, Room D2 RC 413 Artefacts and pitfalls in tomography » Chairman’s introduction [A-097] V. Tsapaki; Athens/GR

Moderators: Y. Bouchareb; London/UK R. Raupach; Forchheim/DE

5

March

Saturday, March 5, 14:00–15:30, Room K RC 1513 IT tools for dose tracking and workflow optimisation » Chairman’s introduction [A-651] A. Trianni; Udine/IT A. Digital Imaging and Communications in Medicine (DICOM) standard and Integrating the Healthcare Enterprise (IHE) [A-652] D. Peck; Detroit, MI/US B. Patient dose index tracking: a must have? [A-653] F. Zanca; Leuven/BE

A. CT [A-098] M. Kachelrieß; Heidelberg/DE

C. Optimising technique using patient dose index tracking software: tips and tricks [A-654] R.W.R. Loose; Nürnberg/DE

B. PET/CT [A-099] T. Beyer; Vienna/AT

» Panel discussion: Dose index tracking in clinical practice

C. MR/PET [A-100] H.H. Quick; Essen/DE » Panel discussion: Imagine imaging without artefacts: dos and don’ts in your clinical practice

www.myESR.org

Final Programme | ECR 2016

159

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Physics in Radiology 5

March

Saturday, March 5, 16:00–17:30, Room K RC 1613 MR: artefacts and devices

Radiographers 2

March

» Chairman’s introduction [A-712] M. Tosetti; Pisa/IT

[B-0142 – B-0152] Moderators: P.H. Hogg; Manchester/UK Y. Menu; Paris/FR

A. Image artefacts in MRI and their mitigation [A-713] D.J. Lurie; Aberdeen/UK B. Imaging around metal implants: artefact reduction in MRI [A-714] C. McGrath; Belfast/IE

2

March

C. Artefacts in perfusion and diffusion MRI [A-715] I. Tsougos; Larissa/GR

6

Moderators: E. Agadakos; Athens/GR E. Sorantin; Graz/AT This session is part of the EuroSafe Imaging campaign.

Sunday, March 6, 10:30–12:00, Room F2 SS 1813 Practical radiation  risk management

3

March

[B-1200 – B-1210]

Moderators: C. Beardmore; London/UK K. Lang; Malmö/SE

This session is part of the EuroSafe Imaging campaign.

6

Sunday, March 6, 14:00–15:30, Room F2 SS 1913 Physics of dual-energy CT and breast imaging

Thursday, March 3, 14:00–15:30, Room G SS 714 Quality issues in ultrasound and CT [B-0708 – B-0718]

Moderators: M. Koutalonis; Colchester/UK R.W.R. Loose; Nürnberg/DE

March

Wednesday, March 2, 14:00–15:30, Room G SS 314 CT parameters:  juggling or struggling? [K-11, B-0345 – B-0354]

» Panel discussion: Clinically applicable tools/ strategies to minimising/avoiding MR imaging artefacts

March

Wednesday, March 2, 10:30–12:00, Room G SS 214 Radiographers’ education: the curriculum

4

March

Friday, March 4, 08:30–10:00, Room D2 RC 914 State-of-the-art breast imaging » Chairmen’s introduction [A-350, A-351] V. Syrgiamiotis; Athens/GR S. Zackrisson; Malmö/SE

[B-1348 – B-1357] Moderators: H. de las Heras Gala; Zorneding/DE I.A. Tsalafoutas; Athens/GR

A. Current status of digital mammography [A-352] C.E. Mercer; Manchester/UK B. Developments in digital mammography [A-353] C. Reis; Lisbon/PT C. Breast MRI and the future [A-354] G. Podobnik; Ljubljana/SI » Panel discussion: The role of multimodality imaging in breast imaging

4

March

Friday, March 4, 10:30–12:00, Room G SS 1014 High dose antidotes [B-0866 – B-0876] Moderators: I. Arkhipova; Moscow/RU S. Brandão; Porto/PT This session is part of the EuroSafe Imaging campaign.

160

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Radiographers 5

March

Saturday, March 5, 08:30–10:00, Room D2 RC 1314 Enhancing research in radiography: a change of culture

5

March

Moderators: C. Leidecker; Forchheim/DE J. Santos; Coimbra/PT

» Chairmen’s introduction [A-557, A-558] I.M. Björkman-Burtscher; Lund/SE J. McNulty; Dublin/IE

A. Safeguarding patients and staff in MRI [A-708] T. Owman; Lund/SE

A. Radiography research updates: new collaborations and initiatives in Europe [A-559] J. McNulty; Dublin/IE

B. Safety aspects in an interventional radiology setting? [A-709] D. Catania; Milan/IT

B. FoRRM: a Formal Radiography Research Mentorship scheme as an instrument for change [A-560] C. Malamateniou; London/UK

C. An introduction to mammography safety: what can be done? [A-710] D. O’Leary; Hertfordshire/UK

C. Translating research evidence into clinical practice [A-561] G. Paulo; Coimbra/PT

D. Safety in CT: dose minimisation and beyond [A-711] R. Booij; Rotterdam/NL

» Panel discussion: Research: the key to advancing the profession of radiography?

5 March

This session is part of the EuroSafe Imaging campaign.

6

March

Saturday, March 5, 10:30–12:00, Room G SS 1414 Safety and patient care in medical imaging

A. Image quality optimisation in MRI: a radiographer’s perspective [A-765] M. Kiss; Miskolc/HU

Moderators: A. Henner; Oulu/FI D. Miletić; Rijeka/HR

B. Fine tuning of image quality in computed tomography, the role of the radiographer [A-766] D. Pekarovic; Ljubljana/SI

Saturday, March 5, 14:00–15:30, Room D2 RC 1514 Innovative education in medical imaging

C. X-ray radiography: tips and tricks for high quality imaging on the frontline [A-767] E. Constantarogianni; Athens/GR

» Chairmen’s introduction [A-646, A-647] P. Bezzina; Msida/MT M. Bachmann Nielsen; Copenhagen/DK A. Is there a role for smartphones and tablets in medical imaging education? [A-648] F. Girard; Pont de Roide/FR

» Panel discussion: The importance of excellent images for advancing the quality of healthcare

6

March

B. Using simulators as an innovative teaching tool in medical imaging [A-649] P. Cosson; Teeside/UK

Sunday, March 6, 10:30–12:00, Room G SS 1814 Getting the radiation dose  as low as possible [K-31, B-1243 – B-1252]

C. Beyond eye candy: developing effective interactive animations to enhance MRI learning [A-650] D. Koumarianos; Athens/GR » Panel discussion: What is the value of innovation in advancing clinical practice and education in radiography?

Sunday, March 6, 08:30–10:00, Room D2 RC 1714 The magic of excellent images » Chairmen’s introduction [A-763, A-764] N. Mekiš; Ljubljana/SI A.P. Parkar; Bergen/NO

[B-1006 – B-1016]

5 March

Saturday, March 5, 16:00–17:30, Room D2 RC 1614 Safety issues in medical imaging

Moderators: H. Ståhlbrandt; Eksjö/SE F. Zarb; Msida/MT This session is part of the EuroSafe Imaging campaign.

6

March

Sunday, March 6, 14:00–15:30, Room G SS 1914 How to improve image quality in MRI and mammography [B-1379 – B-1389] Moderators: B. Bougias; Ioannina/GR E. Szabó; Szeged/HU

www.myESR.org

Final Programme | ECR 2016

161

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Vascular 2

March

Wednesday, March 2, 10:30–12:00, Room L8 SS 215 Vasculopathy: form and function

4

March

[B-0056 – B-0066]

Moderator: R. Morgan; London/UK

Moderators: M. Reiter; Vienna/AT A. van der Lugt; Rotterdam/NL

2 March

Moderators: M. de Bucourt; Berlin/DE J.T. Ortiz-Pérez; Barcelona/ES

2 March

A. The role of US: Doppler, 3D US, CEUS [A-368] P. Ricci; Rome/IT B. 2D and 3D CTA: current concepts [A-369] A. Bücker; Homburg a.d. Saar/DE

Wednesday, March 2, 14:00–15:30, Room L8 SS 315 Peripheral arteries: imaging and therapy [B-0259 – B-0269]

C. Endovascular management [A-370] R. Uberoi; Oxford/UK

4

March

Wednesday, March 2, 16:00–17:30, Room M 1 RC 415 Basic principles of varicose vein diagnosis and endovascular treatment

Moderators: A. Contegiacomo; Rome/IT H. Hoppe; Berne/CH

5

March

A. Diagnostic cross-sectional imaging [A-110] H. Hoppe; Berne/CH

Moderators: K. Nikolaou; Tübingen/DE M. Prokop; Nijmegen/NL

C. Ultrasound guided sclerotherapy [A-112] P.F. Sousa; Ermesinde/PT

5

March

Thursday, March 3, 10:30–12:00, Room L8 SS 615 Optimising vascular imaging techniques [B-0473 – B-0483]

Thursday, March 3, 14:00–15:30, Room Z SS 715 Endovascular therapies: what’s new? [K-18, B-0613 – B-0622] Moderators: F. Fanelli; Rome/IT D.K. Tsetis; Iraklion/GR

3

March

Saturday, March 5, 14:00–15:30, Room M 3 SS 1515 New observations in visceral imaging and therapy [B-1094 – B-1104]

Moderators: A.L.J. Bojanovic; Nis/RS T. Rand; Vienna/AT

3

Saturday, March 5, 10:30–12:00, Room M 3 SS 1415 Pulmonary vasculature: new and improved [B-1039 – B-1049]

B. Saphenous vein ablation [A-111] M. Akesson; Höllviken/SE

March

Friday, March 4, 10:30–12:00, Room Z SS 1015 Thoracic aorta: novel imaging and interventions [B-0762 – B-0772]

Moderator: D. Karnabatidis; Patras/GR

3 March

Friday, March 4, 08:30–10:00, Room M 2 RC 915 Fixing a leaky EVAR

Moderators: J.I. Bilbao; Pamplona/ES K. Katsanos; London/UK

6

March

Sunday, March 6, 10:30–12:00, Room L8 SS 1815 Abdominal aortic and other aneurysms [K-32, B-1170 – B-1179] Moderators: I. Bargellini; Pisa/IT E. Brountzos; Athens/GR

Thursday, March 3, 16:00–17:30, Room M 1 RC 815 Carotid artery disease: so what’s new? Moderator: T. Jargiello; Lublin/PL A. The diagnostic assessment of carotid arteries [A-295] R. Iezzi; Rome/IT B. Carotid stenting vs endarterectomy: is the jury back yet? [A-296] S. MacDonald; Newcastle upon Tyne/UK C. Carotid interventions in the setting of acute CVA [A-297] S. Sencer; Istanbul/TR

162

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Oncologic Imaging 2

March

Wednesday, March 2, 10:30–12:00, Room F1 SS 216a Hepatocellular cancer: characterisation, response and recurrence

3

March

[B-0505 – B-0515]

[B-0088 – B-0098]

Moderators: V. Panebianco; Rome/IT B.M. Schaarschmidt; Düsseldorf/DE

Moderators: M.A. Bali; Brussels/BE A. Fohlen; Caen/FR

2 March

3

March

Wednesday, March 2, 10:30–12:00, Room M 4 SS 216b Advanced imaging methods (2)

Moderators: J. Sosna; Jerusalem/IL T.D. Westwood; Manchester/UK

Moderators: C. Ayuso; Barcelona/ES O.V. Kucheruk; Moscow/RU

4

March

Wednesday, March 2, 14:00–15:30, Room F1 SS 316 Dealing with metastatic disease

Thursday, March 3, 14:00–15:30, Room F1 SS 716 Whole body imaging [K-19, B-0655 – B-0664]

[B-0184 – B-0194]

2 March

Thursday, March 3, 10:30–12:00, Room F1 SS 616 Advanced imaging methods (1)

Friday, March 4, 08:30–10:00, Room F1 RC 916 Diffusion-weighted imaging (DWI) in oncology: how I do it

[B-0291 – B-0301] » Chairman’s introduction [A-339] D.-M. Koh; Sutton/UK

Moderators: D.M. Lambregts; Amsterdam/NL A. Sohaib; London/UK

2

March

A. DWI: how to optimise protocols [A-340] N. Papanikolaou; Iraklion/GR B. DWI in abdominal oncology: ready for clinical practice? [A-341] D.M. Lambregts; Amsterdam/NL

Wednesday, March 2, 16:00–17:30, Room F1 RC 416 Evaluating lymph node involvement: an impossible task?

C. DWI: whole body imaging [A-342] V. Vandecaveye; Leuven/BE

» Chairman’s introduction [A-085] D.-M. Koh; Sutton/UK A. The current criteria for nodal involvement MRI/CTI [A-086] W. Schima; Vienna/AT B. Advanced MRI techniques: what do they contribute? [A-087] H.C. Thoeny; Berne/CH

» Panel discussion: How to optimise DWI for clinical practice?

4

March

[B-0824 – B-0834]

C. PET and other nuclear medicine techniques [A-088] T. Barwick; London/UK

Moderators: J. Rørvik; Bergen/NO W. Sommer; Munich/DE

» Panel discussion: Will imaging ever make diagnostic biopsy unnecessary?

3

March

Thursday, March 3, 08:30–10:00, Room F1 RC 516 A multidisciplinary approach to prostate cancer: can we make a difference? » Chairman’s introduction [A-161] B. Hamm; Berlin/DE A. The urologist: evidence-based clinical decision making [A-162] B.A. Hadaschik; Heidelberg/DE B. The radiologist: evidence-based use of multiparametric MRI [A-163] H.-P. Schlemmer; Heidelberg/DE C. The interventional radiologist [A-164] C. Catalano; Rome/IT

Friday, March 4, 10:30–12:00, Room F1 SS 1016 Prostate and renal tract cancers: advanced detection methods

4

March

Friday, March 4, 16:00–17:30, Room F1 RC 1216 New insights in bone tumour imaging » Chairman’s introduction [A-461] D. Vanel; Bologna/IT A. New insights in treatment-associated changes in patients with bone tumours [A-462] C.R. Krestan; Vienna/AT B. New insights in staging and restaging musculoskeletal tumours [A-463] J.L. Bloem; Leiden/NL C. New insights in imaging for multiple myeloma [A-464] G. Sommer; Basle/CH » Panel discussion: The future of bone tumour imaging

» Panel discussion: Prostate cancer: evidence-based multidisciplinary approach to imaging and treatment

www.myESR.org

Final Programme | ECR 2016

163

Programme by Session Type

REFRESHER COURSES / SCIENTIFIC SESSIONS Oncologic Imaging 5

March

Saturday, March 5, 10:30–12:00, Room M 2 SS 1416 Pelvic and breast cancer

Emergency Radiology 2

March

[B-1028 – B-1038] Moderators: O. Abeyakoon; Cambridge/UK B.D. Klumpp; Tübingen/DE

6 March

Moderator: S. Wirth; Munich/DE A. Liver and spleen [A-049] M. Scaglione; Castel Volturno/IT

Sunday, March 6, 10:30–12:00, Studio 2016 SS 1816 Gastrointestinal cancer: prediction and assessment of therapeutic response

B. Pancreas, bowel and mesentery [A-050] M.A. Patak; Zurich/CH C. Urogenital tract [A-051] R.H. Oyen; Leuven/BE

[B-1160 – B-1169] Moderators: S. Battisti; Rome/IT L.K. Blomqvist; Stockholm/SE

6

March

Wednesday, March 2, 08:30–10:00, Room M 4 RC 117 Abdominal trauma: does it bleed, will it start bleeding or is something else leaking?

2

March

Sunday, March 6, 14:00–15:30, Studio 2016 SS 1916 Assessment and prediction of treatment response

Wednesday, March 2, 16:00–17:30, Room M 4 RC 417 ‘Special patients’ in the emergency room: when and how to image them? Moderator: U. Linsenmaier; Munich/DE

[K-37, B-1316 – B-1325]

A. Children [A-121] V. Miele; Rome/IT

Moderators: L.S. Fournier; Paris/FR A. Gogbashian; Middlesex/UK

B. Pregnant patients [A-122] H. Alkadhi; Zurich/CH C. Elderly patients [A-123] K. Katulska; Poznan/PL

3

March

Thursday, March 3, 10:30–12:00, Room F2 SS 617 Cardiothoracic emergencies [K-15, B-0516 – B-0525] Moderators: F. Carbonetti; Rome/IT J.B. Dormagen; Oslo/NO

3

March

Thursday, March 3, 14:00–15:30, Room D2 SS 717 Trauma of the brain and body [B-0686 – B-0695] Moderators: J.M. Artigas; Zaragoza/ES F. Mrakic Sposta; Milan/IT

4

March

Friday, March 4, 08:30–10:00, Room M 4 RC 917 Acute pain: your friend and enemy in emergency radiology » Chairman’s introduction: patients with acute pain management and therapeutic pathways [A-375] J. Walecki; Warsaw/PL A. Head [A-376] P.C. Maly Sundgren; Lund/SE B. Chest [A-377] C.N. De Cecco; Charleston, SC/US C. Abdomen [A-378] R. Basilico; Chieti/IT » Panel discussion: Where does radiology fit in the pathway?

164

ECR 2016 | Final Programme

www.myESR.org

JOINT SESSIONS

165

Programme by Session Type

JOINT SESSIONS

INVEST IN THE YOUTH THIRTEEN YEARS OF INVESTING IN RADIOLOGY’S NEXT GENERATION

Free registration for the ECR and hotel accommodation voucher For more than 4,500 young radiologists and radiographers from all around the world since 2003

All funded by

166

The aim of the programme is to give radiologists-in-training under 35 or radiographers-in-training who are 30 or younger the chance to participate in the annual meeting of the ESR. ECR 2016 | Final Programme www.myESR.org

Programme by Session Type

JOINT SESSIONS 2

March

Wednesday, March 2, 08:30–10:00, Room L8 EuroSafe Imaging Session 1 Low-dose research in medical radiation protection

2

March

Moderator: L. Rainford; Dublin/IE

Moderator: G. Frija; Paris/FR

» Developing a strategic research agenda for  medical radiation protection: a chance for advancing research in radiology [A-016] W. Stiller; Heidelberg/DE

» An overview of the EuroSafe Imaging  achievements over the past year [A-078] G. Frija; Paris/FR » Update on the concept of Diagnostic Reference Levels [A-079] P. Vock; Spiegel/CH

» Do iodinated contrast media enhance DNA damage after exposure to ionising radiation? [A-017] G. Frija; Paris/FR

» Establishing European Diagnostic Reference Levels for paediatric imaging: an update on the EC tender project PiDRL [A-080] J. Damilakis; Iraklion/GR

» Dose reduction in modern digital plain-radiography on the basis of indication-specific, standardised quality criteria [A-018] D. Spira; Heidelberg/DE

» The European paediatric imaging project [A-081] C. Owens; London/UK

» Paediatric imaging: are risks of ionising radiation exposure established? [A-019] H. Ducou le Pointe; Paris/FR

» The EuroSafe Imaging dose management project [A-082] D. Caramella; Pisa/IT

This session is part of the EuroSafe Imaging campaign.

2

March

Wednesday, March 2, 16:00–17:30, Room E2 EuroSafe Imaging Session 2 EuroSafe Imaging Alliance & Campaign what is new?

» AFROSAFE Imaging Alliance and Campaign [A-083] M.G. Kawooya; Kampala/UG

Wednesday, March 2, 12:30–13:30; Room D2 Clinical Trials in Radiology (CTiR) 1

» Image Wisely and Image Gently: an overview [A-084] D. Frush; Durham, NC/US » Panel discussion Chair: J. Griebel; Neuherberg/DE (HERCA, BfS) Panellists: M. Perez; Geneva/CH (WHO) D. Paez; Vienna/AT (IAEA) G. Simeonov; Luxembourg/LU (EC) N. Denjoy; Brussels/BE (COCIR) G. Paulo; Coimbra/PT (EFRS)

Moderators: R.L. Arenson; San Francisco, CA/US M. Dewey; Berlin/DE » The Swedish CArdioPulmonary BioImage Study (SCAPIS): objectives and design G. Bergström; Gothenburg/SE Discussant: G. Krombach; Giessen/DE » NSsaFe study: observational study on the incidence of nephrogenic systemic fibrosis in renal impaired patients following gadoteric acid administration A. Gottschalk; Frankfurt a. Main/DE Discussant: G. Heinz-Peer; St. Pölten/AT » Computed tomography angiography vs Agatston score for diagnosis of coronary artery disease: results from the international Collaborative MetaAnalysis of Cardiac CT (COME-CCT) V. Wieske; Berlin/DE Discussant: L. Saba; Cagliari/IT » Efficient use of medical imaging in Belgium: where does it go wrong in prescribing imaging studies for the lumbar spine and abdomen? A national multicentric study N. Stichelbaut; Ghent/BE Discussant: F.J. Gilbert; Cambridge/UK

This session is part of the EuroSafe Imaging campaign.

3

March

Thursday, March 3, 12:30–13:30, Room D2 Clinical Trials in Radiology (CTiR) 2 Moderators: R.L. Arenson; San Francisco, CA/US M. Dewey; Berlin/DE » MR-targeted vs TRUS-guided prostate biopsy in patients with high PSA values: a randomized controlled trial D. Regge; Candiolo/IT Discussant: P. Asbach; Berlin/DE » The multicentre DISCHARGE trial pilot study: Image quality and protocol adherence results G. De Rubeis; Rome/IT Discussant: R. Vliegenthart; Groningen/NL » Dynamic stress perfusion CT for detection of inducible myocardial ischemia: rationale and design of the SPECIFIC-trial F. Bamberg; Tübingen/DE Discussant: S. Kajander; Turku/FI » The impact of breast MRI on surgical planning and reoperation rate: first results from the MIPA study G. Di Leo; San Donato Milanese/IT Discussant: E.M. Fallenberg; Berlin/DE

www.myESR.org

Final Programme | ECR 2016

167

Programme by Session Type

JOINT SESSIONS 3

March

Thursday, March 3, 14:00–15:30, Studio 2016 EIBIR Session 1 (European Institute for Biomedical Imaging Research) Joint VPH-PRISM/ASSURE Session from screening to therapy: innovative breast care concepts

Thursday, March 3, 16:00–17:30, Room K ACR Session (American College of Radiology) Delivering higher value care in radiology: how to make it work in clinical practice – perspectives from the American College of Radiology

Moderator: H.K. Hahn; Bremen/DE

Chairpersons: B. Allen, Jr.; Birmingham, AL/US H.-U. Kauczor; Heidelberg/DE

» Introduction: challenges and innovative approaches in image-based breast care [A-224] H.K. Hahn; Bremen/DE

» Awareness to accountability: coping with the mandates for documenting higher-value care [A-288] B. Allen, Jr.; Birmingham, AL/US

» Density patterns, breast cancer risk and masking in screening mammograms [A-225] C. van Gils; Utrecht/NL

» Radiologists’ role in delivering higher-value care through population health management [A-289] W.T. Thorwarth; Reston, VA/US

» Novel ultrasound and MRI technologies for breast cancer screening [A-226] N. Karssemeijer; Nijmegen/NL

» Involving patients in their radiological care: radiologist visibility, personalised care and improving outcomes [A-290] D.C. Kushner; Norfolk, VA/US

» Breast cancer risk and masking risk-based stratification protocols: key drivers of cost-effectiveness [A-227] E. Gray; Manchester/UK » Histopathology images: the new kid on the block of clinical multimodality imaging [A-228] J. van der Laak; Nijmegen/NL » Quantitative treatment planning, response prediction, and monitoring [A-229] K. Pinker-Domenig; New York, NY/US

3 March

3

March

Thursday, March 3, 14:00–15:30, Room N ESOR Session (European School of Radiology) Advancing clinical practice: role of education Moderators: L. Donoso Bach; Barcelona/ES N. Gourtsoyiannis; Athens/GR » Introduction [A-218] L. Donoso Bach; Barcelona/ES » ESOR in action 2016 [A-219] N. Gourtsoyiannis; Athens/GR » Role of remodelling in delivering of learning [A-220] P.R. Ros; Cleveland, OH/US » Role of referral guidelines and clinical decision support systems [A-221] L. Donoso Bach; Barcelona/ES

» Questions and answers

3

March

Thursday, March 3, 16:00–17:30, Room O ESR Working Group on Ultrasound Minimising the risk of transmitting infections through ultrasound: is current practice sufficient? » Chairman’s introduction [A-247] L.E. Derchi; Genoa/IT » Why is it important to consider infection control issues in ultrasound? Low- vs high-risk examinations [A-248] C. Nyhsen; Sunderland/UK » Current accepted practice of ultrasound probe decontamination in endocarvitary and interventional radiology [A-249, A-250] N. Grenier; Bordeaux/FR M. Claudon; Vandoeuvre-les-Nancy/FR » Why current practice may not be safe: main risks of infection transmission and published evidence [A-251] H. Humphreys; Dublin/IE » Panel discussion: Safer practice vs considerable cost implications: are changes needed and feasible?

» MDTs and patient outcomes [A-222] R.H. Reznek; London/UK » Role of research and innovation: essential ingredients for our professional advancement [A-223] H. Hricak; New York, NY/US Awards During the session, scholars and fellows will be awarded certificates for successfully completing the 2015 ESOR Scholarship and Fellowship Programmes.

168

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

JOINT SESSIONS 4

March

Friday, March 4, 08:30–10:00, Room K EFOMP Workshop: Radiation protection for the female patient and female medical staff (European Federation of Organisations for Medical Physics) EF 1 Breast imaging modalities and radiation dose

4

March

Moderators: B. Hamm; Berlin/DE S. Morozov; Moscow/RU A. Communication and conflict resolution in radiology: how to recruit and retain the best team [A-398] P.R. Ros; Cleveland; OH/US B. Impact of structured reporting on communication with referring physicians [A-399] D.P. dos Santos; Mainz/DE

Moderators: J. Damilakis; Iraklion/GR T. Beyer; Vienna/AT » Chairman’s introduction [A-355] J. Damilakis; Iraklion/GR

C. Informed consent in the radiology department: when and how? [A-400] L.H.R. Mendoza; Zaragoza/ES

» Breast CT: technology and patient dose [A-356] I. Sechopoulos; Nijmegen/NL

D. Patients’ expectations in communication with radiologists [A-401] E. Briers; Hasselt/BE

» Digital mammography for screening and diagnosis of breast cancer: breast doses and radiogenic risks [A-357] O. Morrish; Cambridge/UK

» Discussion Management in Radiology is a subcommittee of the ESR Professional Organisation Committee.

» Digital breast tomosynthesis: physical principles and radiation dose levels [A-358] G. Gennaro; Padua/IT

Those involved in the field of healthcare are experiencing a time of increasing pressure, stress and change. The demand for efficiency and effectiveness in all business and administrative matters is constantly growing. MIR addresses current challenges and provides a forum for education and the exchange of ideas and concepts.

This session is part of the EuroSafe Imaging campaign.

4

March

Friday, March 4, 10:30–12:00, Room K EFOMP Workshop: Radiation protection for the female patient and female medical staff (European Federation of Organisations for Medical Physics) EF 2 Pregnancy and lactation Moderators: P. Sharp; Aberdeen/UK V. Tsapaki; Athens/GR » Chairman’s introduction [A-390] P. Sharp; Aberdeen/UK » Radiation protection of pregnant and lactating patients in nuclear medicine [A-391] S. Mattsson; Malmö/SE » Dose management of pregnant patients in x-ray imaging [A-392] J. Damilakis; Iraklion/GR

Friday, March 4, 12:15–13:45, Room D2 MIR @ ECR Session (Management in Radiology) MIR 1 Communication in radiology

4

March

Friday, March 4, 14:00–15:30, Room M 4 Joint Session of the ESR and ESMRMB (European Society for Magnetic Resonance in Medicine and Biology) Cardiac MRI Moderators: E.R. Danielsen; Copenhagen/DK J. Bremerich; Basle/CH » Overview of cardiac MR methods [A-420] S. Kozerke; Zurich/CH » Clinical use of MR in congenital cardiac disease [A-421] V. Muthurangu; London/UK » Clinical use of MR in acquired cardiac disease [A-422] T. Leiner; Utrecht/NL

» Occupational radiation protection: protecting pregnant or potentially pregnant workers in interventional radiology [A-393] A. Trianni; Udine/IT This session is part of the EuroSafe Imaging campaign.

= Interactive session with electronic voting/self assessment

www.myESR.org

Final Programme | ECR 2016

169

Programme by Session Type

JOINT SESSIONS 4

March

Friday, March 4, 14:00–15:30, Room L8 EIBIR Session 2 (European Institute for Biomedical Imaging Research) MITIGATE: What does it take to perform clinical trials in interventional radiology?

4

March

» Introduction [A-411, A-412] S.O. Schönberg; Mannheim/DE W.R. Jaschke; Innsbruck/AT

» Chairmen’s introduction [A-483, A-484] G. Frija; Paris/FR S. Ebdon-Jackson; Didcot/UK

» Overview on clinical trials in interventional radiology in Europe [A-413] A. Gangi; Strasbourg/FR

» Overview of EU radiation protection legislation [A-485] J. Griebel; Neuherberg/DE

» How to implement investigator-initiated or industry-sponsored trials in interventional oncology: SORAMIC vs SIRFLOX [A-414] W. Richter; Berlin/DE

» Regulators’ expectations [A-486] S. Ebdon-Jackson; Didcot/UK » Tools to support implementation of the BSS Directive: ESR perspective [A-487] G. Frija; Paris/FR

» Design of a clinical trial in oligometastatic GIST: results from the MITIGATE consortium [A-415] C. Decristoforo; Innsbruck/AT

» Tools to support implementation of the BSS Directive: medical physicists’ perspective [A-488] J. Damilakis; Iraklion/GR

» Discussion

4

March

» Tools to support implementation of the BSS Directive: radiographers’ perspective [A-489] S.J. Foley; Dublin/IE

Friday, March 4, 14:00–15:30, Room D2 MIR @ ECR Session (Management in Radiology) MIR 2 Improving quality and safety in radiology

» Discussion: Regulators’ vs practitioners’ perspective: two sides of the same coin

Moderators: E.J. Adam; London/UK D.A. Koff; Hamilton, ON/CA A. How to run a safe department? [A-416] P. Cavanagh; Taunton/UK B. Patient satisfaction with radiology departments: are we doing our best? [A-417] G. Paulo; Coimbra/PT

» Discussion This session is part of the EuroSafe Imaging campaign.

4 March

Friday, March 4, 14:00–15:30, Room A Image Interpretation Quiz (IIQ) Imaging with the stars Moderator: A.G. Rockall; London/UK » Team 1: N. Grenier; Bordeaux/FR M. Vernooij; Rotterdam/NL M. Gardarsdottir; Reykjavik/IS S.A. Taylor; London/UK » Team 2: I. Thomassin-Naggara; Paris/FR H.R. Jäger; London/UK A.R. Larici; Rome/IT T.K. Helmberger; Munich/DE

Chairs:

 . Frija; Paris/FR (ESR) G S. Ebdon-Jackson; Didcot/UK (HERCA)

Panellists:

 . Griebel; Neuherberg/DE (HERCA) J J. Damilakis; Iraklion/GR (EFOMP) S.J. Foley; Dublin/IE (EFRS) N. Denjoy; Belgium/BE (COCIR)

This session is part of the EuroSafe Imaging campaign.

C. Is there any evidence for decision support? [A-418] G. Boland; Boston, MA/US D. Dose monitoring and benchmarking: opportunities to improve radiation protection [A-419] D. Caramella; Pisa/IT

Friday, March 4, 16:00–17:30, Room M 1 EuroSafe Imaging Session 3 Joint Session of the ESR and HERCA (Heads of the European Radiological protection Competent Authorities): the new EU-BSS Directive a step forward to patient safety

4

March

Friday, March 4, 16:00–17:30, Room Z EDiR Talk (European Diploma in Radiology) What you should know about the EDiR » Chairmen’s introduction:  The story of the European Diploma in Radiology (EDiR) [A-434, A-435] J. Vilar; Valencia/ES Y. Menu; Paris/FR » Evolution of EDiR [A-436 – A-440] J. Vilar; Valencia/ES P.C. Maly Sundgren; Lund/SE L. McKnight; Langland/UK V. Iranzo; Barcelona/ES H.T. Sarisoy; Kocaeli/TR » EDiR [A-441, A-442] O. Dicle; Izmir/TR E. Jordan; Barcelona/ES

= Interactive session with electronic voting/self assessment

170

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

JOINT SESSIONS 4

March

Friday, March 4, 16:00–17:30, Room D2 MIR @ ECR Session (Management in Radiology) MIR 3 Improving radiology departments

4

March

Moderators: J.K. Bell; Manchester/UK P. Mildenberger; Mainz/DE A. Health and wellbeing in the workplace [A-473] C.L. Cooper; Manchester/UK

» Introduction [A-454] G.P. Krestin; Rotterdam/NL

B. The role of radiology departments in patient-centred care: requirements for improvement [A-474] R. Arenson; San Francisco, CA/US

» Maximising your chances to obtain European research funding: opportunities, strategies, services [A-455] P. Zolda; Vienna/AT

C. Key features for organisational and financial sustainability [A-475] E. Schouman-Claeys; Paris/FR

» An evaluator’s perspective [A-456] M. Dewey; Berlin/DE » Success story of a maximum score project in Horizon 2020 [A-457] C.K. Kuhl; Aachen/DE

D. Clinically relevant reporting in the era of precision medicine [A-476] H. Hricak; New York, NY/US

» Questions and answers

» Discussion

4

March

Friday, March 4, 16:00–17:30, Room L8 EIBIR Session 3 (European Institute for Biomedical Imaging Research) Gateway to European funding for research projects

Friday, March 4, 16:00–17:30, Room B Joint Session of the ESR and the EANM (European Association of Nuclear Medicine) Hybrid imaging: radiology and nuclear medicine Chairpersons: V. Lewington; London/UK K. Riklund; Umea/SE » Introduction [A-425, A-426] K. Riklund; Umea/SE V. Lewington; London/UK » Dementia: the role of radiology [A-427] S. Haller; Geneva/CH » Dementia: the role of nuclear medicine [A-428] V. Garibotto; Geneva/CH » Prostate cancer: PET/CT in early biochemical relapse [A-429] E. Lopci; Rozzano/IT » Prostate cancer: multiparametric MR in the diagnosis and clinical management of prostate cancer [A-430] F. Mrakic Sposta; Milan/IT » Panel discussion: How can collaboration between radiology and nuclear medicine develop imaging and research in hybrid imaging?

www.myESR.org

5

March

Saturday, March 5, 08:30–10:00, Room L8 ESR Patient Advisory Group ESR-PAG 1 Patient-centred care in clinical radiology: do we really put our patients first? » Chairmen’s introduction [A-529, A-530] N. Bedlington; Vienna/AT P. Cavanagh; Taunton/UK » Implementing the ‘driver diagram’ on patient-centred care [A-531] P. Cavanagh; Taunton/UK » View of a patient representative from the neurological disease area [A-532] D. Walsh; Dublin/IE » View of a patient with prostate cancer [A-533] E. Briers; Hasselt/BE » Satisfaction assessment of patient users of an imaging department: an example from the south of France [A-534] D.-G. Carrié; Toulouse/FR » Panel discussion: Question to the audience: does your department perform well in patient-centred care? Is it really all about the patient?

Final Programme | ECR 2016

171

Programme by Session Type

JOINT SESSIONS 5

March

Saturday, March 5, 10:30–12:00, Room L8 ESR Patient Advisory Group ESR-PAG 2 Mind the gap - data-sharing for better patient outcomes the key issues for patients and the radiology community

5

March

» Chairmen’s introduction [A-583, A-584] N. Bedlington; Vienna/AT B. Brkljačić; Zagreb/HR

Moderator: Z.A. Taylor; Sheffield/UK » VPH-DARE@IT: towards early, differential diagnosis of dementia [A-600] A. Frangi; Sheffield/UK

» eHealth, EHR and data protection: friend or foe? [A-585] P. Mildenberger; Mainz/DE

» Clinical platform for data-driven differential diagnostics of cognitive disorders [A-601] M. van Gils; Tampere/FI

» View of a patient representative from the Pelvic Pain Support Network [A-586] J. Birch; Poole/UK

5

March

Saturday, March 5, 13:30–15:30, Room Z EIBIR Session 4 (European Institute for Biomedical Imaging Research) The VPH-DARE@IT Project: delivering a clinical decision support platform for earlier dementia diagnosis

» View of a patient with prostate cancer [A-587] E. Briers; Hasselt/BE

» Shared research as a service platform for translating research into clinical practice for dementia [A-602] S. Varma; Sheffield/UK

» Big data in radiology: how will it enhance personalised medicine? [A-588] H.-U. Kauczor; Heidelberg/DE

» In silico characterisation of white matter microstructure using diffusion MRI [A-603] L. Beltrachini; Sheffield/UK

» Panel discussion: Big data = big issues?

» Fluid transport in the ageing brain: an integrative modelling approach [A-604] Y. Ventikos; London/UK

Saturday, March 5, 12:55–13:55, Room A Junior Image Interpretation Quiz (JIIQ) Millennials showdown: the next generation of radiology

» Phenomenological modelling and the RSS [A-605] W.J. Niessen; Rotterdam/NL

Moderator: F. Arnberg; Stockholm/SE » Team 1: C. Toxopeus; Amsterdam/NL A. Gupta; London/UK » Team 2: F.G. Meinel; Munich/DE D. Penha; Lisbon/PT » Team 3: J.A. Prat-Matifoll; Barcelona/ES O. Urbán; Szeged/HU » Team 4: B. Fejér; Budapest/HU S. Belkacem; Monaco/MC

» Discussion

5

March

Saturday, March 5, 14:00–15:30, Studio 2016 Joint Session of the ESR and ERS (European Respiratory Society) Imaging of airways: what the respirologist needs to know Moderators: N. Karabulut; Denizli/TR S. Ley; Munich/DE » Classification and impact of bronchiectasis [A-623] S. Aliberti; Milan/IT » How to image and report airway disease? [A-624] P.A. Grenier; Paris/FR » Role of airway obstruction and remodeling in the progression of COPD [A-625] I. Adcock; London/UK » Imaging of mucus, inflammation and remodeling in COPD and CF [A-626] H.-U. Kauczor; Heidelberg/DE

= Interactive session with electronic voting/self assessment

172

ECR 2016 | Final Programme

www.myESR.org

Programme by Session Type

JOINT SESSIONS 5

March

Saturday, March 5, 16:00–17:30, Room L8 EuroSafe Imaging Session 4 You too can definitely do audits

5

March

» Chairman’s introduction [A-685] E.J. Adam; London/UK » Experience from an established national programme [A-686] D. Remedios; Harrow/UK

Moderators: M. Claudon; Vandoeuvre-les-Nancy/FR C. Owens; London/UK

» The challenges of introducing a national audit programme [A-687] A. Vargha; Hidegség/HU

» Legal issues with CEUS in children [A-673] P.S. Sidhu; London/UK

» How to make audit easy: the ESR Audit Tool [A-688] P. Cavanagh; Taunton/UK

» CEUS of focal liver lesions in children [A-674] M. Sellars; London/UK

» Panel discussion

» CEUS in blunt abdominal trauma in children [A-675] A. Deganello; London/UK

This session is part of the EuroSafe Imaging campaign.

5

March

Saturday, March 5, 16:00–17:30, Room Z Joint Session of the ESR and ESTRO (European Society for Radiotherapy and Oncology) MRI and MR/PET in radiation treatment planning - challenges and opportunities » Chairmen’s introduction [A-667, A-668] K. Riklund; Umeå/SE V. Valentini; Rome/IT » The benefit of high tesla MRI for radiation oncology planning [A-669] U. van der Heide; Amsterdam/NL » The challenge of in room MRI for treatment delivery [A-670] N. Dinapoli; Rome/IT » The benefit of MR/PET in radiation oncology [A-671] U. Nestle; Freiburg/DE » The challenge of using MR/PET in radiation oncology [A-672] E.-M.B. Larsson; Uppsala/SE » Discussion

Saturday, March 5, 16:00–17:30, Room O Joint Session of the ESR, EFSUMB (European Federation of Societies for Ultrasound in Medicine and Biology) and ESPR (European Society of Paediatric Radiology) Contrast enhanced ultrasound (CEUS) in paediatrics

» CEUS in vesical reflux in children [A-676] C. Duran; Sabadell/ES » CEUS in non-liver indications in paediatric patients [A-677] C.F. Dietrich; Bad Mergentheim/DE

6

March

Sunday, March 6, 08:30–10:00, Room C Joint Session of the ESR and ESHI (European Society for Hybrid Medical Imaging) Medical hybrid imaging Chairpersons: K. Riklund; Umea/SE L. Donoso Bach; Barcelona/ES » Introduction [A-725] L. Donoso Bach; Barcelona/ES » The aims of the new society [A-726] K. Riklund; Umea/SE » Training of hybrid physicians [A-727] G. Antoch; Düsseldorf/DE » The beauty of physics in hybrid imaging [A-728] T. Beyer; Vienna/AT » Functional hybrid imaging: 1+1 = 3? [A-729] O. Clément; Paris/FR » Practical challenges of hybrid imaging in clinical practice [A-730] O. Ratib; Geneva/CH » Discussion

www.myESR.org

Final Programme | ECR 2016

173

Enjoy Vienna’s cultural highlights

More about opera and musical theatre in Vienna: www.myESR.org/arts_culture

Ilia Hollweg and Oedo Kuipers in Mozart! The Musical © VBW / Deen van Meer 2015

Star Alliance™ Conventions Plus

SAVE UP TO 20% ON TRAVEL WITH THE STAR ALLIANCE™ NETWORK

The Star Alliance member airlines are pleased to be appointed as the Official Airline Network for ECR 2016. To obtain the Star Alliance Conventions Plus discounts please follow the below steps to access the Conventions Plus online booking tool: » Visit www.staralliance.com/en/convention-delegates » Under ‘Delegates login’ enter conventions code OS13S16 » The online booking tool opens in a separate window Registered participants travelling to the event qualify for a discount of up to 20%, depending on fare and class of travel booked. The participating airlines for this event are: Adria Airways, Aegean Airlines, Air Canada, Air China, Air India, Air New Zealand, ANA, Asiana, Austrian Airlines, Avianca, Brussels Airlines, Copa Airlines, Croatia Airlines, EgyptAir, Ethiopian Airlines, EVA Airways, LOT Polish Airlines, Lufthansa, Scandinavian Airlines, Shenzhen Airlines, Singapore Airlines, South African Airways, SWISS, TAP Portugal, Thai Airways, Turkish Airlines, United Airlines. Discounts are offered on most published business and economy class fares, excluding website/ internet fares, senior and youth fares, group fares and Round the World fares. When making your travel plans please present confirmation of your registration or proof of attendance for the Event/Convention. Special procedures to be followed for travel to/from Japan. Discounts may be offered by the participating airlines on their own network. To obtain these discounts please contact the respective carriers’ booking office. Contact details can be found on www.staralliance.com/conventionsplus/delegates/ under ‘Conventions Plus Booking Contacts’. Please quote the event code OS13S16 for ticket reservation.

SATELLITE SYMPOSIA

Industrial Satellite Symposia are organised by various international companies. These sessions are a chance to get an industry perspective on various scientific subjects, including technical updates, emerging trends and future innovations. The symposia vary in length from one hour to 90 minutes, with the number of speakers also differing between companies and subjects. Places are allocated on a first-come, first-served basis.

For details of the programmes see separate booklet ‘Industry Programme & On-Show Guide’.

177

Industry Programme

SATELLITE SYMPOSIA 2

March

2 March

Wednesday, March 2, 10:30–12:00, Studio 2016 SY 1a Satellite Symposium jointly organised by  Siemens Healthcare and Bayer HealthCare



3

March

3

March

Wednesday, March 2, 12:15–13:45, Studio 2016 SY 1b Satellite Symposium jointly organised by  Siemens Healthcare and Bayer HealthCare

3

March

2

March

2

March

2

March

2

March

2

March

3

March

178

Wednesday, March 2, 14:00–15:30, Studio 2016 SY 1c Satellite Symposium jointly organised by  Siemens Healthcare and Bayer HealthCare

Wednesday, March 2, 16:00–17:00, Studio 2016 SY 1d Satellite Symposium jointly organised by  Siemens Healthcare and Bayer HealthCare

Wednesday, March 2, 12:30–13:30, Room O SY 2 Satellite Symposium organised by MINT Medical

Wednesday, March 2, 12:30–13:30, Room N SY 3 Satellite Symposium organised by SuperSonic Imagine

Wednesday, March 2, 12:30–13:30, Room L8 SY 4 Satellite Symposium organised by Mindray

Thursday, March 3, 12:30–13:30, Room O SY 5 Satellite Symposium organised by Siemens Healthcare

ECR 2016 | Final Programme

3

March

3

March

3

March

3

March

4

March

4

March

Thursday, March 3, 12:30–13:30, Room N SY 6 Satellite Symposium organised by Siemens Healthcare

Thursday, March 3, 12:30–13:30, Studio 2016 SY 7 Satellite Symposium organised by GE Healthcare

Thursday, March 3, 12:30–13:30, Room E1 SY 8 Satellite Symposium organised by Bracco

Thursday, March 3, 12:30–13:30, Room K SY 9 Satellite Symposium organised by Toshiba

Thursday, March 3, 12:30–13:30, Room G SY 10 Satellite Symposium organised by Samsung

Thursday, March 3, 12:30–13:30, Room M 2 SY 11 Satellite Symposium organised by Bayer Pharma

Thursday, March 3, 12:30–13:30, Room M 5 SY 12 Satellite Symposium organised by Bayer HealthCare

Friday, March 4, 12:30–13:30, Room O SY 13 Satellite Symposium organised by Philips

Friday, March 4, 12:30–13:30, Room N SY 14 Satellite Symposium organised by Siemens Healthcare

www.myESR.org

Industry Programme

SATELLITE SYMPOSIA 4

March

4

March

4

March

4

March

4

March

4

March

Friday, March 4, 12:30–13:30, Studio 2016 SY 15 Satellite Symposium organised by GE Healthcare

Friday, March 4, 12:30–13:30, Room E1 SY 16 Satellite Symposium organised by Bracco

Friday, March 4, 12:30–13:30, Room F2 SY 17 Satellite Symposium jointly organised by Siemens Healthcare and Bayer HealthCare

4

March

4

March

4

March

Friday, March 4, 12:30–13:30, Room K SY 18 Satellite Symposium organised by Toshiba

March

Friday, March 4, 12:30–13:30, Room G SY 19 Satellite Symposium organised by Guerbet

March

Friday, March 4, 12:30–13:30, Room M 3 SY 20 Satellite Symposium organised by HIMSS (Healthcare Information and Management Systems Society)

5

5

5

March

5

March

4

March

4

March

Friday, March 4, 14:00–15:30, Room C SY 21 Satellite Symposium organised by Hologic

Friday, March 4, 14:00–15:30, Room Z SY 22 Satellite Symposium organised by Bayer HealthCare Russia

www.myESR.org

5

March

Friday, March 4, 14:00–15:30, Room O SY 23 Satellite Symposium organised by GE Healthcare Russia

Friday, March 4, 14:00–15:30, Room G SY 24 Satellite Symposium jointly organised by Bracco and Bayer HealthCare

Friday, March 4, 14:00–15:30, Room M 3 SY 25 Satellite Symposium organised by HIMSS (Healthcare Information and Management Systems Society)

Saturday, March 5, 12:30–13:30, Room C SY 26 Satellite Symposium organised by GE Healthcare

Saturday, March 5, 12:30–13:30, Room O SY 27 Satellite Symposium organised by Philips

Saturday, March 5, 12:30–13:30, Room N SY 28 Satellite Symposium organised by Philips

Saturday, March 5, 12:30–13:30, Studio 2016 SY 29 Satellite Symposium organised by Bracco

Saturday, March 5, 12:30–13:30, Room K SY 30 Satellite Symposium organised by Toshiba

Final Programme | ECR 2016

179

Industry Programme

SATELLITE SYMPOSIA www.buchkontor.at

READ ANZEIGE SOMETHING

DI FE EN B U C H KO N TO R

Guidebooks, cookbooks, illustrated books, literature, postcards & souvenirs from Vienna

180

Buchkontor’s ECR Bookstore | Entrance Hall

ECR 2016 | Final Programme

www.myESR.org

INDUSTRY WORKSHOPS

Intensive practical sessions organised directly by a particular company or commercial vendor. Classes are conducted on their own stateof-the-art workstations with expert technical support provided by company staff. Participants have the opportunity to learn from experts about using computers and medical devices in the field of radiology and gain first-hand knowledge. As a registered attendee for the ECR, participation is free of charge.

For details of the programmes see separate booklet ‘Industry Programme & On-Show Guide’.

181

P O S TG R A D UAT E E D U C AT I O N A L PROGRAMME Session numbers are prefixed by E3, EF, EM, HL, MC, MS, NH, PC, RC, SA, SF, TF Presentation numbers are prefixed by the letter A

Key to Abbreviations E3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . European Excellence in Education EF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . EFOMP Workshop EM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .ESR/EFRS meets Session HL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Honorary Lecture MC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mini Course MS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Multidisciplinary Session NH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . New Horizons Session PC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Professional Challenges Session RC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Refresher Course SA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . State of the Art Symposium SF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Special Focus Session TF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Radiology Trainees Forum

181

Postgraduate Educational Programme

08:30–10:00 Room A

Panel discussion: 09:44 How do I approach a case in my routine clinical practice?

E3 - ECR Academies: Interactive Teaching Sessions

08:30–10:00 Room O

E3 121

New Horizons Session

Head and neck cancer after treatment: what you need to know

08:30 A-001 A. Imaging after surgical treatment M. Lell; Erlangen/DE

Learning Objectives: 1. To become familiar with the different surgical techniques. 2. To become familiar with the imaging findings after surgery. 09:15 A-002 B. Imaging after radiotherapy/chemotherapy G. Madani; London/UK

Learning Objectives: 1. To become familiar with common findings after medically treated head and neck tumours. 2. To become familiar with changes after radiotherapy for head and neck tumours. 08:30–10:00 Room B

GI Tract RC 101

Assessing inflammation and fibrosis in Crohn’s disease

08:30 A-003 Chairman’s introduction A. Laghi; Latina/IT

Session Objective: 1. To briefly present how inflammation and fibrosis in Crohn’s disease impact in patient management and list the available tools for a differential diagnosis. 08:35 A-004 A. Is sonography (CEUS and elastography) the right tool? E. Quaia; Trieste/IT

Learning Objectives: 1. To learn about CEUS technique, including imaging acquisition and data post-processing. 2. To become familiar with US elastography, particularly with those techniques useful in the assessment of the small bowel. 3. To understand potential advantages and possible limitations of CEUS and elastography in the assessment of inflammation and fibrosis in Crohn’s disease. 08:58 A-005 B. Is there space for MDCT (spectral imaging, iodine map)? J. Podgorska; Warsaw/PL

Learning Objectives: 1. To understand basic principles of spectral imaging, including data post-processing. 2. To appreciate the strengths and limitations of spectral imaging in the abdomen. 3. To learn about advantages and possible limitations of spectral imaging in the assessment of inflammation and fibrosis in Crohn’s disease.

NH 1

New frontiers in imaging of vascular wall and plaque

08:30 A-007 Chairman’s introduction: How to use the tools? C. Loewe; Vienna/AT

Session Objectives: 1. To learn about the demands in vessel wall and plaque imaging. 2. To understand the importance of non-invasive imaging for risk assessment. 3. To appreciate the necessity of comprehensive assessment in atherosclerosis. 08:35 A-008 Molecular imaging for MR M.R. Makowski; Berlin/DE

Learning Objectives: 1. To understand the potential of MRI for clinical risk assessment in atherosclerosis. 2. To learn about new specific contrast agents for plaque load quantification and plaque remodelling visualisation. 3. To appreciate the value of MRI for predicting future atherosclerotic events. 08:53 A-009 New insights using nuclear and hybrid imaging J. Knuuti; Turku/FI

Learning Objectives: 1. To understand the potential of hybrid techniques for assessing vulnerable plaque and atherosclerosis activity. 2. To learn about new tracers for plaque imaging. 3. To appreciate the importance of functional imaging in atherosclerosis. 09:11 A-010 Ultrasound elastography: how useful can it be? N. Liasis; Athens/GR

Learning Objectives: 1. To become familiar with the technical principles of ultrasound elastography in vessel wall imaging. 2. To learn about the potential of elastography in the identification of the vulnerable plaque. 3. To understand the role of ultrasound elastography in atherosclerosis and risk assessment. 09:29 A-011 New options with CT A. Persson; Linköping/SE

Learning Objectives: 1. To become familiar with the technical possibilities of modern CT in plaque analysis. 2. To learn about the value of multi-energy imaging for functional imaging in atherosclerosis. 3. To appreciate the usefulness of CT based scores for assessment of atherosclerotic plaque burden. Panel discussion: 09:47 Predictive role of imaging in the evolution of atherosclerosis: where do we stand?

09:21 A-006 C. Will MRI (DWI and perfusion) solve the problem? S.A. Taylor; London/UK

Learning Objectives: 1. To understand basic principles of DWI applied to Crohn’s disease. 2. To learn about MR-perfusion protocols and data analysis. 3. To learn about advantages and possible limitations of MRI in the assessment of inflammation and fibrosis in Crohn’s disease.

182

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

08:30–10:00 Room N

08:30–10:00 Room L8

Computer Applications

EuroSafe Imaging Session

RC 105

EuroSafe 1 Low-dose research in medical radiation protection

Daily use of mobile devices in radiology

08:30 A-012 Chairman’s introduction O. Ratib; Geneva/CH

08:35 A-013 A. What did mobile devices change in radiology education? E. Kotter; Freiburg/DE

Learning Objectives: 1. To give an overview of tools available for e-learning. 2. To explore the potential impact of e-learning in the daily radiological practice. 3. To explore future developments and limits of e-learning. 08:58 A-014 B. Is it appropriate to read a study on a smartphone or a tablet? E. Neri; Pisa/IT

Learning Objectives: 1. To give an overview of available DICOM viewers and software for reporting imaging studies. 2. To discuss technical requirements of mobile devices for use in imaging interpretation. 3. To provide insight on future developments of imaging viewing technology. 09:21 A-015 C. Security and ethical issues of mobile device technology E.R. Ranschaert; ‚s-Hertogenbosch/NL

Learning Objectives: 1. To provide an overview of technical solutions for patients’ image and data mobility. 2. To provide a risk assessment analysis (data loss, privacy, etc.) of mobile technology. 3. To give an overview of European legislation in relation to patient image and data mobility. Panel discussion: 09:44 Will mobile technology overcome stationary technology in radiology?

08:30 A-016 Developing a strategic research agenda for medical radiation protection: a chance for advancing research in radiology W. Stiller; Heidelberg/DE

Wednesday

Session Objectives: 1. To give an overview of tools available on mobile devices for education and exam reporting. 2. To underline the impact of mobile devices in routine clinical activity. 3. To learn about the legislative backbone and potential drawbacks of mobile technology.

Moderator: L. Rainford; Dublin/IE

Learning Objectives: 1. To raise awareness of the multi-disciplinary effort to define a common strategic research agenda (SRA) for medical radiation protection. 2. To learn about the research topics identified in view of low-dose imaging. 3. To understand the SRA’s potential for furthering and improving low-dose imaging research and its translation to clinical routine application. 08:53 A-017 Do iodinated contrast media enhance DNA damage after exposure to ionising radiation? G. Frija; Paris/FR

Learning Objectives: 1. To raise awareness of the interrelation of ionising radiation-induced DNA damage and iodinated contrast media usage. 2. To understand the underlying mechanisms of radiation-induced DNA damage in the presence of iodinated contrast agents. 3. To outline the clinical implications in view of contrast-enhanced imaging employing iodinated contrast agents. 09:16 A-018 Dose reduction in modern digital plain-radiography on the basis of indication-specific, standardised quality criteria D. Spira; Heidelberg/DE

Learning Objectives: 1. To learn about the definition of indication-specific objective qualitycontrol criteria for radiation dose reduction in digital radiography. 2. To understand that objective quality-control criteria enable indication-specific radiation dose reduction of 40-50% without loss of relevant diagnostic information. 3. To raise awareness of the dose reduction potential in digital plainradiography of the entire spine, of the full leg in knee malalignment, of the pelvis after total hip arthroplasty or osteosynthesis, and of the knee following total knee arthroplasty. 09:38 A-019 Paediatric imaging: are risks of ionising radiation exposure established? H. Ducou le Pointe; Paris/FR

Learning Objectives: 1. To learn about the risks associated with the exposure to ionising radiation in paediatric imaging. 2. To become familiar with current research methods and underlying theories for defining the risks in paediatric patient populations. 3. To outline the clinical implications in view of paediatric imaging.

www.myESR.org

Final Programme | ECR 2016

183

Postgraduate Educational Programme

08:30–10:00 Room E1

Musculoskeletal RC 110

The elbow: a comprehensive approach

08:30 A-020 Chairman’s introduction A. Alcalá-Galiano; Madrid/ES

Session Objectives: 1. To understand that assessing this joint requires specific technical focus of technique, imaging protocol, choice of coils and sequences and modalities. 2. To learn about the pivotal role of the radiologist in evaluating elbow imaging in order to provide essential information for the arthroscopist. 08:35 A-021 A. The tendons: anatomy, pathology and intervention P. Peetrons; Brussels/BE

Learning Objectives: 1. To become familiar with the normal imaging anatomy and pathological appearances of the elbow tendons. 2. To learn about interventional radiological techniques for treating elbow tendon disease. 08:58 A-022 B. Ligament injury and instability: what to look for and what to say M.C. De Jonge; Amsterdam/NL

Learning Objectives: 1. To become familiar with patterns of abnormality seen in elbow instability. 2. To learn about the imaging findings of elbow instability. 09:21 A-023 C. Nerve entrapment at the elbow L.M. Sconfienza; San Donato Milanese/IT

Learning Objectives: 1. To understand the radiological anatomy of the peripheral nerves at the elbow. 2. To learn about the imaging findings of nerve entrapments at the elbow. Panel discussion: 09:44 US, CT, conventional MR, high field MR: what to choose when?

08:30–10:00 Room F2

Breast RC 102

Breast ultrasound 2016

09:30 A-026 C. Nodal staging of breast cancer: still needed? F. Kilburn-Toppin; Cambridge/UK

Learning Objectives: 1. To know the current debate on sentinel node biopsy and axillary lymph node dissection. 2. To appreciate the clinical role of staging of the axilla using ultrasound with selective ultrasound-guided needle biopsy. 3. To understand the need for discriminating between minimal versus advanced nodal metastatic involvement. 08:30–10:00 Room D1

Chest RC 104

Pneumonia

08:30 A-027 Chairman’s introduction I.E. Tyurin; Moscow/RU

Session Objectives: 1. To review the role of imaging in infectious lung diseases. 2. To become confident in recognising typical patterns. 08:35 A-028 A. Community-acquired pneumonia I. Hartmann; Rotterdam/NL

Learning Objectives: 1. To review the role of imaging examinations in the management of community-acquired pneumonia. 2. To learn about signs which suggest specific pathogens and help to discriminate from noninfectious diseases. 08:58 A-029 B. Tuberculosis E. Castañer; Sabadell/ES

Learning Objectives: 1. To review typical and atypical tuberculosis manifestations on imaging. 2. To differentiate between acute and chronic tuberculosis infection. 09:21 A-030 C. Fungal pneumonia in immunocompromised hosts J. Mayer; Heidelberg/DE

Learning Objectives: 1. To review the various expression of fungal lung infection depending on the type of immune depression. 2. To become familiar with CT signs suggesting angio invasive fungal infection. Panel discussion: 09:44 What is the role of radiologists in the diagnosis and management of lung infections?

Moderator: A. Athanasiou; Athens/FR

08:30 A-024 A. Evidence for screening in dense breasts V. Girardi; Brescia/IT

Learning Objectives: 1. To understand how breast density negatively impacts on sensitivity of screening mammography. 2. To know the results of additional screening methods in women with dense breasts. 3. To be aware of cost considerations for additional screening methods. 09:00 A-025 B. Elastosonography: true advances or false hope? C.S. Balleyguier; Villejuif/FR

Learning Objectives: 1. To understand physical principles of elastosonography. 2. To become familiar with the technique of shear-wave elastosonography of the breast. 3. To appreciate reproducibility and clinical value of elastosonography in clinical practice.

184

ECR 2016 | Final Programme

08:30–10:00 Room D2

Physics in Radiology RC 113

Single-dual-multi-energy CT

08:30 A-031 Chairman’s introduction J. Damilakis; Iraklion/GR

Session Objectives: 1. To learn about the basics of dual energy CT (DECT). 2. To understand today’s photon counting detector technology. 3. To learn how DECT is applied in clinical practice.

www.myESR.org

Postgraduate Educational Programme

08:35 A-032 A. Basics of diagnostic dual energy CT

09:21 A-038 C. Mistakes in assessment of ovarian masses

T. Klinder; Hamburg/DE

I. Thomassin-Naggara; Paris/FR

Learning Objectives: 1. To learn about the underlying physics and today’s technology. 2. To see potential advantages compared to single energy CT. 3. To appreciate the rationale behind clinical applications.

Learning Objectives: 1. To become familiar with benign masses mimicking ovarian cancer. 2. To demonstrate benign and malignant diseases mimicking peritoneal carcinomatosis. 3. To learn about imaging strategies for avoiding these pitfalls.

08:58 A-033 B. Photon counting detector technology for diagnostic CT M. Danielsson; Stockholm/SE

09:21 A-034 C. Do we really need multi-energy CT?

08:30–10:00 Room G

Neuro RC 111

S.T. Schindera; Basle/CH

Learning Objectives: 1. To learn about medical applications and potential benefits. 2. To see which single energy applications should be replaced by dual energy applications, and why. 3. To find out what additional multi-energy CT applications would be nice to have. Panel discussion: 09:44 How many energies do we need in CT?

08:30–10:00 Room K

Genitourinary RC 107

Pitfalls in gynaecologic oncologic imaging: how to avoid them and minimise risks

08:30 A-035 Chairman’s introduction E. Sala; New York, NY/US

Session Objectives: 1. To provide an overview of pitfalls and errors in interpretation of gynaecologic cancers. 2. To become familiar with strategies for avoiding pitfalls. 08:35 A-036 A. Mistakes in assessment of cervical cancer K. Downey; London/UK

Learning Objectives: 1. To become familiar with pitfalls in staging of cervical cancer and in monitoring treatment response. 2. To learn how to differentiate mimics of cervical cancer. 3. To understand the central role of MRI in treatment planning. 08:58 A-037 B. Mistakes in assessment of endometrial cancer T.M. Cunha, M. Horta; Lisbon/PT

Learning Objectives: 1. To become familiar with pitfalls in local tumour spread in endometrial cancer. 2. To learn how to differentiate benign and malignant mimics. 3. To appreciate the complementary value of functional MRI techniques. 4. To understand the potential clinical impact of these mistakes in treatment planning.

www.myESR.org

Wednesday

Learning Objectives: 1. To learn about the underlying physics and technological solutions. 2. To understand the potential advantages compared to dual energy CT. 3. To appreciate how mature today’s photon counting technology is.

Panel discussion: 09:44 How can we improve interdisciplinary communication and avoid misunderstanding in our reports?

Toxic brain disorders Moderator: P. Due-Tønnessen; Oslo/NO

08:30 A-039 A. Alcohol-related changes in the brain M. Knauth; Göttingen/DE

Learning Objectives: 1. To document how imaging can help with diagnosing acute alcohol poisoning and chronic alcoholic encephalopathy. 2. To discuss Wernicke encephalopathy. 3. To present the imaging findings in methanol and ethylene glycol poisoning. 09:00 A-040 B. Recreational drugs and occupational hazards L. Reneman; Amsterdam/NL

Learning Objectives: 1. To present an overview of recreational drugs and how they influence the brain. 2. To illustrate the effect of drugs on imaging studies (amphetamines, ecstasy, cocaine, heroine, methadone, ...). 3. To understand how occupationally used toxic substances can influence the brain (including toluene, cyanide, organophosphates, lead and mercury poisoning, ...). 09:30 A-041 C. Treatment-induced effects on the brain parenchyma J. Alvarez-Linera; Madrid/ES

Learning Objectives: 1. To show the imaging findings after radiation therapy in the acute, early and late delayed stages. 2. To present an overview of long-term sequelae after radiation therapy. 3. To discuss treatment induced leukoencephalopathy after chemotherapy (especially metothrexate). 08:30–10:00 Room M 1

Molecular Imaging RC 106

Molecular imaging: what can we quantify? Moderator: T.H. Helbich; Vienna/AT

08:30 A-042 A. Advanced MRI techniques C.A. Cuénod; Paris/FR

Learning Objectives: 1. To learn about functional MRI (fMRI, DCE-MRI), diffusion tensor imaging (DTI) and diffusion-weighted imaging (DWI). 2. To understand the application of these techniques in the study of the healthy and diseased. 3. To learn about quantification using MR.

Final Programme | ECR 2016

185

Postgraduate Educational Programme

09:00 A-043 B. Advanced PET imaging techniques T. Beyer; Vienna/AT

Learning Objectives: 1. To understand the fundamentals of PET physics relevant to MR/PET imaging. 2. To appreciate the advantages of MR/PET and its complementary role in diagnostic oncology. 3. To learn about the benefits and challenges of quantification in PET. 09:30 A-044 C. Clinical applications of quantitative hybrid imaging in oncology

Panel discussion: 09:44 Practical and economic issues in using high-end guidance for interventional radiology

08:30–10:00 Room M 4

Emergency Radiology RC 117

Moderator: S. Wirth; Munich/DE

L. Umutlu; Essen/DE

Learning Objectives: 1. To become familiar with the role of hybrid imaging in clinical oncology. 2. To learn about quantification in oncology: its benefits and limitations. 3. To understand hybrid imaging applications in relationship to disease presentations. 08:30–10:00 Room M 3

Interventional Radiology RC 109

Image fusion for image-guided interventions

Abdominal trauma: does it bleed, will it start bleeding or is something else leaking?

08:30 A-049 A. Liver and spleen M. Scaglione; Castel Volturno/IT

Learning Objectives: 1. To become familiar with traumatic injuries of the liver and spleen that can result in hemodynamic instability and other clinical complications. 2. To learn how to optimise scanning protocols to diagnose these injuries. 3. To understand the impact of these imaging findings on further management of patients and report accordingly. 09:00 A-050 B. Pancreas, bowel and mesentery M.A. Patak; Zurich/CH

08:30 A-045 Chairman’s introduction A. Adam; London/UK

Session Objectives: 1. To provide an overview of 3D navigation systems. 2. To learn about stereotaxis with manual and automatic aiming devices. 3. To learn about cone beam CT and ultrasound guidance with image fusion. 08:35 A-046 A. Cone-beam CT in vascular and non-vascular interventional procedures T.F. Jakobs; Munich/DE

Learning Objectives: 1. To learn how to use cone-beam CT in guiding interventional procedures. 2. To learn when to use this technique in oncologic biopsies and ablations. 3. To learn how to use this technique in improving efficacy and safety of intra-arterial procedures. 08:58 A-047 B. US image fusion G.H. Mostbeck; Vienna/AT

Learning Objectives: 1. To learn about the technologies used to fuse CT/US and MR/US images. 2. To understand how to use them in clinical practice. 3. To understand the indications for these technologies in difficult cases. 09:21 A-048 C. How can we improve targeting in image-guided interventions: stereotaxis, robotics and advanced techniques L.A. Solbiati; Rozzano/IT

Learning Objectives: 1. To become familiar with principles of stereotaxis and robotics for guiding interventions. 2. To learn about new and advanced techniques in image-guided therapies. 3. To understand when and how to use these techniques in oncologic and non-oncologic interventions.

186

ECR 2016 | Final Programme

Learning Objectives: 1. To become familiar with traumatic injuries of the pancreas, bowel and mesentery that can result in hemodynamic instability and other clinical complications. 2. To learn how to optimise scanning protocols to diagnose these injuries. 3. To understand the impact of these imaging findings on further management of patients and report accordingly. 09:30 A-051 C. Urogenital tract R.H. Oyen; Leuven/BE

Learning Objectives: 1. To become familiar with traumatic injuries of the urogenital tract that can result in hemodynamic instability and other clinical complications. 2. To learn how to optimise scanning protocols to diagnose these injuries. 3. To understand the impact of these imaging findings on further management of patients and report accordingly. 08:30–10:00 Room M 5

E3 - ECR Master Classes (Cardiac) E3 126

Cardiac CT and new interventions

08:30 A-052 Chairman’s introduction A. Jankauskas; Kaunas/LT

Session Objectives: 1. To appreciate the relationship between the evolution of CT technology and growing innovations in cardiovascular intervention equipment. 2. To learn about advantages and disadvantages of preinterventional and postinterventional CT compared to other imaging modalities. 3. To learn techniques for lowering radiation dose during preprocedural and postprocedural CT. 4. To become familiar with possible approaches for interventional procedure and CT, as well as criteria for successful performance.

www.myESR.org

Postgraduate Educational Programme

08:40 A-053 A. CT before and after transcatheter aortic valve interventions (TAVI) J.-N. Dacher; Rouen/FR

Learning Objectives: 1. To learn about the technical principles, possible complications and potential limitations of MDCT acquisition in TAVI candidates. 2. To understand the anatomy of the aortic annulus and to learn about CT prosthesis sizing. 3. To understand the importance of optimal communication of CT results to the Heart Team and to learn about a structured report. 4. To learn how to anticipate the various possible complications of TAVI and to learn how to detect them by postprocedural CT.

P. Blanke; Vancouver, BC/CA

Learning Objectives: 1. To understand the anatomy and normal appearance of the mitral apparatus on cardiac CT. 2. To learn about common mitral valve pathologies including mitral annular calcifications, myxomatous degeneration, mitral valve prolapse and mitral stenosis and their appearance on cardiac CT. 3. To learn about recent advances in TMVI and the role of preoperative cross-sectional imaging for patient and device selection. 4. To understand how CT-derived information can facilitate periprocedural guidance with echocardiography and fluoroscopy. 09:20 A-055 C. CT before and after electrophysiology interventions R. Salgado; Antwerp/BE

Learning Objectives: 1. To learn about the evolving role of CT imaging in patients before and after an electrophysiology intervention. 2. To understand what the electrophysiologist wants to know from the CT examination, and how to adapt your scan protocol accordingly. 3. To become familiar with the commonly performed electrophysiology procedures, their pathophysiological background and the most common complications. Discussion: 09:40 How can CT best facilitate cardiac interventions?

10:30–12:00

E3 - The Beauty of Basic Knowledge: Breast Imaging E3 24A

Breast ultrasound: a primer Moderator: J. Camps Herrero; Valencia/ES

12:30 A-058 Breast ultrasound: a primer A. Tardivon; Paris/FR

Learning Objectives: 1. To review the clinical indications of breast ultrasound. 2. To understand the technical issues tied to a state-of-the-art US exam and new developments. 3. To learn how to deal with lesions detected at mammography and at MRI. 12:30–13:30

Room D1

E3 - The Beauty of Basic Knowledge: Chest Imaging E3 25A

Useful signs in chest radiology Moderator: N. Howarth; Chêne-Bougeries/CH

12:30 A-059 A. Lung parenchyma G.R. Ferretti; Grenoble/FR

Learning Objectives: 1. To review the most useful signs on the chest x-ray. 2. To learn how to interpret the chest x-ray more accurately. 3. To know the appropriate indications of the chest x-ray. 13:00 A-060 B. Mediastinum and chest wall J. Cáceres; Barcelona/ES

Learning Objectives: 1. To review the most useful signs on the chest x-ray. 2. To learn how to interpret the chest x-ray more accurately. 3. To know the appropriate indications of the chest x-ray.

Room A

E3 - ECR Academies: Interactive Teaching Sessions E3 221

Room B

Unexpected findings on brain MRI

10:30 A-056 A. Large ventricles: normal or abnormal? S. Langner; Greifswald/DE

Learning Objectives: 1. To gain a basic understanding of CSF production, resorption and flow. 2. To learn how to differentiate the different forms of hydrocephalus. 3. To learn how to differentiate physiologic changes of the ventricular system from hydrocephalus. 11:15 A-057 B. Incidental lesions on a brain MRI E.T. Tali; Ankara/TR

Learning Objectives: 1. To gain an in-depth understanding of the normal anatomy of the brain. 2. To learn how to identify incidental findings on a brain MRI. 3. To be able to confidently detect and describe normal imaging findings of the brain on x-ray, ultrasound, CT and MRI. 4. To learn how to handle the incidental findings.

www.myESR.org

16:00–17:30

Room B

E3 - ECR Master Classes (Abdominal Viscera) E3 426a

A tour around cholangiopathies

16:00 A-061 Chairman’s introduction C. Matos; Lisbon/PT

Session Objective: 1. To briefly discuss the diagnostic challenge in cholangiopathies. 16:05 A-062 A. Clinical scenarios M. Arvanitaki; Brussels/BE

Learning Objectives: 1. To describe common and uncommon aetiologies of cholangiopathies and their complications. 2. To list laboratory tests to orientate the diagnosis. 3. To define questions which can be asked of radiologists in order to orientate the diagnosis.

Final Programme | ECR 2016

187

Wednesday

09:00 A-054 B. CT before and after transcatheter mitral valve interventions (TMVI)

12:30–13:30

Postgraduate Educational Programme

16:25 A-063 B. Which imaging modalities? J.M. Lee; Seoul/KR

Learning Objectives: 1. To describe the role of imaging modalities. 2. To define the potential role of functional and metabolic imaging modalities. 3. To appraise the cost-benefit of different imaging strategies. 16:45 A-064 C. Treatment: which and when E. Jonas; Stockholm/SE

Learning Objectives: 1. To describe surgical and non-surgical therapeutic options 2. To identify criteria for personalised treatment. 17:05

Multidisciplinary panel discussion

16:00–17:30

Room C

New Horizons Session NH 4

Big data: why should radiologists care?

16:00 A-065 Chairman’s introduction M. Dewey; Berlin/DE

Session Objectives: 1. To appreciate the opportunities and challenges of big data. 2. To understand the current status of big data in radiology. 3. To learn about how big data could change radiology in the future. 16:05 A-066 Big data: big science G. Zanetti; Pula/IT

Learning Objectives: 1. To understand what big data is and how it will impact clinical data integration and analysis. 2. To learn about how to best use them in biomedical research. 3. To appreciate the technological challenges. 16:25 A-067 Big data: big business B.J. Hillman; Charlottesville, VA/US

Learning Objectives: 1. To understand the potential of computerised approaches to analyse large volumes of data so that past experiences can advise improved care for future patients. 2. To learn about how big data analytics have the potential to transform the quality and efficiency of health care. 3. To appreciate that the business of applying big data analytics to health care is in its earliest stages and is likely to develop rapidly in the near future. 16:45 A-068 Big data: what’s in it for the patient? M.G.M. Hunink; Rotterdam/NL

Learning Objectives: 1. To understand how big data can be used to improve patient care and patient outcomes. 2. To learn about big data sources that could be useful to patient management decisions. 3. To appreciate limitations of big data in patient care, including bias in the data and ethical and data privacy issues.

17:05

Panel discussion: How to make best use of big data?

16:00–17:30

Room O

Paediatric RC 412

Chest imaging in paediatrics Moderator: W. Hirsch; Leipzig/DE

16:00 A-069 A. Congenital anomalies of the chest M. Haliloglu; Ankara/TR

Learning Objectives: 1. To discuss best imaging techniques when evaluating congenital chest anomalies. 2. To have an overview of antenatal and postnatal appearances of common congenital chest anomalies. 3. To understand the clinical significance and management of congenital lung and thoracic wall anomalies. 16:30 A-070 B. Lung infection and its complications M.L. Lobo; Lisbon/PT

Learning Objectives: 1. To understand the justification for imaging children with lower respiratory tract infection. 2. To provide tips for accurate diagnosis and to understand differential diagnosis. 3. To become familiar with complications and potential underlying conditions. 17:00 A-071 C. Imaging interstitial lung disease in children: update 2016 M.P. García-Peña; Barcelona/ES

Learning Objectives: 1. To understand optimised protocols. 2. To learn about updated nomenclature of interstitial lung diseases in children. 3. To discuss a systematic approach for the diagnosis of common entities diffusely affecting the paediatric lung. 16:00–17:30

Room N

Head and Neck RC 408

Head and neck imaging: don’t sell your ultrasound yet! Moderator: D.-A. Varoquaux; Marseille/FR

16:00 A-072 A. Salivary gland imaging with ultrasound S. Colley; Birmingham/UK

Learning Objectives: 1. To understand the limitations of clinical examination. 2. To learn about the diagnostic approach to salivary glands. 3. To appreciate how to differentiate salivary gland pathology. 16:30 A-073 B. Masses of the soft parts of the neck S. Robinson; Vienna/AT

Learning Objectives: 1. To become familiar with cervical ultrasound anatomy. 2. To learn about benign neck masses. 17:00 A-074 C. Lymph nodes: differential diagnosis and fine-needle aspiration R. Maroldi; Brescia/IT

Learning Objectives: 1. To get acquainted with normal and abnormal findings. 2. To understand the patterns of nodal involvement. 3. To learn about technique of fine needle aspiration.

188

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

16:00–17:30

Room E1

Musculoskeletal RC 410

16:30 A-081 The European paediatric imaging project C. Owens; London/UK

Learning Objectives: 1. To discuss difficulties with data collection from diverse European radiology centres. 2. To encourage engagement using the ‘Eurosafe Imaging Stars’ model. 3. To analyse the impact of commercial engagement and support in dose optimisation for children.

Bone trauma in the axial skeleton: patterns of injury and how I describe them Moderator: M.-A. Weber; Heidelberg/DE

16:00 A-075 A. Thoracic and lumbar spine

16:40 A-082 The EuroSafe Imaging dose management project D. Caramella; Pisa/IT

Learning Objectives: 1. To become familiar with the types of injury seen in the thoracic and lumbar spine. 2. To learn how to describe the injuries in a manner useful to the clinician.

Learning Objectives: 1. To appreciate that IT tools may enable a systematic analysis of dosimetric behaviours in radiology. 2. To understand how dose management may help to reduce all variations that are not clinically justified and to trigger focused training activities. 3. To discuss the opportunity to shift the emphasis from risk communication to safety reassurance.

16:30 A-076 B. Pelvis

Wednesday

V.N. Cassar-Pullicino; Oswestry/UK

K. Verstraete, F.M.H.M. Vanhoenacker, L. Jans, W. Huysse; Ghent/BE

Learning Objectives: 1. To become familiar with the types of injury seen in the pelvis. 2. To learn how to describe the injuries in a manner useful to the clinician.

16:50 A-083 AFROSAFE Imaging Alliance and Campaign M.G. Kawooya; Kampala/UG

Learning Objectives: 1. To describe the process of the establishment of AFROSAFE. 2. To list the vision, mission, objectives, strategies and actions. 3. To discuss the collaborations with EuroSafe Imaging, Image Gently & Image wisely. 4. To discuss collaboration with patients for patients’ safety (PFP) initiatives in Africa. 5. To review the achievements to date; namely, promotion of DRLs in African countries and raising awareness of radiation safety among policy makers, health-workers and the public.

17:00 A-077 C. Acetabulum A. Kassarjian; Majadahonda/ES

Learning Objectives: 1. To become familiar with the types of injury seen in the acetabulum. 2. To learn how to describe the injuries in a manner useful to the clinician. 16:00–17:30

Room E2

17:00 A-084 Image Wisely and Image Gently: an overview D.P. Frush; Durham, NC/US

EuroSafe Imaging Session

Learning Objectives: 1. To review the history and evolution of the Image Gently and Image Wisely campaigns. 2. To consider the potential future directions and initiatives that Image Gently and Image Wisely may pursue. 3. To discuss methods to insure adherence to best practices in radiation dose monitoring and control.

EuroSafe 2 EuroSafe Imaging Alliance & Campaign - what is new? Moderator: G. Frija; Paris/FR

16:00 A-078 An overview of the EuroSafe Imaging achievements over the past year

17:10

Panel discussion

G. Frija; Paris/FR

Learning Objectives: 1. To highlight the recent activities of EuroSafe Imaging. 2. To introduce the 2015/2016 EuroSafe Imaging roadmap. 3. To point out weaknesses and strengths of the concept. 16:10 A-079 Update on the concept of Diagnostic Reference Levels

16:00–17:30

Room F1

Oncologic Imaging RC 416

Evaluating lymph node involvement: an impossible task?

P. Vock; Spiegel/CH

Learning Objectives: 1. To review the historical development and use of Diagnostic Reference Levels (DRLs). 2. To analyse the advantages and limitations of current DRLs. 3. To discuss modifications and future applications of DRLs. 16:20 A-080 Establishing European Diagnostic Reference Levels for paediatric imaging: an update on the EC tender project PiDRL J. Damilakis; Iraklion/GR

Learning Objectives: 1. To give an overview of the PiDRL project and its achievements. 2. To understand the methodology for establishing and using DRLs for paediatric imaging. 3. To learn about the specific requirements for paediatric DRLs (in comparison to DRLs for adults).

www.myESR.org

16:00 A-085 Chairman’s introduction D.-M. Koh; Sutton/UK

16:05 A-086 A. The current criteria for nodal involvement MRI/CT W. Schima; Vienna/AT

Learning Objectives: 1. To understand the role of local nodal staging and its importance for management and prognosis. 2. To become familiar with the current imaging criteria for assessment of nodal metastases. 3. To understand the diagnostic performance of cross-sectional imaging.

Final Programme | ECR 2016

189

Postgraduate Educational Programme

16:28 A-087 B. Advanced MRI techniques: what do they contribute? H.C. Thoeny; Berne/CH

Learning Objectives: 1. To understand the principle of DWI of nodes. 2. To learn about the appearances of malignant nodes on diffusionweighted MRI. 3. To become familiar with node-specific enhanced MRI. 16:51 A-088 C. PET and other nuclear medicine techniques

16:00–17:30

Chest RC 404

17:14

M. Rémy-Jardin; Lille/FR

Session Objectives: 1. To review the current controversies regarding PE diagnosis. 2. To appreciate the need for defining a standardised management. 16:05 A-094 A. Subsegmental PE, incidental PE: diagnosis and management C.M. Schaefer-Prokop; Amersfoort/NL

Panel discussion: Will imaging ever make diagnostic biopsy unnecessary?

16:00–17:30

Room F2

Breast RC 402

Learning Objectives: 1. To review the characteristics of subsegmental and incidental PE. 2. To suggest an appropriate management in both situations. 16:28 A-095 B. CT not available, contraindicated, or inconclusive: what to do? E.J.R. van Beek; Edinburgh/UK

Radio-pathological correlation: more important than you thought

16:00 A-089 Chairman’s introduction F.J. Gilbert; Cambridge/UK

Learning Objectives: 1. To review the role of US and V/Q scan. 2. To learn about the current performance of MR. 16:51 A-096 C. Can we predict outcome from imaging?

Session Objectives: Radiological findings need to be verified by pathological examination but without a strict and interactive cooperation this correlation may fail. New imaging techniques and new pathological methods/approaches create new challenges.

B. Ghaye; Brussels/BE

Learning Objectives: 1. To learn how clinical findings influence the selection of the imaging strategy in PE. 2. To learn how imaging may predict the outcome of the patient. 3. To learn about the follow-up after treatment.

16:05 A-090 A. Pre-treatment planning C.K. Kuhl; Aachen/DE

Learning Objectives: 1. To know the role of the imaging methods for preoperative staging. 2. To understand the need for imaging-guided needle sampling and localisation for a tailored surgery. 3. To appreciate the need for changing surgical guidelines for treating breast cancer. 16:28 A-091 B. Intra-operative specimen evaluation J. Camps Herrero; Valencia/ES

Learning Objectives: 1. To learn about different imaging techniques for pre-operative marking and intraoperative specimen evaluation. 2. To become familiar with methods for specimen orientation and handling. 3. To understand the need for immediate reporting/reaction from radiological department to surgical room. 16:51 A-092 C. The breast radiologist sitting down with the pathologist T. Tot; Falun/SE

Learning Objectives: 1. To understand the importance of using imaging to guide the pathologist in complex lesions. 2. To know the different ways of correlating radiology and pathology. 3. To learn how to enhance this cooperation in order to achieve the best results in terms of tumour extension and tumour margins.

17:14

190

Panel discussion: How to enhance the interaction between radiologists and pathologists?

ECR 2016 | Final Programme

Pulmonary embolism - persistent controversies

16:00 A-093 Chairman’s introduction

T. Barwick; London/UK

Learning Objectives: 1. To learn the typical appearance on nodal metastatic disease on FDG. 2. To recognise the pitfalls for interpretation. 3. To become familiar with new radiotracers, including choline PET, for the demonstration of nodal disease.

Room D1

17:14

Panel discussion: How to optimise patient management?

16:00–17:30

Room D2

Physics in Radiology RC 413

Artefacts and pitfalls in tomography

16:00 A-097 Chairman’s introduction V. Tsapaki; Athens/GR

Session Objectives: 1. To learn about the origins of image artefacts in tomographic imaging. 2. To understand image distortions in hybrid imaging. 3. To learn about solutions and work-arounds. 16:05 A-098 A. CT M. Kachelrieß; Heidelberg/DE

Learning Objectives: 1. To understand the source of artefacts in clinical CT. 2. To understand the most important correction methods. 3. To find out what artefact correction techniques are actually provided by the CT vendors in their systems. 16:28 A-099 B. PET/CT T. Beyer; Vienna/AT

Learning Objectives: 1. To understand image distortions, artefacts and bias from methodological pitfalls. 2. To appreciate and understand solutions to frequent image distortions. 3. To understand the methodological limitations of PET/CT.

www.myESR.org

Postgraduate Educational Programme

16:51 A-100 C. MR/PET H.H. Quick; Essen/DE

Learning Objectives: 1. To identify common artefacts. 2. To understand the physical origin of and methods to resolve artefacts. 3. To understand the interrelation of MR artefacts and bias in PET quantification.

17:14

Panel discussion: Imagine imaging without artefacts: dos and don’ts in your clinical practice

Room K

E3 - ECR Master Classes (Genitourinary) E3 426b

MR-targeted focal therapies for prostate cancer

16:00 A-101 Chairman’s introduction: the rationale for focal therapy F. Cornud; Paris/FR

Session Objective: 1. To provide an overview of indications, techniques and outcome of MR-targeted treatment of prostate cancer. 16:05 A-102 A. The role of multiparametric MR in the planning phase of focal therapy V. Panebianco; Rome/IT

Learning Objectives: 1. To present the mpMRI criteria in the planning phase of focal treatment. 2. To understand the role of MRI in patient selection. 16:23 A-103 B. MR-targeted high intensity focused ultrasound M.C. Roethke; Heidelberg/DE

Learning Objectives: 1. To become familiar with indications and technique. 2. To demonstrate findings during and after treatment. 3. To show complications and outcome. 16:41 A-104 C. MR-guided cryoablation and focal laser therapy J.J. Fütterer; Nijmegen/NL

Learning Objectives: 1. To become familiar with indications and technique. 2. To demonstrate findings during and after treatment. 3. To show complications and outcome. 16:59 A-105 D. MR-targeted intensity-modulated radiotherapy with focal boost V. Fonteyne; Ghent/BE

Learning Objectives: 1. To become familiar with indications and technique. 2. To illustrate findings during and after treatment. 3. To show complications/toxicity and outcome.

17:17

Panel discussion: What are the challenges in providing focal treatment in prostate cancer?

www.myESR.org

Room G

E3 - ECR Academies: Neuroradiology: from Morphology to Function E3 419

Functional MRI of the brain opens new horizons

16:00 A-106 Chairman’s introduction T.A. Yousry; London/UK

16:03 A-107 A. No function without structure: challenges in diffusion MRI and fiber tractography for clinical research A. Leemans; Utrecht/NL

Learning Objectives: 1. To present an introduction to the use of diffusion MRI and fiber tractography of the brain. 2. To illustrate how these techniques have provided new insights into functional neuroanatomy. 3. To raise awareness about methodological challenges and limitations for clinical applications. 16:32 A-108 B. Clinical utility of fMRI for pre-operative brain mapping H. Urbach; Freiburg/DE

Learning Objectives: 1. To reveal how morphometric analysis of 3D data sets can help to reveal the true extent of a cerebral lesion in the pre-surgical work-up. 2. To demonstrate how fMRI is useful for documenting the spatial relationship of brain lesions to the adjacent eloquent cerebral cortex. 3. To illustrate how diffusion tensor tractography can reveal important white matter tracts such as the corticospinal tract and optic radiation. 17:01 A-109 C. Introduction to resting state fMRI and functional connectomics L. Nyberg; Umea/SE

Learning Objectives: 1. To understand how spontaneous fluctuations in activity in different parts of the brain can be used to study functional brain networks. 2. To review how resting-state functional MRI (rfMRI) can be used to map the macroscopic functional connectome. 3. To highlight some upcoming challenges in functional connectomics, using high-quality rfMRI data being generated by the Human Connectome Project. 16:00–17:30

Room M 1

Vascular RC 415

Basic principles of varicose vein diagnosis and endovascular treatment Moderator: D. Karnabatidis; Patras/GR

16:00 A-110 A. Diagnostic cross-sectional imaging H. Hoppe; Berne/CH

Learning Objectives: 1. To become familiar with the whole spectrum of varicose vein pathology. 2. To learn about technical principles of state-of-the-art lower limb venous imaging studies. 3. To learn how to extrapolate imaging findings into endovascular treatment.

Final Programme | ECR 2016

191

Wednesday

16:00–17:30

16:00–17:30

Postgraduate Educational Programme

16:30 A-111

16:00–17:30 B. Saphenous vein ablation M. Akesson; Höllviken/SE

Learning Objectives: 1. To understand the principles of ablation therapy. 2. To learn the technique for ablation and how to avoid complications. 3. To learn about outcomes and complications. 17:00 A-112

C. Ultrasound guided sclerotherapy

Interventional Radiology RC 409

T. de Baère; Villejuif/FR

Session Objectives: 1. To understand the basic principles of various ablation techniques. 2. To learn how to choose the right ablation technique for a specific lesion. 3. To learn about advantages of each technique over different tissue properties.

Learning Objectives: 1. To learn about the principles of venous sclerotheraphy. 2. To learn about technical principles of US-guided sclerosis of lower limb veins. 3. To learn about pros and cons of US-guided sclerosis versus endovascular ablation. Room M 2

16:05 A-117

Learning Objectives: 1. To learn about the physical and technical basis of radiofrequency ablation. 2. To understand the advantages and limitations of the technique. 3. To become familiar with the current indications in oncology.

Imaging of cardiac valves: new trends Moderator: G. Roditi; Glasgow/UK

16:00 A-113 A. Echocardiography remains the reference technique

16:23 A-118

P.L. Pereira; Heilbronn/DE

Learning Objectives: 1. To learn about state-of-the-art echo techniques to evaluate cardiac valves. 2. To provide a practical approach to assessing valve pathology based on echocardiography. 3. To become familiar with the role of echo in the diagnosis, clinical management and prognosis.

Learning Objectives: 1. To learn about the physical and technical basis of microwave ablation. 2. To understand the advantages and limitations of the technique as compared to RF ablation. 3. To become familiar with the current indications in oncology. 16:41 A-119 C. Cryoablation: ice can be better than heat D.J. Breen; Southampton/UK

Learning Objectives: 1. To learn about the physical and technical basis of cryoablation. 2. To understand the advantages and limitations of the technique. 3. To become familiar with the current indications in oncology.

M. Francone; Rome/IT

Learning Objectives: 1. To learn about the role of MRI in diagnosis and evaluation of valvular disease. 2. To become familiar with state-of-the-art MRI techniques to evaluate valvular disease. 3. To learn about typical imaging findings in MRI with impact on clinical management.

16:59 A-120 D. Irreversible electroporation: principles, technique and clinical applications A. Nilsson; Uppsala/SE

Learning Objectives: 1. To understand the physical and technical basis of irreversible electroporation (IRE). 2. To understand the advantages and limitations of the technique. 3. To become familiar with the current indications in oncology.

C. Does CT have a role in diagnosing valvular disease? G. Feuchtner; Innsbruck/AT

Learning Objectives: 1. To learn about state-of-the-art CT techniques to evaluate cardiac valves at low dose. 2. To review CT appearance of the most common conditions causing valvular disease. 3. To become familiar with the role of CT in the diagnosis and clinical management.

192

B. Microwave ablation: what is the difference?

F. Knebel; Berlin/DE

16:30 A-114 B. MRI is the best comprehensive approach

17:00 A-115

A. Thermal ablation with RF F. Orsi; Milan/IT

Cardiac RC 403

Basic principles of percutaneous tumour ablation

16:00 A-116 Chairman’s introduction

P.F. Sousa; Ermesinde/PT

16:00–17:30

Room M 3

ECR 2016 | Final Programme

17:17

Panel discussion: Selection of ablation modalities: operator’s preference or evidence-based?

www.myESR.org

Postgraduate Educational Programme

16:00–17:30

Room M 4

Emergency Radiology RC 417

‘Special patients’ in the emergency room: when and how to image them? Moderator: U. Linsenmaier; Munich/DE

16:00 A-121 A. Children V. Miele, C.L. Piccolo, M. Trinci; Rome/IT

16:50 A-126/A-127

Questions and answers

S. Weckbach1, J. Sellors2; 1Heidelberg/DE, 2London/UK

Learning Objectives: The discussion will address the following issues: 1. Is it better to report or to ignore IFs? 2. Should there be differences for IFs in clinical imaging than in research studies? 3. Do we need worldwide obliging guidelines for the handling of IFs? 3. Should different categories of IFs have different consequences for the patient/study participant?

Wednesday

Learning Objectives: 1. To become familiar with common non-traumatic emergencies in the paediatric population. 2. To comprehend the rationale of using different diagnostic imaging methods in emergency situations. 3. To understand the impact of imaging findings on patient management. 16:30 A-122 B. Pregnant patients H. Alkadhi; Zurich/CH

Learning Objectives: 1. To become familiar with the most common non-traumatic emergencies in pregnant women. 2. To learn which tests to choose in pregnant patients for the diagnostic evaluation of pulmonary embolism and acute abdomen. 3. To know current guidelines and recommendations for contrast media administration in pregnancy. 17:00 A-123 C. Elderly patients K. Katulska; Poznan/PL

Learning Objectives: 1. To become familiar with typical and atypical clinical emergency situations in the elderly. 2. To understand imaging strategies and the role of different imaging methods in elderly patients. 3. To learn common and specific imaging findings in the elderly population. 16:00–17:30

Room M 5

Pros & Cons Session PS 427

Risks and benefits of reporting incidental findings Moderator: S. Weckbach; Heidelberg/DE Teaser: J. Sellors; London/UK

16:00 A-124 A. Good reasons to ignore incidental findings L. Berlin; Skokie, IL/US

Learning Objectives: 1. To learn a correct definition of radiological ‘incidental finding’ (IF) and understand the underlying ethical problems of IFs. 2. To learn about the impact of IFs on patients’ and study participants’ lives. 3. To understand the risks of reporting IFs. 16:25 A-125 B. Good reasons to report incidental findings A. van der Lugt; Rotterdam/NL

Learning Objectives: 1. To become aware of the differences between reporting an IF in a clinical setting and in a research setting. 2. To become familiar with different approaches of handling IFs. 3. To understand the benefits of reporting IFs.

www.myESR.org

Final Programme | ECR 2016

193

Postgraduate Educational Programme

194

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

08:30–10:00 Room A

08:30–10:00 Room C

E3 - ECR Academies: Interactive Teaching Sessions

Special Focus Session

E3 521

08:30 A-134 Chairman’s introduction

Integrating diagnostic tools in breast imaging

SF 5

Taking imaging to the cloud

J. Reponen; Raahe/FI

08:30 A-128 A. Multimodality breast imaging K. Kinkel; Chêne-Bougeries/CH

Learning Objectives: 1. To appraise the real value of combining all the diagnostic modalities into a final report. 2. To learn how to use the new BI-RADS categorisation system appropriately. 09:15 A-129 B. Multiparametric breast MRI J. Camps Herrero; Valencia/ES

08:35 A-135 How does it work? J. Fernandez-Bayó; Sabadell/ES

Learning Objectives: 1. To learn about the basics of cloud computing. 2. To understand different ways in which these technologies could be applied to medical imaging. 3. To appreciate how PACS architecture and work environment are changing. 4. To become familiar with some practical case examples. 08:58 A-136 What are the benefits? E.R. Ranschaert; ‚s-Hertogenbosch/NL

08:30–10:00 Room B

Abdominal Viscera RC 501

The many faces of benign liver lesions

08:30 A-130 Chairman’s introduction M. Karcaaltincaba; Ankara/TR

Session Objective: 1. To briefly introduce the diagnostic challenges in patients presenting with benign liver lesions. 08:35 A-131 A. Vascular F. Caseiro-Alves; Coimbra/PT

Learning Objectives: 1. To become familiar with typical and infrequent manifestations of benign hypervascular focal liver lesions. 2. To learn how to differentiate between benign and malignant lesions. 3. To appreciate the limitations and complementary roles of CT and MR. 08:58 A-132 B. Cystic-Biliary G. Brancatelli; Palermo/IT

Learning Objectives: 1. To explain the embryological process of ductal plate formation. 2. To describe the imaging features of congenital bile duct pathology. 3. To address how imaging helps make the differential diagnosis. 09:21 A-133 C. Hepatocellular R.L. Baron; Chicago, IL/US

Learning Objectives: 1. To understand the typical aspect of hepatocellular benign lesions on US, CT and MRI. 2. To learn when a liver-specific contrast medium can help us in the proper characterisation of hepatocellular benign liver lesions. 3. To understand the classification of liver adenomas, prognosis and imaging characteristics.

Learning Objectives: 1. To learn about the new possibilities cloud computing brings to radiologists. 2. To understand how this concept can be applied in radiology practice. 3. To understand the benefits of imaging studies being available independent of time and place. 4. To learn about different strategies for image storing and sharing. 09:21 A-137 What are the applications of cloud in radiology? O. Ratib; Geneva/CH

Learning Objectives: 1. To learn about the technical challenges of cloud computing. 2. To understand what the risks are from a security and legal point-ofview. 3. To appreciate the issues related to service agreements with the cloud providers. 4. To discuss the special needs of radiology. Panel discussion: 09:44 Will cloud computing be the future of image storage?

08:30–10:00 Room O

Paediatric RC 512

Imaging of foetus and infant Moderator: A.M. Taylor; London/UK

08:30 A-138 A. Foetal neuro imaging A. Rossi; Genoa/IT

Learning Objectives: 1. To learn how to perform prenatal brain MRI and to recognise normal features during gestation. 2. To highlight the complementary role of brain MRI to prenatal ultrasound. 3. To become familiar with the MRI features of the main congenital malformations and clastic injury.

Panel discussion: 09:44 How do I manage an incidental and potentially benign liver lesion?

www.myESR.org

Final Programme | ECR 2016

195

Thursday

Learning Objectives: 1. To learn about the different technical and clinical aspects of the MRI sequences that are used currently in breast imaging. 2. To know how to unify the information thereof provided in everyday clinical practice.

Session Objectives: 1. To introduce different models of image management and distribution. 2. To discuss new possibilities provided by evolving technology.

Postgraduate Educational Programme

09:00 A-139 B. Foetal body imaging

08:35 A-145 Personalised imaging in practice: a myth?

F. Avni; Lille/FR

F.J. Gilbert; Cambridge/UK

Learning Objectives: 1. To have an overview of foetal abdominal diseases and malformations. 2. To learn about the complementary roles of US and MRI. 3. To understand how prenatal imaging helps in the management of the foetus and the newborn.

Learning Objectives: 1. To define what personalised imaging means in daily radiology practice. 2. To analyse the gaps between theory and practice of an individualised imaging approach. 3. To determine the current level of evidence regarding the concept and practice of individualised imaging.

09:30 A-140 C. Neonatal urinary tract imaging M. Riccabona; Graz/AT

Learning Objectives: 1. To learn about normal appearances and imaging pitfalls of the urinary tract (UT) at birth. 2. To become familiar with the findings and conditions that cause UT dilatation (UTD) and neonatal renal parenchymal anomalies. 3. To discuss imaging strategies in the neonatal period.

08:52 A-146 Personalised imaging and standardised protocols: a contradiction? S.O. Schönberg; Mannheim/DE

Learning Objectives: 1. To investigate whether standardised protocols can cater to individualised imaging. 2. To analyse which parameters influence individualised imaging. 3. To discuss the necessary adaptations of protocols to phenotypic subpopulations.

08:30–10:00 Room N

Head and Neck RC 508

Pathways for tumour spread

09:09 A-147 En route to personalised imaging: the role of multidisciplinary conferences J.A. Verschakelen; Leuven/BE

Moderator: R. Hermans; Leuven/BE

Learning Objectives: 1. To review the potential benefits and drawbacks of interdisciplinary conferences. 2. To determine the role of multidisciplinary conferences for patient treatment. 3. To discuss the political implications in the multidisciplinary management of patients.

08:30 A-141 A. Pathways for oral cavity and oropharynx tumour spread A. Borges; Lisbon/PT

Learning Objectives: 1. To become familiar with the anatomy of the oral cavity and oropharynx. 2. To learn which imaging technique to use. 3. To understand the typical local and remote spread of oral cavity and oropharynx tumours.

09:26 A-148 From personalised to precision imaging: impact on clinical practise G.P. Krestin; Rotterdam/NL

Learning Objectives: 1. To explain the concept of precision imaging. 2. To underline the importance of precision imaging for the future of radiology. 3. To demonstrate how precision imaging is already impacting on our daily clinical practice.

09:00 A-142 B. Pathways for nasopharyngeal tumour spread including perineural spread V. Chong; Singapore/SG

Learning Objectives: 1. To become familiar with the anatomy of the nasopharynx. 2. To learn which imaging technique to use. 3. To understand the typical local and remote spread of nasopharyngeal tumours, including perineural spread. 09:30 A-143 C. Pathway for laryngeal and hypopharyngeal tumour spread R. Kohler; Sion/CH

Learning Objectives: 1. To become familiar with the anatomy of the larynx and hypopharynx. 2. To learn which imaging technique to use. 3. To understand the typical local and remote spread of laryngeal and hypopharyngeal tumours. 08:30–10:00 Studio 2016

Professional Challenges Session PC 5

Personalised radiology: myth or reality?

08:30 A-144 Chairman’s introduction C.J. Herold; Vienna/AT

Session Objectives: 1. To discuss the current state of personalised imaging in Europe. 2. To critically appraise the evidence associated with individualised imaging. 3. To discuss practical aspects of personalised radiology in Europe.

196

ECR 2016 | Final Programme

Panel discussion: 09:43 How to enhance personalised radiology in clinical routine

08:30–10:00 Room L8

New Horizons Session NH 5

Imaging beyond morphology

08:30 A-149 Chairman’s introduction O. Clément; Paris/FR

Session Objectives: 1. To learn about new imaging methods for quantitative imaging. 2. To understand that multimodality and data integration will play a major role in the future. 08:35 A-150 MRI fingerprinting: the future? S. Trattnig; Vienna/AT

Learning Objectives: 1. To learn about the basic concept of MR fingerprinting for quantitative MR imaging. 2. To understand the potential of MR fingerprinting for standardisation in MR. 3. To become familiar with preliminary clinical applications of MR fingerprinting.

www.myESR.org

Postgraduate Educational Programme

09:00 A-151 Receptor-targeted multimodal imaging M. de Jong; Rotterdam/NL

Learning Objectives: 1. To appreciate developments in imaging platforms for multimodal imaging. 2. To appreciate developments in imaging agents for targeted (multimodal) imaging. 09:25 A-152 Radiomics L.S. Fournier; Paris/FR

Learning Objectives: 1. To learn about new methods of image analysis derived from ‘-omics’ methods. 2. To understand processing of big data derived from images. 3. To become familiar with new vocabulary such as Radiomics, radiogenomics, clusters, heat maps, etc. Panel discussion: 09:50 Imaging biomarkers: a key role for radiologists in the future?

08:30–10:00 Room E1

RC 510

Inflammatory arthritis: beyond the radiograph

State of the Art Symposium SA 5

Abdominal diffusion-weighted imaging (DWI): an update

08:30 A-157 Chairman’s introduction L. Martí-Bonmatí; Valencia/ES

Session Objectives: 1. To learn about the technical difficulties and clinical relevance of DW qualitative and quantitative approaches in clinical practice. 2. To become familiar with the role of DW imaging modalities in the detection and quantification of different pathological entities. 3. To understand the impact of DW biomarkers in disease evaluation on different organs. 08:35 A-158 Technical advances: the many faces of DWI N. Papanikolaou; Stockholm/SE

Learning Objectives: 1. To review basic and advanced diffusion models on abdominal organs. 2. To become familiar with techniques and methods for body diffusion applications. 3. To learn about post-processing aspects of diffusion imaging. 09:00 A-159 Biliary ducts and pancreas: main advantages in clinical practice C. Matos; Lisbon/PT

08:30 A-153 Chairman’s introduction M. Reijnierse; Leiden/NL

Session Objectives: 1. To gain insight into the merits of various imaging modalities in the daily practice of radiology of rheumatology. 2. To appreciate the crucial radiological contribution we need to provide in order to support optimal clinical decision making. 08:35 A-154 A. Rheumatoid arthritis: what does MRI show and how do I do it? I. Sudoł-Szopińska; Warsaw/PL

Learning Objectives: 1. To become familiar with MRI techniques used in the assessment of rheumatoid arthritis. 2. To learn about the MRI findings in rheumatoid arthritis and their significance. 08:58 A-155 B. The axial skeleton in spondyloarthritis: conventional radiograph to MRI

Learning Objectives: 1. To define how to incorporate DWI in clinical MR scanners to investigate the bile ducts and the pancreas. 2. To list and compare reported data on the role of quantitative DWI approaches. 3. To identify major diagnostic clinical applications in a multidisciplinary environment. 09:25 A-160 Small bowel: main advantages in clinical practice S.A. Taylor; London/UK

Learning Objectives: 1. To learn about the histopathological changes underlying abnormal diffusion in inflammatory bowel disease. 2. To appreciate optimised DWI protocols for small bowel imaging. 3. To understand the clinical role of DWI in the small bowel, focusing on inflammatory bowel disease. Panel discussion: 09:50 Should we do it qualitative or quantitatively?

R. Campbell; Liverpool/UK

Learning Objectives: 1. To become familiar with imaging findings seen in the axial skeleton in spondyloarthritis. 2. To understand features on imaging which distinguish spondyolarthrtitis from other spinal diseases. 09:21 A-156 C. Ultrasound in inflammatory arthritis: what does it show and what does it mean? A. Klauser; Innsbruck/AT

Learning Objectives: 1. To become familiar with US techniques used in the assessment of inflammatory arthritis. 2. To learn about the US findings in inflammatory arthritis and their significance. Panel discussion: 09:44 How practical is it for radiologists to support ultrasound and MRI for clinical rheumatology? Is it something the rheumatologists should undertake themselves?

www.myESR.org

Final Programme | ECR 2016

197

Thursday

Musculoskeletal

08:30–10:00 Room E2

Postgraduate Educational Programme

08:30–10:00 Room F1

Oncologic Imaging RC 516

A multidisciplinary approach to prostate cancer: can we make a difference?

08:30 A-161 Chairman’s introduction B. Hamm; Berlin/DE

08:35 A-162 A. The urologist: evidence-based clinical decision making

08:58 A-167 B. Linear and reticular pattern F. Molinari; Lille/FR

Learning Objectives: 1. To recognise and interpret typical reticular imaging patterns on HRCT. 2. To differentiate acute and chronic diseases which cause septal pattern. 09:21 A-168 C. Ground glass opacities (GGO) and consolidation J. Vogel-Claussen; Hannover/DE

Learning Objectives: 1. To appreciate the different conditions which cause GGO pattern and consolidation. 2. To learn how to interpret GGO and consolidation in different clinical settings.

B.A. Hadaschik; Heidelberg/DE

Learning Objectives: 1. To understand how a diagnosis is established by PSA evaluation and biopsy. 2. To learn about different treatment options: surgery, radiotherapy, local ablative and hormonal treatment; as well as active surveillance. 3. To learn how imaging impacts treatment selection. 4. To understand what the urologist needs to know from the radiologist. 08:58 A-163 B. The radiologist: evidence-based use of multiparametric MRI H.-P. Schlemmer; Heidelberg/DE

Learning Objectives: 1. To learn how to perform and interpret multiparametric MRI. 2. To become familiar with the PiRADS classification system. 3. To become familiar with the role of imaging for patient stratification and treatment planning. 09:21 A-164 C. The interventional radiologist C. Catalano; Rome/IT

Learning Objectives: 1. To learn the rationale and scientific basis for focal therapies for prostate cancer. 2. To learn how focal therapies are performed in prostate cancer. 3. To learn through personal experience and from literature how multiparametric MRI can guide focal therapies of the prostate. Panel discussion: 09:44 Prostate cancer: evidence-based multidisciplinary approach to imaging and treatment

08:30–10:00 Room D1

Chest RC 504

HRCT - patterns in chest radiology: back to basics and beyond

08:30 A-165 Chairman’s introduction H. Prosch; Vienna/AT

Session Objectives: 1. To emphasise the importance of anatomy in reading HRCT. 2. To appreciate the necessity of defining patterns to improve radiological HRCT diagnoses. 08:35 A-166 A. Secondary pulmonary lobule anatomy: essential to tackle with the nodular pattern T. Frauenfelder; Zurich/CH

Learning Objectives: 1. To become confident in recognising the anatomical compartments of the lung on HRCT. 2. To describe typical nodular imaging patterns of lung disease on HRCT using appropriate terminology.

198

ECR 2016 | Final Programme

Panel discussion: 09:44 Is it always easy to detect a pattern? Tips for success

08:30–10:00 Room D2

Physics in Radiology RC 513

How to assess and communicate examination risks to patients and referring physicians?

08:30 A-169 Chairman’s introduction A. Torresin; Milan/IT

Session Objectives: 1. To understand risks from the use of ionising and electromagnetic radiation. 2. To balance patients’ perspectives with professional attitudes. 3. To discuss approaches and methods for communicating risks to patients and public. 08:34 A-170 A. Radiation risk: a patient’s perspective E. Briers; Hasselt/BE

Learning Objectives: 1. To understand the fears of patients. 2. To learn what is expected from physicians and techs. 3. To learn about ideal communication strategies. 08:47 A-171 B. Radiation risks for patients and staff P. Gilligan; Dublin/IE

Learning Objectives: 1. To get the latest information on stochastic and deterministic risks in radiology. 2. To learn about quantitative risk assessment in typical scenarios. 09:10 A-172 C. Risk in MRI R. Peeters; Leuven/BE

Learning Objectives: 1. To learn about the risks for patients from MRI procedures. 2. To learn about the contraindications for MRI scans. 3. To learn about risks for staff in an MRI department. 09:33 A-173 D. Communicating risks to patients and the public N. Leitgeb; Graz/AT

Learning Objectives: 1. To become familiar with communicating risk according to the imaging modality. 2. To become familiar with important rules in communication. 3. To understand the relationship between hazards and parents’ perceptions regarding imaging of their child. 4. To learn how to select a risk-communication strategy suited to parents and children.

www.myESR.org

Postgraduate Educational Programme

Panel discussion: 09:44 How real are the risks and how do we communicate them?

08:30–10:00 Room M 1

08:30–10:00 Room K

E3 - ECR Master Classes (Molecular Imaging)

E3 - Rising Stars Programme

E3 526

Basic Session 1:

08:30 A-181 Chairman’s introduction

Neuroradiology: brain

08:30 A-174 White matter disorders A. Rovira-Canellas; Barcelona/ES

09:00 A-175 Tumours J. Walecki; Warsaw/PL

09:30 A-176 Stroke E.T. Tali; Ankara/TR

08:30–10:00 Room G

E3 519

Advanced imaging techniques in brain tumours

X. Montet; Geneva/CH

08:35 A-182 A. Perfusion imaging: how I do it - by CT and/or by MRI? C.C. Cyran; Munich/DE

Learning Objectives: 1. To review the fundamentals of perfusion imaging. 2. To review the advantages and disadvantages of CT perfusion imaging. 3. To review the advantages and disadvantages of MR perfusion imaging. 08:53 A-183 B. Liver perfusion V.J. Goh; London/UK

Learning Objectives: 1. To learn the clinical indications for liver perfusion imaging. 2. To become familiar with perfusion protocols for liver imaging. 3. To learn about difficulties in liver perfusion imaging.

Thursday

E3 - ECR Academies: Neuroradiology: from Morphology to Function

Perfusion imaging

09:11 A-184 C. Lung perfusion M. Rémy-Jardin; Lille/FR

08:30 A-177 Chairman’s introduction P.C. Maly Sundgren; Lund/SE

08:33 A-178 A. Clinical utility of perfusion imaging for differentiating brain tumours I.N. Pronin; Moscow/RU

Learning Objectives: 1. To provide practical tips and tricks for performing CT and MR perfusion in patients with brain tumours. 2. To illustrate how certain perfusion derived parameters (rCBV) can be correlated with tumour histology (e.g. angiogenesis, capillary leakage, malignancy grade). 3. To show that intense contrast enhancement is not identical to perfusion. 09:02 A-179 B. Hybrid imaging with MRI/PET of brain tumours

Learning Objectives: 1. To learn the clinical indications for lung perfusion imaging. 2. To become familiar with perfusion protocols for lung imaging (including dual-energy CT). 3. To learn about difficulties in lung perfusion imaging. 09:29 A-185 D. Cerebral perfusion H.R. Jäger; London/UK

Learning Objectives: 1. To learn the clinical indications for cerebral perfusion imaging. 2. To become familiar with perfusion protocols for cerebral imaging. 3. To learn about difficulties in cerebral perfusion imaging. Panel discussion: 09:47 The pros and cons of perfusion imaging

08:30–10:00 Room M 2

N.L. Albert; Munich/DE

Learning Objectives: 1. To show that hybrid imaging with MRI/PET is gaining increasing importance in assessment of tumour activity and malignancy. 2. To demonstrate how MRI/PET can be useful in glioma grading. 3. To provide information on new PET tracers (targeting tumour hypoxia, enzymes in neoplastic metabolic pathways, etc.) and the combination of tracers with therapeutic agents. 09:31 A-180 C. Assessment of brain tumour perfusion and abnormal vascular structure using arterial spin-labelling P. Hales; London/UK

Learning Objectives: 1. To offer a short update on the physical principles and technique of arterial spin-labelling in assessing brain tumour perfusion. 2. To review the advantages and disadvantages of ASL as compared to contrast-enhanced perfusion imaging. 3. To provide clinical examples where ASL has contributed significantly to management and clinical decision making in brain tumour patients.

www.myESR.org

Cardiac RC 503

Novel ways to assess myocardial tissue Moderator: N.N.

08:30 A-186 A. T1 mapping: technical considerations M.R. Makowski; Berlin/DE

Learning Objectives: 1. To learn about the principles of T1 mapping. 2. To learn about specific issues of T1 mapping. 3. To learn how to do and assess T1 mapping. 09:00 A-187 B. T2 mapping: technical considerations C. Tessa; Lido di Camaiore/IT

Learning Objectives: 1. To learn about the principles of T2 mapping. 2. To learn about specific issues of T2 mapping. 3. To learn how to do and assess T2 mapping.

Final Programme | ECR 2016

199

Postgraduate Educational Programme

09:30 A-188 C. Clinical use of T1 and T2 mapping A. de Roos; Leiden/NL

Learning Objectives: 1. To learn about the main fields of application for T1-T2 mapping. 2. To learn the specific parameters useful for the clinical implementation of T1-T2 mapping. 3. To understand the incremental value of T1-T2 mapping over current methodologies. 08:30–10:00 Room M 3

Interventional Radiology RC 509

Imaging and endovascular treatment of pulmonary embolism

08:30 A-189 Chairman’s introduction B. Peynircioglu; Ankara/TR

Session Objectives: 1. To appreciate the value of imaging in therapy planning and follow-up. 2. To learn about patient selection and evidence in catheter directed therapies for PE. 3. To learn about recent and ongoing trials in the endovascular treatment of PE. 08:35 A-190 A. Imaging algorithm for pulmonary embolism B. Ghaye; Brussels/BE

Learning Objectives: 1. To learn how clinical findings influence the selection of the imaging strategy in PE. 2. To learn about the follow-up after treatment. 3. To learn how imaging may predict the outcome of the patient. 08:58 A-191 B. What is new in the recently published guidelines for pulmonary embolism treatment? R. Uberoi; Oxford/UK

Learning Objectives: 1. To learn about the recently published guidelines for PE treatment in stable patients. 2. To learn about the recently published guidelines for PE treatment in unstable patients. 3. To learn about recent therapeutic algorithms in PE treatment. 09:21 A-192 C. Updates on the endovascular treatment of massive and submassive pulmonary embolism S.C. Spiliopoulos; Patras/GR

Learning Objectives: 1. To learn about the rationale of recent and ongoing trials. 2. To learn about the level of evidence for interventional radiology techniques in PE treatment. 3. To learn about clinical results and possible further developments.

08:30–10:00 Room M 4

Joint Course of ESR and RSNA (Radiological Society of North America): Emergency Radiology MC 528

Abdominal emergencies Moderators: A. Palkó; Szeged/HU, R.J. Zagoria; San Francisco, CA/US

08:30 A-193 A. Abdominal injuries A. Palkó; Szeged/HU

Learning Objectives: 1. To understand the significance of injury mechanism and its role in the formation of consequent abdominal lesions and their complications. 2. To learn about the role of proper imaging technique and diagnostic algorithm in the sufficiently fast diagnosis of abdominal injuries. 3. To learn more about the typical and unusual findings of various abdominal traumatic conditions. 09:00 A-194 B. The enemy within: non-traumatic abdominal emergencies R.J. Zagoria; San Francisco, CA/US

Learning Objectives: 1. To learn how to better analyse CT scans for non-traumatic causes of abdominal pain. 2. To learn about the CT signs and causes of bowel ischaemia. 3. To learn about the CT findings of common causes of an ‘acute’ abdomen. 4. To learn about the imaging findings of acute, non-traumatic urinary tract and GI tract emergencies. 09:30 A-195/A-196

C. Interactive case discussion

A. Palkó1, R.J. Zagoria2; 1Szeged/HU, 2San Francisco, CA/US

Learning Objectives: 1. To learn how to better analyse CT scans for traumatic and nontraumatic causes of abdominal pain. 2. To learn about the CT signs and causes of bowel ischaemia and injuries. 3. To learn about the CT findings of common causes of traumatic and non-traumatic ‘acute’ abdomen. 4. To learn about the imaging findings of acute, traumatic and nontraumatic urinary tract and GI tract emergencies. 08:30–10:00 Room M 5

E3 - ECR Academies: Diagnostic Urogenital Radiology E3 522

Retroperitoneum and adrenals Moderator: J. Venancio; Lisbon/PT

Panel discussion: 09:44 Appropriate diagnosis and risk stratification in the management of acute massive and acute sub-massive pulmonary embolism

08:30 A-197 A. Anatomy and imaging techniques of the retroperitoneum F.M. Danza; Rome/IT

Learning Objectives: 1. To become familiar with new insights into the normal anatomy of the retroperitoneum. 2. To understand the spreading of retroperitoneal diseases across spaces. 3. To learn about the optimal CT and MR protocols for imaging of the retroperitoneum.

200 ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

09:00 A-198 B. Differential diagnoses of retroperitoneal masses M.-F. Bellin; Le Kremlin-Bicêtre/FR

Learning Objectives: 1. To become familiar with the typical imaging features of retroperitoneal lesions. 2. To learn about the differential diagnoses of benign and malignant retroperitoneal masses. 3. To understand how recognise the exact extent of retroperitoneal masses. 09:30 A-199 C. Differential diagnoses of adrenal lesions

10:30–12:00

Room K

E3 - Rising Stars Programme Basic Session 2:

Head and neck imaging

10:30 A-202 Orbit P.C. Maly Sundgren; Lund/SE

11:00 A-203 Ear B. Verbist; Leiden/NL

G. Heinz-Peer; St. Pölten/AT

Learning Objectives: 1. To learn about the imaging protocols of adrenal glands, including functional imaging. 2. To understand the typical imaging features of an adenoma on CT and MRI. 3. To become familiar with typical signs of malignancy. 10:30–12:00

Room A

E3 621

Cardiac CT: from stenosis assessment to risk stratification

10:30 A-200 A. CT in stable chest pain

R. Maroldi; Brescia/IT

10:30–12:00

Room M 4

Joint Course of ESR and RSNA (Radiological Society of North America): Emergency Radiology MC 628

Chest emergencies Moderators: A. Palkó; Szeged/HU, R.J. Zagoria; San Francisco, CA/US

10:30 A-205 A. Thoracic injuries

R. Marano; Rome/IT

J.A. Soto; Boston, MA/US

Learning Objectives: 1. To learn the different criteria for risk stratification. 2. To learn the practical way of doing image assessment.

Learning Objectives: 1. To learn how to differentiate traumatic aortic injuries from congenital variants that mimic injury, to distinguish minor from major aortic injuries, and to understand how injury classification can influence management. 2. To become familiar with the various CT appearances suggesting and verifying major airway injury. 3. To understand the various CT appearances of blood/bleeding in the chest and how the location, quantity of blood/bleeding and patient clinical status determine initial treatment. 4. To appreciate the spectrum of cardiac injuries that can be diagnosed on admission contrast-enhanced CT and those that require urgent intervention.

11:15 A-201 B. Cardiac CT in the emergency room G. Feuchtner; Innsbruck/AT

Learning Objectives: 1. To understand the imaging technique. 2. To become familiar with the differential diagnosis.

11:00 A-206 B. Non-traumatic thoracic emergencies C.M. Schaefer-Prokop; Amersfoort/NL

Learning Objectives: 1. To illustrate typical CXR findings made in patients entering the ER with acute dyspnoea and to learn when CT is indicated and diagnostically useful. 2. To learn how to analyse and interpret HRCT patterns of pulmonary opacifications in patients with acute respiratory insufficiency. 3. To learn about radiological key features helpful for differential diagnosis and how to integrate clinical information. 11:30 A-207/A-208 C. Interactive case discussion J.A. Soto1, C.M. Schaefer-Prokop2; 1Boston, MA/US, 2Amersfoort/NL

www.myESR.org

Final Programme | ECR 2016

201

Thursday

E3 - ECR Academies: Interactive Teaching Sessions

11:30 A-204 Sinuses

Postgraduate Educational Programme

10:30–12:00

Room M 5

12:30–13:30

Room D1

E3 - ECR Academies: Diagnostic Urogenital Radiology

E3 - The Beauty of Basic Knowledge: Chest Imaging

E3 622

E3 25B

Kidney Moderator: H.C. Thoeny; Berne/CH

10:30 A-209 A. Differential diagnoses of cystic renal masses M. Claudon; Vandoeuvre-les-Nancy/FR

Learning Objectives: 1. To become familiar with the updated Bosniak classification. 2. To learn about the differential diagnoses of complex cystic renal masses. 3. To become familiar with typical surgical and non-surgical lesions. 11:00 A-210 B. Differential diagnoses of solid renal masses R.H. Oyen; Leuven/BE

Learning Objectives: 1. To learn about the differential diagnoses of solid renal lesions. 2. To become familiar with typical imaging findings of the renal cell carcinoma subtypes. 3. To become familiar with potential criteria for active surveillance of solid renal masses. 11:30 A-211 C. Acute and chronic renal infection N. Grenier; Bordeaux/FR

Learning Objectives: 1. To learn about the different aetiologies of acute renal infection, including typical imaging findings. 2. To learn about the time-point and possibilities for interventions. 3. To understand the causes of chronic renal infection, including typical imaging findings.

How to avoid misdiagnosis on the chest x-ray Moderator: N. Howarth; Chêne-Bougeries/CH

12:30 A-214 A. Neoplastic lesions J. Vlahos; London/UK

Learning Objectives: 1. To review the reasons for misdiagnosis on the chest x-ray. 2. To learn how to focus on blind areas. 3. To know the consequences of a misdiagnosis. 13:00 A-215 B. Non neoplastic lesions A.R. Larici; Rome/IT

Learning Objectives: 1. To review the reasons for misdiagnosis on the chest x-ray. 2. To learn how to interpret the chest x-ray more accurately. 3. To know the consequences of a misdiagnosis. 14:00–15:30

Room A

E3 - ECR Academies: Interactive Teaching Sessions E3 721

Cardiac imaging

14:00 A-216 A. Patterns of delayed enhancement P. Hunold; Lübeck/DE

12:15–12:45

Room A

Plenary Session HL 1

Wilhelm Conrad Röntgen Honorary Lecture Presiding: K. Riklund; Umeå/SE

12:15 A-212 Imaging the invisible killer: towards personalisation of ovarian cancer care

Learning Objectives: 1. To learn the different patterns of delayed enhancement. 2. To understand the influence regarding the prognosis. 14:45 A-217 B. Cardiomyopathies: from diagnosis to prognosis A. Jacquier; Marseille/FR

Learning Objectives: 1. To understand the diagnostic work-up of cardiomyopathies. 2. To review the association between diagnostic findings and clinical outcome.

A.G. Rockall; London/UK

12:30–13:30

Room B

E3 - The Beauty of Basic Knowledge: Breast Imaging E3 24B

Cracking the mystery of needles and gauges Moderator: J. Camps Herrero; Valencia/ES

12:30 A-213 Cracking the mystery of needles and gauges R.M. Pijnappel; Utrecht/NL

Learning Objectives: 1. To learn about the choice of techniques used for guidance in breast interventions. 2. To know the different breast biopsy systems and their indications. 3. To learn the most common practical tips and pitfalls in these procedures.

202

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

14:00–15:30

Room N

ESOR Session Advancing clinical practice: role of education Moderators: L. Donoso; Barcelona/ES, N. Gourtsoyiannis; Athens/GR

14:00 A-218 Introduction L. Donoso; Barcelona/ES

14:05 A-219 ESOR in action 2016 N. Gourtsoyiannis; Athens/GR

14:15 A-220 Role of remodelling in delivering of learning P. Ros; Cleveland, OH/US

14:27 A-221 Role of referral guidelines and clinical decision support systems L. Donoso; Barcelona/ES

14:39 A-222 MDTs and patient outcomes R.H. Reznek; London/UK

14:51 A-223 Role of research and innovation: essential ingredients for our professional advancement H. Hricak; New York, NY/US

Awards

14:00–15:30

Studio 2016

EIBIR Session EIBIR 1

Joint VPH-PRISM/ASSURE Session from screening to therapy: innovative breast care concepts

14:00 A-224 Introduction: challenges and innovative approaches in image-based breast care H.K. Hahn; Bremen/DE

Learning Objectives: 1. To learn about the importance of quantitative predictors in imagebased decision making. 2. To understand how predictors gained from different modalities and disciplines can be fused. 14:10 A-225 Density patterns, breast cancer risk and masking in screening mammograms C. Van Gils; Utrecht/NL

Learning Objectives: 1. To learn about the contribution of different mammographic measures for estimation of breast cancer risk. 2. To understand the importance of knowing the risk of a breast cancer that is likely to be missed with mammography.

www.myESR.org

N. Karssemeijer; Nijmegen/NL

Learning Objectives: 1. To learn how effectiveness and quality breast screening with Automated Breast Ultrasound can be improved by using CAD. 2. To learn about optimising screening workflow with fast MRI protocols and dedicated reading tools for comparison with prior exams. 3. To understand the potential of automated quality assurance methods for MRI and automated breast ultrasound. 14:40 A-227 Breast cancer risk and masking risk-based stratification protocols: key drivers of cost-effectiveness E. Gray; Manchester/UK

Learning Objectives: 1. To learn how mammographic breast density and texture are risk factors for breast cancer independent from those included in the Tyrer-Cusick model and how risk estimation performance is modestly improved by including these variables. 2. To appreciate the substantial uncertainty about key parameters determining the cost-effectiveness of personalised breast screening. 3. To understand how optimising personalised screening based on effectiveness criteria with fixed resource constraints may offer a costeffective improvement on one-size-fits-all screening. 14:55 A-228 Histopathology images: the new kid on the block of clinical multimodality imaging J. van der Laak; Nijmegen/NL

Learning Objectives: 1. To understand the specific challenges of ‘going digital’ in histopathology. 2. To learn about the opportunities of computer aided diagnosis in pathology. 3. To know what the current ‘state of the art’ is in this exciting area of research. 15:10 A-229 Quantitative treatment planning, response prediction, and monitoring K. Pinker-Domenig; New York, NY/US

Learning Objectives: 1. To understand the clinical aspects of neo-adjuvant treatment. 2. To appreciate evidence-based protocols for imaging in this clinical setting. 3. To learn about the imaging challenges of assessment and prediction of response to neoadjuvant treatment. 14:00–15:30

Room M 4

Joint Course of ESR and RSNA (Radiological Society of North America): Emergency Radiology MC 728

CNS emergencies Moderators: A. Palkó; Szeged/HU, R.J. Zagoria; San Francisco, CA/US

14:00 A-230 A. CNS trauma and neurovascular injury H.A. Rowley; Madison, WI/US

Learning Objectives: 1. To become familiar with traumatic brain injury demographics and classification schemes. 2. To learn how to apply appropriateness criteria for head trauma imaging in children and adults. 3. To identify key imaging patterns and pitfalls in the evaluation of brain and neurovascular trauma.

Final Programme | ECR 2016

203

Thursday

Learning Objectives: 1. To review the principles of excellence in delivering medical education with emphasis in radiology. 2. To understand how remodelling the traditional, passive learning in medicine has given way to an interactive style. 3. To enumerate the resources available for multimedia, interactivity and presentations in radiology.

14:25 A-226 Novel ultrasound and MRI technologies for breast cancer screening

Postgraduate Educational Programme

14:30 A-231 B. CNS non-traumatic emergencies M. Smits; Rotterdam/NL

Learning Objectives: 1. To learn about the modalities (MRI/CT) and protocols for nontraumatic neurological emergencies. 2. To learn how to diagnose the main non-traumatic neurological vascular and non-vascular emergencies. 3. To become aware of the pitfalls and limitations of clinical presentation and imaging findings in non-traumatic neurological emergencies.

16:00–17:30

E3 - ECR Academies: Interactive Teaching Sessions E3 821

C.P. Heussel; Heidelberg/DE

Learning Objectives: 1. To appreciate different phenotypes. 2. To learn how to quantify emphysema. 3. To understand how to assess collateral ventilation.

H.A. Rowley1, M. Smits2; 1Madison, WI/US, 2Rotterdam/NL

14:00–15:30

Room M 5

E3 - ECR Academies: Diagnostic Urogenital Radiology

16:45 A-238 B. Diagnostic work-up after treatment of lung emphysema N. Sverzellati; Parma/IT

Learning Objectives: 1. To learn how to personalise treatment. 2. To appreciate successful treatment results. 3. To understand complications and failure of treatment. 16:00–17:30

Room B

GI Tract RC 801

E3 722

Evaluation of patients with lung emphysema

16:00 A-237 A. Pretherapeutic evaluation of lung emphysema

15:00 A-232/A-233 C. Interactive case discussion Learning Objectives: 1. To learn about traumatic brain injury (TBI) and non-traumatic neurological emergencies. 2. To become familiar with imaging manifestations of TBI and nontraumatic neurological emergencies. 3. To understand the clinical implications of radiological imaging findings in TBI and non-traumatic neurological emergencies. 4. To learn about the state-of-the-art radiological imaging options for the assessment of acute TBI and non-traumatic neurological emergencies.

Room A

CT colonography today

Emergencies Moderator: M. Otero-García; Vigo/ES

16:00 A-239 Chairman’s introduction M. Hellström; Gothenburg/SE

14:00 A-234 A. Male pelvis emergencies

Session Objective: 1. To briefly present state-of-the-art in CT colonography, including standardised techniques, evidences on accuracy and guidelines on indications.

M. Bertolotto; Trieste/IT

Learning Objectives: 1. To become familiar with various male pelvis emergencies. 2. To learn about the correct imaging techniques. 3. To understand the differential diagnoses.

16:05 A-240 A. How I perform it P. Lefere; Roeselare/BE

14:30 A-235 B. Gynaecological emergencies

Learning Objectives: 1. To learn about modern approaches to bowel preparation and faecal/ fluid tagging. 2. To become familiar with colon distention, including prevention of possible complications. 3. To learn about different scanning protocols and their use according to patient status and clinical needs.

R.A. Kubik-Huch; Baden/CH

Learning Objectives: 1. To be familiar with various female pelvis emergencies. 2. To learn about the correct imaging techniques. 3. To understand the differential diagnoses. 15:00 A-236 C. Imaging of obstetric and puerperal emergencies M. Weston; Leeds/UK

16:28 A-241 B. How I interpret it T. Mang; Vienna/AT

Learning Objectives: 1. To learn about the imaging techniques performed in pregnancy. 2. To learn about the differential diagnoses of obstetric and puerperal emergencies. 3. To become familiar with typical imaging findings of most common pathologies.

Learning Objectives: 1. To become familiar with different image presentations: 2D, 3D, enhanced views. 2. To appreciate the strengths and limitations of primary 2D and primary 3D reading. 3. To learn about the use of Computed Assisted Diagnosis (CAD) software. 16:51 A-242 C. Screening with CTC D. Regge; Turin/IT

Learning Objectives: 1. To understand basic principles of population and opportunistic screening. 2. To become familiar with data on accuracy of CTC in screening populations. 3. To learn about current guidelines on the use of CTC in screening.

17:14

204 ECR 2016 | Final Programme

Panel discussion: Challenging cases from clinical practice

www.myESR.org

Postgraduate Educational Programme

16:00–17:30

Room C

Special Focus Session

16:05 A-248 Why is it important to consider infection control issues in ultrasound? Low- vs high-risk examinations C. Nyhsen; Sunderland/UK

SF 8a

Common mistakes in breast imaging

Learning Objectives: 1. To understand possible risks of infection transmission though inadequate probe decontamination. 2. To appreciate which ultrasound examinations are of low- versus higher-risk. 3. To recognise the importance of a review of current practice to keep patients as safe as possible.

16:00 A-243 Chairman’s introduction G. Forrai; Budapest/HU

Session Objectives: 1. To become familiar with the common mistakes in breast imaging. 2. To appreciate the main differences and similarities among different breast imaging modalities’ mistakes. 3. To understand how to avoid these dangerous issues.

16:25 A-249/A250

16:05 A-244 Common mistakes in mammography

N. Grenier1, M. Claudon2; 1Bordeaux/FR, 2Vandoeuvre-les-Nancy/FR

E.J. Cornford; Nottingham/UK

Learning Objectives: 1. To appreciate the use of ultrasound in different settings: endovaginal, endorectal, endoscopic and guiding interventional or surgical procedures. 2. To gain insight into currently used probe decontamination protocols after interventional procedures. 3. To learn about any known complications to date.

Learning Objectives: 1. To learn about the classification and types of errors. 2. To learn about the factors that affect our error rates. 3. To appreciate that there are mechanisms for reducing our error rates. 4. To become familiar with some examples of common mammography errors.

P.A.T. Baltzer; Vienna/AT

Learning Objectives: 1. To learn differences between primary- and second-look ultrasound after MRI. 2. To become familiar with common pitfalls in second-look US. 3. To understand how mistakes can be avoided in SLU.

16:45 A-251 Why current practice may not be safe: main risks of infection transmission and published evidence H. Humphreys; Dublin/IE

Learning Objectives: 1. To gain insight into transmission of infection risks from an expert microbiologist. 2. To understand routes of infection and which most important pathogens need to be considered. 3. To learn about best decontamination practices in an “ideal world”.

16:55 A-246 Common mistakes in breast MRI F. Pediconi; Rome/IT

Learning Objectives: 1. To learn about the principal artefacts in breast MR related to the patient and to technical factors, and how to deal with them. 2. To understand the importance of performing breast MR in the correct menstrual cycle phase and the problem of background enhancement. 3. To appreciate the most common pitfalls in breast MR interpretation. 4. To become familiar with possible mistakes related to radiologists’ interpretations.

17:20

Panel discussion: How to avoid common mistakes in breast imaging?

16:00–17:30

Room O

ESR Working Group on Ultrasound Minimising the risk of transmitting infections through ultrasound: is current practice sufficient? 16:00 A-247 Chairman’s introduction L.E. Derchi; Genoa/IT

Session Objectives: 1. To understand potential risks of transmitting infections through ultrasound. 2. To appreciate the difference between low- and high-risk ultrasound examinations with regard to probe decontamination. 3. To discuss how current evidence may necessitate change in our current ultrasound probe decontamination procedures, despite costs involved.

www.myESR.org

17:05

Panel discussion: Safer practice vs considerable cost implications: are changes needed and feasible?

16:00–17:30

Room N

Head and Neck RC 808

Paediatric: how we do head and neck imaging in children Moderator: N.J.M. Freling; Amsterdam/NL

16:00 A-252 A. Temporal bone B. De Foer; Antwerp/BE

Learning Objectives: 1. To understand how impaired function of the temporal bone has major clinical consequences. 2. To learn how to perform CT and MRI in children with hearing loss. 3. To become familiar with the most frequent developmental, inflammatory and neoplastic conditions of temporal bone in children. 16:30 A-253 B. Oral, paranasal sinuses and orbit M. Lell; Erlangen/DE

Learning Objectives: 1. To have an idea of the clinical presentation of oral, paranasal sinuses and orbit in infants and children. 2. To learn how to perform CT and MRI in children with pathology of the face. 3. To become familiar with the most frequent developmental, inflammatory, vascular and neoplastic abnormalities.

Final Programme | ECR 2016

205

Thursday

16:30 A-245 Common mistakes in second-look ultrasound after MRI

Current accepted practice of ultrasound probe decontamination in endocarvitary and interventional radiology

Postgraduate Educational Programme

17:00 A-254 C. Cysts and lumps in the neck A. Ailianou; Geneva/CH

Learning Objectives: 1. To learn an approach to differentiating masses in children based on topography. 2. To be able to differentiate benign congenital, neoplastic and vascular conditions. 3. To learn how to investigate soft tissue masses and which technique to use. 16:00–17:30

16:00–17:30

Musculoskeletal RC 810

V. Vasilevska Nikodinovska; Skopje/MK

Session Objectives: 1. To understand how the structure of reporting influences clinical interpretation and treatment. 2. To appreciate the value of assessing both familiar and less familiar structures in the traumatised knee.

Studio 2016

Clinical decision support (CDS)

16:00 A-255 Chairman’s introduction

16:05 A-261 A. Reporting meniscal tears: pitfalls and how I avoid them G. Andreisek; Zurich/CH

L. Donoso; Barcelona/ES

Session Objectives: 1. To understand what CDS is and how it works. 2. To learn more about imaging referral guidelines in Europe. 3. To understand how CDS can be successfully implemented in practice. 4. To understand the added value and cost-effectiveness of CDS. 16:05 A-256 What is a clinical decision support system?

Learning Objectives: 1. To understand how normal appearances can mimic meniscal tears. 2. To understand pitfalls in the diagnosis of meniscal tears. 16:28 A-262 B. The collateral ligaments and posterolateral corner: what are they, why do they matter and how do I assess them? U. Aydingoz; Ankara/TR

F. Sardanelli; San Donato Milanese/IT

Learning Objectives: 1. To appreciate the significance of the collateral ligaments and posterolateral corner. 2. To understand pitfalls in the diagnosis of posterolateral corner injuries.

Learning Objectives: 1. To understand the principles of and rationale for CDS. 2. To learn how CDS fits into the clinical workflow. 3. To understand why CDS provides much more than just a digital version of guidelines. 16:20 A-257 Imaging referral guidelines in Europe M.G.M. Hunink; Rotterdam/NL

16:51 A-263 C. Imaging the reconstructed ACL in athletes: how to assess and what to report A.P. Parkar; Bergen/NO

Learning Objectives: 1. To understand the challenges of developing guidelines for heterogeneous European countries. 2. To learn about the varying experiences of implementing CDS and imaging referral guidelines in different countries. 3. To understand the differences between an in-depth scientific guideline development process and practical recommendations for daily use of guidelines. 16:35 A-258 An effective clinical decision support system

Sports injuries to the knee: improving my report

16:00 A-260 Chairman’s introduction

Professional Challenges Session PC 8a

Room E1

Learning Objectives: 1. To be able to distinguish normal from pathological postoperative imaging features in ACL reconstruction. 2. To understand the clinical relevance of postoperative ACL reconstruction imaging.

17:14

Panel discussion: How will the patient and clinician be most helped by our report, and is there a role for structured reporting?

G. Boland; Boston, MA/US

Learning Objectives: 1. To understand the practical advantages and benefits of implementing CDS. 2. To understand the managerial and medical challenges of introducing CDS. 3. To learn more about the educational and behavioural changes brought about by CDS. 16:50 A-259 Cost-effectiveness of clinical decision support

17:05

206

16:00–17:30

Room E2

Multidisciplinary Session MS 8

Pancreatic cancer: radiological diagnosis and treatment

16:00 A-264 Chairman’s introduction

P. Mildenberger; Mainz/DE

L. Grenacher; Munich/DE

Learning Objectives: 1. To understand the cost-benefit relation of implementing CDS. 2. To learn more about the various costs-financial and otherwise-of implementing CDS. 3. To understand the direct and indirect benefits of CDS.

Session Objectives: 1. To become familiar with state of the art imaging modalities for diagnosis, staging and therapy of pancreatic ductal carcinoma (PDAC). 2. To learn present decision algorithms for individual therapy strategies of PDAC in tumour boards. 3. To understand the value of new functional imaging modalities of PDAC. 4. To become familiar with new surgical, medical and radiation therapy protocols for PDAC and their potential survival benefit for the patients.

Panel discussion: Is CDS really adding value to healthcare in addition to radiation safety?

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

16:05 A-265 Surgical oncological management

16:37 A-272 The organisational role of EIBIR in EIBALL

J. Werner; Munich/DE

V. Vilgrain; Clichy/FR

Learning Objectives: 1. To understand actual surgical therapeutic options of PDAC and the overall survival. 2. To become familiar with surgical options in case of local recurrence. 3. To understand the value of more aggressive surgical strategies.

Learning Objectives: 1. To become familiar with the European network of EIBIR. 2. To learn about the role of EIBIR in the EIBALL structure. 3. To understand the organisational support activities of EIBIR for the alliance.

16:20 A-266 Medical oncological management D. Jäger; Heidelberg/DE

16:54 A-273 Imaging biomarker development for EIBALL by subspecialty societies

Learning Objectives: 1. To learn about actual chemotherapeutic therapy of PDAC and potential benefit of combination with surgery. 2. To understand the survival benefit of oncological therapies. 3. To understand the development of chemotherapeutic strategies: from Gemcitabine mono to new immunological therapies.

K. Nikolaou; Tübingen/DE

Learning Objectives: 1. To learn about the role of subspecialty societies in imaging biomarker development. 2. To understand the problems still to be solved with imaging biomarkers. 3. To become familiar with the transfer from technical to clinical validation of imaging biomarkers.

16:35 A-267 Radiology oncological management L. Grenacher; Munich/DE

16:50 A-268 Radiation oncological management F. Sterzing; Heidelberg/DE

Learning Objectives: 1. To learn about indications for radiation therapy: state of the art. 2. To understand new radiation techniques and their benefit for patients with PDAC. 17:05

Multidisciplinary case presentation and discussion 1. To learn about decision making in individual cases of PDAC. 2. Multidisciplinary therapy strategies in patients with PDAC: time consuming or individual concept for significant increase of survival?

16:00–17:30

Room F1

Professional Challenges Session

17:11

Panel discussion: What is the role of EIBALL now and in the future

16:00–17:30

Room F2

Special Focus Session SF 8b

Assessing myocardium at-risk with MRI

16:00 A-274 Chairman’s introduction M. Gardarsdottir; Reykjavik/IS

Session Objectives: 1. To understand technique of assessing at-risk myocardium. 2. To understand the different values of T2 imaging and delayed enhancement imaging. 3. To understand what is useful in the acute, sub-acute and chronic settings. 4. To learn how to perform studies with safety and accuracy for patients. 16:05 A-275 T2 imaging M. Gutberlet; Leipzig/DE

PC 8b

An introduction to European Imaging Biomarker Alliance (EIBALL)

16:00 A-269 Chairman’s introduction P.M. Parizel; Antwerp/BE

Session Objectives: 1. To understand the mission and vision of EIBALL. 2. To learn how EIBALL promotes imaging biomarker development. 3. To become familiar with the main activities and collaborations of EIBALL. 16:03 A-270 EIBALL and its mission S. Trattnig; Vienna/AT

Learning Objectives: 1. To become familiar with the goals of EIBALL. 2. To learn about collaborations with QIBA. 3. To understand the different main strengths of EIBALL and QIBA. 16:20 A-271 The potential role of EIBALL for EORTC multicentre trials Y. Liu; Brussels/BE

Learning Objectives: 1. To understand how EORTC benefits from EIBALL. 2. To learn about the role of imaging biomarker in clinical multicentre trials. 3. To become informed of EORTC multicentre trials jointly performed with EIBALL.

www.myESR.org

Learning Objectives: 1. To understand the concept of tissue characterisation with T2 imaging. 2. To learn the meanings of inflammation, oedema and ischaemia. 2. To become acquainted with which sequences to use and what affects T2 imaging. 16:25 A-276 Late gadolinium enhancement S. Kozerke; Zurich/CH

Learning Objectives: 1. To understand the concepts of tissue characterisation with T1and T2 imaging and the concepts of delayed enhancement imaging. 2. To compare reproducibility of T1- and T2-weighted imaging vs quantitative T1 and T2 mapping. 3. To become acquainted with which sequences to use and what effects delayed enhancement imaging. 16:45 A-277 Prognostic value of area-at-risk assessment by T2 and late enhancement imaging A. de Roos; Leiden/NL

Learning Objectives: 1. To understand the concept of myocardial necrosis. 2. To understand different ways of estimating the extent of necrosis with delayed enhancement imaging. 3. To understand how the combined use of delayed enhancement and T2 imaging allows us to estimate salvageable myocardium after coronary occlusion and the clinical importance.

Final Programme | ECR 2016

207

Thursday

Learning Objectives: 1. To learn about diagnosis and staging of PDAC - which modality? 2. To understand the value of new functional imaging techniques. 3. To become familiar with the role of imaging in case of local recurrence.

Postgraduate Educational Programme

Panel discussion: How do we best assess at-risk myocardium and how do we best get the correct information across? Discussion points: 1. What do we need to know in the acute and sub-acute setting? 2. What is the clinical use of the different methods? 3. How do we best assess at-risk myocardium and how do we best get the correct information across?

17:15

16:00–17:30

Room D1

Special Focus Session SF 8c

Imaging in obesity

17:17

16:00–17:30

SF 8d

I.M. Björkman-Burtscher1, C. Malamateniou2; 1Lund/SE, 2London/UK

Session Objectives: 1. To introduce the concept of radiation dose levels and dose optimisation techniques used in CT. 2. To outline the main aim of the talks of the session and how they connect to each other. 3. To refer to the main radiation protection initiatives in Europe led by the ESR. 16:05 A-285 CT radiation dose optimisation: what has been achieved so far? J. Santos; Coimbra/PT

Learning Objectives: 1. To consolidate knowledge regarding current radiation dose levels used in CT. 2. To become familiar with recent advances in dose optimisation using scanner design features and their impact on patient dose. 3. To understand how radiographers can optimise CT radiation doses on an individual basis. 4. To enhance understanding of international optimisation campaigns such as Image Wisely.

16:05 A-279 Epidemiology and current trends in obesity N. Finer; London/UK

16:23 A-280 Fat quantification and advanced body composition assessment using MRI

16:30 A-286 Dose reduction techniques in paediatric CT: from A to Z E. Sorantin; Graz/AT

Learning Objectives: 1. To consolidate knowledge of trends in paediatric CT use and the importance of optimisation in this cohort. 2. To understand how paediatric CT protocols should be ‘child sized’ to ensure dose optimisation in line with the Image Gently initiative. 3. To become familiar with the availability and use of paediatric referral guidelines and diagnostic reference levels and their impact on CT use and justification. 4. To consider the role of superficial shielding during CT scanning.

O. Dahlqvist Leinhard; Linkoping/SE

Learning Objectives: 1. To describe techniques for acquisition of water- and fat-separated MRI and quantitative image analysis. 2. To describe methods for analysis of compartmental adipose tissue and lean muscle tissue quantification. 3. To discuss applications of whole-body-fat and water-separated MRI and their clinical translation. 16:41 A-281 Imaging of modern surgical procedures and their complications

16:55 A-287 Challenges and opportunities in CT dose optimisation: what can we do in the future? S.J. Foley; Dublin/IE

M. Rengo; Latina/IT

Learning Objectives: 1. To understand difficulties in dose estimation in CT using current metrics of CTDI and DLP and the potential role for newer metrics such as size-specific dose estimate (SSDE). 2. To become familiar with the lack of standardisation between scanners and protocols across centres and the role of diagnostic reference levels. 3. To gain an understanding of future developments in scanner design that will aid radiation dose optimisation.

Learning Objectives: 1. To understand the common bariatric surgical procedures. 2. To understand the imaging procedures accordingly. 3. To become familiar with the normal post-operative anatomy. 4. To appreciate the role of imaging in the assessment of suspected immediate and long-term postoperative complications. 16:59 A-282 Is there a role for bariatric embolisation in the treatment of the obese patient? C. Weiss; Baltimore, MD/US

Learning Objectives: 1. To understand the physiologic underpinnings of bariatric interventions. 2. To understand the pre-clinical and early clinical data behind bariatric embolisation. 3. To understand techniques and patient selection for bariatric embolisation. 4. To understand the potential role of bariatric embolisation in the treatment of the obese patient.

208

ECR 2016 | Final Programme

CT radiation dose optimisation: are we doing enough?

16:00 A-283/A-284 Chairmen’s introduction

S. Lee; Manchester/UK

Learning Objectives: 1. To appreciate the scale of the prevalence of obesity worldwide. 2. To recognise the role of the environment and of genetic predisposition on the development of obesity. 3. To understand the impact of adiposity, and adiposity measures on health and disease. 4. To critically appraise the evidence for and against an ‘obesity paradox’.

Room D2

Special Focus Session

16:00 A-278 Chairman’s introduction Session Objectives: 1. To outline the problems that patients with obesity present to the developed nations in the West. 2. To quantify and understand the role of intra-abdominal fat. 3. To evaluate the role of radiology in imaging patients after bariatric surgery 4. To determine the role of gastric embolisation in the treatment of obesity.

Panel discussion: How best to manage obesity and its implications on the radiology department

17:20

Panel discussion: What are the suggested priorities and actions for CT dose optimisation?

www.myESR.org

Postgraduate Educational Programme

16:00–17:30

Room K

American College of Radiology (ACR) Session ACR

Delivering higher value care in radiology: how to make it work in clinical practice - perspectives from the American College of Radiology Moderators: B. Allen, Jr.; Birmingham, AL/US, H.-U. Kauczor; Heidelberg/DE

16:00 A-288 Awareness to accountability: coping with the mandates for documenting higher-value care B. Allen, Jr.; Birmingham, AL/US

16:25 A-289 Radiologists’ role in delivering higher-value care through population health management W.T. Thorwarth; Reston, VA/US

Learning Objectives: 1. To examine current trends and mandates for physician involvement in population health management. 2. To discuss the value radiologists can bring to population health management and how this role will become an important resource for their health systems. 3. To identify the tools radiologists can use in their practices to be effective in population health management by reducing variation in radiological care. 16:50 A-290 Involving patients in their radiological care: radiologist visibility, personalised care and improving outcomes D.C. Kushner; Virginia Beach, VA/US

17:15

Room G

E3 - ECR Academies: Neuroradiology: from Morphology to Function E3 819

Cerebral blood flow quantification

16:00 A-291 Chairman’s introduction A. Jackson1, T. van der Zijden2; 1Manchester/UK, 2Edegem/BE

16:03 A-292 A. Functional imaging of cerebral perfusion A. Krainik; Grenoble/FR

Learning Objectives: 1. To understand that functional imaging of perfusion enables the study of properties such as vasoreactivity to circulating gases, autoregulation and neurovascular coupling. 2. To show that functional imaging of perfusion can influence therapeutic strategy through estimation of the vascular reserve and the risk of ischaemia. 3. To learn that functional MRI of vasoreactivity is of value in understanding functional MRI activation. 16:32 A-293 B. Cerebral blood flow measurements with arterial spinlabelling X. Golay; London/UK

Learning Objectives: 1. To reveal how arterial spin labelling (ASL) can accurately measure cerebral blood flow (CBF). 2. To present an overview of the advantages and limitations of using ASL in adult and paediatric subjects. 3. To show that the use of subject-specific model parameters (for example particularly blood and tissue T1) can improve the accuracy of CBF estimates. 17:01 A-294 C. Cerebrovascular reserve imaging and the consequences of neurovascular uncoupling D. Mikulis; Toronto, ON/CA

Learning Objectives: 1. To understand the consequences of severly reduced CVR in terms of future risk of stroke as well as cortical thinning that can occur in the absence of acute ischaemic events. 2. To review the challenges facing clinical implementation. 3. To understand the potential of CVR for informing patient selection for revascularisation.

Learning Objectives: 1. To discuss the ways radiologists can enhance patients’ experiences throughout the continuum of radiological care. 2. To identify ways to improve patient outcomes through effective communication. 3. To leverage the value of patient-centred radiological care as a resource for health systems.

Vascular

Questions and answers

RC 815

16:00–17:30

Room M 1

Carotid artery disease: so what’s new? Moderator: T. Jargiello; Lublin/PL

16:00 A-295 A. The diagnostic assessment of carotid arteries R. Iezzi; Rome/IT

Learning Objectives: 1. To understand the role of US, CT, MR and DSA in diagnostic assessment. 2. To learn the optimal imaging algorithm for diagnosis and follow up. 3. To appreciate the role of plaque characterisation in routine practice.

www.myESR.org

Final Programme | ECR 2016

209

Thursday

Learning Objectives: 1. To review radiology’s efforts to raise awareness and promote culture change among radiologists to adapt to health system and consumer initiatives for value-driven care. 2. To review organised radiology’s efforts to raise awareness and promote culture change among radiologists to adapt to the mandates of health reform. 3. To discuss radiology societies’ role in empowering radiologists to document the delivery of higher value care through metrics development, policy maker engagement, and data collection/ registry development for reporting quality data to policy makers and certification bodies.

16:00–17:30

Postgraduate Educational Programme

16:30 A-296 B. Carotid stenting vs endarterectomy: is the jury back yet?

17:14

Panel discussion: What is the preferred comprehensive imaging test in heart failure?

S. MacDonald; Newcastle upon Tyne/UK

Learning Objectives: 1. To understand the evidence supporting surgery and endovascular therapy. 2. To understand why the trials have been slow to bring clarity to optimal therapy. 3. To learn how best to triage patients for surgery or endovascular therapy. 17:00 A-297 C. Carotid interventions in the setting of acute CVA S. Sencer; Istanbul/TR

Learning Objectives: 1. To understand the indications and contraindications to carotid stenting. 2. To appreciate how CT/MR can aid patient selection for carotid stenting. 3. To learn about carotid stenting in the setting of acute thrombosis/ dissection. 16:00–17:30

Room M 2

16:00–17:30

Interventional Radiology RC 809

Current trends in transarterial chemoembolisation (TACE) and radioembolisation for HCC

16:00 A-302 Chairman’s introduction A. Denys; Lausanne/CH

Session Objectives: 1. To learn how to select HCC patients for TACE-TAE or radioembolisation. 2. To understand optimal DEB technique for TACE. 3. To understand the role of the radiologist in radioembolisation of HCC. 16:05 A-303 A. Imaging in therapy planning and follow-up L. Crocetti; Pisa/IT

Cardiac RC 803

Room M 3

Learning Objectives: 1. To learn how imaging influences the selection of the embolisation strategy in HCC. 2. To learn about standard and advanced imaging techniques in the follow-up after treatment. 3. To learn how imaging may guide the decision about re-treatment.

Imaging of heart failure

16:00 A-298 Chairman’s introduction C. Loewe; Vienna/AT

Session Objectives: The numbers of patients with systolic or diastolic heart failure are increasing. The role of non-invasive imaging to diagnose (the cause of) heart failure, to assess prognosis and guide treatment, gains importance.

16:28 A-304 B. TACE and TAE for HCC: new agents, new schedules, new combinations K. Malagari; Athens/GR

Learning Objectives: 1. To learn about the results of new treatment schedules and treatment combinations. 2. To learn about the rationale of recent and ongoing trials. 3. To learn about clinical results and possible further developments.

16:05 A-299 A. Current ESC and AHA guidelines: how to choose imaging techniques in heart failure patients? J.T. Ortiz-Pérez; Barcelona/ES

Learning Objectives: 1. To become familiar with the diagnostic algorithm of heart failure according to current guidelines. 2. To learn the strengths and weaknesses of the different imaging techniques in heart failure patients. 3. To discuss the role of imaging techniques to guide clinicians in diagnosis, treatment and follow-up.

16:51 A-305 C. Radioembolisation: critical appraisal of techniques and guidelines for treatment J.I. Bilbao; Pamplona/ES

Learning Objectives: 1. To learn about critical aspects of techniques and dosimetry. 2. To become familiar with ongoing trials and guidelines for treatment. 3. To understand the relative role of TACE/TAE and radioembolisation in HCC.

16:28 A-300 B. Differentiating the causes for heart failure: is MRI the indisputable gold standard? T. Leiner; Utrecht/NL

Learning Objectives: 1. To learn about MRI techniques to evaluate heart failure and its potential causes. 2. To learn a practical approach for differentiating the causes of heart failure using MRI. 3. To become familiar with the role of MRI in the clinical management and prognosis.

17:14

Panel discussion: The intermediate HCC patient: how can we stratify patients and allocate them to different therapies?

16:51 A-301 C. SPECT as an alternative imaging technique F. Caobelli; Hannover/DE

Learning Objectives: 1. To learn about nuclear imaging techniques in the detection of heart failure. 2. To appreciate imaging findings in the diagnosis of heart failure and its causes. 3. To become familiar with the role of nuclear imaging for diagnosis and prognosis in heart failure.

210

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

16:00–17:30

Room M 4

Joint Course of ESR and RSNA (Radiological Society of North America): Emergency Radiology MC 828

General principles: paediatric and ENT emergencies

17:00 A-311

C. Imaging of bladder and urethra J. Lopes Dias; Lisbon/PT

Learning Objectives: 1. To become familiar with various diseases of the bladder and urethra. 2. To learn about the typical imaging findings of malignant and nonmalignant disease. 3. To learn about the most frequent differential diagnoses.

Moderators: A. Palkó; Szeged/HU, R.J. Zagoria; San Francisco, CA/US

16:00 A-306 A. Imaging of polytrauma patients U. Linsenmaier; Munich/DE

Learning Objectives: 1. To learn about general principles of diagnostic imaging in emergency radiology in traumatic and non-traumatic emergencies. 2. To understand the aetiology, background and management of common radiological emergencies. 3. To appreciate the role, indications and protocols for US, CR, MDCT in modern emergency radiology.

Thursday

16:30 A-307 B. Challenges of imaging paediatric abdominal emergencies C.J. Sivit; Cleveland, OH/US

Learning Objectives: 1. To understand the variations of pathology that cause abdominal pain and vomiting in infants and children. 2. To learn how to plan safe and effective imaging protocols using US, CT, and MRI. 3. To recognise pitfalls in the diagnosis of paediatric abdominal emergencies with imaging. 17:00 A-308 C. Imaging in ENT emergencies D. Nunez; New Haven, CT/US

Learning Objectives: 1. To understand imaging findings in patients presenting with acute head and neck conditions using a systematic spatial approach. 2. To get an understanding of the role and indications of CT and MR in acute non-traumatic ENT case management. 3. To learn how to identify the extent of disease and recognise specific complications of cervicofacial infections. 16:00–17:30

Room M 5

E3 - ECR Academies: Diagnostic Urogenital Radiology E3 822

Upper and lower urinary tract Moderator: V. Logager; Copenhagen/DK

16:00 A-309 A. CTU and MRU of the upper urinary tract N.C. Cowan; Portsmouth/UK

Learning Objectives: 1. To learn about the technical requirements of CTU and MRU. 2. To learn about indications, diagnostic accuracy, diagnostic strategies, advantages and limitations of CTU and MRU. 3. To understand the normal imaging findings. 16:30 A-310 B. Imaging of kidney and ureter M.A. Cova; Trieste/IT

Learning Objectives: 1. To learn about the typical signs of urothelial carcinoma in the kidney and ureter, including rare manifestations. 2. To learn about the most frequent differential diagnoses. 3. To understand the potential pitfalls.

www.myESR.org

Final Programme | ECR 2016

211

Postgraduate Educational Programme

212

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

08:30–10:00 Room A

08:30–10:00 Room O

E3 - ECR Academies: Interactive Teaching Sessions

Paediatric

E3 921

RC 912

Moderator: M. Raissaki; Iraklion/GR

Diagnostic evaluation of bone tumours

08:30 A-318 A. Imaging of liver masses

08:30 A-312 A. Bone tumours: benign or malignant?

H. Woodley; Leeds/UK

H.-J. van der Woude; Amsterdam/NL

Learning Objectives: 1. To review the features on conventional radiographs which distinguish benign and malignant bone tumours. 2. To extend this knowledge to analyse features on MRI and CT which can help to distinguish benign and malignant bone tumours. 09:15 A-313 B. Pseudotumours: mimic bone tumours 1

2 1

Hepatobiliary imaging in children

2

F.M.H.M. Vanhoenacker , G. Vanderschueren ; Antwerp/BE, Leuven/BE

Learning Objectives: 1. To review the range of lesions which mimic tumours of the bone. 2. To extend this knowledge to analyse features that identify pseudotumours of the bone. 08:30–10:00 Room B

Abdominal Viscera RC 901 Hepatocellular tumours 08:30 A-314 Chairman’s introduction C. Bartolozzi; Pisa/IT

Session Objective: 1. To briefly introduce the diagnostic challenge of benign and malignant hepatocellular focal lesions.

C.J. Zech; Basle/CH

Learning Objectives: 1. To describe the underlying histopathologic characteristics of hepatocellular adenoma. 2. To define and compare the features of different imaging techniques for the correct diagnosis. 3. To differentiate hepatic adenoma from other hepatocellular focal lesions, i.e. focal nodular hyperplasia. 08:58 A-316 B. HCC staging: what is new in imaging and can predict prognosis C. Ayuso; Barcelona/ES

Learning Objectives: 1. To define HCC staging criteria and their impact on therapeutic management. 2. To describe HCC imaging prognostic factors, including functional and metabolic imaging. 3. To appraise the added clinical value of imaging prognostic factors in the therapeutic management. 09:21 A-317 C. Equivocal nodules in cirrhotic patient: how to solve the puzzle Y. Menu; Paris/FR

Learning Objectives: 1. To describe modern imaging techniques to identify and characterise nodules in cirrhotic patients. 2. To define the added value of hepato-specific contrast agents and multiparametric approach for the differential diagnosis. 3. To appraise an algorithm for the management of equivocal nodules.

09:00 A-319 B. Imaging of biliary disorders S.G.F. Robben; Maastricht/NL

Learning Objectives: 1. To become familiar with the roles of US, CT and MRI. 2. To learn about manifestations of common diseases. 3. To discuss the role of hepatobiliary contrast agents. 09:30 A-320 C. Intervention in the hepatobiliary system S. Franchi-Abella; Le Kremlin-Bicêtre/FR

Learning Objectives: 1. To become familiar with liver biopsy in focal and diffuse hepatic disorders. 2. To highlight the role of interventional radiology in biliary disorders. 3. To learn about the role of interventional radiology in hepatic vascular disorder. 08:30–10:00 Room N

Friday

08:35 A-315 A. The revised adenoma classification

Learning Objectives: 1. To learn about imaging protocols. 2. To learn about common benign and malignant lesions and differential diagnosis. 3. To become familiar with the role of new imaging techniques and hepatocytes-specific contrast agents.

E3 - ECR Academies: Modern Cardiac Imaging E3 920

How to quantify the haemodynamic significance of coronary stenosis Moderator: C. Loewe; Vienna/AT

08:30 A-321 A. CT-angiography: new tools (TAFE, TAG, CT-FFR) G. Pontone; Milan/IT

Learning Objectives: 1. To understand how the haemodynamic significance of coronary stenosis affects the choice of treatment and the patient’s prognosis. 2. To learn about new approaches to grading of coronary stenosis with the help of CTA (TAFE, TAG, CT-FFR). 3. To become familiar with the diagnostic value of these tools in comparison with traditional methods. 09:00 A-322 B. Myocardial perfusion: what can be done with MR and CT R. Vliegenthart; Groningen/NL

Learning Objectives: 1. To appreciate the clinical need for assessment of myocardial perfusion and viability. 2. To understand how perfusion MR and CT are performed in clinical settings. 3. To learn about diagnostic performance of perfusion MR and CT and clinical indications for them.

Panel discussion: 09:44 Impact of imaging on classification and differentiation of hepatocellular lesions

www.myESR.org

Final Programme | ECR 2016

213

Postgraduate Educational Programme

09:30 A-323 C. New players on the field: SPECT/CT, PET/CT, MR/PET

09:45 A-329 What are ontologies?

S.G. Nekolla; Munich/DE

B. Gibaud; Rennes/FR

Learning Objectives: 1. To understand the advantages and limitations of hybrid perfusion imaging. 2. To learn about the diagnostic value of hybrid imaging for studies of myocardial perfusion. 3. To become aware of clinical indications for hybrid myocardial perfusion studies.

Learning Objectives: 1. To understand the requirements for a structured and interoperable “language”. 2. To learn about different ontologies and taxonomies. 3. To consolidate knowledge about “Minimum Information About Biobanking Sharing” (MIABIS) 2.0. 08:30–10:00 Room E1

08:30–10:00 Studio 2016

Professional Challenges Session

Professional Challenges Session PC 9b

PC 9a

Biobanks meet imaging

Radiology ten years from now: where will it be?

Moderators: E. Neri; Pisa/IT, M. Pasterk; Graz/AT

08:30 A-324 How does Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium (BBMRI-ERIC) work? J.-E. Litton; Graz/AT

Learning Objectives: 1. To understand the diversity of human disease, biological samples and corresponding data. 2. To appreciate the benefits provided by biobanks for personalised medicine. 3. To learn about how the biobanking network of BBMRI has established quality assurance in biobanks. 08:45 A-325 Patient rights: data overprotection? M.T. Mayrhofer; Graz/AT

Learning Objectives: 1. To understand the rationale for patient rights. 2. To consolidate knowledge about the implementation of anonymization and pseudonymization. 3. To learn about the upcoming General Data Protection Regulation. 09:00 A-326 What is the difference between a PACS and a clinical bank of radiological images? A. van der Lugt; Rotterdam/NL

Learning Objectives: 1. To appreciate the need for structured and searchable image data and reports. 2. To understand the requirements for a clinical imaging bank. 3. To learn about the intraoperability of clinical image bank and other data repositories. 09:15 A-327 Population-based cohort biobanks: accessing large European prospective cohorts through the biobanking infrastructure BBMRI - large prospective cohorts (LPC) O. Törnwall; Graz/AT

Learning Objectives: 1. To learn about BBMRI - large prospective cohorts (LPC). 2. To understand how to obtain easy access to samples and data. 3. To learn how to transfer expertise from established to new emerging biobanks.

08:30 A-330 Chairman’s introduction C.D. Becker; Geneva/CH

Session Objectives: 1. To define the role of the radiologist in the multidisciplinary environment. 2. To evaluate potential synergies between radiology and pathology in a common management structure. 3. To discuss the leadership challenges in radiology for the next decade. 08:40 A-331 Expanding radiology with new multidisciplinary competencies J.A. Reekers; Amsterdam/NL

Learning Objectives: 1. To explain the need for subspecialisation and clinical involvement for future radiologists. 2. To review the role of the subspecialised radiologist in the modern hospital environment. 3. To discuss strategies to increase visibility of the radiologist in the medical community. 09:00 A-332 Potential synergies between radiology and pathology R.H. Oyen; Leuven/BE

Learning Objectives: 1. To describe the advantages of integrating radiology and pathology in the same organisational structure. 2. To discuss workflow and potential synergies. 3. To review local experience with regard to integration. 09:20 A-333 The beauty of general radiology G.H. Mostbeck; Vienna/AT

Learning Objectives: 1. To define the training requirements and related challenges for complete, transverse core competences in general radiology. 2. To define the practical challenges involved with increasing subspecialisation in radiology. 3. To define the role of the general radiologist in the modern hospital environment. Panel discussion: 09:40 What are the leadership challenges for the next decade?

09:30 A-328 Population-based cohort: image banks F. Bamberg; Tübingen/DE

Learning Objectives: 1. To appreciate the added value provided by imaging in populationbased cohorts. 2. To understand the difference between observation, incidental finding and result. 3. To learn about the intraoperability of biobanks and image banks.

214

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

08:30–10:00 Room E2

08:30–10:00 Room F1

Special Focus Session

Oncologic Imaging

SF 9c

RC 916

Brain hypersignals after repeated gadolinium administrations

Diffusion-weighted imaging (DWI) in oncology: how I do it

08:30 A-334 Chairman’s introduction

08:30 A-339 Chairman’s introduction

V. Runge; Berne/CH

D.-M. Koh; Sutton/UK

Session Objectives: 1. To review old and recent data on gadolinium (Gd) chelates kinetics and toxicity. 2. To learn about the recent abundant literature concerning brain hypersignals. 3. To understand the undertakings and positions of the health agencies.

08:35 A-340 A. DWI: how to optimise protocols N. Papanikolaou; Stockholm/SE

Learning Objectives: 1. To learn about examination protocols and techniques. 2. To understand the different models describing diffusion in various organs and diseases. 3. To become familiar with basic and advanced post-processing aspects.

08:35 A-335 Chemistry of Gd chelates and fundamentals in toxicity S. Aime; Turin/IT

Learning Objectives: 1. To understand the determinants of the in vivo stability of Gd complexes. 2. To understand the physicochemical aspects affecting the biodistribution of Gd.

08:58 A-341 B. DWI in abdominal oncology: ready for clinical practice? D.M. Lambregts; Amsterdam/NL

Learning Objectives: 1. To learn about the different ways diffusion imaging protocols can be used for qualitative and quantitative evaluation of malignant tumours in the abdomen. 2. To understand the pitfalls of using DWI in abdominal oncology. 3. To become familiar with the current clinical applications for DWI in abdominal oncology.

08:52 A-336 Recent literature review A. Radbruch; Heidelberg/DE

Learning Objectives: 1. To review published data on hyperintensities and gadolinium deposition in the brain after repeated gadolinium administrations. 2. To review published data on the differences of hyperintensities and gadolinium deposition in the brain after repeated administrations of macrocyclic and linear gadolinium based contrast agents.

09:21 A-342 C. DWI: whole body imaging V. Vandecaveye; Leuven/BE

T.A. Yousry; London/UK

Learning Objectives: 1. To understand the clinically most important aspects of the function of the dentate nucleus and basal ganglia nuclei. 2. To learn about signal variants and concerned pathologies. 3. To speculate about the potential implications of gadolinium depositions. 09:26 A-338 Recent FDA and EMA undertakings in the matter O. Clément; Paris/FR

Learning Objectives: 1. To learn about the pharmacovigilance actions of the European Medicines agency and the American FDA. 2. To understand the risk minimisation measures. Panel discussion: 09:43 Gadolinium injections: should we change our practice?

Panel discussion: 09:44 How to optimise DWI for clinical practice?

08:30–10:00 Room F2

Special Focus Session SF 9a

Breast density: how not to be confused?

08:30 A-343 Chairman’s introduction E. Azavedo; Stockholm/SE

Session Objectives: 1. To learn why breast density is a diagnostic problem and to understand if it is a prognostic factor. 2. To be able to identify and grade breast density. 3. To understand why dense breast could be a masking process and to learn how to avoid false negatives. 08:35 A-344 The mammographic dense breast F.J. Gilbert; Cambridge/UK

Learning Objectives: 1. To learn the definition of dense breast and the consequences on mammography interpretation. 2. To understand the different methods to measure breast density on mammography. 3. To analyse details that can be associated with abnormalities in dense tissues.

www.myESR.org

Final Programme | ECR 2016

215

Friday

Learning Objectives: 1. To learn about the most common indications of whole body diffusion imaging in cancer staging and treatment planning. 2. To become familiar with normal anatomy and physiological signal at whole body diffusion imaging. 3. To understand how to integrate qualitative and quantitative interpretation criteria into a structured report to optimise communication with the referring clinician.

09:09 A-337 Hypersignals in the brain: which clinical impact

Postgraduate Educational Programme

09:00 A-345 The ultrasound dense breast

08:35 A-352 A. Current status of digital mammography

L.J. Pina Insausti; Pamplona/ES

C.E. Mercer; Manchester/UK

Learning Objectives: 1. To learn the different categories of breast density on ultrasound according to the new BI-RADS lexicon. 2. To learn the impact of breast density on ultrasound analysis and the interest of automatic breast ultrasound in breast cancer screening. 3. To learn how to handle a transducer in dense breasts.

Learning Objectives: 1. To appreciate the strengths and weaknesses of digital mammography in breast imaging. 2. To become familiar with the importance of optimising breast compression for improving image quality. 3. To appreciate the clinical role of digital mammography in highlighting breast pathologies.

09:25 A-346 The MRI dense breast P.A.T. Baltzer; Vienna/AT

Learning Objectives: 1. To learn the differences of breast density and (breast enhancement patterns) background parenchymal enhancement (BPE), on MRI. 2. To understand if breast density or (breast enhancement) BPE have an influence on breast cancer risk. 3. To understand enhancement in diffusely growing malignancies in a dense background. Panel discussion: 09:50 How to overcome the dense breast in screening?

08:58 A-353 B. Developments in digital mammography C. Reis; Lisbon/PT

Learning Objectives: 1. To understand the current developments in digital mammography. 2. To become aware of the potential of tomosynthesis in breast imaging. 3. To become familiar with the current limitations of digital mammography in breast imaging. 09:21 A-354 C. Breast MRI and the future G. Podobnik; Ljubljana/SI

Learning Objectives: 1. To appreciate the strengths and weaknesses of MRI in breast imaging. 2. To understand the role of the radiographer in breast MRI in view of the recent developments in MRI technology. 3. To become aware of possible future developments in and clinical applications of breast MRI.

08:30–10:00 Room D1

Chest RC 904

Low dose and no-dose chest imaging: opportunities and limitations

Panel discussion: 09:44 The role of multimodality imaging in breast imaging

Moderator: A.P. Parkar; Bergen/NO

08:30 A-347 A. Low-dose CT O. Buckley; Dublin/IE

Learning Objectives: 1. To learn about techniques for decreasing the radiation dose on CT. 2. To know in which clinical situations low dose CT should be performed. 09:00 A-348 B. MRI Learning Objectives: 1. To learn about the current lung MR protocols. 2. To know in which clinical situations lung MRI is a helpful adjunct to diagnosis. 09:30 A-349 C. US F. Gleeson; Oxford/UK

Learning Objectives: 1. To learn when and how to perform a US study in the intensive care patient. 2. To become familiar with the strengths and limitations of the technique. 08:30–10:00 Room D2

Radiographers State-of-the-art breast imaging

08:30 A-350/A-351 Chairmen’s introduction V. Syrgiamiotis1, S. Zackrisson2; 1Athens/GR, 2Malmö/SE

Session Objectives: 1. To review current methods of screen-film mammography. 2. To present recent developments in digital mammography. 3. To explain the future of breast MRI techniques.

216

EFOMP Workshop: Radiation Protection for the female patient and female medical staff EF 1

Breast imaging modalities and radiation dose Moderators: T. Beyer; Vienna/AT, J. Damilakis; Iraklion/GR

J. Dinkel; Munich/DE

RC 914

08:30–10:00 Room K

ECR 2016 | Final Programme

08:30 A-355 Chairman’s introduction J. Damilakis; Iraklion/GR

Session Objectives: 1. To become familiar with the advanced breast imaging modalities. 2. To learn about breast doses from these modalities. 3. To appreciate their advantages and limitations. 08:35 A-356 Breast CT: technology and patient dose I. Sechopoulos; Nijmegen/NL

Learning Objectives: 1. To understand the technical aspects of breast CT. 2. To become familiar with breast dose levels from breast CT. 3. To give an overview of future improvements and developments of breast CT. 09:05 A-357 Digital mammography for screening and diagnosis of breast cancer: breast doses and radiogenic risks O. Morrish; Cambridge/UK

Learning Objectives: 1. To learn about breast doses and radiogenic risks from a two-view digital mammography. 2. To become familiar with breast doses and risks of radiation-induced breast cancer associated with mammographic screening. 3. To understand that the risk of radiation-induced breast cancer due to a properly performed mammographic screening programme is minimal.

www.myESR.org

Postgraduate Educational Programme

09:30 A-358 Digital breast tomosynthesis: physical principles and radiation dose levels

08:30–10:00 Room M 1

Molecular Imaging

G. Gennaro; Padua/IT

Learning Objectives: 1. To understand the technical aspects of digital breast tomosynthesis. 2. To become familiar with breast dose levels from digital breast tomosynthesis. 3. To give an overview of future improvements and developments of digital breast tomosynthesis. 08:30–10:00 Room G

E3 - ECR Academies: Neuroradiology: from Morphology to Function E3 919

Functional imaging of the spine

08:30 A-359 Chairman’s introduction M. Muto; Naples/IT

08:33 A-360 A. Measuring CSF flow: technique and clinical usefulness

RC 906

Preclinical imaging as a driver for translational research: how I do it

08:30 A-363 Chairman’s introduction J. Hodler; Zurich/CH

Session Objectives: 1. To learn the translational potential of preclinical research. 2. To understand the needs of preclinical research. 3. To know the physiological differences between small animals and humans. 08:35 A-364 A. Preclinical MR/PET imaging of cancer C. Kuntner-Hannes; Seibersdorf/AT

Learning Objectives: 1. To learn the different targets for molecular imaging of cancer. 2. To understand the needs of standardisation in preclinical imaging. 3. To understand the challenges in quantitative preclinical PET imaging. 08:53 A-365 B. What about nano-technology?

B. Ertl-Wagner; Munich/DE

F.M.A. Kiessling; Aachen/DE

Learning Objectives: 1. To review the physiology of CSF flow during the cardiac cycle. 2. To evaluate the reliability of the quantification of CSF flow rates by use of phase contrast MRI. 3. To show examples where alterations of CSF flow in the craniocervical junction can influence clinical management (e.g. in patients with Chiari Malformation Type I).

Learning Objectives: 1. To understand nano-technology as it is used in imaging. 2. To learn the potential utility and toxicity of nano probes. 3. To understand the elimination route of nano probes. 09:11 A-366 C. View of the young researcher D. Berritto; Acerra/IT

M. Sasiadek; Wroclaw/PL

Learning Objectives: 1. To review the technique of diffusion tensor imaging (DTI) in the assessment of the spinal cord. 2. To document the usefulness of DTI in the detection of cervical spinal cord integrity alterations in different stages of degenerative spine disease. 3. To discuss the value of DTI in other diseases of the spinal cord. 09:31 A-362 C. Functional and quantitative MRI of symptomatic stenoses of the lumbar spine K. Eberhardt; Werneck/DE

Learning Objectives: 1. To review the technique for performing MR myelography of the lumbar spine in flexion and extension. 2. To document the advantages of dynamic MR myelography for quantification of stenoses, motion-related changes, and spondylolistheses of the lumbar spine. 3. To show that dynamic MR myelography may be useful for early detection of spinal and for aminal stenosis, and show illustrative clinical examples.

Learning Objectives: 1. To learn the benefits of preclinical imaging for clinical activities. 2. To learn how to translate the knowledge from pre-clinical to clinical applications. 3. To understand the limitations of translation. 09:29 A-367 D. View of the radiographer R. Harris; London/UK

Learning Objectives: 1. To understand the role of the radiographer as partner. 2. To consolidate knowledge about prerequisites for imaging phantoms and animals. 3. To appreciate the benefits for translational and clinical research. Panel discussion: 09:47 How to set-up an attractive programme

08:30–10:00 Room M 2

Vascular RC 915

Fixing a leaky EVAR Moderator: R. Morgan; London/UK

08:30 A-368 A. The role of US: Doppler, 3D US, CEUS P. Ricci; Rome/IT

Learning Objectives: 1. To understand the techniques of modern US assessment and follow up with case illustration. 2. To appreciate the indications and limits of US in the modern imaging pathway. 3. To learn the latest evidence base for US assessment of endoleaks.

www.myESR.org

Final Programme | ECR 2016

217

Friday

09:02 A-361 B. Diffusion tensor imaging of the spinal cord in the assessment of intramedullary changes

Postgraduate Educational Programme

09:00 A-369 B. 2D and 3D CTA: current concepts A. Bücker; Homburg a.d. Saar/DE

Learning Objectives: 1. To learn the optimal acquisition protocols for CT and MR assessment of endoleaks. 2. To appreciate the imaging characteristics of new grafts and their leaks. 3. To understand the role of CT/MRA in endoleak therapy planning. 09:30 A-370 C. Endovascular management R. Uberoi; Oxford/UK

Learning Objectives: 1. To learn the natural history of endoleaks. 2. To understand the interventional therapy options. 3. To learn the outcome data on interventional therapies for endoleaks. 08:30–10:00 Room M 3

Special Focus Session SF 9b

Imaging in the presence of orthopaedic hardware

08:30 A-371 Chairman’s introduction M. Zanetti; Zurich/CH

Session Objectives: 1. To learn how CT can be optimised in the presence of orthopaedic hardware. 2. To learn how MRI can be optimised in the presence of orthopaedic hardware. 3. To learn about the role of imaging in prosthetic joint infection. 08:35 A-372 Optimising CT for imaging metalwork M.-A. Weber; Heidelberg/DE

Learning Objectives: 1. To understand that orthopaedic hardware should not be considered a contraindication to computed tomography. 2. To become familiar with the factors affecting the magnitude of image artefacts. 3. To learn about new techniques to minimise metal artefacts. 09:00 A-373 What problems do metalwork cause for MRI and how can we solve them? J.V. Dehem; Ypres/BE

Learning Objectives: 1. To understand the challenges metalwork causes for MR imaging of the joints. 2. To become familiar with new MRI metal artefact reduction techniques. 3. To appreciate the growing clinical need for MR imaging of patients with orthopaedic hardware. 09:25 A-374 Imaging prosthetic joint infection: traditionally problematic, but do we have the answers now? F. Kainberger; Vienna/AT

Learning Objectives: 1. To define situations in which imaging may significantly help to improve the diagnosis of infection. 2. To apply modern concepts to the forms of inflammation following endoprosthetic and other orthopaedic procedures. 3. To differentiate infection from other types of hardware loosening.

08:30–10:00 Room M 4

Emergency Radiology RC 917

Acute pain: your friend and enemy in emergency radiology

08:30 A-375 Chairman’s introduction: patients with acute pain management and therapeutic pathways J. Walecki; Warsaw/PL

08:35 A-376 A. Head P.C. Maly Sundgren; Lund/SE

Learning Objectives: 1. To become familiar with common clinical conditions resulting in acute headache. 2. To understand the choice of the best-suited imaging modality. 3. To learn about typical imaging findings in the most common clinical scenarios. 08:59 A-377 B. Chest C.N. De Cecco; Charleston, SC/US

Learning Objectives: 1. To become familiar with clinical conditions resulting in acute pain. 2. To understand which additional data will influence the choice of the correct imaging modality. 3. To learn about typical imaging findings in patients with acute chest pain. 09:23 A-378 C. Abdomen R. Basilico; Chieti/IT

Learning Objectives: 1. To become familiar with common clinical conditions resulting in acute abdominal pain. 2. To understand what clinical information influences the choice of the best-suited imaging modality. 3. To learn typical and less typical imaging findings in patients with acute abdominal pain. Panel discussion: 09:47 Where does radiology fit in the pathway?

08:30–10:00 Room M 5

E3 - ECR Academies: Diagnostic Urogenital Radiology E3 922

Gynaecology Moderator: T. Cunha; Lisbon/PT

08:30 A-379 A. MR imaging techniques and normal anatomy of the female pelvis C.S. Balleyguier; Villejuif/FR

Learning Objectives: 1. To learn about the different MR protocols according to the clinical question. 2. To become familiar with normal imaging findings of the female pelvis. 3. To become familiar with potential pitfalls.

Panel discussion: 09:50 What is the imaging modality of choice after plain films in the presence of orthopaedic hardware?

218

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

09:00 A-380 B. Staging of cervical cancer R. Forstner; Salzburg/AT

10:35 A-385 Mammography screening in Denmark: implementation and results

Learning Objectives: 1. To learn about the MR appearance of cervical cancer, including mimics. 2. To become familiar with the spread of disease. 3. To understand the impact of imaging on therapeutic decision making.

I. Vejborg; Copenhagen/DK

Learning Objectives: 1. To learn about the challenges in implementation of a service cancer screening programme. 2. To learn about the balance between positive and negative effects of a population-based screening programme. 3. To discuss quality assurance of a nationwide mammography screening programme and to present its results.

09:30 A-381 C. Differential diagnoses of adnexal masses S. Swift; Leeds/UK

Learning Objectives: 1. To understand how to identify the origin of the suspicious adnexal mass. 2. To learn about how to differentiate benign from malignant adnexal masses, also applying functional techniques. 3. To understand how to differentiate between benign surgical and nonsurgical lesions. 10:30–12:00

Room A

E3 - ECR Academies: Interactive Teaching Sessions E3 1021

10:55 A-386 Performing MRI preoperatively in all breast cancer patients in Iceland: is it worthwhile? M. Garðarsdóttir; Reykjavik/IS

Learning Objective: 1. To understand the value of preoperative assessment of disease extent as a tool in appropriate surgical planning. 11:05 A-387 Breast density, risk for breast cancer and how to personalise screening: what are the future breast imaging modalities? S. Zackrisson; Malmö/SE

Learning Objectives: 1. To learn about the current knowledge of how to estimate breast cancer risk and if this can be applied in a screening context. 2. To understand what imaging modalities for breast cancer screening we have at hand now and for the future.

Emergency radiology I

10:30 A-382 A. Abdominal vascular emergencies A. Palkó; Szeged/HU

Learning Objectives: 1. To understand the different types of abdominal vascular emergencies. 2. To learn about imaging findings and treatment options.

11:25 A-388 Interval cancers in population-based screening programmes S.R. Hoff; Aalesund/NO

J.D. Dodd; Dublin/IE

Learning Objectives: 1. To understand the imaging technique. 2. To become familiar with the differential diagnosis. 10:30–12:00

Room B

Friday

Learning Objectives: 1. To understand interval cancers, i.e. breast cancers, detected in the interval between two screening examinations. 2. To learn about systematic reviews of interval cancers, as the rate of missed interval cancer can be used as a quality measure of a screening program.

11:15 A-383 B. Chest trauma

11:40 A-389 New developments in MRI and MR image analysis of breast cancer J. Hakumäki; Kuopio/FI

ESR meets the Nordic Countries EM 1

Learning Objectives: 1. To understand the fundamentals of DWI, DCE and MR spectroscopy in breast imaging. 2. To become familiar with the optimised analysis methods for DWI, DCE and MRS. 3. To learn about multiparametric data analysis in 3T breast MRI.

Mammography in Nordic countries: screening and new developments Welcome the ESR President: L. Donoso; Barcelona/ES Presiding: K. Riklund; Umea/SE M. Garðarsdóttir; Reykjavik/IS G. Hagen; Oslo/NO K.R. Nielsen; Copenhagen/DK H. Ståhlbrandt; Eksjö/SE R.L. Vanninen; Kuopio/FI

10:30 A-384 Introduction

10:30–12:00

Room K

EFOMP Workshop: Radiation Protection for the female patient and female medical staff EF 2

Pregnancy and lactation Moderators: P. Sharp; Aberdeen/UK, V. Tsapaki; Anixi/GR

H. Ståhlbrandt; Eksjö/SE

Learning Objectives: 1. To become familiar with radiology in breast cancer in Nordic countries. 2. To learn about screening, individualisation, risk stratification and new methods.

www.myESR.org

10:30 A-390 Chairman’s introduction P. Sharp; Aberdeen/UK

Session Objectives: 1. To learn how to manage and counsel pregnant patients in case of x-ray exposure. 2. To become familiar with issues related to administration of radiopharmaceuticals to pregnant patients and nursing mothers. 3. To learn how to protect pregnant or potentially pregnant personnel working with x-rays.

Final Programme | ECR 2016

219

Postgraduate Educational Programme

10:35 A-391 Radiation protection of pregnant and lactating patients in nuclear medicine

11:30 A-396 C. Staging of prostate cancer A.R. Padhani; London/UK

Learning Objectives: 1. To become familiar with the imaging techniques used for staging, including functional MRI. 2. To become familiar with the common sites of metastases. 3. To learn about what technique to use for follow-up of metastatic disease, including functional techniques.

S. Mattsson; Malmö/SE

Learning Objectives: 1. To discuss issues related to administration of radiopharmaceuticals to pregnant patients. 2. To discuss issues related to administration of radiopharmaceuticals to nursing mothers. 3. To be informed about the exposure of the embryo/foetus to radiation during nuclear medicine procedures performed on the mother. 11:05 A-392 Dose management of pregnant patients in x-ray imaging

12:15–12:45

Room A

Plenary Session

J. Damilakis; Iraklion/GR

Learning Objectives: 1. To learn how to manage pregnant patients in case of intentional and accidental exposure to x-rays. 2. To be informed about the exposure of the embryo/foetus to radiation during diagnostic and interventional x-ray procedures performed on the mother. 3. To learn about new developments in embryo/foetus dose estimation. 11:35 A-393 Occupational radiation protection: protecting pregnant or potentially pregnant workers in interventional radiology A. Trianni; Udine/IT

Learning Objectives: 1. To be informed about dose limits and regulations regarding occupational exposure of pregnant staff working with radiation. 2. To learn how to manage pregnant staff in medical imaging departments. 3. To become familiar with techniques that will keep the dose to the unborn child from the mother’s occupation as low as possible. 10:30–12:00

Room M 5

E3 - ECR Academies: Diagnostic Urogenital Radiology E3 1022

Prostate Moderator: J.J. Fütterer; Nijmegen/NL

10:30 A-394 A. Ultrasound of the prostate T. Fischer; Berlin/DE

Learning Objectives: 1. To become familiar with the technical requirements for performing US of the prostate. 2. To learn about the anatomy of the prostate. 3. To understand how to detect suspicious lesions for ultrasoundguided biopsy. 4. To understand the potential clinical utility of different ultrasound techniques such as Doppler, elastography, CEUS and image fusion. 5. To discuss the evidence for the use of these technologies in routine clinical practice. 11:00 A-395 B. Multiparametric MRI of the prostate G.M. Villeirs; Ghent/BE

Learning Objectives: 1. To become familiar with technical aspects of DCE-MRI, DWI and MR spectroscopy. 2. To understand how to recognise the advantages and limitations of each technique. 3. To understand how to detect significant disease of prostate cancer in the peripheral zone.

220

ECR 2016 | Final Programme

HL 2

Josef Lissner Honorary Lecture Presiding: K. Riklund; Umeå/SE

12:15 A-397 Liver imaging: where do we stand now? V. Vilgrain; Clichy/FR

12:15–13:45

Room D2

MIR @ ECR Session MIR 1

Communication in radiology Moderators: B. Hamm; Berlin/DE, S. Morozov; Moscow/RU

12:15 A-398 A. Communication and conflict resolution in radiology: how to recruit and retain the best team P.R. Ros; Cleveland, OH/US

Learning Objectives: 1. To review the key principles of excellence in building medical imaging teams. 2. To understand how to recruit and retain the best radiology team members. 3. To appreciate the value of communication in conflict resolution and high performance radiology teams. 12:33 A-399 B. Impact of structured reporting on communication with referring physicians D. Pinto dos Santos; Mainz/DE

Learning Objectives: 1. To understand how structured reporting can improve communication with the referring physicians. 2. To learn about how structured reporting can support communication and tracking of actionable findings. 3. To become familiar with current developments in structured reporting. 12:51 A-400 C. Informed consent in the radiology department: when and how? L.H. Ros Mendoza; Zaragoza/ES

Learning Objectives: 1. To learn about the role and importance that informed consent currently has in radiology departments. 2. To discuss the radiological procedures and techniques which do or do not need informed consent. 3. To understand the importance of a thorough and accurate design of informed consent.

www.myESR.org

Postgraduate Educational Programme

13:09 A-401 D. Patients’ expectations in communication with radiologists

14:00–15:30

Room B

EFRS meets Sweden

E. Briers; Hasselt/BE

Learning Objectives: 1. To learn about patients’ expectations when entering the radiology department. 2. To understand the knowledge gap between the “average” patient and the “average” radiologist. 3. To learn how to overcome the knowledge gap without making the message become childish or treating the patient as a child. 4. To appreciate the multiple levels of patient knowledge. 13:27

EM 4

14:00 A-405/A-406 Introduction H.H. Hjemly1, K. Hillergård2; 1Oslo/NO, 2Jönköping/SE

Session Objectives: 1. To become familiar with the knowledge, skills and attitudes needed for competent Swedish radiographers. 2. To learn about the caring approach within the Swedish radiography programme. 3. To understand the research as a process for learning in a Swedish radiography programme.

Discussion

12:30–13:30

Room B

E3 - The Beauty of Basic Knowledge: Breast Imaging E3 24C

14:05 A-407 The Swedish radiographer as a professional B.T. Andersson; Lund/SE

Learning Objectives: 1. To gain insight into the Swedish radiographer as a professional. 2. To become familiar with the knowledge, skills and attitudes needed for competent Swedish radiographers. 3. To consolidate knowledge about core competences and their relation to education and profession. 4. To appreciate the impact of person-centred care in the area of radiography.

Breast cancer staging: why and how Moderator: J. Camps Herrero; Valencia/ES

12:30 A-402 Breast cancer staging: why and how K. Kinkel; Chêne-Bougeries/CH

Learning Objectives: 1. To learn the timing, limitation and advantages of the different imaging techniques in staging breast cancer. 2. To know how to deal with additional lesions and their clinical meaning. 3. To understand the critical role of the radiologist in the pretreatment evaluation of breast cancer.

14:23 A-408 Implementation of a caring approach within the Swedish radiography programme M. Lundén; Gothenburg/SE

Learning Objectives: 1. To learn about the Swedish radiography programme. 2. To appreciate the importance of combining patient care and technical matters in the Swedish radiography programme. 3. To become familiar with and acknowledge the patient’s perspective in the radiography programme. 4. To understand how a caring approach can be accomplished in a radiography programme.

Room D1

E3 - The Beauty of Basic Knowledge: Chest Imaging E3 25C

Reporting chest radiology made easy Moderator: N. Howarth; Chêne-Bougeries/CH

12:30 A-403 A. Interstitial lung disease: 5 golden rules

14:41 A-409 Implementation of a research process and quality improvement within the Swedish radiography programme K. Fridell; Stockholm/SE

S.R. Desai; London/UK

Learning Objectives: 1. To learn about different aspects of the research process in a Swedish radiography programme. 2. To become familiar with different methods for quality improvement and how these can be integrated in a Swedish radiography programme. 3. To understand the research as a process for learning in a Swedish radiography programme.

Learning Objectives: 1. To review diagnostic signs of interstitial lung disease. 2. To learn how to avoid over-diagnosis. 3. To know the limitations of radiological diagnoses. 13:00 A-404 B. Pleural disease C. Beigelman; Lausanne/CH

Learning Objectives: 1. To review the radiological appearance of pleural disease. 2. To learn how to identify typical pleural plaques. 3. To know how to distinguish pleural plaques from pleural metastases.

14:59 A-410 Cultural highlights G. Örnberg; Umeå/SE

15:17

www.myESR.org

Panel discussion

Final Programme | ECR 2016

221

Friday

12:30–13:30

The professional role of Swedish radiographers in medical imaging

Postgraduate Educational Programme

14:00–15:30

Room L8

EIBIR Session

14:18 A-417 B. Patient satisfaction with radiology departments: are we doing our best? G. Paulo; Coimbra/PT

EIBIR 2

14:00 A-411/A-412

MITIGATE: What does it take to perform clinical trials in interventional radiology? Introduction

S.O. Schönberg1, W.R. Jaschke2; 1Mannheim/DE, 2Innsbruck/AT

Session Objectives: 1. To introduce the aims of the session. 2. To highlight the importance of clinical trials in interventional radiology. 3. To introduce the related objectives of the MITIGATE project. 14:10 A-413 Overview on clinical trials in interventional radiology in Europe A. Gangi; Strasbourg/FR

Learning Objectives: 1. To learn about the European framework for clinical trials in interventional radiology. 2 To learn about the requirements for clinical trials in interventional radiology in Europe. 3. To learn about successfully conducted clinical trials in interventional radiology. 14:30 A-414 How to implement investigator-initiated or industry-sponsored trials in interventional oncology: SORAMIC vs SIRFLOX J. Ricke; Magdeburg/DE

Learning Objectives: 1. To learn about two examples of clinical trials in interventional oncology. 2. To learn about the implementation of clinical trials in interventional oncology. 3. To learn more about industry involvement in clinical trials in interventional oncology. 14:50 A-415 Design of a clinical trial in oligometastatic GIST: results from the MITIGATE consortium C. Decristoforo; Innsbruck/AT

Learning Objectives: 1. To learn about the aims of the clinical trial performed in the MITIGATE project. 2. To learn about the design of a clinical trial in oligometastatic GIST. 3. To learn about the expected impact of the clinical trial. 15:10

Discussion

14:00–15:30

Learning Objectives: 1. To learn about the importance of a harmonised and structured communication process with patients. 2. To become aware of patients’ needs and fragilities at the point of care. 3. To understand the importance of health professionals’ teamwork as a tool to developing a patient safety culture.

Room D2

MIR @ ECR Session

14:36 A-418 C. Is there any evidence for decision support? G. Boland; Boston, MA/US

Learning Objectives: 1. To understand the goals of clinical decision support tools. 2. To discuss and evaluate the emerging tools available. 3. To discuss the evidence for improving clinical outcome. 14:54 A-419 D. Dose monitoring and benchmarking: opportunities to improve radiation protection D. Caramella; Pisa/IT

Learning Objectives: 1. To demonstrate the importance of systematic dose monitoring in radiology. 2. To understand how dose monitoring may reduce clinically unjustified variations within and between hospitals. 3. To propose a paradigm shift from risk communication to safety reassurance. 15:12

Discussion

14:00–15:30

Room M 4

Joint Session of the ESR and ESMRMB Cardiac MRI Moderators: J. Bremerich; Basle/CH, E.R. Danielsen; Copenhagen/DK

14:00 A-420 Overview of cardiac MR methods S. Kozerke; Zurich/CH

Learning Objectives: 1. To become familiar with the most important methods in Cardiac MRI covering both methods for examination of congenital and acquired heart disease. 2. To learn about cardiac MRI pulse sequences, the principles of ECG gating, and how movement is handled. 3. To become familiar with dynamic and anatomical cardiac MRI methods. 4. To learn how to recognise pitfalls and imaging artefacts typical for cardiac MRI. 5. To understand reconstruction and volume rendering principles as they apply to cardiac MRI. 14:30 A-421 Clinical use of MR in congenital cardiac disease V. Muthurangu; London/UK

MIR 2

Improving quality and safety in radiology Moderators: E.J. Adam; London/UK, D.A. Koff; Hamilton, ON/CA

14:00 A-416 A. How to run a safe department? P. Cavanagh; Taunton/UK

Learning Objectives: 1. To understand the key drivers for developing a safe radiology service. 2. To learn about a framework that helps to implement a safe system within a radiology department. 3. To learn about approaches that can be used in your department.

222

ECR 2016 | Final Programme

Learning Objectives: 1. To learn about the variety of congenital cardiac disease that benefit from MRI, and to understand which methods are useful in the different diseases. 2. To understand the imaging features and basic clinical features of congenital heart disease including neonatal heart disease, congenital heart disease in childhood and adult congenital heart disease. 3. To appreciate MRI features of congenital vascular anomalies of the cardiovascular system. 4. To appreciate the role of quantitative evaluations in cardiac MRI for congenital heart disease.

www.myESR.org

Postgraduate Educational Programme

15:00 A-422 Clinical use of MR in acquired cardiac disease

16:21 A-428 Dementia: the role of nuclear medicine

T. Leiner; Utrecht/NL

V. Garibotto; Geneva/CH

Learning Objectives: 1. To appreciate the wide range of clinical questions in acquired cardiac disease that may benefit from MRI, and to understand how the different techniques assist clinical decision making. 2. To learn about the MRI features and basic clinical features of cardiomyopathy including acute myocarditis, dilated cardiomyopathy, restrictive and obstructive cardiomyopathy, cardiomyopathy related to systemic disease, infiltrative cardiomyopathy. 3. To appreciate the role of quantitative evaluations in cardiac MRI for acquired heart disease. 4. To understand the role, benefits and limitations of cardiac stress testing in cardiac MRI.

Learning Objectives: 1. To become familiar with the PET and SPECT tracers available for molecular imaging in dementia. 2. To become familiar with typical patterns of hypometabolism in dementia. 3. To understand the added value of molecular imaging by PET and SPECT in dementia. 4. To discuss the potential role of hybrid MR/PET in this field.

16:00–17:30

16:39 A-429 Prostate cancer: PET/CT in early biochemical relapse E. Lopci; Rozzano/IT

Learning Objectives: 1. To learn about the role of PET imaging in the investigation of biochemical relapse in prostate cancer. 2. To become familiar with the role of established tracers including C-11 choline and F-18 fluoride in this clinical context. 3. To gain insight into the potential of emerging tracers, such as Ga-68 PSMA.

Room A

E3 - ECR Academies: Interactive Teaching Sessions E3 1221

Use of staging and classification systems

16:57 A-430 Prostate cancer: multiparametric MR in the diagnosis and clinical management of prostate cancer F. Mrakic Sposta; Milan/IT

16:00 A-423 A. RECIST 1.1 training

Learning Objectives: 1. To learn about the role of multiparametric MRI in the investigation of prostate cancer. 2. To become familiar with the role of morphological sequences, DWI sequences and ADC maps in MRI exams. 3. To gain insight into the potential spectroscopy study of Choline, Citrate and Creatine.

A. Graser; Munich/DE

Learning Objectives: 1. To understand the principle of the RECIST system. 2. To become familiar with the daily oncologic work-up. 16:45 A-424 B. Gastrointestinal-abdominal masses A. Ba-Ssalamah; Vienna/AT

16:00–17:30

Room B

Joint Session of the ESR and the EANM Hybrid imaging: radiology and nuclear medicine 16:00 A-425/A-426 Introduction K. Riklund1, V. Lewington2; 1Umea/SE, 2London/UK

Session Objectives: 1. To learn about collaboration in hybrid imaging. 2. To understand the added value of using both radiology and nuclear medicine in medicine. 16:03 A-427 Dementia: the role of radiology S. Haller; Geneva/CH

Learning Objectives: 1. To learn the typical atrophy patterns of various types of dementia, notably Alzheimer Dementia and fronto-temporal lobar degeneration. 2. To understand the basic principle of arterial spin labelling (ASL). 3. To become familiar with typical patterns of hypoperfusion in dementia.

www.myESR.org

Panel discussion: How can collaboration between radiology and nuclear medicine develop imaging and research in hybrid imaging?

16:00–17:30

Room C

E3 - ECR Academies: Modern Imaging in Colorectal Cancer E3 1218

Rectal cancer: update on organ saving treatments Moderator: L.K. Blomqvist; Stockholm/SE

16:00 A-431 A. The surgical perspective G.L. Beets; Amsterdam/NL

Learning Objectives: 1. To learn about new organ saving treatments in rectal cancer and the clinical background. 2. To know how to select and follow the patients. 3. To understand the factors relevant for clinical decision making. 4. To understand what the surgeon wants to know from radiologists. 16:30 A-432 B. The oncological perspective V. Valentini; Rome/IT

Learning Objectives: 1. To understand the different radiation oncologists’ treatment proposals based on the anatomical and pathological information from imaging. 2. To become familiar with patients’ expectations, taking into consideration the various preoperative radiation treatment schedules with or without chemotherapy. 3. To know how radiation treatment can improve the number of patients with complete response and how it is challenging for the oncologist and the patients.

Final Programme | ECR 2016

223

Friday

Learning Objectives: 1. To learn the characteristic features of some common and atypical abdominal masses. 2. To identify the key imaging findings that assist surgeons or oncologists treating specific abdominal masses.

17:15

Postgraduate Educational Programme

17:00 A-433 C. The radiological perspective

16:28 A-445 B. Dose reduction and image quality in paediatric CT

R.G.H. Beets-Tan; Amsterdam/NL

R.A.J. Nievelstein; Utrecht/NL

Learning Objectives: 1. To learn how radiologists can answer the relevant clinical questions. 2. To understand the role of imaging during the selection for and the follow-up of organ preservation. 3. To know the performance of (MR) imaging for the assessment and prediction of complete response after chemoradiotherapy.

Learning Objectives: 1. To discuss simple steps for dose reduction in paediatric CT. 2. To learn about the image quality and patient dose. 3. To understand common errors when performing paediatric CT.

16:00–17:30

Room Z

EdiR talk

What you should know about the EDiR

16:51 A-446 C. Patient compliance and motion-free protocols in general paediatric MRI G. Schneider; Homburg/ Saar/DE

Learning Objectives: 1. To understand the cost of time versus quality images in paediatric MRI. 2. To learn about the importance of safety and pre-designed protocols in paediatric MRI. 3. To discuss options and technology available for free-breathing children.

16:00 A-434/A-435 Chairmen’s introduction: The story of the European Diploma in Radiology (EDiR) J. Vilar1, Y. Menu2; 1Valencia/ES, 2Paris/FR

Session Objectives: 1. To become informed about the origin of the European Diploma in Radiology. 2. To become aware of the evolution and development of the EDiR. 3. To learn the most relevant facts and figures about the EDiR. 16:15 A-436/A-437/A-438/A-439/A-440

Learning Objectives: 1. To learn some important facts regarding the recent examination at ECR 2016. 2. To become familiar with the new reality of the EDiR: The skills examination, how it works and practical tips. 3. To learn some tricks that may help candidates prepare for the written part. 4. To become informed about the future EDiR forecast. 17:00 A-441/A-442 EDiR O. Dicle1, E. Jordan2; 1Izmir/TR, 2Barcelona/ES

Learning Objectives: 1. To learn how to prepare for the EDiR. 2. To learn how to apply for the EDiR: Where, when and how. 3. To appreciate the real and potential benefits of taking the examination: The point-of-view of an EDiR holder. Room O

Paediatric RC 1212

Panel discussion: What are the essentials in education and training for paediatric imaging

16:00–17:30 Evolution of the EDiR

J. Vilar1, P.C. Maly Sundgren2, L. McKnight3, V. Iranzo4, H.T. Sarisoy5; 1 Valencia/ES, 2Lund/SE, 3Langland/UK, 4Barcelona/ES, 5Kocaeli/TR

16:00–17:30

17:14

Key issues in paediatric imaging

16:00 A-443 Chairman’s introduction J. Portelli; Msida/MT

Session Objectives: 1. To understand the importance of dose reduction parameters. 2. To learn how to improve image quality in paediatric patients when performing studies with ionising radiation. 3. To learn about requisites for a safe and successful paediatric MRI scan. 16:05 A-444 A. Key issues in the x-ray department E. Sorantin; Graz/AT

Room N

E3 - ECR Academies: Modern Cardiac Imaging E3 1220

Essentials of modern imaging in cardiac diseases Moderator: G.I. Kirova-Nedialkova; Sofia/BG

16:00 A-447 A. Major challenges in diagnostic imaging of cardiac diseases M. Oudkerk; Groningen/NL

Learning Objectives: 1. To learn about limitations of standard approaches to diagnosis and assessment of risk in cardiac diseases. 2. To appreciate how these limitations could be overcome with the help of cardiac diagnostic imaging. 3. To learn about new opportunities for assessment of risk and prognosis. 16:30 A-448 B. Backbone of cardiac imaging: CT and MRI M. Gutberlet; Leipzig/DE

Learning Objectives: 1. To review the technical and methodological aspects of coronary and cardiac CT and MRI. 2. To learn about major clinical applications of coronary and cardiac CTA. 3. To become familiar with clinical indications for cardiac MR from a practical point of view. 17:00 A-449 C. Hybrid systems for cardiac applications: essentials J. Knuuti; Turku/FI

Learning Objectives: 1. To learn about types of hybrid scanners for cardiac imaging. 2. To become familiar with types of tracers for cardiac imaging. 3. To become familiar with approaches to selecting scanners and tracers according to the clinical indications.

Learning Objectives: 1. To learn about the image quality and patient dose. 2. To become familiar with standards of acceptable image quality. 3. To become familiar with ways to reduce dose, especially in daily fluoroscopy.

224

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

16:00–17:30

Studio 2016

Genitourinary

16:15 A-455 Maximising your chances to obtain European research funding: opportunities, strategies, services P. Zolda; Vienna/AT

RC 1207

MRI for gynaecologic imaging: how I do it

Learning Objectives: 1. To learn about strategies to obtain funding under Horizon2020. 2. To learn about how EIBIR can support research consortia in the preparation and implementation of projects. 3. To get useful tips for preparing a competitive proposal.

16:00 A-450 Chairman’s introduction C.D. Alt; Düsseldorf/DE

Session Objectives: 1. To learn how to optimise MRI of the female pelvis. 2. To understand the diagnostic benefit of integration of advanced techniques.

16:40 A-456 An evaluator’s perspective M. Dewey; Berlin/DE

Learning Objectives: 1. To learn from the experience of an external expert evaluator under H2020. 2. To understand the mechanisms of proposal evaluation. 3. To get insider information, such as what it takes to prepare a proposal that can convince evaluators.

16:05 A-451 A. Basics of patient preparation and T2W-imaging N.M. deSouza; Sutton/UK

Learning Objectives: 1. To understand the value of patient preparation. 2. To learn how to optimise and tailor protocols in female pelvic imaging. 3. To understand the role of T2WI, and how and when to use 3D techniques.

17:00 A-457 Success story of a maximum score project in Horizon 2020 C.K. Kuhl; Aachen/DE

Learning Objectives: 1. To learn about a successful application on hybrid MR/PET in breast cancer. 2. To understand the actions that led to the submission of a strong application. 3. To learn about next the steps of the project.

16:28 A-452 B. Contrast agents R.A. Kubik-Huch; Baden/CH

16:51 A-453 C. Diffusion and ADC E. Sala; New York, NY/US

Learning Objectives: 1. To understand the technical principles of DWI. 2. To learn how to optimise and integrate DWI in pelvic imaging. 3. To illustrate the added diagnostic value of DWI in female pelvic imaging.

17:14

Panel discussion: Multiparametric MRI of the female pelvis - should it replace tailored protocols?

16:00–17:30

Room L8

EIBIR Session

17:20

Questions and answers

16:00–17:30

Room E1

Musculoskeletal RC 1210

Friday

Learning Objectives: 1. To become familiar with the safety considerations and guidelines for the use of gadolinium with a special focus on imaging pregnant and lactating patients. 2. To learn why, how and when to use IV contrast-enhanced imaging in MRI of the female pelvis. 3. To understand different gadolinium T1W techniques and their clinical value in routine imaging, as well as to become familiar with quantification techniques.

Systemic disease: what to look for in the musculoskeletal system Moderator: A. Cotten; Lille/FR

16:00 A-458 A. Imaging the diabetic foot J. Kramer; Linz/AT

Learning Objectives: 1. To learn about the range of imaging abnormalities seen in the diabetic foot. 2. To become familiar with features that distinguish infection from other abnormalities in the diabetic foot. 16:30 A-459 B. MSK manifestations of non-malignant haematological disease A.H. Karantanas; Iraklion/GR

EIBIR 3

Gateway to European funding for research projects

16:00 A-454 Introduction G.P. Krestin; Rotterdam/NL

Learning Objectives: 1. To learn about the mission, structure and general services of the European Institute for Biomedical Imaging Research (EIBIR). 2. To understand the framework and policy for European research funding. 3. To learn about future calls relevant to the imaging community.

www.myESR.org

Learning Objectives: 1. To understand the way haematological conditions can affect the musculoskeletal system. 2. To become familiar with patterns of imaging abnormality seen in the musculoskeletal system in patients with non-malignant haematological disorders. 17:00 A-460 C. MSK manifestations of renal disease G. Guglielmi; Andria/IT

Learning Objectives: 1. To demonstrate the way renal disease can affect the musculoskeletal system. 2. To become familiar with patterns of imaging abnormality seen in the musculoskeletal system in patients with renal disease.

Final Programme | ECR 2016

225

Postgraduate Educational Programme

16:00–17:30

Room F1

Oncologic Imaging RC 1216

16:30 A-467 Perspectives from thoracic imaging M. Rémy-Jardin; Lille/FR

Learning Objectives: 1. To describe the clinical situations justifying such an integration. 2. To discuss the most adapted scanning protocols. 3. To describe the complementarity between morphology and function in daily practice.

New insights in bone tumour imaging

16:00 A-461 Chairman’s introduction D. Vanel; Bologna/IT

Session Objectives: 1. To become familiar with the treatment strategies in bone tumours. 2. To learn about the role of current imaging techniques in management of bone tumours.

16:55 A-468 Perspectives from cardiac imaging J. Bremerich; Basle/CH

Learning Objectives: 1. To understand the role of the heart in cardiopulmonary diseases. 2. To learn about cardiac imaging modalities and their application in pulmonary diseases. 3. To become familiar with specific cardiac imaging protocols.

16:05 A-462 A. New insights in treatment-associated changes in patients with bone tumours C.R. Krestan; Vienna/AT

Learning Objectives: 1. To understand the treatment strategies in bone tumours. 2. To learn the essentials of sarcoma imaging. 3. To understand post-treatment appearances including chemo- and radiation-induced bone marrow changes. 16:28 A-463 B. New insights in staging and restaging musculoskeletal tumours

17:20

16:00–17:30

Room D1

Chest

J.L. Bloem; Leiden/NL

RC 1204

Learning Objectives: 1. To learn about the role of current imaging techniques in management of bone tumours. 2. To learn the essentials in staging and restaging in bone tumours.

16:00 A-469 Chairman’s introduction Session Objectives: 1. To clarify the terms used to describe occupational lung diseases. 2. To illustrate one modern cause of OLD: denim sandblasters.

G. Sommer; Basle/CH

Learning Objectives: 1. To understand the current concepts of evaluation of multiple myeloma with FDG PET/CT and MR/PET. 2. To understand the role of diffusion-weighted MRI in patients with multiple myeloma.

16:05 A-470 A. Silicosis and coal workers’ pneumoconiosis K. Marten-Engelke; Göttingen/DE

Learning Objectives: 1. To recognise clinical features and occupational history of silicosis and CWP. 2. To appreciate HRCT features of these disorders as well as important differential diagnoses.

Panel discussion: The future of bone tumour imaging

16:00–17:30

Room F2

Professional Challenges Session PC 12a

16:28 A-471 B. Asbestos-related disease S.J. Copley; London/UK

Learning Objectives: 1. To know the wide range of findings associated with asbestos exposure. 2. To appreciate the role of CT-HRCT in the assessment of these patients.

Comprehensive cardiothoracic radiology: the way to go?

16:00 A-465 Chairman’s introduction: A perspective from both worlds: cardiac and thoracic imaging

Occupational lung diseases: the known and the less known

N. Karabulut; Denizli/TR

16:51 A-464 C. New insights in imaging for multiple myeloma

17:14

Panel discussion: How to best increase our impact on this interdisciplinary field?

16:51 A-472 C. Hypersensitivity pneumonitis

E.J.R. van Beek; Edinburgh/UK

P.-Y. Brillet; Bobigny/FR

Session Objectives: 1. To learn about the possible integration of cardiac and thoracic imaging for routine patient care. 2. To understand the need for a holistic approach to cardiothoracic imaging. 3. To become familiar with the main protocols and applications of cardiothoracic imaging.

Learning Objectives: 1. To know about the various professional exposures that can cause HSP. 2. To learn how to recognise the acute, sub-acute and chronic forms of this disease.

16:05 A-466 Challenges and opportunities

17:14

Panel discussion: What are the key findings for diagnosing occupational lung diseases?

A. de Roos; Leiden/NL

Learning Objectives: 1. To learn about challenges in training and education. 2. To learn about multi-organ interaction. 3. To learn about clinical and research opportunities.

226

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

16:00–17:30

Room D2

16:00–17:30

Room K

MIR @ ECR Session

E3 - Rising Stars Programme

MIR 3

Basic Session 3:

Improving radiology departments Moderators: J.K. Bell; Manchester/UK, P. Mildenberger; Mainz/DE

16:00 A-473 A. Health and wellbeing in the workplace C.L. Cooper; Manchester/UK

Learning Objectives: 1. To assess the costs of poor health and wellbeing at work in personal and organisational outcomes. 2. To explore the workplace stressors that deplete wellbeing at work. 3. To highlight strategies for enhancing wellbeing at work and minimising stress. 16:18 A-474 B. The role of radiology departments in patient-centred care: requirements for improvement R.L. Arenson; San Francisco, CA/US

Learning Objectives: 1. To become familiar with information system tools for radiology to become more patient-centric. 2. To understand the importance of radiologists’ interactions with patients. 3. To appreciate the transformation needed for radiology to adapt to new health systems. 16:36 A-475 C. Key features for organisational and financial sustainability E. Schouman-Claeys; Paris/FR

16:54 A-476 D. Clinically relevant reporting in the era of precision medicine H. Hricak; New York, NY/US

Learning Objectives: 1. To learn about key elements of reporting for precision medicine. 2. To understand the synergy between imaging reports and clinical management. 3. To appreciate how advances in oncology change the requirements for radiology reporting. 4. To become familiar with emerging trends in molecular imaging and theranostics that are impacting the demands on clinical radiology. 17:12

Discussion

www.myESR.org

16:00 A-477 Kidney K. Katsanos, A. Adam; London/UK

16:30 A-478 Liver L. Crocetti; Pisa/IT

17:00 A-479 Bones A. Gangi; Strasbourg/FR

16:00–17:30

Room G

Neuro RC 1211

Cerebrovascular disease Moderator: M. Vernooij; Rotterdam/NL

16:00 A-480 A. Vascular distribution territories: arterial and venous A. Dörfler; Erlangen/DE

Learning Objectives: 1. To become familiar with a comprehensive vascular anatomy of the brain. 2. To understand the advantages and limitations of CTA and MRA. 3. To recognise the different imaging patterns in stroke and their prognostic value. 16:30 A-481 B. Detecting microhaemorrhages: why are they important? What are they? Should we use GRE T2* or SWI or both? H.R. Jäger; London/UK

Learning Objectives: 1. To understand the basic physics of the two sequences. 2. To understand the role of both sequences in stroke and other disorders. 3. To recognise imaging patterns that may mimic stroke clinically and radiologically. 17:00 A-482 C. Cerebral perfusion studies in cerebrovascular disease: techniques, indications and applications P.M. Parizel; Antwerp/BE

Learning Objectives: 1. To understand how imaging can help select patients for treatment of acute ischaemic stroke. 2. To show the importance of collateral flow in ischaemic patients. 3. To explain the actual EBM treating patients with acute ischaemic stroke.

Final Programme | ECR 2016

227

Friday

Learning Objectives: 1. To search for economies of scale, developing closer collaboration and possible merging. 2. To promote comprehensive and customised service offers. 3. To rethink the role of each category of staff and develop collaborative care. 4. To focus on the need for long-term goals and innovative policies. 5. To appreciate that investments on quality systems are a source of direct and indirect income.

Interventional radiology: tumour ablation

Postgraduate Educational Programme

16:00–17:30

Room M 1 17:15

EuroSafe Imaging Session EuroSafe 3 Joint Session of the ESR and HERCA: the new EU-BSS Directive - a step forward to patient safety 16:00 A-483/A-484 Chairmen’s introduction

Discussion: Regulators’ vs practitioners’ perspective: two sides of the same coin

16:00–17:30

E3 - ECR Master Classes (Vascular) E3 1226a

G. Frija1, S. Ebdon-Jackson2; 1Paris/FR, 2Didcot/UK

Session Objectives: 1. To provide information about the radiation protection legislation in Europe. 2. To provide an overview of the revised EU-BSS Directive. 3. To address important new and additional requirements, to provide the status quo of the transposition, and to develop a common understanding. 16:04 A-485 Overview of EU radiation protection legislation J. Griebel; Neuherberg/DE

Learning Objectives: 1. To learn about the radiation protection legislation in Europe. 2. To understand the interrelation with other pieces of EU legislation relevant for medical imaging. 3. To understand the basic framework of the revised EU-BSS Directive with respect to medical exposures. 16:19 A-486 Regulators’ expectations S. Ebdon-Jackson; Didcot/UK

Learning Objectives: 1. To understand the need for meaningful justification of exposures prior to them taking place. 2. To understand the relative roles of the referring physician and the imaging specialist in the justification process for exposures. 3. To appreciate the factors that may require reporting of accidental or unintended events to the regulator when the additional dose to individuals may not be clinically significant. 16:39 A-487 Tools to support implementation of the BSS Directive: ESR perspective G. Frija; Paris/FR

Learning Objectives: 1. To detail the current ESR potential. 2. To highlight the difficulty of the task. 3. To give some proposals. 16:51 A-488 Tools to support implementation of the BSS Directive: medical physicists’ perspective J. Damilakis; Iraklion/GR

Learning Objectives: 1. To learn about the role of the Medical Physics Expert (MPE) in the EU-BSS Directive. 2. To understand the main points of the BSS Directive and their relevance for Medical Physicists. 3. To understand how the EU-BSS may influence European Medical Physicists’ professional lives. 17:03 A-489 Tools to support implementation of the BSS Directive: radiographers’ perspective

Room M 2

Interventional radiology for deep venous thrombosis (DVT): ready for prime time? Moderator: J.I. Bilbao; Pamplona/ES

16:00 A-490 A. Imaging of DVT P. Haage; Wuppertal/DE

Learning Objectives: 1. To learn imaging techniques for diagnostic assessment. 2. To understand the indication and role of each modality. 3. To appreciate how imaging helps therapy planning. 16:30 A-491 B. Declotting in the emergency room: why not? R. de Graaf; Maastricht/NL

Learning Objectives: 1. To learn the latest evidence base for endovascular therapy of DVT. 2. To understand the management of acute DVT in 2016. 3. To appreciate the impact of endovascular therapy. 17:00 A-492 C. Filter indications 2016: new oral anticoagulants and other developments M.J. Lee; Dublin/IE

Learning Objectives: 1. To learn an update on the role of inferior vena cava (IVC) filters in 2016. 2. To understand the criteria for failed medical therapy in 2016. 3. To understand best IVC filter practice. 16:00–17:30

Room M 3

E3 - ECR Master Classes (Paediatric) E3 1226b

Expanding horizons in paediatric imaging Moderator: S. Franchi-Abella; Le Kremlin-Bicêtre/FR

16:00 A-493 A. Elastography in paediatrics M. Anooshiravani-Dumont; Geneva/CH

Learning Objectives: 1. To understand the basic principles. 2. To learn about clinical applications. 3. To discuss limitations and potentials. 16:30 A-494 B. Diffusion-weighted imaging: toy or solution? P.D. Humphries; London/UK

Learning Objectives: 1. To discuss peculiarities of diffusion-weighted acquisition in children. 2. To demonstrate clinical applications. 3. To discuss perspectives and limitations.

C. Vandulek1, S.J. Foley2; 1Kaposvár/HU, 2Dublin/IE

Learning Objectives: 1. To clarify the role of radiographers in the EU-BSS Directive. 2. To understand the challenges of implementation of the Directive at a national level from the radiographers’ perspective. 3. To understand the importance of collaborative actions to enhance the effective implementation of the Directive.

228

ECR 2016 | Final Programme

17:00 A-495 C. Contrast-enhanced ultrasound in children D. Kljucevsek; Ljubljana/SI

Learning Objectives: 1. To discuss safety issues. 2. To demonstrate technique and interpretation of contrast-enhanced voiding cysto-urethro-sonography. 3. To discuss endovascular applications.

www.myESR.org

Postgraduate Educational Programme

16:00–17:30

Room M 4

E3 - ECR Master Classes (Emergency Radiology) E3 1226c

16:20 A-502 Teaching methods’ top tips: how you can capture and maintain your students’ attention C. Nyhsen; Sunderland/UK

Learning Objectives: 1. To appreciate the wide variety of teaching methods available. 2. To learn how to relate these appropriately to the various settings in which radiologists teach. 3. To understand how students’ interest is secured by innovative teaching delivery. 4. To appreciate how learning can be reinforced through quizzes and assessments.

Whole body CT in trauma patients Moderator: H. Alkadhi; Zurich/CH

16:00 A-496 A. Improving the triage: which patients should undergo whole-body CT (WBCT)? D.R. Kool; Nijmegen/NL

Learning Objectives: 1. To appreciate the evidence in the literature concerning the benefits of WBCT in trauma. 2. To become aware of the disadvantage of WBCT in trauma patients. 3. To become familiar with the literature concerning the evidence-based selection of patients who will or will not benefit from CT.

16:35 A-503 Online resources: how to find the best case material and tutorials for your medical students P. Pokieser; Vienna/AT

Learning Objectives: 1. To appreciate which freely available online resources exist. 2. To learn how online resources can be used in daily teaching. 3. To learn how e-learning resources can be created locally to make the best use of teaching time and resources.

16:30 A-497 B. How can we improve our WBCT protocol? B. Leidner; Ekerö/SE

Learning Objectives: 1. To become familiar with the evidence in literature concerning the optimal scan protocol in trauma patients in regard to necessary scan phases and contrast media protocols. 2. To appreciate the importance of radiation dose in patients undergoing WBCT. 3. To become familiar with the possibilities of radiation dose reduction in WBCT.

16:50 A-504 Using social media for undergraduate education: this generation’s communication N. Pyatigorskaya; Paris/FR

Learning Objectives: 1. To be aware of the use of social media as e-learning tools. 2. To understand how to use media such as Facebook and Twitter to keep abreast of learning trends and developments. 3. To understand how to follow social media accounts, by demonstration.

17:00 A-498 C. Optimising the value of radiologists in trauma care K.H. Nieboer; Brussels/BE

16:00–17:30

17:05

Panel discussion: Teaching the undergraduate: in what ways is this similar to teaching radiology to other groups and in what ways does it differ?

Room M 5

Professional Challenges Session PC 12b

How to become the undergraduate teacher you always wanted to be

16:00 A-499/A-500 Chairmen’s introduction S.J. Golding1, M. Maas2; 1Oxford/UK, 2Amsterdam/NL

Session Objectives: 1. To understand how radiology teaching needs to be modified to suit the undergraduate. 2. To understand how undergraduates’ interest is enhanced by appropriate learning objectives and novel delivery methods. 3. To appreciate how undergraduate study embraces modern media. 16:05 A-501 The undergraduate curriculum: how to get the balance right B. Ertl-Wagner; Munich/DE

Learning Objectives: 1. To understand that undergraduate learning is directed to what they need to know. 2. To understand how learning objectives are defined to support learning. 3. To learn the role of defining appropriate curricula in teaching undergraduates.

www.myESR.org

Final Programme | ECR 2016

229

Friday

Learning Objectives: 1. To become familiar with the surgeons’ need for fast and accurate information on imaging findings in trauma patients. 2. To recognise imaging findings that influence management decisions in trauma patients. 3. To optimise the timely communication of imaging findings in relation to patient management priorities.

Postgraduate Educational Programme

230

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

08:30–10:00 Room A

08:30–10:00 Room C

E3 - ECR Academies: Interactive Teaching Sessions

E3 - ECR Academies: Modern Imaging in Colorectal Cancer

E3 1321

E3 1318

MR imaging in sports medicine I

08:30 A-505 A. Muscle injury in sports M.G. Mack; Munich/DE

Learning Objectives: 1. To understand the anatomy of the most common injured muscles. 2. To learn the evaluation of muscle injuries and the impact regarding recovery. 09:15 A-506 B. Knee trauma M.O. De Maeseneer; Brussels/BE

Learning Objectives: 1. To learn the anatomy of the most common injured structures. 2. To recognise typical combinations of injuries. 08:30–10:00 Room B

Abdominal Viscera RC 1301

IgG4-related disease: what is it and what do I need to know?

08:30 A-507 Chairman’s introduction S.A. Jackson; Plymouth/UK

Session Objective: 1. To briefly introduce this multi facet disorders that may involve several organs and represent a diagnostic challenge. 08:35 A-508 A. Pancreatic manifestations

Colon cancer: staging and restaging of local disease Moderator: P. Lefere; Roeselare/BE

08:30 A-511 A. Computed tomography for staging E. Rollven; Stockholm/SE

Learning Objectives: 1. To understand the rationale behind local staging of colon cancer. 2. To learn how to assess and report imaging findings. 3. To become familiar with assessment challenges. 09:00 A-512 B. Imaging for restaging after neoadjuvant treatment M. Maas; Maastricht/NL

Learning Objectives: 1. To understand the rationale behind local restaging of colon cancer. 2. To learn how to assess and report imaging findings. 3. To become familiar with assessment challenges. 09:30 A-513 C. Assessment of vasculature prior to laparoscopic resection A. Laghi; Latina/IT

Learning Objectives: 1. To understand CT protocols for angiography. 2. To understand colon vascular anatomy and variants. 3. To learn about radiological demonstration of surgically relevant findings. 08:30–10:00 Room Z

Special Focus Session

R. Pozzi-Mucelli; Verona/IT

08:58 A-509 B. Hepatobiliary manifestations M. Ronot; Clichy/FR

Learning Objectives: 1. To describe clinical, biological presentation and morphological and functional imaging findings for the diagnosis of IgG4-related cholangitis. 2. To discuss the role of imaging to avoid unnecessary invasive diagnostic and/or therapeutic procedures. 3. To discuss the diagnostic criteria to differentiate IgG4-related cholangitis from other causes of cholangitis and biliary cancer. 09:21 A-510 C. Systemic manifestations G. Morana; Treviso/IT

Learning Objectives: 1. To describe extra-pancreatic and extra-biliary manifestation of IgG4related disease. 2. To describe the imaging findings of the most common extrapancreatic and extra-biliary organ involvement. 3. To discuss the role of “whole body” imaging modality for the diagnosis and the follow up of IgG4-related systemic disease.

SF 13a

MR/PET: role in oncology

08:30 A-514 Chairman’s introduction G. Cook; London/UK

Session Objectives: 1. To understand the principles of MR/PET in oncological imaging. 2. To understand the strengths and weaknesses of MR/PET in oncological applications. 3. To understand the level of evidence existing for the clinical use of MR/PET in head and neck, prostate and GI cancers.

Saturday

Learning Objectives: 1. To describe clinical and biological presentation of IgG4-related pancreatitis. 2. To describe morphological and functional (DWI, PET/CT, etc.) imaging features of IgG4-related pancreatitis. 3. To identify imaging findings for the differential diagnosis with other solid pancreatic lesions, i.e. pancreatic cancer, and to avoid unnecessary invasive therapeutic procedures.

08:32 A-515 Principles and possibilities of MR/PET A. Kjaer; Copenhagen/DK

Learning Objectives: 1. To understand the principles of MR/PET in oncological imaging. 2. To understand the strengths and weaknesses of MR/PET in oncological applications. 3. To understand possible future oncological applications of MR/PET. 08:52 A-516 MR/PET: imaging head and neck cancer S. Bisdas; London/UK

Learning Objectives: 1. To understand the strengths and weaknesses of MR/PET in head and neck cancer imaging. 2. To understand the level of evidence existing for the clinical use of MR/PET in head and neck cancer. 3. To understand possible future applications of MR/PET in head and neck cancer.

Panel discussion: 09:44 Tips and tricks in clinical practice

www.myESR.org

Final Programme | ECR 2016

231

Postgraduate Educational Programme

09:12 A-517 MR/PET: imaging prostate cancer A.J. Beer; Ulm/DE

Learning Objectives: 1. To understand the strengths and weaknesses of MR/PET in prostate cancer imaging. 2. To understand the level of evidence existing for the clinical use of MR/PET in prostate cancer. 3. To understand possible future applications of MR/PET in prostate cancer. 09:32 A-518 MR/PET: imaging of GI cancer V.J. Goh; London/UK

Learning Objectives: 1. To understand the strengths and weaknesses of MR/PET in GI cancer. 2. To understand the level of evidence existing for the clinical use of MR/PET in GI cancers. 3. To understand possible future applications of MR/PET in GI cancer. Panel discussion: 09:52 Which clinical indications have enough evidence for routine MR/PET rather than PET/CT?

08:30–10:00 Room O

Paediatric RC 1312

Imaging children with cancer

08:30–10:00 Room N

Head and Neck RC 1308

Pitfalls in interpretation of head and neck disease Moderator: J. Frühwald-Pallamar; Vienna/AT

08:30 A-522 A. Anatomical variants without clinical consequence F.A. Pameijer; Utrecht/NL

Learning Objectives: 1. To gain insight into the great variability of head and neck anatomy. 2. To be able to recognise pseudolesions. 09:00 A-523 B. Anatomical variants posing surgical risks D. Farina; Brescia/IT

Learning Objectives: 1. To learn about structures at risk during functional endoscopic sinus surgery (FESS). 2. To become familiar with vascular variants in the head and neck. 3. To appreciate surgical anatomical landmarks in the head and neck. 09:30 A-524 C. Distinct head and neck disease or systemic disease? B.F. Schuknecht; Zurich/CH

Learning Objectives: 1. To recognise head and neck manifestations of systemic disease. 2. To categorise lesions into different pathologic entities.

Moderator: P. Tomà; Rome/IT

08:30 A-519 A. Imaging of abdominal masses at diagnosis: clues for benignity vs malignancy A.M.J.B. Smets; Amsterdam/NL

Learning Objectives: 1. To become familiar with clinical characteristics and imaging features of a mass suggesting benignity. 2. To emphasise clinical and imaging manifestations of abdominal malignancies. 3. To learn how to report according to international standards. 09:00 A-520 B. From whole body MRI to MR/PET J. Schäfer; Tübingen/DE

Learning Objectives: 1. To understand differences and pitfalls of whole body MRI and MR/ PET in children compared to adults. 2. To compare MR/PET to PET/CT. 3. To discuss the impact of whole body MRI and MR/PET. 09:30 A-521 C. Imaging of complications of therapy K. McHugh; London/UK

Learning Objectives: 1. To become familiar with short- and long-term complications of therapy. 2. To understand complications of surgery, radiotherapy and drug toxicity. 3. To emphasise the effects of immunosuppression in children undergoing chemotherapy.

232

ECR 2016 | Final Programme

08:30–10:00 Studio 2016

Genitourinary RC 1307

Lessons I learned from mistakes in kidney and adrenal imaging

08:30 A-525 Chairman’s introduction S. Dudea; Cluj-Napoca/RO

Session Objectives: 1. To understand RECIST criteria of kidney tumours in light of molecular medicine and functional imaging. 2. To learn about pitfalls and challenges in kidney and adrenal imaging. 08:35 A-526 A. Renal cancer T. Bäuerle; Erlangen/DE

Learning Objectives: 1. To differentiate the most relevant subtypes of renal cell carcinoma using morphologic and functional imaging techniques. 2. To learn about multiparametric CT and MRI methods for discriminate (fat-poor) angiomyolipoma and renal cell carcinoma. 3. To become familiar with the management of complex cysts. 08:58 A-527 B. PET/CT in nephrourology P.A.T. Baltzer; Vienna/AT

Learning Objectives: 1. To become familiar with appropriate use of PET/CT method in pathological entities of nephrourology. 2. To learn about the basic and advanced imaging findings of PET/CT in nephrourology. 3. To become familiar with the common sources of mistakes in PET/CT in the area of nephrourology.

www.myESR.org

Postgraduate Educational Programme

09:21 A-528 C. Common mistakes in tumour percutaneous radiofrequency ablation

09:25 A-534 Satisfaction assessment of patient users of an imaging department: an example from the south of France

J.-M. Correas, C. Delavaud, O. Hélénon; Paris/FR

D.-G. Carrié; Toulouse/FR

Learning Objectives: 1. To describe adrenal and renal ablation techniques to avoid mistakes. 2. To learn what to look for before and during ablation to avoid mistakes. 3. To learn what to look for after adrenal and renal ablation to detect mistakes.

Learning Objectives: 1. To present our experience of satisfaction assessment of patients of a medical imaging department, over a period of 8 years. 2. To show that this kind of regularly practised feedback evaluation allows us to identify possible failures, alert the medical and paramedical staff, and to try to remedy them in an appropriate way. 3. To show that the implementation of this kind of questionnaire is simple and allows us to refocus our practices around the expectations of our patients.

Panel discussion: 09:44 How to manage small lesions of the kidneys incidentally detected in abdominal imaging

08:30–10:00 Room L8

Panel discussion: 09:40 Question to the audience: does your department perform well in patient-centred care? Is it really all about the patient?

ESR Patient Advisory Group (ESR-PAG) ESR-PAG 1 Patient-centred care in clinical radiology: do we really put our patients first? 08:30 A-529 Chairmen’s introduction N. Bedlington1, P. Cavanagh2; 1Vienna/AT, 2Taunton/UK

Session Objectives: 1. To follow up on the introduction of the ‘driver diagram’, a framework for delivering patient-centred care in radiology, presented during the ECR 2015. 2. To explore concrete examples of best practice of implementing patient-centred care in the radiology department and how these might be replicated. 3. To understand how the ESR is embedding patient-centred care in audit and standards. 08:40 A-531 Implementing the ‘driver diagram’ on patient-centred care P. Cavanagh; Taunton/UK

08:55 A-532 View of a patient representative from the neurological disease area D. Walsh; Dublin/IE

Learning Objectives: 1. To learn how implementing the ‘driver diagram’ can help the radiology department to become really patient-centred but that they could use some help from the same patients to reach their objectives. 2. To learn that implementing the diver diagram in their department will be a step-by-step process that can be monitored by patients. 09:10 A-533 View of a patient with prostate cancer E. Briers; Hasselt/BE

Learning Objectives: 1. To understand that procedures as from the implementation of the ‘driver diagram’ should become a continuous process of quality improvement. 2. To understand that implementing the ‘driver diagram’ will sometimes require a change of attitude and personal perspective to bring the patient to the forefront instead of the radiology procedures.

www.myESR.org

Special Focus Session SF 13b

Cholangiocarcinoma: an update

08:30 A-535 Chairman’s introduction R. Manfredi; Verona/IT

Session Objectives: 1. To illustrate diagnostic imaging findings of cholangiocarcinoma helpful in the diagnosis and in the differential diagnosis of cholangiocarcinoma. 2. To illustrate diagnostic imaging findings helpful for treatment planning. 3. To understand indication and technique of interventional radiology for palliative treatment. 08:35 A-536 Classification of cholangiocellular carcinoma (CCC) C. Cantwell; Dublin/IE

Learning Objectives: 1. To illustrate classification of cholangiocellular carcinoma. 2. To become familiar with available therapeutic options according to the type of cholangiocarcinoma. 3. To become familiar with prognostic implication according to the type of cholangiocarcinoma. 08:50 A-537 Imaging in mass-forming intrahepatic (IH) type F. Caseiro-Alves; Coimbra/PT

Learning Objectives: 1. To illustrate diagnostic imaging findings of mass forming cholangiocarcinoma. 2. To learn about diagnostic imaging findings useful for the differential diagnosis of cholangiocarcinoma. 3. To learn the surgical landmarks helpful in treatment planning. 09:05 A-538 Diagnostic assessment of periductal/infiltrating and intraductal-growing types: the view of the diagnostic radiologist R. Kloeckner; Mainz/DE

Learning Objectives: 1. To illustrate diagnostic imaging findings of periductal/infiltrating and intraductal-growing types of cholangiocarcinoma. 2. To learn about diagnostic imaging findings useful for the differential diagnosis of cholangiocarcinoma. 3. To learn the surgical landmarks helpful in treatment planning.

Final Programme | ECR 2016

233

Saturday

Learning Objectives: 1. To explore the implementation of the driver diagram for delivering patient-centred care in radiology. 2. To understand the need for balance between professional responsibility and patient autonomy. 3. To become familiar with methods and examples of good practice and on how to improve the patient-doctor relationship.

08:30–10:00 Room E1

Postgraduate Educational Programme

09:20 A-539 Diagnostic assessment of periductal/infiltrating and intraductal-growing types: the view of the interventional radiologist S. Terraz; Geneva/CH

Learning Objectives: 1. To illustrate diagnostic imaging findings of periductal/infiltrating and intraductal-growing types of cholangiocarcinoma. 2. To learn about diagnostic imaging findings useful for the differential diagnosis of cholangiocarcinoma. 3. To illustrate criteria useful for planning a radiological interventional procedure. 09:35 A-540 Therapeutic role of interventional radiology in unresectable patients G. Carrafiello; Varese/IT

Learning Objectives: 1. To illustrate diagnostic imaging findings of periductal/infiltrating and intraductal-growing types of cholangiocarcinoma. 2. To learn about diagnostic imaging findings useful for the differential diagnosis of cholangiocarcinoma. 3. To illustrate criteria useful for planning a radiological interventional procedure. Panel discussion: 09:50 Can we improve diagnosis and treatment of cholangiocarcinoma?

08:30–10:00 Room E2

Special Focus Session SF 13c

Non-alcoholic fatty liver disease (NAFLD)

08:30 A-541 Chairman’s introduction: Defining the clinical problem C. Bartolozzi; Pisa/IT

Session Objectives: 1. To learn about the clinical relevance of NAFLD and potential evolution towards NASH. 2. To become familiar with the role of imaging modalities in the detection and quantification of the different pathological elements. 3. To understand the incidence/risk of HCC development and its early detection. 08:35 A-542 Imaging in diagnosing and quantifying liver fat V. Vilgrain, M. Ronot, A. Faccinato, B. Leporcq, B.E. Van Beers; Clichy/FR

Learning Objectives: 1. To understand the respective value of imaging modalities in diagnosing liver steatosis. 2. To become familiar with the most recent MR sequences for quantifying liver steatosis. 3. To learn the results and limitations of detecting NASH through imaging. 09:00 A-543 Imaging in diagnosing and staging liver fibrosis L. Martí-Bonmatí; Valencia/ES

Learning Objectives: 1. To understand the biological background, clinical importance and therapeutic implications of early detection of liver fibrosis. 2. To discuss the current status of quantitative imaging evaluation of liver fibrosis. 3. To summarise new and future prospects for novel imaging tools for the qualitative assessment of fibrosis.

234

ECR 2016 | Final Programme

09:25 A-544 Early detection of HCC T. Denecke; Berlin/DE

Learning Objectives: 1. To learn about the potential and technical prerequisites of the available imaging techniques for early detection of HCC. 2. To become familiar with the appearance of HCC and its precursors in diagnostic imaging. 3. To get an overview of the current recommendations and guidelines for early detection of HCC. Panel discussion: 09:50 How to manage the surveillance of the population at risk

08:30–10:00 Room F1

E3 - European Diploma Prep Sessions E3 1323

Cardiac and vascular

08:30 A-545 Chairman’s introduction R. Vliegenthart; Groningen/NL

Session Objectives: 1. To understand the basic principles and techniques of cardiovascular imaging including CT and MRI of the heart and great vessels. 2. To become familiar with the imaging presentations of disorders of the endocardium, the pericardium and the cardiac valves. 3. To understand the MR imaging presentation of disorders of the myocardium. 08:33 A-546 A. Cardiovascular imaging: the basics M. Gutberlet; Leipzig/DE

Learning Objectives: 1. To understand the anatomy, normal variants and abnormalities of the heart and great vessels. 2. To describe the technical aspects and methodology of cardiac and vascular CT. 3. To describe the technical aspects and methodology of cardiac and vascular MRI. 09:02 A-547 B. Cardiovascular imaging: valves, endocardium and aorta C. Loewe; Vienna/AT

Learning Objectives: 1. To recognise the imaging presentation of the different forms of valvular disease. 2. To understand the causes and imaging presentations of endocarditis. 3. To describe the diagnostic evaluation and imaging presentation of common diseases of the great vessels, including aortic dissection and aneurysms. 09:31 A-548 C. Cardiovascular imaging: myocardium and pericardium J. Bogaert; Leuven/BE

Learning Objectives: 1. To describe the diagnostic evaluation and imaging presentation of ischaemic heart disease. 2. To understand the diagnostic evaluation and imaging presentation of myocarditis. 3. To become familiar with the causes and imaging presentations of pericardial effusion.

www.myESR.org

Postgraduate Educational Programme

08:30–10:00 Room F2

Breast

08:54 A-554 Where is the proper place for fast FAST (focused assessment with sonography for trauma)? H. Alkadhi; Zurich/CH

RC 1302

Tailoring breast cancer screening to risk level

Learning Objectives: 1. To understand the role of emergency ultrasound. 2. To become familiar with indications and protocol of FAST examination. 3. To learn about typical, alert findings.

Moderator: R. Pijnappel; Utrecht/NL

08:30 A-549 A. Calculating, using and improving individual risk estimates S.W. Duffy; London/UK

09:13 A-555 Missed lesions in trauma patients: the Damocles’ sword R. Basilico; Chieti/IT

Learning Objectives: 1. To know the different models for risk evaluation. 2. To understand the limitations of risk modelling for predicting the individual risk. 3. To appreciate the potential applications of risk modelling for tailoring breast cancer screening. 09:00 A-550 B. Intermediate risk: the grey zone S.H. Heywang-Köbrunner; Munich/DE

Learning Objectives: 1. To become familiar with limitations in emergency imaging. 2. To learn about the most common fatal missed injuries in polytrauma patients. 3. To understand the methods for avoiding misdiagnosis in polytrauma imaging. 09:32 A-556 Geriatric trauma: what is different? E. Dick; London/UK

Learning Objectives: 1. To become familiar with the concept of increased breast cancer risk. 2. To discuss the role of breast density in relation to cancer risk. 3. To evaluate the evidence in favour of intensive screening protocols in women at intermediate risk.

Learning Objectives: 1. To become familiar with limitations in emergency imaging. 2. To learn about the most common fatal missed injuries in polytrauma patients. 3. To understand the methods for avoiding misdiagnosis in polytrauma imaging.

09:30 A-551 C. High risk: MRI alone? F. Sardanelli; San Donato Milanese/IT

Learning Objectives: 1. To appreciate the evidence in favour of MRI for screening high-risk women in terms of diagnostic performance and patient outcome. 2. To become aware of the value of MRI alone for screening women with high-risk genes. 3. To become aware of the need for using mammography as an adjunct to MRI when screening women who have had previous thoracic radiation therapy.

09:51

Panel discussion: How is the role of the radiologist changing in the management of trauma patients?

08:30–10:00 Room D2

Radiographers RC 1314

Enhancing research in radiography: a change of culture

08:30–10:00 Room D1

Special Focus Session

08:30 A-557/A-558 Chairmen’s introduction J. McNulty1, I.M. Björkman-Burtscher2; 1Dublin/IE, 2Lund/SE

SF 13d

08:30 A-552 Chairman’s introduction M. Stajgis; Poznan/PL

Session Objectives: 1. To understand the impact of modern diagnostic imaging on management of trauma patients. 2. To become familiar with limitations in emergency imaging in different clinical settings. 3. To recognise the position of the radiologist in the polytrauma emergency team. 08:35 A-553 ‘When time is gold’: whole-body CT in polytrauma patients S. Wirth; Munich/DE

Learning Objectives: 1. To understand the impact of imaging findings on patient management. 2. To learn the accepted protocols in polytrauma CT imaging. 3. To become familiar with the most common typical and atypical imaging findings.

www.myESR.org

Session Objectives: 1. To offer recent updates on radiography research initiatives on a European level. 2. To discuss the use of a formal mentoring scheme in improving radiography research capacity. 3. To propose methods for improving evidence-based practice in radiography.

Saturday

Severe trauma patients: myths, realities and future

08:35 A-559 A. Radiography research updates: new collaborations and initiatives in Europe J. McNulty; Dublin/IE

Learning Objectives: 1. To appreciate the importance and necessity of evidence-based practice. 2. To outline the potential for research collaborations between radiographers both nationally and at European level to broaden the evidence base and enhance the reputation of the profession. 3. To identify practical measures for developing new collaborations and initiatives, using current examples from Europe and beyond.

Final Programme | ECR 2016

235

Postgraduate Educational Programme

08:58 A-560 B. FoRRM: a Formal Radiography Research Mentorship scheme as an instrument for change

09:00 A-566 B. Don’t forget the facet joints and posterior elements L. van den Hauwe, J.W. Van Goethem, M. Faure, T. Van Den Wyngaert, J. Huyskens, F. De Belder, C. Venstermans, P.M. Parizel; Antwerp/BE

C. Malamateniou; London/UK

Learning Objectives: 1. To understand the importance of research in developing the radiography profession. 2. To become familiar with research mentorship schemes as a method of disseminating knowledge, enhancing research capacity and quality and informing evidence based practice. 3. To discuss the practicalities, challenges and opportunities emerging from a dedicated national formal radiography research mentorship scheme in the UK and its feasibility and potential in a European perspective.

Learning Objectives: 1. To become familiar with the anatomy of the facet joints and the posterior elements. 2. To understand the pathophysiological principle underlying the degenerative changes of these structures. 3. To appreciate the effect of these changes on the therapeutic approach. 09:30 A-567 C. What to say and not to say in your report M.M. Thurnher; Vienna/AT

Learning Objectives: 1. To understand the legal value of a report. 2. To demonstrate how detailed a report should be. 3. To understand the importance of a clinical information and the relevance of assessing previous examinations.

09:21 A-561 C. Translating research evidence into clinical practice G. Paulo; Coimbra/PT

Learning Objectives: 1. To learn about the barriers and enablers to translating research evidence into clinical practice. 2. To provide guidance on how radiographers can lead change and ensure best practices are in place. 3. To be aware of useful tools for collaboration and dissemination of research evidence (e.g. EFRS Radiography Research Network). Panel discussion: 09:44 Research: the key to advancing the profession of radiography?

08:30–10:00 Room K

10:30–12:00

E3 - ECR Academies: Interactive Teaching Sessions E3 1421

D. Farina; Brescia/IT

Learning Objectives: 1. To understand the anatomy. 2. To understand the most common lesions and their differential diagnosis.

Musculoskeletal: trauma

08:30 A-562 Shoulder M. Zanetti; Zurich/CH

Skull base lesions

10:30 A-568 A. Imaging of the cavernous sinus and the anterior skull base

E3 - Rising Stars Programme Basic Session 4:

Room A

11:15 A-569 B. Imaging of the central skull base D.-A. Varoquaux; Marseille/FR

Learning Objectives: 1. To understand the anatomy. 2. To understand the most common lesions and their differential diagnosis.

09:00 A-563 Knee K. Verstraete; Ghent/BE

09:30 A-564 Ankle J. Kramer; Linz/AT

10:30–12:00

Room B

ESR meets Japan 08:30–10:00 Room G

Neuro RC 1311

EM 2

State-of-the-art radiology Welcome by the ESR President: L. Donoso; Barcelona/ES

Reporting the degenerative lumbar spine

Presiding: K. Riklund; Umea/SE H. Honda; Fukuoka/JP

Moderator: D. Zlatareva; Plovdiv/BG

08:30 A-565 A. Disc nomenclature: how I make my report J. Rankine; Leeds/UK

Learning Objectives: 1. To become familiar with the different nomenclatures in degenerative disc disease and their anatomic substrates. 2. To learn how to differentiate between the different types of disc disease. 3. To appreciate how the different types of degenerative disc diseases determine the therapeutic approach.

10:30 A-570 Introduction: Radiology today in Japan H. Honda; Fukuoka/JP

Learning Objectives: 1. To learn about the organisation of radiology in Japan. 2. To review the up-to-date radiology in neuro, chest, and abdomen. 3. To learn about Japanese radiology and culture through photographs. 4. To express appreciation to the ESR for inviting Japan to meet the ESR. 10:35 A-571 State-of-the-art of neuroimaging S. Aoki; Tokyo/JP

Learning Objectives: 1. To have an overview of recent techniques of neuroimaging. 2. To learn about differential diagnoses of DWI abnormalities. 3. To learn fundamentals of advanced diffusion analysis beyond DTI.

236

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

10:55 A-572 Interlude: Radiologists’ intermission: refreshing photostream on our beautiful country (I)

11:30 A-578 Intestinal ischaemia: key points for the radiologist R. Grassi; Naples/IT

Learning Objectives: 1. To understand that mesenteric ischaemia is not an isolated clinical entity, but a complex of diseases that includes occlusive forms, nonocclusive forms and reperfusion damage after ischaemia. 2. To appreciate that radiological findings vary widely according to the underlying pathophysiology and the phase of damage, even if in some conditions they can overlap showing similar features. 3. To become familiar with radiological findings that may help to distinguish between the different forms of ischaemia, since a correct and early etiological diagnosis is crucial to plan the therapeutic approaches.

Y. Miki; Osaka/JP

11:00 A-573 Advanced liver imaging: improving treatment decisions T. Murakami; Osaka/JP

Learning Objectives: 1. To learn about the advanced liver imaging techniques. 2. To understand how to use multimodality fusion imaging of US, CT and MRI for treatment of liver tumour. 3. To become familiar with advanced liver imaging of US, CT and MRI. 11:20 A-574 Interlude: Radiologists’ intermission: refreshing photostream on our beautiful country (II) T. Taoka; Nagoya/JP

11:25 A-575 Diagnostic imaging of thymic tumours

10:30–12:00

Room N

Computer Applications RC 1405

Will the good old PACS disappear?

N. Tomiyama; Osaka/JP

Learning Objectives: 1. To become familiar with major types of thymic tumours and WHO histological classification of thymoma. 2. To learn about imaging findings of thymic tumours including CT, MRI, and PET. 3. To understand how to use CT, MRI, and PET in the diagnosis of thymic tumours. Panel discussion: Always be a pioneer: state-of-the-art technologies from Japan

11:45

10:30 A-579 Chairman’s introduction D. Regge; Turin/IT

Session Objectives: 1. To explain when and how to replace PACS. 2. To provide insight on how to improve interconnectivity and information sharing in medicine. 3. To envisage the role of off-site archiving solutions in radiology. 10:35 A-580 A. It’s time for PACS replacement: how-to guide, recommendations and pitfalls S. Morozov; Moscow/RU

10:30–12:00

Room O

Learning Objectives: 1. To explain why and when PACS should be replaced. 2. To provide recommendations for PACS replacement and risk assessment analysis including image migration issues. 3. To give a practical example of how PACS is replaced in a large health facility or region.

RTF - Radiology Trainees Forum TF 1

Highlighted Lectures Moderators: M. Basta-Nikolic; Novi Sad/RS, D. Berritto; Naples/IT

10:30 A-576 Imaging of prostate cancer

10:58 A-581 B. Enterprise-based vendor-neutral archiving: is this the future of PACS? J. Fernandez-Bayó; Sabadell/ES

Learning Objectives: 1. To learn about imaging modalities used for the detection of prostate cancer, as well as imaging-guided procedures used for its histopathological verification. 2. To become familiar with current protocols and ways of performing these examinations. 3. To learn the typical presentation of prostate cancer on different imaging modalities, together with the most common differential diagnoses.4. To point out pearls and pitfalls of prostate cancer imaging.

Learning Objectives: 1. To provide a definition of vendor-neutral archiving and describe its key features. 2. To discuss the role of vendor-neutral archiving in archiving and sharing information from different medical specialties. 3. To describe hurdles along the path to fully implementing enterprise bases’ vendor-neutral archiving systems. 11:21 A-582 C. Does PACS into the cloud means PACS evaporates? J. Schillebeeckx; Knokke/BE

Learning Objectives: 1. To explain the concept of cloud archiving and its advantages. 2. To address limitations and risks of cloud PACS solutions. 3. To give insight on future developments of cloud technology.

11:00 A-577 Rectal cancer: tips for a better staging L. Curvo-Semedo; Coimbra/PT

Learning Objectives: 1. To understand how to perform an optimal MR examination for staging rectal cancer with emphasis on the most important technical issues. 2. To become familiar with the main difficulties in diagnosis and staging of rectal cancer, and to understand the role of MRI in solving them. 3. To learn about the added value of functional imaging modalities in rectal cancer staging. 4. To understand how to report primary staging MR imaging findings.

www.myESR.org

11:44

Panel discussion: How will increased interconnection affect radiologists’ day-to-day life?

Final Programme | ECR 2016

237

Saturday

S. Stojanovic; Novi Sad/RS

Postgraduate Educational Programme

10:30–12:00

Room L8

10:30–12:00

Room F1

ESR Patient Advisory Group (ESR-PAG)

E3 - European Diploma Prep Sessions

ESR-PAG 2 Mind the gap - data-sharing for better patient outcomes - the key issues for patients and the radiology community

E3 1423

10:30 A-583/A-584 Chairmen’s introduction N. Bedlington1, B. Brkljačić2; 1Vienna/AT, 2Zagreb/HR

Session Objectives: 1. To understand the importance of eHealth and interoperability, particularly in the era of big data, etc. 2. To understand the legal challenges and issues with regards to data protection and the patient’s perspective. 3. To learn how the proposed data protection legislation potentially affects health research. 10:40 A-585 eHealth, EHR and data protection: friend or foe? P. Mildenberger; Mainz/DE

Learning Objectives: 1. To learn about different concepts and implementations of eHealthSolutions throughout Europe. 2. To appreciate advantages and opportunities of data-sharing. 3. To understand risks of EHR & eHealth and learn how IT and legislation could help. 10:55 A-586 View of a patient representative from the Pelvic Pain Support Network J. Birch; Poole/UK

Learning Objectives: 1. To understand the key concerns for patients. 2. To explore whether the needs of patients can be reconciled with those of radiologists and researchers. 11:10 A-587 View of a patient with prostate cancer E. Briers; Hasselt/BE

Learning Objectives: 1. To understand that the outcome for a patient depends on the collaboration and data sharing between all the medical professionals that are taking care of the patient. 2. To explore that diagnostic data become more relevant and important both for patients (future patients) and clinicians if diagnostic data are linked to the outcome data to allow clinicians to improve the diagnostic questions in relation to a given disease-pathology. 3. To understand that patients are willing to share their data and images to improve the fate of future patients, especially for patients suffering from serious life threatening diseases like cancer. 11:25 A-588 Big data in radiology: how will it enhance personalised medicine? H.-U. Kauczor; Heidelberg/DE

Learning Objectives: 1. To understand the main features of personalised medicine. 2. To appreciate the value of imaging biomarkers for personalised medicine. 3. To learn how to exploit big data in radiology.

11:40

Panel discussion: Big data = big issues?

Head and neck

10:30 A-589 Chairman’s introduction M.G. Mack; Munich/DE

Session Objectives: 1. To become familiar with the anatomy and imaging presentation of the most common disorders of the temporal bone and skull base. 2. To understand the imaging presentation of common inflammatory and neoplastic disorders of the nose, paranasal sinuses and nasopharynx. 3. To describe the typical imaging features of the most common neoplastic disorders of the oral cavity, oropharynx, hypopharynx and larynx. 10:33 A-590 A. Temporal bone and skull base A. Trojanowska; Lublin/PL

Learning Objectives: 1. To differentiate the anatomy, normal variants and congenital disorders of the temporal bone. 2. To understand the causes and imaging features of hearing and vestibular disorders. 3. To describe the imaging presentation of the most common tumours of the skull base. 11:02 A-591 B. Nose, paranasal sinuses and nasopharynx C. Czerny; Vienna/AT

Learning Objectives: 1. To describe the anatomy and normal variants of the nose, paranasal sinuses and nasopharynx. 2. To differentiate the imaging features of acute and chronic inflammatory changes of the nose and paranasal sinuses. 3. To understand the imaging features of benign and malignant tumours of the nose, paranasal sinuses and nasopharynx. 11:31 A-592 C. Oral cavity, oro- and hypopharynx and larynx M. Becker; Geneva/CH

Learning Objectives: 1. To describe the normal imaging anatomy of the oral cavity, oropharynx, hypopharynx and larynx. 2. To understand the imaging features of tumours of the oral cavity and oropharynx. 3. To describe the imaging features of tumours of the hypopharynx. 4. To understand the imaging features of tumours of the larynx. 10:30–12:00

Room K

E3 - Rising Stars Programme Basic Session 5:

Neuroradiology: spine

10:30 A-593 Anatomy and congenital disorders A. Rossi; Genoa/IT

11:00 A-594 Tumours M.M. Thurnher; Vienna/AT

11:30 A-595 Degenerative disease of the spine M. Sasiadek; Wroclaw/PL

238

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

12:15–12:45

Room A

13:30–15:30

Room Z

Plenary Session

EIBIR Session

HL 3

EIBIR 4

Sven-Ivar Seldinger Honorary Lecture Presiding: K. Riklund; Umeå/SE

12:15 A-596 Imaging and micronavigation: time to redraw the map? S. Holmin; Stockholm/SE

12:30–13:30

Room B

E3 - The Beauty of Basic Knowledge: Breast Imaging E3 24D

Ductal carcinoma in situ (DCIS): small tumour but big problem Moderator: J. Camps Herrero; Valencia/ES

12:30 A-597 Ductal carcinoma in situ (DCIS): small tumour but big problem G. Forrai; Budapest/HU

Learning Objectives: 1. To understand the differences between DCIS and invasive ductal carcinoma (IDC) in terms of pathology and imaging and the clinical implications thereof. 2. To learn the semiologic gamut of DCIS in the different techniques. 3. To know how to stage DCIS. 12:30–13:30

Room D1

E3 - The Beauty of Basic Knowledge: Chest Imaging E3 25D

Measurements in chest radiology Moderator: N. Howarth; Chêne-Bougeries/CH

12:30 A-598 A. Heart and great vessels: how, why, when? Learning Objectives: 1. To review the most useful measurements on cross-sectional imaging of the heart and great vessels. 2. To learn how to accurately perform these measurements. 3. To know when the measurements are of clinical importance. 13:00 A-599 B. Lung nodules: is volume better than size? M. Prokop; Nijmegen/NL

Learning Objectives: 1. To review the management of pulmonary nodules seen on CT. 2. To learn how to accurately perform the measurement of nodule volume and size. 3. To know the limitations of the lung nodule measurement.

www.myESR.org

Moderator: Z.A. Taylor; Sheffield/UK

13:30 A-600 VPH-DARE@IT: towards early, differential diagnosis of dementia A. Frangi; Barcelona/ES

Learning Objectives: 1. To learn about the objectives of this major European collaborative project. 2. To understand how this project will enable earlier diagnosis of dementia and improve our understanding of it. 13:40 A-601 Clinical platform for data-driven differential diagnostics of cognitive disorders M. van Gils, J. Mattila, J. Lötjönen, T. Urhemaa, A. Umer, A. Tolonen, J. Koikkalainen; Tampere/FI

Learning Objectives: 1. To appreciate the challenge of developing a clinical support platform for cognitive disorders. 2. To learn about the clinical decision support platform being developed by the VPH-DARE@IT project. 3. To understand how this platform will work in practice. 14:00 A-602 Shared research as a service platform for translating research into clinical practice for dementia S. Varma; Sheffield/UK

Learning Objectives: 1. To understand the implications of workflow for underlying infrastructure. 2. To learn how the VPH-DARE@IT will enable workflows to utilise distributed date stores for scientific analysis. 3. To learn about the emerging scientific workflows and understand the infrastructure in the context of VPH-DARE@IT use cases. 14:20 A-603 In silico characterisation of white matter microstructure using diffusion MRI L. Beltrachini; Sheffield/UK

Learning Objectives: 1. To learn how NMR is used to characterise white matter tissue. 2. To understand the numerical framework used in VPH-DARE@IT for dMRI simulations. 3. To learn about the construction of statistical computational models of white matter microstructure. 14:40 A-604 Fluid transport in the ageing brain: an integrative modelling approach Y. Ventikos; London/UK

Learning Objectives: 1. To learn what longitudinal population neuroimaging can bring to the study of the brain. 2. To learn about the models being developed in the VPH-DARE@IT project. 3. To appreciate the possible applications of the models in early and differential diagnosis of dementia.

Final Programme | ECR 2016

239

Saturday

G. Fassa-Ashrafpoor; Chêne-Bougeries/CH

The VPH-DARE@IT Project: delivering a clinical decision support platform for earlier dementia diagnosis

Postgraduate Educational Programme

15:00 A-605 Phenomenological modelling and the RSS

14:43 A-611 Sore throat

W.J. Niessen; Rotterdam/NL

D. Farina; Brescia/IT

Learning Objectives: 1. To understand how VPH-DARE@IT develops models of the ageing brain. 2. To learn about the possible application of the models in early and differential diagnosis of dementia. 3. To appreciate the link between genetic and environmental factors and the brain model.

Learning Objectives: 1. To learn about the causes of sore throat. 2. To get acquainted with pattern of spread of infections. 3. To understand the risk of tumour. 15:03 A-612 Lumps of the infrahyoid neck M.G. Mack; Munich/DE

15:20

Discussion

14:00–15:30

Room A

E3 - ECR Academies: Interactive Teaching Sessions E3 1521

Genitourinary and gastrointestinal radiology

14:00 A-606 A. Prostate MRI using PI-RADS H.C. Thoeny; Berne/CH

Learning Objectives: 1. To learn the clinical indications for prostate MRI. 2. To assess technical considerations for performance of multiparametric prostate MRI. 14:45 A-607 B. New aspects of renal tumours N. Grenier; Bordeaux/FR

Learning Objectives: 1. To become familiar with the different types and classifications of renal tumours. 2. To understand the key imaging findings of the different tumours. 14:00–15:30

Room B

Special Focus Session SF 15

Learning Objectives: 1. To choose the most appropriate imaging modality for neck lumps. 2. To review congenital neck masses. 3. To become familiar with acquired causes of neck swelling.

Head and neck radiology: from symptoms to diagnosis

14:00 A-608 Chairman’s introduction B. Verbist; Leiden/NL

Session Objectives: 1. To learn how to guide imaging approach and interpretation based on symptoms. 2. To discuss clinical vs radiological differential diagnoses in common ENT problems. 14:03 A-609 Tinnitus M. Lemmerling; Ghent/BE

Learning Objectives: 1. To learn about the clinical presentation of tinnitus. 2. To discuss the imaging algorithm for evaluation of tinnitus. 3. To get an overview of the differential diagnoses of tinnitus. 14:23 A-610 Stuffy and runny nose S. Colley; Birmingham/UK

Learning Objectives: 1. To understand imaging indications in case of rhinorrhea or nasal obstruction. 2. To learn about sinonasal infections. 3. To appreciate the role of imaging in sinonasal tumours.

240 ECR 2016 | Final Programme

15:23

Panel discussion: To what extent do symptoms guide your imaging approach and interpretation?

14:00–15:30

Room C

E3 - ECR Academies: Modern Imaging in Colorectal Cancer E3 1518

Colorectal cancer: synchronous and metachronous metastases Moderator: T.K. Helmberger; Munich/DE

14:00 A-613 A. Clinical management: what needs to be improved? T. Holm; Stockholm/SE

Learning Objectives: 1. To understand how common distant metastases are in CRC. 2. To learn about current clinical management of metastatic disease. 3. To learn about approaches aiming at improving outcome. 14:30 A-614 B. Optimal diagnostic algorithm A. Ba-Ssalamah; Vienna/AT

Learning Objectives: 1. To understand the pre-treatment imaging algorithm for liver metastases. 2. To learn about the role of MRI for detection of liver metastases. 3. To learn about alternative approaches and challenges. 15:00 A-615 C. PET/CT vs MR/PET: which and when? P. Veit-Haibach; Zürich/CH

Learning Objectives: 1. To learn about the role of FDG PET/CT for staging of CRC. 2. To learn about the role of FDG PET/CT for restaging of CRC. 3. To become familiar with the possible role of MR/PET vs PET/CT. 14:00–15:30

Room O

E3 - ECR Master Classes (Interventional Radiology) E3 1526

Fire and ice outside the liver

14:00 A-616 Chairman’s introduction M. Bezzi; Rome/IT

Session Objectives: 1. To learn about patient selection and evidence for ablation techniques outside the liver. 2. To understand how to increase the safety of ablation outside the liver. 3. To learn about recent and ongoing trials of ablation outside the liver.

www.myESR.org

Postgraduate Educational Programme

14:05 A-617 A. Lung ablation: update and level of evidence W. Prevoo; Amsterdam/NL

M. Beer; Ulm/DE

Learning Objectives: 1. To understand the advantages and limitations of thermal ablation in the lung. 2. To understand the advantages and limitations of cryoablation in the lung. 3. To learn about recent and ongoing trials and the level of evidence.

Learning Objectives: 1. To learn the essential basics of cardiac spectroscopy. 2. To understand advantages and limitations of cardiac spectroscopy. 3. To appreciate the importance of spectroscopy for myocardial characterisation.

14:30 A-618 B. Renal ablation: update and level of evidence C.M. Sommer; Heidelberg/DE

Learning Objectives: 1. To understand the advantages and limitations of thermal ablation in the kidney. 2. To understand the advantages and limitations of cryoablation in the kidney. 3. To learn about recent and ongoing trials and the level of evidence. 14:55 A-619 C. Bone and soft tissues ablation: update and level of evidence A. Gangi; Strasbourg/FR

Learning Objectives: 1. To understand the advantages and limitations of thermal ablation in the bone and soft tissues. 2. To understand the advantages and limitations of cryoablation in the bone and soft tissues. 3. To learn about recent and ongoing trials and the level of evidence.

15:20

15:00 A-622 C. Cardiac spectroscopy: is it ready for clinical practice?

Panel discussion: How to strengthen the role of ablation beyond the liver in everyday clinical practice and how to prove the value of what we do

14:00–15:30

Room N

E3 - ECR Academies: Modern Cardiac Imaging E3 1520

Myocardial characterisation: established modalities vs new ones Moderator: J. Bremerich; Basle/CH

D.V. Ryzhkova; St. Petersburg/RU

Learning Objectives: 1. To appreciate the clinical need for assessment of myocardial perfusion and viability. 2. To know more about imaging modalities used for these indications. 3. To comparatively evaluate hybrid imaging vs single-modality modalities (CT, MRI). 14:30 A-621 B. T1 and T2-mapping: new items in the radiology toolbox

Studio 2016

Joint Session of the ESR and ERS Imaging of airways: what the respirologist needs to know Moderators: N. Karabulut; Denizli/TR, S. Ley; Munich/DE

14:00 A-623 Classification and impact of bronchiectasis S. Aliberti; Milan/IT

Learning Objectives: 1. To appreciate the difference between cystic fibrosis and non-cystic fibrosis bronchiectasis. 2. To understand the difference between chronic bronchitis and bronchiectasis. 3. To learn about the treatment options of bronchiectasis. 14:23 A-624 How to image and report airway disease? P. Grenier; Paris/FR

Learning Objectives: 1. To appreciate CT acquisition and visualisation protocols in airway disease. 2. To consolidate knowledge on how to measure airway lumen and wall. 3. To learn how to report what the clinician needs to know. 14:46 A-625 Role of airway obstruction and remodeling in the progression of COPD I. Adcock; London/UK

Learning Objectives: 1. To understand the pathophysiology of chronic bronchitis and airway obstruction. 2. To consolidate knowledge about the effects of smoking on airway remodelling. 3. To learn about different treatment options. 15:08 A-626 Imaging of mucus, inflammation and remodeling in COPD and CF H.-U. Kauczor; Heidelberg/DE

Learning Objectives: 1. To understand the concept of the COPD airway phenotype at imaging. 2. To learn about airway obstruction, air trapping and hypoxic vasoconstriction. 3. To appreciate the potential of MRI to differentiate mucus and inflammation.

P. Croisille; Saint-Etienne/FR

Learning Objectives: 1. To learn about technical basics of myocardial mapping in cardiac MR. 2. To learn what types of diagnostic information could be obtained with mapping. 3. To become familiar with results of clinical application of this technique.

www.myESR.org

Final Programme | ECR 2016

241

Saturday

14:00 A-620 A. Hybrid systems in the assessment of myocardial perfusion and viability

14:00–15:30

Postgraduate Educational Programme

14:00–15:30

Room E1

Musculoskeletal RC 1510

14:21 A-633 The role of imaging in preoperative planning and follow-up F. Rengier; Heidelberg/DE

Learning Objectives: 1. To learn about the concepts of preoperative planning. 2. To understand key figures and definitions. 3. To appreciate the use of innovative imaging methods. 4. To become familiar with the meaning of diagnostic preoperative workup.

Shoulder MRI: mastering technique and making my report relevant

14:00 A-627 Chairman’s introduction M. Maas; Amsterdam/NL

Session Objectives: 1. To understand the level of expertise that patients expect for adequate performance and reading of shoulder MRI. 2. To gain insight into differentiating normal age-related changes from clinical relevant MR features.

14:39 A-634 Implantation techniques and long-term results R. Uberoi; Oxford/UK

Learning Objectives: 1. To learn about the basic concepts of endovascular techniques. 2. To understand basic mechanical and anatomic considerations. 3. To appreciate the use of innovative endovascular tools. 4. To become familiar with the latest research in the field.

14:05 A-628 A. The normal MRI: techniques and anatomy E. Llopis; Valencia/ES

Learning Objectives: 1. To become familiar with MRI techniques for imaging the shoulder. 2. To understand normal MRI shoulder anatomy, and normal variants seen.

14:57 A-635 Imaging and treatment of endoleaks M. Gschwendtner; Linz/AT

Learning Objectives: 1. To learn about the nomenclature and pathophysiological backup of endoleaks. 2. To understand the basic concepts in treatment und surveillance of endoleaks. 3. To appreciate the use of innovative tools for treatment and surveillance. 4. To become familiar with the key facts and figures regarding the scientific workup.

14:28 A-629 B. Rotator cuff tears: what are they and what do they look like? K.-F. Kreitner; Mainz/DE

Learning Objectives: 1. To become familiar with the anatomical basis of rotator cuff tears. 2. To learn about the MRI findings of rotator cuff pathology. 14:51 A-630 C. Patterns of instability: what does the MRI show? A.J. Grainger; Leeds/UK

Learning Objectives: 1. To become familiar with patterns of abnormality seen in shoulder instability. 2. To learn about the MRI findings of shoulder instability. Panel discussion: How are the indications for MR arthrography in the shoulder changing?

15:14

14:00–15:30

Room E2

State of the Art Symposium SA 15

Endovascular abdominal aneurysm repair (EVAR): where do we stand now?

14:00 A-631 Chairman’s introduction T. Rand; Vienna/AT

Session Objectives: 1. To introduce the basic concepts of EVAR. 2. To underline the major role of radiology in EVAR. 14:03 A-632 Endovascular versus open surgical repair: what do we know so far? D.K. Tsetis; Iraklion/GR

Learning Objectives: 1. To learn about the basic concepts of the treatment of abdominal aortic aneurysms. 2. To understand the principles of endovascular repair. 3. To appreciate innovative endovascular treatment options. 4. To become familiar with the latest research in the field.

242

ECR 2016 | Final Programme

15:15

Panel discussion: The key role of the radiologist in endovascular abdominal aortic aneurysm repair 1. To discuss where the further development of aortic endovascular treatment will go. 2. To discuss the role of the radiologist in this concept. 3. To conclude where we stand now.

14:00–15:30

Room F1

E3 - European Diploma Prep Sessions E3 1523

Gynaecological and obstetrics

14:00 A-636 Chairman’s introduction C.D. Alt; Düsseldorf/DE

Session Objectives: 1. To understand the imaging presentation of the most common benign and malignant disorders of the uterus. 2. To become familiar with inflammatory and neoplastic disorders of the adnexa. 3. To understand the principles of foetal images and the imaging presentation of the most common foetal disorders. 14:03 A-637 A. Imaging of the uterus R.A. Kubik-Huch; Baden/CH

Learning Objectives: 1. To understand the advantages and limits of ultrasound, hysterosalpingography, CT and MRI in imaging the uterus. 2. To become familiar with the normal anatomy of the uterus and to know the variations of the uterus during genital life and during the menstrual cycle. 3. To learn about congenital anomalies as well as the most relevant benign and malignant uterine pathologies. 4. To be able to explain the technique of a pelvic MRI and to know the contra-indications of MRI, the required preparation of the patient and the choice of technical parameters depending on indications.

www.myESR.org

Postgraduate Educational Programme

14:32 A-638 B. Disorders of the adnexa

14:30 A-644 B. Mediastinal masses: role of CT

E. Sala; New York, NY/US

M. Occhipinti; Rome/IT

Learning Objectives: 1. To describe the imaging features of benign tumours of the ovaries. 2. To understand the diagnostic evaluation and imaging features of malignant tumours of the ovaries. 3. To explain the imaging features of inflammatory disorders of the Fallopian tubes.

Learning Objectives: 1. To learn the most common causes of mediastinal masses. 2. To recognise signs which allow us to characterise mediastinal lesions. 15:00 A-645 C. A new look at the mediastinum: role of MRI and PET/CT F.L. Giesel; Heidelberg/DE

15:01 A-639 C. Fundamentals of foetal imaging

Learning Objectives: 1. To learn when and how to apply MR for mediastinal disease. 2. To learn when and how to apply PET/CT for mediastinal masses.

D. Prayer; Vienna/AT

Learning Objectives: 1. To describe the methodology and technical principles of foetal MR imaging. 2. To understand the imaging presentation of common pathologies of the foetal central nervous system. 3. To understand the imaging presentation of common pathologies of the foetal body. 14:00–15:30

Room F2

Breast

14:00–15:30

Room D2

Radiographers RC 1514

Innovative education in medical imaging

14:00 A-646/A-647 Chairmen’s introduction P. Bezzina1, M. Bachmann Nielsen2; 1Msida/MT, 2Copenhagen/DK

RC 1502

Session Objectives: 1. To understand the role of handheld devices in medical imaging education. 2. To appraise the use of simulators as an innovative educational tool in radiology. 3. To discuss the use of interactive application to teaching and learning in medical imaging.

Update on BI-RADS Moderator: G. Esen; Istanbul/TR

14:00 A-640 A. Mammography U. Bick; Berlin/DE

Learning Objectives: 1. To learn about the recently updated BI-RADS® lexicon. 2. To become familiar with the mammography descriptors. 3. To understand the usefulness of the BI-RADS® categories and their clinical application.

14:05 A-648 A. Is there a role for smartphones and tablets in medical imaging education? F. Girard; Pont de Roide/FR

Learning Objectives: 1. To review the current educational uses of hand-held electronic devices in medical imaging. 2. To discuss the potential advantages and disadvantages of technologyenhanced learning in medical imaging. 3. To suggest potential future uses of smartphones and tablets in radiography education.

14:30 A-641 B. Ultrasound A. Evans; Dundee/UK

Learning Objectives: 1. To learn about the recently updated BI-RADS® lexicon. 2. To become familiar with the ultrasound descriptors. 3. To understand the usefulness of the BI-RADS® categories and their clinical application.

P. Cosson; Teeside/UK

M.H. Fuchsjäger; Graz/AT

Learning Objectives: 1. To appraise the current methods used in healthcare simulation for education. 2. To explore the benefits and disadvantages of these methods in radiography education. 3. To suggest future uses and further improvements of simulators in radiography education.

Learning Objectives: 1. To learn about the recently updated BI-RADS® lexicon. 2. To become familiar with the MRI descriptors. 3. To understand the usefulness of the BI-RADS® categories and their clinical application. 14:00–15:30

Room D1

Chest RC 1504

14:51 A-650 C. Beyond eye candy: developing effective interactive animations to enhance MRI learning D. Koumarianos; Athens/GR

Mediastinal disease revisited

Learning Objectives: 1. To review the current educational uses of interactive animations in medical imaging. 2. To discuss the potential advantages and disadvantages of multimedia in medical imaging education. 3. To demonstrate the development of educationally effective interactive animations.

Moderator: A. Persson; Linköping/SE

14:00 A-643 A. The crucial role of chest x-ray: mediastinal lines and stripes E.E.J.G. Coche; Brussels/BE

Learning Objectives: 1. To become familiar with the signs that indicate mediastinal pathology. 2. To confidently identify and localise a mediastinal mass on chest x-ray.

www.myESR.org

15:14

Panel discussion: What is the value of innovation in advancing clinical practice and education in radiography?

Final Programme | ECR 2016

243

Saturday

15:00 A-642 C. MRI

14:28 A-649 B. Using simulators as an innovative teaching tool in medical imaging

Postgraduate Educational Programme

14:00–15:30

Room K

Physics in Radiology

14:30 A-656 B. How can I improve my reporting of T2-hyperintense lesions? A. Rovira-Cañellas; Barcelona/ES

RC 1513

IT tools for dose tracking and workflow optimisation

14:00 A-651 Chairman’s introduction A. Trianni; Udine/IT

Session Objectives: 1. To understand the pros and cons of dose tracking in modern day radiology imaging. 2. To review IT standards for dose tracking. 3. To learn about dose optimisation from using dose tracking tools. 14:05 A-652 A. Digital Imaging and Communications in Medicine (DICOM) standard and Integrating the Healthcare Enterprise (IHE) D. Peck; Detroit, MI/US

Learning Objectives: 1. To understand the current DICOM standard. 2. To learn about new DICOM efforts which will significantly impact imaging systems’ operations. 3. To understand how IHE coordinates the integration and management of DICOM objects. 14:28 A-653 B. Patient dose index tracking: a must have? F. Zanca; Leuven/BE

Learning Objectives: 1. To identify informatics and tools for tracking patient radiation dose. 2. To learn about some possible uses in clinical practice. 3. To learn about some examples of patient radiation dose tracking. 14:51 A-654 C. Optimising technique using patient dose index tracking software: tips and tricks R.W.R. Loose; Nuremberg/DE

Learning Objectives: 1. To learn how to use the DICOM header to improve technique and outcome for the patient. 2. To learn how to use the DICOM header to improve performance of the automatic exposure control system. 3. To take advantage of dose tracking information in order to compare technique among different CT scanners.

15:14

Panel discussion: Dose index tracking in clinical practice

14:00–15:30

Room G

Neuro RC 1511

15:00 A-657 C. Is there a need for quantitative reporting of white matter lesions? F. Barkhof; London/UK, Amsterdam/NL

Learning Objectives: 1. To understand the importance of quantitative analysis in white matter lesions. 2. To show how to perform the quantitative analysis. 3. To understand the importance of follow-up in in patients with white matter lesions. 16:00–17:30

Room A

E3 - ECR Academies: Interactive Teaching Sessions E3 1621

Emergency radiology II

16:00 A-658 A. Brain trauma M. Smits; Rotterdam/NL

Learning Objectives: 1. To understand the different types of brain trauma. 2. To become familiar with the differential diagnosis. 16:45 A-659 B. Peripheral vascular injury J. Ferda; Plzen/CZ

Learning Objectives: 1. To understand the different types of peripheral vascular injury. 2. To become familiar with the different imaging techniques. 3. To become familiar with interventional treatment options. 16:00–17:30

Room B

Abdominal Viscera RC 1601

The spleen: the forgotten organ

16:00 A-660 Chairman’s introduction

White spots in the brain Moderator: E.T. Tali; Ankara/TR

14:00 A-655 A. White spots and blots in the brain: what are they? T.A. Yousry; London/UK

Learning Objectives: 1. To understand what white spots are. 2. To make differential diagnoses in brain white spots. 3. To demonstrate how to study patients with brain white spots.

244

Learning Objectives: 1. To understand if it is possible to use a structured report with white brain abnormality. 2. To learn how to define a comprehensive imaging protocol for those patients. 3. To appreciate the role of modern imaging techniques for defining white brain hyperintense T2 lesions.

ECR 2016 | Final Programme

L.H. Ros Mendoza; Zaragoza/ES

Session Objective: 1. To briefly introduce the diagnostic challenges imaging spleen. 16:05 A-661 A. Acute and chronic splenic disease G. Zamboni; Verona/IT

Learning Objectives: 1. To describe the most common causes of acute and chronic splenic disease, excluding malignant lesions. 2. To define imaging protocols, including functional and metabolic techniques, to apply for the detection and characterisation.

www.myESR.org

Postgraduate Educational Programme

16:28 A-662 B. The incidental splenic lesion M. Laniado; Dresden/DE

Learning Objectives: 1. To describe the most common causes of splenic incidentaloma and their imaging appearance. 2. To define imaging protocols, including functional and metabolic techniques, for the differential diagnosis. 3. To propose an algorithm for the management of incidental splenic lesions.

16:00–17:30

Joint Session of the ESR and ESTRO ESR/ESTRO

K. Riklund1, V. Valentini2; 1Umea/SE, 2Rome/IT

Session Objectives: 1. To learn about the contribution of multimodality/hybrid imaging and in-room imaging to define tumour extension to favour optimisation in radiation oncology treatment. 2. To understand the feasibility of multimodality/hybrid imaging and in-room imaging to optimise radiation oncology treatment. 3. To appreciate the role of multimodality/hybrid imaging and in-room imaging to drive treatment strategies for the cure of the tumour and for the quality of life of the patients. 4. To become familiar with the clinical need of multidisciplinary specialists to position the role of imaging as pivotal in modern oncology.

S. Gourtsoyianni; London/UK

Learning Objectives: 1. To describe the clinical presentation and imaging findings for focal and diffuse neoplastic malignant lesions. 2. To discuss the indication of splenic lesion biopsy and its diagnostic contribution. Panel discussion: How to manage incidental findings in clinical routine practice

16:00–17:30

Room C

E3 - ECR Academies: Modern Imaging in Colorectal Cancer E3 1618

16:03 A-669 The benefit of high tesla MRI for radiation oncology planning U. van der Heide; Amsterdam/NL

Learning Objectives: 1. To learn about the contribution of MRI and in-room MRI to define tumour extension and organ-at-risk movements to favour optimisation in radiation oncology treatment. 2. To understand the benefit of MRI in-room to optimise radiation oncology treatment. 3. To appreciate the role of MRI and in-room MRI to drive treatment strategies for the cure of the tumour and for the quality of life of the patients.

Rectal cancer: staging and restaging local disease Moderator: D.-M. Koh; Sutton/UK

16:00 A-664 A. Transrectal ultrasonography J.E.R. Waage; Hillerod/DK

Learning Objectives: 1. To understand the role of TRUS for staging rectal tumours. 2. To become familiar with new TRUS techniques. 3. To learn about TRUS for restaging of rectal cancer.

16:23 A-670 The challenge of in room MRI for treatment delivery N. Dinapoli; Rome/IT

D.M. Lambregts; Amsterdam/NL

17:00 A-666 C. Multiparametric assessment of treatment response

16:43 A-671 The benefit of MR/PET in radiation oncology U. Nestle; Freiburg/DE

Learning Objectives: 1. To learn about the contribution of MR/PET to defining tumour extension and organ-at-risk movements to favour optimisation in radiation oncology treatment. 2. To understand the benefit of MR/PET for optimising radiation oncology treatment. 3. To appreciate the role of MR/PET in driving treatment strategies for the cure of the tumour and for the quality of life of the patients.

N. Papanikolaou; Stockholm/SE

Learning Objectives: 1. To understand the rationale behind multiparametric imaging in rectal cancer. 2. To learn how to approach images in a multiparametric setting. 3. To get an overview of available software platforms.

17:03 A-672 The challenge of using MR/PET in radiation oncology E.-M.B. Larsson; Uppsala/SE

Learning Objectives: 1. To learn about the limitations of MR/PET in defining tumour extension and organ-at-risk movements to favour optimisation in radiation oncology treatment. 2. To understand the constraints of MR/PET in optimising radiation oncology treatment. 3. To appreciate the uncertainties of MR/PET in driving treatment strategies for the cure of the tumour and for the quality of life of the patients. 17:23

www.myESR.org

Discussion

Final Programme | ECR 2016

245

Saturday

Learning Objectives: 1. To learn about the limitations to defining tumour extension and organ-at-risk movements to favour optimisation in radiation oncology treatment. 2. To understand the constraints of optimising radiation oncology treatment. 3. To appreciate the uncertainties of driving treatment strategies for the cure of the tumour and for the quality of life of the patients.

16:30 A-665 B. Emerging MR-techniques Learning Objectives: 1. To understand which MR sequences are used in clinical practice. 2. To become familiar with new imaging techniques used in rectal cancer. 3. To learn about how to use DWI for restaging of rectal cancer.

MR and MR/PET in radiation treatment planning - challenges and opportunities

16:00 A-667/A-668 Chairmen’s introduction

16:51 A-663 C. Malignant lesions

17:14

Room Z

Postgraduate Educational Programme

16:00–17:30

Room O

Joint Session of the ESR, EFSUMB and ESPR Contrast enhanced ultrasound (CEUS) in paediatrics Moderators: M. Claudon; Vandoeuvre-les-Nancy/FR, C. Owens; London/UK

16:00 A-673 Legal issues with CEUS in children P.S. Sidhu; London/UK

Learning Objectives: 1. To understand the current status of unlicensed drug therapy in children. 2. To understand the legal position of prescribing unlicensed drugs in children. 3. To understand the responsibilities of performing CEUS in children. 16:18 A-674 CEUS of focal liver lesions in children M. Sellars; London/UK

Learning Objectives: 1. To illustrate the spectrum of focal liver lesions in the paediatric population. 2. To understand the role of CEUS in the diagnostic pathway of children with chronic liver disease. 3. To review CEUS findings of common and uncommon benign and malignant focal liver lesions in children. 16:36 A-675 CEUS in blunt abdominal trauma in children A. Deganello; London/UK

Learning Objectives: 1. To illustrate the usefulness of CEUS in the setting of paediatric trauma. 2. To discuss the implications of repeated radiation exposure in children following trauma. 3. To review CEUS findings of the most frequent types of solid abdominal organ injuries occurring in children. 16:54 A-676 CEUS in vesical reflux in children C. Duran; Sabadell/ES

Learning Objectives: 1. To illustrate the protocol for the study of the urinary tract, including the urethra, with second-generation contrast agents. 2. To demonstrate the high quality of the images obtained with this procedure. 3. To show that voiding urosonography can diagnose the most prevalent urethral pathologies. 17:12 A-677 CEUS in non-liver indications in paediatric patients C.F. Dietrich; Bad Mergentheim/DE

Learning Objectives: 1. To understand indications of CEUS beyond the liver. 2. To understand extravascular and intracavitary applications of CEUS (except vesical reflux). 3. To discuss off label use in children (and adults).

16:00–17:30

Room N

E3 - ECR Academies: Modern Cardiac Imaging E3 1620

Cardiac imaging: to new horizons Moderator: E. Mousseaux; Paris/FR

16:00 A-678 A. New approaches for coronary atherosclerotic plaque characterisation E.J.R. van Beek; Edinburgh/UK

Learning Objectives: 1. To appreciate the importance of atherosclerotic plaque characterisation with imaging. 2. To learn about developments of PET/CT and MR/PET applications for coronary plaque imaging. 3. To become aware of new research directions in this field and their possible significance. 16:30 A-679 B. Imaging of microvascular disease R. Manka; Zurich/CH

Learning Objectives: 1. To learn about pathophysiology of coronary circulation in microvascular disease. 2. To appreciate the significance of imaging of microvascular disease in a clinical setting. 3. To learn about advantages, limitations and further perspectives of cardiac imaging in this pathology. 17:00 A-680 C. Tracking of stem cells in cardiac repair: role of MR and hybrid imaging L. Natale; Rome/IT

Learning Objectives: 1. To become familiar with the application of cardiac stem cells therapy. 2. To become familiar with techniques for stem cell labelling with radionuclide and magnetic tracers. 3. To learn about the use of hybrid imaging for the assessment of cardiac repair and remodelling during therapy with stem cells. 16:00–17:30

Studio 2016

Multidisciplinary Session MS 16a

Uterine myomas: radiological diagnosis and treatment

16:00 A-681 Chairman’s introduction A.-M. Belli; London/UK

Session Objectives: 1. To learn about the imaging characteristics of fibroids before and after treatment. 2. To understand the information required by gynaecologists and interventional radiologists from imaging. 3. To learn about the different therapeutic options and their outcomes. 4. To understand the impact of fibroids and the different treatment strategies on fertility. 16:05 A-682 Imaging of fibroids R. Das; London/UK

Learning Objectives: 1. To describe imaging characteristics of fibroids. 2. To differentiate from other relevant pathology including malignancy. 3. To report the information required by the gynaecologist before and after surgical and radiological intervention.

246

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

16:25 A-683 Epidemiology, clinical presentation and non radiological therapeutic options for the treatment of fibroids

16:00–17:30

Room E1

Multidisciplinary Session

I. Manyonda; London/UK

Learning Objectives: 1. To describe the clinical presentation of fibroids. 2. To describe the medical and surgical treatment options and their outcomes. 3. To describe what is known about the impact of fibroids on fertility and how these treatments impact on this.

MS 16b

16:00 A-689 Chairman’s introduction M. Padrón; Madrid/ES

Session Objectives: 1. To understand the point-of-view of the different actors involved in a sport injury based on personal experiences. 2. To learn how to focus on a sport injury with a multidisciplinary approach. 3. To review actual concepts on diagnosis and management of sports injuries.

16:45 A-684 Radiological treatments for fibroids A.-M. Belli; London/UK

Learning Objectives: 1. To describe the radiological treatment options of uterine artery embolisation and HIFU. 2. To present the current evidence on outcomes. 3. To describe how to manage expectations and complications. 17:05

Multidisciplinary case discussion

16:00–17:30

16:05 A-690 What does the radiologist offer? C. Faletti; Turin/IT

Learning Objectives: 1. To become familiar with the specific role the radiologist has in the management of sports injuries. 2. To understand the relative importance of what should be and should not be included in the radiological report. 3. To understand the role of imaging-guided intervention in the management of sports injury.

Room L8

EuroSafe Imaging Session EuroSafe 4 You too can definitely do audits 16:00 A-685 Chairman’s introduction

16:20 A-691 How I face a sport injury: the sport physician’s approach

E.J. Adam; London/UK

J.-M. Alonso; Doha/QA

Session Objectives: 1. To learn how to introduce an effective clinical audit programme. 2. To introduce the ESR audit tool as an aid to improving quality in radiology services. 3. To explore how the use of such a system will satisfy external authorities.

Learning Objectives: 1. To identify the injury mechanism. 2. To localise which anatomic structures are affected. 3. To select and indicate the appropriate imaging techniques. 16:35 A-692 The physiotherapist’s view

16:05 A-686 Experience from an established national programme

A. Zerolo; Madrid/ES

Learning Objectives: 1. To learn how an established national clinical audit programme can work effectively. 2. To learn how to design, run, and publish audits. 3. To understand the benefits of local clinical audit. 16:30 A-687 The challenges of introducing a national audit programme

16:50 A-693 The surgeon’s perspective

A. Vargha; Hidegség/HU

M. Leyes; Madrid/ES

Learning Objectives: 1. To highlight which kind of critical issues could occur on a national level during implementing an international (EU) guideline for clinical audit. 2. To understand ways to avoid unnecessary turf battles. 3. To appreciate how to set up a realistic plan for clinical audit implementation in radiology.

Learning Objectives: 1. To become familiar with the specific role the surgeon has in the management of sports injuries. 2. To understand the aspects of the radiological report which are most important to the surgeon. 3. To understand how the radiologist goes on to influence the management of athletic injuries from the surgeon’s perspective. 4. To understand the information that orthopaedic surgeons consider critical for preoperative planning and reconstruction of the multiple ligament knee injury in sports.

16:55 A-688 How to make audit easy: the ESR Audit Tool P. Cavanagh; Taunton/UK

Learning Objectives: 1. To learn about the ESR Clinical Audit Tool. 2. To understand how it can be used at local and national levels. 3. To explore what makes clinical audit an effective quality improvement tool.

17:05

Multidisciplinary case presentation and discussion: Which aspects of radiological practice help and which hinder the team approachto managing the injured athlete? How can we improve on this?

Panel discussion

www.myESR.org

Final Programme | ECR 2016

247

Saturday

Learning Objectives: 1. To become familiar with the specific role the physiotherapist has in the management of sports injuries. 2. To understand the aspects of the radiological report which are most important to the physiotherapist. 3. To understand how the radiologist goes on to influence the management of athletic injuries from the physiotherapist’s perspective.

D. Remedios; Harrow/UK

17:20

Sports injuries: diagnosis and management

Postgraduate Educational Programme

16:00–17:30

Room E2

16:00–17:30

Room F1

Special Focus Session

E3 - European Diploma Prep Sessions

SF 16

E3 1623

Prostate MRI: increasing need?

16:00 A-694 Chairman’s introduction

16:00 A-698 Chairman’s introduction

J.C. Vilanova; Girona/ES

M. Szczerbo-Trojanowska; Lublin/PL

Session Objectives: 1. To learn about the current role of prostate MRI in managing prostate cancer. 2. To become familiar with the current recommendations and guidelines for multiparametric technique of prostate MRI. 3. To discuss the different indications of prostate MRI and analyse the improved value for patients. 4. To provide an update on the new advances in prostate mpMRI.

Session Objectives: 1. To understand the principles and techniques of angiography and image-guided interventions. 2. To become familiar with the different methods of hepatobiliary interventions. 3. To describe the most common vascular interventions.

16:05 A-695 MRI before the first prostate biopsy: has the time come? B. Hamm; Berlin/DE

Learning Objectives: 1. To learn about the current status of TRUS-guided biopsy. 2. To discuss possible inclusion criteria for MRI before the first prostate biopsy. 3. To learn about the histological Gleason grading with special reference to MRI findings. 4. To discuss further steps for radiology in the detection of prostate cancer. 16:28 A-696 The role of prostate MRI in active surveillance A.R. Padhani; London/UK

Learning Objectives: 1. To provide an overview of the concepts underpinning active surveillance (AS) strategies for low risk prostate cancer. 2. To discuss the role of mpMRI for confirming clinical patient selection criteria for AS and highlight the benefits of mpMRI for detecting cases at higher risk and thus unsuited for AS. 3. To demonstrate changing imaging phenotype during AS period and corresponding clinical actions. 4. To highlight need for effective communication with clinicians regarding initial and continued suitability for AS. 16:51 A-697 Is prostate MRI accurate enough for focal treatment planning? V. Panebianco; Rome/IT

Learning Objectives: 1. To provide an overview of mpMRI in terms of accuracy, sensitivity, specificity and especially PPV and PNV in the initial diagnosis of PCa. 2. To discuss the role of mpMRI as an important tool for selection criteria for focal therapy. 3. To demonstrate the role of mpMRI to guide the targeted therapy. 4. To underline the role of mpMRI in the follow-up of the patients treated and its reproducibility.

17:14

Interventional

Panel discussion: Does the use of MRI improve the outcome in prostate cancer?

16:03 A-699 A. Basic principles of angiography and image-guided interventions T.K. Helmberger; Munich/DE

Learning Objectives: 1. To describe the normal anatomy and normal variants of the arterial and venous vascular system. 2. To understand diagnostic and interventional angiographic techniques. 3. To explain basic percutaneous image-guided techniques including abscess drainage and biopsy taking. 16:32 A-700 B. Interventions of the hepatobiliary system J.I. Bilbao; Pamplona/ES

Learning Objectives: 1. To describe the normal anatomy and normal variants of the hepatobiliary system. 2. To explain vascular hepatic interventions including transarterial chemoembolisation. 3. To understand percutaneous hepatobiliary interventions including thermal ablation techniques. 17:01 A-701 C. Vascular interventions J.A. Reekers; Amsterdam/NL

Learning Objectives: 1. To explain endovascular treatment options of atherosclerotic diseases. 2. To understand common angioplasty procedures, such as renal, iliac and femoral angioplasties. 3. To describe indications and techniques for arterial stenting procedures. 4. To explain techniques of arterial embolisation and coiling. 16:00–17:30

Room F2

Breast RC 1602

Tomosynthesis: the new mammography Moderator: D. Bernardi; Trento/IT

16:00 A-702 A. Should we abandon 2D mammography? S. Zackrisson; Malmö/SE

Learning Objectives: 1. To understand the technique of 2D mammography and what the limits could be. 2. To know how to calculate radiation dose in 2D mammography and ways to improve image quality. 3. To understand when 2D mammography is better than DBT.

248

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

16:30 A-703 B. Clinical validation and results in the last 5 years: where do we stand?

16:23 A-709 B. Safety aspects in an interventional radiology setting? D. Catania; Milan/IT

Learning Objectives: 1. To become aware of patient and staff risk in an interventional radiology setting. 2. To appreciate the importance of radiation protection measures considering the nature of interventional procedures. 3. To recognise the need for education and training in interventional radiology settings in order to promote radiation safety.

P. Skaane; Oslo/NO

Learning Objectives: 1. To become familiar with the technique of DBT. 2. To understand the results of DBT in the screening and diagnostics settings. 3. To know the evolution of tomosynthesis in screening organisation. 17:00 A-704 C. The future of mammography: my predictions E.M. Fallenberg; Berlin/DE

Learning Objectives: 1. To understand the role of mammography in analysing and characterising breast lesions. 2. To become familiar with new developments in digital mammography such as contrast mammography, tomosynthesis and 3D contrast mammography. 3. To learn about the new potential of combining mammography with molecular imaging, optical imaging and texture analysis. 16:00–17:30

Room D1

16:46 A-710 C. An introduction to mammography safety: what can be done? D. O’Leary; Hertfordshire/UK

Learning Objectives: 1. To understand the definition of safety in a mammography context. 2. To become aware of mammography best practices in radiation protection, compression and infection control. 3. To understand the radiographer’s role as safety gatekeeper in mammography. 17:08 A-711

D. Safety in CT: dose minimisation and beyond R. Booij; Rotterdam/NL

E3 - ECR Master Classes (Chest) E3 1626

Less common infiltrative lung diseases Moderator: M. Regier; Hamburg/DE

16:00 A-705 A. Pleuroparenchymal fibro elastosis A. Devaraj; London/UK

Learning Objectives: 1. To become familiar with this newly recognised idiopathic interstitial pneumonia. 2. To learn how to interpret upper zone changes on thoracic CT. 16:30 A-706 B. Alveolar proteinosis W.F.M. De Wever; Leuven/BE

Learning Objectives: 1. To become familiar with the CT features enabling the radiologist to suggest this diagnosis. 2. To learn about other diseases with crazy-paving as a predominant pattern.

A. Oikonomou; Toronto, ON/CA

Learning Objectives: 1. To learn about the parenchymatous and pleural manifestations of the disease. 2. To learn how to distinguish LLM from other cystic diseases of the lung. 16:00–17:30

Room D2

Radiographers

16:00–17:30

Room K

Physics in Radiology RC 1613

MR: artefacts and devices

16:00 A-712 Chairman’s introduction M. Tosetti; Pisa/IT

Session Objectives: 1. To learn about MR image distortions. 2. To appreciate the appearance of metal-induced image distortions in MRI. 3. To appreciate image distortions in perfusion- and diffusion-weighted imaging. 16:05 A-713 A. Image artefacts in MRI and their mitigation D.J. Lurie; Aberdeen/UK

Learning Objectives: 1. To identify common types of artefacts in MR images. 2. To learn about the physical origins of artefacts in MRI. 3. To learn methods of minimising artefacts on MR images. 16:28 A-714 B. Imaging around metal implants: artefact reduction in MRI C. McGrath; Belfast/IE

RC 1614

Safety issues in medical imaging Moderators: C. Leidecker; Forchheim/DE, J. Santos; Coimbra/PT

16:00 A-708 A. Safeguarding patients and staff in MRI

Learning Objectives: 1. To review the origin of signal in MRI. 2. To understand the MRI physics of artefact reduction around metal implants. 3. To understand the parameters used in an optimised imaging protocol.

T. Owman; Lund/SE

Learning Objectives: 1. To understand the patient and staff risk in MRI examinations. 2. To become familiar with guidelines and recommendations for patient and staff safety. 3. To become aware of the importance of the role of radiographer in MRI safety.

www.myESR.org

Final Programme | ECR 2016

249

Saturday

17:00 A-707 C. Lymphangioleiomyomatosis

Learning Objectives: 1. To become aware of international recommendations, standards and directives in order to promote safety. 2. To consolidate knowledge in dose reduction of CT examinations. 3. To enhance understanding about the tradeoffs between dose reduction and image quality.

Postgraduate Educational Programme

16:51 A-715 C. Artefacts in perfusion and diffusion MRI I. Tsougos; Larissa/GR

Learning Objectives: 1. To review the artefacts and pitfalls of diffusion MRI on a qualitative basis, especially in terms of eddy currents and sensitivity to motion. 2. To review and evaluate the possible issues that can affect the accuracy of measurements regarding dynamic susceptibility contrast (DSC)MRI (measurements of cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT)). 3. To introduce possible strategies that have been developed to mitigate or overcome these artefacts and pitfalls.

17:14

Panel discussion: Clinically applicable tools/strategies to minimising/ avoiding MR imaging artefacts

16:00–17:30

Room G

Neuro RC 1611

Update on endovascular stroke treatment: a medical breakthrough? Moderator: S. Rohde; Dortmund/DE

16:00 A-716 A. A critical appraisal of the current literature W. van Zwam; Maastricht/NL

Learning Objectives: 1. To understand the strengths and shortcomings of the relevant multicentre trials assessing the role of endovascular treatment in patients with acute ischaemic stroke. 2. To understand the outcomes of these trials, the context in which they were achieved and how they can be ensured in a different environment. 3. To appreciate potential differences in management of patients with anterior vs posterior circulation strokes. 16:30 A-717 B. Which techniques can we use to reopen an occluded cerebral blood vessel? T. van der Zijden; Edegem/BE

Learning Objectives: 1. To understand the principles underlying endovascular clot aspiration. 2. To become familiar with the different materials available for mechanical clot retrieval. 3. To understand the circumstances in which stenting of an intracranial blood vessel is needed. 17:00 A-718 C. Endovascular stroke treatment: ethical and economical concerns K.-O. Løvblad; Geneva/CH

Learning Objectives: 1. To appreciate the structure that is necessary to organise interventional stroke treatment for a large population. 2. To understand the cost implications and their mitigation. 3. To become familiar with the associated ethical concerns (such as informed consent) and the different ways of addressing them.

250

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

08:30–10:00 Room A

08:30–10:00 Room C

E3 - ECR Academies: Interactive Teaching Sessions

Joint Session of the ESR and ESHI

E3 1721

Moderator: K. Riklund; Umea/SE

MR imaging in sports medicine II

08:30 A-719 A. Sports injuries of the ankle P. Robinson; Leeds/UK

Learning Objectives: 1. To learn the anatomy of the ankle. 2. To learn the evaluation of common ankle injuries. 09:15 A-720 B. Shoulder injury M. Zanetti; Zurich/CH

Learning Objectives: 1. To review the anatomy of the shoulder in 3-dimensions. 2. To learn the evaluation of common shoulder injuries. 08:30–10:00 Room B

Abdominal Viscera

Medical hybrid imaging 08:30 A-725 Introduction L. Donoso; Barcelona/ES

Learning Objectives: 1. To become familiar with the background of the decision to create this new society. 2. To learn about the aims of the new society. 3. To get an overview of physics, training and medical use in hybrid imaging. 08:35 A-726 The aims of the new society K. Riklund; Umea/SE

Learning Objectives: 1. To introduce the new society. 2. To inform about the activities of the new society. 08:50 A-727 Training of hybrid physicians G. Antoch; Düsseldorf/DE

RC 1701

Differential diagnosis in pancreatic imaging

08:30 A-721 Chairman’s introduction B. Marincek; Cleveland, OH/US

Session Objective: 1. To briefly introduce the diagnostic challenge in patients presenting cystic or solid pancreatic lesions. 08:35 A-722 A. Pancreatic cancer or pancreatitis R. Manfredi; Verona/IT

Learning Objectives: 1. To learn about the inflammatory lesions, which can mimic a pancreatic tumour. 2. To become familiar with the imaging features, which can support the differential diagnosis between pancreatic cancer and pancreatitis. 3. To understand the value of the integration of the imaging modalities that define the correct diagnosis. 08:58 A-723 B. Cystic tumours vs pseudocysts M.A. Bali; Brussels/BE

Learning Objectives: 1. To become familiar with the imaging features of cystic tumours and pseudocysts. 2. To become familiar with the clinical presentation and the radiological signs that may be observed in cystic tumours and pseudocysts. 3. To understand the value of the integration of the imaging modalities that define the correct diagnosis.

C. Stoupis; Männedorf/CH

Learning Objectives: 1. To become familiar with the most common incidental findings in the pancreas with different imaging modalities. 2. To understand how to define the correct diagnosis. 3. To discuss how to manage incidental findings.

09:05 A-728 The beauty of physics in hybrid imaging T. Beyer; Vienna/AT

Learning Objectives: 1. To lay out the fundamentals of physics in hybrid imaging. 2. To illustrate physics and physicists as partners to hybrid imaging users. 3. To speculate on the future of hybrid imaging as supported through physics. 09:20 A-729 Functional hybrid imaging: 1+1 = 3? O. Clément; Paris/FR

Learning Objectives: 1. To learn about the functional capabilities of hybrid imaging techniques. 2. To understand that combined functional information results in additional cross correlation and validation. 09:35 A-730 Practical challenges of hybrid imaging in clinical practice O. Ratib; Geneva/CH

Learning Objectives: 1. To review the current applications of hybrid imaging in wellestablished clinical pathways. 2. To become familiar with the added values of hybrid imaging in patient management. 3. To learn about opportunities beyond diagnostic applications.

Sunday

09:21 A-724 C. Incidental findings

Learning Objectives: 1. To understand why implementation of training programs for hybrid physicians is mandatory. 2. To become familiar with current differences in training programs when comparing European countries. 3. To recognise the need for a standardised European hybrid training program.

09:50 Discussion

Panel discussion: 09:44 How do we manage difficult cases and incidental findings?

www.myESR.org

Final Programme | ECR 2016

251

Postgraduate Educational Programme

08:30–10:00 Room O

08:30–10:00 Room N

Professional Challenges Session

E3 - ECR Master Classes (Head and Neck)

PC 17

E3 1726a

European variation in imaging: focus on technology

08:30 A-731 Chairman’s introduction G. Frija; Paris/FR

Session Objectives: 1. To highlight the current European disparities in terms of eHealth; in particular, teleradiology and equipment. 2. To explore the opportunities, benefits and possible concerns arising from a harmonised European approach. 08:33 A-732 PACS and eHealth D. Caramella; Pisa/IT

Learning Objectives: 1. To understand the European perspective of interoperability issues regarding radiology. 2. To become familiar with the availability of departmental, enterprisewide and cross-enterprise communication of radiological studies and reports. 08:48 A-733 Reporting and communication O. Ratib; Geneva/CH

Learning Objectives: 1. To understand the value of clinical radiology. 2. To explore opportunities for improved reporting solutions, e.g. structured reporting. 3. To learn the requirements for communication of relevant or unexpected findings. 09:03 A-734 Procedure codes and lexica in radiology for supporting workflow improvements P. Mildenberger; Mainz/DE

Learning Objectives: 1. To become familiar with available coding systems for procedures and radiological findings. 2. To explore opportunities for a European approach. 09:18 A-735 Equipment and innovation B. Brkljačić; Zagreb/HR

Learning Objectives: 1. To become familiar with the need for innovation of radiological equipment - opportunities and weaknesses for radiology departments throughout Europe. 2. To understand the dependency between radiation exposure and equipment renewal. 3. To understand the dependency between innovation, equipment renewal and quality of imaging practice and to discuss procurement issues. Panel discussion: 09:33 What is the European vision on imaging technology?

Characterisation of salivary gland masses Moderator: A. Trojanowska; Lublin/PL

08:30 A-736 A. Ultrasound C. Karaman; Aydin/TR

Learning Objectives: 1. To recognise the signs of malignancy with B-mode and Doppler mode. 2. To become familiar with the technique and clinical applications of US elastography and contrast-enhanced US for salivary gland tumours. 3. To be able to specify the role of fine US fine needle aspiration cytology and US core needle biopsy. 09:00 A-737 B. CT, MRI and PET/CT N.J.M. Freling; Amsterdam/NL

Learning Objectives: 1. To learn how to perform CT and MRI when a tumour of salivary glands is suspected. 2. To learn the morphological signs of malignancy at CT and MRI. 3. To know the role and limits of FDG PET in salivary gland tumours. 09:30 A-738 C. MRI diffusion and perfusion S. Espinoza-Boireau; Paris/FR

Learning Objectives: 1. To become familiar with the principles of MRI diffusion and perfusion. 2. To understand how to integrate these techniques in the MRI protocol in daily practice. 3. To learn the role of these techniques in mass characterisation. 08:30–10:00 Studio 2016

Genitourinary RC 1707

Prostate imaging: how I do it

08:30 A-739 Chairman’s introduction H.-P. Schlemmer; Heidelberg/DE

Session Objectives: 1. To learn the fundamentals of multiparametric MRI in prostate cancer. 2. To become familiar with the current options for image-guided biopsy. 3. To understand the clinical relevance of multiparametric MRI for treatment decision-making during active surveillance and after initial therapy. 08:35 A-740 A. Detection and assessment of aggressiveness P. Puech; Lille/FR

Learning Objectives: 1. To understand the different types of prostate cancer within the gland. 2. To become familiar with common pitfalls of prostate cancer semiology at multiparametric MRI. 3. To understand the MRI “biomarkers” of prostate cancer aggressiveness. 08:58 A-741 B. Image-guided biopsy and staging J.J. Fütterer; Nijmegen/NL

Learning Objectives: 1. To understand the techniques of prostate biopsy. 2. To become familiar with in-bore MR and MR/TRUS fusion guided biopsy approaches. 3. To learn about the optimal imaging protocol for the staging of prostate cancer.

252

ECR 2016 | Final Programme

www.myESR.org

Postgraduate Educational Programme

09:21 A-742 C. Role of imaging in active surveillance and detection of recurrence V. Logager; Copenhagen/DK

Learning Objectives: 1. To learn about the role of multiparametric MRI in guiding therapy towards active surveillance. 2. To learn about the imaging findings in local recurrence after treatment. 3. To understand the impact in treatment planning as a consequence of these findings. Panel discussion: 09:44 Multiparametric MRI: what are the challenges and strategies to solve these?

09:35 A-747 Ionising radiation: when should we be concerned? J. Damilakis; Iraklion/GR

Learning Objectives: 1. To describe the basic concepts of radiation risks to the developing foetus at various gestational ages. 2. To identify implementation strategies for dose reduction in emergency imaging of pregnant patients. 3. To be familiar with medicolegal risk management guidelines. 09:50 Panel discussion with sample cases presentation: Emergency in pregnancy: what is best for the mother and baby?

08:30–10:00 Room E2 08:30–10:00 Room E1

Special Focus Session

State of the Art Symposium

SF 17a

SA 17

08:30 A-748 Chairman’s introduction

Emergency imaging of the pregnant patient

Neuro imaging in paediatrics

A. Rossi; Genoa/IT

08:30 A-743 Chairman’s introduction R. Basilico; Chieti/IT

Session Objectives: 1. To consolidate knowledge of the role and the appropriate uses of the different imaging techniques. 2. To become familiar with the risk of using imaging modalities in pregnant emergency patients. 3. To learn about radiation dose concerns related to emergency in pregnancy. 08:35 A-744 Polytrauma: US, CT or MR A. Palkó; Szeged/HU

Learning Objectives: 1. To discuss the imaging modalities used in the evaluation of pregnant trauma patients. 2. To identify the imaging findings associated with non-pregnancyrelated and pregnancy-specific injuries. 3. To become familiar with a diagnostic imaging algorithm for the evaluation of polytrauma in pregnancy. 09:00 A-745 Pulmonary embolism: CT or scintigraphy? M.-P. Revel; Paris/FR

Learning Objectives: 1. To review the role of CTA and pulmonary scintigraphy for the diagnosis of pulmonary embolism during pregnancy. 2. To learn how to optimise CTA protocols and pulmonary scintigraphy for adequately ruling out pulmonary embolism. 3. To review key imaging findings.

M. Wozniak; Lublin/PL

Learning Objectives: 1. To review the biological effects and safety of MRI. 2. To review procedural issues, indications and contraindications for MRI in pregnant emergency patients. 3. To discuss the risks associated with the administration of iodinated and gadolinium-based contrast agents during pregnancy, and how to monitor or avoid them.

08:35 A-749 Imaging of metabolic disorders in children B. Ertl-Wagner; Munich/DE

Learning Objectives: 1. To learn about the concept of MRI pattern recognition in metabolic disorders. 2. To understand the value of MRI-based grouping of patients for genetic studies. 3. To appreciate the contribution of MR techniques to the diagnosis and research of metabolic disorders. 4. To become familiar with more detailed MRI analysis and interpretation for metabolic disorders. 09:00 A-750 Imaging in paediatric epilepsy T.A.G.M. Huisman; Baltimore, MD/US

Learning Objectives: 1. To learn about the various pathologies that may result in paediatric epilepsy. 2. To understand that a complete diagnostic workup requires a multidisciplinary approach. 3. To become familiar with the MR imaging sequences that are indicated. 09:25 A-751 Imaging headache in children E. Vázquez; Barcelona/ES

Learning Objectives: 1. To learn about the role and value of neuroimaging in children with the different types of headaches, mainly primary and secondary headaches. 2. To become familiar with subtle symptoms or signs (“red flags”) that raise suspicion of intracranial pathology worthy for prompt neuroimaging. 3. To emphasise some underlying aetiologies, such as neoplasms or vascular disorders, that may be potentially life threatening. Panel discussion: 09:50 Can we do without CT in paediatric neuroimaging?

www.myESR.org

Final Programme | ECR 2016

253

Sunday

09:20 A-746 MRI and contrast media: what are the risks for the foetus?

Session Objectives: 1. To become familiar with the MRI features of complex neuropaediatric disorders. 2. To learn how to organise specific MRI study protocols and sequences for children with neurological disorders. 3. To consolidate MRI as the modality of choice for paediatric neuroimaging.

Postgraduate Educational Programme

08:30–10:00 Room F1

E3 - ECR Master Classes (Oncologic Imaging) E3 1726b

Personalised medicine in oncology: what can imaging offer? Moderator: R.G.H. Beets-Tan; Maastricht/NL

08:30 A-752 A. Personalised medicine in oncology: hope or reality? E.E. Voest; Amsterdam/NL

Learning Objectives: 1. To become familiar with the concept of personalised medicine. 2. To learn about the current state-of-the-art management of metastatic disease. 3. To learn how biomarkers can contribute to a personalised approach. 08:55 A-753 B. Radiogenomics: can this assist personalised medicine?

09:00 A-756 B. How can we manage the non-mass breast (enigma) pattern? F. Pediconi; Rome/IT

Learning Objectives: 1. To learn the definition of non-mass in mammography and MRI and to understand why interpretation is difficult. 2. To understand the pathological correlations and the clinical problems. 3. To appraise how new technical developments can help define an appropriate integrated strategy. 09:30 A-757 C. New developments in breast MRI L. Umutlu; Essen/DE

Learning Objectives: 1. To know the principle of non-contrast breast MRI: texture analysis. 2. To understand advantages and limitations of DWI in breast MRI. 3. To become familiar with the main results of high field breast MRI, including their advantages and limitations.

V.J. Goh; London/UK

Learning Objectives: 1. To understand the rationale for radiogenomics in oncology. 2. To learn about the different strategies that can be used to extract data. 3. To understand how radiogenomics may improve tumour phenotyping. 09:20 A-754 C. Hybrid PET/MRI: the next step in personalised cancer care? A. Kjaer; Copenhagen/DK

Learning Objectives: 1. To learn how FDG and non-FDG PET tracers can allow us to visualise cancer cells. 2. To learn about the potential of MRI/PET to improve tumour phenotyping. 3. To learn how MRI/PET could contribute to a personalised approach in oncology. Panel discussion: 09:45 Can imaging facilitate a personalised medicine approach in oncology?

08:30–10:00 Room F2

E3 - ECR Master Classes (Breast) E3 1726c

Challenging questions for breast imaging in 2016: breast density, how to solve the non-mass enigma, new developments in breast MRI Moderator: R.M. Mann; Nijmegen/NL

08:30 A-755 A. Breast density: what the breast radiologist needs to know S.J. Vinnicombe; Dundee/UK

Learning Objectives: 1. To learn the definition of dense breast and the consequences on mammography interpretation and strategies to overcome the limitations of the different modalities. 2. To understand the different methods to measure breast density on mammography, ultrasound and MRI. 3. To understand if breast density or (breast enhancement) BPE have an influence on breast cancer risk.

254

ECR 2016 | Final Programme

08:30–10:00 Room D1

Special Focus Session SF 17b

Actionable pulmonary nodules: should we rely on size only?

08:30 A-758 Chairman’s introduction L. Bonomo; Rome/IT

Session Objectives: 1. To learn about the intrinsic limitations of pulmonary nodule size by both 2D and 3D tools. 2. To appreciate the need of integrating size with other morphological characteristics as well as functional data and clinical parameters. 08:33 A-759 Limitations of nodule measurements A.R. Larici; Rome/IT

Learning Objectives: 1. To describe the limitations of 2D and 3D measurements of lung nodules, including growth measurements during follow-up. 2. To investigate the role of computer-aided diagnosis (CAD) in defining an actionable nodule. 08:51 A-760 Shape and density: predictors of subtypes and mutations in NSCLC? O.L. Sedlaczek; Heidelberg/DE

Learning Objectives: 1. To appreciate the relevance of morphological characteristics of pulmonary nodules, i.e. shape and density, as predictors of subtypes and mutations in NSCLC. 2. To learn how shape and density influence the management of pulmonary nodules. 09:09 A-761 Proliferation tracers and not only R. Boellaard; Amsterdam/NL

Learning Objectives: 1. To become familiar with tracers used in hybrid imaging, not only well-known proliferation tracers but also all other tracers regarding perfusion, hypoxia, and metabolism, helpful for characterising lung nodules. 2. To have an in-depth understanding of the role of hybrid imaging in the evaluation of pulmonary nodules.

www.myESR.org

Postgraduate Educational Programme

09:27 A-762 How necessary is clinical data? A.A. Bankier; Boston, MA/US

Learning Objectives: 1. To investigate clinical data, whether it is significant or not in defining a nodule as actionable. 2. To describe the strategy for managing a solitary pulmonary nodule by taking into account clinical data.

08:30–10:00 Room K

E3 - Rising Stars Programme Basic Session 6: Thoracic emergencies 08:30 A-768 Vascular R. Morgan; London/UK

Panel discussion: 09:45 How to define an actionable nodule in daily practice?

09:00 A-769 Pulmonary C.M. Schaefer-Prokop; Amersfoort/NL

08:30–10:00 Room D2

Radiographers

09:30 A-770 Cardiac C. Loewe; Vienna/AT

RC 1714

The magic of excellent images

08:30 A-763/A-764 Chairmen’s introduction N. Mekis1, A.P. Parkar2; 1Ljubljana/SI, 2Bergen/NO

Session Objectives: 1. To understand the contribution of the radiographers in image quality optimisation. 2. To expand on the challenges and perspectives of image quality in each field. 3. To discuss the importance of excellent images in patient care. 08:35 A-765 A. Image quality optimisation in MRI: a radiographer’s perspective M. Kiss; Miskolc/HU

Learning Objectives: 1. To understand the role of radiographers in MR image quality optimisation. 2. To learn how to effectively and systematically modify scan parameters to optimise MRI protocols. 3. To become aware of recent developments in MRI software and hardware and how these can be used to further optimise image quality in MRI. 08:58 A-766 B. Fine tuning of image quality in computed tomography, the role of the radiographer D. Pekarovic, U. Zdešar; Ljubljana/SI

Learning Objectives: 1. To become familiar with the recent technological advances in CT and how these can be exploited for image quality optimisation. 2. To become aware of the range of possibilities relating to image quality optimisation in CT. 3. To understand the role of the radiographer in optimising CT imaging protocols. 09:21 A-767 C. X-ray radiography: tips and tricks for high quality imaging on the frontline

08:30–10:00 Room G

E3 - ECR Master Classes (Neuro) E3 1726d

Imaging in dementia Moderator: D. Van Westen; Lund/SE

08:30 A-771 A. The neurochemistry of the Alzheimer’s continuum S. Engelborghs; Antwerp/BE

Learning Objectives: 1. To introduce current concepts about the physicochemical and molecular basis of dementia. 2. To understand what misfolded proteins are, and how they play a role in the pathogenesis of (different types of) dementia. 3. To provide an insider view of current and future research avenues in dementia, and to illustrate the contribution of imaging studies. 09:00 A-772 B. MR contribution to diagnosis and differential diagnosis F. Barkhof; London/UK, Amsterdam/NL

Learning Objectives: 1. To understand the concept of mild cognitive impairment (MCI). 2. To learn how to diagnose the different dementia forms using conventional MR. 3. To understand the role of advanced MR techniques in diagnosing dementia. 09:30 A-773 C. PET imaging in dementia K. Herholz; Manchester/UK

Learning Objectives: 1. To appreciate the different ligands relevant to the diagnosis of dementia 2. To understand the sensitivity and specificity of the amyloid-tracer PIB. 3. To appreciate the clinical relevance of PIB.

E. Constantarogianni; Athens/GR

Sunday

Learning Objectives: 1. To introduce the importance of image quality optimisation in x-ray radiography. 2. To discuss the contribution of the radiographer in creating high quality x-ray images. 3. To become aware of strategies for optimal use of hardware and software to facilitate diagnosis. Panel discussion: 09:44 The importance of excellent images for advancing the quality of healthcare

www.myESR.org

Final Programme | ECR 2016

255

Postgraduate Educational Programme

10:30–12:00

Room A

E3 - ECR Master Classes (Musculoskeletal) E3 1826

10:35 A-780 The law of radiology in Colombia: how we arrived to it R. Restrepo; Medellin/CO

Learning Objectives: 1. To learn about government regulation of the practice of radiology in Colombia. 2. To become familiar with the existing regulations for the practice of radiology in different countries. 3. To understand the application of Act 657 of 2001, which regulates the practice of radiology in Colombia. 4. To promote a comprehensive strategy for navigating the radiologycentred regulatory laws.

MSK and intervention

10:30 A-774 Chairman’s introduction A. Gangi; Strasbourg/FR

10:36 A-775 A. How to biopsy soft tissue and bone tumours G.K.O. Åström; Uppsala/SE

Learning Objectives: 1. To learn which tumours are ‘no touch’. 2. To demonstrate how to plan a biopsy: when to culture and when to biopsy. 3. To discuss complications and how to deal with them.

10:55

11:00 A-781 Percutaneous biopsies: how do I do it? F. Uriza; Bogota/CO

Learning Objectives: 1. To propose possible modifications to conventional biopsy techniques tailored to certain cases where ideal conditions cannot be met. 2. To present the local experience of a high complexity hospital in Latin America. 3. To determine when a multimodality imaging evaluation prior to biopsy is required. 4. To establish in which cases contrast administration is appropriate before a CT-guided biopsy is conducted.

10:57 A-776 B. Lower back pain: what can I do? D.J. Wilson; Oxford/UK

Learning Objectives: 1. To learn which common pathologies account for lower back pain that we can treat. 2. To illustrate the common technique used in the specific pathologies. 11:18 A-777 C. Injectables - steroids and platelet-rich plasma (PRP): how and when? M.J.C.M. Rutten; ‘s-Hertogenbosch/NL

Interlude: The history of radiology in Colombia

11:20

Interlude: Colombia, magical realism

11:25 A-782 Minor interventional procedures in tropical diseases

Learning Objectives: 1. To learn about appropriate technique in MSK joint and tendon intervention. 2. To learn about the complications. 3. To illustrate the evidence on the use of steroids and PRP.

A. Morillo; Bogota/CO

Learning Objectives: 1. To learn about various manifestations of tropical diseases. 2. To review cases of tropical diseases that can benefit from interventional procedures. 3. To become familiar with the role of interventional radiology in the diagnosis and management of tropical diseases. 4. To understand the indications of interventional procedures in specific manifestations of tropical diseases.

11:39 A-778 D. Painful solitary bone lesions: what is the most appropriate approach? F. Arrigoni; L’Aquila/IT

Learning Objectives: 1. To learn which painful bone lesions can be treated. 2. To learn how to plan the treatment and how to choose the most appropriate technique. 3. To illustrate complications and diagnostic follow-up. 10:30–12:00

Room B

11:45

Panel discussion: Minimally-invasive procedures: is there a place for the non-interventionalradiologists?

10:30–12:00

Room O

Professional Challenges Session

ESR meets Colombia

PC 18

EM 3

10:30 A-783/A-784 Chairmen’s introduction

From practice to reality: how we do it Welcome by the ESR President: L. Donoso; Barcelona/ES Presiding: K. Riklund; Umea/SE F.G. Lubinus; Bucaramanga/CO

10:30 A-779 Introduction F.G. Lubinus; Bucaramanga/CO

Session Objectives: 1. To have a glance at our country’s peculiarities; not only the cultural aspects, but also its laws and management of diseases. 2. To explore new ways of finding solutions to possible problems presented in our profession.

256

ECR 2016 | Final Programme

Monitoring safety and quality

G. Frija1, A. Torresin2; 1Paris/FR, 2Milan/IT

Session Objectives: 1. To introduce experiences of safety and quality management. 2. To focus on the specific aspects of dose management. 3. To highlight the need of a strong IT support. 10:35 A-785 Experience of total management of quality and safety L. Oleaga Zufiría; Barcelona/ES

Learning Objectives: 1. To introduce the concept of overall quality and safety in a radiology department. 2. To define the distinct aspects of quality and safety to be monitored. 3. To indicate several tools that can be used or implemented for quality control.

www.myESR.org

Postgraduate Educational Programme

10:55 A-786 Dose monitoring systems in CT

11:31 A-792 C. Paediatric abdominal imaging

D. Caramella; Pisa/IT

S.G.F. Robben; Maastricht/NL

Learning Objectives: 1. To highlight the importance of systematic dose monitoring in CT. 2. To demonstrate that dose monitoring may reduce clinically unjustified variations. 3. To propose a paradigm shift from risk communication to safety assurance.

Learning Objectives: 1. To understand the imaging features of congenital disorders of the abdomen. 2. To describe the diagnostic evaluation and imaging presentation of appendicitis in children. 3. To describe the diagnostic evaluation and imaging presentation of volvulus and intussusception in children. 4. To understand the imaging presentation of the most common oncologic disorders of the abdomen in children.

11:15 A-787 Experience from a group of imaging centres A. Palkó; Szeged/HU

Learning Objectives: 1. To explain how quality and safety management principles may be realised in the everyday practice of radiology service providers. 2. To discuss the significance of standardising various aspects of quality and safety in workflow management, image and report quality and patient comfort. 3. To emphasise the importance of uniform attitude and networking in a multi-centre service-providing system. 11:30 A-788 Dose monitoring systems in interventional radiology A. England; Salford/UK

Learning Objectives: 1. To introduce the concept of dose monitoring systems within interventional radiology. 2. To focus on the different dose monitoring solutions available within clinical practice. 3. To highlight the benefit of real-time dose monitoring for patients and staff.

11:45

Panel discussion: What are the bottlenecks in safety and quality management?

10:30–12:00

Room F1

E3 - European Diploma Prep Sessions E3 1823

Paediatric

12:30–13:30

Room B

E3 - The Beauty of Basic Knowledge: Breast Imaging E3 24E

High-risk lesions: solving the dilemma Moderator: J. Camps Herrero; Valencia/ES

12:30 A-793 High-risk lesions: solving the dilemma A. Linda; Udine/IT

Learning Objectives: 1. To learn about the most common high risk lesions and their respective breast cancer risks. 2. To know how to manage these lesions in a multimodal way. 3. To understand how to deal with these lesions in terms of intervention and follow-up. 12:30–13:30

Room D1

E3 - The Beauty of Basic Knowledge: Chest Imaging E3 25E

Dose optimisation made easy in computed tomography of the chest Moderator: N. Howarth; Chêne-Bougeries/CH

10:30 A-789 Chairman’s introduction V. Donoghue; Dublin/IE

Session Objectives: 1. To understand the imaging features of the most common congenital and neoplastic disorders of the brain in children and adolescents. 2. To describe the imaging presentations of the most common disorders of the lung and mediastinum in the paediatric age group. 3. To be familiar with the imaging features of important acute disorders of the abdomen in children and adolescents. 10:33 A-790 A. Paediatric neuro imaging M.I. Argyropoulou; Ioannina/GR

D. Tack; Baudour/BE

Learning Objectives: 1. To review the frequently used terms in qualifying CT dose. 2. To learn how to explain dose description to your patients. 3. To know the lack of appropriateness of the terms used. 13:00 A-795 B. CT angiography and CT of lung disease X. Montet; Geneva/CH

Learning Objectives: 1. To review practical methods of dose reduction in CT angiography and CT of lung disease. 2. To learn how to apply these methods in everyday practice. 3. To know that these practical methods are independent of the CT scanner.

11:02 A-791 B. Paediatric chest imaging C. Owens; London/UK

Learning Objectives: 1. To describe the normal development of the lung and mediastinum. 2. To explain imaging features of congenital disorders of the lung and mediastinum. 3. To understand the imaging manifestations of respiratory distress and bronchopulmonary dysplasia in infants. 4. To describe the most common tumours of the chest in children.

www.myESR.org

Final Programme | ECR 2016

257

Sunday

Learning Objectives: 1. To describe the normal development of the brain. 2. To explain the most common congenital disorders of the brain. 3. To understand the most common brain tumours in children and adolescents.

12:30 A-794 A. Dose descriptors

Postgraduate Educational Programme

14:00–15:30

Room F1

E3 - European Diploma Prep Sessions E3 1923

Urogenital

14:00 A-803 Chairman’s introduction D. Akata; Ankara/TR

Session Objectives: 1. To become familiar with the imaging presentation of common neoplastic and infectious disorders of the kidneys. 2. To describe the typical imaging features of calculous and neoplastic disorders of the ureter and bladder. 3. To understand the imaging presentation of benign and malignant disorders of the prostate. 14:03 A-804 A. Renal and adrenal imaging L.E. Derchi; Genoa/IT

Learning Objectives: 1. To describe the normal imaging anatomy and variants of the kidney and adrenal. 2. To understand the imaging features of benign and malignant tumours of the kidneys. 3. To describe imaging features of benign and malignant tumours of the adrenal glands. 4. To explain the imaging features of infectious disorders of the kidneys. 14:32 A-805 B. Imaging of the ureter and bladder J.-M. Correas, R. Renard Pena, O. Hélénon; Paris/FR

Learning Objectives: 1. To explain the imaging anatomy and variants of the ureter and bladder. 2. To understand the diagnostic evaluation and imaging features of calculi of the ureter and bladder. 3. To describe the imaging features of benign and malignant tumours of the ureter and bladder. 15:01 A-806 C. Prostate imaging H.C. Thoeny; Berne/CH

Learning Objectives: 1. To explain the PIRADS system in prostate imaging. 2. To describe the imaging features of benign prostatic hypertrophy. 3. To understand the imaging features of prostate cancer. 4. To describe the imaging features of inflammatory changes of the prostate.

258

ECR 2016 | Final Programme

www.myESR.org

SCIENTIFIC SESSIONS AND CLINICAL TRIALS I N R A D I O LO GY

Session numbers are prefixed by SS Presentation numbers are prefixed by the letter B The Clinical Trials in Radiology sessions are listed at the end of this section. (page 339)

There are 53 Invest in the Youth scientific paper presenters at ECR 2016. You can find their sessions marked with SPEAKER SUPPORTED BY INVEST IN THE YOUTH

on the following pages.

259

Scientific Sessions

10:30–12:00

11:50 B-0011

Room B

Abdominal Viscera

CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas T. Kim, S. Kim, K. Lee, J. Han; Seoul/KR

SS 201a

Pancreas and bile ducts Moderators: B. Choi; Seoul/KR, G. Zamboni; Verona/IT

10:30–12:00 10:30 B-0001

Distribution and correlation of pancreatic gland and duct dimensions on MRCP in patients without evidence of chronic pancreatitis

Breast SS 202

F. Akisik, Q. Wang, G. Jennings, T. Tirkes, K. Sandrasegaran; Indianapolis, IN/US

10:38 B-0002

Use of grape molasses “Pekmez” as a negative oral contrast agent for magnetic resonance cholangiopancreatography

MRCP pancreatic dimensions as predictors of chronic pancreatitis severity F. Akisik, Q. Wang, G. Jennings, T. Tirkes, K. Sandrasegaran; Indianapolis, IN/US

10:54 B-0004 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:02 B-0005

Breast biopsy Moderators: S. Allen; Sutton/UK, N.N.

10:30 B-0012

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

B. Degirmenci, M. Kara, H. Demirtas, A. Umul, O. Yılmaz, A. Senol, M. Kayan; Isparta/TR

10:46 B-0003

Room C

10:38 B-0013

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

10:46 B-0014

Type 1 and type 2 autoimmune pancreatitis: is there any difference in MRI? R. Negrelli, G. Avesani, E. Boninsegna, L. Frulloni, R. Manfredi, R. Pozzi Mucelli; Verona/IT

True false negative rate of benign histology after stereotactic vacuum-assisted biopsy for BI-RADS IV calcifications in the breast F.E.M. Dams, P.J. Westenend, H.S. Roodenburg-Kooij, M.C. Rozendaal, M.C.J.M. Kock; Dordrecht/NL

A comprehensive analysis of factors contributing to marker migration during stereotactic core needle breast biopsies M. Khalid, A. Jain, M.M. Qureshi, K. Buch, A. Hirsch, M.W. Grinstaff, J.A. Kaplan, B.N. Bloch; Boston, MA/US

Vacuum-assisted breast biopsy guided by dedicated breast CT: first clinical experiences compared with conventional stereotactic breast biopsy S. Wienbeck, E. von Fintel, J. Lotz, U. Fischer; Göttingen/DE

MRI-MRCP findings in focal and diffuse autoimmune pancreatitis and comparison of focal type of the head and of the body-tail

10:54 B-0015

G. Avesani, R. Negrelli, E. Boninsegna, L. Frulloni, R. Manfredi, R. Pozzi Mucelli; Verona/IT

Management strategies for benign papillomas without atypia diagnosed at percutaneous imaging guided breast core biopsy in recently published reports S. Moon, H. Jung, K. Ko, S. Kim; Seongnam-si/KR

11:10 B-0006

Pancreatic cysts as incidental finding in populationbased imaging: clinical relevance

11:02 B-0016

M.-L. Kromrey, J.-P. Kühn, R. Bülow, J. Hübner, N. Hosten; Greiswald/DE

11:18 B-0007

L. Gristina, F. Valdora, L. Cevasco, B. Bignotti, S. Tosto, F. Monetti, F. Rossi, A. Tagliafico, M. Calabrese; Genoa/IT

Multimodal MRI of the liver for detecting of acute inflammation in patients with primary sclerotic cholangitis

11:10 B-0017

J. Yamamura, S. Keller, H. Kooijman, F. Kording, C. Schramm, T. Schuler, G. Adam; Hamburg/DE

11:26 B-0008

MR cholangiography screening in longstanding IBD: prevalence of bile duct pathology indicative of sclerosing cholangitis in a population based cohort 2

1

2

11:18 B-0018

3

A.K. Lunder , J.R. Hov , A. Borthne , E. Viktil , G. Johannesen , K. Tveit4, J. Gleditsch5, M. Vatn1, A. Negård1; 1Lørenskog/NO, 2 Oslo/NO, 3Skien/NO, 4Kristiansand/NO, 5Fredrikstad/NO

Correlation of UK 5-point breast imaging classification and BI-RADS classification of calcification with final histology. Which is a better predictor of malignancy? L. Metaxa1, T. Suaris1, K. Hunter2, P. Dilks1, S. Dani1, S. O’Keeffe1; 1 London/UK, 2Dublin/IE

Extra-hepatic portal vein obstruction (EHPVO) with cholangiopathy: imaging based criteria on the basis of CT and MRCP findings for disease classification and management S. Thapar, S. Desai, A.S. Bhadoria, S. Pargewar, S. Rajesh, A. Mukund, K. Bansal, B. Surekha, S.K. Sarin; New Delhi/IN

11:42 B-0010

Non-surgical complete excision of small suspicious breast lesions using the breast lesion excision biopsy system (BLES) N.M. Abdel Razek; Giza/EG

1

11:34 B-0009

Effects on short-term quality of life of vacuum assissted breast biopsy: comparison between digital breast tomosynthesis and digital mammography

Added value of point shear-wave elastography in the diagnosis of acute cholecystitis

11:26 B-0019

MR-only lesions: yield of biopsy M. Boada, J. Vilanova, J. Barcelo, M. Villalón; Girona/ES

11:34 B-0020

Ultrasound-guided core-needle breast biopsy: comparison of small-sized needles (16G/18G) versus 14G needle diagnostic accuracy R. Rella, M. Giuliani, F. Patrolecco, S.E. Di Giovanni, G. Carlino, M. Romani, P. Rinaldi, P. Belli, L. Bonomo; Rome/IT

J.E. Kim, D.S. Choi, K. Bae, C.Y. Jeong, H.O. Kim; Jinju/KR

260

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

11:42 B-0021

Vacuum-assisted complete excision of solid intraductal/intracystic masses and complex cysts: is follow-up necessary?

11:26 B-0030

V. Quinn-Laurin, J.-C. Hogue, S. Pinault, N. Duchesne; Quebec, QC/CA

11:50 B-0022

Quantitative 3D breast ultrasound analysis may reduce the number of biopsies for benign breast lesions

A. Priola, S. Priola, D. Gned, A. Veltri; Orbassano/IT

11:34 B-0031

Room Z

F. Giganti, A. Ambrosi, D. Chiari, A. Esposito, C. Staudacher, A. Del Maschio, F. De Cobelli; Milan/IT

11:42 B-0032

Molecular Imaging SS 206 10:30 B-0023

Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma Z.M.H.S. Peng; Guangzhou/CN

PET/CT and MR in oncology Moderators: S. Chatziioannou; Athens/GR, N.N.

Added value of apparent diffusion coefficient in the preoperative MRI staging of gastric cancer: comparison with postoperative histology

11:50 B-0033

Benefit assessment of 18F-FDG-PET/CT in patients with advanced melanoma based on the analysis of clinical management changes using the “linked evidence approach”

Investigation of a novel small field of view hybrid compact gamma camera (HCGC) for scintigraphic imaging M.S. Alqahtani1, J.E. Lees1, S.L. Bugby1, L.K. Jambi1, B. Bhatia1, N. Dawood1, W. McKnight1, A.H. Ng2, A.C. Perkins2; 1Leicester/UK, 2 Nottingham/UK

S.-C. Schüle, P. Martus, A. Forschner, K. Nikolaou, C. la Fougère, B. Gückel, C. Pfannenberg; Tübingen/DE

10:30–12:00 10:38 B-0024

10:46 B-0025

Tumour heterogeneity measurement using [18F] FDG PET/CT in patients with lung cancer

GI Tract

N.M. Hughes, P. Murphy, T. Mou, E. Wolsztynski, J. Huang, F. O’Sullivan, K.N. O’Regan; Cork/IE

SS 201b

FDG SUVmax and metabolic tumour burden are associated with major chemotherapy-related tumour markers in NSCLC patients

10:30 B-0035

Morphological distribution and metabolic activity of brown adipose tissue in adult humans A.S. Becker, H.W. Nagel, C. Wolfrum, I.A. Burger; Zurich/CH

11:02 B-0027

11:10 B-0028

10:38 B-0036

10:46 B-0037

Optimisation of iterative image reconstruction for high-definition digital PET/CT

C.L. Wright1, K. Binzel1, J. Zhang1, E. Wuthrick1, P. Maniawski2, M.V. Knopp1; 1Columbus, OH/US, 2Cleveland, OH/US

CT characteristics and clinical relevance of the small-bowel faeces sign in patients with small-bowel obstruction: are there different faeces signs? W. Khaled1, L. Corno1, A.-M. Chuong1, M. Benadjaoud2, I. Boulay-Coletta1, M. Zins1; 1Paris/FR, 2Villejuif/FR

10:54 B-0038 Phase Ia trial comparing digital photon counting detector PET/CT with current photomultiplier PET technology for Yttrium-90 imaging after radioembolisation

Initial experiences with ultra low-dose CT scanning in body packers J.P.D. Noordmans, R.W.F. Geenen, A.M. Wagenvoort, W. Kool, P.R. Algra; Alkmaar/NL

K. Binzel, J. Zhang, T. Saif, A. Siva, C. Lehn, M.V. Knopp; Columbus, OH/US

11:18 B-0029

MR enterography in Celiac disease: correlation with endoscopic, histopathologic, serologic and genetic features A. Radmard, A. Hashemi Taheri, E. Salehian Nik, S. Kolahdoozan, B. Mirminachi, G. Ekhlasi, M. Sotoudeh, R. Malekzadeh, B. Shahbazkhani; Tehran/IR

Evaluation of 68Ga-PSMA-PET/CT in primary staging of prostate cancer patients C. Uprimny, A. Kroiss, L. Geraldo Roig, C. Decristoforo, D. Kendler, E. von Guggenberg, I.J. Virgolini; Innsbruck/AT

A guided tour through the GI tract Moderators: K. Skrobisz-Balandowska; Gdansk/PL, B.E. Van Beers; Clichy/FR

L. Bai, Y. Guo, X. Duan; Xi’an/CN

10:54 B-0026

Room O

Meckel’s diverticulum revisited: MDCT by tracing distal ileal artery of superior mesenteric artery for identifying origin of Meckel’s diverticulum Y. Ra, Y. Ku, S. Lee; Gyeonggi-do/KR

11:02 B-0039

Imaging of gastrointestinal melanoma metastases: correlation with surgical and pathological findings A.E. Othman, T. Eigentler, G. Bier, C. Kloth, C. Pfannenberg, H. Bösmüller, C. Thiel, K. Nikolaou, B. Klumpp; Tübingen/DE

www.myESR.org

Final Programme | ECR 2016

261

Wednesday

A.S.S. Meel-van den Abeelen, G. Weijers, J.C.M. van Zelst, J.M. Thijssen, R.M. Mann, C.L. de Korte; Nijmegen/NL

10:30–12:00

Accuracy of diffusion-weighted MR for distinguishing benign conditions from tumours of the anterior mediastinum: comparison of perfusion sensitive vs. perfusion free ADC measurements

Scientific Sessions

11:10 B-0040

Gastrointestinal involvement from renal cell carcinoma: CT findings and clinicoradiologic features

11:02 B-0049

H. Park, H. Kim, S. Park, J. Lee, A. Kim, H. Ha; Seoul/KR

11:18 B-0041

M. Avanesov, J. Münch, J. Weinrich, L. Well, D. Säring, C. Stehning, E. Tahir, G. Adam, G. Lund; Hamburg/DE

Midgut neuroendocrine tumours: is there a link between mesenteric fibrosis and carcinoid heart disease?

11:10 B-0050

V. Rodriguez Laval, M. Pavel, I. Steffen, B. Wiedenmann, T. Denecke; Berlin/DE

11:26 B-0042

Imaging in dengue: what every radiologist needs to know

11:18 B-0051

Complex morbidity - perianal fistulae and involvement of external genitalia: MR imaging findings and significance of fistulogram

11:26 B-0052

Image quality and diagnostic acceptability of a novel 80 kVp CT low dose protocol with automated tube current modulation in screening of body packing

10:30–12:00

11:34 B-0053

Cardiomyopathies (1)

11:42 B-0054

Moderators: F. Bamberg; Tübingen/DE, R. Dore; Pavia/IT

LGE cardiac imaging on a 3-T scanner: retrospective comparison of breath-holding two-dimensional (2D) phase-sensitive inversion recovery (PSIR) and breathholding 2D IR sequences

11:50 B-0055

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

10:54 B-0048 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

262

Radiation-induced myocardial injury after mediastinal radiotherapy for esophageal cancer N. Kadoya, H. Ota, R. Umezawa, Y. Nakajima, M. Saito, K. Takase, K. Jingu; Sendai/JP

10:30–12:00 Sphericity index (SI) of the left ventricle assessed by cardiovascular magnetic resonance imaging (CMRI) in non-ischemic dilated cardiomyopathies A. Zidi, N. Mnif; Tunis/TN

10:46 B-0047

Compared analysis of two different software for iron overload quantification in cardiac MRI R. Malago, G. Sala, M. Tezza, C. Barbiani, G. Finetto, G. Tabacco, S. Catelan, R. Pozzi Mucelli; Verona/IT

V. Vellucci, A. Mancini, A. Di Sibio, F. Bruno, L. Panebianco, M. Paoli, R. Masi, E. Di Cesare, C. Masciocchi; L’Aquila/IT

10:38 B-0046

Increased epicardial fat and signs of impaired sistolic left ventricular function in NAFLD patients: MRI evaluation and correlation with abdominal and liver fat C. Berzovini, R. Faletti, G. Battisti, E. Vanni, C. Gallesio, E. Mosso, E. Bugianesi, M. Rizzetto, G. Gandini; Turin/IT

Room N

Cardiac

10:30 B-0045

Native myocardial T1-times are not necessarily increased with myocardial collagen: a preclinical study in hypertensive hypertrophic heart disease U. Reiter1, G. Reiter1, G. Adelsmayr1, M. Manninger1, J. Schipke2, A. Greiser3, C. Mühlfeld2, H. Post4, M. Fuchsjäger1; 1Graz/AT, 2 Hannover/DE, 3Erlangen/DE, 4Berlin/DE

J. Aissa, J. Boos, C. Rubbert, J. Caspers, C. Thomas, P. Kröpil, G. Antoch, F. Miese; Düsseldorf/DE

SS 203a

Quantitative T1 mapping for detecting fibrosis and myocardial interstitial expansion in hypertrophic cardiomyopathy D. An, L. Wu, B. Chen, R. Ouyang, J. Xu; Shanghai/CN

S. Devu, U. Matapathi, P. Pantrangam, K. Marathu, R. Sunnadkal; Hyderabad/IN

11:42 B-0044

Delayed myocardial enhancement in paediatric hypertrophic cardiomyopathy: correlation with LV functional and demographic parameters N.H. Behairy, W. EL Mozy, S. El Saeidi, M. Shafik; Cairo/EG

K. Shirodkar, H. Mohanty, M. Bind, V. Mulla, S. Nandikoor, S. Reddy, S. H.N, G. Mallarajapatna; Bangalore/IN

11:34 B-0043

Prediction of the estimated 5 year risk of sudden cardiac death (SCD) by quantitative CMR sequences in patients with hypertrophic cardiomyopathy (HCM)

Room L8

Vascular SS 215

Vasculopathy: form and function Moderators: M. Reiter; Vienna/AT, A. Van der Lugt; Rotterdam/NL

Diagnostic implications of feature tracking derived left and right atrial strain parameters in CMR-positive acute myocarditis

10:30 B-0056

B. Baessler1, A. Dick1, F. Schaarschmidt2, G. Michels1, D. Maintz1, A.C. Bunck1; 1Cologne/DE, 2Hannover/DE

Validation of a novel analytical approach to quantitative myocardial edema imaging in acute myocarditis using T2-mapping B. Baessler1, F. Schaarschmidt2, A. Dick1, M. Treutlein1, B. Schnackenburg3, C. Stehning3, G. Michels1, D. Maintz1, A.C. Bunck1; 1 Cologne/DE, 2Hannover/DE, 3Hamburg/DE

ECR 2016 | Final Programme

18

F-fluorocholine PET-CT imaging of vulnerable atherosclerotic plaques: prospective study with immunohistochemical validation S.A. Vöö1, R. Kwee1, J. Sluimer1, F. Schreuder1, R. Wierts1, R. van Oostenbrugge1, M.J. Daemen2, F.M. Mottaghy1, M. Kooi1; 1 Maastricht/NL, 2Amsterdam/NL

10:38 B-0057

Assessment of endothelial dynfunction, coronary and carotid atherosclerosis in juvenile diabetics M.A.A.A. Salem; Aguza - Giza/EG

www.myESR.org

Scientific Sessions

10:46 B-0058

10:30–12:00 3D black-blood T1-mVISTA for detection of temporal and ophthalmic artery involvement in patients with giant cell arteritis N.N. Sommer1, K.M. Treitl1, E. Coppenrath1, H. Kooijman2, W.H. Sommer1, M.F. Reiser1, T. Saam1; 1Munich/DE, 2Hamburg/DE

10:54 B-0059

Comparative study of neovascularisation in homogeneous and heterogeneous with juxtaluminal black area hypoechoic carotid plaques by SMI and CEUS

11:02 B-0060

The relation between cardiovascular risk factors and aortic wall characteristics in healthy, young adults using 3D black-blood VISTA magnetic resonance vessel wall imaging

Musculoskeletal SS 210

Moderators: R. Hemke; Amsterdam/NL, I.-M. Noebauer-Huhmann; Vienna/AT

10:30 K-03

Common genetic influence on the carotid and femoral intima-media thickening: new potential in screening?

10:39 B-0067

10:47 B-0068

10:55 B-0069

Morphology of atherosclerotic plaques in carotid arteries determined by computed tomography and 10-year cardio-vascular risk assessment (risk SCORE) in patients with hypertension

Genetic variability in the renin-angiotensinaldosterone system and volume of carotid bodies evaluated by carotid artery computed tomography angiography in hypertensive patients

11:11 B-0071

Is class III obesity increase cardiovascular risk?

11:19 B-0072

Ultrasonographic evaluation of CCA and FA IMT and compliance after atorvastatin treatment in premenopausal dyslipidaemic females N. Yurttutan1, M. Baykara1, O. Gundogdu Secen2, B. Kizildag1, M.A. Sarica1; 1Kahramanmaras/TR, 2Elazig/TR

www.myESR.org

Value of Dixon based MRI for the evaluation of inflammatory activity on sacroiliac joint comparative with variety of fat suppression and water-fat separation methods B. Alvarez de Sierra Garcia1, J. Calatayud2, D. Exposito2; 1Madrid/ES, 2 Mostoles/ES

11:27 B-0073

M. Baykara, F.M. Yazar, N. Yurttutan, B. Kızıldağ, M.A. Sarıca; Kahramanmaraş/TR

11:50 B-0066

Sacroiliac radiographic progression after a 2 years follow-up period in recent onset spondyloarthritis: data from the DESIR cohort M. Dougados, C. Demattei, R. van den Berg, F. Thevenin, M. Reijnierse, D. Loeuille, A. Feydy, P. Claudepierre, D. van der Heijde; Paris/FR

P. Jazwiec, P. Gac, M. Chaszczewska-Markowska, K. Bogunia-Kubik, G. Mazur, R. Poreba; Wroclaw/PL

11:42 B-0065

Does a multiplanar precontrast approach improve our diagnostic confidence for bone marrow edema detection and localisation in the sacroiliac joint of patients with spondyloarthritis? C. Giraudo, M. Weber, A. Puchner, J. Grisar, F. Kainberger, C. Schueller-Weidekamm; Vienna/AT

N. Nelassov, M. Morgunov, I. Hripun, V. Dombrovsky, S. Vorobiev, O. Eroshenko, T. Karkoshka; Rostov-on-Don/RU

11:34 B-0064

Diagnostic value of MRI changes within the sacroiliac joint space in spondyloarthritis F. Laloo1, N. Herregods1, G. Varkas1, J. Jaremko2, X. Baraliakos3, D. Elewaut1, F. Van den Bosch1, K. Verstraete1, L. Jans1; 1Gent/BE, 2 Edmonton, AB/CA, 3Herne/DE

11:03 B-0070

Sonographic assessment of brachial artery reactive hyperemia in patients with diabetes and polymorphism in the gene of nitric oxide endothelial synthase using time interval method

Evaluation of inflammatory activity in psoriatic arthritis of the hand with integrated 18F-PET/MRI N. Guberina, A. Körber, M. Forsting, A. Bockisch, A. Sabet, T. Pöppel; Essen/DE

P. Gac, P. Jazwiec, M. Poreba, G. Mazur, R. Poreba; Wroclaw/PL

11:26 B-0063

Identification of specific CT features for the diagnosis of CPPD arthropathy of the wrist K. Ziegeler, T. Diekhoff, S. Hermann, A. Böttner, B. Hamm, K.-G. Hermann; Berlin/DE

D.L. Tarnoki1, A.D. Tarnoki1, B. Fejer1, L. Littvay1, P. Maurovich Horvat1, P. Lucatelli2, C. Baracchini3, G. Schillaci4, M.A. Stazi2; 1Budapest/HU, 2 Rome/IT, 3Padua/IT, 4Terni/IT

11:18 B-0062

Keynote lecture B. Vande Berg; Brussels/BE

A.L.M. Eikendal1, H.M. den Ruijter1, C. Haaring1, J.J.M. Westenberg2, R.J. van der Geest2, M.L. Bots1, I.E. Hoefer1, T. Leiner1; 1Utrecht/NL, 2 Leiden/NL

11:10 B-0061

Trauma and inflammation

Wednesday

Q. Yong, L. Zhang, L. Feng, J. Yuan, S. Shi, J. Bao, T. Pu; Beijing/CN

Room E1

Medial collateral ligament avulsion fracture of the knee: classification and imaging features H.-S. Koo, W. Jin, S. Park, J. Kim, J. Park, K. Ryu; Seoul/KR

11:35 B-0074

Comparison of ssEPI-DWI derived ADC maps with standard FS PD-TSE sequences for detection of traumatic bone marrow lesions (BML) after knee trauma A. Klengel1, S. Klengel2, I. Boettger2, N. Roenisch2, T. Kahn1, P. Stumpp1; 1Leipzig/DE, 2Riesa/DE

Final Programme | ECR 2016

263

Scientific Sessions

11:43 B-0075

A systematic review of studies assessing the anatomic centres of the femoral and tibial footprints of the anterior cruciate ligament

11:34 B-0085

A.P. Parkar1, M.E.A.P. Adriaensen2, S. Vindfeld1, E. Solheim1; 1 Bergen/NO, 2Heerlen/NL

11:51 B-0076

C. Eraslan, M. Calli, A. Oral, O. Kitis, S. Yilmaz; Izmir/TR

11:42 B-0086 Visualisation of the popliteomeniscal fascicles in the posterolateral corner of the knee with 3D-MRI: a feasibility study A.L. Falkowski1, R.W. Huegli2, J.A. Jacobson3, M.T. Hirschmann2, O. Magerkurth4; 1Basle/CH, 2Bruderholz/CH, 3Ann Arbor, MI/US, 4 Baden/CH

10:30–12:00

Comparison of the diagnostic success of MR imaging, FDG- PET imaging and FDG-PET/MR fusion images in the imaging of pharmacoresistant epilepsy

Hippocampal malrotation in benign temporal lobe epilepsy: a volumetric study K. Rahmat, C.-Y. Lau, K.-S. Lim, N. Ramli; Kuala Lumpur/MY

11:50 B-0087

Epilepsy cases: fMRI and MR tractography as qualitative and quantitative tools for proper localisation and pre-operative planning M.K. Metkees1, A.M. Sarry El Din1, Y. Abbas2, E. Geneidi2, A. Gaber2, W. Reda2; 1Giza/EG, 2Cairo/EG

Room E2

Neuro SS 211a

Paediatric and epilepsy Moderators: N. Bargalló; Barcelona/ES, I. Koerte; Munich/DE

10:30 B-0077

Room F1

Oncologic Imaging SS 216a

Connectivity-based parcellation of the developing foetal thalamus: topological changes during gestation A. Jakab, G. Kasprian, G.M. Gruber, D. Prayer, G. Langs; Vienna/AT

10:38 B-0078

10:30–12:00

Hepatocellular cancer: characterisation, response and recurrence Moderators: M.A. Bali; Brussels/BE, A. Fohlen; Caen/FR

10:30 B-0088

Accuracy in antenatal ultrasound in diagnosis of posterior fossa lesions with postnatal MRI correlation

Comparison of HCC tumour size measured in MRI and histopathology: does the sequence matter? M. Armbruster, D. Nörenberg, K. Hoffmann, J. Andrassy, H. Kramer; Munich/DE

S. Bhatnagar1, D. Shah2; 1Delhi/IN, 2Mumbai/IN

10:46 B-0079

10:38 B-0089 Graph theory analysis of single-subject grey matter structure may be beneficial in the diagnostic work-up of malformations of cortical development

The correlation between the minimum and average ADC values of hepatocellular carcinoma and pathological grade X. Li, K. Zhang, Z. Ye; Tianjin/CN

L.R. Kozák, G. Gyebnár, Z. Klimaj, G. Rudas, P. Barsi; Budapest/HU

10:54 B-0080

10:46 B-0090 Data-driven identification of white matter (WM) changes can help finding hard-to-identify malformations of cortical development (MCDs) G. Gyebnar, Z. Klimaj, G. Rudas, P. Barsi, L.R. Kozak; Budapest/HU

11:02 B-0081

Quantitative approach to the posterior cranial fossa and cranio-cervical junction in asymptomatic children with achondroplasia

S. Ahn1, J. Kim1, S. Kim1, J. Han1, Y. Jang2; 1Seoul/KR, 2Incheon/KR

10:54 B-0091

M. Panfili, R. Calandrelli, G. D’Apolito, G. Di Lella, C. Colosimo; Rome/IT

11:10 B-0082

Structural brain alterations of Down syndrome in early childhood evaluation by DTI and volumetric analyses

The role of combined structural MR imaging and spect in refractory epilepsy H. Taha, K. Rahmat, K.-S. Lim, F. Fadzli, N. Ramli; Kuala Lumpur/MY

11:26 B-0084

Combing interictal arterial spin-labelling (ASL) MRI perfusion and FDG PET in assessment of focal cortical dysplasia (FCD) causing intractable epilepsy

The role of diffusion weighted MR imaging in follow-up of response of loco regional interventional therapy of hepatocelleular carcinoma H.M.K. Imam, H.M.A.H. Seif, G.S. Seifeldein, W.M. Abbas; Assuit/EG

11:02 B-0092

The role of perfusion-CT as an early predictor of survival in patients with advanced hepatocellular carcinoma treated with Sorafenib G. Querques, D. Ippolito, C. Talei Franzesi, P. Bonaffini, A. Nasatti, S. Sironi; Monza/IT

H. Günbey1, M. Ceyhan Bilgici1, K. Aslan1, A. Has2, M. Ogur1, A. Alhan2, L. Incesu1; 1Samsun/TR, 2Ankara/TR

11:18 B-0083

Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI to predict early recurrence, microscopic vessel invasion and tumor grade using image features and texture analysis

11:10 B-0093

Diagnostic accuracy of dual-energy CT with spectral imaging compared to single-energy CT in hepatocellular carcinoma: radiologic-pathologic correlation G. Lorenzoni, I. Bargellini, D. Lauretti, F. Turini, V. Caciagli, D. Campani, R. Cioni, C. Bartolozzi; Pisa/IT

A. Garg, K. Bhullar, S. Gaikwad, M. Tripathi, M. Tripathi, G. Shukla, M.B. Singh, S. Chandra, C.S. Bal; New Dehli/IN

264

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

11:18 B-0094

Advanced hepatocellular carcinoma: pre-treatment contrast-enhanced CT texture as prognostic biomarker in patients treated with sorafenib

11:11 B-0104

S. Mulé1, B. Ganeshan2, A. Dohan3, G. Thiéfin1, C. Hoeffel1; 1Reims/FR, 2 Brighton/UK, 3Paris/FR

11:26 B-0095

Contrast-enhanced ultrasound features for differentiation of histologically proven small solitary (d 2cm) liver metastases and hepatocellular carcinomas

H. Pasquier, F. Gardavaud, M. Chiaradia, F. Legou, A. Rahmouni, A. Luciani; Creteil/FR

11:19 B-0105

11:27 B-0106

Y. Ueno1, T. Yoshikawa1, Y. Ohno1, N. Negi1, H. Inokawa2, N. Sugihara2, T. Murakami1, Y. Fujisawa2, K. Sugimura1; 1Kobe/JP, 2Otawara/JP

D. Ippolito, G. Querques, C. Talei Franzesi, P.A. Bonaffini, S. Lombardi, S. Sironi; Monza/IT

11:42 B-0097 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:50 B-0098

Imaging of tumour vessel normalisation under anti angiogenic therapy

11:35 B-0107

M. Bouaboula, L. Mauge, D. Bouda, I. Galy-Fauroux, G. Autret, D. Helley, D. Balvay, L. Fournier; Paris/FR

RGD modified nano iron probe targeted hepatocellular carcinoma cells

Model-based iterative reconstruction technique for low radiation dose abdominal CT: comparison with hybrid iterative reconstruction and filtered back projection techniques

Standard deviation and noise power spectrum as critera for achievable dose reduction with three types of iterative reconstruction G. Van Gompel, N. Buls, J. de Mey; Brussels/BE

11:43 B-0108

Y. Xu, Y. Xu; Shanghai/CN

Effect of tube voltage on CT radiation dose: compared with 100 kVp vs 120 kVp using iterative reconstruction algorithm K. Sim, M. Kim, B. Park, D. Sung, N. Han; Seoul/KR

10:30–12:00

Room F2

Physics in Radiology

10:30–12:00

Room D1

Chest SS 213

CT imaging: effects of body size and use of iterative reconstruction

SS 204

10:30 K-04

10:30

B-0109 Keynote lecture

Is body mass index superior to body weight as a surrogate parameter in the calculation of size specific dose estimates (SSDE)?

Whole lung dynamic perfusion CT for risk stratification of arterial occlusions L. Jimenez-Juan1, H. Mehrez1, C. Dey1, S. Homampour1, P. Salazer-ferrer2, N. Paul1; 1Toronto, ON/CA, 2Minnetonka, MN/US

J. Andersson; Umeå/SE

10:39 B-0099

Pulmonary vessels and perfusion Moderators: E.E.J.G. Coche; Brussels/BE, N.N.

Moderators: B.M. Gramer; Munich/DE, A. Jahnen; Esch-sur-Alzette/LU

10:38 B-0110

J. Boos, J. Aissa, P. Heusch, R.S. Lanzman, C. Schleich, C. Thomas, G. Antoch, P. Kröpil; Düsseldorf/DE

Dual-energy pulmonary blood volume CT for treatment evaluation of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension H. Ota, H. Takagi, K. Sugimura, K. Takase; Sendai/JP

10:47 B-0101

Body mass index based GSI assist in abdominal CT: investigation of radiation dose and image noise

10:46 B-0111

Y. Chai, J. Gao, P. Lv; Zhengzhou/CN

10:55 B-0102

The effect of KV Assist on radiation dose reduction and image quality for abdominal CT in different BMI groups P. Hou; Zhengzhou/CN

11:03 B-0103

Iterative reconstruction comparison in CT: model base (MBIR-VEO), adaptive statistical (ASIR) and new adaptive statistical iterative (ASIR-V)

A new CT-score predictor of haemodynamic changes in patients with chronic thromboembolic pulmonary hypertension M.B. Leone, M. Giannotta, M. Palazzini, M. Cefarelli, S. Martìn Suàrez, M.L. Bacchi Reggiani, N. Galiè, M. Zompatori; Bologna/IT

10:54 B-0112

Pulmonary vessel volume (PVV) change vs change in forced vital capacity (FVC) as a predictor of mortality in IPF J. Jacob1, B. Bartholmai2, R. Karwoski2, A. Nair1, S. Raghunath2, S. Rajagopalan2, S.L.F. Walsh1, A. Wells1, D. Hansell1; 1London/UK, 2 Rochester, MN/US

P. De Marco, M. Guernieri, D. Origgi; Milan/IT

www.myESR.org

Final Programme | ECR 2016

265

Wednesday

Diagnostic value of quantitative perfusion maps with CT-perfusion technique in assessment of tumour response to Sorafenib treatment in patients with advanced HCC lesions

Comparison of different iterative and FBP reconstruction techniques with respect to image quality in chest CT examinations H.K. Andersen1, D. Völgyes2, A. Stray-Pedersen1, A.C.T. Martinsen1; 1 Oslo/NO, 2Gjøvik/NO

W. Wang, Y. Dong, X.-L. Zhang, F. Mao; Shanghai/CN

11:34 B-0096

Assessment of new model-based iterative reconstruction kernels for the detectability of small hypervascular liver lesions: a phantom study

Scientific Sessions

11:02 B-0113

Prognostic value of CT-angiographic features of right ventricular dysfunction in patients with acute pulmonary embolism M. Wiśniewska, P. Palczewski, M. Gołębiowski, M. Bielecki, S. Goliszek, P. Pruszczyk; Warsaw/PL

11:10 B-0114

The relation between severity of contrast reflux into the inferior caval vein on CTA and mortality in patients with acute pulmonary embolism W. Kroon1, A. Braber2, J.-W.C. Gratama2, F. van Raamt2, P.E. Spronk2, H.J. van der Zaag-Loonen2; 1Deventer/NL, 2Apeldoorn/NL

11:18 B-0115

Acute pulmonary embolism among patients with and without malignancy: comparison of cardiac measurements using CT pulmonary angiography G. Aviram, Y. Hadad, E. Soikher, A. Bendet, S. Berliner, S. Greenberg, Y. Topilsky, T. Ziv-Baran, A. Milwidsky; Tel-Aviv/IL

11:34 B-0117

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

10:54 B-0123 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:02 B-0124

Automatic assessment of cardiac load due to acute pulmonary embolism: saddle vs. central and peripheral emboli distribution G. Aviram, O. Sadovnik, E. Soikher, A. Bendet, T. Ziv-Baran, S. Berliner, H. Shmueli, L. Friedensohn, Y. Topilsky; Tel-Aviv/IL

11:26 B-0116

10:46 B-0122

Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: correlations between computed tomography findings and cerebral complications

11:10 B-0125

Coronary and vascular calcification assessed by computed tomography in patients with pulmonary embolism

Diagnostic imaging in the diagnosis of suspected pulmonary embolism during pregnancy and the immediate post-partum period

10:30–12:00

11:18 B-0126

11:26 B-0127

11:34 B-0128 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:42 B-0129

10:38 B-0121

US/CT guided percutaneous treatment of renal tumours using radiofrequency and microwave ablation

Renal T1 tumours and ablative techniques: which one to use?

Comparison of cryoablation and microwave ablation for percutaneous renal ablation: focus upon safety and efficacy

11:50 B-0130

Ablation outside the liver

Ultrasound-guided radiofrequency ablation (RFA) to treat benign thyroid nodules: effectiveness after one and six months C. De Angelis, C.G. Monaco, L.C. Pescatori, F. Sardanelli, L.M. Sconfienza, G. Mauri; San Donato Milanese/IT

R. Cervelli, S. Mazzeo, B. Pontillo Contillo, L. De Napoli, P. Miccoli, D. Caramella; Pisa/IT

E. Mavrovi, M. Cuinet, B. Richioud, C. Mastier, F. Pilleul, G. Chvetzoff, A.-C. Kalenderian; Lyon/FR

Evaluation of microwave ablation (MWA) of lung malignancies with real-time enhanced spatial energy control to achieve a spherical ablation zone

MWA, RFA and LITT in patients with non-colorectal lung metastases: comparative evaluation of tumour volume and recurrence rates T.J. Vogl, S. Exner, S. Zangos, K. Eichler, N.-E. Nour-Eldin; Frankfurt a. Main/DE

10:30–12:00

Room K

Genitourinary SS 207

Radiofrequency ablation as an alternative local treatment for hyperfunctional solid thyroid nodules: a single centre experience

Evaluation of pain reduction after percutaneous thoracic cryoneurolysis in chest wall metastatic patients

T.J. Vogl, L. Basten, B. Panahi, N.-E. Nour-Eldin, N.N.N. Naguib; Frankfurt a. Main/DE

Moderators: G. Carrafiello; Varese/IT, M. Tsitskari; Athens/GR

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Management of renal tumours by US-guided radiofrequency ablation: our experience in 140 patients

A. Velarde Pedraza, A. Gil Sierra, J. Abadal Villayandre, E. Galvez Gonzalez, M. Alvarez Perez; Madrid/ES

Room D2

Interventional Radiology

10:30 B-0120

E. Mavrovi, H. Beji, O. Tredan, T. Bachelot, I. Ray-Coquard, P. Heudel, M. Peix, N. Guerin, F. Pilleul; Lyon/FR

G. Mauri, G.M. Varano, P. Della Vigna, G. Bonomo, F. Orsi; Milan/IT

S. Reddy, A. Hill, D. Patel; Edinburgh/UK

SS 209

Primary breast tumour percutaneous cryoablation in patients with metastatic breast cancer

S. Grigoriadis1, D. Filippiadis1, J. Zechlinski2, A. Mazioti1, A. Kelekis1, S. Tutton2, N. Kelekis1; 1Athens/GR, 2Wisconsin, WI/US

M.C. Williams1, N. Morley1, K. Muir1, E.J.H. van Beek1, J.H. Reid2, J. Murchison1; 1Edinburgh/UK, 2Melrose/UK

11:50 B-0119

A. Pisani Mainini1, L.M. Sconfienza1, M. Alì1, G. Di Leo1, F. Sardanelli1, G. Mauri2; 1Milan/IT, 2San Donato Milanese/IT

A.C. Montealegre Angarita, M. Rendon Villa, X. Serres, E. Trilla, M. Juarez Garcia; Barcelona/ES

J. Etievant, N. Vinurel, S. Dupuis-Girod, E. Decullier, D. Gamondes, C. Khouatra, V. Cottin, D. Revel; Bron/FR

11:42 B-0118

Thermal ablation of benign thyroid nodules: a systematic review and meta-analysis

Technical advances Moderators: U.G. Mueller-Lisse; Munich/DE, R. Turkay; Istanbul/TR

10:30 B-0131

Preoperative CT findings to predict postoperative inguinal hernia after robot-assisted laparoscopic radical prostatectomy K. Sim, D. Sung, N. Han, B. Park, M. Kim, Y. Cho, S. Cho; Seoul/KR

266

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:38 B-0132

10:30–12:00 MR spectroscopy in the differentiation of benign, borderline and malignant cystic epithelial ovarian tumours F. Ma, J. Qiang, G. Zhang; Shanghai/CN

10:46 B-0133

Radiographers SS 214

10:30 B-0142

10:38 B-0143

J. Mc Nulty1, S. Lewis2, S. Lane3, P. White4, S. Mackay3; 1Dublin/IE, 2 Sydney/AU, 3Liverpool/UK, 4Hong Kong/HK

11:18 B-0137

2

2

11:02 B-0146

J.G. Stowe, J. McNulty; Dublin/IE

11:10 B-0147

11:18 B-0148

Renal allograft shearwave elastography: a new diagnostic tool to assess chronic allograft alterations compared with biopsy

11:26 B-0149

N. Gaini1, E. Yilmaz1, B. Çağlı1, S.A. Tuncel1, M. Bulakci2, H. Genchellac1, M.E. Ünlü1; 1Edirne/TR, 2Istanbul/TR

1

2

2

2

Radiographer’s expectations for role development: a survey in the perspective of Norwegian radiography students F. Tavares, A.F.C.L. Abrantes, L.P. Ribeiro, R.P.P. Almeida, J.P. Pinheiro, K.B. Azevedo, S. Rodrigues; Faro/PT

11:42 B-0151

Zoomed EPI-DWI of the kidney using twodimensional spatially-selective radiofrequency excitation pulses

Validation of a competence profile for MR radiographers using a formal research process J. Castillo1, C.J. Caruana1, P.S. Morgan2, C. Westbrook3, A. Mizzi1; 1 Msida/MT, 2Nottingham/UK, 3Cambridge/UK

11:34 B-0150

The contribution of diffusion tensor imaging in chronic kidney disease

A national survey on radiographers and research: roles and attitudes K.G. Vikestad1, L. Hafskjold2, E. Kjelle2, S. Sebuodegaard1, S. Hofvind1; 1 Oslo/NO, 2Kongsberg/NO

C. Sportoletti, S. Brocchi, A. Croci Chiocchini, A. Scrivo, G. Comai, C. Serra, A. Marchetti, M. Zompatori; Bologna/IT

11:50 B-0141

The impact of education on radiologic technology as a developing scientific discipline in Austria G. Unterhumer, L. Handlechner; Vienna/AT

MRI to evaluate the response of the locally advanced cervical cancer to CCRT: MRS (magnetic resonance spectroscopy), DWI (diffusion weighted image) and T2WI H. Kwon, B. Kang; Seoul/KR

11:42 B-0140

Blending healthcare and educational technologies to enhance radiography healthcare information technology education

2

F. Albarello , G.C. Parenti , I. Nanni , F. Ansaloni , A. Passari , M. Giganti1, P. Campioni1, M. Valentino3; 1Ferrara/IT, 2Ravenna/IT, 3 Tolmezzo/IT

11:34 B-0139

Inter-professional simulation-based education in trauma: human factors M.L. Howard, C. Brown, J. Morse; Aberdeen/UK

Addition of diffusion-weighted imaging for the clinical MR assessment of acute pyelonephritis (APN): a prospective multicentric study 2

Social media and simulation: using a simulation suite and digital media to develop analytical and reflective skills in the undergraduate radiographer E.M. Carver; Wrexham/UK

Acustic radiation force impulse (ARFI) evaluation of small (<4 cm) renal masses-preliminary results

1

11:26 B-0138

10:46 B-0144

10:54 B-0145

C. Bruno, A. Bucci, C. Dallaserra, R. Pozzi Mucelli; Verona/IT

Emotional intelligence and academic performance in radiography education

Good practice: lumbosacral spine x-ray examination K. Paalimäki-Paakki, A. Henner; Oulu/FI

2

Y. He , P. Riffel , D. Hausmann , S.O. Schönberg , U. Attenberger ; 1 Beijing/CN, 2Mannheim/DE

11:50 B-0152

Accuracy of the interpretation of chest radiographs for the radiographers L.P. Ribeiro1, D. Pinto1, A.F.C.L. Abrantes1, R.P.P. Almeida1, K.B. Azevedo1, J.P. Pinheiro1, S. Rodrigues1, C.A. da Silva2; 1Faro/PT, 2 Evora/PT

www.myESR.org

Final Programme | ECR 2016

267

Wednesday

Perfusion and diffusion characteristics of endometrial malignancy based on intraxovel incoherent motion MR imaging at 3.0 T: differentiation from uterine nonmalignant tissues J. Liu, Z. Wang; Tianjin/CN

11:10 B-0136

Continuing professional development (CPD) considerations in a newly state registered profession J.M. Grehan, M.-L. Butler, L.A. Rainford; Dublin/IE

Evaluation of slice encoding for metal artefact correction (SEMAC) sequences in patients with intrauterine contraceptive device: removing metal artifacts in MR scans of female pelvic regions C. Guo1, Z. Wang1, H. Zhang1, T. Qian2, N. Yutaka3; 1Changchun/CN, 2 Beijing/CN, 3California, CA/US

11:02 B-0135

Radiographers’ education: the curriculum Moderators: P.H. Hogg; Manchester/UK, N.N.

Sonoelastography in differentiation between endometrial hyperplasia and endometrial carcinoma M. Shady, M. Abdel Latif, H. Nabil; Mansoura/EG

10:54 B-0134

Room G

Scientific Sessions

10:30–12:00

Room M 1

10:30–12:00

Room M 2

Head and Neck

Paediatric

SS 208

SS 212

Orbits and olfaction Moderators: L.S. Politi; Worcester, MA/US, T. Rodt; Hannover/DE

Moderators: P. Gulino; Florence/IT, D. Prayer; Vienna/AT

10:30 B-0163

10:30 K-02

Keynote lecture P.-Y. Marcy; Ollioules/FR

10:39 B-0153

Usefulness of colour Doppler flow imaging in the management of lacrimal gland lesions

Can real-time ultrasound elastography be used in early period of Graves’ ophthalmopathy instead of MRI? K. Agladioglu, E.N. Cetin, G. Pekel, R. Yagci, K. Yilmaz; Denizli/TR

11:03 B-0156

Infra-orbital nerve involvement on MRI in IgG4related ophthalmic disease (IgG4-ROD): a specific sign? A. Lecler, J. Bensoussan, R. Deschamps, H. Picart, O. Galatoire, M. Zmuda, J.-C. Sadik; Paris/FR

11:19 B-0158

10:46 B-0165

Paediatric CNS T1 shortening after gadolinium: influence of radiation and chemotherapy S. Kinner, T.B. Schubert, S. Rebsamen, R. Bruce, S. Reeder, H. Rowley; Madison, WI/US

10:54 B-0166

Subarachnoid/subdural hyper-intensity on diffusionweighted MRI predicts severe brain parenchymal injury in children with meningitis? Z. Qiao; Shanghai/CN

11:02 B-0167

Safety of gadoteric acid in over 1,600 children included in a prospective observational study M. Hackenbroch, D. Chang, D. Maintz; Cologne/DE

11:10 B-0168

Isolated and syndromic corpus callosum dysgenesis (CCD): diagnostic value of foetal MRI S. Bernardo, V. Vinci, M. Saldari, E. Marchionni, A. Antonelli, A. Pizzuti, C. Catalano, L. Manganaro; Rome/IT

Post-orbital exenteration: CT findings S.M. Elkhamary; Riyadh/SA

11:27 B-0159

Dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion MR imaging in paediatric neurooncology, first step: a clinical feasibility study M. Martucci, A. Botto, G.M. Di Lella, E. Ruberto, R. Russo, T. Verdolotti, S. Gaudino, C. Colosimo; Rome/IT

Diffusion tensor imaging of extraocular muscle in thyroid associated orbitopathy J. Han, H. Seo, H. Lee, Y. Lee; Ansansi Gyunggido/KR

11:11 B-0157

10:38 B-0164

Morphometric symptoms of dacryocystitis in nonenhanced computed tomography A. Ageev1, A. Dergilev2, V. Obodov1, O. Zykov1; 1Ekaterinburg/RU, 2 Novosibirsk/RU

10:55 B-0155

Arterial spin labeling predicts cerebellar tumour grading in children: correlations between histopathological vascular density and perfusion MRI V. Dangouloff-Ros1, C. Deroulers2, E. Shotar1, D. Grévent1, R. Calmon1, S. Puget1, F. Brunelle1, P. Varlet1, N. Boddaert1; 1Paris/FR, 2Orsay/FR

A. Lecler, F. Lafitte, P. Koskas, E. Nau, P.-V. Jacomet, O. Berges; Paris/FR

10:47 B-0154

Brain and neck

11:18 B-0169

Residence times of non-specific gadolinium-based contrast media in orbital mass lesions: results of pharmocokinetic contrast-enhanced MRI studies

Application of 3D cranial ultrasonography for followup of neonates: can it replace follow-up 2D cranial ultrasonography? Y. Kim, Y. Choi, J.-E. Cheon, H. Choi, T. Kim, H. Cho, J.-E. Park, W. Kim, I.-O. Kim; Seoul/KR

K. Erb-Eigner, P. Asbach, M. Taupitz, R. Lawaczeck; Berlin/DE

11:35 B-0160

11:26 B-0170 Ocular color Doppler ultrasound (OCDUS) assessment of blood flow velocities changes in central retinal artery (CRA) and vein (CRV) after islet transplantation in type 1 diabetic patients A. Di Chiara, M. Venturini, P. Maffi, L. Piemonti, P. Fiorina, A. Secchi, F. De Cobelli, A. Del Maschio; Milan/IT

11:43 B-0161

Diffusion-weighted magnetic resonance imaging in diabetic retinopathy

11:34 B-0171

Evaluation of parotid glands with real-time ultrasound elastography in children

11:42 B-0172

Ultrasonographic differentiation between thyroglossal duct cyst and dermoid cyst in children H. Choi, Y. Choi, J.-E. Cheon, W. Kim, I.-O. Kim, S. Jang; Seoul/KR

Evaluation of olfactory functional MRI in major depressive patients before and after treatment S. Hibat-Allah, K. Tran Dong, D. Ducreux; Paris/FR

268

A. Hambardzumyan, N.H. Dallakyan; Yerevan/AM

G. Gungor1, N. Yurttutan1, N. Bílal1, M.S. Menzilcioglu2, M. Duymus2, S. Avcu2, S. Citil1; 1Kahramanmaras/TR, 2Ankara/TR

V. Burulday, K. Örnek, M. Inal, H. Güler, B. Ünal Daphan, N. Örnek; Kirikkale/TR

11:51 B-0162

Intraoperative navigated neuroultrasound in elective and urgent enfant and paediatric neurosurgery

ECR 2016 | Final Programme

11:50 B-0173

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Diagnostic reference levels for emergency head CT in paediatric patients Z. Vawda, W. Groenewald, J.M. Akudugu, R.D. Pitcher; Cape Town/ZA

www.myESR.org

Scientific Sessions

10:30–12:00

Room M 3

Cardiac SS 203b

11:43 B-0183

The evolving role of cardiac CT Moderators: F. Cademartiri; Rotterdam/NL, G. Feuchtner; Innsbruck/AT

Differences in aortic valve area estimation due to left ventricular outflow tract area discrepancy measured by transthoracic echocardiography and CT planimetry J. Fijalkowska, D. Galaska, J. Pienkowska, B. Regent, K. Dziadziuszko, R. Galaska, E. Szurowska, M. Fijalkowski; Gdansk/PL

10:30 K-01 Keynote lecture F. Wolf; Vienna/AT

Oncologic Imaging C.S.I., coronary scene investigation: plaque composition analysis in a STEMI population

SS 216b

10:30 B-0184 Diagnostic accuracy of coronary CT angiography with 3rd generation dual-source CT and automated tube voltage selection: clinical application in a nonobese and obese patient population S. Mangold1, J. Wichmann1, C. De Cecco1, A. Varga-Szemes1, D. Caruso1, Z. Poole1, S. Fuller1, K. Nikolaou2, U.J. Schoepf1; 1Charleston, SC/US, 2Tübingen/DE

10:55 B-0176

10:38 B-0185

Contrast media reduction in CT-angiography of coronary artery bypass grafts

Preliminary study on high-pitch dual-source CT coronary angiography with low contrast volume injection protocols at ultra low tube voltage (70kV) Y. Yi, Y.-N. Wang, J.-M. Liu, J. Cao, Y. Wang, Z.-Y. Jin; Beijing/CN

11:11 B-0179

10:46 B-0186

10:54 B-0187

The impact of different fat compartments on the presence of coronary artery disease

Coronary computed tomographic angiography at 80 kVp and knowledge-based iterative model reconstruction is non-inferior to that at 100 kVp with iterative reconstruction 11:10 B-0189

Change of liver metastases under therapy: do target lesions represent the changes in the hepatic tumour burden? F.O. Hofmann, V. Heinemann, J. Holch, A. Baumann, N. Hesse, M. D‘Anastasi, W.H. Sommer; Munich/DE

11:18 B-0190 A vulnerability marker for coronary artery plaque using ECG-gated CT histographic analysis: comparison with intravascular ultrasound (IVUS)

Contrast-enhanced diffusion-weighted MRI vs contrast-enhanced CT for detecting liver metastases for potentially resectable pancreatic ductal adenocarcinoma J.J. Hermans, D. Riviere, E. van Geenen, M. van Zanten, S. Radema, K. van Laarhoven; Nijmegen/NL

O. Ghekiere1, A. Nchimi1, J. Djekic1, M. El Hachemi1, M. Isabelle1, D. Hansen2, P. Vanhoenacker3, A. De Roos4, P. Dendale2; 1Liège/BE, 2 Hasselt/BE, 3Aalst/BE, 4Leiden/NL

11:35 B-0182

Hyperintensity on delayed-phase, gadobutrolenhanced MRI is a significant predictor of survival in a nonsurgical population with colorectal liver metastases H.M. Cheung, J. Kim, J.M. Hudson, L. Milot; Toronto, ON/CA

11:02 B-0188

Coronary CT angiography: patient-related factors determining image quality using a volumetric CT scanner

Evaluation of primary and secondary liver lesions: dual energy CT (DECT) vs. MRI T.J. Vogl, N. Ring, R. Bauer, M. Kerl; Frankfurt a. Main/DE

J. Lee, C. Park, T. Kim; Seoul/KR

11:27 B-0181

Interval increase in lesion enhancement on hepatocellular phase gadoxetic acid enhanced MRI is associated with complete response to chemotherapy in colorectal liver metastases S. Islam, R. Yinn, A. Riddell, H. Tam, D.-M. Koh; London/UK

Z.D. Drobni, M. Kolossvary, D. Horcsik, J. Karady, A. Jermendy, A.D. Tarnoki, G. Jermendy, B. Merkely, P. Maurovich-Horvat; Budapest/HU

11:19 B-0180

Impact of preoperative sarcopenia and visceral obesity, assessed through CT-scan imaging, on postoperative outcome in pancreatic cancer patients undergoing pancreaticoduodenectomy A. Damascelli, G. Cristel, N. Pecorelli, G. Carrara, M. Braga, A. Del Maschio, F. De Cobelli; Milan/IT

K. Higashigaito, A. Plass, D. Husarik, F. Maisano, H. Alkadhi; Zurich/CH

11:03 B-0177

Advanced imaging methods (2) Moderators: C. Ayuso; Barcelona/ES, O.V. Kucheruk; Moscow/RU

S.R. Fuller, D. Caruso, S. Hinen, J.L. Wichmann, C.N. De Cecco, S. Mangold, C. Tesche, A. Varga-Szemes, U.J. Schoepf; Charleston, SC/US

10:47 B-0175

Room M 4

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Chemical shift MRI at 3 T to differentiate hepatocellular carcinoma and non-hepatocellular malignant tumors of the liver K. Ozturk, E. Soylu, G. Savci; Bursa/TR

C. Lim1, J. Park1, J. Lee1, E.-J. Kang2; 1Taegu/KR, 2Busan/KR

11:26 B-0191

Whole liver CT texture analysis to predict the development of colorectal liver metastases: a multicentre study R.C.J. Beckers1, D.M. Lambregts1, R.S. Schnerr1, S.-X. Rao2, A.G.H. Kessels1, M. Maas1, G.L. Beets3, C. Verhoef4, R.G.H. Beets-Tan3; 1 Maastricht/NL, 2Shanghai/CN, 3Amsterdam/NL, 4Rotterdam/NL

www.myESR.org

Final Programme | ECR 2016

269

Wednesday

10:39 B-0174

10:30–12:00

Scientific Sessions

11:34 B-0192

Whole volume vs segmental CT texture analysis of the liver: can we predict which areas are at risk to develop metachronous colorectal liver metastases?

11:18 B-0201

R.C.J. Beckers1, D.M. Lambregts1, R.S. Schnerr1, A.G.H. Kessels1, M. Maas1, S.R. Pruijssers1, L.A. da Costa Andrade2, G.L. Beets3, R.G.H. Beets-Tan3; 1Maastricht/NL, 2Coimbra/PT, 3Amsterdam/NL

11:42 B-0193

Quantitative functional MRI in a clinical orthotopic model of pancreatic cancer in immunocompetent Lewis rats

L. Valero1, S. Marco2, N. Fretellier1, F. Baudimont3, J.-L. Guerquin-Kern2, M. Rasschaert1, P. Robert1, J.-M. Idee1, C. Corot1; 1 Roissy/FR, 2Orsay/FR, 3Saint Herblain/FR

11:26 B-0202

L. Zheng, Z. Zhang, W. Li, A.C. Gordon, A.C. Larson; Chicago, IL/US

11:50 B-0194

Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumours

Imaging and identification of gadolinium deposits in deep cerebellar nuclei of gadodiamide-repeatedly treated rats

Signal intensity evaluation in dentate nuclei, pons, globus pallidus and thalamus in patients with multiple sclerosis: gadolinium retention assessment C. Tramontini, J.A. Mora, F. Aluja, C. Herazo-Bustos, C. Navas; Bogota/CO

11:34 B-0203

K. Sugimoto, K. Saito, Y. Kobayashi, F. Moriyasu; Tokyo/JP

MRI analysis of diffuse axonal injury: haemorrhagic lesions in the mesencephalon indicate poor longterm outcome S. Abu Hamdeh, N. Marklund, M. Lannsjö, T. Howells, R. Raininko, J. Wikström, P. Enblad; Uppsala/SE

10:30–12:00

Room M 5

Neuro SS 211b

11:42 B-0204

P. Pullens1, L. Claes2, J. Verheyden2, P.M. Parizel1, .. on behalf of CENTER-TBI Participants&Investigators1; 1Antwerp/BE, 2 Leuven/BE

Gadolinium deposition and trauma Moderators: H. Hanelore; Cluj-Napoca/RO, N.N.

10:30 B-0195

Comparative study of Gd deposits in rat brain after repeated, high doses of linear and macrocyclic contrast agents for magnetic resonance imaging

11:50 B-0205

J. Lohrke; Berlin/DE

10:38 B-0196

Accumulation of gadolinium-based contrast media in the dentate nucleus and globus pallidus: a 18-year longitudinal study of a multiple sclerosis cohort Y. Forslin, F. Hashim, S. Shams, G. Bergendal, J. Martola, M. Kristoffersen-Wiberg, S. Fredrikson, P. Aspelin, T. Granberg; Stockholm/SE

10:46 B-0197

10:54 B-0198

High T1 signal intensity in the dentate nucleus after multiple exposures to gadiodiamide: intra-individual comparison between T1- weighted spin echo and 3D MP-RAGE sequences

14:00–15:30

Changes in brain signal intensity (SI) after repeated injections of gadolinium-based contrast agent (GBCA): a systematic review

SS 301a

14:00 K-05

Keynote lecture A.M. Riddell; London/UK

14:09 B-0206

Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterisation of liver metastases P. Bannas1, C. Bookwalter2, T. Ziemlewicz2, U. Motosugi3, A. Munoz del Rio2, T. Potretzke2, G. Adam1, S. Nagle2, S.B. Reeder2; 1 Hamburg/DE, 2Madison, WI/US, 3Yamanashi/JP

14:17 B-0207

Efficiency of non-contrast-enhanced liver imaging sequences added to initial rectal MRI in rectal cancer patients S. Kim, K. Kim, S. Hwang, S. Park, H. Kim; Suwon-si/KR

Signal change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide J. Ramalho, R.C. Semelka, M. AlObaidy, M. Ramalho, R. Hoffmann Nunes, M. Castillo; Chapel Hill, NC/US

270

Liver metastases: detection, characterisation and treatment response assessment Moderators: E. Kasatkina; Heidelberg/DE, A.M. Riddell; London/UK

G. Di Leo, F. Doniselli, M. Alì, F. Sardanelli; San Donato Milanese/IT

11:10 B-0200

Room B

Abdominal Viscera

J. Ramalho, M. Ramalho, M. AlObaidy, R. Hoffmann Nunes, M. Castillo, R.C. Semelka; Chapel Hill, NC/US

11:02 B-0199

Structured reporting of traumatic brain injury CT images by trained neuroscientists for clinical research: an inter-rater reliability study T. Vande Vyvere1, L. Claes2, L. van den Hauwe1, G. Wilms2, D. Smeets2, P.M. Parizel1; 1Antwerp/BE, 2Leuven/BE

Does gadolinium remain in our heads? A comparison trial of T1 signal intensity after repeated administration of gadoterate meglumine B.-N. Marincu, M. Forsting, L. Umutlu; Essen/DE

High quality MRI data needs visual quality control: a multicenter experience

ECR 2016 | Final Programme

14:25 B-0208

Can we predict the treatment response of colorectal liver metastasis using hepatobiliary phase (HBP) in Gd-EOB-DTPA-enhanced MR imaging? H. Lee, C. Lee, Y. Park, J. Lee, J. Choi, K. Kim, C. Park; Seoul/KR

www.myESR.org

Scientific Sessions

14:33 B-0209

Presurgical staging of colorectal liver metastases after chemotherapy: evaluation with diffusionweighted MR imaging and gadoxetic acid-enhanced MRI at 3T device P. Boraschi, F. Donati, L. Urbani, M. Castagna, F. Pacciardi, R. Gigoni, F. Falaschi; Pisa/IT

14:41 B-0210

Comparison of PET/CT and geometric accuracy for predicting local tumour progression 24 h post-RF ablation of liver metastases F. Vandenbroucke, J. Vandemeulebroucke, J. de Mey; Brussels/BE

15:05 B-0213

P. Clauser1, M. Bazzocchi2, M. Marcon3, M.A. Marino1, C. Zuiani2, M. Dietzel4, P.A.T. Baltzer1; 1Vienna/AT, 2Udine/IT, 3Zurich/CH, 4 Erlangen/DE

14:40 B-0221

14:48 B-0222

14:56 B-0223

Comparision of contrast-enhanced ultrasound with CT in differential diagnosis of liver abscess from malignant hepatic tumours

15:04 B-0224

15:12 B-0225

SS 302

15:20 B-0226

Breast innovation, biomarkers Moderators: C.S. Balleyguier; Villejuif/FR, M.H. Fuchsjäger; Graz/AT

14:00 B-0216

Quantification of microvascular hemodynamics in mice breast cancer using in vivo synchrotron radiation (SR) microangiography M. Torii1, T. Fukui2, M. Inoue1, S. Kanao1, T. Inagaki3, H. Tsuchimochi3, K. Umetani4, M. Shirai3, M. Toi1; 1Kyoto/JP, 2Tokyo/JP, 3Osaka/JP, 4 Hyogo/JP

14:08 B-0217

A prospective evaluation of a 3D functional infrared imaging for risk assessment in women at high risk for breast cancer D. Izhaky1, A. Shalmon2, A. Rundstein2, Y. Servadio2, M. Gotlieb2, E. Mor1, M. Sklair-Levy2; 1Air Port City/IL, 2Ramat Gan/IL

14:00–15:30

Room Z

Computer Applications SS 305

Developing tools for clinical workflow management Moderators: L. Faggioni; Pisa/IT, B. Gibaud; Rennes/FR

Opto-acoustic breast imaging: downclassification and upclassification of suspicious breast masses R.M. Pijnappel1, C. Meeuwis2, B. Bisschops3, J. Veltman4, P.T. Lavin5, R.M. Mann6; 1Utrecht/NL, 2Arnhem/NL, 3Dordrecht/NL, 4 Hengelo/NL, 5Framingham, MA/US, 6Nijmegen/NL

14:16 B-0218

Diffuse reflectance spectroscopy measured during biopsy procedures for tissue characterisation of breast tissue L.L. de Boer1, C.E. Loo1, G.A. Winter-Warnars1, J.W. Spliethoff1, T.M. Bydlon2, B.H. Hendriks2, A. Fioole-Bruining1, M. van Loveren1, T.J. Ruers1; 1Amsterdam/NL, 2Eindhoven/NL

Room C

Breast

Hybrid PET-MR for predicting pathologic complete response to neadjuvant chemotherapy in breast cancer - preliminary experiences B. Goorts, M.L. Smidt, S. Vöö, F.M. Mottaghy, J.E. Wildberger, M.B.I. Lobbes; Maastricht/NL

Y. Lee, H. Lee, Y. Cha, S. Wee, K. Yoon; Iksan/KR

14:00–15:30

Second-look US using real-time virtual sonography increases the sonographic detection rate of MRIdetected lesions with non-mass like enhancement on breast MRI S. Nakano, K. Fujii, J. Kousaka, Y. Mouri, T. Ando, R. Tetsuka, M. Goto, T. Imai, T. Ishiguchi; Aichi/JP

J.D. Kovac, G. Lilic, A. Djuric-Stefanovic, L. Lazic, D. Vasin, T. Nikolic, M. Mitrovic, D. Masulovic, D. Saranovic; Belgrade/RS

15:21 B-0215

Visualisation of microcalcifications by conebeam breast CT in comparison to full field digital mammography S. Wienbeck, E. von Fintel, J. Lotz, U. Fischer; Göttingen/DE

Evaluation of primary and secondary liver lesions: dual energy CT (DECT) vs. MRI

The value of diffusion-weighted MRI for the differentiation of intrahepatic cholangiocellular carcinoma and solitary hypovascular liver metastases

The predictive factors associated with the early and late recurrence in breast cancer: predictive factors on radiography and clinical-pathology B. Kim, E. Choi, S. Choi, G. Jin; Jeonju-si/KR

T.J. Vogl, N. Ring, M.J. Kerl, R.W. Bauer; Frankfurt a. Main/DE

15:13 B-0214

Beyond choline: in vivo proton MR-spectroscopy fingerprinting of breast lesions

14:00 B-0227

What is the utility of three-dimensional surface rendering reconstruction of volumetric CT data in routine CT reporting? J.S.Z. Lee1, E.K. Woo2; 1Oxford/UK, 2Buckinghamshire/UK

First clinical experiences with a noncontrast conebeam breast CT for the detection of breast masses S. Wienbeck, E. von Fintel, J. Lotz, U. Fischer; Göttingen/DE

www.myESR.org

14:08 B-0228

Structured reporting: evidence-based? M. Nobel, S.G.F. Robben; Maastricht/NL

Final Programme | ECR 2016

271

Wednesday

14:57 B-0212

14:32 B-0220

Respiratory gated PET/CT of the liver: a novel method and its impact on the detection of colorectal liver metastases A. Schulz, J.C. Godt, J.B. Dormagen, J.E. Holtedahl, T.V. Bogsrud, K.J. Labori, N.-E. Kløw, T. Bach-Gansmo; Oslo/NO

Radiological imaging features of breast cancer according to the molecular subtypes M. Nazli; Istanbul/TR

Effect of duration of scan acquisition on 256 Slice MDCT perfusion values in liver metastates A.K. Sharma, N. Sharma; Delhi/IN

14:49 B-0211

14:24 B-0219

Scientific Sessions

14:16 B-0229

Structured reporting of CT examinations in acute pulmonary embolism

14:17 B-0239

B.O.T. Sabel, J. Plum, N. Kneidinger, G. Leuschner, B. Raziorrouh, L. Koletzko, R. Schinner, M.F. Reiser, F.G. Meinel; Munich/DE

14:24 B-0230

L. Lambert1, P. Ourednicek2, W. Giepmans3, J. Jahoda1, L. Hruska1, A. Lambertova1, J. Danes1; 1Prague/CZ, 2Brno/CZ, 3Best/NL

Identifying structural quality deficits by systematic reporting of erroneous action A. Escher, S. Schindera, A. Streuber; Basle/CH

14:32 B-0231

14:25 B-0240

Radiology reporting workflows: the development and testing of a semi-naturalistic observational technique using eyetracking, scene video and screen capture S.J. Rickaby, M. Colbert; Kingston upon Thames/UK

14:40 B-0232

Standard and ultra low-dose CT colonography: comparison of performance of filtered back projection, hybrid iterative reconstruction technique and iterative model reconstruction

Initial study on radiation dose and image quality of ultra-low current and voltage CT colonography with iterative model reconstruction Y. Lian1, W. Cao2, J. Dong1, H. Wang1, Y. Jiang1, J. Gao1; 1 Zhengzhou/CN, 2Guangzhou/CN

14:33 B-0241

Automatic indication detection for imaging decision support in clinical workflows

Follow-up of acute complicated diverticulitis: role of CT colonography M. Bassi, E. Raimondi, Z. Ferrante, B. Malta, C. Montalto, R. Rizzati, M. Giganti, G. Benea; Ferrara/IT

E. Pons, L.M.M. Braun, J.A. Kors, M.G.M. Hunink; Rotterdam/NL

14:48 B-0233

14:41 B-0243 CARDS: the decision support tool for radiologists examining head CT images P. Martynov, N. Mitropolskii, K. Kukkola, L. Mutanen, J. Reponen, A. Makynen; Oulu/FI

14:56 B-0234

Big Data in optimising radiology management: from passive storage to real-time response O. Pianykh; Boston, MA/US

15:04 B-0235

Is explorative data analysis one milestone on the way to value based radiology? A. Escher, J. Truong, A. Streuber; Basle/CH

15:12 B-0236

Estimating prevalence of rare diseases using a large radiology report database

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:49 B-0244 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:57 B-0245 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Visceral fat volume as a predictor of acute complicated diverticulitis V.S. Martín, C.A. León, M.N. Hinestroza, L.O. Robador, F.D. Formoso, L.S. Toledo, M.T. Mohamad, M.A. Armas, M.S. Rodriguez; Las Palmas de Gran Canaria/ES

MR imaging in preoperative staging of primary colon cancer patients: a feasibility study E. Nerad1, M. Lahaye2, D.M. Lambregts3, E. Kersten1, H. van den Bosch1, F. Bakers3, G. Beets2, H. Grabsch3, R.G.H. Beets-Tan2; 1Eindhoven/NL, 2Amsterdam/NL, 3Maastricht/NL

Diagnostic performance of MR imaging in preoperative staging of primary colon cancer patients E. Nerad1, M. Lahaye2, D.M. Lambregts3, E. Kersten1, H.C.M. van den Bosch1, G. Beets2, F. Bakers3, H. Grabsch3, R.G.H. Beets-Tan2; 1Eindhoven/NL, 2Amsterdam/NL, 3Maastricht/NL

C.E. Kahn; Philadelphia, PA/US

15:20 B-0237

15:05 B-0247 Identification of rare imaging findings: application of natural language processing

M. Pannatier, P. Bize, D. Hahnloser, R. Meuli, S. Schmidt; Lausanne/CH

E. Pons, J.J. Visser, M.G.M. Hunink; Rotterdam/NL

14:00–15:30

Room O

GI Tract SS 301b

14:00–15:30

Colon

Keynote lecture

SS 303a

Diagnostic value of CAD-assisted CT colonography in the assessment of nonpolypoid colorectal lesions (NPLs) using CT colonography: a single-centre experience M. Santoni, M. Ciolina, A. Pichi, P. Baldassari, M. Iannitti, C. Cavallini, D. Diacinti, F. Iafrate; Rome/IT

272

ECR 2016 | Final Programme

Cardiomyopathies (2) Moderators: J. Broncano; Cordoba/ES, A. de Roos; Leiden/NL

14:00 B-0248

M. Hellström; Gothenburg/SE

14:09 B-0238

Room N

Cardiac Moderators: R. Maksimović; Belgrade/RS, T. Mang; Vienna/AT

14:00 K-06

Management of active colonic bleeding detected by angio- MDCT: interventional radiology versus surgery

The role of cardiac magnetic resonance (CMR) imaging in the differentiation of arrhythmogenic right ventricular cardiomyopathy (ARVC) and athlete’s heart H. Vago, C. Czimbalmos, I. Csecs, A. Toth, F.I. Suhai, O. Kiss, N. Sydo, D. Becker, B. Merkely; Budapest/HU

14:08 B-0249

Role of T1 mapping in cardiac amyloidosis M. Dal Corso, E. Gavazzi, D. Farina, R. Maroldi; Brescia/IT

www.myESR.org

Scientific Sessions

14:16 B-0250

Left-ventricular geometry associated with outflow obstruction in patients with hypertrophic cardiomyopathy: 3D CT analysis

14:08 B-0260

M. Brodmann1, C. Wissgott2, A. Holden3, R. Staffa4, T. Zeller5, T. Vasudevan6, P. Schneider7; 1Graz/AT, 2Heide/DE, 3 Grafton Auckland/NZ, 4Brno/CZ, 5Bad Krozingen/DE, 6 Hamilton/NZ, 7Honolulu, HI/US

Y. Song, D. Yang; Seoul/KR

14:24 B-0251

Cardiac MR or delayed enhanced CT in patients with sudden occurrence of ventricular arrhythmias and normal coronary arteries: comparison with endomyocardial biopsy

14:16 B-0261

Late gadolinium enhancement and systolic function in non-ischemic dilated cardiomyopathy

T1mapping: diagnostic value in hypertrophic cardiomyopathy with no apparent fibrosis in late gadolinium enhancement

A. Meyer, A. Schmid, W. Lang, U. Rother; Erlangen/DE

14:32 B-0263

R. Ouyang, L. Wu, J. Xu; Shanghai/CN

14:48 B-0254

Role of cardiac magnetic resonance in the diagnosis of ARVC/D and phenocopies

Early cardiac involvement in asymptomatic patients with systemic sclerosis (Ssc) established using cardiac magnetic resonance (CMR) V. Vellucci, A. Di Sibio, A. Gennarelli, V. Felli, C. Marsecano, G. Michelini, R. Masi, E. Di Cesare, C. Masciocchi; L’Aquila/IT

15:04 B-0256

Cardiac magnetic resonance (CMR) findings in patients with new onset of ventricular arrhythmias M. Cava, A. Esposito, G. Benedetti, D. Vignale, A. Palmisano, A. Del Maschio, F. De Cobelli; Milan/IT

15:12 B-0257

Dobutamine stress-induced impairment of cardiac and myocardial performance in a preclinical model of HFpEF: a cardiac magnetic resonance imaging study 1

1

1

1

2

U. Reiter , G. Reiter , G. Adelsmayr , M. Manninger , A. Alogna , A.F. Stalder3, D. Scherr1, H. Post2, M. Fuchsjäger1; 1Graz/AT, 2 Berlin/DE, 3Erlangen/DE

15:20 B-0258

CT vs MRI: comparison of right atrium volumetry S. Rheinheimer, C. Reh, J. Figiel, A.H. Mahnken; Marburg/DE

14:00–15:30

Peripheral arteries: imaging and therapy Moderators: M. de Bucourt; Berlin/DE, J.T. Ortiz-Pérez; Barcelona/ES

14:00 B-0259

14:40 B-0264

Noise-optimised virtual monochromatic imaging improves image quality in 3rd-generation dualsource dual-energy CT angiography of the lower extremity run-off J.L. Wichmann1, C.N. De Cecco2, A. Varga-Szemes2, S. Mangold2, T.J. Vogl1, U.J. Schoepf2; 1Frankfurt a. Main/DE, 2Charleston, SC/US

14:48 B-0265

Nonenhanced MR angiography of the foot with flow spoiled-fresh blood imaging(FS-FBI): feasibility study and comparison of different parameters Y. Zhang1, D. Cao1, S. Yu2; 1Fuzhou/CN, 2Nanyang/CN

14:56 B-0266

2D-Perfusion angiography of the foot: technical considerations and initial analysis T. Rodt1, T. Murray2, M. McCavert2, M. Given2, F. McGrath2, M. Lee2; 1 Hannover/DE, 2Dublin/IE

15:04 B-0267

Outcomes of infrapopliteal angioplasty for limb salvage in critical limb ischaemia M. Sheehan, H. Kok, P. Thanaratnam, E. Ryan, H. Asadi, R. Bajwa, K. Pennycooke, M. Given, M. Lee; Dublin/IE

15:12 B-0268

Room L8

Vascular SS 315

Impact of a noise-optimized virtual monoenergetic reconstruction algorithm on stent visualization and detection of in-stent restenosis in lower extremity run-off CT angiography S. Mangold1, J. Wichmann1, C. De Cecco1, A. Varga-Szemes1, D. Caruso1, A. Stubenrauch1, S. Fuller1, K. Nikolaou2, U.J. Schoepf1; 1 Charleston, SC/US, 2Tübingen/DE

A.M. Amadu1, J.C.L. Rodrigues2, A. Ghosh Dastidar2, A. Baritussio2, C.B. Lawton2, G. Venuti2, G.B. Meloni1, M. Conti1, C. Bucciarelli-Ducci2; 1 Sassari/IT, 2Bristol/UK

14:56 B-0255

Below-the-knee angioplasty in dialysis patients with critical limb ischemia- outcomes with respect to pedal arch involvement

Radiation dose and contrast medium volume reduction in lower extremity CT angiography with iterative model reconstruction (IMR) algorithm W.-L. Qian1, D.-J. Zhou1, C. Feng1, H. Wang1, Y. Jiang2, J.-M. Xu1; 1 Suzhou/CN, 2Shanghai/CN

15:20 B-0269

Extreme low radiation dose CT angiography of lowdose extremity using iterative model reconstruction algorithm W.-L. Qian1, D.-J. Zhou1, C. Feng1, H. Wang1, Y. Jiang2, J.-M. Xu1; 1 Suzhou/CN, 2Shanghai/CN

The angiosome concept evaluated on the base of micro-perfusion - an O2C guided study U. Rother, W. Lang, R.E. Horch, A. Meyer; Erlangen/DE

www.myESR.org

Final Programme | ECR 2016

273

Wednesday

14:24 B-0262

M. Scarabello, P.M. Cannaò, M. Petrini, F. Riva, F. Secchi, F. Sardanelli; Milan/IT

14:40 B-0253

Subclavian artery stent fractures: prevalence and predisposing factors A. Hüttl, A. Hüttl, E.M. Végh, H. Sarkadi, B. Nemes, K. Hüttl, E. Dósa; Budapest/HU

A. Palmisano, A. Esposito, C. Colantoni, M. Cava, S. Sala, F. De Cobelli, A. Del Maschio; Milan/IT

14:32 B-0252

Tack optimised balloon angioplasty below the knee (TOBA-BTK): six months results

Scientific Sessions

14:00–15:30

15:20 B-0280

Room E1

Musculoskeletal

Do we need image guidance for subacromial subdeltoid injections? G.M. Allen, M. DeDea, D.J. Wilson; Oxford/UK

SS 310

Ultrasound Moderators: P. Peetrons; Brussels/BE, L.M. Sconfienza; San Donato Milanese/IT

14:00 B-0270

MR - US fusion imaging to guide lumbar facet joint injections A. Corazza, R. Sartoris, P. Caruso, G. Turtulici, A. Arcidiacono, S. Perugin Bernardi, D. Orlandi, E. Silvestri; Genoa/IT

14:16 B-0272

MR T2 mapping to evaluate the effect of ultrasound (US)-guided intra-articular injection of hyaluronic acid (HA) on articular cartilage

SS 311a

New approach for B-mode ultrasound (US) measurements of the plantar aponeurosis in healthy volunteers M.M.H. Abd Ellah, C. Kornreif, C. Kremser, W. Jaschke, A. Klauser; Innsbruck/AT

14:32 B-0274

14:00 K-07 14:09 B-0281

A. Stadlbauer, A. Merkel, B. Sommer, S. Brandner, M. Zimmermann, M. Buchfelder, K. Rössler; Erlangen/DE

14:17 B-0282

14:56 B-0277

Shear wave ultrasound elastography is a reliable and repeatable method to measure elastic modulus of patellar and achilles tendons

14:25 B-0283

Ultrasound evaluation of meniscal implant extrusion, after meniscus reconstruction and impact of the extrusion on patients quality of life 1

1

14:33 B-0284

14:41 B-0285

2 1

Multiparametric MR imaging of oxygen metabolism and angiogenesis in glioma patients

Comparison of ferumoxytol and gadolinium enhancement changes in response to Avastin in high grade glioma patients A. Horváth1, C. Várallyay2, D. Schwartz2, P. Ambady2, P. Bogner1, E. Neuwelt2; 1Pécs/HU, 2Portland, OR/US

Ulnar neuropathy at the elbow: visualisation of cause of ulnar entrapment with high-resolution ultrasound is predictive of outcome after transposition

14:49 B-0286

M. Schertz, J. Silvera, C. Mutschler, C. Bernard, E. Masmejean; Paris/FR

Prognostic value of preoperative dynamic contrastenhanced MRI perfusion parameters for high-grade glioma patients A. Ulyte1, M. Skardelly2, J. Schittenhelm2, C. Braun2, B. Bender2, S. Bisdas3; 1Vilnius/LT, 2Tübingen/DE, 3London/UK

Therapeutic implications of nerve ultrasound in leprosy

14:57 B-0287

Visualisation of the deep branch of the ulnar nerve using high-resolution ultrasound G. Riegler, D. Lieba-Samal, H. Platzgummer, C. Pivec, S. Jengojan, P. Brugger, M. Vierhapper, G. Bodner; Vienna/AT

15:12 B-0279

Magnetic resonance imaging biomarkers for assessment of vascular pathologies in glioma

A. Stadlbauer1, M. Zimmermann1, K. Rössler1, S. Oberndorfer2, M. Buchfelder1, A. Dörfler1, G. Heinz2; 1Erlangen/DE, 2St. Pölten/AT

Y. Aswani, S. Saifi; Mumbai/IN

15:04 B-0278

Assessment of tumour oxygenation and its impact on treatment response in bevacizumab treated recurrent glioblastoma D. Bonekamp1, K. Mouridsen2, A. Radbruch1, A. Wick1, H.-P. Schlemmer1, W. Wick1, M. Bendszus1, L. Østergaard2, P. Kickingereder1; 1Heidelberg/DE, 2Aarhus/DK

T. Pobozy , K. Slynarski , K. Sklinda , M. Frel ; Warsaw/PL, 2 Otwock/PL

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Intraoperative MR imaging of cerebral oxygen metabolism in patients with brain tumours

A. Stadlbauer1, M. Zimmermann1, K. Rössler1, S. Oberndorfer2, M. Buchfelder1, A. Dörfler1, G. Heinz2; 1Erlangen/DE, 2St. Pölten/AT

1

14:48 B-0276

Keynote lecture P. Due-Tonnessen; Oslo/NO

S. Tas, M. Onur, A. Soylu, S. Yilmaz, F. Korkusuz; Ankara/TR

14:40 B-0275

Cerebral tumours (1) Moderators: A. Falini; Milan/IT, F.P. Kuhn; Zurich/CH

G. Ferrero1, E. Fabbro1, F. Fiz2, D. Dettore2, G. Serafini1; 1 Pietra Ligure/IT, 2Genoa/IT

14:24 B-0273

Room E2

Neuro Ultrasonography-guided injection for quadriceps fat pad edema: a 6-month clinical and radiological follow-up Z. Maras Ozdemir1, U. Aydingoz2, M.F. Korkmaz1, V. Tunay Bayrakcı2, F.B. Ergen2, O.A. Atay2, O. Baysal1; 1Malatya/TR, 2Ankara/TR

14:08 B-0271

14:00–15:30

Visualisation of the recurrent motor branch of the median nerve using high-resolution ultrasound

Prognosis prediction of non-enhancing T2 high signal intensity lesion after standard treatment in glioblastoma: application of dynamic contrastenhanced MR imaging R. Kim, S. Choi; Seoul/KR

15:05 B-0288

Intravoxel incoherent motion diffusion-weighted MR imaging in differentiation of meningiomas: initial study Y. Lu1, K. Shek2, B. Yin1, D. Geng1; 1Shanghai/CN, 2Honkong/CN

G. Riegler, D. Lieba-Samal, C. Pivec, H. Platzgummer, S. Jengojan, P. Brugger, M. Vierhapper, G. Bodner; Vienna/AT

274

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

15:13 B-0289

14:56 B-0298

Quantitatively evaluate the efficacy of diffusion kurtosis imaging in grading gliomas: a preliminary study J. Chu1, Y. Wang1, J. Zhao1, X. Yan2, X. Li1; 1Guangzhou/CN, 2 Shanghai/CN

15:21 B-0290

Contrast-enhanced PET/CT for oncologic indications: reproducibility and comparison to the two-step procedure, including PET/CT and contrast-enhanced CT from radiology (COMBITEP study) A.L. Cazeau, S. Ferron, M. Pulido, C. Bellera, S. Mathoulin Pelissier, J. Palussiere, A. Dutertre, Y. Godbert, E. Descat; Bordeaux/FR

Diagnostic accuracy of MR imaging techniques for treatment response assessment in patients with high grade glioma: a systematic review and meta-analysis

15:04 B-0299

S. Spiga, D. Ippolito, C. Talei Franzesi, V. Besostri, E. Orsini, S. Sironi; Monza/IT

14:00–15:30

Room F1 15:12 B-0300

Oncologic Imaging SS 316

Dealing with metastatic disease

C. Giraudo, D. Senn, G. Karanikas, M. Weber, M. Raderer, M. Mayerhoefer; Vienna/AT

Moderators: D.M. Lambregts; Amsterdam/NL, A. Sohaib; London/UK

14:00 B-0291

[18F]-FDG-PET/MR for staging and restaging of lymphoma patients: is the use of DWI justified?

15:20 B-0301 The application of DW-MRI in the staging of oesophageal cancer: prospective comparison with EUS and MDCT

The quantitative CEUS features of clinically suspicious non-Hodgkin lymphoma involved superficial lymph nodes: a preliminary study J. Shi; Shanghai/CN

F. Giganti, P.G. Arcidiacono, R. Nicoletti, A. Ambrosi, E. Orsenigo, E. Mazza, A. Del Maschio, F. De Cobelli; Milan/IT

14:08 B-0292

14:00–15:30

Room F2

Physics in Radiology

One-step one-phase vs. multi-step multi-phase whole-body staging CT - comparison of radiation dose and diagnostic confidence

SS 313

D. Zinsser, R. Marcus, E. Körner, A. Othman, F. Bamberg, K. Nikolaou, M. Notohamiprodjo; Tübingen/DE

Radiation risk assessment and awareness Moderators: N. Buls; Brussels/BE, O. Ciraj-Bjelac; Belgrade/RS

14:16 B-0293

14:00 K-10

Sentinel lymph node (SLN) melanoma micrometastasis managed conservatively: sonography (US) patterns of recurrence 1

1

2

1

V. Tsapaki; Athens/GR 1

O. Catalano , C. Caracò , A. Nunziata , F. Sandomenico , A. Petrillo ; 1 Naples/IT, 2Ercolano/IT

14:24 B-0294

Can unenhanced multiparametric MRI substitute gadolinium-enhanced MRI in the characterisation of vertebral marrow infiltrative lesions? D.Z. Zidan, H. El Ghazaly; Cairo/EG

14:32 B-0295

Keynote lecture

Association of quality and quantity of bone metastases as well as volumetric bone mineral density with the prevalence of vertebral fractures in breast cancer patients V. Neuhaus, N. Abdullayev, M. Hellmich, S. Krämer, D. Maintz, B. Krug, J. Borggrefe; Cologne/DE

14:09 B-0302

The transatlantic race of CT radiation dose: Europe vs United States A. Euler, A. Parakh, S. Schindera; Basle/CH

14:17 B-0303

Patient organ dose with computed tomography - a review of present methodology and DICOM information: executive summary of the joint report of AAPM task group 246 and EFOMP J.S. Andersson1, W. Pavlicek2; 1Umeå/SE, 2Scottsdale, AZ/US

14:25 B-0304

Are the existing national diagnostic reference levels for CT outdated? A. Euler, A. Parakh, S. Schindera; Basle/CH

14:40 B-0296

Primary tumor detection in CUP of neuroendocrine origin: additional value of 68Ga-DOTA-TATE-PET/CT compared to contrast-enhanced CT

14:33 B-0305

P. Kazmierczak, A. Rominger, V. Wenter, C. Spitzweg, C. Auernhammer, M. Angele, C. Rist, M.F. Reiser, C.C. Cyran; Munich/DE

14:48 B-0297

S. Maroof, T. Alam; Kabul/AF

14:41 B-0306 Patterns of metastatic spread and its implications on follow up strategies in uveal melanoma C. Kloth, A. Othman, G. Bier, R. Syha, T. Eigentler, C. Garbe, K. Nikolaou, B. Klumpp; Tübingen/DE

www.myESR.org

Awareness and knowledge of ionising radiation hazard among medical students and residents in Kabul, Afghanistan

Improving radiation awareness and feeling of personal security of non-radiological medical staff in computed tomography scanning room by implementing a traffic light system C. Heilmaier, A. Mayor, N. Zuber, P. Fodor, D. Weishaupt; Zurich/CH

Final Programme | ECR 2016

275

Wednesday

B.R.J. van Dijken, P.J. van Laar, G.A. Holtman, A. van der Hoorn; Groningen/NL

Diagnostic value of whole-body ultra low dose CT (WBULDCT) in comparison with spinal magnetic resonance imaging (SMRI) in the assessment of disease in patients with multiple myeloma (MM)

Scientific Sessions

14:49 B-0307

Radiation risk from screening mammography

14:32 B-0316

R.M.K. M.Ali, A. England, A. Tootell, P. Hogg; Manchester/UK

14:57 B-0308

A successful dose management quality improvement project (QIP): data-driven multi-disciplinary approach to managing patient radiation in computed tomography (CT) L. Laurent; Park Ridge, IL/US

15:05 B-0309

Utilising a server based simulation to compare effective organ dose of 70kV dynamic CT examinations to diagnostic standard triphasic abdominal CT J.F.M. Gawlitza; Mannheim/DE

15:13 B-0310

Y. Ohno1, Y. Kishida1, S. Seki1, H. Koyama1, T. Yoshikawa1, M. Yui2, A. Lu3, M. Miyazaki3, K. Sugimura1; 1Kobe/JP, 2Otawara/JP, 3Vernon Hills, IL/US

14:40 B-0317 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:48 B-0318

Introducing a dose monitoring software in conventional x-ray imaging: initial experiences

Conventional x-ray dose analysis in emergency rooms in different hospitals using a centralised electronic platform

Room D1

14:56 B-0319

Chemical exchange saturation transfer (CEST) imaging vs FDG-PET/CT: capability for differentiation of malignant from benign pulmonary lesions Y. Ohno1, M. Yui2, M. Miyazaki3, Y. Kishida1, S. Seki1, H. Koyama1, T. Yoshikawa1, K. Sugimura1; 1Kobe/JP, 2Otawara/JP, 3Vernon Hills, IL/US

15:04 B-0320

Chest SS 304

A role of diffusion-weighted MRI in prediction of mediastinal lymph node metastasis in patients with NSCLC: comparison to PET results E.U.A.K. Yilmaz; Izmir/TR

E. Fraile Moreno, C. Benito, J. Azpeitia, J. Albillos, E. Dominguez, P. Fraga, J. Galobardes, T. Villarejo; Madrid/ES

14:00–15:30

Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria M. Vivoda Tomšič1, K. Šurlan Popovič1, S. Bisdas2, V. Kovač1, I. Serša1; 1 Ljubljana/SI, 2London/UK

C. Heilmaier, N. Zuber, D. Weishaupt; Zurich/CH

15:21 B-0311

Pulmonary thin-section MR imaging with ultrashort TE: comparison of capability for lung nodule detection and nodule type classification with lowand standard-dose thin-section CTs

Diaphragmatic dynamic magnetic resonance imaging (MRI): preliminary results and perspectives R. Lotte, S. Boussouar, F. Le Pimpec-Barthes, A. Charpentier, K. Dang Tran, C. Rivera, B. Lambert, P. Halimi, A.-C. Hernigou; Paris/FR

Lung MRI Moderators: P. Ciet; Rotterdam/NL, N.N.

14:00 B-0312

15:12 B-0321 Free-breathing 3D T1-weighted fat-saturated contrast-enhanced gradient-echo sequence with radial data sampling in thoracic and cardiovascular MRI C. Ruff1, R. Grimm2, A. Hornung1, M. Kündel1, J. Weiß1, F. Bamberg1, K. Nikolaou1, M. Notohamiprodjo1; 1Tübingen/DE, 2Erlangen/DE

14:08 B-0313

Automated 3D segmentation of pulmonary magnetic resonance angiography in patients with pulmonary arterial hypertension: correlation with pulmonary arterial systolic pressure C. Melzig1, S. Wörz1, S. Ley2, C. Fink3, S. Partovi4, K. Rohr1, H.-U. Kauczor1, E. Grünig1, F. Rengier1; 1Heidelberg/DE, 2Munich/DE, 3 Celle/DE, 4Cleveland, OH/US

14:16 B-0314

S. Veldhoen, D. Stäb, A.M. Weng, A.S. Kunz, A. Fischer, C. Wirth, H. Hebestreit, T.A. Bley, H. Köstler; Würzburg/DE

14:24 B-0315

R. Lee, G. Lo Goh, H. Ai, K. Chan, C. Yuen, W. Chung, M. Hung; Hong Kong/CN

15:20 B-0322

Semi-quantitative visual scoring of fibrosing lung disease using T2-weighted BLADE sequences and comparison with multidetector computed tomography

Pulmonary embolism detection with 3D ultrashort echo time MRI: experimental study in canines P. Bannas1, L.C. Bell2, K.M. Johnson2, M.L. Schiebler2, C.J. Francois2, U. Motosugi2, D. Consigny2, S.B. Reeder2, S.K. Nagle2; 1Hamburg/DE, 2 Madison, WI/US

14:00–15:30

Room D2

Interventional Radiology SS 309

Pulmonary perfusion phase imaging using selfgated Fourier decomposition MRI reveals perfusion inhomogeneities in patients with cystic fibrosis

3 Tesla MRI evaluation of pectus carinatum with breath-hold imaging

Musculoskeletal Moderators: A. Diamantopoulos; London/UK, S. Marcia; Cagliari/IT

14:00 B-0323

Retrospective analysis in 20 consecutive patients undergoing percutaneous MR-guided cryoablation of Morton’s neuroma: clinical results and insight on a new emerging treatment R. Cazzato1, J. Garnon1, G. Tsoumakidou1, G. Koch1, J. Caudrelier1, X. Buy2, P. Rao1, M.-A. Thenint1, A. Gangi1; 1Strasbourg/FR, 2 Bordeaux/FR

M.T.A. Buzan1, J. Dinkel2, M. Eichinger3, D. Colombi4, M. Kreuter3, F. Herth3, H.-U. Kauczor3, C. Pop1, C. Heussel3; 1Cluj-Napoca/RO, 2 Munich/DE, 3Heidelberg/DE, 4Parma/IT

276

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

14:08 B-0324

14:00–15:30 Treatment of supraspinatus tendinopathy: dry needling as a stand-alone procedure vs dry needling and platelet-rich plasma (prp) F. Bruno, A. La Marra, S. Mariani, F. Arrigoni, L. Zugaro, A. Barile, C. Masciocchi; L’Aquila/IT

14:16 B-0325

Genitourinary SS 307

Percutaneous long bone cementoplasty for palliation of malignant lesions of the limbs in 196 patients

14:00 B-0334

Effectiveness of percutaneous vertebroplasty in cases of multiple myeloma with vertebral pain

F. Dietzel, L. Schimmöller, M. Quentin, D. Blondin, C. Arsov, R. Rabenalt, G. Antoch, H.E. Gabbert, P. Albers; Düsseldorf/DE

14:08 B-0335

Cementoplasty for arthrodesis screw loosening: a technique to prolong the useful life of an implant S. Perez Aguilera, M. Zauner Jakubik; Sabadell/ES

14:48 B-0329 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:56 B-0330

Radiological percutaneous osteosynthesis and cementoplasty for impending malignant pathological fracture of the proximal femur E. Mavrovi, H. Beji, A.-C. Kalenderian, G. Vaz, C. Mastier, P. Thiesse, B. Richioud; Lyon/FR

14:16 B-0336

15:04 B-0331

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

15:12 B-0332

14:24 B-0337

Qualification biopsies by elastic fusion registration in active surveillance for localised prostate cancer D. Portalez, R. Aziza, M. Roumiguie, S. Sanson, B.A. Malavaud; Toulouse/FR

14:32 B-0338

Sepsis and other complications related to TRUSguided prostate biopsy: 3-year experience at a regional cancer centre C. Crowley1, A. Cahill2, J. Buckley2, F. O’ Brien2, K. O’ Regan2; 1 Dublin/IE, 2Cork/IE

14:40 B-0339

Should MRI after prostate biopsy be delayed? J. Choi, S. Jung, M. Choi; Seoul/KR

Role of CT-guided percutaneuos cryoablation combined with cementoplasty for bone lesion in weight-bearing areas

14:48 B-0340

S. Quarchioni, F. Arrigoni, S. Mariani, A. La Marra, L. Zugaro, A. Barile, C. Masciocchi; L’Aquila/IT

Efficacy of ultrasound-guided needle tenotomy for the treatment of chronic tendinopathies

Combined microwave ablation and percutaneous screws fixation plus cementoplasty in the treatment of painful bone metastases

Risk-based patient selection for MRI-targeted prostate biopsy after negative transrectal ultrasoundguided random biopsy avoids unnecessary MRI scans A.R. Alberts, I.G. Schoots, L.P. Bokhorst, G.J.L.H. Leenders, C.H. Bangma, M.J. Roobol; Rotterdam/NL

14:56 B-0341

F. Bruno, A. La Marra, S. Mariani, F. Arrigoni, L. Zugaro, A. Barile, C. Masciocchi; L’Aquila/IT

15:20 B-0333

MRI-targeted prostate biopsy outcomes after previous negative TRUS-guided random biopsy: correlation to risk-based patient selection A.R. Alberts, M.J. Roobol, L.P. Bokhorst, C.H. Bangma, I.G. Schoots; Rotterdam/NL

Percutaneous intra-articular neurolysis with pulsed radiofrequency in knee osteoarthritis D. Filippiadis, S. Grigoriadis, A. Mazioti, S. Spiliopoulos, E. Brountzos, N. Kelekis, A. Kelekis; Athens/GR

Are single shot biopsies sufficient for targeted MRguided prostate cancer detection? T. Ullrich, L. Schimmöller, M. Quentin, F. Dietzel, C. Arsov, R. Rabenalt, D. Blondin, P. Albers, G. Antoch; Düsseldorf/DE

M. Inecikli1, Ö. Nas2, B. Hakyemez2; 1Rize/TR, 2Bursa/TR

14:40 B-0328

Prospective randomised evaluation of MR-guided inbore versus MRI/ultrasound fusion plus TRUS-guided prostate biopsy in patients with prior negative biopsies

Localisation of primary prostate cancer by simultaneous 68gallium-HBED-CC-PSMA PET/MRI M. Eiber, G. Weirich, K. Holzapfel, M. Souvatzoglou, I. Rauscher, B. Haller, M. Schwaiger, T. Maurer; Munich/DE

15:04 B-0342

C. Pusceddu, N. Ballicu, B. Sotgia, R. Fele, L. Melis; Cagliari/IT

Magnetic resonance spectroscopy of the prostate: in vitro comparison of the choline-plus-creatine-overcitrate ratio at 1.5 T and 3.0 T U.G. Mueller-Lisse1, M. Scherr2, A. Meister1, M.F. Reiser1, U.L. Mueller-Lisse1; 1Munich/DE, 2Murnau a. Staffelsee/DE

15:12 B-0343

ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility F. Giganti, A. Coppola, A. Ambrosi, S. Ravelli, A. Esposito, A. Briganti, F. Montorsi, A. Del Maschio, F. De Cobelli; Milan/IT

www.myESR.org

Final Programme | ECR 2016

277

Wednesday

Usefulness of O2-O3 intradiscal versus steroid intraforaminal injection in back pain control: a prospective double-blind trial in patients with different discovertebral pathologies M. Perri1, T. Popolizio1, C. Marsecano2, M. Varrassi2, A. Splendiani2, M. Carlo2; 1San Giovanni Rotondo/IT, 2L’Aquila/IT

14:32 B-0327

Prostate cancer: targeted biopsy and beyond Moderators: M. Meissnitzer; Salzburg/AT, N.N.

E. Lanza1, R. Cazzato2, R. Grasso3, X. Buy4, J. Palussiere4, V. Pedicini1, L. Balzarini1, D. Poretti1; 1Rozzano/IT, 2Strasbourg/FR, 3Rome/IT, 4 Bordeaux/FR

14:24 B-0326

Room K

Scientific Sessions

15:20 B-0344

Index lesion characterised by 11C-choline PET/CT and 3-Tesla MRI spectroscopy in primary prostate carcinoma: clinical implications in the era of imageguided therapy M.D. Hernández-Argüello, J. Solorzano, I. Pascual, A. Benito, M. Collantes, C. Padula, M. Cabaleros, J. Pardo, J.A. Richter; Pamplona/ES

14:00–15:30

15:13 B-0353

J. Coward1, R. Lawson1, T. Kane2, M. Elias3, A. Howes4, J. Birchall5, P. Hogg1; 1Manchester/UK, 2Blackpool/UK, 3Wrexham/UK, 4 Prestcot/UK, 5Derby/UK

15:21 B-0354

Room G

CT parameters: juggling or struggling? Moderators: E. Agadakos; Athens/GR, E. Sorantin; Graz/AT

The visible and the invisible in cone beam CT: the role of radiographer M. Simoncini1, M. Biondi1, L. Amata1, M. Virgilio2, L. Giuliani2, C. Ottonello1; 1Pomezia/IT, 2Rome/IT

Radiographers SS 314

Multi-center analysis of incidental findings on low resolution CT attenuation correction (CTAC) images: an extended study

14:00–15:30

Room M 1

Head and Neck

14:00 K-11

Keynote lecture A. Hartvig Sode; Odense/DK

SS 308

Salivary glands, neck, parathyroid Moderators: G. Conte; Milan/IT, C. Czerny; Vienna/AT

14:09 B-0345

Optimisation of chest computed tomography using a phantom: impact of mAs and reconstruction techniques on image quality C.S. Reis1, T. Faquir2, V. Harsaker3, P. Hogg2, L. Kristoffersen3, I.L. van Rein4, K. Stancombe2, N.C. Warmerdam4, C. Wergeland3; 1 Lisbon/PT, 2Salford/UK, 3Oslo/NO, 4Groningen/NL

14:17 B-0346 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:25 B-0347

14:00 B-0355

B. Brea Alvarez, L. Esteban, Y. García-Hidalgo, M. Tuñón; Majadahonda/ES

14:08 B-0356

Noise variations across clinically accepted paediatric body CT scans

MRI with diffusion weighted imaging of salivary gland tumours, prediction of the benignancy and malignancy

M. O’Connor, S. Foley; Dublin/IE

A. Youssef, D. Abdelhady Mohammed, R. Edward; Cairo/EG

14:16 B-0357 Short and long term effects of clinical audit on compliance with procedures in CT scanning 14:24 B-0358 Analysis of CT exposure parameters, dose values and image noise in order to promote the harmonisation of CT examinations

Coronary computed tomography angiography: evaluation of the effects of cradle sagging on stairstep artifacts

14:32 B-0359

S. Lee, J. Kang, H. Koo, S. Kim, D. Seo; Seoul/KR

14:49 B-0350

Optimisation of CT follow-up protocol’s in patients with gastrointestinal stromal cancer

Assessment of image quality criteria from abdominal CT examinations A.F.C.L. Abrantes, P. Paias, L.P. Ribeiro, A.M. Ribeiro, R.P.P. Almeida, K.B. Azevedo; Faro/PT

15:05 B-0352

Carotid plaque PET/CT standardised uptake values measurements as a biomarker for stroke: software reproducibility challenges N. Giannotti, J. McNulty, S. Foley, P. Kelly; Dublin/IE

Assessing the influence of MRI scan position on image quality of head and neck MR images for radiotherapy treatment planning L. Xiao, M. Yuen, Y. Tung, P. Wong, H. Ho; New Territories/HK

14:40 B-0360

R. Pinilla1, M.I.R. Ortega1, E.M. Campos1, M. Monteiro2; 1Madrid/ES, 2 Coimbra/PT

14:57 B-0351

Ultrasound-guided salivary gland core needle biopsy: the road to take M.A. Schuller Arteaga, L. Antón Mendez, M. Udondo González del Tánago, J.L. Del Cura Rodríguez, A. Bilbao González, R.M. Zabala Landa, I. Korta Gómez, A. Viteri Jusue, D. Grande Icarán; Bilbao/ES

A. Carriço, F. Palumbo, R. Cristina, G. Paulo, J. Santos; Coimbra/PT

14:41 B-0349

Assessment of salivary gland tumours using MRI and CT: impact of experience on diagnostic accuracy T.J. Vogl, T. Stark-Paulsen, M. Albrecht, N.-E. Nour-Eldin, H. Ackermann, A. Maataoui; Frankfurt a. Main/DE

A. Oliveri1, N. Howarth2, H. Salame1, P. Gevenois1, D. Tack1; 1Ath/BE, 2 Chenes-Bougeries/CH

14:33 B-0348

MRI: the technique of choice in the study of Warthin tumours

Cervical adipose tissue to airway volume ratio (CAT:AV): a novel anthropometric measure, its anatomic relationship to sleep apnea, cerebrovascular accident and overall mortality H.S. Maresky1, P.A. Gottlieb1, L. Copel1, D. Ahoubim2, S. Tal1; 1Zrifin/IL, 2 Miami, FL/US

14:48 B-0361

Accuracy of magnetic resonance imaging for subglottic stenosis grading in patients with granulomatosis with polyangiitis M. Kupka, P. Bannas, L. Linsenhoff, G. Adam, F. Henes; Hamburg/DE

14:56 B-0362

MRI of neck victims of survived strangulation: evaluation of cases C. Bruguier, J. Grimm, J.-B. Zerlauth, K. Michaud, P. Mangin, R. Meuli, S. Grabherr; Lausanne/CH

278

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

15:04 B-0363

Multi-modality imaging of patients with carotidynia and clinical correlation

14:57 B-0373

A. Lecler, G. Volle, M. Obadia, P. Roux, J. Savatovsky, O. Gout, J.-C. Sadik; Paris/FR

15:12 B-0364

C. Hagelstein1, M. Weis1, T. Henzler1, U. Lechel2, K. Neff1, G. Brix2, S.O. Schönberg1, A. Schegerer2; 1Mannheim/DE, 2Neuherberg/DE

Preliminary results of 18F-Fluorocholine PET/MRI show excellent accuracy in patients with primary hyperparathyroidism and inconclusive conventional imaging

15:05 B-0374

J. Zhang, N. Hall, K. Binzel, M. Natwa, M.V. Knopp; Columbus, OH/US

15:13 B-0375

One-stop SPECT-CT-guided ultrasound for parathyroid adenoma localisation - a single centre experience P. Touska1, A. Elstob1, N. Rao2, A. Parthipun1; 1London/UK, 2 Birmingham/UK

Feasibility of low dose 18FDG PET/CT in pediatric oncology

Use of diagnostic computed tomography in paediatric PET-CT: is diagnostic CT essential? C. Loberg, C. Kuhl, A. Heinzel, F. Mottaghy, F. Verburg; Aachen/DE

14:00–15:30

Room M 3

Cardiac 14:00–15:30

Room M 2

SS 303b

Paediatric SS 312

Thorax and musculoskeletal Moderators: C. Balassy; Vienna/AT, Z. Yazici; Bursa/TR

14:00 K-09

Moderators: R. Fischbach; Hamburg/DE, M. Francone; Rome/IT

14:00 B-0376

Juvenile idiopathic arthritis (JIA): whole-body MRI (WBMRI) approach in diagnosis and assessment of therapeutic efficacy

14:08 B-0377

P. Arcuri1, S. Roccia2, G. Raiola1, M. Cirillo1, A. Pingitore1, G. Fodero1; 1 Catanzaro/IT, 2Lamezia Terme/IT

14:17 B-0367

Radiological phenotype/ genotype correlations of constitutional bone diseases involving the parathyroid hormone (PTH) and its signaling pathways

Serial analysis of aortic haemodynamics in patients with repaired aortic coarctation by 4D flow MRI

14:16 B-0378

14:24 B-0379

J. Geiger1, J. Romberg2, D. Hirtler2, K. Gottfried2, B. Stiller2; Zurich/CH, 2Freiburg/DE

Role of dual-source computed tomography in identification of respiratory symptomatic patients affected by true isolated vascular rings

Lung perfusion with dual-energy CT: can we achieve a diagnostic image quality in children? M. Remy-Jardin, T. Santangelo, A. Deschildre, J.-B. Faivre, A. Hutt, J. Rémy; Lille/FR

14:49 B-0372

Computed tomography angiography and perfusion CT to assess coronary artery stenosis causing perfusion defects R. Boughrarou; Algiers/DZ

14:32 B-0380

T.P. Santangelo, M. Trezzi, G. Muscogiuri, M. Maurizi Enrici, S. Albanese, A. Carotti, P. Tomà, A. Secinaro; Rome/IT

14:41 B-0370

Comparison between CT perfusion imaging of the myocardium and intracoronary transluminal attenuation gradient in coronary CT angiography for the assessment of coronary artery stenosis B.M. Gramer, I. Baur, M. Rasper, M. Rasper, A. Leber; Munich/DE

1

14:33 B-0369

Computed tomography coronary angiography vs stress cardiac magnetic resonance for the management of symptomatic revascularized patients: a cost effectiveness study G. Pontone1, D. Andreini1, C. Rota1, M. Guglielmo1, S. Mushtaq1, A. Baggiano1, A. Solbiati1, A. Guaricci2, M. Pepi1; 1Milan/IT, 2Foggia/IT

M. Lahkim, A. Durand, V. Merzoug, A. Linglart, C. Adamsbaum; Le Kremlin-Bicêtre Cedex/FR

14:25 B-0368

Quantification of myocardial perfusion defects at third-generation dual-source CT in an ex-vivo porcine heart model G. Pelgrim1, S. Van Tuijl2, K. Slump3, M. Stijnen2, M. Oudkerk1, R. Vliegenthart1; 1Groningen/NL, 2Eindhoven/NL, 3Enschede/NL

Keynote lecture A.C. Offiah; Sheffield/UK

14:09 B-0366

CT perfusion

Optimal timing of static CT iodine distribution scans based on dynamic CT myocardial perfusion imaging data G. Pelgrim1, E.R. Nieuwenhuis1, J.L. Wichmann2, C.N. De Cecco2, R. Van der Geest3, K.H. Slump4, M. Oudkerk1, U.J. Schoepf2, R. Vliegenthart1; 1Groningen/NL, 2Charleston, SC/US, 3Leiden/NL, 4 Enschede/NL

14:40 B-0381

Morphological coronary stenosis characteristics by CCTA: comparison with invasive fractional flow reserve L. Macron, J.-L. Sablayrolles; Saint Denis/FR

Multi-detector computed tomography of paediatric large airway diseases: comparison between virtual bronchoscopy and fiberoptic bronchoscopy T.S. Jugpal, A. Garg, J. Kumar, G.R. Sethi; New Delhi/IN

www.myESR.org

Final Programme | ECR 2016

279

Wednesday

W.P. Kluijfhout1, T.A. Hope1, M.R. Vriens2, J.E. Gosnell1, W.T. Shen1, Q.-Y. Duh1, C.M. Glastonbury1, I. Suh1, M.H. Pampaloni1; 1San Francisco, CA/US, 2Utrecht/NL

15:20 B-0365

Comparison of organ doses between 70 kVp chest CT and 100 kVp chest CT with a dedicated tin filter for spectral shaping using thermoluminescent dosimeter measurements in a pediatric phantom

Scientific Sessions

14:48 B-0382

Adenosine triphosphate stress dynamic perfusion CT imaging to identify myocardial ischemia: correlation with coronary CTA and invasive coronary angiography E. Tahir1, T. Kido1, Y. Tanabe1, N. Fukuyama1, T. Kido1, J. Yamamura2, G.K. Lund2, G. Adam2, T. Mochizuki1; 1Toon, Ehime/JP, 2Hamburg/DE

14:56 B-0383

Acceptance of combined coronary CT angiography and myocardial CT perfusion versus conventional coronary angiography in patients with coronary stents

14:24 B-0390

S. Shams1, M. Larvie2, M. Lev2, J. Martola1, A. Charidimou2, M. Kristoffersen Wiberg1, L.-O. Wahlund1; 1Stockholm/SE, 2Boston, MA/US

14:32 B-0391

Potential usefulness of cardiac output and total peripheral resistance as indicators of adequate vasodilation in myocardial perfusion imaging

14:40 B-0392

14:48 B-0393

Optimal scan delay time for quantitative CT myocardial perfusion imaging

14:56 B-0394

Relationship of cardiovascular risk factors to myocardial perfusion parameters using dynamic computed tomography myocardial perfusion imaging G. Pelgrim1, R. Vliegenthart1, F.G. Meinel2, J.L. Wichmann3, F. Pugliese4, C.N. De Cecco3, M. Oudkerk1, U.J. Schoepf3; 1 Groningen/NL, 2Munich/DE, 3Charleston, SC/US, 4London/UK

14:00–15:30

15:04 B-0395

Room M 4 15:12 B-0396

Dementia

The clinical impact of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with cognitive impairment

Medial temporal lobe atrophy grades in a homogeneous 75-year-old cognitively normal population 1

1

2

1

15:20 B-0397

Rating scores of medial temporal atrophy from CT and MR images are highly correlated D. Van Westen1, M. Johnsson2, C. Håkansson1, L. Minthon3, O. Lindberg3, S. Palmqvist3, O. Hansson3; 1Lund/SE, 2Trelleborg/SE, 3 Malmö/SE

14:00–15:30

Room M 5

Neuro

1

V. Velickaite , J. Kullberg , L. Cavallin , L. Lind , H. Ahlström , L. Kilander1, E. Westman2, E.-M.B. Larsson1; 1Uppsala/SE, 2 Stockholm/SE

14:16 B-0389

Changes of systolic cerebrospinal fluid flow in patients with normal pressure hydrocephalus exceed age-related alterations S. Stoecklein1, S. Lause1, A. Pomschar1, R. Schniepp1, S. Lee2, K. Jahn1, N. Alperin2, B. Ertl-Wagner1; 1Munich/DE, 2Miami, FL/US

H. Motara1, T. Olusoga2, G. Russell3, S. Jamieson1, S. Ahmed2, A. Pillai3, A. Scarsbrook1, C. Patel1, F. Chowdhury1; 1Leeds/UK, 2Harrogate/UK, 3 Saltaire/UK

14:08 B-0388

Alterations of white matter integrity in HIVassociated neurocognitive disorder: a tract-based spatial statistics study S. Oh1, W. Lee2, N.-Y. Shin2, S.-K. Lee2, S. Lim2; 1Cheonan/KR, 2 Seoul/KR

Moderators: N. Pyatigorskaya; Paris/FR, M.A. van Buchem; Leiden/NL

14:00 B-0387

Iterative metal artifact reduction in computed tomography following deep-brain-stimulation (DBS) surgery J. Aissa, J. Boos, C. Schleich, R. Lanzman, P. Kröpil, G. Antoch, C. Thomas; Düsseldorf/DE

Neuro SS 311b

Altered brain connectivity in dementia: a correlation study between functional and structural data V. Onofrj1, F. Piludu1, F. Vecchio1, F. Miraglia1, G. Granata1, M. Caulo2, P. Bramanti3, P.M. Rossini1, C. Colosimo1; 1Rome/IT, 2Chieti/IT, 3 Messina/IT

N. Nagasawa, K. Kitagawa, A. Yamazaki, H. Sakuma; Tsu/JP

15:20 B-0386

Brain MR pallidal index do not correlate with clinical functional scale in extrapiramidal syndromic cirrhotic patients E. Soligo, A. Stecco, M. Carecchio, R. Matheoud, A. Carriero; Novara/IT

N. Nagasawa, K. Kitagawa, A. Yamazaki, H. Sakuma; Tsu/JP

15:12 B-0385

Analysis of hippocampal subfield in patients with mild Alzheimer’s disease Y. Liu, H. Yuan, X. Zeng, Z. Wang; Beijing/CN

S. Feger1, M. Rief1, P. Martus2, M. Laule1, M. Dewey1, E. Schönenberger3; 1 Berlin/DE, 2Tübingen/DE, 3Hannover/DE

15:04 B-0384

Microinfarcts detected on MRI - another important imaging biomarker in cognitive impairment?

The role of quantitative MR R2* brain iron deposition in patients with Alzheimer disease and its correlation with cerebral perfusion R. Esposito, M. Maccarone, S. Salice, G. Caracciolo, S. Delli Pizzi, L. Valentino, P. Chiacchiaretta, A. Ferretti, A. Tartaro; Chieti/IT

SS 311c

Neurovascular interventions (1) Moderators: A. Biondi; Besancon/FR, H.P. Schemuth; Essen/DE

14:00 K-08

Keynote lecture A. Biondi; Besancon/FR

14:09 B-0398

Results of the acute recanalisation of thromboembolic ischaemic stroke with pREset (ARTESp) trial W. Kurre1, B. Schwaiger2, A. Gersing2, T. Niederstadt3, W. Reith4, S. Felber5, S. Prothmann2; 1Stuttgart/DE, 2Munich/DE, 3Münster/DE, 4 Homburg/DE, 5Koblenz/DE

280

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

14:17 B-0399

Impact of patient transfer on clinical outcome after endovascular recanalisation - analysis from the acute recanalisation of thrombo-embolic ischaemic stroke with pREset (ARTESp) trial W. Kurre1, B. Schwaiger2, A. Gersing2, W. Reith3, T. Niederstadt4, S. Felber5, S. Prothmann2; 1Stuttgart/DE, 2Munich/DE, 3Homburg/DE, 4 Münster/DE, 5Koblenz/DE

14:25 B-0400

Wednesday

Reduction in cerebral embolic lesions during Transcatheter Aortic Valve Replacement (TAVR) with an embolic protection device (MISTRAL-C) H. Ahmad1, A. van der Lugt1, L. van Gils1, N.M. van Mieghem1, H.W. van der Werf2, G. Brueren3, A.F.M. van den Heuvel2, P. Koudstaal1, P.P.T. de Jaegere1; 1Rotterdam/NL, 2Groningen/NL, 3 Eindhoven/NL

14:33 B-0401

Endovascular occlusion of intracranial vessels using nBCA embolisation, controlled by adenosine-induced asystole F. Thaher, M. Aguilar, C. Harmening, W. Kurre, R. Martinez, P. Kurucz, O. Ganslandt, H. Henkes; Stuttgart/DE

14:41 B-0402

Prediction of long-term functional outcome after subarachnoid hemorrhage using machine learning C. Rubbert, R. May, D. Martens, B. Turowski, C. Mathys, J. Caspers; Düsseldorf/DE

14:49 B-0403

Thrombo-embolic complications during intracranial arterial endovascular procedures treated with stent retrievers by mechanical thrombectomy: technical and clinical results M. Voormolen, T. van der Zijden, T. Menovsky, L. Yperzeele, I. Baar, O. d‘Archambeau, F. De Belder, P.M. Parizel; Edegem/BE

14:57 B-0404

CT angiography/perfusion (CTA-CTP) for early detection of vascular complications after subarachnoid haemorrage (SH) due to aneurysm rupture E. Puglielli, L. Gregori, V. Di Mizio, R. Lattanzi, A. Bernardini, V. Di Egidio; Teramo/IT

15:05 B-0405

Imaging anatomy of dural blood supply from pial arteries: evaluated by 3D rotational angiography in normal subjects and pathologic conditions S. Tanoue1, H. Kiyosue1, H. Mori1, T. Kubo1, K. Sugita1, R. Ishibashi2, A. Ishii2; 1Oita/JP, 2Kitakyushu/JP

15:13 B-0406

Safety and efficacy of intravenous tirofiban as antiplatelet premedication for stent-assisted coiling in acutely ruptured intracranial aneurysms J. Lee, B. Kim, M. Kang, S. Kim, S. Choi; Busan/KR

15:21 B-0407

Association of automatically quantified blood volume after aneurysmal subarachnoid haemorrhage with delayed cerebral ischemia I.A.J. Zijlstra; Amsterdam/NL

www.myESR.org

Final Programme | ECR 2016

281

Scientific Sessions

282

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:30–12:00

Room B

Abdominal Viscera SS 601a

11:42 B-0417

Chronic liver disease and primary liver tumours

E. Talakic, S. Schaffellner, D. Kniepeiss, H. Müller, R. Stauber, H. Schöllnast; Graz/AT

Moderators: D.E. Malone; Dublin/IE, P. Rodriguez; Madrid/ES

10:30 B-0408

Surveillance for hepatocellular carcinoma in high-risk patients: abdominal ultrasound compared to crosssectional imaging: results of 5-year cohort follow-up

Volume CT-perfusion of the liver and spleen: is there a correlation between hepatic venous pressure gradient (HVPG) and perfusion in patients with liver cirrhosis?

10:30–12:00

Room C

Breast

L. van Dam, F.E.J.A. Willemssen, R.S. Dwarkasing; Rotterdam/NL

SS 602a 10:38 B-0409

Comparison of diagnostic performance of gadoxetic acid-enhanced liver MR imaging with multidetector CT in detection of Dysplastic nodules and early hepatocellular carcinoma B. Kim, J. Lee, J. Kim; Seoul/KR

10:46 B-0410

J. Yoon, J. Lee, K. Lee, J. Han; Seoul/KR

10:54 B-0411

11:18 B-0414

Comparison of imaging features of intrahepatic mass-forming cholangiocarcinoma on gadoxetic acid-enhanced MR imaging with and without chronic liver disease J. Kim, J.-Y. Choi; Seoul/KR

11:26 B-0415

10:38 B-0420

10:46 B-0421

Abbreviated combined MR protocol: a new faster strategy for characterising breast lesions M. Telegrafo, T. Introna, L. Coi, L. Rella, A. Stabile Ianora, G. Angelelli, M. Moschetta; Bari/IT

10:54 B-0422

Breast MRI in the screening setting: is maximum intensity projection (MIP) a reliable technique for cancer detection? M. Orsi, M. Cellina, E. Battaglia, F. Barmettler, G. Oliva; Milan/IT

11:02 B-0423

Intraductal breast disease in magnetic resonance imaging: a systematic diagnostic approach P. Clauser1, M. Marcon2, M. Mahajan3, M.A. Marino1, P. Kapetas1, R. Woitek1, P.A.T. Baltzer1; 1Vienna/AT, 2Zurich/CH, 3Ottawa, ON/CA

11:10 B-0424

B1+ field correction of T1 estimation is necessary for quantitative breast DCE MRI even at 1.5T W. Tsai, K. Kao, K. Chang, C.E. Lin; Taipei/TW

Intrahepatic mass-forming cholangiocarcinoma in high-risk patients for hepatocellular carcinoma: how does LI-RADS v2014 work on gadoxetic acidenhanced MRI?

11:18 B-0425

I. Joo, J. Lee, S. Lee, J. Lee, J. Park, J. Han; Seoul/KR

11:34 B-0416

Only in invasive lobular cancers breast MRI use is associated with a lower risk of surgical margin involvement and reduced number of mastectomies: a “real world” analysis in the Netherlands M. Lobbes1, I. Vriens1, G. Nieuwenhuijzen2, L. Boersma1, T. van Dalen3, H. Struikmans4, S. Siesling3, A. Voogd1, V. Tjan-Heijnen1; 1 Maastricht/NL, 2Eindhoven/NL, 3Utrecht/NL, 4The Hague/NL

Hepatocellular carcinoma in non-cirrhotic liver. Multimodality imaging findings M. Diaz-Zamudio, J. Dosal Bañuelos, C. Escalona-Huerta, A. Hernandez-Martinez, F. Hofmann Gonzalez; Mexico City/MX

Breast cancer detection in dense breast with abbreviated breast MRI protocol: first hundred cases M. Nadrljanski, D. Pavlovic - Stankovic, N. Spasic, V. Plesinac - Karapandzic, M. Nikitovic, Z. Milosevic; Belgrade/RS

Quantitative assessment of washout in hepatocellular carcinoma using MRI R. Kloeckner, D. Pinto dos Santos, K.-F. Kreitner, A. Leicher-Düber, A. Weinmann, J. Mittler, C. Düber; Mainz/DE

11:10 B-0413

10:30 B-0419

Evaluation of combined read-out of Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading S. Kinner, T.C. Lauenstein, J. Best, S. Bertram, M. Reinboldt, J. Goebel; Essen/DE

11:02 B-0412

Moderators: A. Sever; Maidstone/UK, I. Thomassin-Naggara; Paris/FR

Comparison of the accuracy between liver and spleen elastography using acoustic radiation force impulse and other noninvasive tests in predicting the presence of esophageal varices

Breast structure and risk of breast cancers: the MR risk factors C. Iacconi1, C. Marini2, G. Angelini2, D. Della Latta3, M. Giannelli2, M. Moretti2, D. Mazzotta2; 1Carrara/IT, 2Pisa/IT, 3Massa/IT

11:26 B-0426

Pure ductal carcinoma in situ: evaluation of earlyphase dynamic characteristics on ultrafast breast MRI C. Borelli1, R.D. Mus2, S. Vreemann2, M. Dalmis2, A. Gubern-Mérida2, R.M. Mann2; 1Rome/IT, 2Nijmegen/NL

H. Kwon, B. Kim, J. Lee, J. Cho, J. Oh, J. Lee, S. Lee; Busan/KR

www.myESR.org

Final Programme | ECR 2016

283

Thursday

Added value of Gd-EOB-DTPA enhanced liver MRI for diagnosis of small HCC and atypical hepatic nodules (d2cm)

Breast MRI: new sequences and applications

Scientific Sessions

11:34 B-0427

Are the magnetic resonance imaging (MRI) features of the pleomorphic variant of invasive lobular carcinoma (ILC) different from classic ILC of the breast? P.M. Yeap, A. Evans, C. Purdie, J. Lee, S. Waugh, S. Vinnicombe; Dundee/UK

11:42 B-0428

The value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH): can we safely follow patients rather than perform surgery? K. Tsuchiya1, D. Schacht1, D. Sheth1, N. Mori2, K. Kulkarni1, R. Reddy1, J. Mueller1, G. Karczmar1, H. Abe1; 1Chicago, IL/US, 2Sendai/JP

10:30–12:00

11:18 B-0436

11:26 B-0437

Moderators: S. Bickelhaupt; Heidelberg/DE, M. de Bruijne; Rotterdam/NL

10:30 B-0430 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

An optimum combination of biological fingerprints extracted from edge-enhanced chest radiograph to identify misfiled images in a picture archiving and communication system Y. Shimizu, Y. Matsunobu, J. Morishita; Fukuoka/JP

10:38 B-0431

10:46 B-0432

11:34 B-0438

S. Mauf, U. Held, D. Gascho, R. Baumeister, W. Schweitzer, P. Flach, T. Ruder, T. Nguyen-Kim, M.J. Thali, T. Jentzsch; Zurich/CH

11:42 B-0439

Evaluation of a new fully automated pulmonary lobe segmentation algorithm on inspiratory and expiratory MDCT scans over 4 time-points O. Weinheimer1, M.O. Wielpütz1, P. Konietzke1, C.P. Heußel1, H.-U. Kauczor1, C.J. Galban2, T.E. Robinson3; 1Heidelberg/DE, 2 Ann Arbor, MI/US, 3Palo Alto, CA/US

11:50 B-0440

Surface fitting based automatic segmentation and quantification of pulmonary fissures and lobes

A patient identification system using a combination of objective and subjective similarities in bedside chest radiographs to prevent filing mistakes

10:30–12:00

Y. Sakai, T. Kato, K. Iwase, K. Takahashi, A. Hattori, Y. Nakamura, J. Morishita; Fukuoka/JP

GI Tract SS 601b

Development and evaluation of a computer-aided diagnosis system for diagnosis of interstitial lung diseases in high-resolution CT

10:30 B-0441

Multimodality imaging of Crohn’s disease

Diagnostic value of 4th generation iterative reconstrution algorithm with low dose CTenterography protocol in follow-up of Crohn’s disease patients: comparison with standard dose S. Lombardi, D. Ippolito, C. Talei Franzesi, C. Trattenero, P. Bonaffini, S. Sironi; Monza/IT

10:38 B-0442

Improvement of perfusion characterisation in two lung tumour subtypes using de-noised CT perfusion maps S. Baiocco1, D. Barone2, G. Gavelli2, A. Bevilacqua1; 1Bologna/IT, 2 Meldola/IT

Room O

Moderators: S. Gourtsoyianni; London/UK, C. Hoeffel; Reims/FR

Comparison of manual vs. fully automated lobebased quantification of pulmonary air-trapping on paired inspiratory-expiratory MDCT in school age children with CF P. Konietzke1, O. Weinheimer1, M.O. Wielpütz1, C.P. Heußel1, H.-U. Kauczor1, C.J. Galban2, T.E. Robinson3; 1Heidelberg/DE, 2 Ann Arbor, MI/US, 3Palo Alto, CA/US

11:02 B-0434

The unfolded chest cage: flat rib projection is superior in the detection of rib fractures for trauma surgeons and medical laypersons compared to conventional multi planar reformation

Y. Hong, T. Nair, J. Lee; Suwon-city/KR

S.S. Martin, M.H. Albrecht, T.J. Vogl, V. Jacobi; Frankfurt/DE

10:54 B-0433

Automatic method to support radiologists in choosing the most representative slices in CT perfusion of lung cancer S. Malavasi1, D. Barone2, S. Baiocco1, A. Bevilacqua1, G. Gavelli2; 1 Bologna/IT, 2Meldola/IT

Room Z

Image processing techniques (1)

Impact of segmentation techniques on the performance of a CT texture-based lung nodule classification system J.M.Y. Willaime, L.C. Pickup, D. Boukerroui, A. Talwar, M.J. Gooding, F.V. Gleeson, T. Kadir; Oxford/UK

Computer Applications SS 605

Texture analysis of blood flow maps in CT perfusion studies of NSCLC: correlation with the overall survival S. Baiocco1, D. Barone2, G. Gavelli2, A. Bevilacqua1; 1Bologna/IT, 2 Meldola/IT

Influence of fat separation and spatial resolution on the results of automated volumetric MRI measurements of fibroglandular breast tissue G.J. Wengert, K. Pinker-Domenig, T.H. Helbich, W.-D. Vogl, P. Clauser, H. Bickel, M.-A. Marino, H. Magometschnigg, P.A.T. Baltzer; Vienna/AT

11:50 B-0429

11:10 B-0435

Warm CO2 CT enteroclysis or virtual enteroscopy (VE): preliminary experience of a new technique for small bowel imaging on Crohn’s patients with subocclusive or complicated disease D. Szapiro, L. Bidaut, J. Serhan, A. Matthews, T. Hartley, A. Gangi; Kirkcaldy/UK

10:46 B-0443

The value of dual energy CT in the detection of pathological intestinal segments in patients with Crohn disease (CD) A. Villanueva, G. Tardáguila, C. Martínez, C. Varela; Vigo/ES

284

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:54 B-0444

Long-term performance of readers trained in grading Crohn’s disease activity using MRI

10:38 B-0453

C.A.J. Puylaert, J.A.W. Tielbeek, S. Bipat, T.N. Boellaard, C.Y. Nio, J. Stoker; Amsterdam/NL

11:02 B-0445

L. Barbuto, C. Nappi, A. Ponsiglione, M. Puglia, M. Imbriaco, E. Nicolai, L. Spinelli, A. Cuocolo; Naples/IT

Diffusion-weighted MRI for evaluating ileocolonic inflammation in Crohn’ disease: how does it contribute to diagnose disease activity?

10:46 B-0454

X. Li1, X. Jiang1, Z. Zhang2, S. Huang1, J. Lin1, L. Huang1, C. Sun1, Z. Li1; 1 Guangzhou/CN, 2Dallas, TX/US

11:10 B-0446

Evaluation of three MRE index for grading Crohn’s disease activity

In vivo axial-strain sonoelastography helps distinguish acutely inflamed from fibrotic terminal ileum strictures in patients with Crohn’s disease

Dynamic contrast enhanced MRI of small bowel: diagnostic value of quantitative perfusion analysis in vascular assessment between inflammatory and fibrotic lesions in Crohn’s disease S. Lombardi, D. Ippolito, C. Talei Franzesi, S. Sironi; Monza/IT

11:34 B-0449

Comparison of magnetisation transfer and diffusionweighted MRI for detection of bowel fibrosis in Crohn’s disease: initial experience X. Jiang1, X. Li1, Z. Zhang2, S. Huang1, J. Lin1, L. Huang1, C. Sun1, Z. Li1; 1 Guangzhou/CN, 2Dallas, TX/US

11:42 B-0450

Evaluation of quantitative PET/MR-E biomarkers for discriminating inflammatory from fibrotic strictures in Crohn’s disease O.A. Catalano, M. Gee, D. Sahani, U. Mahmood, B. Rosen, D. Gervais; Boston, MA/US

11:50 B-0451

10:54 B-0455

T. Emrich, N. Abegunewardene, A. Theruvath, K. Oberholzer, T. Muenzel, C. Dueber, K.-F. Kreitner; Mainz/DE

11:02 B-0456

10:30–12:00

11:10 B-0457 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:18 B-0459

Cardiac magnetic resonance volume analysis in patients with single ventricle F. Secchi, M. Petrini, A. Cozzi, P. Cannaò, F. Sardanelli; Milan/IT

11:26 B-0460

Patient satisfaction with coronary CT angiography, myocardial CT perfusion, myocardial perfusion MRI, SPECT myocardial perfusion imaging and conventional coronary angiography S. Feger1, M. Rief1, E. Zimmermann1, F. Richter1, R. Röhle1, M. Dewey1, E. Schönenberger2; 1Berlin/DE, 2Hannover/DE

11:34 B-0461

Room N

Contrast enhanced magnetic resonance imaging of the heart in the quantification of myocardial damage in drug-resistant hypertension O. Mochula, W. Ussov; Tomsk/RU

Evolving techniques Moderators: A.J.B.S. Madureira; Porto/PT, M. Meyer; Mannheim/DE

10:30 B-0452

Cardiac magnetic resonance characteristics of patients with the clinical signs of ST-elevation myocardial infarction and normal coronary angiography F. Suhai, C. Czimbalmos, I. Csécs, A. Tóth, B. Horváth, E. Szima Mármarosi, D. Becker, B. Merkely, H. Vágó; Budapest/HU

Cardiac SS 603

Detection and quantification of myocardial infarction using a dark blood late gadolinium enhancement technique A. Varga-Szemes1, G. Muscogiuri1, P. Suranyi1, W.G. Rehwald2, C.N. De Cecco1, S. Mangold1, D. Caruso1, S.R. Fuller1, U.J. Schoepf1; 1 Charleston, SC/US, 2Chicago, IL/US

MRI features of proctitis in Crohn’s disease C.J. Tutein Nolthenius, S. Bipat, B. Mearadji, A. Spijkerboer, A. Montauban van Swijndregt, C.I.J. Ponsioen, J. Stoker; Amsterdam/NL

Dependency of prevalence and extent of infarct size (IS) and microvascular obstruction (MO) on the timing of imaging and constrast injection after infarction

11:42 B-0462

Cardiac magnetic resonance (CMR) evaluation of non-compacted myocardium: comparison of two software packages E. Pershina1, M. Gutberlet2, M. Grothoff2; 1Moscow/RU, 2Leipzig/DE

Self-navigated 3D radial whole-heart MRA for the assessment of coronary artery anomalies in paediatric patients: comparison with coronary CTA A. Varga-Szemes1, G. Muscogiuri1, C.N. De Cecco1, P. Suranyi1, S. Mangold1, D. Piccini2, A. Hlavacek1, A.C. Nutting1, U.J. Schoepf1; 1 Charleston, SC/US, 2Lausanne/CH

www.myESR.org

Final Programme | ECR 2016

285

Thursday

L.M. Sconfienza1, L. Pescatori2, F.M. Doniselli2, F. Cavallaro1, G. Tontini1, L. Pastorelli1, M. Vecchi1, F. Sardanelli1; 1San Donato Milanese/IT, 2 Milan/IT

11:26 B-0448

Relationship between myocardial fibrosis and left ventricular functional impairment in diabetes mellitus type-II: preliminary results N. Galea, F. Ciolina, R. Pofi, T. Feola, C. Catalano, M. Francone, I. Carbone; Rome/IT

J. Rimola1, A. Alvarez-Cofiño2, T. Pérez-Jeldres3, C. Ayuso1, S. Rodríguez1, I. Alfaro1, I. Ordás1, J. Panés1; 1Barcelona/ES, 2Gijón/ES, 3 Santiago de Chile/CL

11:18 B-0447

Simultaneous positron emission tomographymagnetic resonance imaging for the early detection of cardiac involvement in patients with AndersonFabry disease

Scientific Sessions

10:30–12:00

11:51 B-0472

Studio 2016

Genitourinary SS 607a

Guidelines for intra-luminal uterine hypodensity (ILUH) seen on CTs of postmenopausal women M. Yassin, M. Amitai, N. Kanana, S. Apter, S. Raskin, E. Konen, E. Klang; Ramat Gan/IL

Female pelvis Moderators: O. Nikolic; Novi Sad/RS, K. Pyra; Lublin/PL

10:30 K-13

10:30–12:00 Keynote lecture

Vascular

D. Akata; Ankara/TR

10:39 B-0463

SS 615 Preoperative prediction using clinical and CT parameters for optimal resection in advanced ovarian cancer B. Kim, S. Kim; Daegu/KR

10:47 B-0464

Room L8

Optimising vascular imaging techniques Moderators: A.L.J. Bojanovic; Nis/RS, T. Rand; Vienna/AT

10:30 B-0473

CT predictors for selecting conservative surgery or adnexectomy to treat adnexal torsion

Effects on intra-coronary attenuation using different iodine concentrations (240, 300 and 370 mg/ml) whilst maintaining identical IDR (EICAR-trial) B.M.F. Hendriks, C. Mihl, M. Kok, S. Altintas, B.L.J.H. Kietselaer, J.E. Wildberger, M. Das; Maastricht/NL

Y. Yim, S. Jung, M. Yu, H. Park, Y. Kim, H. Jeon; Seoul/KR

10:55 B-0465

10:38 B-0474 MRI to evaluate myometrium invasion in patients with placenta previa: correlation with histological findings G. Frauenfelder, M.I. Ginocchio, M. Morlando, P.P. Mainenti, P. Martinelli, S. Maurea; Naples/IT

11:03 B-0466

G. Ivanac, M. Dzoic Dominkovic, K. Ivanac, B. Brkljačić; Zagreb/HR

Magnetic resonance elastography as a predictor of response to treatment of magnetic resonance-guided focused ultrasound surgery for uterine fibroids: a preliminary study

10:46 B-0475 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

A leiomyoma scoring system for selecting patients for uterine artery embolisation

10:54 B-0476

N.N.N. Naguib, N.-E.A. Nour-Eldin, T. Gruber-Rouh, R. Hammerstingl, S. Zangos, T.J. Vogl; Frankfurt a. Main/DE

11:19 B-0468

Colorectal infiltrating endometriosis: can MRI predict the need of intestinal resection? 1

2

1

Perfusion quantification of vascular malformations using contrast-enhanced ultrasound (CEUS) with time intensity curve analysis (TIC) before and after percutaneous treatment I. Wiesinger, W.A. Wohlgemuth, C. Stroszczynski, E.M. Jung; Regensburg/DE

S. Ichikawa1, U. Motosugi1, M. Omori1, K. Sano2, S. Hirata1, H. Onishi1; 1 Chuo-shi, Yamanashi/JP, 2Hidaka-shi, Saitama/JP

11:11 B-0467

Measurement of blood velocities in renal, intrarenal and carotid arteries: comparison of Ultrafast Doppler and conventional color duplex Doppler

As low as reasonabily achievable: lowest dose CT angiography in patients with endoleak after endovascular aneurysm repair R. Pizzolato, M. Belgrano, G. Poillucci, A. Spezzacatene, M. Cova; Trieste/IT

11:02 B-0477

1

A. Scardapane , F. Lorusso , P. Pignataro , A.A. Stabile Ianora , G. Angelelli1; 1Bari/IT, 2Castellana Grotte/IT

Ultra-low dose and volume contrast medium (CM) for aorta CTA: using IMR for substantial dose and volume CM reduction in a prospective clinical study P. Hou; Zhengzhou/CN

11:27 B-0469

Role and benefits of intraoperative ultrasound guidance in intracavitary brachytherapy for cervical cancer

11:10 B-0478

M. Hofmann, J. Salamon, C. Jung, M.G. Kaul, A. vom Scheidt, G. Adam, H. Ittrich, T. Knopp; Hamburg/DE

T. Akbas, G. Ugurluer, M. Acil, T. Arpaci, M. Serin; Adana/TR

11:35 B-0470

Leiomyoma maximal diameter versus leiomyoma volume: which is more reliable for proper patient selection for uterine artery embolisation

11:18 B-0479

N.N.N. Naguib, N.-E.A. Nour-Eldin, T. Gruber-Rouh, T. Lehnert, S. Zangos, T.J. Vogl; Frankfurt a. Main/DE

11:43 B-0471

Evaluation of pre-embolisation MRI-parameters of uterine fibroids for predicting volume reduction and quality-of-life score after uterine artery embolisation (UAE) I. Kalina, A. Tóth, É. Valcseva, P. Kaposi, N. Ács, S. Várbíró, V. Bérczi; Budapest/HU

286

ECR 2016 | Final Programme

Multi-spectral MPI for real time 3D tracking of endovascular devices

Investigation into MR angiography as a possible replacement for rotational angiography or CT angiography for cerebrovascular computational fluid dynamics H. Isoda1, Y. Yoneyama1, A. Fukuyama1, M. Terada2, M. Kamiya2, K. Otsubo2, T. Kosugi3, Y. Komori4, S. Naganawa1; 1Nagoya/JP, 2 Iwata/JP, 3Hamamatsu/JP, 4Tokyo/JP

11:26 B-0480

Submillisievert CT angiography for carotid arteries using new adaptive statistical iterative reconstruction -V A.D. Annoni, A. Formenti, G. Pontone, E. Nobili, A. Baggiano, E. Conte, P. Montorsi, M. Pepi, D. Andreini; Milan/IT

www.myESR.org

Scientific Sessions

11:34 B-0481

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:42 B-0482

Comparison of quantitative analysis to qualitative analysis for interpretation of lower limb lymphoscintigraphy

11:26 B-0491

E.C. Nganga; Nairobi/KE

Head and neck CT-angiography (HNCTA): Low and patient tailored versus standard contrast medium protocol

M. Raudner, D. Stelzeneder, C. Kronnerwetter, K. Pieber, R. Windhager, V. Juras, S. Trattnig; Vienna/AT

11:34 B-0492

L. Capitolo, F. Cesarani, C. Vaudagna, E. Armando; Asti/IT

11:50 B-0483

The impact of MRI total spine on targeted patient selection for surgical therapy of geriatric vertebral fractures C. Weber, C. Ossadnik, T. Abel, H. Hentschel, P. Bannas; Hamburg/DE

Diagnostic accuracy for the detection of arterial bleeding of the abdomen can be improved with noise-optimized virtual monoenergetic dual-energy CT

11:42 B-0493

S.S. Martin, J.L. Wichmann, J.-E. Scholtz, H. Weyer, A.M. Bucher, R.W. Bauer, V. Jacobi, T.J. Vogl, M.H. Albrecht; Frankfurt/DE

10:30–12:00

Room E1

11:50 B-0494

Evaliation of diffusion-weighted MRI in osteoporosis Q. Ren; Shijiazhuang/CN

10:30–12:00

Thursday

Body composition

Comparison of changes in quantitative computed tomography bone structure and bone density using two different iterative reconstruction methods J. Borggrefe1, N. Abdullayev1, F. Thomsen2, M. Hellmich1, T. Damm3, C.-C. Glüer3, B. Krug1; 1Cologne/DE, 2Bahía Blanca/AR, 3Kiel/DE

Musculoskeletal SS 610a

Five-year follow-up T2 mapping of the lumbar intervertebral disc at 3.0 Tesla: quantified imaging methods for prognostic patient assessment

Room E2

Moderators: G. Guglielmi; Andria/IT, A.S. Issever; Berlin/DE

10:30 B-0484

Neuro The diagnostic efficiency of CT value in the patients with osteoporosis compared with bone mineral density (BMD) based on quantitative computed tomography (QCT) P. Lei, J. Jiao, X. Chai; Guiyang/CN

SS 611

Cerebrovascular disease (1) Moderators: K.M. Thierfelder; Munich/DE, P. Vilela; Almada/PT

10:30 K-14

Keynote lecture P. Vilela; Almada/PT

10:38 B-0485

Association of MRS-based bone marrow fat fraction and unsaturation level with vertebral bone strength

10:39 B-0495

T. Baum1, S. Ruschke1, C. Cordes1, M. Dieckmeyer1, H. Kooijman2, R. Burgkart1, E.J. Rummeny1, J.S. Bauer1, D.C. Karampinos1; 1 Munich/DE, 2Hamburg/DE

10:46 B-0486

MRI to evaluate the effectiveness of enzyme replacement therapy in type 1 Gaucher’s disease patients

K. Tsuchiya, M. Yamashita, S. Ichisaka, M. Hara, M. Kokan, T. Suzuki; Tokyo/JP

10:47 B-0496

B.C.S. Rabelo, R.R. Nobre, A.M.A. Lopes, R.T. Domingues, R.M.V. Mota, R.G. Horta, L.L.S. Gavio, R. Strecker; Belo Horizonte/BR

10:54 B-0487

11:02 B-0488

Body mass is associated with chronic adventitial shearing injuries in subcutaneous fat

10:55 B-0497

T.C. Gaunt, F. Carey, A. Toms; Norwich/UK

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Current smokers have a faster decline in bone density than former smokers: a longitudinal CT study

11:03 B-0498

Validity of estimating muscles and fat volume from single MRI slice in older adults with sarcopenia and sarcopenic obesity Y.X. Yang, M.S. Chong, L. Tay, S. Yew, A. Yeo, C.H. Tan; Singapore/SG

11:18 B-0490

Sex estimation using cross sectional MDCT anatomy of C1 vertebrae

Internal carotid artery stenosis and collateral recruitment in stroke patients J.W. Dankbaar, K. Kerckhoffs, A.D. Horsch, I.C. van der Schaaf, L.J. Kappelle, B.K. Velthuis; Utrecht/NL

F.A.A. Mohamed Hoesein1, E. Pompe1, J. Bartstra1, H.J.J. Verhaar1, M. Oudkerk2, H.J. de Koning3, J.-W.J. Lammers1, P.A. de Jong1; 1 Utrecht/NL, 2Groningen/NL, 3Rotterdam/NL

11:10 B-0489

Collateral flow assessment in intracranial major trunk stenoocclusive diseases by fast non-contrast timeresolved MR angiography using arterial spin labelling

Comparison of four different collateral scores in acute ischemic stroke by CT angiography F. Seker, A. Potreck, M. Möhlenbruch, M. Bendszus, M. Pham; Heidelberg/DE

Perfusion CT indexes and derived blood-brain barrier permeability predicts hemorrhagic transformation risk after intravenous thrombolysis in acute stroke G. Carbo1, V. Cuba1, J. Puig1, G. Blasco1, J. Daunis-i-Estadella1, M. Castellanos1, C. Van Eendenburg1, C. Aboud2, S. Pedraza1; 1 Girona/ES, 2Valencia/ES

11:11 B-0499

Blood brain barrier disruption after endovascular stroke therapy: prediction of infarct development with dual-energy computed tomography T. Djurdjevic, B. Glodny, M. Knoflach, B. Matosevic, S. Kiechl, E.R. Gizewski, A.E. Grams; Innsbruck/AT

A. Solmaz Tuncer1, S. Gürel2, S. Halıcıoğlu2, E. Dağıstan2, Z. Coşgun2, S. Gür2; 1Manisa/TR, 2Bolu/TR

www.myESR.org

Final Programme | ECR 2016

287

Scientific Sessions

11:19 B-0500

Cerebrovascular reserve mapping in severe intracranial arterial stenosis

11:02 B-0509

A. Krainik, O. Heck, N. Boudiaf, I. Favre, E. Condamine, J. Pietras, K. Boubagra, F. Tahon, O. Detante; Grenoble/FR

11:27 B-0501

CT-perfusion (CTP) and lepto-meningeal score (LMs) for imaging based patient selection thrombectomy in acute ischemic stroke

H.A. Nasr1, H.R.S. Farghaly2, A.O. Al Qarni3; 1Cairo/EG, 2Assiut/EG, 3 Riyadh/SA

11:10 B-0510

E. Puglielli, R. Lattanzi, S. Roiati, V. Di Mizio, L. Gregori, V. Di Egidio; Teramo/IT

11:35 B-0502

Utility of diffusion and perfusion MRI for predicting perihemorrhagic edema growth after intracerebral haemorrhage

11:18 B-0511

Intravoxel incoherent motion diffusion weighted imaging in evaluating the radio-sensitivity of nasopharyngeal carcinoma xenografts Y. Xiao, Y. Chen, J. Pan, D. Zheng, X. Zheng, Y. Chen; Fuzhou/CN

Combining motor function and diffusion tensor imaging in the hyperacute intracerebral haemorrhage accurately predict functional motor outcome

11:26 B-0512

V.L. Cuba Camasca, G. Carbó, J. Puig, G. Blasco, S. Pedraza; Girona/ES

11:51 B-0504

Comparison of clinicoradiologic characteristics of lung adenocarcinomas harbouring ALK rearrangements or EGFR mutations treated by surgical resection H. Wang1, M. Schabath2, Y. Liu1, Y. Han1, Q. Li1, R. Gillies2, Z. Ye1; 1 Tianjin/CN, 2Tampa, FL/US

G. Carbo, V. Cuba, J. Puig, G. Blasco, J. Daunis-i-Estadella, M. Terceño, Y. Silva, J. Serena, S. Pedraza; Girona/ES

11:43 B-0503

Thyroid incidentalomas on 18F-FDG PET/CT in oncology patients: are there any predictors for malignancy?

Iterative model reconstruction in brain CT in patients with stroke

Pseudoprogression in cancer immunotherapy: diagnostic imaging features V. Kurra, R.J. Sullivan, J.F. Gainor, F.S. Hodi, L. Gandhi, C.A. Sadow, G.J. Harris, K.T. Flaherty, S.I. Lee; Boston, MA/US

11:34 B-0513

X. Liu, L. Chen, W. Qi, Y. Jiang, Y. Liu, M. Zhang, N. Hong; Beijing/CN

Potential prognostic impact of CT-quantified abdominal muscle and fat re-distribution under chemotherapy in lung cancer patients J. Nattenmüller, R. Wochner, T. Muley, M. Steins, S. Hummler, H.-U. Kauczor, M.O. Wielpütz, C.P. Heussel; Heidelberg/DE

10:30–12:00

Room F1

Oncologic Imaging SS 616

11:42 B-0514

Advanced imaging methods (1) Moderators: V. Panebianco; Rome/IT, B.M. Schaarschmidt; Düsseldorf/DE

10:30 B-0505

Nasopharyngeal carcinoma: predictive value of IVIMDWI on the radio-sensitivity

C. Santini1, A. Arranja2, A. Dankova3, F. Schosseler2, K. Morawska4, P. Dubruel4, E. Mendes3, M. de Jong1, M. Bernsen1; 1Rotterdam/NL, 2 Strasbourg/FR, 3Delft/NL, 4Gent/BE

11:50 B-0515

Y. Xiao, Y. Chen, Y. Chen, Z. He, J. Pan; Fuzhou/CN

10:38 B-0506

CT perfusion heterogeneity as a prognostic biomarker in NSCLC S. Baiocco1, D. Barone2, G. Gavelli2, A. Bevilacqua1; 1Bologna/IT, 2 Meldola/IT

Intravoxel incoherent motion imaging (IVIM) in head and neck cancers and nodal metastases: can we predict patient outcome? R. Balaji, D. Arivudainambi; Chennai/IN

10:46 B-0507

Intravenous vs intratumoral: effect of different inection routes on biodistribution and tumour accumulation of Pluronic-P94

Image quality and radiation dose of third generation dual-energy CT of the head and neck compared with a standard acquisition S. Suntharalingam, A. Wetter, E. Stenzel, N. Guberina, A. Ringelstein, T. Schlosser, M. Forsting, K. Nassenstein; Essen/DE

10:30–12:00

Room F2

Emergency Radiology SS 617

Cardiothoracic emergencies Moderators: F. Carbonetti; Rome/IT, J.B. Dormagen; Oslo/NO

10:30 K-15

Keynote lecture V.E. Sinitsyn; Moscow/RU

10:54 B-0508

Dual phase dual-energy CT in patients treated with erlotinib for advanced non-small cell lung cancer: possible benefits of iodine quantification in response assessment J. Baxa1, T. Matouskova1, T. Flohr2, B. Schmidt2, M. Sedlmair2, J. Ferda1; 1 Plzen/CZ, 2Forchheim/DE

10:39 B-0516

Radiological pattern of bomb blast injuries A. Raouf, R. Sayani; Karachi/PK

10:47 B-0517

Volume of intra-abdominal air measured by CT: a potential marker for abdominal compartment syndrome in trauma patients? E.C. Schubert, E.J. Rummeny, K.-G. Kanz, K. Holzapfel; Munich/DE

288

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:55 B-0518

Cardiovascular signs suggestive of thoracic compartment syndrome (TCS) in emergency setting

10:55 B-0528

C. Liguori1, G. Frauenfelder1, F. Giurazza2, P.P. Saturnino1, C. Acampora1, L. Romano1; 1Naples/IT, 2Rome/IT

11:03 B-0519

Triple rule-out CT in the emergency department patient: should we just do it?

J. Moon, J. Cheung, S. Koh, K. Lee; Anyang, Gyeonggi-do/KR

11:03 B-0529

F. Morsbach, K. Higashigaito, D. Benz, H. Alkadhi; Zurich/CH

11:11 B-0520

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:19 B-0521

HER2 positive breast cancer: correlation with quantitative contrast-enhanced ultrasound parameters W. Jia, J.-N. Shi, X.-C. Fei, K.-W. Shen, M. Chen; Shanghai/CN

Assessment of the adequacy of the coronary CT scan requests at the Emergency Department V. García de Pereda De Blas, I. Tavera Bahillo, E. Camuera González, J. Correa Zapata, I. Arrieta Artieda, M. Carreras Aja; Barakaldo/ES

Pulmonary embolism: do we evaluate the risk factors properly in the ED? Pulmonary angio-CT in risk stratified patients according to the revised Geneva score

11:11 B-0530

11:19 B-0531

C.L. Piccolo, S. Ianniello, B. Sessa, G.L. Buquicchio, M. Trinci, V. Miele; Rome/IT

Impact of Real-time Virtual Sonography, a coordinated US and MRI system, on the detection of conventional B-mode-occult lesions in second-look US for MRI-detected breast lesions S. Nakano, R. Tetsuka, K. Fujii, J. Kousaka, Y. Mouri, T. Ando, M. Goto, T. Imai, T. Ishiguchi; Aichi/JP

11:27 B-0532

Breast elastography: does strain ratio value depend on Regions Of Interest (ROIs) placement? E. Maggini, E. Mancuso, V. Maldur, F. Pediconi, P. Ricci; Rome/IT

11:35 B-0523

Comparisons of CT grading with clinical outcome of gastric corrosive injury at emergency room Y.-C. Wong, L.-J. Wang, C.-H. Wu; Taoyuan City/TW

11:43 B-0525

Value of multi-detector CT in identifying diagnostic findings in blunt bowel and/or mesenteric trauma: our experience M.C. Firetto, A.A. Lemos, E. Perucchini, T. Canini, P.R. Biondetti; Milan/IT

11:35 B-0533 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:43 B-0534

Categorisation of focal breast lesions according to the BI-RADS US lexicon: role of a computer-aided decision-making support (S-Detect) A.A.M. Orlando, M. Safina, L. Lodato, G. Buffa, A. Cirino, R. Ienzi, A. Taibbi, T.V. Bartolotta; Palermo/IT

Ultrasound within the Austrian mammography screening: benefit of regular quality assurance for clinical partners S. Wildner, C. Kollmann; Vienna/AT

10:30–12:00

Room D1

Breast SS 602b

11:51 B-0535

Breast ultrasound

J. van Zelst, M. Balkenhol, M. Imhof-Tas, N. Karssemeijer, R. Mann; Nijmegen/NL

Moderators: B. Brkljačić; Zagreb/HR, A. Domingo; Tarragona/ES

10:30 K-12

Keynote lecture B. Brkljačić; Zagreb/HR

10:39 B-0526

10:30–12:00

Room D2

Interventional Radiology Does pleomorphic invasive lobular carcinoma (ILC) have different mammographic and ultrasound features compared with classical ILC?

SS 609

Fast and accurate screening of women with dense breasts with a dedicated computer-aided detectionbased reading protocol in automated 3D breast ultrasound J. van Zelst1, A. Gubern-Merida1, D. Drieling2, T. Tan1, M. Rutten3, N. Karssemeijer1, R. Mann1; 1Nijmegen/NL, 2Bremen/DE, 3 ‘s-Hertogenbosch/NL

www.myESR.org

Non-vascular techniques in the abdomen Moderators: O. Akhan; Ankara/TR, D. Kuhelj; Ljubljana/SI

P.M. Yeap, S. Vinnicombe, C. Purdie, J. Lee, A. Evans; Dundee/UK

10:47 B-0527

Imaging molecular subtypes of invasive ductal carcinoma in automated 3D breast ultrasound: how to recognise cancers with a poor prognosis

10:30 B-0536

The minimally-invasive-treatment of ureteric stenosis in children with balloon-angioplasty and double-Jstenting A. Sanabria, S. Lombardo, J. Espejo, M. Perez, L. Zurera, J. Betancourth; Cordoba/ES

Final Programme | ECR 2016

289

Thursday

First-line diagnosis of paediatric pneumonia in emergency: lung ultrasound in addiction to chest-XR and its role in follow-up

The added value of breast ultrasound elastography for differentiating between benign and malignant lesions H.-J. Kim1, S. Kim1, M. Jang1, B. Yun1, J. Chang2, N. Cho2; 1 Gyeonggi-do/KR, 2Seoul/KR

M. Arias L., H. Maestre, M. Lorente, R. Jimenez, J. Perez, F. Garcia, A. Mas, A. Franco; San Juan de Alicante/ES

11:27 B-0522

Comparison of SRmax, SRave and color map of elastography in differentiating malignant from benign breast lesions

Scientific Sessions

10:38 B-0537

10:30–12:00 Combined endoscopic-radiological ureteral rendezvous: technique and results C. Zini, M. Corona, C. Cirelli, P. Lucatelli, G. Ricciuti, F.M. Salvatori; Rome/IT

10:46 B-0538

Musculoskeletal SS 610b

Colonic stenting: is still useful in the treatment of malignant obstruction?

Percutaneous radiologic gastrostomy in amyotrophic lateral sclerosis (ALS) patients with minimal intravenous analgesia: technical success, safety and efficacy N. Mani1, R.K. Varma2; 1St. Louis, MO/US, 2Pittsburgh, PA/US

11:02 B-0540

10:30 B-0547

10:38 B-0548

Endoluminal RFA assisted percutaneous recanalisation of biliary and main pancreatic duct obstruction, caused by inoperable malignancy

Does preoperative percutaneous transhepatic biliary drainage (PTBD) plays a role in reducing complications after pancreaticoduodenectomy for pancreatic head carcinoma?

Hepatic encephalopathy after TIPS: time to improve the classification? A. Discalzi, M. Calandri, E. Soncin, M. Fronda, A. Doriguzzi Breatta, C. Gazzera, D. Righi, P. Fonio, G. Gandini; Turin/IT

11:26 B-0543

Tunnelled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome I. Indesteege, A. Laenen, C. Verslype, H. Prenen, I. Vergote, G. Maleux; Leuven/BE

11:34 B-0544

Outcomes of fluoroscopic and ultrasound guided placement versus laparoscopic placement of peritoneal dialysis catheters A.M.K. Abdel Aal1, A.S. Moustafa1, M.F. Hamed2, N. Ertel1; 1Birmingham, AL/US, 2Tuscaloosa, AL/US

11:42 B-0545

CT-guided placement of hyperthermia catheters in oncologic patients to support regional deep hyperthermia treatment P. Kröpil, R. Wessalowski, C. Thomas, G. Antoch, R. Lanzman; Düsseldorf/DE

11:50 B-0546

Radiologic placement of uncovered stents for the treatment of malignant colonic obstruction at ascending and transverse colon J. Yoon, S. Kwon; Seoul/KR

Focal cartilage defects are associated with cartilage damage progression in the same subregion and new cartilage damage development in the same tibiofemoral compartment: the MOST Study A. Guermazi1, D. Hayashi1, F.W. Roemer1, J. Niu1, E.K. Quinn1, M.D. Crema1, M.C. Nevitt2, D.T. Felson1; 1Boston, MA/US, 2 San Francisco, CA/US

10:46 B-0549

M. Fronda, G. Di Guardia, S. Silvestri, A. Discalzi, A. Doriguzzi Breatta, D. Righi, P. Fonio, G. Gandini; Turin/IT

11:18 B-0542

Grating-based x-ray phase-contrast imaging: a new high-resolution non-contrast enhanced quantitative cartilage imaging technique? An experimental feasibility study P.M. Jungmann1, L. Birnbacher2, M. Viermetz2, P. Föhr1, D.C. Karampinos1, F. Lohöfer1, M. Wildgruber1, E.J. Rummeny1, J. Herzen2; 1Munich/DE, 2Garching/DE

M. Mizandari1, N. Habib2; 1Tbilisi/GE, 2London/UK

11:10 B-0541

Cartilage assessment Moderators: E.H.G. Oei; Rotterdam/NL, S. Trattnig; Vienna/AT

P. Crivelli, M. Carboni, S. Profili, M. Conti, G. Meloni; Sassari/IT

11:54 B-0539

Room G

Weight loss is associated with slower cartilage degeneration over 96 months in obese and overweight subjects: data from the Osteoarthritis Initiative A.S. Gersing, B.J. Schwaiger, J. Zarnowski, G. Feuerriegel, J. Guimaraes, L. Facchetti, N. Chancheck, M.C. Nevitt, T.M. Link; San Francisco, CA/US

10:54 B-0550

Quantitative T2* analysis of articular cartilage of the tibiotalar joint in professional soccer players and healthy individuals at 3T MRI C. Behzadi, F.O. Henes, A. Quitzke, M.G. Kaul, G. Adam, M. Regier; Hamburg/DE

11:02 B-0551

Chondrocalcinosisis associated with accelerated degeneration of the knee joint: data from the Osteoarthritis Initiative A. Gersing1, B.J. Schwaiger1, U. Heilmeier1, L. Facchetti1, N. Lane2, M.C. Nevitt1, C.E. McCulloch1, L.S. Steinbach1, T.M. Link1; 1 San Francisco, CA/US, 2Sacramento, CA/US

11:10 B-0552 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:18 B-0553

The role of MRI in the diagnosis of early forms of osteoarthritis at visualisation of articular cartilage lesions of knee and ankle joints in young athletes I.N. Dutova, A. Karpenko; St. Petersburg/RU

Efficacy of an outpatient musculoskeletal interventional radiology practice model in the treatment of knee osteoarthritis using autologous blood derived growth factors A.X. Doss; Nedlands/AU

11:26 B-0554

Value of fat-suppressed fluid-sensitive MRI sequences for the detection and characterisation of Modic I endplate changes of the lumbar spine T. Finkenstaedt1, F. Del Grande2, N. Bolog1, N. Ulrich1, S. Tok1, O. Kolokythas3, J. Steurer1, G. Andreisek1, S. Winklhofer4; 1Zurich/CH, 2 Lugano/CH, 3Winterthur/CH, 4San Francisco, CA/US

290

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

11:34 B-0555

Cross-sectional and longitudinal layer-specific femorotibial cartilage T2 mapping in knees without risk of, with risk of, and with early knee osteoarthritis

11:18 B-0564

W. Wirth1, F.W. Roemer2, S. Maschek1, F. Eckstein1; 1Salzburg/AT, 2 Erlangen/DE

11:42 B-0556

Initial experience of high resolution PET/MRI imaging of ACL graft viability using 18F-FDG and 3T

G. Widmann, C. Url, D. Dejaco, A.-K. Haug, N. Fischer, D. Riedl, H. Riechelmann; Innsbruck/AT

11:26 B-0565

K. Binzel1, R. Magnussen1, C. Kaeding1, D. Flanigan1, W. Wei1, M.U. Knopp2, M.V. Knopp1; 1Columbus, OH/US, 2Malibu, CA/US

11:50 B-0557

Sensitivity and specificity of the Whole-Organ Magnetic Resonance Imaging Score (WORMS) in patients after anterior cruciate ligament injury

Room M 1

11:34 B-0566

11:42 B-0567

10:30 B-0558

Discrimination post-therapeutic changes from local residual / recurrent tumoural tissue in malignant neck masses following therapy using MR diffusion weighted imaging A. Baiomy, A. Youssef, E.M.M. Mahmoud, M.A.M. Yehya; Cairo/EG

11:50 B-0568

Diffusion-weighted imaging using readoutsegmented EPI sequence (RESOLVE) in the head and neck cancer

Detection of cartilage invasion in laryngeal carcinoma with dynamic-contrast enhanced CT J.W. Dankbaar, J. Oosterbroek, E.A. Jager, H.W. de Jong, F.A. Pameijer, C.P. Raaijmakers, S.M. Willems, C.H. Terhaard, M.E. Philippens; Utrecht/NL

S. Kim, S. Jung; Seoul/KR

10:38 B-0559

10:30–12:00 SR EPI DWI vs. SS EPI DWI in head and neck cancer I. Platzek, H.H. Kitzler, V. Plodeck, H. Leonhardt, V. Gudziol, M. Laniado; Dresden/DE

10:46 B-0560

10:54 B-0561

Differentiation of incidental tracer uptake in the head and neck area: a comparison between 18F-FDG PET/ CT and 18F-FDG PET/MRI

Role of pre-operative ultrasonography for tumour thickness evaluation in guiding management in patients with oral tongue squamous cell carcinoma A.V. Nair1, P. Meera2, P.K. Nazer2, P.V. Ramachandran2; 1Trivandrum/IN, Kochi/IN

2

11:02 B-0562

Genitourinary SS 607b

B.M. Schaarschmidt1, B. Gomez2, C. Buchbender1, J. Grueneisen2, L.M. Sawicki1, V. Ruhlmann2, A. Wetter2, G. Antoch1, P. Heusch1; 1 Düsseldorf/DE, 2Essen/DE

Room M 2

New frontiers: urolithiasis and renal function Moderators: M.-F. Bellin; Le Kremlin-Bicêtre/FR, J. Lopes Dias; Lisbon/PT

10:30 B-0569

Determination of optimal imaging setting for urolithiasis CT using FBP, statistical IR, and knowledge-based IMR: physical human phantom study S. Park; Seoul/KR

10:38 B-0570

Vascular pattern analysis on microvascular ultrasonography in differentiating metastatic lymphadenopathy from tuberculous lymphadenitis

Feasibility of in vitro differentiation of urinary stones using manufacturer-recommended and doseoptimised protocols with single-source split-filter dual-energy CT A. Parakh1, A. Euler1, D. Boll1, F. Morsbach2, D. Mueller2, Z. Szucs-Farkas3, S. Schindera1; 1Basle/CH, 2Zurich/CH, 3Berne/CH

I. Ryoo, S. Suh, S. Chae, A. Park, M. Ku, H. Shin, H. Seol; Seoul/KR

11:10 B-0563

10:46 B-0571 Standardisation of diffusion weighted MRI technique in characterisation of cervical lymphadenopathy A.M. Aboelsouad, H. Atta, M. Abd Ellah, A. Gabr, H.M.K. Imam; Assuit/EG

www.myESR.org

Attenuation-based automatic tube voltage selection with tube current adaption in nonenhanced CT for detection of urolithiasis: diagnostic performance and radiation exposure G.-M. Zhang, H. Sun, H.-D. Xue, Z.-Y. Jin; Beijing/CN

Final Programme | ECR 2016

291

Thursday

Pre- and post-operative imaging in oncology Moderators: A. Borges; Lisbon/PT, S. Steens; Nijmegen/NL

Change in ADC as a promising imaging biomarker for predicting long-term loco-regional control for locally advanced head and neck cancer treated with chemoradiotherapy A. Balbo Mussetto, M. Petracchini, A. Tribunella, A. Macera, S. Cavanna, C. Lario, T. Gallo, S. Cirillo; Turin/IT

Head and Neck SS 608

Role of dynamic contrast-enhanced and diffusion weighted MRI in the differentiation between posttreatment changes and recurrent laryngeal cancers S.D. Abouelenein; Alexandria/EG

B.J. Schwaiger1, A.S. Gersing1, B. Ma1, S.A. Rodeo2, A.J. Krych3, T.M. Link1, S. Majumdar1; 1San Francisco, CA/US, 2New York, NY/US, 3 Rochester, MN/US

10:30–12:00

Estimation of tumour and lymph node volumes in head and neck cancer to predict response to radiochemotherapy

Scientific Sessions

10:54 B-0572

Virtual nonenhancced images generated from spectral CT: determinants of detection of urinary calculi in the renal collecting system

10:38 B-0581

R. Daghistani, V. Delannoy, J.-B. Faivre, J. Giordano, J. Rémy, M. Remy-Jardin; Lille/FR

Y. Chen, P.J. Lv, J.B. Gao; Zhengzhou/CN, Henan/CN

11:02 B-0573

Prediction of surgically induced chronic kidney disease after total nephrectomy: body surface area adjusted virtually calculated renal cortical volume on CT S. Hwang, D. Sung, S. You, N. Han, B. Park, M. Kim, S. Cho; Seoul/KR

11:10 B-0574

Evaluation of Iterative model reconstruction (IMR) in ultra low-dose MDCT for urinary stone detection: a comparison to filtered-back-projection and iDose level 4

10:46 B-0582

10:54 B-0583

11:02 B-0584

Non-invasive measurements of renal haemodynamics over 24 hours in healthy volunteers using ASL, BOLD and phase contrast

11:10 B-0585

Comparison of CT findings between bacteremic and non-bacteremic acute pyelonephritis due to Escherichia coli

Radiation dose and image quality of 80 kVp renal artery CT angiography with SAFIRE: comparison with 120 kVp renal artery CT angiography with FBP

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:50 B-0579

11:18 B-0586

11:26 B-0587

Contrast-induced nephropathy, does it occur in an unselected cohort with normal or moderately reduced renal function? A prospective study

Prognostication using longitudinal change in idiopathic pulmonary fibrosis (IPF): analysis of change in computer and visual CT variables and forced vital capacity (FVC) J. Jacob1, B. Bartholmai2, R. Karwoski2, A. Nair1, S. Raghunath2, S. Rajagopalan2, S. Walsh1, A. Wells1, D. Hansell1; 1London/UK, 2 Rochester, MN/US

J. Carlqvist, J. Brandberg, M. Hellström; Göteborg/SE

11:34 B-0588 Measurement of CT perfusion parameters in kidneys with single renal artery vs double renal arteries: is it different?

10:30–12:00

Impact of different types and levels of iterative reconstructions on emphysema quantification by computed tomography scanner S.P. Martin, J. Gariani, A.-L. Hachulla-Lemaire, D. Adler, W. Karenovics, X. Montet; Geneva/CH

11:42 B-0589 Room M 3

Computed tomography quantification of emphysema with COPD module in IntelliSpace Portal7 E. De Boer, N. Warringa, L. Meijering, J. Wiersma, S. Walen, J.W.K. van den Berg, M.F. Boomsma; Zwolle/NL

Chest Spectral CT, advanced CT analysis and emphysema Moderators: F. Molinari; Lille/FR, M. Silva; Parma/IT

10:30 B-0580

Mortality prediction in pulmonary fibrosis: comparison of computer and visual CT analysis and pulmonary function tests (PFT) with the gender, age, physiology (GAP) staging system J. Jacob1, B. Bartholmai2, A. Brun1, R. Egashira1, A. Nair1, S. Rajagopalan2, S.L.F. Walsh1, A. Wells1, D. Hansell1; 1London/UK, 2 Rochester, MN/US

M.T. El-Diasty, G. Gaballa, M.E. Abou-Elghar, T.A. El-Diasty; Mansoura/EG

SS 604

Patient information in connection with radiological examinations is inadequate L. Ukkola, H. Oikarinen, A. Henner, O. Tervonen; Oulu/FI

P. Lei, G. Shen, J. Jiao, X. Wang; Guiyang/CN

11:42 B-0578

Can spectral CT imaging improve the differentiation between malignant and benign solitary pulmonary nodules? Y. Zhang, J. Cheng, X. Hua, M. Yu, C. Xu, F. Zhang, J. Xu, H. Wu; Shanghai/CN

D. Kim, S. Oh, B.-K. Je, S. Lee, D. Hong; Ansan/KR

11:34 B-0577

Diagnosis of solitary pulmonary nodule: one-step spectral and perfusion imaging S. Wang, J. Gao; Zhengzhou/CN

P. Eckerbom1, E. Cox2, I. Subasic1, J. Weis1, F. Palm1, P. Hansell1, S. Francis2, P. Liss1; 1Uppsala/SE, 2Nottingham/UK

11:26 B-0576

What is the optimal monochromatic keV level for lung parenchyma analysis in spectral CT? A qualitative study on 50 patients M. Ohana, A. Labani, M.-Y. Jeung, C. Roy; Strasbourg/FR

J. Schmidt-Holtz, A. Laqmani, S. Butscheidt, M. Kurfürst, M. Avanesov, C. Behzadi, H.-D. Nagel, G. Adam, M. Regier; Hamburg/DE

11:18 B-0575

Single energy scanning of large adult patients: can we improve image quality with spectral shaping?

11:50 B-0590

Is spectral separation improved with the thirdgeneration of dual-source CT systems? M. Remy-Jardin, C. Bortolotto, S. Khung, J.-B. Faivre, A. Duhamel, J. Rémy; Lille/FR

Transforming thoracic oncologic CT examinations into a CT pulmonary angiography for the detection of pulmonary embolism using ultra low keV monoenergetic reconstructions H. Haubenreisser, A. Tecl, M. Meyer, S.O. Schönberg, T. Henzler; Mannheim/DE

292

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

14:00–15:30

Room B

Abdominal Viscera SS 701a

15:12 B-0600

Functional imaging of liver and spleen Moderators: P. Leander; Malmö/SE, A. Wibmer; Vienna/AT

14:00 B-0591

Diffusion-weighted imaging (DWI) of the liver in assessing chronic liver disease: effects of the fat and iron deposition on apparent diffusion coefficient (ADC) values

M. Wang, J. Gao; Zhengzhou/CN

15:20 B-0601

A. Kahraman, B. Kahraman, Z. Ozdemir, C. Gormeli, N. Sahin, S. Yilmaz; Malatya/TR

14:08 B-0592

14:16 B-0593

J. Kim, C. Lee, Y. Park, J. Lee, J. Choi, K. Kim, C. Park, H. Lee; Seoul/KR

14:00–15:30

K.K. Lomovtseva, A. Glotov, D. Babaeva, D. Kalinin, G. Karmazanovsky; Moscow/RU

Breast SS 702

Diffusion weighted imaging of upper abdominal organs in different time points: value of normalisation using spleen as a reference organ

Biexponential model of intravoxel incoherent motion MRI in evaluation of the hepatic warm ischemia reperfusion injury: A preliminary experimental study in a rabbit model

14:00 B-0602

14:48 B-0597

14:08 B-0603

14:16 B-0604

H. Ogul1, L. Karaca1, R. Sade1, M. Kantarci1, U. Bayraktutan1, B. Gündogdu1, N. Karabulut2, Y. Akyuz3, M. Turkeli1; 1Erzurum/TR, 2 Denizli/TR, 3Yozgat/TR

15:04 B-0599

Spectral CT combined with contrast-enhanced ultrasonography (CEUS) in evaluation on the blood perfusion and the correlation with angiogenesis of rabbit VX2 liver tumour M. Wang, J. Gao; Zhengzhou/CN

Apparent diffusion coefficient values of breast cancer and normal breast tissue in diffusionweighted imaging: effects of the menstrual cycle and menopausal status J. Kim, H. Kang; Busan/KR

14:24 B-0605

The value of Gadoxetic acid-enhanced and diffusionweighted MR imaging for distinguishing benign and malignant splenic masses

Role of apparent diffusion coefficient values using 3T magnetic resonance imaging in differentiation of hepatic alveolar echinococcosis from primary hepatic tumours

Microstructural environment analysis of breast lesions with diffusion kurtosis imaging L. Nogueira1, F. Borlinhas2, S. Brandão3, R.G. Nunes2, J. Loureiro3, I. Ramos3, H.A. Ferreira2; 1Vila Nova de Gaia/PT, 2Lisbon/PT, 3 Porto/PT

DCIS (ductal carcinoma in situ) in breast MRI: comparison of diffusion-weighted imaging findings in pure DCIS and in DCIS with associated invasive cancer or microinvasion S. Bednarova, I. Bednarova, P. d’Angelo, A. Linda, R. Girometti, C. Zuiani, M. Bazzocchi; Udine/IT

S.-Y. Choi1, S. Kim2, K. Jang2, T. Kang2, K. Song2, J. Moon2; 1 Bucheon/KR, 2Seoul/KR

14:56 B-0598

Diffusion tensor imaging (DTI) is an accurate and solid imaging biomarker for early response evaluation to neoadjuvant chemotheraphy E. Garcia Oliver1, J. Camps Herrero1, M. Forment Navarro1, V. Ricart Selma1, E. Furman-Haran2, N. Nissan2, H. Degani2; 1Alzira/ES, 2 Rehovot/IL

The characteristics for metabolism and diffusion in various hepatic masses: a preliminary study E. Kong, I. Cho; Daegu/KR

Breast MRI-DWI (1) Moderators: F. Pediconi; Rome/IT, F. Thibault; Paris/FR

Q. Ji, Z.-Q. Chu; Tianjin/CN

14:40 B-0596

Room C

14:32 B-0606

The usefulness of the qualitative analysis of breast lesions at high-resolution diffusion-weighted MRI as an adjunct to quantitative analysis Y. An1, J. Byeon1, B. Kang2; 1Suwon/KR, 2Seoul/KR

14:40 B-0607

Role of diffusion weighted imaging with background suppresion in early detection of breast cancer in young patients K.E. Allam; Cairo/EG

14:48 B-0608

Predicting tumour proliferation and aggressiveness with breast MRI: role of quantitative diffusionweighted imaging (DWI) G. Cristel, A. Damascelli, C. Losio, E. Schiani, M. Panzeri, M. Rodighiero, P. Panizza, F. De Cobelli, A. Del Maschio; Milan/IT

www.myESR.org

Final Programme | ECR 2016

293

Thursday

A step towards scan time minimisation: simultaneous multislice-accelerated diffusion-weighted imaging of the liver

J. Song, J. Byon, E. Kim; Jeonju/KR

14:32 B-0595

Unexpected increase of apparent diffusion coefficient (ADC) value in conversion from regenerative nodule/degenerative nodule (RN/DN) to hepatocellular carcinoma (HCC)

The ADC value of focal solid liver lesions: does it depend on tumour cellularity?

J. Taron1, P. Martirosian1, M. Erb1, T. Kuestner2, J. Weiss1, M. Notohamiprodjo1, N. Schwenzer1, K. Nikolaou1, C. Schraml1; 1 Tübingen/DE, 2Stuttgart/DE

14:24 B-0594

Spectral CT combined with dynamic contrastenhanced magnetic resonance imaging in evaluation on the blood perfusion and the correlation with angiogenesis of rabbit VX2 liver tumour

Scientific Sessions

14:56 B-0609

Inter-observer agreement of semi-automated quantitative lesion analysis in breast diffusionweighted imaging

14:49 B-0618

H. Dijkstra1, M.D. Dorrius1, M. Wielema1, K. Jaspers1, R.M. Pijnappel2, M. Oudkerk1, P.E. Sijens1; 1Groningen/NL, 2Utrecht/NL

15:04 B-0610

The additional value of ADC and IVIM in dynamic contrast-enhanced MRI of the breast

P.M. Kitrou, S. Spiliopoulos, P. Papadimatos, V. Theodosiadou, A. Lepida, N. Christeas, D. Karnabatidis; Patras/GR

14:57 B-0619

M.D. Dorrius1, H. Dijkstra1, M. Wielema1, K. Jaspers1, R.M. Pijnapel2, M. Oudkerk1, P.E. Sijens1; 1Groningen/NL, 2Utrecht/NL

15:12 B-0611

Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions

15:05 B-0620

2-years experience in endovascular treatment of ruptured cerebral aneurysms: comparison between simple coiling and stent-assisted-coiling F. Giurazza1, R. Pimentel Silva2, M. Tecame3, G. Guarnieri3, M. Muto3; 1 Rome/IT, 2Lisbon/PT, 3Naples/IT

Role of MRI diffusion as an adjunct to contrast enhanced MRI of the breast for the evaluation of breast cancer patients receiving neoadjuvant chemotherapy

15:13 B-0621

H.H.N. El Kassas, M. Helal, A. Abu Rabia, N. Abd El Razik, S. Gareer, A. Farahat, M.H. Zedan; Cairo/EG

14:00–15:30

Placement of central venous catheters in the routine clinical setting: estimation of the costs and the learning curve of radiologist newly learning the implantation procedures R. Rotzinger1, B. Gebauer1, D. Schnapauff1, F. Streitparth1, G. Wieners1, C. Grieser1, P. Freyhardt1, B. Hamm1, M.H. Maurer2; 1Berlin/DE, 2 Berne/CH

Room Z 15:21 B-0622

Vascular SS 715

Influence of renal denervation on aortic distensibility in ApoE-deficient rats: assessment by ultrahigh field MRI P. Fries, A. Müller, J. Stroeder, M. Hohl, D. Linz, M. Böhm, F. Mahfoud, G. Schneider, A. Buecker; Homburg/DE

D. Rajgopal1, K. Bhawat2; 1Manglore/IN, 2Davangere/IN

15:20 B-0612

Paclitaxel-coated balloon vs plain balloon angioplasty for the treatment of symptomatic central venous stenosis in dialysis access

Endovascular therapies: what’s new? Moderators: F. Fanelli; Rome/IT, D.K. Tsetis; Iraklion/GR

Radiation dose reduction during transjugular intrahepatic portosystemic shunt (TIPS) implantation using a novel image-processing platform C. Spink, T. Schmidt, M. Grass, M. Avanesov, G. Adam, P. Bannas, A. Koops; Hamburg/DE

14:00 K-18

Keynote lecture F. Fanelli; Rome/IT

14:00–15:30 14:09 B-0613

TPA immobilisation on iron oxide nanocubes and localised magnetic hyperthermia accelerate blood clot lysis

GI Tract SS 701b

E. Vörös1, M. Cho2, Z. Garami2, I. Battyáni1, P. Decuzzi3, K. Tóth1; 1 Pecs/HU, 2Houston, TX/US, 3Genoa/IT

14:17 B-0614

3D-guidance for catheter-based interventions with tessellated heart models for cardiovascular interventions in congenital heart disease (CHD)

Balloon-assisted n-butyl cyanoacrylate glue embolisation mixed with Lipiodol and ethanol to reduce catheter adhesion

14:00 B-0623

Rotational atherothrombectomy in combination with drug eluting balloon angioplasty for femoropopliteal occlusions: 12 month outcome F. Scheer, C. Luedtke, E. Schlöricke, P. Kamusella, R. Andresen, C. Wissgott; Heide/DE

14:41 B-0617

Quantitative radiomics features as prognostic indicator of esophageal cancer undergoing chemoradiotherapy Y. Cho, C. Park, S. Park, J. Goo; Seoul/KR

14:08 B-0624

J. Koizumi1, T. Hara1, T. Sekiguchi1, C. Itou1, T. Ichikawa1, B.J. d’Othee2; 1 Isehara City/JP, 2Baltimore, MD/US

14:33 B-0616

Advanced imaging of the oesophagus and stomach Moderators: O. Ekberg; Malmö/SE, M.A. Mazzei; Siena/IT

M. Glöckler, N. Ehret, O. Rompel, S. Dittrich; Erlangen/DE

14:25 B-0615

Room O

Role of qualitative CT features in differential diagnosis of post-inflammatory oesophageal strictures (corrosive, peptic) from oesophageal cancer using two-phase dynamic MDCT S.A. Buryakina, G.G. Karmazanovsky, D.V. Ruchkin, Q. Yang, A.V. Vishnevskaya; Moscow/RU

14:16 B-0625

The efficacy of cine-magnetic resonance imaging in accurate evaluation of the invasion level of tumour tissue in esophageal carcinoma M. Ozgokce1, F. Alper2, A. Yavuz1, H. Ogul2, Y. Aydin2, A. Batur1, A. Eroglu2; 1Van/TR, 2Erzurum/TR

Time extended lyse-and-wait technique for thrombosed hemodialysis access S. Regus, W. Lang, M. Heinz, M. Uder, A. Schmid; Erlangen/DE

294

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

14:24 B-0626

Pre-treatment contrast-enhanced CT texture analysis (CTTA) of gastric cancer to predict response to neoadjuvant chemotherapy: comparison with histological tumour regression grade (TRG) P. Marra, A. Salerno, S. Antunes, F. Giganti, A. Esposito, F. De Cobelli, A. Del Maschio; Milan/IT

14:32 B-0627

14:24 B-0637

14:32 B-0638

The prognostic significance of extramural venous invasion detected by multiple-row detector computed tomography in stage III gastric cancer

G. Benedetti, A. Esposito, M. Cava, M. Colombo, D. Velardo, S. Previtali, P. Rovere Querini, A. Del Maschio, F. De Cobelli; Milan/IT

14:40 B-0639

Comparison between CT Net enhancement and PET/ CT SUV for N staging of gastric cancer

14:48 B-0640

A.A. Stabile Ianora, N.M. Lucarelli, M. Telegrafo, A. Scardapane, A.A. Niccoli, P. Pignataro, M. Moschetta, G. Angelelli; Bari/IT

15:04 B-0632

Can we identify the normal and abnormal radiological findings after laparoscopic, adjustable gastric banding (LAGB)?

14:56 B-0641

Contribution of CT in management of acute abdominal pain after gastric bypass: correlation between radiological and surgical findings

14:00–15:30

15:04 B-0642

Muscles

15:12 B-0643

Moderators: J. Oudeman; Amsterdam/NL, D.J. Wilson; Oxford/UK

14:00 B-0634

14:08 B-0635

Assessment of fatty degeneration of the gastrocnemius and soleus muscles in patients with achillodynia using MRI: reliability of the Goutallier classification system

Association of physical activity measured by accelerometer with longitudinal changes of knee joint abnormalities and cartilage T2: data from the Osteoarthritis Initiative A. Gersing1, M. Kretzschmar1, C. Claudi1, B.J. Schwaiger1, G.B. Joseph1, D. Dunlop2, M.C. Nevitt1, C.E. McCulloch1, T. Link1; 1San Francisco, CA/US, 2Chicago, IL/US

Diffusion tensor imaging-based tractography of the myopathic and dystrophic skeletal muscle S. Keller1, A. Golsari1, M. Gelderblom1, H. Kooijman-Kurfuerst1, J. Wang2, G. Adam1, J. Yamamura1; 1Hamburg/DE, 2Dallas, TX/US

Comparison of T2* relaxation times of articular cartilage of the knee in elite professional soccer players and age-and BMI-matched volunteers C. Behzadi, G.H. Welsch, F.O. Henes, A. Quitzke, G. Schoen, G. Adam, M. Regier; Hamburg/DE

Room E1

Musculoskeletal

Can echo intensity obtained from ultrasonography images reflect muscle strength in the frail elderly population? R. Mirón Mombiela, C. Borrás, F. Facal de Castro, P. Moreno; Valencia/ES

F. Cuccioli, P. Karila Cohen, J. Laissy, J. Marmuse, K. Arapis; Paris/FR

SS 710

Do iliopsoas and gluteus maximus change with aging? A MRI investigation in healthy adult volunteers. R. Crawford1, S. Franckenberg2, P. Kälin2, M.A. Fischer2, D. Nanz2, E.J. Ulbrich2; 1Winterthur/CH, 2Zurich/CH

M. Andronikou- Zouvani; Paralimni/CY

15:12 B-0633

MRI of acute groin injury in athletes with a focus on the adductor muscles: reliability and patterns of injury F.W. Roemer1, A. Serner2, P. Hölmich3, K. Thorborg3, A. Weir2, J.L. Tol2, A. Guermazi4; 1Erlangen/DE, 2Doha/QA, 3Amager-Hvidovre/DK, 4 Boston, MA/US

F. Giganti, S. Antunes, A. Salerno, A. Ambrosi, P. Marra, E. Orsenigo, A. Esposito, A. Del Maschio, F. De Cobelli; Milan/IT

14:56 B-0631

From myocardial to skeletal muscle: late gadolinium enhancement as a new tool to reveal involvement in idiopathic inflammatory myopathies

15:20 B-0644 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Application of a sub-set of skinfold sites for ultrasound measurement of subcutaneous adiposity and percentage body fat estimation in athletes D.C. O’Neill, O. Cronin, S.B. O’Neill, D. Herlihy, D. Keohane, T. Woods, M. Molloy, E. Falvey; Cork/IE

B.C.S. Rabelo, R.R. Nobre, A.M.A. Lopes, E.J.S. Ribeiro, D.S. Baumfeld, R. Strecker; Belo Horizonte/BR

www.myESR.org

Final Programme | ECR 2016

295

Thursday

Gastric cancer: texture analysis from multidetector computed tomography as a potential prognostic biomarker

Can we diagnose piriformis muscle syndrome via sonoelastography: preliminary findings of twentyone patients M. Baykara, A. Demirel, E. Berk, B. Kızıldağ, M.A. Sarıca, N. Yurttutan; Kahramanmaraş/TR

J. Cheng, J. Wu, Y. Ye, C. Zhang, Y. Zhang, Y. Wang; Beijing/CN

14:48 B-0629

Characteristic MR signal intensity pattern of exerciseinduced rhabdomyolysis in thigh muscle: differential point from other causes and its clinical significance E. Yeon; Seoul/KR

Usefulness of dynamic CT transmural sign to evaluate T staging of gastric cancer: histopathologic correlation S. Lee, D. Chung; Seoul/KR

14:40 B-0628

14:16 B-0636

Scientific Sessions

14:00–15:30

Room E2

Neuro SS 711

14:00–15:30

Oncologic Imaging Cerebrovascular disease (2)

SS 716

Moderators: U. Lamot; Ljubljana/SI, Z. Merhemic; Sarajevo/BA

14:00 B-0645

Added value of morphologic characteristics of intracranial arteries to future stroke risk N. Han, J. Jang, H. Byun, K. Lee, J. Koo, H. Choi, S.-L. Jung, K.-J. Ahn, B.-S. Kim; Seoul/KR

14:08 B-0646

14:16 B-0647

14:00 K-19

Keynote lecture J. Sosna; Jerusalem/IL

14:09 B-0655

Morphological characteristics of intracranial arteries: their association with atherosclerotic risk factors and white matter hyperintensities

Whole-body MRI with and without DWI: comparison of capability for recurrence assessment with PET/CT, PET/MRI and conventional radiological examination in NSCLC patients

H. Byun, J. Jang, N. Han, S. Lee, H. Choi, S. Jung, K. Ahn, B.-S. Kim; Seoul/KR

Y. Ohno1, Y. Kishida1, S. Seki1, H. Koyama1, K. Aoyagi2, H. Yamagata2, K. Sugimura1; 1Kobe/JP, 2Otawara/JP

Intracranial atherosclerotic plaque enhancement: is it a predictive marker of ischaemic stroke?

14:17 B-0656

Comparative performance of 18F-FDG PET/ MRI and 18F-FDG PET/CT regarding detection and characterisation of pulmonary lesions in 121 oncologic patients L.M. Sawicki1, J. Grueneisen2, C. Buchbender1, B.M. Schaarschmidt1, V. Ruhlmann2, A. Wetter2, L. Umutlu2, G. Antoch1, P. Heusch1; 1 Düsseldorf/DE, 2Essen/DE

Intracranial vascular findings in a large tri-ethnic cohort A.J. Schmitt, L. Smith, A. Hughes, N. Chaturvedi, R.H. Jager; London/UK

14:32 B-0649

Whole body imaging Moderators: J. Sosna; Jerusalem/IL, T.D. Westwood; Manchester/UK

A.H. Elmokadem1, F. Sherazi2, T.J. Carroll2, A. Honarmand2, A. Shaibania2, M.C. Hurley2, S.A. Ansari2; 1Mansoura/EG, 2Chicago, IL/US

14:24 B-0648

Room F1

14:25 B-0657

Influence of staging differences between 18F-FDG PET/CT and 18F-FDG PET/MRI on therapeutic decisions in non-small cell lung cancer patients B.M. Schaarschmidt1, J. Grueneisen2, M. Metzenmacher2, B. Gomez2, P. Heusch1, V. Ruhlmann2, L. Umutlu2, G. Antoch1, C. Buchbender1; 1 Düsseldorf/DE, 2Essen/DE

Is there any relationship between carotid artery plaque and cerebral micro bleed? F. Mubarak; Karachi/PK

14:40 B-0650

14:33 B-0658 Distinction of atherosclerotic intimal and non-intimal calcification in the intracranial carotid artery on CT: a histopathological comparison

D. Albano, C. Patti, L. La Grutta, E. Grassedonio, A. Mulè, R. Lagalla, M. Midiri, M. Galia; Palermo/IT

R. Kockelkoren, A. Vos, W. van Hecke, A. Vink, W.P.T.M. Mali, J. Hendrikse, D.H. Koek, P.A. de Jong, J. de Vis; Utrecht/NL

14:48 B-0651

Osteonecrosis detected by whole body magnetic resonance (WB-MRI) in patients with Hodgkin lymphoma treated by BEACOPP

14:41 B-0659 The importance of interface irregularity between the tumour and brain parenchyma in differentiating between typical and atypical meningiomas: correlation with pathology

Qualitative and quantitative evaluation of whole body MRI with DWI for bone marrow involvement in follicular lymphoma A. Balbo Mussetto1, C. Saviolo1, M. Petracchini1, E. Vietti1, C. Lario1, A. De Libero1, D. Gottardi1, C. Tarella2, S. Cirillo1; 1Turin/IT, 2Milan/IT

J. Lee, K. Ahn, B. Kim, S. Jung, H. Choi, J. Jang, S. Lee; Seoul/KR

14:56 B-0652

15:04 B-0653

14:49 B-0660 Diagnostic accuracy of 3D black blood MR imaging with high resolution T1 SPACE in the evaluation of intracranial arterial thrombosis

Pre- and post-treatment relationship of glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI: preliminary results of an [18F]-FDG-PET/MR study

A.H. Elmokadem1, T.J. Carroll2, M.C. Hurley2, A. Shaibani2, S.A. Ansari2; 1 Mansoura/EG, 2Chicago, IL/US

C. Giraudo, M. Weber, M. Raderer, D. Senn, G. Karanikas, M. Mayerhoefer; Vienna/AT

Added value of 3D proton-density weighted images in diagnosis of intracranial arterial dissection

14:57 B-0661

W. Lee, J. Kim, N.-Y. Shin, Y. Kim, S. Lim, S.-K. Lee; Seoul/KR

15:12 B-0654

High-resolution magnetic resonance (HR-MR) findings of intracranial artery dissection based on quantitative analysis N. Lee, S. Jung, H. Kim, C.-G. Choi, S. Kim, D. Lee, D. Suh; Seoul/KR

Assessing progressive disease in myeloma patients with whole-body diffusion-weighted imaging: a prospective study comparing whole body T1-WI, T2STIR-WI and laboratory findings S. Pans, V. Goosens, N. Noppe, F. De Keyzer, M. Delforge; Leuven/BE

15:05 B-0662

Efficacy of whole-body low-dose CT (WBLDCT) in the staging of patients with multiple myeloma (MM): comparison with whole-boby magnetic resonance imaging (WBMRI) E.B. Orsini, D. Ippolito, C. Talei Franzesi, V. Besostri, S. Spiga, S. Sironi; Monza/IT

296

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

15:13 B-0663

A comparative study between whole body diffusion imaging with background signal suppression (DWIBS) and FDG PET/CT in assessment of lymphoma patients A.M. Wafaie1, M. Kotb2, M. El-Azab2, A. Abo El-Regal2; 1Giza/EG, 2 Cairo/EG

15:21 B-0664

Generating evidence for clinical benefit of PET/CT based on the results of an oncologic PET/CT registry - filling the gap between diagnostic accuracy and patient outcome? C. Pfannenberg, B. Gueckel, S.-C. Schuele, N. Schwenzer, S. Kaufmann, A.-C. Mueller, C. la Fougere, K. Nikolaou, P. Martus; Tübingen/DE

14:00–15:30

Room F2

Physics in Radiology SS 713

14:48 B-0671

K. Hellbach1, A. Yaroshenko2, K. Willer2, S. Auweter1, M.F. Reiser1, A. Hilgendorff3, O. Eickelberg3, F. Pfeiffer2, F.G. Meinel1; 1Munich/DE, 2 Garching/DE, 3Neuherberg/DE

14:56 B-0672

15:04 B-0673

15:12 B-0674

Innovations in radiology

CT thermometry for temperature monitoring in tumour hyperthermal treatments: influence of ROI size and scan setting

In vivo skin moisturizing measurement by highresolution 3-T MR imaging

The impact of dual axis rotational coronary angiography (DARCA) on patient and staff exposure while using novel X-ray imaging technology D. Buytaert, B. Drieghe, J. De Pooter, Y. Taeymans, K. Bacher; Gent/BE

14:00–15:30

Room D1

Chest

T. Lindner1, O. Jansen1, M. Helle2; 1Kiel/DE, 2Hamburg/DE

14:16 B-0667

14:24 B-0668

SS 704

Moderators: G. Aviram; Tel Aviv/IL, E. Jon; Vitoria/ES

Whole-Body MRI: Inter- and Intra-Reproducibility of Quantitative, Organ-specific Measures across different 3 Tesla MR Scanners in the Pilot-Study of the German National Cohort

14:00 K-16

C.L. Schlett1, T. Hendel2, J. Hirsch3, T. Ittermann4, H.-U. Kauczor1, M. Forsting5, F. Bamberg6, .. the German National Cohort1; 1 Heidelberg/DE, 2Munich/DE, 3Bremen/DE, 4Greifswald/DE, 5 Essen/DE, 6Tübingen/DE

14:09 B-0676

Preoperative CT predicting recurrence of surgically resected adenocardinoma of the lung H. Lee1, H. Koo1, H. Xu2, C.-M. Choi1, J. Song1, H. Kim1, J. Lee1, M. Kim1; 1 Seoul/KR, 2Nanjing/CN

Application of MR-based joint estimation of attenuation and activity distributions to clinical nonTOF PET/MR

14:17 B-0677

Respiratory motion compensation for simultaneous PET/MR based on strongly undersampled MR data

Role of delayed enhanced phase in the intra-thoracic staging of lung cancer: what does it add? P. Franchi, A.R. Larici, A. del Ciello, A. Farchione, G. Cicchetti, M. Occhipinti, L. Bonomo; Rome/IT

14:25 B-0678

C.M. Rank, T. Heußer, A. Wetscherek, H.-P. Schlemmer, M. Kachelrieß; Heidelberg/DE

14:40 B-0670

Keynote lecture C.J. Herold; Vienna/AT

T. Heußer1, C.M. Rank1, M.T. Freitag1, A. Dimitrakopoulou-Strauss1, H.-P. Schlemmer1, T. Beyer2, M. Kachelrieß1; 1Heidelberg/DE, 2 Vienna/AT

14:32 B-0669

Lung cancer

Inflammatory myofibroblastic tumour of the lung in adults: CT and 18 FDG PET characteristics with pathologic correlations in a single tertiary referral center S. Lim, M. Kim; Seoul/KR

Multi-purpose robotic x-ray system enabling 2D/3D imaging of standing patients: assessment of 3D imaging performance A. Fieselmann, J. Steinbrener, A.K. Jerebko, T. Mertelmeier; Erlangen/DE

www.myESR.org

14:33 B-0679

Baseline results from an Italian CT lung cancer screening program compared to the NLST data M. Occhipinti, P. Franchi, M. Ciliberto, L. Tonetti, G. Cicchetti, A.R. Larici, L. Bonomo; Rome/IT

Final Programme | ECR 2016

297

Thursday

G. Frauenfelder1, F. Giurazza2, E. Schena2, P. Saccomandi2, C. Massaroni2, B. Beomonte Zobel2; 1Naples/IT, 2Rome/IT

15:20 B-0675

Cycled superselective pseudo-continuous Arterial Spin Labeling without the need for acquiring a control image

Large volume data acquisition for intraoperative imaging with mobile C-Arm CT systems J. Kuntz1, M. Knaup1, C. Fleischmann2, M. Kachelrieß1; 1Heidelberg/DE, 2 Nürnberg/DE

J. Mesrar, J. Ognard, S. Ghomadi, D. Chechin, L. Misery, D. Ben Salem; Brest/FR

14:08 B-0666

Novel x-ray detector technology for quantitative material information in digital radiography J.J. Cowling1, G. Gibson1, N. Loxley1, P. Scott1, P. White2, K.J. Robson2, B. Lopez3; 1Sedgefield/UK, 2Newcastle upon Tyne/UK, 3Durham/UK

Moderators: Y. Bouchareb; London/UK, R. Raupach; Forcheim/DE

14:00 B-0665

Facilitated diagnosis of pneumothoraces in mice using x-ray dark-field radiography

Scientific Sessions

14:41 B-0680

Gynecomastia seen on CT examinations in the general male population

14:24 B-0689

N. Kanana, M. Amitai, S. Raskin, M. Yassin, M. Sklair, E. Konen, E. Klang; Ramat Gan/IL

14:49 B-0681

Lung cancers in patients with fibrothorax and chronic empyema caused by tuberculosis

M.T. Nummela1, F.V. Bensch1, S.K. Koskinen2; 1Helsinki/FI, 2 Stockholm/SE

14:32 B-0690

H. Xu1, H.J. Koo2, H.N. Lee2, S. Lim2, M.Y. Kim2; 1Nanjing/CN, 2Seoul/KR

14:57 B-0682

Multi-detector computed tomography features of peripheral lung cancer associated with cystic airspace Y. Wang, L. Fan, S. Liu; Shanghai/CN

15:05 B-0683 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

15:13 B-0684

Dynamic contrast-enhanced perfusion area-detector CT vs FDG-PET/CT: capability for therapeutic outcome prediction in non-small cell lung cancer patients with chemoradiotherapy Y. Ohno1, Y. Kishida1, S. Seki1, H. Koyama1, Y. Fujisawa2, N. Sugihara2, T. Yoshikawa1, K. Sugimura1; 1Kobe/JP, 2Otawara/JP

15:21 B-0685

Dynamic CE-perfusion area-detector CT: comparison of capability for N-stage assessment with FDG-PET/ CT in non-small cell lung cancer patients Y. Ohno1, Y. Kishida1, S. Seki1, H. Koyama1, Y. Fujisawa2, N. Sugihara2, T. Yoshikawa1, K. Sugimura1; 1Kobe/JP, 2Otawara/JP

14:00–15:30

SS 717

14:40 B-0691

Trauma of the brain and body

14:48 B-0692

14:08 B-0687

14:56 B-0693

Use of IV-contrast versus IV-and oral-contrast in the evaluation of abdominal pain on CT in the emergency department M. Wasserman1, K. Melamud2, J. Soto1; 1Boston, MA/US, 2Philadelphia, PA/US

15:04 B-0694

Contribution of diffusion-weighted MR imaging to non-enhanced CT in evaluation of acute abdominopelvic pain O. Ozdemir, Y. Metin, N. Orhan Metin, Ö. Yavaşi, Ö. Bilir, S. Kalcan; Rize/TR

15:12 B-0695

Clinical relevance of consecutive CT scans for the evaluation and monitoring of geriatric pelvic fractures C. Weber, T.H. Schroeder; Hamburg/DE

Excess use of minor head injury CT examinations in the emergency department (ER)

14:00–15:30

A. Beytelman1, E. Klang1, E. Konen1, D. Greenberg2, E. Zimlichman1; 1 Ramat Gan/IL, 2Beer Sheva/IL

Genitourinary SS 707

Head CT scans from Emergency Department: a misplaced screening? 14:00 B-0697 Acute cervical traumatic spinal cord injury: MRI with diffusion-weighted imaging correlated with neurologic outcome T. Nakagawa1, J. Isogai2, N. Harata2, T. Miyazaki2; 1Kawasaki-city, Kanagawa/JP, 2Asahi-city, Chiba/JP

Room K

Prostate cancer: routine and novel MRI techniques Moderators: D. Bonekamp; Hirschberg/DE, N.C. Cowan; Portsmouth/UK

A. Bernardini, S. Roiati, R. Lattanzi, M. Di Bartolomeo, F. Iannessi, F. Navarra, L.M. Gregori, E.G. Puglielli, V. Di Egidio; Teramo/IT

14:16 B-0688

“Concordance” revisited: a multi-disciplinary appraisal of concordant preliminary abdominopelvic CT reports J.M. Brown, E. Dickerson, R. Kaza, R. Cohan, J. Ellis, M. Davenport; Ann Arbor, MI/US

Moderators: J.M. Artigas; Zaragoza/ES, F. Mrakic Sposta; Milan/IT

14:00 B-0686

Screening for blunt cerebrovascular injury (BCVI) by two-phased whole body CT (WBCT) after acute blunt trauma using modified Denver criteria: a review of 373 cases E.A. Varjonen1, F.V. Bensch1, S.K. Koskinen2; 1Helsinki/FI, 2 Stockholm/SE

Room D2

Emergency Radiology

Nontraumatic incidental findings in patients undergoing whole-body computed tomography at initial emergency admission E. Kroczek1, G. Wieners1, I. Steffen1, T. Lindner1, F. Streitparth1, B. Hamm1, M.H. Maurer2; 1Berlin/DE, 2Berne/CH

CT-guided core needle biopsy of pulmonary nodules smaller than 2 cm: analysis of 469 procedures S. Gálvez García1, A. Prieto Fernández1, A. Muñoz Ruiz1, E. Nava Tomás1, H. Chung2, J. Sanz Díaz1, S. Sánchez García1, M. Morán Hevia1, M. Vicente Quílez1; 1Oviedo/ES, 2Los Ángeles, CA/US

Costal cartilage fractures: an overlooked injury in polytrauma patients? A review of 978 consecutive blunt trauma patients

Correlation of prostate volume and cancer detection as assessed by MRI volumetry M. Haas, H. Cash, B. Hamm, P. Asbach; Berlin/DE

14:08 B-0698

Comparison of image quality and patient discomfort in prostate MRI using a pelvic array or an endorectal coil B.K. Barth1, A. Cornelius2, D. Nanz1, D. Eberli1, O.F. Donati1; 1Zurich/CH, 2 Aarau/CH

298

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

14:16 B-0699

14:00–15:30 Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy R. Renard-Penna, G. Cancel-Tassin, E. comperat, P. Mozer, P. Leon, M. Roupret, M.-O. Bitker, O. Lucidarme, O. Cussenot; Paris/FR

14:24 B-0700

Pre-active surveillance multiparametric MRI predicts short-term outcomes

Radiographers SS 714

Differences in quantitative perfusion parameters between normal transitional, normal peripheral and tumour regions from 3T DCE-MR images of the prostate R. Sanz-Requena, L. Marti-Bonmati, R. Perez, G. Garcia-Marti, A. Mañas-Garcia; Valencia/ES

14:40 B-0702

14:00 B-0708

A.A. Qurashi1, L.A. Rainford1, A. Ajlan2, K. Khashoggi2, L. Ashkar2, M. Alraddadi3, M. Alghamdi2, M. Althubaiti2, S.J. Foley1; 1Dublin/IE, 2 Jeddah/SA, 3Madinah/SA

14:08 B-0709

Diagnostic performance of the monoexponential model and diffusion kurtosis imaging in the analysis of prostate cancer

14:16 B-0710

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:24 B-0711

Effect of temporal resolution on diagnostic performance of DCE-MRI of the prostate

14:32 B-0712

Potential role of diffusion weighted MRI for predicting extracapsular extension of prostate cancer

14:40 B-0713

Prostate DCE-MRI: improved SNR with 32-element receiver arrays S. Riederer, E. Borisch, A. Froemming, R. Grimm, A. Kawashima, J. Trzasko; Rochester, MN/US

15:20 B-0707

Image quality evaluation of a high-resolution 3D SPACE T2-weighted sequence (SPACE) in prostate multiparametric MRI (mp-MRI)

An analysis of the validity and reliability of a handheld ultrasound device for measuring rectus femoris muscle size

Reproducibility of ultrasound parameters (echointensity and thickness) of quadriceps muscle

Assessment of musculoskeletal ultrasound pathologies by radiographers and undergraduated radiography students A.F.C.L. Abrantes, I. Rodrigues, R.P.P. Almeida, J.P. Pinheiro, O. Lesyuk; Faro/PT

14:48 B-0714

P. Pricolo, S. Alessi, P. Summers, E. Tagliabue, G. Petralia; Milan/IT

15:12 B-0706

M. O’Connor, S. Foley; Dublin/IE

R.A. Santos, P. Armada-da-Silva; Coimbra/PT

A. Othman, F. Falkner, J. Weiss, S. Kruck, P. Martirosian, K. Nikolaou, M. Notohamiprodjo; Tübingen/DE

15:04 B-0705

Manual vs automated visceral adipose tissue quantification in paedatric CT: which is best?

W. Nijholt1, A. Bakker1, A. Bennet2, M. Borgen3, A. Ellermann1, P. Hogg2, P. Gamboa4, L. Vorster5, I.-J. Aandahl3; 1Groningen/NL, 2 Salford/UK, 3Oslo/NO, 4Lisbon/PT, 5Bloemfontein/ZA

N. Adubeiro1, L. Nogueira1, E. Ribeiro1, J.M. La Fuente1, H.A. Ferreira2; 1 Porto/PT, 2Lisbon/PT

14:56 B-0704

Body composition changes in obese population S.J.M. Alqahtani, K.M. Knapp, R.M. Palfrey, S.J. Hopkins, J.R. Meakin, J. Fulford; Exeter/UK

M.D. Hernández-Argüello, J. Solorzano, A. Benito, M. Collantes, M. Rodríguez-Fraile, I. Pascual, J. Madrid, J. Pardo, J. Richter; Pamplona/ES

14:48 B-0703

Abdominal CT for obese patients: investigating optimal scan parameters

Thursday

Index lesion detection with diffusion-weighted imaging at 3 Tesla MRI and its correlation with choline kinase-Alfa-Į overexpression in primary prostate carcinoma

Quality issues in ultrasound and CT Moderators: C. Beardmore; London/UK, K. Lang; Malmö/SE

F. Sanguedolce1, G. Petralia2, H. Sokhi3, N. Anyamene4, G. Hellawell5, A. Padhani4; 1Northampton/UK, 2Milan/IT, 3Uxbridge/UK, 4 Northwood/UK, 5Harrow/UK

14:32 B-0701

Room G

Do radiologists agree when reviewing ultrasound examinations performed by a sonographer and a radiologist? C. Stenman1, R. Glavas1, K. Jansson1, A.-L. Enlund1, L. Thorelius2, Ö. Smedby3; 1Linköping/SE, 2Barcelona/ES, 3Stockholm/SE

14:56 B-0715

Quality assurance in Irish ultrasound departments A.M. Ward, M.T. Stanton; Dublin/IE

15:04 B-0716

Are physical measures good indicators of clinical image quality at low dose levels? A pilot study L. Lanca1, E.N. Andersen2, G. Carvalho1, M. van Gerwen3, J. Jorge4, M. Kleiker5, B. Markali2, P. Nightingale6, P. Hogg6; 1Lisbon/PT, 2 Oslo/NO, 3Eindhoven/NL, 4Lausanne/CH, 5Groningen/NL, 6 Manchester/UK

E. Armando, L. Capitolo, F. Cesarani; Asti/IT

15:12 B-0717

Effectiveness of the American Association of Physics in Medicine criteria to assess diagnostic monitors K.B. Azevedo, N. Messias, L.P. Ribeiro, J.P. Pinheiro, R.P.P. Almeida, P. Sousa, A.M. Ribeiro, A.F.C.L. Abrantes; Faro/PT

15:20 B-0718

Use of anatomical side markers (ASMs) during planar x-ray imaging S. Attard, J.G. Couto, F. Zarb; Msida/MT

www.myESR.org

Final Programme | ECR 2016

299

Scientific Sessions

14:00–15:30

Room M 1

14:00–15:30

Room M 2

Head and Neck

Abdominal Viscera

SS 708

SS 701c

Temporal bone Moderators: S. Kösling; Halle a.d. Saale/DE, K. Markiet; Gdansk/PL

14:00 K-17

Advances in CT Moderators: E. Akchurina; Moscow/RU, N.N.

14:00 B-0729 Keynote lecture

Image quality - cutting through noise D.M. Jackson, K.K. Lau, A. Borsaru; Clayton/AU

F. Veillon; Strasbourg/FR

14:09 B-0719

14:08 B-0730 Structured reporting of the petrous bone: potential effects on surgical planning

D. Schmidt, M. Söderberg, C. Lee Christoffersen, H. Lindvall, M. Nilsson, P. Leander; Malmö/SE

M. Armbruster, S. Gassenmaier, M. Haack, W. Sommer, F. Braun; Munich/DE

14:17 B-0720 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:25 B-0722

14:16 B-0731 Fractures of the temporal bone: an easier way to read your CT A. Venkatasamy1, F. Veillon1, B. Rock1, S. Riehm1, P. Meriot2, P. Baur1, A. Charpiot1; 1Strasbourg/FR, 2Brest/FR

Determination of cochlea length via flat panel CT is reliable and safe

14:24 B-0732

14:32 B-0733

Virtual monochromatic spectral CT in small feeding arteries of abdominal tumours: can spectral image fusion optimise the image quality? Y. Zhou, J.B. Gao; Zhengzhou/CN

Flat panel computed tomography versus multislice computed tomography in diagnosis of superior canal dehinscence

14:40 B-0734

C. Loberg, J. Ilgner, C.K. Kuhl; Aachen/DE

14:49 B-0725

Preserving image quality in low contrast media and radiation dose abdominal MDCT using iterative reconstruction algorithm in normal-weight patients E. Belousova, E. Kondratyev, G. Karmazanovsky; Moscow/RU

Reduction of cochlear implant metal artifact in 1024 high-resolution CT: value of orthopedic metal artifact reduction (O-MAR) algorithm C. Ding, X. Lu, Q. Wang; Shenyang/CN

14:41 B-0724

Dilute concentration or reduce injection rate? Optimisation of reducing iodine delivery rate for lowenergy contrast enhanced body CT S. Takahashi, N. Negi, K. Kagawa, E. Suehiro, T. Nishii, Y. Ueno, A. Kono, H. Kawamitsu, K. Sugimura; Kobe/JP

C. Loberg, J. Ilgner, M. Westhofen, C. Kuhl; Aachen/DE

14:33 B-0723

Image quality and radiation dose warrants routine use of abdominal dual energy CT

Dose performance of virtual monochromatic spectral CT protocol optimised for “double low scanning” on oesophageal cancer? Y. Zhou, J.B. Gao; Zhengzhou/CN

Multiplanar reconstruction of the internal auditory canal using high resolution MR-imaging: effect of constitutional differences on the size of the cochlear and facial nerves

14:48 B-0735

N.N.N. Naguib, N.-E. Nour-Eldin, T. Gruber-Rouh, M. Harth, T.J. Vogl; Frankfurt a. Main/DE

Optimal monochromatic spectral computed tomography with low iodine concentration contrast medium in a rabbit VX2 liver model: investigation of image quality and detection Y. Zhou, J.B. Gao; Zhengzhou/CN

14:57 B-0726

Diagnostic accuracy of TSE diffusion weighted MR imaging for the diagnosis of cholesteatoma

14:56 B-0736

B. Ozgen Mocan, E. Bulut, A. Dolgun, D. Bajin, L. Sennaroglu; Ankara/TR

15:05 B-0727

Y. Gao, X. Lu, P. Wang; Shenyang/CN

Repeated postoperative follow-up DWI to detect residual or recurrent cholesteatoma W. Venderink, S. Steens, D. Kunst, A. Meijer, E. Mylanus; Nijmegen/NL

15:13 B-0728

Comparison of iterative model reconstruction (IMR) and hybrid iterative reconstruction (iDose4) in lymph nodes evaluation and diagnostic confidence with 40% radiation dose reduction

15:04 B-0737

Efficacy of water-equivalent diameter for radiation dose optimisation K.K. Lau, O. Wong, R. Evans, A. Kuganesan, K. Buchan; Melbourne/AU

Follow-up MRI of vestibular schwannoma: is it worthy to measure volume? J. Lisý, M. Chovanec, L. Mikšík, J. Betka, R. Pipková, E. Zvěřina; Prague/CZ

15:12 B-0738

Why have we adopted 120 kVp in abdominal CT for decades? 100 kVp is enough J. Choi, S. Jung, M. Choi; Seoul/KR

300 ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

15:20 B-0739

Quantitative response evaluation of hepatocellular carcinoma after transarterial chemoembolisation using 70 kVp 4D volume perfusion CT of the liver

14:56 B-0747

X. Wang1, T. Henzler2, S. Diehl2, S.O. Schönberg2, Z.-Y. Jin1, H.-D. Xue1, A. Smakic2; 1Beijing/CN, 2Mannheim/DE

14:00–15:30

Room M 3

P. Maurovich-Horvat, J. Karady, M. Kolossvary, A.L. Jermendy, A. Bartykowszki, M. Karolyi, A. Panajotu, Z. Bagyura, B. Merkely; Budapest/HU

15:04 B-0748

Cardiac SS 703

Epidemiology, prognosis and trials

The most powerful high-risk coronary plaque criteria by coronary CTA for prediction of major cardiac events (MACE): a long term follow-up study

15:12 B-0749

15:20 B-0750

Intravascular ultrasound in pulmonary arterial hypertension vasoreactivity testing

Thursday

Impact of computed tomography coronary angiography on clinical management and outcomes in patients with suspected angina due to coronary heart disease

Cystatin C is associated with non-obstructive coronary artery disease determined by coronary computed tomography angiography E.B. Brolin1, S. Agewall2, K. Cederlund1, C. Ekenbäck1, L. Henareh1, K. Malmqvist1, A. Rück1, A. Svensson1, P. Tornvall1; 1Stockholm/SE, 2 Oslo/NO

G. Feuchtner, J. Kerber, P. Burghard, A. Klauser, A. Mayr, F. Plank; Innsbruck/AT

14:08 B-0741

Atherosclerotic burden and cardiac remodelling in healthy South Asian and European adults: a cohort comparison study J. Weir-McCall, D. Cassidy, J.J.F. Belch, S. Gandy, G. Houston, M. Lambert, R. Littleford, A.D. Struthers, F. Khan; Dundee/UK

Moderators: K. Gruszczynska; Katowice/PL, N.N.

14:00 B-0740

Semmelweis cardiac CT registry: the feasibility of automated data collection with a structured reporting tool

O. Sagaydak, N. Danilov, Y. Matchin, T. Martinuk, I. Chazova; Moscow/RU

M.C. Williams1, A. Hunter1, A. Shah1, V. Assi1, S. Lewis1, G. Roditi2, E.J.R. van Beek1, A. Timmis3, D.E. Newby1; 1Edinburgh/UK, 2 Glasgow/UK, 3London/UK

14:16 B-0742

Coronary atherosclerosis features for the prediction of ischaemic events (CAFÉ-PIE study): a CT scan integrated score from a bi-center registry A. Guaricci1, N. Brunetti1, F. De Rosa1, M. Guglielmo2, S. Mushtaq2, L. Mascarini1, D. Andreini2, M. Pepi2, G. Pontone2; 1Foggia/IT, 2Milan/IT

14:24 B-0743

Performance of cardiac CT compared to functional testing in women and men with suspected coronary artery disease: the multicenter, randomized CRESCENT trial M.M. Lubbers, A. Dedic, A. Coenen, T. Galema, M. Ouhlous, A. Niezen, M. Hunink, G. Krestin, K. Nieman; Rotterdam/NL

14:32 B-0744

Quantitative coronary plaque analysis predicts high-risk plaque morphology on coronary computed tomography: the results from the ROMICAT II trial T. Liu1, P. Maurovich-Horvat2, T. Mayrhofer2, S. Puchner2, M. Lu2, K. Ghemigian2, P. Kitslaar2, U. Hoffmann2, M. Ferencik2; 1 Shenyang/CN, 2Boston, MA/US

14:40 B-0745

Prognostic value of CT coronary angiography in asymptomatic patients with suspected coronary artery disease: meta-analysis of observational studies M. Fusaro, G. Balestriero, L. La torre, C. Bortolanza, G. Morana; Treviso/IT

14:48 B-0746

Assessment of semi-automatic plaque quantification of non-calcified plaque as a predictor of outcome for acute chest pain patients at coronary CT angiography A.M. Bucher1, R. Wang2, J.L. Wichman1, F.G. Meinel3, C.N. De Cecco4, T.J. Vogl1, U.J. Schoepf4; 1Frankfurt a. Main/DE, 2Beijing/CN, 3 Munich/DE, 4Charleston, SC/US

www.myESR.org

Final Programme | ECR 2016

301

Scientific Sessions

302

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:30–12:00

Room C

Breast

11:50 B-0761

MR spectroscopy evaluation of breast cancer using Signal-to-Noise Ratio (SNR) as a prognostic indicator S.B. Grover, P. Jain, S.K. Jain, A. Mandal; New Delhi/IN

SS 1002

Breast MRI-DWI (2) and various MRI applications Moderators: M. Di Matteo; Rome/IT, N.N.

10:30 B-0751

10:30–12:00

Vascular Potential of intravoxel incoherent motion and diffusion in MR imaging of ductal carcinoma of breast: new vistas

SS 1015

R. Balaji, D. Arivudainambi; Chennai/IN

10:38 B-0752

Room Z

Monoexponential, Biexponential and Stretchedexponential diffusion-weighted MR imaging in the differentiation of benign and malignant breast lesions

Thoracic aorta: novel imaging and interventions Moderators: A. Contegiacomo; Rome/IT, N.N.

10:30 B-0762

Percutaneous valvuloplasty: minimal-invasive restoration of vein valve function using cross-linked hyaluronan J. Ragg; Berlin/DE

Y. Jin; Zhengzhou/CN

10:46 B-0753

10:38 B-0763 The influence of regions of interest demarcation approaches on apparent diffusion coefficient in breast lesions

A.A. Azarine, O. Chandesris, E. Mousseaux, Z. Mallat, N. Kachenoura, C. Picard, O. Clément, A. Redheuil; Paris/FR

L. Nogueira1, S. Brandão1, R.G. Nunes2, H.A. Ferreira2, J. Loureiro1, I. Ramos1; 1Porto/PT, 2Lisbon/PT

10:54 B-0754

10:46 B-0764 Diagnostic performance of DWI and DCE-MR for evaluating residual breast cancer after local excision I. Youn, S. Choi, Y. Choi, S. Kook; Seoul/KR

Diagnostic performance of diffusion-weighted imaging in breast lesions: comparison among diffusion-weighted imaging, dynamic contrast enhanced MRI and combined MRI

T.A.U. Leidenberger1, M. Farag1, C. Weis1, M. Müller-Eschner1, K. Kallenbach1, R. Dillmann2, H.-U. Kauczor1, C. Beller1, F. Rengier1; 1 Heidelberg/DE, 2Karlsruhe/DE

10:54 B-0765

K. Kim1, Y. Kim1, J. Seo1, C. Hwang1, H. Han1, C.M. Kuzmiak2; 1 Daejeon/KR, 2Chapel Hill, NC/US

11:10 B-0756

Single screening breast MR imaging for early surveillance after breast conservation therapy: pilot study

Motion artefacts in breast MRI: impact on diagnostic performance P. Clauser1, M. Dietzel2, C.G. Kaiser3, M.A. Marino1, P. Kapetas1, R. Woitek1, P.A.T. Baltzer1; 1Vienna/AT, 2Erlangen/DE, 3Mannheim/DE

11:26 B-0758

11:02 B-0766

11:34 B-0759

11:10 B-0767

11:18 B-0768

Recall rates in surveillance breast MRIs performed in women at high risk of developing breast cancer

Incidental breast lesions detected on body-MRI: frequency, clinical relevance, and patient outcomes B. Bignotti, F. Nosenzo, L. Gristina, M. Perinetti, S. Barbagallo, L. Secondini, G. Succio, M. Calabrese, A. Tagliafico; Genoa/IT

www.myESR.org

Diagnostic value of Low kV MDCT angiography protocol with low contrast medium volume in transcatheter aortic valve implantation (TAVI) planning C.R.G.L. Talei Franzesi, D. Ippolito, P.A. Bonaffini, F. Del Buono, L. Riva, S. Sironi; Monza/IT

3D black-blood VISTA magnetic resonance vessel wall imaging of the thoracic aorta in healthy, young adults: reproducibility and indications for sample sizes in therapeutic trials A.L.M. Eikendal1, B.A. Blomberg1, C. Haaring1, T. Saam2, R.J. van der Geest3, M.L. Bots1, H.M. den Ruijter1, I.E. Hoefer1, T. Leiner1; 1 Utrecht/NL, 2Munich/DE, 3Leiden/NL

S. O’Keeffe, C. Longman, T. Suaris; London/UK

11:42 B-0760

Heritability estimates of aortic root geometry based on computed tomography and echocardiography C. Celeng1, M. Kolossváry1, A. Kovács1, A. Molnár1, Á. Jermendy1, D. Tárnoki1, S. Voros2, B. Merkely1, P. Maurovich-Horvat1; 1 Budapest/HU, 2Richmond, VA/US

A simple scoring system for breast MRI interpretation: does it compensate for reader experience? M.A. Marino, P. Clauser, R. Woitek, G.J. Wengert, P. Kapetas, M. Bernathova, K. Pinker-Domenig, T.H. Helbich, P.A.T. Baltzer; Vienna/AT

Aortic coarctation: assessment of stent patency with computed tomography vs magnetic resonance imaging R.W. van Hamersvelt1, A.M. den Harder1, D. Sucha1, J.P.J. Martens1, A.M.R. Schilham1, C. Bos1, R.P.J. Budde2, J.M.P.J. Breur1, T. Leiner1; 1 Utrecht/NL, 2Rotterdam/NL

S. Kim, B.-M. Gil, B. Kang; Seoul/KR

11:18 B-0757

Noninvasive 4D pressure difference mapping derived from 4D flow MRI in patients with syndromic aortic root aneurysm

11:26 B-0769

Aortic tortuosity: a new finding in patients with Mucopolysaccharidosis type IVa (MPS IVa) Y. Tanyildizi, S. Gökce, E. Mengel, C. Kampmann, W. Müller-Forell, J. Hennermann; Mainz/DE

Final Programme | ECR 2016

303

Friday

11:02 B-0755

Reduced strain and distensibility of the ascending aorta in human STAT3 deficiency patients with frequent medium-size-artery aneurysms

Scientific Sessions

11:34 B-0770

Contrast-enhanced T1 free-breathing gradient echo sequences in comparison with standard T1 breathhold gradient echo sequences in the evaluation of thoraco-abdominal aortic disease

11:19 B-0778

C.R.G.L. Talei Franzesi, D. Ippolito, S. Drago, S. Lombardi, S. Spiga, S. Sironi; Monza/IT

11:42 B-0771

E. Quaia, A. Gennari, V. Ulcigrai, M. Cova; Trieste/IT

11:27 B-0779 The aortic mechanical properties in patients with the essential hypertension environmentally exposed to cigarette smoke P. Gac, M. Poreba, G. Mazur, R. Poreba; Wroclaw/PL

11:50 B-0772

Thoracic endovascular aortic repair for complicated type B intramural hematoma (IMH) and penetranting ulcers (PAU): endoleak, follow up and long term survival

Room O

11:35 B-0780

11:43 B-0781

Rectal cancer: staging and restaging 11:51 B-0782

Keynote lecture C. Stoupis; Männedorf/CH

10:39 B-0773

Iodine quantification to distinguish T stage in rectal cancer by computed tomographic gemstone spectral imaging: initial experience

Multiparametric MRI for prediction of pathological complete response (pCR) to neoadjuvant chemoradiation therapy (CRT) in locally advanced rectal cancer (LARC) A. Palmisano, A. Esposito, A. Di Chiara, P. Passoni, N. Slim, L. Albarello, A. Del Maschio, F. De Cobelli; Milan/IT

Moderators: L. Curvo-Semedo; Coimbra/PT, A. Plumb; London/UK

10:30 K-20

Evaluation of rectal cancer response to therapy: role of magnetic resonance tumour regression grade (MRTRG) to predict pathological complete response S. Picchia, M. Rengo, D. De Santis, M. Zerunian, T. Biondi, S. Badia, A. Laghi; Latina/IT

GI Tract SS 1001a

T2 weighted-MRI volumetry at different time points for prediction of pathological response to neoadjuvant chemoradiation therapy (CRT) in locally advanced rectal cancer A. Di Chiara, A. Palmisano, A. Esposito, P. Passoni, N. Slim, C. Fiorino, N. Di Muzio, A. Del Maschio, F. De Cobelli; Milan/IT

F. Barbosa, E. De Febis, P. Brambillasca, M. Solcia, C. Migliorisi, M. Nichelatti, A. Lista, F. Romani, A. Rampoldi; Milan/IT

10:30–12:00

The value of tumoural volume change measured on MR images to identify responders after neoadjuvant chemo-radiation therapy in patient with locally advanced rectal cancer

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Local nodal metastasis in rectal cancer in patients with and without neoadjuvant therapy: correlation of MRI findings with histopathological results in an Irish tertiary referral centre C. Fenelon, N. Sheehy; Dublin/IE

10:30–12:00

Room N

X. Li, Y. Li, Z. Ye; Tianjin/CN

10:47 B-0774

Cardiac Diagnostic accuracy of MDCT imaging in assessment of mesorectal fascia invasion in rectal cancer: comparison study with standard magnetic resonance imaging S.G. Drago, D. Ippolito, C. Talei Franzesi, D. Fior, S. Sironi; Monza/IT

10:55 B-0775

SS 1003

Moderators: D. Brisbois; Liège/BE, J.M. Kerl; Darmstadt/DE

10:30 K-21

Diagnostic value of 4th generation iterative reconstruction algorithm with low dose CT-protocol in assessment of mesorectal fascia in rectal cancer: comparison with magnetic resonance

10:39 B-0783

Prediction of sphincter preserving by MRI: accuracy and reproducibility between a radiologist and a surgeon

An optimised correction factor for calcium scoring using advanced modeled iterative reconstruction in 3rd generation dual-source CT: in vitro and in vivo analysis D. Caruso1, J.L. Wichmann1, C.N. De Cecco1, S. Mangold1, C. Tesche1, C. Canstein1, A. Varga-Szemes1, A. Laghi2, U.J. Schoepf1; 1Charleston, SC/US, 2Rome/IT

10:47 B-0784

J. Krdzalic, M. Maas, S. Engelen, J. van Griethuysen, D.M. Lambregts, G. Beets, R.G.H. Beets-Tan; Maastricht/NL

11:11 B-0777

Keynote lecture C.N. De Cecco; Charleston, SC/US

S.G. Drago, D. Ippolito, C. Talei Franzesi, A. Casiraghi, S. Sironi; Monza/IT

11:03 B-0776

CT of the coronary arteries

CT calcium score of coronary artery calcification progression in rheumatoid arthritis over a 10-year period and risk factors for progression M.-Y. Ng, J.-H. Liu, K.-F. Mak, C.-S. Lau, H.-F. Tse, K.-H. Yiu; Hong Kong/CN

Diagnostic accuracy of dynamic contrast-enhanced MRI for locoregionar staging of rectal cancer M. Armbruster, W. Sommer, M.F. Reiser, M. Brandlhuber; Munich/DE

10:55 B-0785

Cardiac CT and coronary angiography evaluation in an NSTEMI population S.R. Fuller, D. Caruso, J. Rames, J.L. Wichmann, C.N. De Cecco, S. Mangold, C. Tesche, A. Varga-Szemes, U.J. Schoepf; Charleston, SC/US

304 ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

11:03 B-0786

Morphological features of left atrial appendage in 748 consecutive coronary computed tomography angiography patients without atrial fibrillation

10:46 B-0795

M. Korhonen1, J. Parkkonen1, M. Hedman1, A.T. Muuronen1, J. Onatsu1, P. Mustonen2, R. Vanninen1, M. Taina1; 1Kuopio/FI, 2Jyväskylä/FI

11:11 B-0787

R.A.P. Takx1, B. Szilveszter2, H. Emami2, T. Mayrhofer3, T. Leiner1, U. Hoffmann2; 1Utrecht/NL, 2Boston, MA/US, 3Stralsund/DE

11:19 B-0788

K. James, P. Nicholson, J. Murphy, G. Wyse, N. Fanning; Cork/IE

10:54 B-0796 Prognostic value of coronary CT angiography: a meta-analysis

The effect of sleep duration on the presence of coronary artery disease

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:02 B-0797

G. Marosi, Z. Drobni, B. Szilveszter, M. Kolossváry, T. Csűry, M. Vecsey-Nagy, A. Molnár, B. Merkely, P. Maurovich-Horvat; Budapest/HU

11:27 B-0789

11:35 B-0790

Dose reduction with high-pitch spiral mode coronary calcium scanning in high and irregular heart rates

11:43 B-0791

B. Horehledova, M. Kok, N.G. Eijsvoogel, B.M.F. Hendriks, B.L.J.H. Kietselaer, J.E. Wildberger, M. Das; Maastricht/NL

11:51 B-0792

11:18 B-0799

11:26 B-0800

Role of CT-angiography and digital subtractional angiography in cerebral aneurysm volume estimation A. Navichenka, A. Beimanov, P. Konovalov, B. Piskun, A. Gontchar; Minsk/BY

11:34 B-0801

Prevalence and clinical impact of incidental CTA findings in the work-up for transcatheter aortic valve implantation

11:42 B-0802

Automated detection of coiled aneurysm recurrence using 3D TOF MRA

Studio 2016

Acute ischemic stroke (AIS), outcome predictors after intra-arterial thrombectomy E. Puglielli, R. Lattanzi, L. Gregori, V. Di Mizio, V. Di Egidio; Teramo/IT

11:50 B-0803

Thrombo-aspiration in acute ischemic cerebral stroke: first results M. Voormolen, T. van der Zijden, O. d‘Archambeau, F. De Belder, J. Maes, L. Yperzeele, I. Baar, P.M. Parizel; Edegem/BE

Neuro Neurovascular interventions (2) Moderators: T. Kau; Klagenfurt/AT, N.N.

10:30–12:00

Room E1

Musculoskeletal Prediction of stent-retriever thrombectomy outcomes by dynamic CT angiography in patients with acute carotid T or MCA occlusions

SS 1010a

10:30 K-24 Endovascular therapy of low and intermediate grade lateral intracranial dural arteriovenous fistulas: results and complications of different technical approaches L.M. Ertl, H. Brückmann, M. Kunz, A. Crispin, G. Fesl; Munich/DE

Oncology Moderators: S. Boudabbous; Geneva/CH, K. Wörtler; Munich/DE

K.M. Thierfelder, W.H. Sommer, B. Ertl-Wagner, S.E. Beyer, F.G. Meinel, W.G. Kunz, M.F. Reiser, H. Janssen; Munich/DE

10:38 B-0794

The use of practice parameters for quality assurance of diagnostic craniocervical catheter angiographic procedures

A.S. Tuan, R.W. Hurst, M. Bilello; Philadelphia, PA/US

10:30–12:00

10:30 B-0793

Manual aspiration thrombectomy using penumbra catheter in patients with acute M1 occlusion: a single center study

A. Lai, T. Lee, B. Lai, K. Tang, W. Leung, S. Lo, J. Khoo; Hong Kong/HK

F. van Kesteren, E.M.A. Wiegerinck, J. Stoker, J. Baan Jr., R.N. Planken; Amsterdam/NL

SS 1011a

Cerebral aneurysms: accuracy of 256-MDCT non-subtracted and subtracted volumetric CT angiography in diagnosis

Keynote lecture K. Wörtler; Munich/DE

10:39 B-0804

Differentiation of benign and malignant marrow infiltration with multiparametric MR imaging: pilot study J. Baik, J.-Y. Jung, W.-H. Jee; Seoul/KR

www.myESR.org

Final Programme | ECR 2016

305

Friday

Aortic valve stenosis evaluation: differences in estimated aortic valve area and aortic stenosis severity comparing echocardiography and CTA results

S. Gargalas1, J. Jones2; 1Oxford/UK, 2Cambridge/UK

Y. Kim, H. Kwak, G. Chung, S. Hwang; Jeonju-si/KR

Dual source cardiac CT angiography (CCTA) in the preparticipation screening of competitive athletes C. Rutigliano, C. Santangelo, C. Grippo, B. Merlino, G. Savino, R. Marano, L. Bonomo; Rome/IT

Cost-effectiveness of mechanical thrombectomy in acute ischaemic stroke: an independent study of a UK centre

A.K. Sharma, N.S. Sharma; Delhi/IN

11:10 B-0798

M. Vonder1, R. Vliegenthart1, P.M.A. van Ooijen1, J.W. Gratama2, D. Kuijpers3, C.M. van der Aalst4, M. van Aerde4, H.J. de Koning4, M. Oudkerk1; 1Groningen/NL, 2Apeldoorn/NL, 3Den Haag/NL, 4 Rotterdam/NL

Experience and outcomes in the use of a pipeline embolisation device (PED) for the treatment of intracranial aneurysms: a single-centre study

Scientific Sessions

10:47 B-0805

Staging multiple myeloma patients: quantitative analysis of apparent diffusion coefficient (ADC) maps as potential marker for bone marrow involvement characterisation P.A. Bonaffini, D. Ippolito, A. Casiraghi, A. Nasatti, C. Talei Franzesi, S. Sironi; Monza/IT

10:55 B-0806

Usefulness of computer-aided detection (CADe) using temporal subtraction and 3D non-rigid registration for detecting bone metastasis on whole body thin-slice CT 1

1

1

1

1

D. Hasegawa , Y. Ichikawa , R. Nakayama , Y. Kurobe , S. Chino , M. Ishida1, K. Kitagawa1, S. Murashima2, H. Sakuma1; 1Tsu/JP, 2 Matsusaka/JP

Relationship of acute brain lesions on MRI after cardiac arrest treated with hypothermia to neurological outcome 6 months later E. Wallin, S. Rubertsson, I.-M. Larsson, M.-L. Kristofferzon, E.-M.B. Larsson, R. Raininko; Uppsala/SE

10:46 B-0815

Differentiation of multiple myeloma and metastases of the spine using diffusion-weighted MR imaging including ADC histogram moments at 3T G. Park, W.-H. Jee, S.-Y. Lee, J.-Y. Jung, K.-Y. Ha, C.-K. Min, Y. Son, M. Paek; Seoul/KR

11:03 B-0807

10:38 B-0814

Susceptibility-diffusion mismatch in hyperacute stroke: correlation with perfusion-diffusion mismatch and clinical outcome M. Dejobert, X. Cazals, M. Annan, S. Debiais, J.-P. Cottier; Tours/FR

10:54 B-0816

Large vessel acute ischemic stroke active reperfusion therapy comparison A. Balodis, M. Radzina, M. Preinbergs, K. Kupcs, E. Miglāne, J. Savlovskis, H. Kidikas, A. Veiss; Riga/LV

11:02 B-0817

Comparison of high-resolution magnetic resonance with digital subtraction angiography in intracranial artery disease N. Lee, S. Jung, H. Kim, C.-G. Choi, S. Kim, D. Lee, D. Suh; Seoul/KR

11:11 B-0808

Chondrogenic tumours: role of advanced magnetic resonance imaging

11:10 B-0818

W.M. Amin, H.T. Kotb, A.A. Farahat, M.S. Barakat, A.E. Rafallah, S.H. Fadel; Alexandria/EG

11:19 B-0809

Dynamic contrast-enhanced MR imaging in osteoid osteoma: relationships with clinical and CT characteristics P. Pottecher1, E. Sibileau2, L. Emerich2, S. Touraine2, B. Hamze2, C. Parlier2, D. Petrover2, J. Laredo2, V. Bousson2; 1Dijon/FR, 2Paris/FR

11:27 B-0810

Multivariate data analysis as a clinical tool for differentiating intraarticular synovial sarcomas from localised pigmented villonodular synovitis D. Nordemar1, J. Öberg2, O. Brosjö2, M. Skorpil2; 1Stockholm/SE, 2 Solna/SE

11:35 B-0811

11:43 B-0812

Diagnostic performance of conventional MRI and apparent diffusion coefficient values in differentiating benign and malignant soft tissue tumours Y. Yoon, D. Oh, Y. Song; Seoul/KR

10:30–12:00

Cerebrovascular disease (3)

Dual-energy CT of the brain: comparison between virtual unenhanced images and true unenhanced ones in the detection of intracranial hemorrhage M. Bonatti1, F. Lombardo2, G. Zamboni2, A. Cipriani1, R. Pozzi Mucelli2, G. Bonatti1; 1Bolzano/IT, 2Verona/IT

11:26 B-0820

Crossed cerebellar diaschisis in patients with acute MCA infarction: analysis of CT perfusion characteristics W.H. Sommer, K. Thierfelder, H. Janssen, L. von Baumgarten; Munich/DE

11:34 B-0821

Raw arterial spin labelling data can help identify arterial occlusion in acute ischaemic stroke M. Majer, M. Mejdoubi, M. Schertz, S. Colombani, A. Arrigo; Fort De France/FR

11:42 B-0822

Quantifying intracranial plaque permeability with dynamic contrast enhanced MRI P. Vakil1, A.H. Elmokadem2, F. Sherazi1, C.G. Cantrell1, T.J. Carroll1, S. Ansari1; 1Chicago, IL/US, 2Mansoura/EG

11:50 B-0823 Moderators: M. Buruian; Targu-Mures/RO, T. Rostovtseva; St. Petersburg/RU

10:30 B-0813

11:18 B-0819

Room E2

Neuro SS 1011b

A. Viguier, S. Patsoura, N. Raposo, V. Cazzola, L. Claviere, J.F. Albucher, F. Chollet, V. Larrue, F. Bonneville; Toulouse/FR

Enchondroma vs low-grade chondrosarcoma: the role of dynamic contrast MRI D. Costachescu; Timisoara/RO

Subdural and convexity subarachnoid haemorrhage are more frequently associated with acute spontaneous lobar haematoma in cerebral amyloid angiopathy

Acute/subacute small ischaemic lesions on DWI in patients with cerebral amyloid angiopathy and cortical superficial siderosis E. Gangemi1, A. Charidimou2, D. Werring2, R. Jäger2; 1Rome/IT, 2 London/UK

Predictive value of perfusional CT parameters in evaluating reperfusional effectiveness in acute ischemic stroke patients A. Bernardoni, E. Raimondi, A. Clarizia, M. Padroni, E. Groppo, C. Tamborino, A. Saletti, M. Giganti, E. Fainardi; Ferrara/IT

306

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:30–12:00

Room F1

Oncologic Imaging SS 1016

Prostate and renal tract cancers: advanced detection methods Moderators: J. Rørvik; Bergen/NO, W.H. Sommer; Munich/DE

10:30 B-0824 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

10:38 B-0825

11:50 B-0834

A. Stanzione, V. Chianca, N. Longo, F. Fusco, R. Liuzzi, M. Imbriaco, A. Brunetti; Naples/IT

E. Raimondi, M. Bassi, M. Tilli, S. Dall’ara, R. Rizzati, M. Simone, M. Giganti, G. Benea; Ferrara/IT

The feasibility of k-means clustering of dynamic contrast-enhanced MRI pharmacokinetic parameters in predicting prostate cancer risk stratification

TRUS-MRI image navigation for prostate cancer recurrence targeted biopsy: initial experience

10:30–12:00

SS 1001b

10:30 B-0835

Diffusion tensor imaging of the prostate: assessing response following cyber knife therapy

X. Wang1, T. Henzler2, S. Diehl2, S.O. Schönberg2, H.-D. Xue1, Z.-Y. Jin1, A. Smakic2; 1Beijing/CN, 2Mannheim/DE

Detection of prostate cancer lesions with multiparametric MRI (mp-MRI): what is the difference between pelvic phased-array of 32 channels and endorectal-pelvic phased-array coils

10:46 B-0837

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Predictive value of paradoxical uptake on hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI for response to transcatheter arterial chemoembolisation in hepatocellular carcinoma J. Kim, C. Lee, Y. Park, J. Lee, J. Choi, K. Kim, C. Park, H. Lee; Seoul/KR

Diagnostic efficacy of MRI-guided in-bore prostate biopsy in patients with inconclusive results of transrectal ultrasound (TRUS) or TRUS-guided biopsy

10:54 B-0838

Prognostic significance of liver stiffness measurements on MR elastrography in patients with hepatocellular carcinoma treated with radiofrequency ablation J. Kim, J. Lee, D. Lee, W. Chang, J. Han; Seoul/KR

Our experience with whole body MRI for metastatic prostate cancer detection E. Kvyatkovskaya, V. Kuplevatsky, M. Cherkashin, N. Berezina, D. Roschin; St. Petersburg/RU

11:34 B-0832

Comparison between quantitative dual-energy CT iodine maps and dynamic volume perfusion CT parameters in patients with hepatocellular carcinoma before and after TACE

Comparison between Likert scale, prostate imaging reporting and data system (PIRADS) v1 and v2 in detection and characterisation of prostate cancer using multiparametric (mp) MRI L. Zantedeschi, D. Cenzi, M. Motton, G. Schenal, A. Borsato, S. Montemezzi; Verona/IT

11:02 B-0839

Evaluation of treatment response of radiotherapy for HCC using pre- and post-treatment magnetic resonance imaging S. Song, W. Jeong, J. Kim, Y. Kim, D. Choi, H. Park, J. Yu, J.-H. Lee; Seoul/KR

11:10 B-0840

Assessment of post interventional hepatocellular carcinoma using morphological and functional MR data M.A.M. Saad, A.M. Magdy; Fayoom/EG

www.myESR.org

Final Programme | ECR 2016

307

Friday

10:38 B-0836

V. Kuplevatsky, M. Cherkashin, D. Roschin, N. Berezina, N. Vorobyov; St. Petersburg/RU

11:26 B-0831

Dynamic contrast enhanced perfusion CT imaging as an early predictor for tumour response to Sorafenib treatment in patients with advanced HCC lesions: preliminary results D. Ippolito, G. Querques, C. Talei Franzesi, P.A. Bonaffini, D. Fior, S. Sironi; Monza/IT

N. Dervishi1, A. Fornari2, M. Petracchini2, M. Manfredi1, A. Tribunella2, D. Gned1, A. De Pascale1, A. Veltri1, S. Cirillo2; 1Orbassano/IT, 2Turin/IT

11:18 B-0830

Hepatocellular carcinoma: evaluation of therapeutic response Moderators: D. Akata; Ankara/TR, L. Crocetti; Pisa/IT

R. Balaji; Chennai/IN

11:10 B-0829

Room F2

Abdominal Viscera

Multidetector computed tomographic urography (MDCTU): its practical role in the diagnosis of upper tract urothelial cancer in high-risk patients S. Kravchick1, E. Cherniavsky2, R. Topopolsky2, L. Linov2; 1Tzrefin/IL, 2 Ashkelon/IL

11:02 B-0828

H.T. Nguyen1, Z. Shah1, A. Mortazavi1, K. Pohar1, L. Wei1, G. Jia2, D. Zynger1, M. Knopp1; 1Columbus, OH/US, 2Baton Rouge, LA/US

Role of contrast-enhanced ultrasound (CEUS) after inconclusive contrast-enhanced computed tomography or magnetic resonance in evaluating hypovascular small renal masses

V. Kapustin, A. Gromov, V. Shirokorad, D. Koshurnikov; Moscow/RU

10:54 B-0827

Diffusion-weighted MRI of urinary bladder: noninvasive quantification of tumor heterogeneity to differentiate malignant from benign tissues

Sensitivity of a biparametric (T2 and diffusionweighted) 3T magnetic resonance imaging protocol for prostate cancer imaging

S.N. Elias1, F.G. Petros1, G. Jia2, H. Nguyen1, Z. Shah1, D. Zynger1, R. Abaza3, M.V. Knopp1; 1Columbus, OH/US, 2Baton Rouge, LA/US, 3 Dublin, OH/US

10:46 B-0826

11:42 B-0833

Scientific Sessions

11:18 B-0841

Hypointensity rim of hepatocellular carcinoma on arterial phase of dynamic contrast-enhanced MRI can predict low recurrence rate after hepatectomy Y. Fujinaga, M. Kurozumi, A. Fujita, A. Yamada, K. Ueda, T. Uehara, M. Kadoya; Matsumoto/JP

11:26 B-0842

Value of registration of preprocedure MR imaging and postprocedure multidetect CT for therapeutic response assessment of radiofrequency ablation for hepatocellular carcinoma J. Park, J. Lee, D. Lee, I. Joo, J. Yoon, J. Park, J. Yoon, J. Han; Seoul/KR

11:34 B-0843

Microwave ablation of large HCCs using a new device: a case series L. Tarantino1, P. Ambrosino2; 1Pagani/IT, 2Naples/IT

11:42 B-0844

Microwave ablation of large HCCs by simultaneous multiple antennae insertion: long term follow-up L. Tarantino1, P. Tarantino2, P. Ambrosino2; 1Pagani/IT, 2Naples/IT

11:50 B-0845

11:10 B-0851

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:18 B-0852

10:30–12:00

A. Fuentealba, D. Ramirez, J. Durán, N. Rossel, R. Aris, S. Aguirre, A. Pizarro, M. Castro; Santiago/CL

Chest x-ray and detecting acute heart failure: what is the clinical value? D. Goei, P. Visser, I. Koster, P. van der Valk, M. Kock; Dordrecht/NL

11:26 B-0853

Computed tomography-based differentiation of acute mediastinitis from postoperative residuals after thoracic surgery with sternotomy B. Foldyna, M. Müller, C. Luecke, M. Haensig, S. Nitzsche, T. Klemm, F. Mohr, M. Gutberlet, L. Lehmkuhl; Leipzig/DE

11:34 B-0854

Chest CT findings of toxocariasis: correlation with laboratory results M. Koh, I. Lee; Anyang city/KR

11:42 B-0855

Value of computed tomography of the chest in patients with acute respiratory distress syndrome C. Berliner, S. Marcel, S. Braune, M. Metschke, H. Klose, S. Kluge, G. Adam, A. Laqmani; Hamburg/DE

Percutaneous ablation of small HCCs: comparison of 3 commercially available microwave devices L. Tarantino1, P. Ambrosino2; 1Pagani/IT, 2Naples/IT

Chest x-ray in acute nontraumatic disease, is it a reliable diagnostic tool?

11:50 B-0856

Room D1

Comparison of HRCT features of pneumocystis Jiroveci pneumonia in patients with and without HIV M.A. Karimi, S. Kahkouee, F. Mami; Tehran/IR

Chest SS 1004

Imaging methods: something old, something new Moderators: J. Mayer; Heidelberg/DE, E.J. Stern; Seattle, WA/US

10:30 B-0846

Added value of dual energy subtraction radiography compared to standard conventional radiography using computed tomography as standard of reference

Bone suppression images improve radiologists’ performance on detection of lung nodules on chest radiographs Y. Wang, L. Fan, Y. Guan, Y. Xia, S. Liu, W. Zou; Shanghai/CN

10:46 B-0848

Digital tomosynthesis as problem-solving technique to confirm or exclude pulmonary lesions in the hidden areas E. Baratella, E. Quaia, P. Gabriele, S. Kus, C. Cercato, M. Cova; Trieste/IT

10:54 B-0849

Digital tomosynthesis in the diagnosis of chest diseases and injuries V. Nechaev; Moscow/RU

11:02 B-0850

Room D2

Interventional Radiology SS 1009

Liver ablation Moderators: J. Garnon; Strasbourg/FR, N.N.

K. Martini, M. Bässler, T. Frauenfelder; Zurich/CH

10:38 B-0847

10:30–12:00

Radiological interpretation quality in lung imaging of organ donors and its clinical relevance - a retrospective analysis

10:30 K-23

Keynote lecture N.N.

10:39 B-0857

Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors X. Jing, J. Ding, Y. Wang, F. Wang, Y. Wang; Tianjin/CN

10:47 B-0858

Post-surgical recurrence of HCC along the resection margin treated by percutaneous US-guided ablation M. Calandri1, C. Gazzera1, S. Yevich2, A. Veltri3, P. Fonio1, G. Gandini1; 1 Turin/IT, 2Villejuif/FR, 3Orbassano/IT

10:55 B-0859

Intraparenchymal hydrodissection in liver to minimise flow mediated cooling from vessels during radiofrequency ablation of hepatocellular carcinoma A.K. Chaturvedi; New Delhi/IN

11:03 B-0860

Evaluation of thermal microwave ablation (MWA) of liver malignancy with real-time enhanced spatial energy control to achieve a spherical ablation zone T.J. Vogl, L. Basten, B. Panahi, N.N.N. Naguib, N.-E. Nour-Eldin; Frankfurt a. Main/DE

G. Bozovic1, C. Adlercreutz1, P. Höglund1, I. Bjorkman-Burtscher1, P. Reinstrup1, R. Ingemansson1, C. Schaefer-Prokop2, R. Siemund1, M. Geijer1; 1Lund/SE, 2Utrecht/NL

308

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

11:11 B-0861

11:10 B-0871

MR-guided microwave ablation in hepatic tumours: initial results in clinical routine R. Hoffmann, H. Rempp, D. Kessler, J. Weiss, K. Nikolaou, S. Clasen; Tübingen/DE

11:19 B-0862

Microwave ablation in colorectal liver metastases: comparison of volume decrease, progression time, recurrence and survival rates with two different microwave systems 11:26 B-0873

Applied energy and ablation volume after CT-guided radiofrequency- and microwave ablation of colorectal liver metastases

Exposure index in digital radiology L.P. Ribeiro, J. Ribeiro, R.P.P. Almeida, S. Rodrigues, A.F.C.L. Abrantes, K.B. Azevedo, J.P. Pinheiro, O. Lesyuk; Faro/PT

11:34 B-0874

Dosimetric advantage of percutaneous femoral artery approach vs radial approach in coronary angiography: preliminary analysis D. Aviano1, S. Presilla1, M. Mangiarotti2, F. Ruda1, M. Moccetti1; 1 Lugano/CH, 2Varese/IT

Does DEB-TACE enhance the local effect of IRE? Imaging and histopathological evaluation in a porcine model

11:42 B-0875

P. Isfort1, P. Rauen1, H.-S. Na1, N. Ito2, C. Wilkmann1, C. Kuhl1, P. Bruners1; 1Aachen/DE, 2Tokyo/JP

11:43 B-0865

An evaluation of organ doses and effective dose with dual-energy CT (DECT) and single-energy CT (SECT) using adult whole body imaging protocols K. Yagami1, T. Miyoshi1, S. Shigeyama1, H. Okada1, T. Ukai2, S. Suzuki2; 1 Gifu/JP, 2Toyoake/JP

W.J. Heerink, R. Vliegenthart, M. Oudkerk, K.P. de Jong; Groningen/NL

11:35 B-0864

T. Berglund; Trondheim/NO

11:18 B-0872

T.J. Vogl, A. Hagar, E. Mbalisike, S. Zangos; Frankfurt a. Main/DE

11:27 B-0863

Skindoses in cardiac intervention at St. Olavs University Hospital Norway

Effect of patient size on radiation dose for abdominal MDCT performed with automatic exposure control O. Seraydarmansour; Tehran/IR

Iterative metal artefact reduction for CT-guided microwave antenna positioning: impact on image quality for different exposure settings 1

1

1

2

1

11:50 B-0876 1

T.D. Do , C. Schlett , C. Melzig , T. Gockner , P. Flechsig , P.L. Peireira , H.-U. Kauczor1, W. Stiller1, C.M. Sommer1; 1Heidelberg/DE, 2Mainz/DE

Room G

S. Kwon1, J. Lee1, D. Han2; 1Seoul/KR, 2Sungnam-si/KR

10:30–12:00

Room M 1

Radiographers

Head and Neck

SS 1014

SS 1008

High dose antidotes

Patient doses in lumbar spine A. Henner, K. Paalimäki-Paakki; Oulu/FI

10:38 B-0867

10:46 B-0868

10:30 B-0877

10:38 B-0878

Small fov cone beam computed tomography: dosimetry for temporomandibular joint exam 10:46 B-0879 Quantification of tertiary scatter radiation in a CT room R.P.P. Almeida, A. Calafate, P. Sousa, S. Rodrigues, L.P. Ribeiro, J.P. Pinheiro, K.B. Azevedo, A.F.C.L. Abrantes; Faro/PT

11:02 B-0870

Analysis of overexposed areas in paediatric plain radiography

3rd dual-source CT of the neck using automated tube voltage adaptation in combination with advanced modeled iterative reconstruction: evaluation of image quality and radiation dose J.-E. Scholtz, J.L. Wichmann, K. Hüsers, M.H. Albrecht, M. Beeres, S. Fischer, R.W. Bauer, T.J. Vogl, B. Bodelle; Frankfurt a. Main/DE

M.V.L. Oliveira1, M. Andrade Almeida2, W. Batista1, P. Flores1; 1 Salvador/BR, 2recife/BR

10:54 B-0869

Advanced modeled iterative reconstruction in lowtube-voltage contrast-enhanced neck CT: evaluation of objective and subjective image quality J.-E. Scholtz, M. Kaup, K. Hüsers, M.H. Albrecht, B. Bodelle, R.W. Bauer, T. Lehnert, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main/DE

Patient skin dose in interventional radiology: an international review of procedures L. O’Hora1, M.-L. Butler1, D. Catania2, M. Ong3, R. Decoster4, J. Offermans5, T. Starc6, L. Rainford1; 1Dublin/IE, 2Milan/IT, 3 Singapore/SG, 4Brussles/BE, 5Maastricht/NL, 6Ljubljana/SI

Maxillofacial imaging Moderators: N.I. Traykova; Plovdiv/BG, G. Widmann; Innsbruck/AT

Moderators: I. Arkhipova; Moscow/RU, S. Brandão; Porto/PT

10:30 B-0866

Friday

10:30–12:00

Study of the effect of classification of patients on CT radiation dose

Low-dose CT of the paranasal sinuses: minimising x-ray exposure with spectral shaping W. Wuest, M. May, M. Uder, M. Lell; Erlangen/DE

10:54 B-0880

Effect of spectral shaping on radiation dose in computed tomography of the paranasal sinuses M.S. May, M. Lell, M. Uder, W. Wüst; Erlangen/DE

A. Pereira, B. Poiares, B. Esteves, G. Paulo, J. Santos; Coimbra/PT

www.myESR.org

Final Programme | ECR 2016

309

Scientific Sessions

11:02 B-0881

Radiation exposure (RE) and image quality of lowdose computed tomography (CT) of the paranasal sinuses (PS) using iterative reconstructions (IR)

10:46 B-0890

M. Cellina, G. Sciveres, D. Mariani, M. Orsi, B. Tagliaferri, G. Oliva; Milan/IT

11:10 B-0882

Cone beam CT (CBCT) and multislice CT (MSCT) in the diagnostic imaging of the maxillary sinuses: evaluation of patient radiation dose and radiographic assessment of findings

L. Monti, M. Salsano, G. Soglia, M. Colella Bisogno, A. Simonetti, G. Torre, P. Rossi, L. Bonomo, P. Tomà; Rome/IT

10:54 B-0893

Incidental findings in cone beam CT of the maxillofacial region

11:02 B-0894

M.J. Braun1, T. Rauneker2, T. Hoffmann2, F. Dammann3, J. Dreyhaupt2, M. Beer2; 1Günzburg/DE, 2Ulm/DE, 3Göppingen/DE

11:26 B-0884

Bisphosphonate-induced osteonecrosis of the jaws: CT image spectrums and their correlation with disease prognosis

Morphometric analysis of joint elements and masticatory muscles in temporomandibular joint dysfunction F. Duman1, A.E. Cicekcibasi2, N. Atci1, I. Damlar1, E. Dogru1, F. Öztürk1, T. Duman1; 1Hatay/TR, 2Konya/TR

11:42 B-0886

Sleep MRI with EEG: assessment of mechanism and obstruction level in patients with obstructive sleep apnea syndrome P. Kavcic, A. Koren, B. Koritnik, L. Dolenc Groselj; Ljubljana/SI

11:50 B-0887

Diagnosing bone involvement in buccal malignancies with DWIBS (diffusion-weighted whole body imaging with background signal suppression): is it a better tool?

11:10 B-0895

Room M 2

Comparison of amniotic fluid volumetry between fetal sonography (AFI) und MRI (AFVMRI) and its’ correlation to diffusion parameters (ADC) of the foetal kidney E. Kudryavtseva1, D. Güllmar1, A. Fiedler1, U. John1, D. Renz1, D. Schlembach2, E. Schleußner1, U. Schneider1, H.-J. Mentzel1; 1 Jena/DE, 2Berlin/DE

11:18 B-0896 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:26 B-0897

Can fetal MRI predit the need for neonatal emergency procedures? M. Saldari, V. Vinci, S. Bernardo, L. Manganaro, C. Catalano; Rome/IT

Fetal MRI: 3T or 1.5T? K. Pegoretti, S. Arulkumaran, J. Allsop, M.J. Fox, A. Price, J. Hajnal, M. Rutherford, C. Malamateniou; London/UK

11:34 B-0898

Postmortem MRI as a method of evaluating the degree of maceration at intrauterine fetal death S.M. Voevodin, U.N. Tumanova, V.M. Liapin, A.I. Shchegolev, G.T. Sukhikh; Moscow/RU

R. Balaji; Chennai/IN

10:30–12:00

MRI-US fusion imaging in real-time virtual sonography for the evaluation of foetal anomalies: preliminary study S. Bernardo, V. Vinci, M. Saldari, A. Giancotti, C. Catalano, L. Manganaro; Rome/IT

H. Kim, J. Kim, S.-Y. Jeong; Seoul/KR

11:34 B-0885

Bowel contraction amplitude measured in CINE MR enterography (MRE) as a marker of inflammatory activity in children with Crohn’s disease J. Podgorska, R. Pacho, P. Albrecht, I. Łazowska-Przeorek; Warsaw/PL

E. Saukko, H. Niiniviita, H. Lauren; Turku/FI

11:18 B-0883

Accuracy of ultrasound signs, ARFI and clinicolaboratoristic data for detection of biliary atresia in cholestatic patients

10:30–12:00

Room M 3

Paediatric

Molecular Imaging

SS 1012

SS 1006

Abdominal and foetal imaging Moderators: G. Kasprian; Vienna/AT, G. Papaioannou; Athens/GR

10:30 B-0888

Can we avoid unnecessary scrotal exploration? The value of the sonographic chondral sign in the diagnosis of hydatid of Morgagni torsion in children: a decade’s experience

Moderators: A.M. Herneth; Vienna/AT, N.N.

10:30 K-22

Diffusion-weighted imaging (DWI) in paediatric liver MRI - confuses or helps? E. Petrash, E. Mikhaylova, D. Sevryukov; Moscow/RU

Keynote lecture G. Cook; London/UK

10:39 B-0899

V.N. Zefov, S.M. El-Maadawy, D. Abdul Rahman; Dubai/AE

10:38 B-0889

Advanced hybrid imaging in oncology

Variations of clinical PET/MR operations: an international web-based survey T. Beyer1, K. Herrmann2, J. Czernin3; 1Vienna/AT, 2Würzburg/DE, 3 Los Angeles, CA/US

10:47 B-0900

Comparison of [18F] choline PET/CT with [18F] choline MRI/PET in patients with suspected recurrent prostate cancer: a prospective study A. Wetter1, B. Schaarschmidt2, S. Lütje1, H. Rübben1, T. Lauenstein1; 1 Essen/DE, 2Düsseldorf/DE

310

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:55 B-0901

Focal 18F-FDG uptake in PET/MRI indicates activated facet arthrosis and guides facet block therapy

10:38 B-0910

L.M. Sawicki1, B.M. Schaarschmidt1, P. Heusch1, C. Buchbender1, S. Rosenbaum-Krumme2, L. Umutlu2, A. Bockisch2, G. Antoch1, F.W. Floeth1; 1Düsseldorf/DE, 2Essen/DE

11:03 B-0902

F. Schmaranzer1, M. Kogler2, M. Reichkendler2, E. Schmaranzer2; 1 Innsbruck/AT, 2St. Johann i. Tirol/AT

10:46 B-0911 A comparison between 18F-FDG-PET/CT and 18F-FDG-PET/MRI for detection of primary head-andneck cancer

Comparison of whole-body PET/MRI and wholebody DWI/MRI for the evaluation of patients with lymphoma

10:54 B-0912

J. Grueneisen1, L. Sawicki2, B. Schaarschmidt2, S. Suntharalingam1, H. Quick1, M. Forsting1, L. Umutlu1; 1Essen/DE, 2Düsseldorf/DE

11:19 B-0904

11:27 B-0905

SUV-quantification of physiological lung tissue in an integrated PET/MR-system: impact of lung density and bone tissue 11:10 B-0914

Evaluation of a FAST-protocol for simultaneous PET/ MRI used for staging patients with lymphoma

P. Stumpp, R. Diogo, M. Gawlitza, S. Purz, A. Boehm, O. Sabri, T. Kahn; Leipzig/DE

11:43 B-0907

Impact of combined FDG-PET/CT and MRI on detection of local recurrence and nodal metastases of thyroid cancer J.-M. Hempel1, R. Kloeckner2, S. Krick2, S. Schadmand-Fischer2, M. Schreckenberger2, M. Miederer2; 1Tübingen/DE, 2Mainz/DE

11:51 B-0908

Sentinel lymph node detection and in vivo/ex vivo assessment of melanin distribution by means of multispectral optoacoustic tomography in patients with malignant melanoma I. Stoffels1, S. Morscher2, N.C. Burton2, J. Klode1; 1Essen/DE, 2 Munich/DE

10:30–12:00

Room M 4

Evaluation of usability and comparison of radial sequences and reconstructions in MRI assessment of hips with femoroacetabular impingement (FAI) A. Pomianowska1, J. Walecki1, J. Czubak1, M. Złotorowicz1, J. Ludwikowska2, M. Frel1; 1Otwock/PL, 2Warsaw/PL

11:18 B-0915

Osteophytes of the fovea capitis femoris are a common finding in MRI of asymptomatic volunteers S. Bensler, C.A. Agten, C.W.A. Pfirrmann, R. Sutter; Zurich/CH

11:26 B-0916

A review of 10 years’ experience: prevalence and patterns of radiographically occult femoral and pelvic fractures detected by MRI following low-energy trauma P.M. Yeap, T.B. Oliver; Dundee/UK

11:34 B-0917

Non-contrast enhanced MRI with diffusion-weighted imaging: diagnostic performance for abscess formation in cellulitis patients in comparison with contrast-enhanced MRI J. Baik1, J.-Y. Jung1, C.-W. Chun2, W.-H. Jee1; 1Seoul/KR, 2 Uijeongbu/KR

11:42 B-0918

Diagnostic accuracy of conventional MRI in detecting long biceps muscle tendon abnormalities R. Lee, S. Choi, J. Ahn, C. Kang, D. Shin, M. Lee, K. Lee; Gangneung-si/KR

Musculoskeletal SS 1010b

Hip and shoulder Moderators: S.E. Anderson; Baden/CH, T. Geith; Munich/DE

10:30 B-0909

Indirect arthrography with 3D PD SPACE and 3D T1 VIBE at 3 T MRI for the detection of acetabular labral tears A. Lazik, O. Kraff, K. Körsmeier, S. Landgraeber, J.M. Theysohn; Essen/DE

www.myESR.org

Final Programme | ECR 2016

311

Friday

Simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with suspected recurrence or residual manifestation of head and neck cancer

Scoring hip OA with MRI (SHOMRI) for the longitudinal assessment of MRI in hip osteoarthritis in correlation with clinical progression B.J. Schwaiger, A.S. Gersing, S. Lee, L. Nardo, M.A. Samaan, R.B. Souza, T.M. Link, S. Majumdar; San Francisco, CA/US

J. Grueneisen1, L. Sawicki2, B. Schaarschmidt2, S. Suntharalingam1, H. Quick1, M. Forsting1, L. Umutlu1; 1Essen/DE, 2Düsseldorf/DE

11:35 B-0906

Validation of joint space mapping: a new 3D approach to quantitative multimodal hip joint space assessment T.D. Turmezei, A.H. Gee, K.E.S. Poole, G.M. Treece; Cambridge/UK

11:02 B-0913

F.F. Seith, H. Schmidt, I. Bezrukov, S.-C. Schüle, C. Schraml, C. Pfannenberg, C. La Fougère, K. Nikolaou, N. Schwenzer; Tübingen/DE

MRI assessment of hip joint cartilage in patients with femoroacetabular impingement (FAI): usability and comparison of radial sequences and reconstructions A. Pomianowska1, J. Walecki1, J. Czubak1, M. Złotorowicz1, J. Ludwikowska2, M. Frel1; 1Otwock/PL, 2Warsaw/PL

P. Stumpp, Y. Risy, S. Purz, M. Gawlitza, O. Sabri, T. Kahn; Leipzig/DE

11:11 B-0903

Utility of MR arthrography with and without leg traction in detection of loose bodies in the hip joint

Scientific Sessions

312

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:30–12:00

Room C

Breast SS 1402a

11:42 B-0930

Breast cancers missed by screening radiologists can be detected by reading mammograms from distance I.L. Schreutelkamp1, R.M. Kwee2, P. Veekmans3, M.S.O. van Wissen2, M.E.A.P. Adriaensen2; 1Maastricht/NL, 2Heerlen/NL, 3Weert/NL

Screening Moderators: S. Perez Rodrigo; Madrid/ES, R.M. Pijnappel; Utrecht/NL

10:30–12:00 10:30 B-0920

10:38 B-0921

Screen detected cancers vs interval cancers: influence of image modality and breast density

Molecular Imaging

L. Timmermans1, L. Bleyen1, I. De Brabander2, K. Lemmens3, A. Van Steen3, C. Van Ongeval3, K. Van Herck1, K. Bacher1, H. Thierens1; 1Gent/BE, 2Brussels/BE, 3Leuven/BE

SS 1406

Prognostic factors of interval carcinomas occurring in an intermediate and high risk breast cancer screening program

Interpretation time in a population-based breast screening program: digital breast tomosynthesis versus 2D mammography

10:30 B-0931

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:02 B-0924

Poulation-based biennal mammographic screening: how many women ask for more?

10:38 B-0932

10:46 B-0933

10:54 B-0934

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:34 B-0929

Multiparametric contrast-enhanced ultrasound with VEGFR-2-targeted microbubbles and DCE-MRI for monitoring the effects of regorafenib on colon carcinoma xenografts in rats

11:02 B-0935

11:10 B-0936

Radiolabeled somatostatin receptor agonist versus antagonist for molecular imaging and therapy S. Dalm, J. Nonnekens, G. Doeswijk, E. de Blois, D. van Gent, M. Konijnenberg, M. de Jong; Rotterdam/NL

11:18 B-0937

A four year review of screening-detected breast cancers with discordant interpretations on double read screening mammography

Complaints against radiologist submitted to disciplinary tribunals (DT) in the Netherlands (20072014)

RGD peptide-modified PEGylated dendrimerentrapped gold nanoparticles for targeted CT imaging of breast carcinoma K. Li; Shanghai/CN

15 years of imaging of the male breast: a retrospective analysis

B. Batohi, M.J. Michell, D. Evans, J. Goligher, J. Morel, C. Peacock, K. Satchithananda, R. Wasan, S. Wijesuriya, R. Rahim; London/UK

Saturday

Type and extent of surgery for screen-detected and interval cancers at blinded vs non-blinded double reading in a population-based screening mammography programme

O. Scholz, H. Amer, F. Schmitzberger, K.-J. Winzer, H. Schmuschkowitsch, E.M. Fallenberg; Berlin/DE

11:26 B-0928

Ga-TRAP-(RGD)3-PET/CT for the in vivo assessment of Įvß3-integrin expression as biomarker of early antiangiogenic therapy effects in experimental breast cancer

R.S. Eschbach, D.A. Clevert, H. Hirner-Eppeneder, P.M. Kazmierczak, M. Moser, M. Schneider, D. Tadros, M.F. Reiser, C.C. Cyran; Munich/DE

R.J.P. Weber1, R.M.G. van Bommel1, W. Setz-Pels1, A.C. Voogd1, E.G. Klompenhouwer1, M.W. Louwman1, L.J.A. Strobbe2, V.C.G. Tjan-Heijnen3, L.E.M. Duijm1; 1Eindhoven/NL, 2Nijmegen/NL, 3 Maastricht/NL

11:18 B-0926

68

P. Kazmierczak, A. Todica, H. Hirner-Eppeneder, A. Rominger, M.F. Reiser, C.C. Cyran; Munich/DE

L. Robinson1, C. Ure1, J. Wray1, M. Griffiths1, C. Hill2, G. Shires2, J. Stein Hodgins3, B. Scragg4; 1Salford/UK, 2Manchester/UK, 3 Bolton/UK, 4Burnley/UK

11:10 B-0925

In vivo imaging of prostate cancer using an antiPSMA fragment as a probe C. Mazzocco1, N. Grenier1, G. Fracasso2, C. Germain-Genevois1, N. Dugot-Senant1, F. Couillaud1; 1Bordeaux/FR, 2Verona/IT

A. Pisani Mainini1, L.A. Carbonaro2, C. De Angelis1, I. Ioan1, A. Benedek2, L. Menicagli2, R.M. Trimboli2, R. Lucchini3, F. Sardanelli2; 1 Milan/IT, 2San Donato Milanese/IT, 3Vimodrone/IT

Engaging users in service improvement using social media: an example from breast screening

Įvß3-integrin-targeted MRI for the assessment of early anti-angiogenic therapy effects in experimental breast cancer P.M. Kazmierczak, M. Schneider, T. Habereder, H. Hirner-Eppeneder, R. Eschbach, M. Moser, M.F. Reiser, C.C. Cyran; Munich/DE

A. Nitrosi1, M. Bertolini1, C. Campari1, L. Braglia1, V. Iotti1, R. Vacondio1, V. Ginocchi2, P. Pattacini1, M. Iori1; 1Reggio Emilia/IT, 2Guastalla/IT

10:54 B-0923

Advanced experimental imaging Moderators: S. Walker-Samuel; London/UK, B. Wängler; Mannheim/DE

S. Vreemann, A. Gubern-Mérida, S. Lardenoije, N. Karssemeijer, R.M. Mann; Nijmegen/NL

10:46 B-0922

Room Z

Probing thePI3K/Akt/mTOR signalling inhibitors response in breast cancer cellsby 31P-NMR spectroscopy S.M. Phyu, T.A.D. Smith, C.-C. Tseng; Aberdeen/UK

11:26 B-0938

Semi-quantitative dynamic contrast-enhanced magnetic resonance imaging parameters for evaluating tumour hypoxia in a maxillofacial VX2 rabbit model L. Zheng1, Y. Li2, Z. Zhang1, G. Zhang2; 1Chicago, IL/US, 2Shanghai/CN

G.J. Jager, M.J.C.M. Rutten; ‚s-Hertogenbosch/NL

www.myESR.org

Final Programme | ECR 2016

313

Scientific Sessions

11:34 B-0939

The complement system and its influence on the development of acute renal failure: non-invasive renal perfusion measurement by MRI

11:27 B-0948

B.J.U. Hensen, A. Thorenz, R. Chen, M. Meier, A. Klos, F. Wacker, D. Hartung, F. Güler, K. Hüper; Hannover/DE

11:42 B-0940

Treatment of murine colon tumours using gold nanoparticles and localised hyperthermia

F. Giganti, N. Petrides, C. Moore, M. Emberton, C. Allen, A. Kirkham; London/UK

11:35 B-0949

B.-F. Lee, N.-T. Chiu; Tainan/TW

11:50 B-0941

The variability of prostate cancer volume by multiparametric MRI (mpMRI): results from an active surveillance cohort

Accuracy of multiparametric MRI in detection and extension of high-grade prostate cancer using PIRADS version 2 criteria N. Demany, V. Tissot, J. Ognard, A. Valeri, D. Ben Salem; Brest/FR

USPIO-labeling in M1 and M2 macrophage population: an in vitro MR study

11:43 B-0950

C. Zini1, M. Venneri1, S. Miglietta1, M. Rengo1, N. Porta2, A. Isidori1, V. Petrozza2, A. Laghi1; 1Rome/IT, 2Latina/IT

Low PI-RADS scores exclude extracapsular extension of prostate cancer: a histology validated study including 301 operated patients S. Alessi, P. Pricolo, P. Summers, E. Tagliabue, G. Petralia; Milan/IT

10:30–12:00

Studio 2016

Genitourinary SS 1407

11:51 B-0951

Multi-parametric MR of prostate cancer: an update

Validation of 3T MRI including diffusion-weighted imaging for nodal staging of newly diagnosed intermediate- and high-risk prostate cancer C.M. von Below; Uppsala/SE

Moderators: D. Junker; Innsbruck/AT, J.C. Vilanova; Girona/ES

10:30–12:00

10:30 K-26

Keynote lecture

Room E1

Musculoskeletal

J.C. Vilanova; Girona/ES

10:39 B-0942

SS 1410 Comparison of the prostate imaging reporting and data system version 1 and 2 in a cohort of 245 patients with histopathological and long term follow up P.J.L. De Visschere, E. Pattyn, P. Ost, T. Claeys, G. Villeirs; Gent/BE

10:47 B-0943

Does PI-RADS version 2 perform better than version 1.0 in the classification of prostate lesions in mpMRI?

Head-to-head comparison of PI-RADS v1 and v2 in prostate lesions biopsied by MR-guided in-bore biopsy S. Polanec, H. Bickel, D. Georg, K. Pinker Domenig, M. Susani, T.H. Helbich, P.A.T. Baltzer; Vienna/AT

11:03 B-0945

Moderators: A. Cotten; Lille/FR, N.N.

10:30 B-0952

10:38 B-0953

10:46 B-0954

Metal artefact reduction capacity of virtual monochromatic dual-layer detector spectral CT-imaging in unilateral and bilateral total hip prostheses R.H.H. Wellenberg1, M.F. Boomsma1, J.A.C. van Osch1, A. Vlassenbroek2, J. Milles3, M.A. Edens1, G.J. Streekstra4, M. Maas4, C.H. Slump5; 1Zwolle/NL, 2Brussels/BE, 3Eindhoven/NL, 4 Amsterdam/NL, 5Enschede/NL

Influence of the PI-RADS version on the scoring of prostatic lesions

Multiparametric magnetic resonance imaging of prostate cancer: diagnosis and stratification of patients with PIRADS 3 pattern through a multivariate statistical analysis

Effects of contrast enhancement on phantom-less bone mineral density measurements in computed tomography N. Abdullayev1, V.-F. Neuhaus1, G. Bratke1, S. Voss1, A. Wulff2, D. Maintz1, J. Borggrefe1; 1Cologne/DE, 2Quakenbrück/DE

P. Asbach, H. Cash, B. Hamm, M. Haas; Berlin/DE

11:11 B-0946

Can we predict who can benefit from axial-loaded MRI? T. Lorenc, P. Palczewski, D. Wojcik, M. Golebiowski; Warsaw/PL

S. Lucarini1, L. Noferini1, L.N. Mazzoni2, L. Galastri1, S. Busoni1, I. Menchi1; 1Florence/IT, 2Siena/IT

10:55 B-0944

Applications in CT and MR: something old, something new

10:54 B-0955

Clinical evaluation of a commercially available algorithm for metal artefact reduction for CT in patients with orthopaedic implants D. Schmitz, R. Seidel, R. Dabew, A. Buecker; Homburg/DE

V. Panebianco; Rome/IT

11:19 B-0947

11:02 B-0956 Multiparametric MRI in the follow-up of low-risk prostate cancer patients on active surveillance A.R. Padhani1, G. Petralia2, H. Sokhi3, F. Sanguedolce4, N. Anyamene1, G. Hellawell5; 1Northwood/UK, 2Milan/IT, 3Uxbridge/UK, 4 Northampton/UK, 5Harrow/UK

314

ECR 2016 | Final Programme

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Intra-subject comparison of 3 metal artifact reduction techniques for MDCT of arthroplasty implants V. Kalia1, M.K. Fuld2, S.R. Raman2, E.K. Fishman2, J. Fritz2; 1Burlington, VT/US, 2Baltimore, MD/US

www.myESR.org

Scientific Sessions

11:10 B-0957

Image quality of iterative reconstructions compared with filtered back projection in cervical spine CT

10:54 B-0966

M. Geijer1, T. Malmquist1, S. Götestrand1, E. Gunnlaugsson1, A. Löve2, H. Geijer3; 1Lund/SE, 2Reykjavik/IS, 3Örebro/SE

11:18 B-0958

The role of contrast enhanced computed tomography in the diagnosis of necrotising fasciitis and comparison with the laboratory risk indicator for necrotising fasciitis (LRINEC)

Y. Li, J. Lin, H. Li, Y. Bao; Shanghai/CN

11:02 B-0967

F. Carbonetti, A. Cremona, V. Carusi, M. Guidi, M. Di Girolamo, E. Iannicelli, G. Francione, V. David; Rome/IT

11:26 B-0959

Application of DTI in the evaluation of peripheral nerve tumours and in the preoperative planning of surgical intervention

11:10 B-0968

11:18 B-0969 Role of diffusion tensor imaging and tractography of median nerve as a quantitative method in diagnosing carpal tunnel syndrome (CTS)

R. Giggens, K. Partington; Oxford/UK

11:50 B-0962

Low-dose full-spine CT with iterative model reconstruction (IMR) algorithm in children with scoliosis A.-N. Hu1, Y. Jiang2, B. Zhu1; 1Nanjing/CN, 2Shanghai/CN

10:30–12:00

11:34 B-0971

11:42 B-0972

Interpretation and clinical use of amide proton transfer imaging signal MTRasym(3.5ppm) in acute ischemic stroke

11:50 B-0973

Cerebral whole brain CT-Perfusion with single rotation angiography (srCTA) of the neck - evaluation of a one-stop-shopping CT stroke protocol S. Wong, L. De-Paoli, K. Hausegger; Klagenfurt/AT

10:30–12:00

Room F2

Abdominal Viscera CT perfusion CBV and blood-brain barrier permeability measured in infarct core and ischaemic penumbra of acute ischemic stroke patients with haemorrhagic transformation

Predictive value of small vessel occlusions detected by CT perfusion-based wavelet-transformed angiography in patients with acute ischemic stroke W.G. Kunz, W.H. Sommer, B. Ertl-Wagner, O. Dietrich, L. Havla, M.F. Reiser, K.M. Thierfelder; Munich/DE

SS 1401

Advances in abdominal MRI Moderators: A.J. van der Molen; Leiden/NL, N.N.

10:30 B-0974

Evaluation of hypointense liver lesions during hepatobiliary phase MR imaging in normal and cirrhotic livers: is increasing flip angle reliable? Y.-D. Xiao; Changsha/CN

10:38 B-0975

A short breath-hold high-resolution technique may be the first step to overcoming degraded hepatic arterial phase in liver MR imaging: a prospective randomised control study C.-H. Lee, J. Kim, J. Yoo, Y. Park, C. Park; Seoul/KR

www.myESR.org

Final Programme | ECR 2016

315

Saturday

Cerebrovascular disease (4)

A. Clarizia, E. Raimondi, G. Di Cecco, E. Groppo, A. Bernardoni, A. Saletti, M. Giganti, E. Fainardi; Ferrara/IT

10:46 B-0965

Patient selection using the e-ASPECTS software for automated detection of acute ischaemic stroke on a mobile stroke unit I. Grunwald1, A. Kühn2, K. Fassbender3; 1Chelmsford/UK, 2Worcester, MA/US, 3Homurg/DE

X. Luo1, M. Chen1, J. Zhou2; 1Beijing/CN, 2Baltimore, MD/US

10:38 B-0964

Amigo: a new tool to report functional MRI of cerebrovascular reserve E. Condamine, O. Heck, N. Boudiaf, T. Perret, J. Pietras, C. Remy, A. Krainik; Grenoble/FR

Room E2

Moderators: D. Bos; Rotterdam/NL, C. Calli; Izmir/TR

10:30 B-0963

Imaging the remodeling of ipsilateral internal capsule following focal cerebral ischemia in rats by DKI X. Zhang, Y. Yang, L. Yin, X. Hao, J. Tian; Shanghai/CN

Neuro SS 1411a

Perivascular spaces in the hippocampus are associated with markers of vascular disease only, and not of Alzheimer´s disease D. Van Westen, C. Panizo, L. Minthon, S. Palmqvist, O. Hansson; Lund/SE

11:26 B-0970 Whole-body MRI: can it be used as a screening tool in multiple hereditary exostoses (MHE) and Ollier disease?

Diagnostic accuracy of whole-brain CT perfusion in MRI-confirmed infratentorial infarctions K.M. Thierfelder, C. Bollwein, B. Ertl-Wagner, L. von Baumgarten, H. Janssen, M.F. Reiser, W.H. Sommer; Munich/DE

M.M.H. Abd Ellah, C. Kremser, F. Cartez-Zumelzu, E. Gizewski, A. Klauser; Innsbruck/AT

11:42 B-0961

Advanced virtual monoenergetic reconstruction of unenhanced head CT for detection of intracranial hemorrhage: optimisation of kiloelectron volt settings to improve image contrast J.-E. Scholtz, M.H. Albrecht, S. Martin, S. Mahmoudi, C. Frellesen, R.W. Bauer, T.J. Vogl, J.L. Wichmann; Frankfurt a. Main/DE

L. Patriarca, S. Mariani, A. La Marra, F. Arrigoni, A. Barile, C. Masciocchi; L’Aquila/IT

11:34 B-0960

Cerebral blood flow measured by 3D arterial spin labelling MRI in MELAS patients with m.3243A>G mutation: a preliminary study

Scientific Sessions

10:46 B-0976

10:30–12:00 Impact of CAIPIRINHA VIBE on interobserver agreement in comparison with conventional VIBE sequences in contrast-enhanced MRI of focal liver lesions

Chest SS 1404 10:30 K-25

Gadoxetic acid-enhanced MR-imaging in chronic liver disease - correlation of perfusion parameters and hepatic uptake function with histology B. Leporq1, J.-L. Daire1, C. Pastor2, C. Sempoux3, R. Meuli3, P. Deltenre3, B. van Beers1, S. Schmidt3; 1Paris/FR, 2Geneva/CH, 3Lausanne/CH

11:02 B-0978

Influence of different contrast agent application protocols on transient severe motion (TSM) at gadoxetate disodium-enhanced MRI K.I. Ringe, C. von Falck, H.-J. Raatschen, F. Wacker, J. Hinrichs; Hannover/DE

11:10 B-0979

Impact of injection protocol on arterial tumour enhancement, artifacts, and arterial blood gases in rabbit VX2 tumour model: comparison of Gd-EOBDTPA and Gd-DTPA

10:39 B-0985

Measuring liver fat content on MRI: the effect on accuracy of simplified sampling protocols

Quantification of liver proton-density fat fraction in ultra-high-field MR systems: magnitude and complex fitting approach J.-P. Kühn, C. Mahlke, B. Mensel, M.-L. Kromrey, N. Hosten; Greiswald/DE

11:34 B-0982

Quantitative MR imaging of hepatic steatosis: validation in ex vivo human livers P. Bannas1, H. Kramer2, D. Hernando3, R. Agni3, U. Motosugi3, S.D. Sharma3, L. Fernandez3, G. Adam1, S.B. Reeder3; 1Hamburg/DE, 2 Munich/DE, 3Madison, WI/US

11:42 B-0983

C. Ludes; Strasbourg/FR

10:47 B-0986

Radiation dose reduction with 320-row sequential wide-volume over helical acquisitions in chest CT: a prospective study in an ultra-low-dose setting E. Meyer1, A. Labani1, F. Severac1, M.-Y. Jeung1, C. Ludes1, A. Meyer1, K. Haouin2, C. Roy1, M. Ohana1; 1Strasbourg/FR, 2Puteaux/FR

10:55 B-0987

11:03 B-0988

Effect of tin filtration on image quality and radiation dose: preliminary experience with a third-generation dual-source CT system in 133 adult patients

Image quality and sharpness of ground-glass nodules on ultralow-dose CT at 0.3 mSv using Tin filtration: comparison of five iterative reconstruction strengths V. Ai1, R. Wong1, K. Otani2, W. Chin3, S. Lau1, L. Leung1, G. Lo1; 1 Hong Kong/HK, 2Tokyo/JP, 3Singapore/SG

11:11 B-0989

Detection of artificial pulmonary lung nodules in ultralow-dose CT using an ex vivo lung phantom C.A. Burgard, T. Gaaß, D. Bondesson, M.F. Reiser, J. Dinkel; Munich/DE

11:19 B-0990

Optimum slice-based MRI estimates of visceral adipose tissue volumes in patients with excess weight: influence of gender, age and BMI range A. Schaudinn, N. Linder, N. Garnov, M. Blüher, T. Karlas, A. Dietrich, T. Schütz, T. Kahn, H. Busse; Leipzig/DE

11:50 B-0984

Ultra low dose unenhanced chest CT with iterative reconstruction: should we acquire it at 80kV or 135kV? A qualitative and quantitative prospective study on 51 patients

R. Daghistani, S. Khung, J.-B. Faivre, A. Duhamel, J. Rémy, M. Remy-Jardin; Lille/FR

J. Sun, A.J. Procter, P. Malcolm, A. Toms; Norwich/UK

11:26 B-0981

Keynote lecture J. Neuwirth; Prague/CZ

T. Tsuboyama1, J. Gregor2, T. Kim1, M. Hori1, H. Onishi1, M. Tatsumi1, M. Sakane1, P. Hubertus2, N. Tomiyama1; 1Suita/JP, 2Berlin/DE

11:18 B-0980

Chest CT dose reduction Moderators: T. Henzler; Mannheim/DE, D. Tack; Baudour/BE

M.H. Albrecht, J.L. Wichmann, B. Bodelle, P. Dewes, A.M. Bucher, R.W. Bauer, S. Zangos, T. Lehnert, T.J. Vogl; Frankfurt a. Main/DE

10:54 B-0977

Room D1

Equal delineation of mediastinal, hilar, and peripheral lymph nodes at 64-row-MDCT of the chest with a one-millisievert protocol when compared with standard dose U.G. Mueller-Lisse, L. Marwitz, A. Tufman, R. Huber, M.F. Reiser, M. Paolini; Munich/DE

11:27 B-0991

The application of kV assist in low-dose chest CT screening Z.-L. Zhang; Beijing/CN

Monitoring of abdominal fat compartments by magnetic resonance imaging in obese subjects during a low-calorie weight-loss program

11:35 B-0992

J.-P. Kühn, M.-L. Kromrey, L. Vogt, C. Mahlke, J. Mayerle, M. Lerch, N. Hosten; Greiswald/DE

Chest CT for airway stent evaluation in patients with malignant tracheal stenosis with iterative reconstruction algorithms T. Li1, Z. Yonggao1, J. Yan2, G. Jianbo1; 1Zhenzhou/CN, 2Shanghai/CN

11:43 B-0993

Image quality of CT pulmonary angiography at reduced radiation exposure and contrast material volume using iterative model image reconstruction and iDose4 technique in comparison to FBP A. Laqmani1, S. Butscheidt1, M. Kurfürst1, J. Schmidt-Holtz1, C. Behzadi1, S. Sehner1, H. Nagel2, G. Adam1, M. Regier1; 1Hamburg/DE, 2 Buchholz/DE

316

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

11:51 B-0994

Spine evaluation in 70 kV thoracic CT: dose effectiveness and image quality

11:34 B-1003

C. Polkowski, B. Bodelle, T.J. Vogl; Frankfurt a. Main/DE

10:30–12:00

SS 1409

T.J. Vogl1, S. Koch1, B. Gebauer2, W. Willinek3, C. Engelke4, R. Brüning5, F. Wacker6, A. Enk7; 1Frankfurt a. Main/DE, 2Berlin/DE, 3Trier/DE, 4 Göttingen/DE, 5Hamburg/DE, 6Hannover/DE, 7Heidelberg/DE

Room D2

Interventional Radiology

11:42 B-1004

Intra-arterial therapies in the liver Moderators: R.F. Dondelinger; Liège/BE, C. Schmid-Tannwald; Munich/DE

10:30 B-0995

Yttrium-90 radioembolisation for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response

Unresectable isolated hepatic metastases from uveal melanoma: treatment with chemosaturation with percutaneous hepatic perfusion of melphalan

Transarterial chemoembolisation (TACE) treatment of liver metastases: intraprocedural volume measurement by FAST C-arm-CT during treatment T.J. Vogl, F. Dörr, S. Zangos, N.N.N. Naguib; Frankfurt a. Main/DE

11:50 B-1005

Tace of liver metastases from CR cancer with DEBIRI tecniquein association with CHT: five years of our experience and follow-up G. Scevola, M. Rastelli, G. Loreni; Rome/IT

C. Rosenbaum, A. van den Hoven, M. Braat, M. Koopman, M. Lam, B. Zonnenberg, H. Verkooijen, M. van den Bosch; Utrecht/NL

10:30–12:00 10:38 B-0996

Selective internal radiation therapy in patients with progressing neuroendocrine liver metastases C. Ebeling Barbier, U. Garske-Roman, M. Sandström, R. Nyman, D. Granberg; Uppsala/SE

10:46 B-0997

Radiographers SS 1414

Reduced peri-procedural analgesia following replacement of water for injection (WFI) with glucose 5% (G5) as the infusion medium for 90yttrium resin microspheres

Trends for using lipiodol-Doxorubicin vs drugeluting beads-Doxorubicin for transarterial chemoembolisation in hepatocellular carcinoma: a single-centre experience A.S. Moustafa, A.M.K. Abdel Aal, D. Redden, S. Saddekni, D. Dubay; Birmingham, AL/US

10:30 B-1006

Surgical resection versus radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolisation in the treatment of single large hepatocellular carcinoma A. Posa, R. Iezzi, G. Coppola, E.G.M. Antonuccio, A. Gasbarrini, L. Bonomo; Rome/IT

11:10 B-1000

L.P. Ribeiro, I. Bodião, O. Lesyuk, A.F.C.L. Abrantes, R.P.P. Almeida, J.P. Pinheiro; Faro/PT

10:38 B-1007

P. Hogan, J. Lowe; Dublin/IE

10:46 B-1008

An investigation into the effectiveness of common cleaning wipes in removing infection control risks from radiographic cassettes M.J. Mann, K. Szczepura, A. England; Manchester/UK

10:54 B-1009

Radiation exposition of staff in SIRT: a proposal for a better ß radiation protection

11:02 B-1010

Development in radiological department practices: an analysis of clinical audits in the years 2002 - 2014

Survey on patient safety culture: an approach into imaging departments K.B. Azevedo, E. Bernardino, A.F.C.L. Abrantes, A.M. Ribeiro, C.A. da Silva, R.P.P. Almeida, N.M. Pinto, L.P. Ribeiro; Faro/PT

Single-session combined radiofrequency ablation and transarterial chemoembolisation in the treatment of hepatocellular carcinoma

11:10 B-1011

A.M. Gabr1, M.A. Dawoud1, R.E. Mohamed1, M.S. El Waraki2; 1Tanta/EG, 2 Shebin El Koum/EG

11:26 B-1002

An investigation of radiography staff uniforms as vectors for infection: comparing home-laundering processes with hospital-laundering

K. Miettunen1, E. Metsälä2; 1Vantaa/FI, 2Helsinki/FI

R. Adamus, E. Guni, R. Loose; Nuremberg/DE

11:18 B-1001

Work-place related ergonomic conditions as prognostic factors for work-related musculoskeletal disorders (WRMD) in radiographers

Local hepatic tumour control in patients with HCC undergoing transarterial lipiodol embolisation followed by microwave ablation R. Seidel, A. Massmann, P. Fries, G. Schneider, A. Buecker; Homburg/DE

www.myESR.org

Complementary alternative medicine (CAM) to reduce MRI anxiety S.I. Glenn; Portland, OR/US

11:18 B-1012

The radiographers’ role in information giving prior to consent for computed tomography scans: a crosssectional survey L.C. Hadley, D. O’Leary, T. Watson; Hertfordshire/UK

Final Programme | ECR 2016

317

Saturday

11:02 B-0999

Safety and patient care in medical imaging Moderators: A. Henner; Oulu/FI, D. Miletić; Rijeka/HR

K.J. Paprottka, S. Lehner, W.P. Fendler, H. Ilhan, A. Rominger, W. Sommer, D.A. Clevert, M.F. Reiser, P.M. Paprottka; Munich/DE

10:54 B-0998

Room G

Scientific Sessions

11:26 B-1013

Patient participation in MRI: patient experiences and image quality addressing breath-hold acquisitions

11:18 B-1023

E.M. Funk, A. Anderzen-Carlsson, P. Thunberg; Örebro/SE

11:34 B-1014

D. Park, J. Park, J. Lee, Y. Choi, J. Baek; Seoul/KR

Evaluation of magnetic resonance acoustic noise in 1.5 and 3 Tesla scanners V.M. Silva, I. Ramos, J. Moreira, M. Marques; Porto/PT

11:42 B-1015

Papillary thyroid cancer: optimal scan delay for contrast-enhanced CT in detecting lateral lymph node metastasis by quantitative assessment of enhancement

11:26 B-1024

Patient perceptions of radiographer communication skills

Which nodules should have repeat biopsies: the role of thyroid imaging and reporting system (TI-RADS) in cases of nodiagnostic cytology M.A. Öztek, K. Çeken, G.A. Ocak, A. Dablan, E. Durmaz, A. Kabaalioğlu, E.I. Gürer, A. Apaydın, T. Sindel; Antalya/TR

J. Vieira, L.P. Ribeiro, R.P.P. Almeida, A.F.C.L. Abrantes; Faro/PT

11:50 B-1016

11:34 B-1025 First year radiography students’ perceptions of professionalism T. Kukkes1, V. Challen2, Z. Läänelaid1; 1Tartu/EE, 2Lancaster/UK

10:30–12:00

Room M 1

Head and Neck SS 1408

Thyroid nodules Moderators: K.S.S. Bhatia; Shatin/HK, N.N.

10:30 B-1017

The role of core needle biopsy as first-line in diagnosis for initially detected thyroid nodules: core needle biopsy could achieve highly diagnostic yield H. Kim, Y. Kim, J. Seo, J. Lee, H. Han, K. Kim, S. Park; Daejeon/KR

11:42 B-1026 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

11:50 B-1027

Sonographic assessment of thyroid nodules: a comparison of current guidelines

Perfusion analysis in malignant and benign thyroid lesions: analysis of microvascularisation in contrastenhanced ultrasound (CEUS) I. Wiesinger, E. Kroiss, C. Stroszczynski, E.M. Jung; Regensburg/DE

Thyroid ultrasound in patients with chronic hepatitis C treated with interferon alpha A. Bianek-Bodzak, K. Skrobisz- Balandowska, L. Obolonczyk, K. Sworczak; Gdansk/PL

P. Navin, A.M. Egan, B. Hutchinson, D. Bergin, M. Bell, J. Bruzzi; Galway/IE

10:38 B-1018

10:30–12:00 The assessment of thyroid imaging reporting and data system (TIRADS) in malignancy risk stratification

Oncologic Imaging SS 1416

P. Priedītis, M. Tirāne, K. Stepanovs, M. Radziņa, M. Rauda, I. Štrumfa, M. Sperga; Riga/LV

10:46 B-1019

Malignancy risk stratification of multinodular Goitre: a retrospective review of ultrasound features and their impact on histopathology and cancer risk

Relationship between elasticity imaging and ultrasonography in the assessment of the thyroid nodule

10:30 B-1028

Ultrasound features of conventional papillary thyroid carcinoma and follicular variant papillary thyroid carcinoma

10:38 B-1029

Contrast enhanced ultrasound in diagnosis of solitary thyroid nodules, preliminary study on papillary cancer P. Prieditis, M. Radzina, I. Strumfa, Z. Narbuts, A. Ozolins, A. Vanags; Riga/LV

Role of MR imaging in selection of patients with cervical cancer for abdominal radical trachelectomy Z. Jiang, X. Ju, W. Peng, B. Yu; Shanghai/CN

10:46 B-1030

N.M. Hughes, J. Barry, L. Feeley, P. Sheahan; Cork/IE

11:10 B-1022

MpMRI of endometrial adenocarcinoma: association of the ADC histographic analysis and MRI tumour volumetry with histological features of biologic aggressiveness E. Venturini, M. Jannone, A. Palmisano, F. Giganti, A. Esposito, G. Mangili, M. Candiani, A. Del Maschio, F. De Cobelli; Milan/IT

F.J. Campoy-Balbontín, M.C. Jurado-Gómez, J.C. Pérez-Tejada, C. Almeida-Gonzalez, R. Aznar-Méndez; Sevilla/ES

11:02 B-1021

Pelvic and breast cancer Moderators: O. Abeyakoon; Cambridge/UK, B. Klumpp; Tübingen/DE

B.S. Kelly; Dublin/IE

10:54 B-1020

Room M 2

Pre-operative DWI MRI and PET studies of uterine cervical cancer lesions: added value of combined quantitative and volumetric analysis P.A. Bonaffini, C. Crivellaro, M. Cuzzocrea, A. Casiraghi, D. Ippolito, C. Talei Franzesi, C. Landoni, S. Sironi; Monza/IT

10:54 B-1031

Three-dimensional contrast enhanced ultrasound in treatment prediction for breast cancer: comparison with dynamic contrast-enhanced magnetic resonance imaging and pathology M. Chen, W. Jia, L. Tang, W.-M. Chai, D.-B. Wang, X.-C. Fei, J.-R. He, W.-P. Wang; Shanghai/CN

318

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

11:02 B-1032

Method of contour analysis of neoplasms in x-ray mammograms

10:54 B-1042

V. Sevastyanov, E. Romanycheva, Y. Furman; Yoshkar-Ola/RU

11:10 B-1033

Can contrast-enhanced ultrasound features of metastatic axillary lymph nodes reflect biological performances of primary breast cancer?

L. Li, J. Gao, J. Liu; Zhengzhou/CN

11:02 B-1043

Urinary bladder mass: histopathological and cell type prediction by apparent diffusion coefficient H.M.K. Imam, D.A. Hameed, G.S. Seifeldein, E.M. Moussa, R.S. Al Johi; Assuit/EG

11:26 B-1035

USPIO-enhanced MRI as a potential predictor of tumour aggressiveness P. Seyfer1, C. Hengl1, A.H. Mahnken1, J.T. Heverhagen2; 1Marburg/DE, 2 Berne/CH

11:34 B-1036

11:42 B-1037

11:10 B-1044

11:18 B-1045

11:26 B-1046

Whole body diffusion-weighted MRI for tumour characterisation, staging and prediction of complete resection in ovarian carcinoma: a comparison with CT

Whole-body diffusion-weighted magnetic resonance imaging for staging of women with cancer during pregnancy: a pilot study

Room M 3

Vascular

Moderators: N.N.

10:30 B-1039

Intermittent contrast injection method for triple rule out computed tomography T. Fujikawa, K. Ishida, H. Nobusawa, S. Yamamoto, S. Sasaguri; Kawasaki/JP

10:38 B-1040

CT measured pulmonary artery trunk diameter in a rheumatoid arthritis population without pulmonary hypertension: association with disability and disease activity T.S. Vieira, C. Esteves, M. Bernardes, A. Sá Pinto, D. Gonçalves, J.G. Pereira; Porto/PT

11:50 B-1049

Embolisation of pulmonary arterio-venous malformations using hydrogel-coated coils mid-term results J.-P. Pelage, A. Letellier, V. Le Pennec, M.-A. Jegonday, A. Fohlen; Caen/FR

Individually tailored contrast enhancement in CT pulmonary angiography B.M.F. Hendriks, M. Kok, C. Mihl, J.E. Wildberger, M. Das; Maastricht/NL

10:46 B-1041

Suction/inspiration against resistance: a new breathing technique to improve contrast density within the pulmonary artery A. Gutzeit; Zurich/CH

www.myESR.org

Final Programme | ECR 2016

319

Saturday

11:42 B-1048

Pulmonary vasculature: new and improved

Quantitative evaluation of linear models to estimate CT-perfusion from single-acquisition dual-energy iodine maps acquired at peak tissue enhancement S. Skornitzke, F. Fritz, M. Koell, P. Mayer, J. Hansen, G. Pahn, M. Klauß, H.-U. Kauczor, W. Stiller; Heidelberg/DE

R. Dresen, S. Han, K. Michielsen, F. De Keyzer, F. Amant, V. Vandecaveye; Leuven/BE

SS 1415

Cardiac and hemodynamic effect of arterial obstruction in cancer-related acute pulmonary embolism J. Plasencia-Martínez1, A. Carmona-Bayonas1, D. Calvo-Temprano2, P. Jiménez-Fonseca2, M. Benegas-Urtega3, M. Sánchez-González3, D. Varona-Porres3, D. Martínez-de-la-Haza3, S. Hernández-Muñiz4; 1 Murcia/ES, 2Oviedo/ES, 3Barcelona/ES, 4Madrid/ES

11:34 B-1047

10:30–12:00

Contrast-enhanced MRI for quantitative lung perfusion imaging using the dual-bolus approach: comparison of three different contrast agents and recommendation of feasible doses S. Veldhoen1, M. Oechsner2, A. Fischer1, A.M. Weng1, A.S. Kunz1, T.A. Bley1, H. Köstler1, C.O. Ritter3; 1Würzburg/DE, 2Munich/DE, 3 Göttingen/DE

K.L.M. Michielsen1, I. Vergote1, R. Vanslembrouck1, E. Mussen1, F. Amant1, K. Leunen1, F. De Keyzer1, G. Souverijns2, V. Vandecaveye1; 1 Leuven/BE, 2Hasselt/BE

11:50 B-1038

Chronic thromboembolic pulmonary hypertension: cone beam computed tomography vs. 64-row multidetector computed tomography J.B. Hinrichs, J. Renne, M.M. Hoeper, K. Olsson, F. Wacker, B.C. Meyer, C. von Falck; Hannover/DE

Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer: initial results L.M. Sawicki1, J. Grueneisen2, B. Schaarschmidt1, C. Buchbender1, P. Heusch1, V. Ruhlmann2, L. Umutlu2, G. Antoch1, S. Kinner2; 1 Düsseldorf/DE, 2Essen/DE

Automated 3D MRI volumetry of the pulmonary arteries for predicting pulmonary hypertension has excellent intra- and interobserver agreement C. Melzig1, S. Wörz1, S. Ley2, C. Fink3, S. Partovi4, K. Rohr1, H.-U. Kauczor1, E. Grünig1, F. Rengier1; 1Heidelberg/DE, 2Munich/DE, 3 Celle/DE, 4Cleveland, OH/US

W. Jia, J.-n. Shi, X.-c. Fei, K.-w. Shen, M. Chen; Shanghai/CN

11:18 B-1034

The feasibility of body-weight and BMI based individualised protocol in CT pulmonary angiography

Scientific Sessions

10:30–12:00

Room M 4

Neuro SS 1411b

11:42 B-1059

Cerebral tumours (2)

A. Zikou, G. Alexiou, A. Goussia, P. Kosta, V. Xydis, M. Argyropoulou I; Ioannina/GR

Moderators: J. Gillard; Cambridge/UK, S. Looby; Dublin/IE

10:30 B-1050

Differentiation between high-grade gliomas and metastatic brain tumours using diffusion tensor imaging metrics

11:50 B-1060

Evaluation of vascular permeability in gliomas by dynamic susceptibility contrast (DSC) method using “K2” value and histogram analysis

Multiparametric analysis of follow-up of low grade gliomas: comparison between perfusion and diffusion MR and F-DOPA PET M. Rossi Espagnet, A. Romano, V. Mancuso, F. Tavanti, F. Cicone, C. Scaringi, A. Bozzao; Rome/IT

A.E.E. El-Morsy, L.G. El-Serougy, A.A.k.A. Razek, A.E. Mousa, H.F. Eldawoody; Al Monsoura/EG

10:38 B-1051

The role of diffusion tensor imagin (DTI) and dynamic susceptibility perfusion (DSP) MRI in the evaluation of meningioma grades and subtypes

10:30–12:00

Room M 5

Breast

T. Taoka, H. Kawai, T. Nakane, S. Naganawa; Nagoya/JP

SS 1402b 10:46 B-1052

A preliminary study for differential diagnosis of brain mass: quantitative evaluation from asymmetric magnetization transfer ratio (MTRasym) by amide proton transfer imaging J. Chu1, X. Li1, J. Zhao1, X. Yan2, Y. Wang1; 1Guangzhou/CN, 2 Shanghai/CN

10:54 B-1053

11:02 B-1054

Moderators: M. Bernathova; Vienna/AT, L.J. Pina Insausti; Pamplona/ES

10:30 B-1061

Brain F-18Fluorocholine PET and the correlation between MRI in the diagnosis and follow-up of gliomas S. Bonilla Saborido, E. Granell Moreno, F. Nuñez Marín, A. Lozano Martinez, M. Camacho Marti, A. Fernandez Leon, B. Gomez Ansón; Barcelona/ES

Contrast-spectral mammography and MRI update in background parenchymal enhancement

Contrast enhanced spectral mammography (CESM) as first exam in symptomatic patients: a monocentric prospective study on 226 patients J. Smadja, C. Balleyguier, J. Arfi-Rouche, M.-C. Mathieu, C. Mazouni, S. Delaloge, A. Dunant, C. Dromain; Villejuif/FR

10:38 B-1062

Monitoring neo-adjuvant chemotherapy: comparison of contrast-enhanced spectral mammography (CESM) and MRI versus breast cancer characteristics V. Iotti1, S. Ravaioli1, R. Sghedoni1, C. Coriani1, R. Vacondio1, S. Caffarri2, A. Nitrosi1, G. Tondelli3, P. Pattacini1; 1Reggio Emilia/IT, 2Guastalla/IT, 3 Scandiano/IT

Potential role of quantitative MRI assessment in differentiating high from low-grade gliomas E.A.S. Geneidi, L.A. Habib, N.A. Chalabi; Cairo/EG

11:10 B-1055

Quantification of diminished glioma volume following neurosurgical resection and correlation to survival

10:46 B-1063

M.S. Jochelson, D.D. Dershaw, J.S. Sung, M.C. Hughes, D.A. Goldman, C.S. Moskowitz, D.A. Mangino, M.E. Robson, E.A. Morris; New York, NY/US

A. Blomstergren, A. Rydelius, J. Lätt, J. Bengzon, P.C. Sundgren; Lund/SE

11:18 B-1056

10:54 B-1064 A pilot study of differentiating different intraaxial brain tumours: quantitative evaluation of multiparameters from diffusion kurtosis imaging in tumour parenchyma J. Chu1, Y. Wang1, J. Zhao1, X. Yan2, X. Li1; 1Guangzhou/CN, 2 Shanghai/CN

11:26 B-1057

11:34 B-1058

Place of value of integrated [18F] FDG-PET/MRI in cerebral staging of NSCLC patients C. Deuschl1, F. Nensa1, J. Grueneisen1, P. Heusch2, T. Poeppel1, M. Forsting1, L. Umutlu1, M. Schlamann3; 1Essen/DE, 2Düsseldorf/DE, 3 Gießen/DE

320

ECR 2016 | Final Programme

Contrast-enhanced spectral mammography in recalls from the breast cancer screening program: validation of results in a larger multireader, multicase study U. Lalji1, S. Gommers1, M. van Goethem2, S. Vanwetswinkel1, R. Pijnappel3, P. Nelemans1, M. Smidt1, J.E. Wildberger1, M. Lobbes1; 1 Maastricht/NL, 2Antwerp/BE, 3Utrecht/NL

11:02 B-1065

The role of MR-perfusion in the follow-up of primitive cerebral malignant neoplasms: single-center experience on 36 patients R. Pimentel Silva1, R. Senese2, F. Zeccolini2, F. Giurazza3, F.M. Giugliano2, R. Izzo2, M. Muto2; 1Lisbon/PT, 2Naples/IT, 3Rome/IT

Comparison of breast cancer screening with contrastenhanced mammography vs MRI

Pre-operative evaluation of breast cancer by contrast enhanced digital mammography S.A. Tawfik, N.M. Abdel Razek, Y.M. Tuhamy, O.Z. Youssif, A.E. Eissa; Cairo/EG

11:10 B-1066

Comparative study between tomosynthesis, contrast enhanced spectral mammography and breast ultrasound as complementary techniques in mammography of dense breasts M.M.H.H. Hanafy, R.M.K. Fouad, H.A.M.A. Azzam, A.A.Y. Youssef; Cairo/EG

www.myESR.org

Scientific Sessions

11:18 B-1067

Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer

14:32 B-1076

M. Moschetta, M. Telegrafo, T. Introna, L. Coi, L. Rella, A. Stabile Ianora, G. Angelelli; Bari/IT

11:26 B-1068

G. Pontone, D. Andreini, A. Annoni, M. Petullà, E. Russo, E. Innocenti, M. Guglielmo, S. Mushtaq, M. Pepi; Milan/IT

Repeated surgery in invasive lobular breast cancer after pre-surgical MRI: role of additional ductal carcinoma in situ and background parenchymal enhancement

14:40 B-1077

H. Preibsch, V. Richter, B.M. Wietek, M. Hahn, A. Staebler, K. Nikolaou, B. Wiesinger; Tübingen/DE

11:34 B-1069

Quantitative evaluation of background parenchymal enhancement (BPE) on breast MRI: a feasibility study with a semi-automatic and automatic software compared to observer-based scores

14:48 B-1078

2

2

2

1

1

C. You , C. Kaiser , A. Kaiser , J. Knaudt , Y.J. Gu , W.J. Peng , S.O. Schönberg2; 1Shanghai/CN, 2Mannheim/DE

11:50 B-1071

Background parenchymal enhancement as a predictor of breast cancer grade: a pilot study 1

1

2

Routine MDCT results in an increased diagnostic certainty and a therapeutic change in patients with suspected prosthetic heart valve dysfunction D. Suchá1, P. Symersky2, R.B.A. van den Brink2, W. Tanis3, M.F.L. Meijs4, J. Habets1, S.A.J. Chamuleau1, L.A. van Herwerden1, R.P.J. Budde5; 1 Utrecht/NL, 2Amsterdam/NL, 3The Hague/NL, 4Twente/NL, 5 Rotterdam/NL

The assessment of background parenchymal enhancement (BPE) in the high risk population: What causes BPE? 1

Using coronary CT angiography for guiding invasive coronary angiography: Potential role to reduce intraprocedural radiation exposure C.R.T. Arendt, P. Dewes, J.L. Wichmann, J.M. Kerl, T.J. Vogl, R.W. Bauer; Frankfurt a. Main/DE

B. Bignotti, A. Tagliafico, G. Tagliafico, L. Gristina, L. Cevasco, F. Valdora, A. Signori, S. Tosto, M. Calabrese; Genoa/IT

11:42 B-1070

Submillisievert computed tomography with MBIR before pulmonary veins radiofrequency catheter ablation of atrial fibrillation: impact on radiation exposure and outcome

14:56 B-1079 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

15:04 B-1080

1

S. Vreemann , A. Gubern-Mérida , C. Borelli , N. Karssemeijer , R.M. Mann1; 1Nijmegen/NL, 2Rome/IT

Ejection fraction and left-atrial diameter are predictors of NT-proBNP recovery after transcatheter aortic valve implantation J. Schmid, R. Maderthaner, K. Ablasser, T. Stojakovic, J.S. Binder, P. Rainer; Graz/AT

Reduction in risk of contrast-induced nephropathy (CIN) in Pre-TAVI CT coronary angiography using a novel low-volume, low-viscosity contrast protocol M. Crawford Jefferson, P. Donnelly, P. Ball; Belfast/UK

14:00–15:30

Room M 1

15:12 B-1081

Cardiac SS 1503

Interventional applications

M. Kantarci, R. Sade, H. Ogul, S. Sevimli, I. Tanboga, A. Colak, L. Karaca; Erzurum/TR

Moderators: D. Maintz; Cologne/DE, E. Pershina; Moscow/RU

14:00 B-1072

15:20 B-1082

S.R. Fuller, D. Caruso, M. Stroebel, P. Burghard, C.N. De Cecco, S. Mangold, C. Tesche, A. Varga-Szemes, U.J. Schoepf; Charleston, SC/US

14:08 B-1073

Aortic valve planimetry by high-resolution 3-dimensional MR image acquisition with a breathhold H. Kim, Y. Choe, S. Kim, M. Kim, Y. Kim, S.-J. Park; Seoul/KR

14:16 B-1074

D. Suchá1, P. Symersky2, L.M. de Heer1, W.P.T.M. Mali1, L.A. van Herwerden1, R.P.J. Budde3; 1Utrecht/NL, 2Amsterdam/NL, 3 Rotterdam/NL

14:00–15:30

Liver fibrosis: imaging assessment Moderators: F. Caseiro-Alves; Coimbra/PT, S.K. Venkatesh; Rochester, MN/US

14:00 B-1083

A. Palmisano, A. Esposito, S. Antunes, C. Colantoni, C. Bisceglia, F. Baratto, P. Della Bella, F. De Cobelli, A. Del Maschio; Milan/IT

14:24 B-1075

Room M 2

Abdominal Viscera SS 1501

Integrated electroanatomic mapping with threedimensional computed tomographic images for real-time guided ablations: comparison with standard procedure

Biological aortic heart valves deform after surgical implantation: a multidetector-row computed tomography study

Liver stiffness is better than serum biomarkers in liver fibrosis staging: study on surgical specimens in patients with chronic hepatitis B Q. Lu, Y. Luo, C.-L. Lu; Chengdu/CN

Comparison of transthoracic echocardiography versus cardiac magnetic for ICD therapy in primary prevention strategy dilated cardiomyopathy patients 1

1

1

1

1

G. Pontone , D. Andreini , A. Solbiati , M. Guglielmo , S. Mushtaq , A. Baggiano1, C. Rota1, A. Guaricci2, M. Pepi1; 1Milan/IT, 2Foggia/IT

14:08 B-1084

Real-time elastography (RTE): noninvasive diagnostic tool in evaluation of liver stiffness in patients with chronic viral hepatitis, correlated to biopsy M. Schiavone, D. Ippolito, C. Talei Franzesi, P. Bonaffini, S. Sironi; Monza/IT

www.myESR.org

Final Programme | ECR 2016

321

Saturday

Preoperative CT evaluation of minimally invasive Leipzig loop repair of the mitral valve apparatus: direct comparison with intra-surgical measurements

Left atrial appendage thrombus as a preventable cause of stroke: complex imaging modalities versus prone position MDCT

Scientific Sessions

14:16 B-1085

Accuracy of the QElaXto® shear wave technique for staging liver fibrosis

14:08 B-1095

G. Ferraioli, L. Maiocchi, R. Lissandrin, C. Tinelli, C. Filice; Pavia/IT

14:24 B-1086

A. Ismail, M. Abdulkadir Tabari; Kano/NG

14:16 B-1096

How many valid measurements are necessary to assess liver stiffness using 2D-SWE.GE? F.B. Bende, I. Sporea, A. Popescu, R. Sirli, R. Mare, R. Lupusoru; Timisoara/RO

14:32 B-1087

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:48 B-1089

The performance of 2D SWE.GE compared to transient elastography for the evaluation of liver stiffness: preliminary results

14:24 B-1097

Quantitative 3T MR imaging techniques for staging liver fat steatosis and fibrosis in chronic liver diseases: the HEPATOMAP protocol

14:32 B-1099

14:40 B-1100

Feasibility of different b values of MRI diffusion in quantitative assessment of liver fibrosis

14:48 B-1101

Fractionally encoded 3D MR elastography in nonalcoholic fatty liver disease: comparison with histological grading 14:56 B-1102 Coefficient of variation as imaging biomarker of hepatic fibrosis in chronic hepatitis B patients on Gd-EOB MRI; feasibility for prediction of HCC and comparison to clinical biomarker

1

1

1

2

1

1

1

J. Xu , X. Wang , Y. You , Q. Wang , H. Liu , J. Lei , H.D. Xue , Z.Y. Jin ; 1 Beijing/CN, 2Shanghai/CN

14:00–15:30

The effect of Dexamethasone on inflammatory response after uterine artery embolisation J. Kim, S. Kim, M. Kim, M. Shin, W. Shin, G. Kim, S. Park, J. Won, D. Lee; Seoul/KR

Gd-EOB-DTPA-enhanced MRI: perfusion and multihepatocyte-phase images for the evaluation of liver fibrosis induced by carbon tetrachloride in rats 1

Visceral artery aneurysms (VAA) single center case series in endovascular treatment using up-to-date materials, based on 11 patients during the past 2 years A. Pellegrin, P. Divis, V. Gavrilovic, M. Puppato, A. Vit, M. Sponza; Udine/IT

J. Lee, G. Lee, K.-H. Yoon, Y. Lee, J. Ryu, H. Jun, T.-H. Kim; Iksan City, Jeonbuk/KR

15:20 B-1093

Use of GnRH-agonist therapy in patients affected by uterine fibroids treated with uterine artery embolizstion: MRI evaluation of necrotic area reabsorption time and clinical outcome F. Smaldone, F. Ferrari, F. Arrigoni, A. Miccoli, S. Carducci, A. Giordano, C. Masciocchi; L’Aquila/IT

Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis

J.H. Runge1, L.P. Smits1, J. Verheij1, R. Sinkus2, A.J. Nederveen1, U.H. Beuers1, J. Stoker1; 1Amsterdam/NL, 2London/UK

15:12 B-1092

Longitudinal monitoring of hepatic blood flow before and after TIPS implantation using 4D-flow MRI P. Bannas1, A. Roldan-Alzate2, K.M. Johnson2, O. Ozkan2, U. Motosugi2, O. Wieben2, G. Adam1, S.B. Reeder2, H. Kramer3; 1 Hamburg/DE, 2Madison, WI/US, 3Munich/DE

L. Cuminal1, O. Beuf1, B. Leporq2, J. Dumortier1, S. Gaillard1, V. Hervieu1, O. Guillaud1, A. Muller1, P.-J. Valette1; 1Lyon/FR, 2Villeurbanne/FR

J. Chen, R. Gao, B. Song; Chengdu/CN

15:04 B-1091

Uterine artery embolisation for prevention and treatment of obstetric bleeding B. Abishev; Astana/KZ

M.A. ElRefaei1, M. Refaat2, M. ElTohamy1; 1Zagazig/EG, 2Benha/EG

14:56 B-1090

Prostatic artery embolization (PAE) for patients with high surgical risk, prostatic hyperplasia and users of permanent urinary catheter P. Largo Flores, K. Vivancos Costaleite, J. Cuesta Pérez, A. Friera Reyes; Madrid/ES

I. Sporea, F. Bende, A. Popescu, R. Sirli, R. Mare, R. Lupusoru; Timisoara/RO

14:40 B-1088

Dynamic and morphologic evaluation of erectile dysfunction on penile Doppler sonography and contrast cavernosography

Room M 3

15:04 B-1103

Effects on renal function of transcatheter embolisation in renal bleeding L. Spezia, C. Sozzi, A. Contro, G. Mansueto, R. Pozzi Mucelli; Verona/IT

15:12 B-1104

First experiences of prostatic artery embolisation for large benign prostatic hyperplasia ahead of a randomised controlled trial A. Massmann, M. Saar, G.K. Schneider, M. Stoeckle, S. Siemer, A. Buecker, C. Niklas; Homburg a.d. Saar/DE

Vascular SS 1515

New observations in visceral imaging and therapy Moderators: J.I. Bilbao; Pamplona/ES, N.N.

14:00 B-1094

Pelvic artery imaging: comparison of carbon dioxide enhanced digital subtraction angiography (CO2-DSA) and C-Arm computed tomography (CO2-CACT) J. Hinrichs, T. Werncke, F. Wacker, B. Meyer, C. von Falck; Hannover/DE

322

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

14:00–15:30

15:12 B-1114

Room M 4

Neuro SS 1511

A. Pomschar, K. Moritz, F. Schwarz, T. Kümpfel, M.F. Reiser, B. Ertl-Wagner; Munich/DE

Multiple sclerosis Moderators: K.-O. Løvblad; Geneva/CH, R. Woitek; Vienna/AT

14:00 B-1105

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Increased volume of adenoids in patients with multiple sclerosis: a MRI study

15:20 B-1115

Increased cortical grey matter lesion detection in multiple sclerosis with 7T MRI: a postmortem verification study

Multiple sclerosis imaging at 3-Tesla MR: comparison between 3D-FLAIR sequence and standard T2-TSE for the detection of inflammatory lesions A.S. Alhasan1, K. Gaillot2, P. Bertrand2, A. Guennoc2, M. Lauvin2, J. Cottier2; 1Madinah/SA, 2Tours/FR

I.D. Kilsdonk1, L.E. Jonkman1, R. Klaver1, S.J. Van Veluw2, P.J.W. Pouwels1, M.P. Wattjes1, P.R. Luijten2, F. Barkhof1, J.J.G. Geurts1; 1 Amsterdam/NL, 2Utrecht/NL

14:00–15:30 14:08 B-1106

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:16 B-1107

Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis

Breast SS 1502

U. Lamot, K. Šurlan Popovič, J. Avsenik; Ljubljana/SI

Comparison of diffusion weighted image and enhanced T1- weighted sequence in patients with multiple sclerosis

Real-time elastography for the assessment of spasticity: our experience in multiple sclerosis patients

14:00 B-1116

Association of MR features, clinical presentation and levels of matrix metalloproteinases in patients with clinically isolated syndrome and relapsing remiting multiple sclerosis

14:08 B-1117

14:16 B-1118

14:24 B-1119

Atrophy and other MRI-parameters as predictors of neurological deficit in relapsing remitting multiple sclerosis: a 3-year follow-up study

G.G. Waade1, R. Highnam2, I.H.R. Hauge1, M.F. McEntee3, S. Hofvind1, E. Denton4, J.F. Kelly5, J.J. Sarwar6, P. Hogg6; 1Oslo/NO, 2 Wellington/NZ, 3Sydney/AU, 4Norfolk/UK, 5Chester/UK, 6 Salford/UK

I. Krotenkova, V. Bryukhov, M. Zakharova, M. Krotenkova, S. Morozova, L. Askarova; Moscow/RU

14:56 B-1112

Longitudinal analysis of imaging biomarkers from MR segmentation of white matter lesion in patients with multiple sclerosis L. Lajarín Cano, J. Tomás Cucarella, A. Alberich-Bayarri, B. Casanova, L. Marti-Bonmati; Valencia/ES

15:04 B-1113

Assessment of the diagnostic accuracy of double inversion recovery sequence in comparison with FLAIR and T2W_TSE in detection of brain multiple sclerosis plaques 1

1

2 1

2

Z. Abidi , F. Faeghi , Z. Mardanshahi ; Tehran/IR, Sari/IR

Error in recorded compressed breast thickness measurement impacts on volumetric density classification

14:32 B-1120

Disagreement between the 4th and 5th editions of the BI-RADS density lexicon M. Abdolell1, K.M. Tsuruda1, S.E. Iles1, J. Caines1, C.B. Lightfoot1, P. Brown1, S.A. Raza2, G.H. Schaller1; 1Halifax, NS/CA, 2Sydney, NS/CA

14:40 B-1121

Decrease of breast density in BRCA patients following oophorectomy, using Volpara software A. Lecler, A. Dunant, C. Dromain, S. Delaloge, O. Caron, C. Balleyguier; Paris/FR

14:48 B-1122

The impact of breast density on radiologist fixation time in mammography W. Alomaim1, D. O’Leary2, J. Ryan1, L. Rainford1, S. Foley1; 1Dublin/IE, 2 Hertfordshire/UK

www.myESR.org

Final Programme | ECR 2016

323

Saturday

14:48 B-1111

Mammographic breast density and HER2 overexpression assessment improves the Nottingham Prognostic Index prognostic ability in patients with invasive breast cancer A.N.J. Masarwah, P. Auvinen, M. Sudah, V. Dabravolskaite, O. Arponen, A. Sutela, S. Oikari, V.-M. Kosma, R. Vanninen; Kuopio/FI

Normal-appearing white matter hypoperfusion in multiple sclerosis: assessment with DCE MRI M. Ingrisch1, S. Sourbron2, M. Schneider1, S. Herberich1, T. Kümpfel1, R. Hohlfeld1, M.F. Reiser1, B. Ertl-Wagner1; 1Munich/DE, 2Leeds/UK

Breast density measurements with ultrasound tomography: a comparison with non-contrast MRI E. O’flynn1, J. Fromageau1, A. Ledger1, A. Messa1, A. D’Aquino1, M. Schmidt1, N. Duric2, A. Swerdlow1, J. Bamber1; 1Sutton/UK, 2Detroit, MI/US

D. Stojanov, S. Jjubisavljevic, I. Stojanovic, S. Vojinovic; Nis/RS

14:40 B-1110

BI-RADS-based subjective estimation of fibroglandular breast tissue with magnetic resonance imaging: comparison to automated quantitative assessment G.J. Wengert1, T.H. Helbich1, R. Woitek1, P. Kapetas1, P.A.T. Baltzer1, W.-D. Vogl1, M. Weber1, A. Meyer-Baese2, K. Pinker-Domenig1; 1 Vienna/AT, 2Tallahassee, FL/US

G. Illomei, G. Coghe, J. Frau, G. Spinicci, M. Marrosu; Cagliari/IT

14:32 B-1109

Breast density: an update Moderators: R. Schulz-Wendtland; Erlangen/DE, N.N.

A. Abolhasani Foroughi, A. Nikseresht, M. Nazeri, R. Salahi, H. Heidari; Shiraz/IR

14:24 B-1108

Room M 5

Scientific Sessions

14:56 B-1123

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

15:04 B-1124

Is mammographic breast density related to breast cancer risk based on personal/family history? I. Ioan1, A. Pisani Mainini1, C. De Angelis1, I. Riva2, G. Di Leo2, F. Sardanelli2; 1Milan/IT, 2San Donato Milanese/IT

Classification of mammographic densities and breast cancer risk: results from the Egyptian national breast screening study N.A.M. Chalabi; Cairo/EG

15:12 B-1125

Agreement between radiologists’ visual assessments and automated software: BI-RADS 5th edition density classifications M. Abdolell1, K. Tsuruda1, S.E. Iles1, J. Caines1, C.B. Lightfoot1, P. Brown1, S.A. Raza2, G. Schaller1; 1Halifax, NS/CA, 2Sydney, NS/CA

15:20 B-1126

Background parenchymal enhancement is not associated with breast cancer in a non-high-risk population B. Bennani-Baiti1, M. Dietzel2, P.A.T. Baltzer1; 1Vienna/AT, Erlangen/DE

2

324

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:30–12:00

11:51 B-1136

Room C

Breast SS 1802

Digital breast tomosynthesis: an update Moderators: T. Knogler; Vienna/AT, A. Selim; Cairo/EG

10:30 K-27

E.F. Harkness1, S. Astley1, L. Tucker2, S. Duffy3, F.J. Gilbert2; 1 Manchester/UK, 2Cambridge/UK, 3London/UK

Keynote lecture T.H. Helbich; Vienna/AT

10:39 B-1127

10:30–12:00

A comparison of FFDM and synthetic 2D images with DBT: which images do readers prefer for assessment of different radiological features? 1

1

2

2

1

11:27 B-1133

Computerised image quality assessment in automated 3D breast ultrasound images J. Schwaab1, A. Malavé Dos Santos1, Y. Diez2, R. Martí2, J. van Zelst3, A. Bensouda Mourri4, J. Gregori1, M. Günther5; 1Heidelberg/DE, 2 Girona/ES, 3Nijmegen/NL, 4Brussels/BE, 5Bremen/DE

10:46 B-1139

Displaying inguinal lymph nodes prior to transplantation in a deep inferior epigastric perforator flap breast reconstruction using an innovative projection method S. Hummelink, L.J. Schultze Kool, D.J.O. Ulrich; Nijmegen/NL

10:54 B-1140

Automated nipple detection in 3D breast ultrasound scans M. Costa1, D. Ermacora2, S. Pesente3, A. Nicolucci4, S. Kus1, R. Longo1; 1 Trieste/IT, 2Udine/IT, 3Turin/IT, 4Firenze/IT

11:02 B-1141

Digital breast tomosynthesis: thick vs thin slices clinical performance and reading time A. Stork, D.F. Seitz, E. Wegjan, P. Begemann, J. Kemper; Düsseldorf/DE

I.F. Vieira1, M. Koole1, F.D. Keyzer1, E. Dresen1, S. Han1, I. Vergote1, F. Amant1, F.R.A. Lima2, V. Vandecaveye1; 1Leuven/BE, 2Recife/BR

11:10 B-1142

F. Carbonetti1, G. Quarta Colosso1, C. Briani1, A. Laghi2, M. Rengo2, V. David1, E. Iannicelli1; 1Rome/IT, 2Latina/IT

11:18 B-1143

A new ultrasound-based method to detect liver steatosis using CT as reference standard L.C. Pescatori1, R. Casale2, C. Messina1, F.M. Doniselli1, G. Di Leo3, F. Sardanelli3, L.M. Sconfienza3; 1Milan/IT, 2Rome/IT, 3 San Donato Milanese/IT

Assessment of the extent of microcalcifications to predict the size of a DCIS: comparison between tomosynthesis and conventional mammography

Digital breast tomosynthesis vs mammography: which modality provides more accurate prediction of margin status in specimen radiography?

Texture analysis with CT in GIST tumours: correlation with mitotic index and risk’s assessment

Sunday

Comparison of lesion detection and characterisation of benign and malignant masses with digital mammography, synthesised 2D mammography (SM) and digital breast tomosynthesis (DBT)

N. Berger, S. Dubach-Schwizer, Z. Varga, C. Rageth, T. Frauenfelder, A. Boss; Zurich/CH

11:43 B-1135

10:38 B-1138

1D-histogram feature analysis of the apparent diffusion coefficient improves diffusion-weighted imaging for lymph node characterisation in cervical cancer

L. Sinn, K. Wong, T. Lam, S. Lam, V. Lau, J. Ip, G. Ho, J. Leung, W. Lam; Hong Kong/HK

11:35 B-1134

Automated volumetric lesion quantification in automated 3D breast ultrasound: comparison of 5 breast lesion segmentation algorithms O. Diaz1, R. Agarwal1, A. Gubern-Merida2, J. van Zelst2, Y. Diez3, R. Martí1; 1Girona/ES, 2Nijmegen/NL, 3Sendai/JP

Reduction in digital breast tomosynthesis interpretation time by slabbing of the reconstructed slices G. Agasthya1, C.J. D’Orsi1, A. Holbrook1, C. Ho1, M. Piraner1, M. Newell1, L. Gilliland1, I. Sechopoulos2; 1Atlanta, GA/US, 2Nijmegen/NL

11:19 B-1132

10:30 B-1137

Synthetic mammography (SM) reconstructed from digital breast tomosynthesis (DBT): has anything changed in the BI-RADS category assignment? M. Fasciano, M. Durando, G. Mariscotti, F. Esposito, C. Casella, P. Campanino, P. Fonio, G. Gandini; Turin/IT

11:11 B-1131

Image processing techniques (2) Moderators: A. Alberich-Bayarri; Valencia/ES, U. Bick; Berlin/DE

Digital breast tomosynthesis: is peritumoral fat an ally in breast cancer detection? J.M. Madrid, F.M. Caballeros, P. Garcia-Barquin, M. Millor, L. Pina, A. Elizalde; Pamplona/ES

11:03 B-1130

SS 1805

2

J.M. Madrid , M. Caballeros , P. Matínez-Miravete , N. Rodriquez-Spiteri1, A. Elizalde1, L. Pina1; 1Pamplona/ES, 2 Zaragoza/ES

10:55 B-1129

Computer Applications

The influence of inmuhistochemical patterns of breast tumours in the detection of additional cancers by digital breast tomosyntesis and ultrasound 1

Room Z

1

L. Tucker , S. Ramasundara , J. Myles , S.W. Duffy , F.J. Gilbert ; 1 Cambridge/UK, 2London/UK

10:47 B-1128

Does previous reader performance in a test set of DBT images predict performance in a retrospective reading trial using DBT in addition to mammography?

11:26 B-1144

Software for CT-based quantification of abdominal adipose tissue: preliminary evaluation in normal weight patients A. Schaudinn, A. Hudak, N. Linder, N. Garnov, G. Stocker, U. Hacker, T. Kahn, H. Busse; Leipzig/DE

H. Amer1, F. Schmitzberger1, J. Kussmaul1, M.F. El Tohamy2, H.I. Tantawy2, E.M. Fallenberg1; 1Berlin/DE, 2Zagazig/EG

www.myESR.org

Final Programme | ECR 2016

325

Scientific Sessions

11:34 B-1145

Automatic segmentation of visceral fat in 7T MRI of mice

11:26 B-1155

P. Marra, S. Antunes, T. Canu, F. De Cobelli, C. Tacchetti, A. Esposito, A. Del Maschio; Milan/IT

11:42 B-1146

A novel method for the assessment of joint space width and subchondral bone micro architecture

T. Kaasalainen, J. Peltonen, M. Soikkeli, S. Heikkinen, M. Timonen, O. Sipilä; Helsinki/FI

11:34 B-1156

R. Ljuhar1, H. Canhão2, J. Branco2, A. Rodrigues2, N. Gouveia2, J. Hladuvka1, T. Haftner1, D. Ljuhar1, B. Norman1, S. Nehrer3, A. Fahrleitner-Pammer4, H.-P. Dimai4; 1Vienna/AT, 2Lisbon/PT, 3 Krems/AT, 4Graz/AT

11:50 B-1147

Joint space mapping: a novel platform for multiparametric quantitative 3D joint analysis from multimodal cross-sectional imaging data

Magnetic resonance evaluation of myocardial and liver iron deposition using T1 and T2* mapping methods: a phantom study

Reproducibility of native and contrast-enhanced CMR techniques to measure lesion size following acute myocardial infarction E. Tahir, M. Sinn, M. Avanesov, J. Wien, D. Saering, U.K. Radunski, K. Muellerleile, G. Adam, G.K. Lund; Hamburg/DE

11:42 B-1158

T.D. Turmezei, A.H. Gee, K.E.S. Poole, G.M. Treece; Cambridge/UK

Patients without aortic disease and with aortic dissection using velocity encoding 4D MRI: assessment of wall shear stress and peak velocity A. Huber, J. Rudolph, M. Rasper, A. Sträter, M. Settles, C. Reeps, H.-H. Eckstein, E.J. Rummeny; Munich/DE

10:30–12:00

Room N 10:30–12:00

Cardiac SS 1803

MR (1) Moderators: K. Pagonidis; Iraklion/GR, N.N.

10:30 B-1148

4D flow MRI in stented versus stentless aortic valve bioprosthesis at 1 year after surgery F. van Kesteren, L.W.L.M. Wollersheim, J. Baan Jr., A. Nederveen, B.A.J.M. de Mol, P. van Ooij, R.N. Planken; Amsterdam/NL

10:38 B-1149

10:46 B-1150

Oncologic Imaging SS 1816

10:30 B-1160

10:38 B-1161

Real-time SPARSE-SENSE cine imaging in atrial fibrillation: a feasibility study

K. Warin-Fresse1, P. Guérin1, B. Guyomarc‘h Delassale1, D. Le Touze1, T. Senage1, J. Dacher2; 1Nantes/FR, 2Rouen/FR

11:02 B-1152

SPARSE-SENSE cine imaging with high spatial and high temporal resolution for left ventricular functional assessment J. Goebel, F. Nensa, H.P. Schemuth, S. Maderwald, M. Gratz, H.H. Quick, T. Schlosser, K. Nassenstein; Essen/DE

11:10 B-1153

Native slice-averaged T1 mapping as screening tool for diffuse cardiac pathologies J. Goebel, I. Seifert, F. Nensa, H.P. Schemuth, S. Maderwald, T. Schlosser, C. Jensen, K. Nassenstein; Essen/DE

11:18 B-1154

Myocardial T1 mapping in asymptomatic subjects: variations according to left ventricular segments and correlation with cardiovascular risk factors

Comparison of perfusion parameters calculated from dynamic volume perfusion CT and perfusion MRI in patients with rectal cancer S. Sudarski, T. Floss, T. Gaa, U. Attenberger, H. Haubenreisser, S.O. Schönberg, T. Henzler; Mannheim/DE

10:46 B-1162 Conception and realisation of a amagnetic pulsatil flow phantom to compare 2D phase contrast post treatment software

Long-term follow-up features on rectal MRI during ‘wait-and-see’ in clinical complete responders after chemoradiotherapy: an update of 68 patients M.M. van Heeswijk1, D.M. Lambregts1, B.J.P. Hupkens1, R.C.J. Beckers1, M. Maas1, M.E. van der Sande2, G.L. Beets1, R.G.H. Beets-Tan1; 1 Maastricht/NL, Amsterdam/NL, 2Amsterdam/NL

J. Goebel, E. Tezgah, F. Nensa, H.P. Schemuth, S. Maderwald, M. Gratz, H.H. Quick, T. Schlosser, K. Nassenstein; Essen/DE

10:54 B-1151

Gastrointestinal cancer: prediction and assessment of therapeutic response Moderators: S. Battisti; Rome/IT, N.N.

Myocardial alterations in grating-based phasecontrast computed tomography (gb-PCCT) S. Notohamiprodjo1, N. Webber1, L. Birnbacher2, M. Willner2, J. Herzen2, D. Mayr1, H. Bartsch1, T. Saam1, H. Hetterich1; 1Munich/DE, 2 Garching/DE

Studio 2016

Application of texture analysis based on ADC maps in discriminating different stages of rectal cancer L. Liu; Beijing/CN

10:54 B-1163

Clinical assessment of diffusion-weighted MRI for restaging rectal cancer: is there a learning curve? M.M. van Heeswijk1, D.M. Lambregts2, L. Andrade3, M. Maas1, G.L. Beets1, R.G.H. Beets-Tan1; 1Maastricht/NL, Amsterdam/NL, 2 Maastricht/Amsterdam/NL, 3Coimbra/PT, Maastricht/NL

11:02 B-1164

MRI of rectal cancer: pathologic correlation of preoperative tumour staging T. Rostovtseva, N. Ananyeva, S. Vasilyev, E. Smirnova, R. Ezhova; St. Petersburg/RU

11:10 B-1165

Dynamic contrast enhanced MRI in rectal cancer: tumours with poor prognosis show low vascularity M. Maas1, G. Shakirin2, D.M. Lambregts1, M. Weibrecht2, M. Perkuhn2, M. Martens1, R. Dijkhoff1, G. Beets3, R.G.H. Beets-Tan3; 1Maastricht/NL, 2 Aachen/DE, 3Amsterdam/NL

Y. Kim, M. Kim, H. Kim, Y. Choe, S. Cho, S. Kim, S.-C. Lee; Seoul/KR

326

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

11:18 B-1166

Multiparametric functional imaging assessment of primary rectal cancer: correlation between diffusion, perfusion, magnetisation transfer and signal intensity measurements

11:03 B-1173

D.M. Lambregts1, G. Shakirin2, M. Maas1, M. Weibrecht2, M.J. Lahaye3, M.M. van Heeswijk1, G.L. Beets1, M. Perkuhn2, R.G.H. Beets-Tan1; 1 Maastricht/NL, Amsterdam/NL, 2Aachen/DE, 3Amsterdam/NL

11:26 B-1167

C.R.G.L. Talei Franzesi, D. Ippolito, D. Fior, C. Cangiotti, G. Brembilla, S. Sironi; Monza/IT

11:11 B-1174 Anal cancer: local response assessment using MRI at 3 and 6 month post chemoradiotherapy R. Kochhar, A.G. Renehan, D. Mullan, B. Chakrabarty, B.M. Carrington; Manchester/UK

11:34 B-1168

Assessment of rectal tumour height and length on MRI: effect of using DWI instead of T2-weighted MRI

11:19 B-1175

Preoperative CT and MRI prediction of nonresectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms

10:30–12:00

CT vs. PET-CT: correlations and differences in the diagnosis of aorto-iliac prosthetic vascular graft infections D. Klug, W.J. Hofmann, A. Becherer, M. Cejna; Feldkirch/AT

11:27 B-1176

B. Menassel1, A. Duclos1, G. Passot1, A. Dohan2, C. Payet1, S. Isaac1, P.-J. Valette1, O. Glehen1, P. Rousset1; 1Lyon/FR, 2Paris/FR

CT angiography in long-term follow-up after endovascular aneurysm repair (EVAR) - combined dose reduction techniques R.A. Rotzinger, J. Kahn, G. Böning, B. Hamm, F. Streitparth; Berlin/DE

M.M. van Heeswijk1, D.M. Lambregts1, L. den Ouden2, M.C. Ageitos-Casais3, M. Maas1, G.L. Beets1, R.G.H. Beets-Tan1; 1 Maastricht/NL, Amsterdam/NL, 2Maastricht/NL, 3 Santiago de Compostela/ES, Maastricht/NL

11:42 B-1169

Low kV CT-angiography (CTA) with low contrast medium volume using a 256 MDCT scanner in the evaluation of abdominal aorta disease: diagnostic quality and radiation dose reduction

Isolated iliac artery aneurysms: a single centre experience G. Leale, R. Fossaceca, G. Guzzardi, P. Cerini, I. Divenuto, G. Parziale, A. Carriero; Novara/IT

11:35 B-1177

Room L8

The evaluation of different tube voltages multidetector CT angiography in assessment of aorta and lower peripheral arterial occlusive disease D. Zhang, H. Xue, X. Wang, Z. Jin; Beijing/CN

Vascular SS 1815

Abdominal aortic and other aneurysms

11:43 B-1178

Moderators: I. Bargellini; Pisa/IT, E. Brountzos; Athens/GR

10:30 K-32

Keynote lecture

M.H. Albrecht1, S.S. Martin2, J.-E. Scholtz2, N.-E.A. Nour-Eldin2, S. Fischer2, R.W. Bauer2, U.J. Schoepf1, T.J. Vogl2, J.L. Wichmann2; 1 Charleston, SC/US, 2Frankfurt am Main/DE

E. Brountzos; Athens/GR

10:39 B-1170

Investigation of reference levels and radiation dose associated with abdominal EVAR (endovascular aneurysm repair) procedures across several European centres

Comparison of different virtual monoenergetic and linear-blended algorithms for dual-energy CT angiography of the thorax and abdomen: effects on contrast and image quality

11:51 B-1179

The prevalence of posterior circumflex humeral artery aneurysms in elite volleyball players D. van de Pol, P.P.F.M. Kuijer, M. Pannekoek-Hekman, A. Terpstra, M. Maas, R.N. Planken; Amsterdam/NL

E. Tuthill1, L. O’ Hora1, M. O’ Donohoe1, S. Panci2, D. Campion3, R. Trenti4, E. Fox1, D. Catania5, L. Rainford1; 1Dublin/IE, 2Florence/IT, 3 Turin/IT, 4Bologna/IT, 5Milan/IT

10:30–12:00 10:47 B-1171

Does dynamic volumetric CT angiography of endoleak after endovascular aortic aneurysm repair using 320-detector row CT add additional information with dynamic CT angiography?

10:55 B-1172

Musculoskeletal SS 1810

Ligaments, tendons and joints Moderators: A.H. Karantanas; Iraklion/GR, A. Sachs; Vienna/AT

10:30 K-29

Sunday

M. Inoue, Y. Yamada, M. Tamura, S. Nakatsuka, S. Oguro, M. Jinzaki; Tokyo/JP

Room E1

Keynote lecture M.F. Reiser; Munich/DE

Preliminary validation of a new protocol in EVAR follow-up: digital tomosynthesis and CEUS vs computed tomography angiography S. Guerrini1, M.A. Mazzei1, F.G. Mazzei1, N. Cioffi Squitieri1, G. de Donato1, G. Galzerano1, F. Setacci2, C. Setacci1, L. Volterrani1; 1 Siena/IT, 2Rome/IT

10:39 B-1180 SPEAKER SUPPORTED BY INVEST IN THE YOUTH

10:47 B-1181

MRI of the painful carpal boss: variations at the extensor carpi radialis brevis insertion and imaging findings in regional traumatic and overuse injuries M.T. Nevalainen1, J.B. Roedl2, W.B. Morrison2, A.C. Zoga2; 1Oulu/FI, 2 Philadelphia, PA/US

Cone-beam CT in diagnosis of scaphoid fractures R. Edlund, M. Skorpil, G. Lapidus, J. Backlund; Stockholm/SE

www.myESR.org

Final Programme | ECR 2016

327

Scientific Sessions

10:55 B-1182

Structured reporting vs free-text reporting of MRI examinations of the shoulder: impact on surgical planning W.H. Sommer, M. Armbruster, M.F. Reiser, F. Haasters, T. Helfen, N. Sommer; Munich/DE

11:03 B-1183

10:55 B-1192

T. Almansoori, R. Glikstein, P. Hamagandi, S. Patro, C. Torres, B. Schwarz; Ottawa, ON/CA

11:03 B-1193

MRI features of acute gouty arthritis on top of chronic gouty involvement in different joints Y. Ragab, Y. Emad; Cairo/EG

11:11 B-1184

Diagnostic value of CT arthrography at the ankle

11:11 B-1194

The importance of the talonavicular ligament in ankle sprain

Assessment of hindfoot malalignment using MRI: evaluation of the apparent moment arm measurements (Saltzman view) on non-weightbearing coronal MR images 1

2

2

11:19 B-1195

11:27 B-1196

2 1

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Anterior screw fixation of traumatic type 2 odontoid fractures with Xper-CT and fluoroscopic. Our preliminary experience in angiographical suite D. Leni, F. Vacirca, D. Fior, A. Vimercati, D. Ippolito, P. Allegranza, R. Corso; Monza/IT

Magnetic resonanace imaging findings in early stage diabetic foot and correlation with etiologies vasculopathy and neuropathy

11:35 B-1197

I. Karalok, L. Ulusoy; Istanbul/TR

11:43 B-1188

Dynamic DTI of the cervical spine shows diffusivity changes in healthy subjects F.P. Kuhn, A. Feydy, N. Launay, M.-M. Lefèvre-Colau, S. Poiraudeau, S. Laporte, P. Lindberg; Paris/FR

N.E. Bueber , A. Frigg , M. Zanetti , N. Mamisch-Saupe ; Grabs/CH, 2 Zurich/CH

11:35 B-1187

MRI criteria for disease management decision in patients with herniated intravertebral discs A. Smirnova1, A. Tkachev2, N. Plakhotina1, D. Archakov2; 1 St. Petersburg/RU, 2Volgograd/RU

M. De Dea, G.M. Allen, M. Watson, D.J. Wilson; Oxford/UK

11:27 B-1186

CT findings predict clinical outcome after dynamic posterior stabilisation in patients with painful segmental instability of the lower spine B.J. Schwaiger, A.S. Gersing, M. Behr, C. Zimmer, F. Ringel, J.S. Bauer; Munich/DE

P.M. Jungmann, J.S. Bauer, T. Baum, S. Braun, C. Holwein, E.J. Rummeny, A.B. Imhoff, K. Wörtler; Munich/DE

11:19 B-1185

Early cervical spine degenerative changes in MS patients under 35 years of age

CAIPIRINHA acceleration for rapid high-spatialresolution isotropic 3D MRI of the ankle V. Kalia1, G.K. Thawait2, R. Johnson3, W.D. Gilson2, E. Raithel4, J. Fritz2; 1 South Burlington, VT/US, 2Baltimore, MD/US, 3Cary, NC/US, 4 Erlangen/DE

Automated adaptive multiplane-multiangle oblique (AAMO) rendering of volumetric spine CT N. Titelbaum, I. Corcuera-Solano, A. Doshi, P. Pawha, L.N. Tanenbaum; New York, NY/US

11:43 B-1198

Changes of mental imaginary motor task fMRI activation in chronic spinal cord injury treated by intrathecal baclofen J. Keller, R. Jech, I. Stetkarova; Prague/CZ

11:51 B-1189

MR finding of peroneal tendon subluxation: a key structure of fibrous ridge

11:51 B-1199

Y. Kobashi, A. Baba, Y. Nozawa, S. Yamazoe, T. Mogami; Chiba/JP

10:30–12:00

Magnetic resonance image findings of adjacent segment degeneration in isthmic and degenerative spondylolisthesis O. Elibol1, B. Guclu1, M. Tiryaki1, K.Y. Safak1, A.Y. Demirci2, B. Kömür1, E. Gur1, D. Gulabi1, T. Baysal1; 1Istanbul/TR, 2Bursa/TR

Room E2

Neuro 10:30–12:00

SS 1811

Spine Moderators: S. Morozova; Moscow/RU, J. Van Goethem; Antwerp/BE

Physics in Radiology SS 1813

10:30 K-30

Room F2

Practical radiation risk management Moderators: M. Koutalonis; Colchester/UK, R.W.R. Loose; Nürnberg/DE

Keynote lecture J. Van Goethem; Antwerp/BE

10:39 B-1190

10:30 B-1200 Correlation of age- and gender-dependent bone marrow fat of the lumbar spine with body fat measures: an MRI study using water-fat separation MRI in a healthy population with normal BMI E. Dappa, L. Filli, D. Nanz, M.A. Fischer, E.J. Ulbrich; Zurich/CH

10:47 B-1191

Dynamic lumbar myelography using EOS imaging: validation against computed radiography (CR)

Effect of the topogram projection angle on organ dose in chest CT with tube current modulation N. Saltybaeva, H. Alkadhi; Zurich/CH

10:38 B-1201

Impact of the scout view orientation on the radiation exposure and image quality in thoracic and abdominal CT S. Suntharalingam, A. Wetter, N. Guberina, J. Theysohn, A. Ringelstein, T. Schlosser, M. Forsting, K. Nassenstein; Essen/DE

F.P. Kuhn, S. Hammoud, G. Corcos, S. Charlon, N.-E. Regnard, M.-M. Lefèvre-Colau, J.-L. Drapé, A. Feydy; Paris/FR

328

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:46 B-1202

Scan direction and scout acquisition influences the dose reducing effect of automatic tube current modulation in CT

10:47 B-1212

F. Doellinger1, A. Poellinger2, R.-H. Huebner1, J.-M. Kuhnigk3, D. Herzog1, C. Thomsen1, V. Schreiter1, D. Theilig1; 1Berlin/DE, 2 Berne/CH, 3Bremen/DE

C. Franck, K. Bacher; Ghent/BE

10:54 B-1203

Impact of automated attenuation-based tube voltage selection on radiation dose at CT: an observational study on a global scale

10:55 B-1213

F. Meinel1, J. Spearman2, U.J. Schoepf2, M. Rottenkolber1, I. Driesser3, C. Canstein4, K. Thierfelder1, A. Krazinski2, C. De Cecco5; 1Munich/DE, 2 Charleston, SC/US, 3Forchheim/DE, 4Malvern, PA/US, 5Rome/IT

11:02 B-1204

Variable SD scanning for dose reduction in chest, abdomen and pelvic CT

Breast bismuth shielding in coronary CT angiography: is it worth it?

Association between 18F-FDG-PET/CT metabolic activity and CT density of the aortic wall and severity of lung emphysema A. Marin, A. Gangi, J. Murchison, W. MacNee, E. van Beek, S. Mirsadraee; Edinburgh/UK

11:03 B-1214

Rib fractures: a common comorbidity in COPD A. Rai, R. Rubtsov, C. Brunner, M. Wielpütz, T. Muley, R. Eberhardt, M. Eichinger, H.-U. Kauczor, C.P. Heußel; Heidelberg/DE

M. Paravasthu, S. Kandel, C. Farrell, P. Rogalla; Toronto, ON/CA

11:10 B-1205

Endobronchial valve treatment in pulmonary emphysema: is objective evaluation of the best target lobe with quantitative CT beneficial for outcome?

11:11 B-1215

N. Moraitis, K. Perisinakis, K. Pagonidis, A. Tzedakis, J. Damilakis; Iraklion/GR

Chemotherapy induced interstitial pneumonitis: thinsection CT characteristics and longitudinal CT followup L. Han Na, M. Kim; Seoul/KR

11:18 B-1206

Assessment of diagnostic low dose CT chest protocols in the province of Nova Scotia

11:19 B-1216

E. Tonkopi, D. Manos, M. Abdolell; Halifax, NS/CA

11:26 B-1207

Low dose CT protocol optimisation for the assessment of acute appendicitis: a phantom study H. Niiniviita, J. Virtanen; Turku/FI

11:34 B-1208

P. Leutz1, O. Weinheimer1, M. Lederlin2, H.-U. Kauczor1, C.P. Heussel1, M.O. Wielpütz1; 1Heidelberg/DE, 2Rennes/FR

11:27 B-1217

An investigation into the impact of the ‘anode heel effect’ on patient gonadal dose in AP pelvis radiographic examination

Ultra-low dose chest CT: lung dose and radiationinduced cancer risk reduction

11:35 B-1218

N. Saltybaeva, H. Alkadhi; Zurich/CH

11:50 B-1210

Comparison of radiation exposure associated with intraoperative CBCT and follow-up MDCT for evaluating EVAR procedures

10:30–12:00

11:43 B-1219

Moderators: D. Kienzl-Palma; Vienna/AT, N.N.

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

Chest x-ray and CT aspects of lung involvement in microscopic polyangiitis M. Robella, R. Placido, G. Cortese, G. Quattrocchio, D. Roccatello; Turin/IT

Keynote lecture P.A. Grenier; Paris/FR

10:39 B-1211

Long-term effect of smoking cessation on emphysema progression in smokers-at-risk in a lung cancer screening population B. Jobst, M. Trauth, O. Weinheimer, N. Becker, S. Delorme, H.-U. Kauczor, M. Wielpütz; Heidelberg/DE

www.myESR.org

Final Programme | ECR 2016

329

Sunday

11:51 B-1220

COPD and infiltrative lung diseases

Diagnostic contribution of HRCT in the diagnosis and differentiation of interstitial lung diseases using ICOERD visual grading score and Bayes’ rule for post hoc probability prediction C. Weber1, K. Peldschus1, G. Adam1, K.F. Rabe2, L. Welker2, T.H. Schroeder1; 1Hamburg/DE, 2Grosshansdorf/DE

Room D1

Chest

10:30 K-28

The identification of systemic integrin activation in idiopathic and systemic sclerosis pulmonary fibrosis using 18F-fluciclatide positron emission tomography S. Mirsadraee, A. Marin, W. Jenkins, M. Connell, A. Tavares, A. Fletcher, N. Hirani, E.J. van Beek; Edinburgh/UK

A. Steuwe, P. Geisbüsch, C.J. Schulz, D. Böckler, H.-U. Kauczor, W. Stiller; Heidelberg/DE

SS 1804

Relationship between CT patterns of lung injury and serum N-terminal-peptide type III procollagen (NT-PCP-III) in patients with severe acute respiratory distress syndrome (ARDS) A. Nair, L. Camporata, N.A. Barrett, N. Sharma, S.R. Desai; London/UK

H.A.A.B. Mraity, A. England, P. Hogg; Salford/UK

11:42 B-1209

Influence of exposure parameters and iterative reconstruction on automatic airway degmentation and analysis on MDCT: an ex-vivo phantom study

Scientific Sessions

10:30–12:00

Room D2

10:30–12:00

Room K

Interventional Radiology

Genitourinary

SS 1809

SS 1807

Peri- and postprocedural imaging Moderators: A. Bharadwaz; Aarhus/DK, A.D. Kelekis; Athens/GR

10:30 B-1222

Moderators: G. Heinz-Peer; St. Pölten/AT, R. Huzjan Korunić; Zagreb/HR

Dynamic 4D-CT angiography of the upper abdomen for guiding TACE: impact on reduction of contrast material, operator radiation exposure, catheter consumption and diagnostic confidence M.H. Albrecht, T.J. Vogl, J.L. Wichmann, S. Fischer, R. Hammerstingl, M. Harth, A. Thalhammer, S. Zangos, R.W. Bauer; Frankfurt a. Main/DE

10:38 B-1223

11:02 B-1226

10:46 B-1234

Clear cell adenocarcinoma of the urethra: MR image findings for differentiation from nonadenocarcinomas T. Kim, S. Kim, K. Moon, S. Woo, J. Cho, S. Kim; Seoul/KR

10:54 B-1235

Can quantitative CT texture analysis be used to differentiate between low- and high-grade urothelial carcinoma? G.-M. Zhang, H. Sun, H.-D. Xue, Z.-Y. Jin; Beijing/CN

11:02 B-1236

Qualitative assessment and quantitative assessment for evaluation of optimal linear blending image in dual-source dual-energy CT for detection of renal solid mass P. Lei1, X. Wang1, X. Wang2, J. Jiao1; 1Guiyang/CN, 2Beijing/CN

11:10 B-1238

Dose reference levels in paediatric interventional radiology

Complementary value of contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of complex renal cysts E. Raimondi, M. Bassi, Z. Ferrante, M. Tilli, S. Dall’ara, R. Rizzati, M. Giganti, G. Benea; Ferrara/IT

B. Habib Geryes1, A. Bak2, O. Naggara1, F. Brunelle1, G. Saliou2; 1 Paris/FR, 2Le Kremlin-Bicêtre/FR

11:18 B-1228

Evaluation of enhancement degree in small renal masses using multiphasic CT scan: can we discriminate between renal cell tumours and oncocytomas? M. Di Carlo, C. Gaudiano, F. Busato, A. Poerio, S. Pucci, R. Golfieri; Bologna/IT

MRI evaluation of uterine morphology and clinical response in women treated by MRgFUS: 4 year follow-up F. Smaldone, F. Ferrari, A. Miccoli, F. Arrigoni, S. Iafrate, I. Capretti, C. Masciocchi; L’Aquila/IT

11:10 B-1227

10:38 B-1233

CT-guided radiopharmaceutical marking of lung nodules: technical and results C. Grassi Zamora, M. de Albert, G. Solana Tubau, F. Martinez Torrens, E. Carreño G, L. Farras Roca, D. Nova Vaca; Barcelona/ES

CT prediction of histologic grade of small clear cell renal cell carcinoma K. Sim, D. Sung, S. Choi, N. Han, B. Park, M. Kim, S. Cho; Seoul/KR

Real-time 3D MPI-guided angioplasty using an MRI road map and blood pool agent approach: next steps towards interventional MPI J. Salamon, M. Hofmann, C. Jung, M.G. Kaul, R. Reimer, A. vom Scheidt, G. Adam, T. Knopp, H. Ittrich; Hamburg/DE

10:54 B-1225

10:30 B-1232

A novel approach to predict local tumor progression for hepatocellular carcinoma after radiofrequency ablation: 3D measurement of tumor area exposed to post-ablation margins A. Hocquelet1, H. Trillaud1, P. Balageas1, N. Frulio1, C. Salut1, B. Denis de Senneville2; 1Bordeaux/FR, 2Talence/FR

10:46 B-1224

Tumours of the urinary tract and adrenals

11:18 B-1239 Value of contrast-enhanced ultrasound in guidance of percutaneous biopsy of anterior mediastinal lesions

Peritoneal seeding of renal cell carcinoma: analysis of histologic characteristics and prognosis S. Park, H. Jang, S. Park, Y. Oh, D. Jung; Seoul/KR

Y. Dong, W.-P. Wang, F. Mao, Z.-B. Ji; Shanghai/CN

11:26 B-1229

11:26 B-1240 Preliminary in vitro and in vivo results of a MR-safe guidewire

L. Ponhold1, S. Sevcenco2, G. Heinz1, P.A.T. Baltzer2; 1St. Pölten/AT, 2 Vienna/AT

A. Massmann, A. Buecker, G.K. Schneider; Homburg a.d. Saar/DE

11:34 B-1230

MRI-guided biopsies and MR-guided wire localisation biopsies of soft tissue tumours based on contrastenhanced images

11:34 B-1241

330

The value of chemical shift MRI in characterising adrenal incidentalomas found in routine contrastenhanced CT Y.-W. Wu, C. Tan; Singapore/SG

G. Schneider, J. Stroeder, A. Raguwaran, A. Buecker; Homburg a.d. Saar/DE

11:42 B-1231

Diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness

11:42 B-1242 FDG PET/CT guided biopsy

Radiological formula for differentiating between secreting and non secreting adrenal adenomas

S. Brocchi, A. Cappelli, C. Mosconi, M. Renzulli, F. Modestino, C. Nanni, T. Balbi, S. Fanti, R. Golfieri; Bologna/IT

C. Mosconi, V. Vicennati, D. Papadopoulos, R. Pasquali, R. Golfieri; Bologna/IT

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

10:30–12:00

Room G

14:00–15:30

Radiographers

Breast

SS 1814

SS 1902a

Getting the radiation dose as low as possible Moderators: H. Ståhlbrandt; Eksjö/SE, F. Zarb; Msida/MT

10:30 K-31 10:39 B-1243

10:47 B-1244

14:00 K-34 14:09 B-1253

14:17 B-1254

The use of secondary lead rubber protection in paediatric extremity radiographic examinations

The impact of paediatric computed tomography tube current and tube voltage modulation intensity in organ dose and image quality

Radiation dose reduction on lens and thyroid in orthopantomography exams

14:25 B-1255

An investigation of how to improve recall and awareness of radiation dose levels associated with cardiovascular interventional procedures

14:33 B-1256

Additional copper filtration for adult chest imaging and it’s impact on dose and image quality

14:41 B-1257

Radioprotection in thorax CT: an approach with the application of bismuth breast shield

14:49 B-1258

14:57 B-1259

C. Heilmaier, N. Zuber, D. Weishaupt; Zurich/CH

11:43 B-1251

M.A. Marino, P. Clauser, R. Woitek, G. Wengert, P. Kapetas, M. Bernathova, K. Pinker-Domenig, T.H. Helbich, P.A.T. Baltzer; Vienna/AT

15:05 B-1260

Radioprotection in mobile x-ray examinations

Paediatric imaging radiation dose awareness and use of referral guidelines amongst radiology practitioners and radiographers J.L. Portelli1, J. McNulty2, P. Bezzina1, L. Rainford2; 1Msida/MT, 2 Dublin/IE

www.myESR.org

Diffusion tensor imaging parametric 1 maps are more accurate than grey-scale parametric ADC maps in evaluating early response to neoadjuvant chemotherapy E. Taberner López, J. Camps Herrero, C. Martinez Rubio, J. Cano Gimeno, J. Cuevas Sanz, M. Taberner Bonastre, J. Lorca Chapa; Alzira/ES

A.F.C.L. Abrantes, C. Rebelo, P. Sousa, S. Rodrigues, R.P.P. Almeida, J.P. Pinheiro, K.B. Azevedo, L.P. Ribeiro; Faro/PT

11:51 B-1252

Combined evaluation of contrast-enhanced magnetic resonance imaging and diffusion weighted imaging of the breast: a multi-reader study

Sunday

Does radiation awareness of CT technologists change, when a dose monitoring software is used for real-time monitoring of patient dose?

Evaluating the diagnostic sensitivity of computed diffusion-weighted MR imaging in the detection of breast cancer E.A.M. O’Flynn, M. Blackledge, D. Collins, K. Downey, S. Doran, S. Dumontiel, W. Mok, M.O. Leach, D.-M. Koh; Sutton/UK

R.P.P. Almeida, E. Santos, P. Sousa, S. Rodrigues, L.P. Ribeiro, K.B. Azevedo, N.M. Pinto, A.F.C.L. Abrantes; Faro/PT

11:35 B-1250

The impact of incorporating Dynamic ContrastEnhanced MRI in the diagnostic workup of inflammatory breast disorders R.M. Kamal, E. Faker, R. Farouk, D. El Messeidy, A. Hatw; Cairo/EG

N. Mekiš1, S. Foley2, G. Paulo3, T. Starc1, L. Rainford2, J. Santos3; 1 Ljubljana/SI, 2Dublin/IE, 3Coimbra/PT

11:27 B-1249

Time-signal intensity curve analysis in breast MRI: still a role for lesion characterisation? M. Telegrafo, T. Introna, L. Coi, L. Rella, A. Stabile Ianora, G. Angelelli, M. Moschetta; Bari/IT

S. Mullen, J. Mc Nulty, L. O’Hora, V. Mc Guire, T. Buchanan, P. Gilligan, L. Rainford; Dublin/IE

11:19 B-1248

Multiparametric analysis of morphologic and functional MRI signs with correlation to degree of nuclear atypia at DCIS L. Vanovcanova, V. Lehotska, K. Rauova; Bratislava/SK

R.P.P. Almeida, J.R. Santos, S. Rodrigues, P. Sousa, L.P. Ribeiro, K.B. Azevedo, J.P. Pinheiro, A.F.C.L. Abrantes; Faro/PT

11:11 B-1247

3T MR spectroscopy in the multi-parametric MRI evaluation of breast lesions: a pattern recognition approach C. Cavedon, L. Camera, I. Baglio, G. Meliadò, F. Caumo, S. Montemezzi; Verona/IT

M. Alves, P. Fernandes, D. Costa, G. Paulo, J. Santos; Coimbra/PT

11:03 B-1246

Correlation between 3T multiparametric MRI and prognostic indicators in breast cancer L. Camera, C. Cavedon, I. Baglio, G. Meliadò, G. Barbazeni, S. Montemezzi; Verona/IT

C. Bloomfield, A. England; Manchester/UK

10:55 B-1245

Keynote lecture K. Pinker-Domenig; New York, NY/US

Positioning for a conventional skyline patella projection: evaluation of torso position and its relationship with eye lens and thyroid dose J. Li, K. Szczepura, A. Tootle, A. England; Manchester/UK

Multiparametric breast MRI, PET Moderators: E.M. Fallenberg; Berlin/DE, G. Forrai; Budapest/HU

Keynote lecture P. Bezzina; Msida/MT

Room A

15:13 B-1261

Accuracy of diffusion kurtosis imaging in characterisation of breast lesions A. Christou1, A. Ghiatas2, D. Priovolos2, K. Veliou3, H. Bougias3; 1 Doncaster/UK, 2Athens/GR, 3Ioannina/GR

Final Programme | ECR 2016

331

Scientific Sessions

15:21 B-1262

Analysis and correlation of 18F-FDG uptake in different immuno-histochemical subtypes of breast carcinoma H.S. Mohanty, G. Rajan Mj, K. Shirodkar, S. Kumar Gg, S. Nandikoor; Bangalore/IN

14:00–15:30

15:13 B-1271

Magnetic resonance pancreatic fat-fraction and volume: association with obesity V. Cuba, A. Gimeno, G. Blasco, J. Puig, S. Pedraza, J. Fernández-Real; Girona/ES

15:21 B-1272

Room B

Abdominal Viscera

Solid pseudopapillary tumour of the pancreas: gadoxetic-acid-enhanced MRI and DWI with emphasis on differentiation from neuroendocrine neoplasm Y. Choi, C. Park, G. Han, S. Kim, N. Lee; Busan/KR

SS 1901a

Benign and malignant pancreatic diseases Moderators: J.M. Lee; Seoul/KR, M. Spirovski; Sremska Kamenica/RS

14:00 K-33

Keynote lecture

14:00–15:30

Breast SS 1902b

J.M. Lee; Seoul/KR

14:09 B-1263

Nonhypervascular pancreatic neuroendocrine tumour: differential diagnosis from pancreatic ductal adenocarcinoma on MR imaging

MDCT features of pancreatic neuroendocrine tumours correlate with intratumoral microvascular density and predict tumour grade E. Belousova, A. Glotov, D. Kalinin, G. Karmazanovsky; Moscow/RU

14:25 B-1265

Insulinoma localisation with cross-sectional imaging: head-to-head comparison of CECT, DCE-CT and multi-sequence MR L. Zhu, H.-D. Xue, Z.-Y. Sun, H. Sun, X. Wang, Z.-Y. Jin; Beijing/CN

14:33 B-1266

14:00 B-1273

Localisation of CT-equivocal insulinomas: value of multi-sequence pancreatic MR

Quantitative assessment of the pancreatic tumours by means of perfusion-related parameters derived from low-dose CT perfusion Y.I. Nerestyuk, G. Karmazanovsky, Y. Gepalova; Moscow/RU

14:49 B-1268

M. Panzeri, C. Losio, A. Palmisano, R. Cavallin, R. Maria Grazia, P. Panizza, F. De Cobelli, A. Del Maschio; Milan/IT

14:08 B-1274

14:16 B-1275 14:24 B-1276

Tumour volume analysis TVA vs RECIST

Contrast-enhanced ultrasound with quantitative perfusion analysis for early pancreatic ductal adenocarcinoma in C57BL/6 mouse model: comparison with PET-CT

Diffusion weighted imaging of pancreatic adenocarcinoma: which model is the most appropriate?

Hybrid PET-MR imaging for accurate nodal staging prior to neoadjuvant chemotherapy in breast cancer patients - preliminary results B. Goorts, M.L. Smidt, S. Vöö, T.J.A. van Nijnatten, F.M. Mottaghy, J.E. Wildberger, M.B.I. Lobbes; Maastricht/NL

14:32 B-1277

Differentiation of heterogeneously enhancing pancreatic lesions: key features on multiphasic multidetector CT

Y. Dong, W.-P. Wang, Y.-J. Jiang, J.-Y. Cao; Shanghai/CN

15:05 B-1270

Can MRI features before and after neoadjuvant chemotherapy predict surgical margins? Q. Zhao1, O. Abeyakoon2, A. Muellner3, L. Carbonaro4, E. Sutton3, S. Wang1, E. Morris3; 1Shanghai/CN, 2Cambridge/UK, 3New York, NY/US, 4San Donato Milanese/IT

Preoperative planning using an MRI-US fusion imaging system for breast-conserving surgery in patients with non-mass-like enhancement on breast MRI T. Ando, S. Nakano, K. Fujii, J. Kousaka, Y. Mouri, R. Tetsuka, M. Goto, T. Imai, T. Ishiguchi; Aichi/JP

L. Zhu, H.-d. Xue, W. Liu, X. Wang, H. Sun, Z.-y. Jin; Beijing/CN

14:57 B-1269

Baseline breast evaluation with multiparametric MRI: prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer

A. Gordon, J. Morden, A. Lim, S. Cleator; London/UK

L. Zhu, H.-D. Xue, Z.-Y. Sun, X. Wang, H. Sun, Z.-Y. Jin; Beijing/CN

14:41 B-1267

Preoperative imaging, neoadjuvant chemotherapy, imaging of the axilla Moderators: C. Dromain; Villejuif/FR, P. Panizza; Milan/IT

S. Jeon, J. Lee, I. Joo, E. Lee, H. Park, J. Han, J. Park; Seoul/KR

14:17 B-1264

Room C

14:40 B-1278

Contrast enhanced ultrasound in axillary sentinel node assessment: does risk stratification improve yield N. Larkman, N. Sharma, I. Haigh; Leeds/UK

14:48 B-1279

Can MRI diffusion accurately detect complete pathological response in breast cancer patients receiving neoadjuvant chemotherapy? S.W.Y. Gareer, H.H.N. El Kassas, M. Helal, A. Abu Rabia, N. Abd El Razik, M.H. Zedan, A. Farahat; Cairo/EG

G.C. Manikis1, K. Nikiforaki1, N. Papanikolaou2, N. Albiin2, N. Kartalis2, K. Marias1; 1Iraklion/GR, 2Stockholm/SE

332

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

14:56 B-1280

Radiologic imaging features of breast cancer according to the molecular subtypes

14:41 B-1288

M.A. Nazli, I.N. Mutlu, Ö.N. Kilickesmez, C. Kelten, D. Can Tirabulus, A.H. Yardimci, T.F. Cermik; Istanbul/TR

15:04 B-1281

A. Parakh, A. Euler, S. Schindera; Basle/CH

Diagnostic performance of standard breast MRI for axillary nodal staging T.J.A. van Nijnatten, E.H. Ploumen, B. Goorts, S. Vanwetswinkel, P.J. Nelemans, M. Schavemaker, R.G.H. Beets-Tan, M.L. Smidt, M.B.I. Lobbes; Maastricht/NL

15:12 B-1282

Axillary lymph node fine-needle aspiration biopsy in invasive breast cancer: usefulness of adding core-needle biopsy when cytological diagnosis is discordant or insufficient

14:57 B-1290

14:00–15:30

15:05 B-1291

15:13 B-1292

15:21 B-1293

Quality control and safety issues in radiology

Keynote lecture

14:00 B-1295

G. Han, S. Kim, N. Lee; Busan/KR

14:08 B-1296

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

14:16 B-1297

Quality control in a radiology department by protocol standardisation and high dose justification T. De Bondt1, F. Zanca2, J. De Roeck1, L. Brouhon1, M. Geldof1, F. Deferme1, P.M. Parizel1; 1Antwerp/BE, 2Diegem/BE

Prediction of late postoperative hemorrhage after the Whipple procedure by CT performed at early postoperative periods

Pancreatic volume and texture as radiological predictors of pancreatic fistula after Whipple procedure

Sunday

S.T. Schindera1, R. LeCoultre2, J. Bize2, E.M. Merkle1, R. Meuli2, F.R. Verdun2; 1Basle/CH, 2Lausanne/CH

Abdominal surgery: the added value of radiology Moderators: I. Dudás; Budapest/HU, D. Vorwerk; Ingolstadt/DE

The feasibility of ultra-low dose 80 kVp and 20 ml contrast medium pulmonary CT angiography with iterative reconstruction

Benchmarking of CT radiation dose parameters: comparison of two academic institutions in Switzerland

Room O

Abdominal Viscera SS 1901b

J. Liu, J. Gao; Zhengzhou/CN

14:33 B-1287

Knowledge of radiology informatics among radiologists and residents in training in a developing country A. Kharat, A. Shah; Pune/IN

The adaptive statistical iterative reconstruction V technique for radiation dose reduction in abdominal CT B. Kim, H. Kwon, J. Lee, J. Cho, J. Oh, S. Lee; Busan/KR

14:25 B-1286

Preliminary assessment of a radiological safety management platform shared in six hospitals

14:00–15:30 B. Kelly; Belfast/UK

14:17 B-1285

Is ISO 9001:2015 standard better for teleradiology services for reduction of risks for patients, doctors and healthcare providers than the old version 2008?

P. Fraga, C. Benito, E. Fraile, J. Azpeitia, J. Albillos; Madrid/ES

Moderators: R. Salvador; Barcelona/ES, P.M.A. van Ooijen; Groningen/NL

14:09 B-1284

DICOM and HL7 security worldwide: adoption maps and country ratings

P. Sögner1, T. Möller2; 1Feldkirch/AT, 2Dillingen/DE

Room Z

Computer Applications

14:00 K-35

Metal artifact reduction of hip prostheses: comparison of an iterative algorithm with virtual monoenergetic extrapolations from dual-energy CT

O. Pianykh; Newton Highlands, MA/US

Evaluation of residual tumour after neoadjuvant chemotherapy (NAC) in patients with breast cancers: can we settle on DWI-MR sequence? I. Leconte, B. Lacoste, L. Fellah, M. Berliere, C. Galant, N. Michoux; Brussels/BE

SS 1905

14:49 B-1289

K. Higashigaito1, F. Angst1, V.M. Runge2, H. Alkadhi1, O. Donati1; 1 Zurich/CH, 2Berne/CH

J. Oliver Goldaracena, C. Martinez Gamarra, V. Córdoba Chicote, A. Verón Sánchez, M. Roca Navarro, A. Andres Mateo; Madrid/ES

15:20 B-1283

Big-data analytics and visualisation of a threeyear CT radiation dose optimisation program at an academic center using radiation dose monitoring software

I. Shrainer, V. Voropaev, E. Mershina, V. Lyadov, V. Sinitsyn; Moscow/RU

MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma after major hepatectomy S. Jang, J. Lee, D. Lee, I. Joo, J. Yoon, W. Chang, J. Han; Seoul/KR

14:24 B-1298

Different strategies to induce hypertrophy of the future liver remnant (FLR) in case of major hepatic resection: a prospective comparative study in 118 patients P. Marra, M. Venturini, C. Sallemi, F. Ratti, F. De Cobelli, L. Aldrighetti, A. Del Maschio; Milan/IT

www.myESR.org

Final Programme | ECR 2016

333

Scientific Sessions

14:32 B-1299

Accuracy of simple approaches to assessing liver volume in radiological imaging

14:32 B-1309

J.-P. Kühn, A.-M. Roloff, M.-L. Kromrey, N. Hosten, P. Heiss; Greiswald/DE

14:40 B-1300

Intraoperative constrast enhanced ultrasound and color coded elastography for characterisation of liver lesions before surgical resection

A. Yamada, M. Ishida, Y. Goto, M. Uno, S. Nakamori, Y. Ichikawa, M. Nagata, K. Kitagawa, H. Sakuma; Tsu, Mie/JP

14:40 B-1310

N. Platz Batista da Silva, M. Loss, M. Hornung, C. Stroszczynski, E.M. Jung; Regensburg/DE

14:48 B-1301

Biliary cast syndrome: which T1 weighted sequence is able to show it best in patients after liver transplantation?

14:48 B-1311

Pre-operative prediction of operating time for laparoscopic cholecystectomy using ultrasonographic and MRCP parameters

14:56 B-1312

Nutritional status as a negative prognostic factor for postoperative complications after pancreaticoduodenectomy

15:04 B-1313

14:00–15:30

15:12 B-1314

Room N

Is it possible to distinguish infarcted area and areaat-risk using native T1 map in patients with acute ST-elevation myocardial infarction? N. Galea, M. Francone, A. Fiorelli, L. De Luca, L. Agati, C. Catalano, I. Carbone; Rome/IT

Cardiac MR (2) Moderators: A. Esposito; Milan/IT, C. Herzog; Munich/DE

14:00 B-1305

Quantification of myocardial extra-cellular volume (ECV) in adenosine stress/rest perfusion CMR examinations: effect of contrast dose M. Caballeros, J. Madrid, P. Garcia Barquin, P. Bartolome, J. Pueyo, G. Bastarrika; Pamplona/ES

Correlation between MRI imaging of intestinal endometriosis and laparoscopy in 80 lesions A. Brandão, B. Barbosa, L. Cardeman, C. Crispi; Rio de Janeiro/BR

SS 1903

Accuracy and time-efficiency of an automated software tool to assess left ventricular volumes in cardiac MRI P. Bartolome, P. Garcia Barquin, A. Quilez, M. Caballeros, J.C. Pueyo, G. Bastarrika; Pamplona/ES

R. Cervelli, C. Cappelli, L. Barbarello, U. Boggi, C. Bartolozzi; Pisa/IT

15:12 B-1304

Late gadolinium enhancement (LGE) at 1.5 and 3 Tesla GE: can stronger fields detect more areas of fibrosis/necrosis? Preliminary evaluation A. Mancini, V. Vellucci, L. Patriarca, F. Bruno, L. Panebianco, M. Paoli, R. Masi, E. Di Cesare, C. Masciocchi; L’Aquila/IT

S. Vujnovic1, D. Stojanov2; 1Banjaluka/BA, 2Niš/RS

15:04 B-1303

Assessment of left-ventricle non-compacted myocardium magnetic resonance parameters modified by novel semi-automatic pixel intensitybased approach of trabeculae measurement E. Pershina, V. Sinitsin, E. Mershina; Moscow/RU

S. Kinner1, P. Hunold2, A. Dechene1, T. Lauenstein1, A. Laader1; 1 Essen/DE, 2Lübeck/DE

14:56 B-1302

Diagnostic performance of 3.0-T whole-heart coronary MR angiography performed as a part of routine contrast-enhanced CMR study

15:20 B-1315

Evaluation of miocardial viability in patients with coronary hearth disease: MR-diagnostics

Evaluation of left atrial function with MRI in patients with atrial fibrillation before and after pulmonary vein isolation and linear catheter ablation of the left atrial anterior line A. Curta, S. Fichtner, R. Wakili, H. Estner, H. Kramer; Munich/DE

A. Ikramov, N. Djuraeva, M. Pirnazarov, A. Amirkhamzaev, A. Chekeridi, T. Zulina; Tashkent/UZ

14:08 B-1306

14:00–15:30 Comparison of cardiac imaging planes for quantification of T1 maps and myocardial extracellular volume (ECV)

Oncologic Imaging SS 1916

M. Caballeros, J.M. Madrid, P. Bartolome, P. Garcia Barquin, J. Pueyo, G. Bastarrika; Pamplona/ES

14:16 B-1307

Assessment and prediction of treatment response Moderators: L.S. Fournier; Paris/FR, A. Gogbashian; Middlesex/UK

Diagnostic image contribution of gadoliniumenhanced VIBE sequences in cardiac MRI N. Guberina, T. Schlosser, F. Nensa, M. Forsting, K. Naßenstein; Essen/DE

14:24 B-1308

Studio 2016

Simple and rapid evaluation of left ventricular function in cardiac MRI A. Zidi, N. Mnif; Tunis/TN

14:00 K-37

Keynote lecture L.S. Fournier; Paris/FR

14:09 B-1316

Tumour response evaluation in daily practice: comparison between free-text evaluation and RECIST 1.1 criteria J. Goebel1, J. Hoischen2, H.P. Schemuth1, S. Kinner1, F. Nensa1, K. Nassenstein1; 1Essen/DE, 2Düsseldorf/DE

334

ECR 2016 | Final Programme

www.myESR.org

Scientific Sessions

14:17 B-1317

14:00–15:30 Prognosis of pN0 esophageal cancer: determined by characteristic of lymph nodes on pre- and post neoadjuvant chemotherapy multi-detector row CT Y.-K. Chi, Y. Chen, X.-T. Li, Y.-S. Sun; Beijing/CN

Room L8

Genitourinary SS 1907

Imaging of the reproductive system Moderators: G. Masselli; Rome/IT, K.B. Puzakov; Moscow/RU

14:25 B-1318

Enhancement on subtraction MRI can predict lesion progression of hepatic metastasis in malignant melanoma patients

14:00 B-1326

M. Lee, S.-E. Baek, H. Kim; Seoul/KR

14:33 B-1319

The added value of diffusion-weighted MRI in diagnosis of polycystic ovary syndrome: a preliminary study M. Deveer1, R. Deveer1, N. Cullu1, O. Yeniceri1, A. Sivrioglu2; 1Mugla/TR, 2 Istanbul/TR

18F-FDG PET/CT prognostic value in the treatment of metastatic melanoma with anti-PD1 monoclonal antibodies

14:08 B-1327

L. Facchetti, L. Nardo, K. Loo, A. Algazi, K. Tsai, A. Daud, M.H. Pampaloni; San Francisco, CA/US

Cyclic changes of the junction zone on 3T MR images in young and middle-aged females during the menstrual cycle: anatomical and functional values Y. He, N. Ding, H. Xue; Beijing/CN

14:41 B-1320

Prognostic value of baseline 18F-FDG PET/CT and laboratory parameters in treatment of metastatic melanoma with anti-PD1 monoclonal antibodies

14:16 B-1328

L. Nardo, L. Facchetti, K. Loo, A. Algazi, K. Tsai, A. Daud, M.H. Pampaloni; San Francisco, CA/US

14:49 B-1321

G. Durhan, H. Ünverdi, C. Deveci, M. Büyükşireci, T. Değirmenci, A. Bayrak, P. Koşar, S. Hücümenoğlu, Y. Ergün; Ankara/TR

Early shear-wave elastography measurements in liver metastasis after neoadjuvant chemotherapy: preliminary results

14:24 B-1329

J.F. Carlsen, C. Ewertsen, C. Lauritzen, M.B. Nielsen; Copenhagen/DK

14:57 B-1322

Estimated relative hepatic tumour burden at baseline CT in a colorectal cancer cohort treated first-line with targeted therapy: predictive relevance with respect to overall survival

Neuroendocrine tumours treated with 90Y-DOTATOC radionuclide therapy: early response assessment with whole body diffusion-weighted MRI predicts survival V. Vandecaveye, S. Van Binnebeek, R. Dresen, K. Haustermans, C. Verslype, E. Van Cutsem, F. De Keyzer, D. Christophe; Leuven/BE

15:13 B-1324

14:32 B-1330

14:40 B-1331

Pretreatment tumour CT density is associated with overall and progression-free survival and tumour growth in patients with metastatic renal cell carcinoma under antiangiogenic therapy S. Matoori, A. Sohaib, D.-M. Koh, Y. Thian, A. Gutzeit; Sutton/UK

Adnexal torsion: added diagnostic value of coronal reformations at CT Y. Yim, S. Jung, M. Yu, H. Park, Y. Kim, H. Jeon; Seoul/KR

14:48 B-1332

Role of diffusion-weighted magnetic resonance imaging of testes in patients with testicular varicocele J. Asogan Vaishnavi, S. C.R., A. Ali, H. Bhat, S. Sharma; Chennai/IN

14:56 B-1333

Injection free Imaging: evaluation of diffusion weighted MRI over contrast enhanced MRI in testicular torsion B. Jeevanandham; Coimbatore/IN

15:04 B-1334

SPEAKER SUPPORTED BY INVEST IN THE YOUTH

15:12 B-1335

Quantitative evaluation of dynamic contrast enhanced MRI in the differentiation between benign and malignant testicular lesions M. Saldari, V. Vinci, S. Bernardo, L. Manganaro, C. Catalano; Rome/IT

The role of imaging in paratesticular sarcomas D. Ap Dafydd, C. Messiou, K. Thway, E. Moskovic; London/UK

www.myESR.org

Final Programme | ECR 2016

335

Sunday

15:21 B-1325

The value of preoperative static and dynamic MRI for predicting occult stress urinary incontinence N. Li, C. Yu; Tianjin/CN

Added value of pre-treatment apparent diffusion coefficient in rectal cancer for predicting local recurrence M. Lee, S. Cho, G. Kim, H. Kim, K. Shin, S. Lee, W. Kim, J. Park, G. Choi; Daegu/KR

Apparent diffusion coefficient is significantly decreased in monochorionic diamniotic twin pregnancies with selective intrauterine growth restriction L. Fu; Shanghai/CN

N. Hesse, V. Heinemann, J. Holch, F. Hofmann, A. Baumann, M. D‘Anastasi, W. Sommer; Munich/DE

15:05 B-1323

Placental elasticity and histopathological findings in normal and intrauterine growth restriction pregnancies assessed with strain elastography in ex vivo placenta

Scientific Sessions

14:00–15:30

Room E2

Neuro SS 1911

15:20 B-1347

Movement disorders and neurodegenerative diseases

R. Ezhova, N. Ananyeva, I. Galsman, M. Davletkhanova, T. Rostovtseva; St. Petersburg/RU

Moderators: L. Haider; Vienna/AT, S. Lehéricy; Paris/FR

14:00 B-1337

Can 3D FLAIR reflect intact presynaptic dopaminergic function in patients with parkinsonism? S. Oh1, W. Lee2, N.-Y. Shin2, S.-K. Lee2, S. Lim2; 1Cheonan/KR, 2 Seoul/KR

14:08 B-1338

Special aspects of hippocampal morphology in patients with depressive disorders compared to healthy volunteers: neurocognitive and MRI comparison

14:00–15:30

Room F2

Physics in Radiology SS 1913

Peculiarities of tremor-related brain activation in Parkinson’s disease during motion: fMRI study

Physics of dual-energy CT and breast imaging Moderators: H. de las Heras Gala; Zorneding/DE, I.A. Tsalafoutas; Athens/GR

O. Omelchenko, Z. Rozhkova, I. Karaban; Kyiv/UA

14:16 B-1339

Increased connectivity between sensorimotor and attentional areas in Parkinson’s Disease

14:00 B-1348

M. Onu; Bucharest/RO

14:24 B-1340

Magnetic resonance spectroscopy of supraventricular areas and immunological markers in Parkinson disease J. Khomenko, E. Gromova, G. Kataeva, M. Karpenko, I. Milukhina, A. Bogdan; St. Petersburg/RU

14:32 B-1341

14:40 B-1342

J. Hansen1, C.M. Sommer2, S. Würstlin2, G. Pahn1, S. Skornitzke1, H.-U. Kauczor1, G.M. Richter2, W. Stiller1; 1Heidelberg/DE, 2 Stuttgart/DE

14:08 B-1349

Functional connectivity and gray matter volume changes in the Multiple-Demand Network of Parkinson patients C. Mathys1, F. Hoffstaedter2, J. Caspers1, M. Südmeyer1, C. Eickhoff2, K. Reetz3, B. Turowski1, A. Schnitzler1, S. Eickhoff1; 1Düsseldorf/DE, 2 Jülich/DE, 3Aachen/DE

14:16 B-1350

Differential functional connectivity changes of right DLPFC subdivisions in Parkinson’s disease 14:24 B-1351 Utility of susceptibility weighted imaging in differentiating patterns of iron deposition in Parkinson disease and the Parkinson-plus syndromes

15:04 B-1345

1H MRS and fMRI investigation of metabolism and dysfunction of the resting state default mode network in patients with Parkinson’s disease and different level of cognitive impairment

15:12 B-1346

Involvement of corpus callosum differs in bulbar vs. limb onset amyotrophic lateral sclerosis M.P. Vora; Himachal Pradesh/IN

336

ECR 2016 | Final Programme

Quantitative comparison of single-acquisition dualenergy iodine maps as an alternative to abdominal CT-perfusion measured with the Patlak model S. Skornitzke1, F. Fritz1, M. Klauß1, J. Hansen1, G. Pahn1, L. Grenacher2, H.-U. Kauczor1, W. Stiller1; 1Heidelberg/DE, 2Munich/DE

14:40 B-1353

Quantitative susceptibility mapping at 7T to evaluate the primary motor cortex of ALS patients G. Donatelli, M. Costagli, L. Biagi, D. Frosini, G. Siciliano, M. Tosetti, M. Cosottini; Pisa/IT

Spectral filtration in paediatric and adult chest CT examinations: a phantom study on dose reduction and image quality S. Suntharalingam1, S. Labus1, T. Allmendinger2, K. Nassenstein1, A. Wetter1; 1Essen/DE, 2Forchheim/DE

14:32 B-1352

Z.Z. Rozhkova, O. Omelchenko; Kiev/UA

Clinical investigation of single source dual energy computed tomography (SSDECT) accuracy in quantification of iodine concentration in calf liver simulated lesions C. Riedl, U. Mahmood, A. Agostini, L. Mannelli; New York, NY/US

C.S. Oustwani, A.W. Korutz, M. Lester, Y. Kianirad, T. Simuni, T. Hijaz; Chicago, IL/US

14:56 B-1344

Dual Energy CT (DE-CT) bone densitometry: assessing a potential alternative to DXA and quantitative CT (qCT) in imaging-based bone mineral density analysis P.C. Hofmann1, M. Sedlmair1, B. Krauss1, B. Schmidt1, J.L. Wichmann2, R.W. Bauer2, T.G. Flohr1, A.H. Mahnken1; 1Forchheim/DE, 2 Frankfurt a. Main/DE

J. Caspers, F. Hoffstaedter, C. Mathys, M. Südmeyer, E.C. Cieslik, C. Rubbert, B. Turowski, A. Schnitzler, S.B. Eickhoff; Düsseldorf/DE

14:48 B-1343

Evaluation of optimal dual-energy (DE) blending ratios for linearly generated DE-blended images in dependency of radiation exposure level and acquisition mode

Computed tomography blood flow measurements: a phantom experiment S. Prevrhal, C. Spink, M. Grass, M. Bless, A. Schlaefer, H. Ittrich, M. Regier, G. Adam; Hamburg/DE

14:48 B-1354

Beam width and beam edge measurements in CT, mammography and radiotherapy with a sustainable electronic ruler H. de las Heras1, K. Mair2, O. Blanck3, Q. AlZoubi4, B. Renger5, R. Klausz6, Y. Popova6, D. Coll-Segarra7, F. Schöfer1; 1Zorneding/DE, 2 Kempten/DE, 3Lübeck/DE, 4Amman/JO, 5Munich/DE, 6Buc/DE, 7 Nashville, TN/US

www.myESR.org

Scientific Sessions

14:56 B-1355

Towards a framework to objectively assess clinical image quality in digital mammography

14:40 B-1364

C. Balta1, R.W. Bouwman1, R.E. van Engen1, S. Schopphoven2, I. Sechopoulos1, N. Karssemeijer1, M.J.M. Broeders1, W.J.H. Veldkamp3; 1 Nijmegen/NL, 2Marburg/DE, 3Leiden/NL

15:04 B-1356

Y. Ohno1, A. Yaguchi2, T. Okazaki2, K. Aoyagi3, N. Sugihara3, S. Kaminaga3, T. Yoshikawa1, K. Sugimura1; 1Kobe/JP, 2Kawasaki/JP, 3 Otawara/JP

Comparison of phantom target detectability for synthetic and conventional digital mammograms L. Cockmartin, N.W. Marshall, E. Martens, G. Yegin, H. Bosmans; Leuven/BE

15:12 B-1357

14:48 B-1365

14:00–15:30

14:56 B-1366

Room D1

Chest 15:04 B-1367

CT-texture analysis of pulmonary ground glass nodules: tumour heterogeneity correlates with in-situ/minimally and invasive adenocarcinoma pathology

Performance of semi-automated software in segmenting ground-glass and solid components and comparison of software and pathology measurements in resected pulmonary adenocarcinomas J.G. Cohen1, R.-E. Yoo2, C. Park2, C. Lee2, D. Chung2, Y. Kim2, G. Ferretti1, B. Van Ginneken3, J. Goo2; 1Grenoble/FR, 2Seoul/KR, 3 Nijmegen/NL

14:16 B-1360

15:12 B-1368

14:00–15:30

Room D2

Interventional Radiology SS 1909

Endovascular Moderators: V. Bérczi; Budapest/HU, M. Krokidis; Cambridge/UK

CT texture analysis for independent prediction of tumour recurrence in patients with surgically resected adenocarcinoma of the lung

14:00 K-36 14:09 B-1376

E.T. Scholten1, C. Jacobs1, C. Schaefer-Prokop1, J. Rühaak2, H.J. de Koning3, M. Oudkerk4, P.A. de Jong5, M. Prokop1, B. van Ginneken1; 1Nijmegen/NL, 2Lübeck/DE, 3Rotterdam/NL, 4 Groningen/NL, 5Utrecht/NL

Fabrication and assessment of 3D printed anatomical models of the lower limb for femoral vessel access training in interventional radiology M.K. O’Reilly, G. Sugrue, T. Geoghegan, J.F.X. Jones; Dublin/IE

14:17 B-1369

Prostatic artery embolisation for benign prostatic hyperplasia: anatomical factors affecting the procedure performance A. Cannavale1, B. Maher2, T. Bryant2, N. Hacking2; 1Canterbury/UK, 2 Southampton/UK

14:25 B-1370

Uterine artery embolisation for adenomyosis: portending factors affecting the clinical outcome A. Cannavale1, D. Miligkos2, B. Maher2, B. Karunyam2, I. Wilson2, N. Hacking2; 1Canterbury/UK, 2Southampton/UK

www.myESR.org

Final Programme | ECR 2016

337

Sunday

Lung cancer textural analysis: to contrast or not to contrast

Temporal subtraction of chest CT in lung cancer screening

Keynote lecture C. Binkert; Winterthur/CH

A. Farchione, A. Larici, N. Dinapoli, R. Gatta, C. Masciocchi, A. Damiani, P. Franchi, V. Valentini, L. Bonomo; Rome/IT

14:32 B-1362

Baseline prognostication in diffuse fibrosing lung diseases (FLD): evaluation of computer-based quantitative CT analysis against visual CT analysis and pulmonary function tests (PFT) J. Jacob1, B. Bartholmai2, A. Brun1, R. Egashira3, R. Karwoski2, M. Kokosi1, S. Raghunath2, A. Wells1, D. Hansell1; 1London/UK, 2 Rochester, MN/US, 3Saga/JP

J. Jang1, H. Koo1, Y. Sung1, H. Xu2, C.-M. Choi1, J. Lee1, M. Kim1; 1 Seoul/KR, 2Nanjing/CN

14:24 B-1361

Longitudinal analysis in idiopathic pulmonary fibrosis: changes in lung mass as a new biomarker for quantitative computed tomography T. Kracke, B. Hensen, T.A. Alten, O. Solyanik, T. Werncke, A. Prasse, A. Großhennig, F. Wacker, H.-O. Shin; Hannover/DE

J.G. Cohen1, E. Reymond1, M. Medici1, M. Lederlin2, F. Laurent3, A.-C. Toffart1, A. Jankowski1, S. Lantuejoul1, G.R. Ferretti1; 1 Grenoble/FR, 2Rennes/FR, 3Bordeaux/FR

14:08 B-1363

Prediction of decline in forced vital capacity by texture-based automated quantification of regional disease patterns on initial CT in idiopathic pulmonary fibrosis H. Park, S. Lee, J. Seo, S. Lee, N. Kim, S. Oh, J. Song; Seoul/KR

Computer-based quantification and texture analysis Moderators: R. Cesar; Golnik/SI, M. Regier; Hamburg/DE

14:00 B-1358

Influence of computed tomography dose reduction and iterative reconstruction on pulmonary nodule volumetry A.M. den Harder1, M.J. Willemink1, R.W. van Hamersvelt1, E.-j.P. Vonken1, A.M. Schilham1, J.-W.J. Lammers1, R.P. Budde2, T. Leiner1, P.A. de Jong1; 1Utrecht/NL, 2Rotterdam/NL

Phantom and visual grading analysis of three breast tomosynthesis reconstruction methods K. Michielsen, C. Van Ongeval, A. Van Steen, M. Keupers, J. Soens, H. Ghunaim, D. Petrov, L. Cockmartin, J. Nuyts; Leuven/BE

SS 1904

FIRST vs AIDR 3D vs. FBP methods: accuracy of computer-aided volumetry (CADv) for lowdose lung cancer CT screening protocols in QIBA recommended lung nodule phantom study

Scientific Sessions

14:33 B-1371

Fourteen-year experience of PAVMs embolisation in patients with hereditary haemorrhagic telangiectasia: what has changed?

14:24 B-1382

S. Bongiovanni, A. Antonietti, A. Balderi, F. Pedrazzini, D. Sortino, M. Grosso; Cuneo/IT

14:41 B-1372

Optimisation of image quality and dose in direct digital chest radiography for a neonatal chest phantom, using Cu filtration V. Harsaker, A. Raszkowski, C. Cin, S. Bamboi, T. Granhus; Oslo/NO

14:32 B-1383 Endosaccular embolisation of visceral artery aneurysms with adjunctive techniques M. Maruno, H. Kiyosue, S. Tanoue, N. Hongo, S. Matsumoto, H. Mori; Yufu-shi/JP

Computed ultra high b value diffusion-weighted MR imaging of the prostate: what is the clinical added value of extrapolated b3000 images for prostate cancer detection? M. Hakkert, M. Hakkert; Haarlem/NL

14:49 B-1373

Investigation of international conformance of health economic analyses by comparing open and endovascular repair of abdominal aortic aneurysm regarding costs and outcomes A. Nagy, E. Nagy, A. Palkó, Z. Palásthy, T. Takács, L. Baráth; Szeged/HU

14:57 B-1374

Inducing false lumen thrombosis in type B aortic dissection by selectively excluding true lumen reentry points M. Wojtaszek, E. Wnuk, R. Maciag, K. Lamparski, K. Korzeniowski, O. Rowinski; Warsaw/PL

15:05 B-1375

Endovenous radiofrequency ablation for the treatment of varicose veins: a single center experience S. Riva, G. Guzzardi, R. Fossaceca, P. Cerini, A. Galbiati, A. Carriero; Novara/IT

15:13 B-1377

In vitro quantitative analysis of blood flow blockage effect of Amplatzer vascular plugs (AVP): comparison of AVP-I and AVP-II K. Hidaka, T. Tajikawa, K. Osuga; Suita/JP

15:21 B-1378

14:40 B-1384

A.R.R. Videira, S.R.R. Martins, M.C.P. Ribeiro, P.J. Sousa, J.G.C. Mascarenhas; Lisbon/PT

14:48 B-1385

14:56 B-1386

Radiographers SS 1914

Assessment of image quality criteria from brain MRI examinations L.P. Ribeiro, C. Alves, A.M. Ribeiro, A.F.C.L. Abrantes, K.B. Azevedo, O. Lesyuk, N.M. Pinto, R.P.P. Almeida; Faro/PT

15:04 B-1387

Reducing metal artefacts in MRI: a retrospective analysis of improved diagnostic quality and reporting confidence without the use of specialised commercial pulses/techniques C. Pereira, K. Partington; Oxford/UK

15:12 B-1388

Carotid stents: seven-year experience

Room G

Optimisation of MR imaging for the evaluation of human placental anatomy E. Routledge, C. Malamateniou, M. Lohezic, J.M. Allsop, M.J. Fox, B. Kainz, A. Price, J.V. Hajnal, M.A. Rutherford; London/UK

Reduction in respiratory motion artefacts on gadoxetate-enhanced (Primovist) MRI after training technicians A. Gutzeit, J. Fröhlich, S. Matoori; Zurich/CH

T. Kokovic, V. Till, A. Petres, D. Ilic, S. Stojanovic; Novi Sad/RS

14:00–15:30

Magnetic resonance cholangiopancreatography applying a natural negative oral contrast - black tea

15:20 B-1389

Evaluation of the corpus callosum by MRI related to the frontal atrophy in the elderly people M.C.P. Ribeiro, J.E. O’Neill, J.F. Cruz-Maurício; Lisbon/PT

How to improve image quality in MRI and mammography Moderators: B. Bougias; Ioannina/GR, E. Szabó; Szeged/HU

14:00 B-1379

Breast compression: an exploration of decision making in mammography J.M. Nightingale, F.J. Murphy, L. Robinson; Greater Manchester/UK

14:08 B-1380

A system for automatic mammography images quality control - images acquisition and examination A. Golja, S. Androjna, U. Štrekelj, I. Koceva, J. Izlakar, N. Mekiš, J. Žibert; Ljubljana/SI

14:16 B-1381

A system for automatic mammography images quality control: a development of a system for automatic image artifacts detection A. Iskra, G. Bensa, J. Šomen, K. Lokar, M. Podvratnik, U. Zdešar, N. Mekiš, J. Žibert; Ljubljana/SI

338

ECR 2016 | Final Programme

www.myESR.org

Clinical Trials in Radiology

12:30–13:30

Room D2

Clinical Trials in Radiology 1 Moderators: R. Arenson; San Francisco, MI/US M. Dewey; Berlin/DE

12:30 The Swedish CArdioPulmonary BioImage Study (SCAPIS): objectives and design

Wednesday

G. Bergström1, A. Blomberg2, J. Brandberg1, K. Cederlund3, G. Engström4, J. Engvall5, M.G. Hansson6, T. Jernberg3, L. Lind6, E. Lindberg6, M. Persson4, A. Rosengren1, J. Sundström6, S. Söderberg2, K. Torén1, C. Östgren5; 1Gothenburg/SE, 2Umeå/SE, 3 Stockholm/SE, 4Lund/SE, 5Linköping/SE, 6Uppsala/SE

12:40 Discussant: G. Krombach; Giessen/DE

12:45 NSsaFe study: observational study on the incidence of nephrogenic systemic fibrosis in renal impaired patients following gadoteric acid administration A. Gottschalk, B. Kress; Frankfurt a. Main/DE

12:55 Discussant: G. Heinz-Peer; St. Pölten/AT

13:00 Computed tomography angiography vs Agatston score for diagnosis of coronary artery disease: results from the international Collaborative Meta-Analysis of Cardiac CT (COME-CCT) V. Wieske1, H. Alkadhi2, S. Leschka3, B.L. Nørgaard4, J. Knuuti5, A.C.P. Diederichsen6, B.A. Halvorsen7, H. Mickley6, K. Sun8, R.R. Büchel2, S. Muraglia9, R. Marcus10, M. Walther11, P. Schlattmann11, M. Dewey1; 1Berlin/DE, 2Zurich/CH, 3St. Gallen/CH, 4 Aarhus/DK, 5Turku/FI, 6Odense C/DK, 7Fredrikstad/NO, 8 Inner Mongolia Province/CN, 9Trento/IT, 10Tübingen/DE, 11Jena/DE

13:10 Discussant: L. Saba; Cagliari/IT

13:15 Efficient use of medical imaging in Belgium: where does it go wrong in prescribing imaging studies for the lumbar spine and abdomen? A national multicentric study N. Stichelbaut, P. Hoste, B. De Roo, L. Annemans, K. Verstraete; Ghent/BE

13:25 Discussant: F.J. Gilbert; Cambridge/UK

www.myESR.org

Final Programme | ECR 2016

339

Clinical Trials in Radiology

12:30–13:30

Room D2

Clinical Trials in Radiology 2 Moderators: R. Arenson; San Francisco, CA/US M. Dewey; Berlin/DE

12:30 MR-targeted vs TRUS-guided prostate biopsy in patients with high PSA values: a randomized controlled trial F. Russo1, S. Mazzetti1, V. Giannini1, A. Giacobbe2, D. Collura2, E. Castelli2, G. Muto3, D. Regge1; 1Candiolo/IT, 2Turin/IT, 3Rome/IT

12:40 Discussant: P. Asbach; Berlin/DE

12:45 The multicentre DISCHARGE trial pilot study: Image quality and protocol adherence results G. De Rubeis1, M. Dewey2, on behalf of the DISCHARGE Consortium; 1 Rome/IT, 2Berlin/DE

Thursday

12:55 Discussant: R. Vliegenthart; Groningen/NL

13:00 Dynamic stress perfusion CT for detection of inducible myocardial ischemia: rationale and design of the SPECIFIC-trial F. Bamberg1, B. Ghoshhajra2, U. Hoffmann2, K. Kitakawa3, A. Kono4, R. Vliegenthart5, P. van der Harst5, H. Alkadhi6, R. Manka6, U. Schoepf7, D. Steinberg7, S. Achenbach8, M. Lell8, T. Geisler1, K. Nikolaou1, F. Pugliese9, A. Coenen10, K. Nieman10; 1Tübingen/DE, 2 Boston, MA/US, 3Mie/JP, 4Kobe/JP, 5Groningen/NL, 6Zurich/CH, 7 Charlston, SC/US, 8Erlangen/DE, 9London/GB, 10Rotterdam/NL

13:10 Discussant: S. Kajander; Turku/FI

13:15 The impact of breast MRI on surgical planning and reoperation rate: first results from the MIPA study R.M. Trimboli1, G. Di Leo1, D. Sacchetto2, R. Mann3, M. Álvarez Benito4, C. Zuiani5, E. Wenkel6, K. Siegmann-Luz7, M. Lobbes8, C. Balleyguier9, K. Pinker-Domenig10, M. Calabrese11, J. Veltman12, U. Aksoy Ozcan13, F. Pediconi14, J. Camps Herrero15, G. Forrai16, S. Harms17, I.-M. Obdeijn18, M. Van Goethem19, M. Docema20, J. Anderson21, C. Losio22, F. Gilbert23, T. Helbich10, N. Houssami24, F. Sardanelli1; 1San Donato Milanese/IT, 2 Turin/IT, 3Nijmegen/NL, 4Cordoba/IT, 5Udine/IT, 6Erlangen/DE, 7 Tübingen/DE, 8Maastricht/NL, 9Villejuif/FR, 10Vienna/AT, 11Genoa/IT, 12 Almelo/NL, 13Istanbul/TR, 14Rome/IT, 15Alzira/ES, 16Budapest/HU, 17 Fayetteville, AR/US, 18Rotterdam/NL, 19Edegem/BE, 20 São Paulo/BR, 21Perth/AU, 22Milan/IT, 23Cambridge/GB, 24 Sydney/AU

13:25 Discussant: E.M. Fallenberg; Berlin/DE

340 ECR 2016 | Final Programme

www.myESR.org

LIST OF AU T H O R S & C O -AU T H O R S

341

List of Authors & Co-Authors

A Aandahl I.-J.: B-0711 Abadal Villayandre J.: B-0126 Abaza R.: B-0825 Abbas W.M.: B-0091 Abbas Y.: B-0087 Abd El Razik N.: B-0612, B-1279 Abd Ellah M.: B-0563 Abd Ellah M.M.H.: B-0273, B-0960 Abdel Aal A.M.K.: B-0544, B-0998 Abdel Latif M.: B-0133 Abdel Razek N.M.: B-0017, B-1065 Abdelhady Mohammed D.: B-0356 Abdolell M.: B-1120, B-1125, B-1206 Abdul Rahman D.: B-0888 Abdulkadir Tabari M.: B-1095 Abdullayev N.: B-0295, B-0493, B-0953 Abe H.: B-0429 Abegunewardene N.: B-0455 Abel T.: B-0492 Abeyakoon O.: B-1274 Abidi Z.: B-1113 Abishev B.: B-1097 Ablasser K.: B-1079 Abo El-Regal A.: B-0663 Aboelsouad A.M.: B-0563 Abolhasani Foroughi A.: B-1107 Aboud C.: B-0498 Abouelenein S.D.: B-0565 Abou-Elghar M.E.: B-0579 Abrantes A.F.C.L.: B-0150, B-0152, B-0351, B-0713, B-0717, B-0869, B-0873, B-1006, B-1010, B-1015, B-1246, B-1249, B-1251, B-1386 Abu Hamdeh S.: B-0203 Abu-Eid M.: B-0721 Abu Rabia A.: B-0612, B-1279 Acampora C.: B-0518 Achenbach S.: CTiR 2 Acil M.: B-0469 Ackermann H.: B-0357 Ács N.: B-0471 Adam A.: A-045, A-477 Adam E.J.: A-685 Adam G.: B-0007, B-0049, B-0206, B-0361, B-0382, B-0478, B-0550, B-0574, B-0622, B-0634, B-0642, B-0855, B-0982, B-0993, B-1099, B-1156, B-1219, B-1224, B-1353 Adamsbaum C.: B-0367 Adamus R.: B-1000 Adcock I.: A-625 Adelsmayr G.: B-0052, B-0257 Adler D.: B-0588 Adlercreutz C.: B-0850 Adriaensen M.E.A.P.: B-0075, B-0930 Adubeiro N.: B-0703 Agarwal R.: B-1137 Agasthya G.: B-1131 Agati L.: B-1314 Ageev A.: B-0154 Ageitos-Casais M.C.: B-1168 Agewall S.: B-0749 Agladioglu K.: B-0155

342

ECR 2016 | Final Programme

Agni R.: B-0982 Agostini A.: B-1350 Agten C.A.: B-0915 Aguilar M.: B-0401 Aguirre S.: B-0851 Ahlström H.: B-0388 Ahmad H.: B-0400 Ahmed S.: B-0387 Ahn J.H.: B-0918 Ahn K.: B-0646 Ahn K.J.: B-0651 Ahn K.-J.: B-0645 Ahn S.J.: B-0090 Ahoubim D.: B-0360 Ai H.G.V.: B-0321 Ai V.: B-0988 Ailianou A.: A-254 Aime S.: A-335 Aissa J.: B-0044, B-0099, B-0394 Ajlan A.: B-0708 Akata D.: A-803, K-13 Akbas T.: B-0469 Akesson M.: A-111 Akisik F.: B-0001, B-0003 Aksoy Ozcan U.: CTiR 2 Akudugu J.M.: B-0173 Akyuz Y.: B-0598 Al Johi R.S.: B-1034 Al Qarni A.O.: B-0509 Alam T.: B-0305 Albanese S.: B-0369 Albano D.: B-0658 Albarello F.: B-0137 Albarello L.: B-0781 Alberich-Bayarri A.: B-1112 Albers P.: B-0334, B-0335 Albert N.L.: A-179 Alberts A.R.: B-0336, B-0340 Albiin N.: B-1270 Albillos J.C.: B-0311, B-1292 Albrecht M.H.: B-0357, B-0432, B-0483, B-0877, B-0878, B-0967, B-0976, B-1178, B-1222 Albrecht P.: B-0893 Albucher J.F.: B-0818 Alcalá-Galiano A.: A-020 Aldrighetti L.: B-1298 Alessi S.: B-0705, B-0950 Alexiou G.: B-1059 Alfaro I.: B-0446 Algazi A.: B-1319, B-1320 Alghamdi M.: B-0708 Algra P.R.: B-0036 Alhan A.: B-0082 Alhasan A.S.: B-1115 Ali A.: B-1332 Alì M.: B-0122, B-0199 Aliberti S.: A-623 Alkadhi H.: A-122, A-554, B-0176, B-0519, B-1200, B-1209, B-1289, CTiR 1, CTiR 2 Allam K.E.: B-0607 Allegranza P.: B-1196 Allen C.: B-0948 Allen G.M.: B-0280, B-1185 Allen, Jr. B.: A-288

Allmendinger T.: B-1351 Allsop J.: B-0897 Allsop J.M.: B-1385 Almansoori T.: B-1192 Almeida R.P.P.: B-0150, B-0152, B-0351, B-0713, B-0717, B-0869, B-0873, B-1006, B-1010, B-1015, B-1246, B-1249, B-1251, B-1386 Almeida-Gonzalez C.: B-1020 AlObaidy M.: B-0198, B-0200 Alogna A.: B-0257 Alomaim W.: B-1122 Alonso J.-M.: A-691 Alper F.: B-0625 Alperin N.: B-0396 Alqahtani M.S.: B-0033 Alqahtani S.J.M.: B-0709 Alraddadi M.: B-0708 Alt C.D.: A-450, A-636 Alten T.A.: B-1367 Althubaiti M.: B-0708 Altintas S.: B-0473 Aluja F.: B-0202 Álvarez Benito M.: CTiR 2 Alvarez de Sierra Garcia B.: B-0072 Alvarez Perez M.J.: B-0126 Alvarez-Cofiño A.: B-0446 Alvarez-Linera J.: A-041 Alves C.: B-1386 Alves M.: B-1245 AlZoubi Q.: B-1354 Amadu A.M.: B-0254 Amant F.: B-1037, B-1038, B-1141 Amata L.: B-0354 Ambady P.: B-0285 Ambrosi A.: B-0031, B-0291, B-0343, B-0629 Ambrosino P.: B-0843, B-0844, B-0845 Amer H.: B-0926, B-1135 Amin W.M.: B-0808 Amirkhamzaev A.: B-1305 Amitai M.: B-0472, B-0680 An D.: B-0051 An Y.Y.: B-0606 Ananyeva N.: B-1164, B-1347 Andersen E.N.: B-0716 Andersen H.K.: B-0105 Anderson J.: CTiR 2 Andersson B.T.: A-407 Andersson J.: K-04 Andersson J.S.: B-0303 Anderzen-Carlsson A.: B-1013 Ando T.: B-0223, B-0531, B-1277 Andrade Almeida M.E.: B-0868 Andrade L.: B-1163 Andrassy J.: B-0088 Andreini D.: B-0377, B-0480, B-0742, B-1075, B-1076 Andreisek G.: A-261, B-0554 Andres Mateo A.: B-1282 Andresen R.: B-0616 Androjna S.: B-1380 Andronikou- Zouvani M.: B-0632 Angele M.: B-0296

www.myESR.org

List of Authors & Co-Authors

Angelelli G.: B-0421, B-0468, B-0631, B-1067, B-1256 Angelini G.: B-0425 Angst F.: B-1289 Annan M.: B-0815 Annemans L.: CTiR 1 Annoni A.: B-1076 Annoni A.D.: B-0480 Anooshiravani-Dumont M.: A-493 Ansaloni F.: B-0137 Ansari S.: B-0822 Ansari S.A.: B-0647, B-0652 Antoch G.: A-727, B-0044, B-0099, B-0334, B-0335, B-0394, B-0545, B-0560, B-0656, B-0657, B-0901, B-1036 Antón Mendez L.: B-0358 Antonelli A.: B-0168 Antonietti A.: B-1371 Antonuccio E.G.M.: B-0999 Antunes S.: B-0626, B-0629, B-1074, B-1145 Anyamene N.: B-0700, B-0947 Aoki S.: A-571 Aoyagi K.: B-0655, B-1364 Ap Dafydd D.: B-1335 Apaydın A.: B-1024 Apter S.: B-0472 Arapis K.: B-0633 Archakov D.: B-1194 Arcidiacono A.: B-0271 Arcidiacono P.G.: B-0291 Arcuri P.P.: B-0366 Arendt C.R.T.: B-1077 Arenson R.L.: A-474 Arfi-Rouche J.: B-1061 Argyropoulou I M.: B-1059 Argyropoulou M.I.: A-790 Arias L. M.E.: B-0521 Aris R.: B-0851 Arivudainambi D.: B-0506, B-0751 Armada-da-Silva P.: B-0712 Armando E.: B-0482, B-0707 Armas M.A.: B-0243 Armbruster M.: B-0088, B-0719, B-0777, B-1182 Arpaci T.: B-0469 Arponen O.: B-1118 Arranja A.: B-0514 Arrieta Artieda I.: B-0520 Arrigo A.: B-0821 Arrigoni F.: A-778, B-0324, B-0331, B-0332, B-0959, B-1100, B-1226 Arsov C.: B-0334, B-0335 Arulkumaran S.: B-0897 Arvanitaki M.: A-062 Asadi H.: B-0267 Asbach P.: B-0159, B-0697, B-0945 Ashkar L.: B-0708 Askarova L.: B-1111 Aslan K.: B-0082 Asogan Vaishnavi J.: B-1332 Aspelin P.: B-0196 Assi V.: B-0741 Astley S.: B-1136 Åström G.K.O.: A-775 Aswani Y.: B-0277

www.myESR.org

Atay O.A.: B-0270 Atci N.: B-0885 Atta H.: B-0563 Attard S.: B-0718 Attenberger U.: B-0141, B-1161 Auernhammer C.: B-0296 Autret G.: B-0097 Auvinen P.: B-1118 Auweter S.: B-0671 Avanesov M.: B-0049, B-0574, B-0622, B-1156 Avcu S.: B-0171 Avesani G.: B-0004, B-0005 Aviano D.: B-0874 Aviram G.: B-0115, B-0116 Avni F.E.: A-139 Avsenik J.: B-1106 Aydin Y.: B-0625 Aydingoz U.: A-262, B-0270 Ayuso C.: A-316, B-0446 Azarine A.A.A.: B-0763 Azavedo E.: A-343 Azevedo K.B.: B-0150, B-0152, B-0351, B-0717, B-0869, B-0873, B-1010, B-1246, B-1249, B-1251, B-1386 Aziza R.: B-0337 Aznar-Méndez R.: B-1020 Azpeitia J.: B-0311, B-1292 Azzam H.A.M.A.: B-1066

B Baan Jr. J.: B-0792, B-1148 Baar I.: B-0403, B-0803 Baba A.: B-1189 Babaeva D.: B-0592 Bacchi Reggiani M.L.: B-0111 Bachelot T.: B-0123 Bacher K.: B-0675, B-0920, B-1202 Bach-Gansmo T.: B-0211 Bachmann Nielsen M.: A-647 Backlund J.: B-1181 Badia S.: B-0780 Bae K.: B-0010 Baek J.H.: B-1023 Baek S.-E.: B-1318 Baessler B.: B-0047, B-0048 Baggiano A.: B-0377, B-0480, B-1075 Baglio I.: B-1253, B-1254 Bagyura Z.: B-0747 Bai L.: B-0025 Baik J.S.: B-0804, B-0917 Baiocco S.: B-0434, B-0435, B-0437, B-0515 Baiomy A.: B-0567 Bajin D.: B-0726 Bajwa R.: B-0267 Bak A.: B-1227 Bakers F.: B-0244, B-0245 Bakker A.: B-0711 Bal C.S.: B-0084 Balageas P.: B-1223 Balaji R.: B-0506, B-0751, B-0828, B-0887 Balbi T.: B-1231 Balbo Mussetto A.: B-0566, B-0659 Baldassari P.: B-0238

Balderi A.: B-1371 Balestriero G.: B-0745 Bali M.A.: A-723 Balkenhol M.: B-0535 Ball P.: B-1080 Balleyguier C.S.: A-025, A-379, B-1061, B-1121, CTiR 2 Ballicu N.: B-0333 Balodis A.: B-0816 Balta C.: B-1355 Baltzer P.A.: B-1126 Baltzer P.A.T.: A-245, A-346, A-527, B-0220, B-0423, B-0428, B-0757, B-0758, B-0944, B-1116, B-1240, B-1259 Balvay D.: B-0097 Balzarini L.: B-0325 Bamber J.: B-1117 Bamberg F.: A-328, B-0292, B-0312, B-0667, CTiR 2 Bamboi S.: B-1382 Bangma C.H.: B-0336, B-0340 Bankier A.A.: A-762 Bannas P.: B-0206, B-0322, B-0361, B-0492, B-0622, B-0982, B-1099 Bansal K.: B-0009 Bao J.: B-0059 Bao Y.: B-0966 Baracchini C.: B-0061 Barakat M.S.: B-0808 Baraliakos X.: B-0069 Baratella E.: B-0848 Baráth L.: B-1373 Baratto F.: B-1074 Barbagallo S.: B-0760 Barbarello L.: B-1303 Barbazeni G.: B-1253 Barbiani C.: B-0054 Barbosa B.: B-1304 Barbosa F.: B-0772 Barbuto L.: B-0453 Barcelo J.: B-0019 Bargellini I.: B-0093 Barile A.: B-0324, B-0331, B-0332, B-0959 Baritussio A.: B-0254 Barkhof F.: A-657, A-772, B-1105 Barmettler F.: B-0422 Baron R.L.: A-133 Barone D.: B-0434, B-0435, B-0437, B-0515 Barrett N.A.: B-1217 Barry J.: B-1021 Barsi P.: B-0079, B-0080 Barth B.K.: B-0698 Bartholmai B.: B-0112, B-0586, B-0587, B-1368 Bartolome P.: B-1306, B-1312, B-1313 Bartolotta T.V.: B-0533 Bartolozzi C.: A-314, A-541, B-0093, B-1303 Bartsch H.: B-1149 Bartstra J.: B-0488 Bartykowszki A.: B-0747 Barwick T.: A-088 Basilico R.: A-378, A-555, A-743 Ba-Ssalamah A.: A-424, A-614 Bassi M.: B-0241, B-0834, B-1238 Bässler M.: B-0846

Final Programme | ECR 2016

343

List of Authors & Co-Authors

Bastarrika G.: B-1306, B-1312, B-1313 Basten L.: B-0129, B-0860 Batista W.: B-0868 Batohi B.: B-0928 Battaglia E.: B-0422 Battisti G.: B-0053 Battyáni I.: B-0613 Batur A.: B-0625 Baudimont F.: B-0201 Bauer J.S.: B-0485, B-1184, B-1193 Bauer R.: B-0186 Bauer R.W.: B-0213, B-0483, B-0877, B-0878, B-0967, B-0976, B-1077, B-1178, B-1222, B-1349 Bäuerle T.: A-526 Baum T.: B-0485, B-1184 Baumann A.: B-0189, B-1322 Baumeister R.: B-0438 Baumfeld D.S.: B-0635 Baur I.: B-0378 Baur P.: B-0720 Baxa J.: B-0508 Baykara M.: B-0065, B-0066, B-0637 Bayrak A.: B-1328 Bayraktutan U.: B-0598 Baysal O.: B-0270 Baysal T.: B-1199 Bazzocchi M.: B-0220, B-0605 Becherer A.: B-1175 Becker A.S.: B-0026 Becker C.D.: A-330 Becker D.: B-0248, B-0457 Becker M.: A-592 Becker N.: B-1211 Beckers R.C.J.: B-0191, B-0192, B-1160 Bedlington N.: A-529, A-583 Bednarova I.: B-0605 Bednarova S.: B-0605 Beer A.J.: A-517 Beer M.: A-622, B-0883 Beeres M.: B-0878 Beets G.: B-0244, B-0245, B-0776, B-1165 Beets G.L.: A-431, B-0191, B-0192, B-1160, B-1163, B-1166, B-1168 Beets-Tan R.G.H.: A-433, B-0191, B-0192, B-0244, B-0245, B-0776, B-1160, B-1163, B-1165, B-1166, B-1168, B-1281 Begemann P.: B-1132 Behairy N.H.: B-0050 Behr M.: B-1193 Behzadi C.: B-0550, B-0574, B-0642, B-0993 Beigelman C.: A-404 Beimanov A.: B-0800 Beji H.: B-0123, B-0329 Belch J.J.F.: B-0748 Belgrano M.: B-0476 Bell L.C.: B-0322 Bell M.: B-1017 Beller C.J.: B-0764 Bellera C.: B-0298 Belli A.-M.: A-681, A-684 Belli P.: B-0020 Bellin M.-F.: A-198 Belousova E.: B-0732, B-1264

344

ECR 2016 | Final Programme

Beltrachini L.: A-603 Ben Salem D.: B-0665, B-0949 Benadjaoud M.: B-0037 Bende F.: B-1087 Bende F.B.: B-1086 Bender B.: B-0286 Bendet A.: B-0115, B-0116 Bendszus M.: B-0282, B-0497 Benea G.: B-0241, B-0834, B-1238 Benedek A.: B-0923 Benedetti G.: B-0256, B-0638 Benegas-Urtega M.: B-1046 Bengzon J.: B-1055 Benito A.: B-0344, B-0702 Benito C.: B-0311, B-1292 Bennani-Baiti B.: B-1126 Bennet A.: B-0711 Bensa G.: B-1381 Bensch F.V.: B-0689, B-0691 Bensler S.: B-0915 Bensouda Mourri A.: B-1138 Bensoussan J.: B-0157 Benz D.: B-0519 Beomonte Zobel B.: B-0674 Bérczi V.: B-0471 Berezina N.: B-0830, B-0831 Bergendal G.: B-0196 Berger N.: B-1134 Berges O.: B-0153 Bergin D.: B-1017 Berglund T.: B-0871 Bergström G.: CTiR 1 Berk E.: B-0637 Berliere M.: B-1283 Berlin L.: A-124 Berliner C.: B-0855 Berliner S.: B-0115, B-0116 Bernard C.: B-0276 Bernardes M.: B-1048 Bernardini A.: B-0404, B-0687 Bernardino E.: B-1010 Bernardo S.: B-0168, B-0894, B-0896, B-1334 Bernardoni A.: B-0813, B-0964 Bernathova M.: B-0758, B-1259 Bernsen M.: B-0514 Berritto D.: A-366 Bertolini M.: B-0922 Bertolotto M.: A-234 Bertram S.: B-0411 Bertrand P.: B-1115 Berzovini C.M.: B-0053 Besostri V.: B-0299, B-0662 Best J.: B-0411 Betancourth J.E.: B-0536 Betka J.: B-0728 Beuers U.H.: B-1091 Beuf O.: B-1088 Bevilacqua A.: B-0434, B-0435, B-0437, B-0515 Beyer S.E.: B-0793 Beyer T.: A-043, A-099, A-728, B-0668, B-0899 Beytelman A.: B-0686 Bezrukov I.: B-0904

Bezzi M.: A-616 Bezzina P.: A-646, B-1252, K-31 Bhadoria A.S.: B-0009 Bhat H.: B-1332 Bhatia B.: B-0033 Bhatnagar S.: B-0078 Bhawat K.: B-0611 Bhullar K.: B-0084 Biagi L.: B-1345 Bianek-Bodzak A.: B-1027 Bick U.: A-640 Bickel H.: B-0428, B-0944 Bidaut L.: B-0442 Bielecki M.: B-0113 Bier G.: B-0039, B-0297 Bignotti B.: B-0016, B-0760, B-1069 Bílal N.: B-0171 Bilbao González A.: B-0358 Bilbao J.I.: A-305, A-700 Bilello M.: B-0801 Bilir Ö.: B-0694 Bind M.: B-0042 Binder J.S.: B-1079 Binkert C.: K-36 Binzel K.: B-0028, B-0029, B-0374, B-0556 Biondetti P.R.: B-0525 Biondi A.: K-08 Biondi M.: B-0354 Biondi T.: B-0780 Bipat S.: B-0444, B-0451 Birch J.: A-586 Birchall J.: B-0353 Birnbacher L.: B-0547, B-1149 Bisceglia C.: B-1074 Bisdas S.: A-516, B-0286, B-0317 Bisschops B.: B-0217 Bitker M.-O.: B-0699 Bize J.: B-1286 Bize P.: B-0247 Björkman-Burtscher I.M.: A-283, A-558, B-0850 Blackledge M.: B-1258 Blanck O.: B-1354 Blanke P.: A-054 Blasco G.: B-0498, B-0502, B-0503, B-1271 Bless M.: B-1353 Bley T.A.: B-0314, B-1045 Bleyen L.: B-0920 Bloch B.N.: B-0013 Bloem J.L.: A-463 Blomberg A.: CTiR 1 Blomberg B.A.: B-0768 Blomstergren A.: B-1055 Blondin D.: B-0334, B-0335 Bloomfield C.: B-1244 Blüher M.: B-0983 Boada M.: B-0019 Bockisch A.: B-0068, B-0901 Böckler D.: B-1210 Boddaert N.: B-0163 Bodelle B.: B-0877, B-0878, B-0976, B-0994 Bodião I.: B-1006 Bodner G.: B-0278, B-0279 Boehm A.: B-0906

www.myESR.org

List of Authors & Co-Authors

Boellaard R.: A-761 Boellaard T.N.: B-0444 Boersma L.: B-0420 Boettger I.: B-0074 Bogaert J.: A-548 Bogdan A.: B-1340 Boggi U.: B-1303 Bogner P.: B-0285 Bogsrud T.V.: B-0211 Bogunia-Kubik K.: B-0064 Böhm M.: B-0619 Bokhorst L.P.: B-0336, B-0340 Boland G.: A-258, A-418 Boll D.: B-0570 Bollwein C.: B-0968 Bolog N.: B-0554 Bonaffini P.A.: B-0092, B-0096, B-0441, B-0767, B-0805, B-0835, B-1030, B-1084 Bonatti G.: B-0819 Bonatti M.: B-0819 Bondesson D.: B-0989 Bonekamp D.: B-0282 Bongiovanni S.: B-1371 Bonilla Saborido S.: B-1053 Böning G.: B-1174 Boninsegna E.: B-0004, B-0005 Bonneville F.: B-0818 Bonomo G.: B-0125 Bonomo L.: A-758, B-0020, B-0677, B-0679, B-0790, B-0890, B-0999, B-1361 Booij R.: A-711 Bookwalter C.: B-0206 Boomsma M.F.: B-0589, B-0954 Boos J.: B-0044, B-0099, B-0394 Boraschi P.: B-0209 Borelli C.: B-0426, B-1071 Borgen M.: B-0711 Borges A.: A-141 Borggrefe J.: B-0295, B-0493, B-0953 Borisch E.: B-0706 Borlinhas F.: B-0603 Borrás C.: B-0641 Borsaru A.: B-0729 Borsato A.: B-0832 Borthne A.: B-0008 Bortolanza C.: B-0745 Bortolotto C.: B-0590 Bos C.: B-0765 Bosmans H.: B-1356 Bösmüller H.: B-0039 Boss A.: B-1134 Bots M.L.: B-0060, B-0768 Böttner A.: B-0067 Botto A.: B-0164 Bouaboula M.: B-0097 Boubagra K.: B-0500 Bouda D.: B-0097 Boudiaf N.: B-0500, B-0971 Boughrarou R.: B-0379 Bougias H.: B-1261 Boukerroui D.: B-0436 Boulay-Coletta I.: B-0037 Bousson V.: B-0809 Boussouar S.: B-0320 Bouwman R.W.: B-1355

www.myESR.org

Bozovic G.: B-0850 Bozzao A.: B-1060 Braat M.: B-0995 Braber A.: B-0114 Braga M.: B-0184 Braglia L.: B-0922 Bramanti P.: B-0393 Brambillasca P.: B-0772 Brancatelli G.: A-132 Branco J.: B-1146 Brandão A.: B-1304 Brandão S.: B-0603, B-0753 Brandberg J.: B-0578, CTiR 1 Brandlhuber M.: B-0777 Brandner S.: B-0281 Bratke G.: B-0953 Braun C.: B-0286 Braun F.: B-0719 Braun L.M.M.: B-0232 Braun M.J.: B-0883 Braun S.: B-1184 Braune S.: B-0855 Brea Alvarez B.: B-0355 Breen D.J.: A-119 Brembilla G.: B-1173 Bremerich J.: A-468 Breur J.M.P.J.: B-0765 Briani C.: B-1142 Briers E.: A-170, A-401, A-533, A-587 Briganti A.: B-0343 Brillet P.-Y.: A-472 Brix G.: B-0373 Brkljačić B.: A-584, A-735, B-0474, K-12 Brocchi S.: B-0139, B-1231 Brodmann M.: B-0260 Broeders M.J.M.: B-1355 Brolin E.B.: B-0749 Brosjö O.: B-0810 Brouhon L.: B-1287 Brountzos E.: B-0330, K-32 Brown C.: B-0145 Brown J.M.: B-0692 Brown P.: B-1120, B-1125 Bruce R.: B-0165 Brückmann H.: B-0794 Brueren G.: B-0400 Brugger P.: B-0278, B-0279 Bruguier C.: B-0362 Brun A.L.: B-0586, B-1368 Brunelle F.: B-0163, B-1227 Bruners P.: B-0864 Brunetti A.: B-0824 Brunetti N.D.: B-0742 Brüning R.: B-1003 Brunner C.: B-1214 Bruno C.: B-0136 Bruno F.: B-0045, B-0324, B-0332, B-1311 Bruzzi J.: B-1017 Bryant T.: B-1369 Bryukhov V.: B-1111 Bucci A.: B-0136 Bucciarelli-Ducci C.: B-0254 Buch K.: B-0013 Buchan K.: B-0737 Buchanan T.: B-1247

Buchbender C.: B-0560, B-0656, B-0657, B-0901, B-1036 Büchel R.: CTiR 1 Bucher A.M.: B-0483, B-0746, B-0976 Buchfelder M.: B-0281, B-0283, B-0284 Bücker A.: A-369 Buckley J.: B-0338 Buckley O.: A-347 Budde R.P.: B-1365 Budde R.P.J.: B-0765, B-1078, B-1082 Bueber N.E.: B-1186 Buecker A.: B-0619, B-0955, B-1002, B-1104, B-1229, B-1230 Buffa G.: B-0533 Bugby S.L.: B-0033 Bugianesi E.: B-0053 Bulakci M.: B-0140 Bülow R.: B-0006 Buls N.: B-0107 Bulut E.: B-0726 Bunck A.C.: B-0047, B-0048 Buquicchio G.L.: B-0522 Burgard C.A.: B-0989 Burger I.A.: B-0026 Burghard P.: B-0740, B-1072 Burgkart R.: B-0485 Burton N.C.: B-0908 Burulday V.: B-0161 Buryakina S.A.: B-0624 Busato F.: B-1233 Busoni S.: B-0943 Busse H.: B-0983, B-1144 Butler M.L.: B-0867 Butler M.-L.: B-0142 Butscheidt S.: B-0574, B-0993 Buy X.: B-0323, B-0325 Buytaert D.: B-0675 Büyükşireci M.: B-1328 Buzan M.T.A.: B-0315 Bydlon T.M.: B-0225 Byeon J.H.: B-0606 Byon J.H.: B-0594 Byun H.: B-0645, B-0646

C C.R. S.: B-1332 Cabaleros M.: B-0344 Caballeros F.M.: B-1129 Caballeros M.: B-1128, B-1306, B-1312, B-1313 Cáceres J.: A-060 Caciagli V.: B-0093 Caffarri S.: B-1062 Çağlı B.: B-0140 Cahill A.: B-0338 Caines J.: B-1120, B-1125 Calabrese M.: B-0016, B-0760, B-1069, CTiR 2 Calafate A.: B-0869 Calandrelli R.: B-0081 Calandri M.: B-0542, B-0858 Calatayud J.: B-0072 Calli M.C.: B-0085 Calmon R.: B-0163 Calvo-Temprano D.: B-1046 Camacho Marti M.D.V.: B-1053

Final Programme | ECR 2016

345

List of Authors & Co-Authors

Camera L.: B-1253, B-1254 Campani D.: B-0093 Campanino P.: B-1130 Campari C.: B-0922 Campbell R.: A-155 Campion D.: B-1170 Campioni P.: B-0137 Camporata L.: B-1217 Campos E.M.: B-0350 Campoy-Balbontín F.J.: B-1020 Camps Herrero J.: A-091, A-129, B-0602, B-1260, CTiR 2 Camuera González E.: B-0520 Can Tirabulus D.: B-1280 Cancel-Tassin G.: B-0699 Candiani M.: B-1028 Cangiotti C.: B-1173 Canhão H.: B-1146 Canini T.: B-0525 Cannaò P.M.: B-0252, B-0459 Cannavale A.: B-1369, B-1370 Cano Gimeno J.: B-1260 Canstein C.: B-0783, B-1203 Cantrell C.G.: B-0822 Cantwell C.: A-536 Canu T.: B-1145 Cao D.: B-0265 Cao J.: B-0177 Cao J.-Y.: B-1269 Cao W.: B-0240 Caobelli F.: A-301 Capitolo L.: B-0482, B-0707 Cappelli A.: B-1231 Cappelli C.: B-1303 Capretti I.: B-1226 Caracciolo G.: B-0389 Caracò C.: B-0293 Caramella D.: A-082, A-419, A-732, A-786, B-0121 Carbo G.: B-0498, B-0502, B-0503 Carbonaro L.A.: B-0923, B-1274 Carbone I.: B-0454, B-1314 Carbonetti F.: B-0958, B-1142 Carboni M.: B-0538 Cardeman L.: B-1304 Carducci S.: B-1100 Carecchio M.: B-0392 Carey F.: B-0487 Carlino G.: B-0020 Carlo M.: B-0326 Carlqvist J.: B-0578 Carlsen J.F.: B-1321 Carmona-Bayonas A.: B-1046 Caron O.: B-1121 Carotti A.: B-0369 Carrafiello G.: A-540 Carrara G.: B-0184 Carreño G E.: B-1225 Carreras Aja M.: B-0520 Carriço A.: B-0348 Carrié D.-G.: A-534 Carriero A.: B-0392, B-1176, B-1375 Carrington B.M.: B-1167 Carroll T.J.: B-0647, B-0652, B-0822 Cartez-Zumelzu F.: B-0960

346

ECR 2016 | Final Programme

Caruana C.J.: B-0149 Carusi V.: B-0958 Caruso D.: B-0174, B-0175, B-0263, B-0456, B-0783, B-0785, B-1072 Caruso P.: B-0271 Carvalho G.: B-0716 Carver E.M.: B-0144 Casale R.: B-1143 Casanova B.: B-1112 Caseiro-Alves F.: A-131, A-537 Casella C.: B-1130 Cash H.: B-0697, B-0945 Casiraghi A.: B-0775, B-0805, B-1030 Caspers J.: B-0044, B-0402, B-1341, B-1342 Cassar-Pullicino V.N.: A-075 Cassidy D.: B-0748 Castagna M.: B-0209 Castañer E.: A-029 Castellanos M.: B-0498 Castelli E.: CTiR 2 Castillo J.: B-0149 Castillo M.: B-0198, B-0200 Castro M.: B-0851 Catalano C.: A-164, B-0168, B-0454, B-0894, B-0896, B-1314, B-1334 Catalano O.: B-0293 Catalano O.A.: B-0450 Catania D.: A-709, B-0867, B-1170 Catelan S.: B-0054 Caudrelier J.: B-0323 Caulo M.: B-0393 Caumo F.: B-1254 Cava M.: B-0251, B-0256, B-0638 Cavallaro F.: B-0447 Cavallin L.: B-0388 Cavallin R.N.: B-1273 Cavallini C.: B-0238 Cavanagh P.: A-416, A-530, A-531, A-688 Cavanna S.: B-0566 Cavedon C.: B-1253, B-1254 Cazals X.: B-0815 Cazeau A.L.: B-0298 Cazzato R.L.: B-0323, B-0325 Cazzola V.: B-0818 Cederlund K.: B-0749; CTiR 1 Cefarelli M.: B-0111 Cejna M.: B-1175 Çeken K.: B-1024 Celeng C.: B-0766 Cellina M.: B-0422, B-0881 Cenzi D.: B-0832 Cercato C.: B-0848 Cerini P.: B-1176, B-1375 Cermik T.F.: B-1280 Cervelli R.: B-0121, B-1303 Cesarani F.: B-0482, B-0707 Cetin E.N.: B-0155 Cevasco L.: B-0016, B-1069 Ceyhan Bilgici M.: B-0082 Cha Y.: B-0215 Chae S.Y.: B-0562 Chai W.-M.: B-1031 Chai X.: B-0484 Chai Y.: B-0101 Chakrabarty B.: B-1167

Chalabi N.A.: B-1054 Chalabi N.A.M.: B-1124 Challen V.: B-1016 Chamuleau S.A.J.: B-1078 Chan K.M.: B-0321 Chancheck N.: B-0549 Chandesris O.: B-0763 Chandra S.: B-0084 Chang D.H.: B-0167 Chang J.M.: B-0530 Chang K.: B-0424 Chang W.: B-0838, B-1297 Charidimou A.: B-0390, B-0823 Charlon S.: B-1191 Charpentier A.: B-0320 Charpiot A.: B-0720, B-0721 Chaszczewska-Markowska M.: B-0064 Chaturvedi A.K.: B-0859 Chaturvedi N.: B-0648 Chazova I.: B-0750 Chechin D.: B-0665 Chekeridi A.: B-1305 Chen B.: B-0051 Chen J.: B-1090 Chen L.: B-0504 Chen M.: B-0529, B-0963, B-1031, B-1033 Chen R.: B-0939 Chen Y.: B-0505, B-0511, B-0572, B-1317 Cheng J.: B-0584, B-0628 Cheon J.-E.: B-0169, B-0172 Cherkashin M.: B-0830, B-0831 Cherniavsky E.: B-0827 Cheung H.M.: B-0187 Cheung J.Y.: B-0528 Chi Y.-K.: B-1317 Chiacchiaretta P.: B-0389 Chianca V.: B-0824 Chiaradia M.: B-0104 Chiari D.: B-0031 Chin W.L.: B-0988 Chino S.: B-0807 Chiu N.-T.: B-0940 Cho H.S.: B-0169 Cho I.: B-0596 Cho J.: B-0416, B-1284 Cho J.Y.: B-1234 Cho M.: B-0613 Cho N.: B-0530 Cho S.B.: B-0131, B-0573, B-1232 Cho S.H.: B-1324 Cho S.J.: B-1154 Cho Y.: B-0623 Cho Y.H.: B-0131 Choe Y.H.: B-1073, B-1154 Choi C.-G.: B-0654, B-0817 Choi C.-M.: B-0676, B-1360 Choi D.: B-0839 Choi D.S.: B-0010 Choi E.J.: B-0221 Choi G.S.: B-1324 Choi H.I.: B-0169, B-0172 Choi H.S.: B-0645, B-0646, B-0651 Choi J.: B-0339, B-0738 Choi J.W.: B-0208, B-0601, B-0837 Choi J.-Y.: B-0414

www.myESR.org

List of Authors & Co-Authors

Choi M.H.: B-0339, B-0738 Choi S.: B-0406, B-0754 Choi S.A.: B-0221 Choi S.H.: B-0287 Choi S.J.: B-0918 Choi S.Y.: B-1232 Choi S.-Y.: B-0597 Choi Y.: B-0172, B-1272 Choi Y.H.: B-0169 Choi Y.J.: B-0754, B-1023 Chollet F.: B-0818 Chong M.S.: B-0489 Chong V.: A-142 Chovanec M.: B-0728 Chowdhury F.: B-0387 Christeas N.: B-0618 Christophe D.: B-1323 Christou A.: B-1261 Chu J.P.: B-0289, B-1052, B-1056 Chu Z.-Q.: B-0595 Chun C.-W.: B-0917 Chung D.H.: B-1363 Chung D.J.: B-0627 Chung G.H.: B-0798 Chung H.: B-0683 Chung W.K.: B-0321 Chuong A.-M.: B-0037 Chvetzoff G.: B-0128 Cicchetti G.: B-0677, B-0679 Cicekcibasi A.E.: B-0885 Cicone F.: B-1060 Cieslik E.C.: B-1342 Ciliberto M.: B-0679 Cin C.: B-1382 Cioffi Squitieri N.: B-1172 Ciolina F.: B-0454 Ciolina M.: B-0238 Cioni R.: B-0093 Cipriani A.: B-0819 Cirelli C.: B-0537 Cirillo M.: B-0366 Cirillo S.: B-0566, B-0659, B-0829 Cirino A.: B-0533 Citil S.: B-0171 Claes L.: B-0204, B-0205 Claeys T.: B-0942 Clarizia A.: B-0813, B-0964 Clasen S.: B-0861 Claudepierre P.: B-0071 Claudi C.: B-0643 Claudon M.: A-209, A-250 Clauser P.: B-0220, B-0423, B-0428, B-0757, B-0758, B-1259 Claviere L.: B-0818 Cleator S.: B-1275 Clément O.: A-149, A-338, A-729, B-0763 Clevert D.A.: B-0934, B-0997 Coche E.E.J.G.: A-643 Cockmartin L.: B-1356, B-1357 Coenen A.: B-0743, CTiR 2 Coghe G.: B-1108 Cohan R.: B-0692 Cohen J.G.: B-1358, B-1363 Coi L.: B-0421, B-1067, B-1256 Colak A.: B-1081

www.myESR.org

Colantoni C.: B-0251, B-1074 Colbert M.: B-0231 Colella Bisogno M.: B-0890 Collantes M.: B-0344, B-0702 Colley S.: A-072, A-610 Collins D.: B-1258 Coll-Segarra D.: B-1354 Collura D.: CTiR 2 Colombani S.: B-0821 Colombi D.: B-0315 Colombo M.: B-0638 Colosimo C.: B-0081, B-0164, B-0393 Comai G.: B-0139 Comperat E.: B-0699 Condamine E.: B-0500, B-0971 Connell M.C.: B-1218 Consigny D.: B-0322 Constantarogianni E.: A-767 Conte E.: B-0480 Conti M.: B-0254, B-0538 Contro A.: B-1103 Cook G.: A-514, K-22 Cooper C.L.: A-473 Copel L.: B-0360 Copley S.J.: A-471 Coppenrath E.: B-0058 Coppola A.: B-0343 Coppola G.: B-0999 Corazza A.: B-0271 Corcos G.: B-1191 Corcuera-Solano I.: B-1197 Cordes C.: B-0485 Córdoba Chicote V.: B-1282 Coriani C.: B-1062 Cornelius A.: B-0698 Cornford E.J.: A-244 Corno L.: B-0037 Cornud F.: A-101 Corona M.: B-0537 Corot C.: B-0201 Correa Zapata J.C.: B-0520 Correas J.-M.: A-528, A-805 Corso R.: B-1196 Cortese G.: B-1220 Coşgun Z.: B-0490 Cosottini M.: B-1345 Cosson P.: A-649 Costa D.: B-1245 Costa M.: B-1140 Costachescu D.: B-0811 Costagli M.: B-1345 Cottier J.P.: B-1115 Cottier J.-P.: B-0815 Cottin V.: B-0117 Couillaud F.: B-0932 Couto J.G.: B-0718 Cova M.: B-0476 Cova M.A.: A-310, B-0778, B-0848 Cowan N.C.: A-309 Coward J.: B-0353 Cowling J.J.: B-0672 Cox E.: B-0575 Cozzi A.: B-0459 Crawford Jefferson M.: B-1080 Crawford R.: B-0640

Crema M.D.: B-0548 Cremona A.: B-0958 Crispi C.: B-1304 Crispin A.: B-0794 Cristel G.: B-0184, B-0608 Cristina R.: B-0348 Crivellaro C.: B-1030 Crivelli P.: B-0538 Crocetti L.: A-303, A-478 Croci Chiocchini A.L.: B-0139 Croisille P.: A-621 Cronin O.: B-0644 Crowley C.: B-0338 Cruz-Maurício J.F.: B-1389 Csecs I.: B-0248, B-0457 Csűry T.D.: B-0788 Cuba Camasca V.L.: B-0503 Cuba V.: B-0498, B-0502, B-1271 Cuccioli F.: B-0633 Cuénod C.A.: A-042 Cuesta Pérez J.J.: B-1096 Cuevas Sanz J.M.: B-1260 Cuinet M.: B-0128 Cullu N.: B-1326 Cuminal L.: B-1088 Cunha T.M.: A-037 Cuocolo A.: B-0453 Curta A.: B-1315 Curvo-Semedo L.: A-577 Cussenot O.: B-0699 Cuzzocrea M.: B-1030 Cyran C.C.: A-182, B-0296, B-0931, B-0933, B-0934 Czernin J.: B-0899 Czerny C.: A-591 Czimbalmos C.: B-0248, B-0457 Czubak J.: B-0911, B-0914

D da Costa Andrade L.A.: B-0192 da Silva C.A.: B-0152, B-1010 Dabew R.: B-0955 Dablan A.: B-1024 Dabravolskaite V.: B-1118 Dacher J.N.: B-1151 Dacher J.-N.: A-053 Daemen M.J.: B-0056 Daghistani R.: B-0581, B-0987 Dağıstan E.: B-0490 Dahlqvist Leinhard O.: A-280 Daire J.-L.: B-0977 Dal Corso M.: B-0249 Dallakyan N.H.: B-0170 Dall’ara S.: B-0834, B-1238 Dallaserra C.: B-0136 Dalm S.: B-0936 Dalmis M.: B-0426 Damascelli A.: B-0184, B-0608 Damiani A.: B-1361 Damilakis J.: A-031, A-080, A-355, A-392, A-488, A-747, B-1205 Damlar I.: B-0885 Damm T.: B-0493 Dammann F.: B-0883 Dams F.E.M.: B-0012

Final Programme | ECR 2016

347

List of Authors & Co-Authors

D’Anastasi M.: B-0189, B-1322 Danes J.: B-0239 Dang Tran K.: B-0320 d’Angelo P.: B-0605 Dangouloff-Ros V.: B-0163 Dani S.: B-0018 Danielsson M.: A-033 Danilov N.: B-0750 Dankbaar J.W.: B-0496, B-0568 Dankova A.: B-0514 Danza F.M.: A-197 D’Apolito G.: B-0081 Dappa E.: B-1190 D’Aquino A.: B-1117 d’Archambeau O.: B-0403, B-0803 Das M.: B-0473, B-0791, B-1040 Das R.: A-682 Daud A.: B-1319, B-1320 Daunis-i-Estadella J.: B-0498, B-0502 Davenport M.: B-0692 David V.: B-0958, B-1142 Davletkhanova M.: B-1347 Dawood N.: B-0033 Dawoud M.A.A.: B-1001 de Albert M.: B-1225 De Angelis C.: B-0120, B-0923, B-1123 de Baère T.: A-116 De Belder F.: A-566, B-0403, B-0803 de Blois E.: B-0936 De Boer E.: B-0589 de Boer L.L.: B-0225 De Bondt T.: B-1287 De Brabander I.: B-0920 De Cecco C.N.: A-377, B-0174, B-0175, B-0263, B-0264, B-0380, B-0386, B-0452, B-0456, B-0746, B-0783, B-0785, B-1072, B-1203, K-21 De Cobelli F.: B-0031, B-0160, B-0184, B-0251, B-0256, B-0291, B-0343, B-0608, B-0626, B-0629, B-0638, B-0779, B-0781, B-1028, B-1074, B-1145, B-1273, B-1298 De Dea M.: B-1185 de Donato G.: B-1172 De Febis E.: B-0772 De Foer B.: A-252 de Graaf R.: A-491 de Heer L.M.: B-1082 de Jaegere P.P.T.: B-0400 de Jong H.W.: B-0568 de Jong K.P.: B-0863 de Jong M.: A-151, B-0514, B-0936 de Jong P.A.: B-0488, B-0650, B-1362, B-1365 De Jonge M.C.: A-022 De Keyzer F.: B-0661, B-1037, B-1038, B-1323 de Koning H.J.: B-0488, B-0789, B-1362 de Korte C.L.: B-0022 de las Heras H.: B-1354 De Libero A.: B-0659 De Luca L.: B-1314 De Maeseneer M.O.: A-506 De Marco P.: B-0103 de Mey J.: B-0107, B-0212

348

ECR 2016 | Final Programme

de Mol B.A.J.M.: B-1148 De Napoli L.: B-0121 De Pascale A.: B-0829 De Pooter J.: B-0675 De Roeck J.: B-1287 De Roo B.: CTiR 1 de Roos A.: A-188, A-277, A-466, B-0181 De Rosa F.: B-0742 De Rubeis G.: CTiR 2 De Santis D.: B-0780 de Vis J.: B-0650 De Visschere P.J.L.: B-0942 De Wever W.F.M.: A-706 Debiais S.: B-0815 Dechene A.: B-1301 Decoster R.: B-0867 Decristoforo C.: A-415, B-0027 Decullier E.: B-0117 Decuzzi P.: B-0613 DeDea M.: B-0280 Dedic A.: B-0743 Deferme F.: B-1287 Deganello A.: A-675 Degani H.: B-0602 Degirmenci B.: B-0002 Değirmenci T.: B-1328 Dehem J.V.: A-373 Dejaco D.: B-0564 Dejobert M.: B-0815 Del Buono F.: B-0767 del Ciello A.: B-0677 Del Cura Rodríguez J.L.: B-0358 Del Grande F.: B-0554 Del Maschio A.: B-0031, B-0160, B-0184, B-0251, B-0256, B-0291, B-0343, B-0608, B-0626, B-0629, B-0638, B-0779, B-0781, B-1028, B-1074, B-1145, B-1273, B-1298 Delaloge S.: B-1061, B-1121 Delannoy V.: B-0581 Delavaud C.: A-528 Delforge M.: B-0661 Della Bella P.: B-1074 Della Latta D.: B-0425 Della Vigna P.: B-0125 Delli Pizzi S.: B-0389 Delorme S.: B-1211 Deltenre P.: B-0977 Demany N.: B-0949 Demattei C.: B-0071 Demirci A.Y.: B-1199 Demirel A.: B-0637 Demirtas H.: B-0002 den Harder A.M.: B-0765, B-1365 den Ouden L.: B-1168 den Ruijter H.M.: B-0060, B-0768 Dendale P.: B-0181 Denecke T.: A-544, B-0041 Denis de Senneville B.: B-1223 Denton E.: B-1119 Denys A.: A-302 De-Paoli L.: B-0973 Derchi L.E.: A-247, A-804 Dergilev A.: B-0154 Deroulers C.: B-0163

Dershaw D.D.: B-1063 Dervishi N.: B-0829 Desai S.: B-0009 Desai S.R.: A-403, B-1217 Descat E.: B-0298 Deschamps R.: B-0157 Deschildre A.: B-0370 deSouza N.M.: A-451 Detante O.: B-0500 Dettore D.: B-0272 Deuschl C.: B-1058 Devaraj A.: A-705 Deveci C.: B-1328 Deveer M.: B-1326 Deveer R.: B-1326 Devu S.: B-0043 Dewes P.: B-0976, B-1077 Dewey M.: A-065, A-456, B-0383, B-0460, CTiR 1, CTiR 2 Dey C.: B-0109 Di Bartolomeo M.P.: B-0687 Di Carlo M.: B-1233 Di Cecco G.: B-0964 Di Cesare E.: B-0045, B-0255, B-1311 Di Chiara A.: B-0160, B-0779, B-0781 Di Egidio V.: B-0404, B-0501, B-0687, B-0802 Di Giovanni S.E.: B-0020 Di Girolamo M.: B-0958 Di Guardia G.: B-0541 Di Lella G.M.: B-0081, B-0164 Di Leo G.: B-0122, B-0199, B-1123, B-1143, CTiR 2 Di Mizio V.: B-0404, B-0501, B-0802 Di Muzio N.: B-0779 Di Sibio A.: B-0045, B-0255 Diacinti D.: B-0238 Diaz O.: B-1137 Diaz-Zamudio M.: B-0413 Dick A.: B-0047, B-0048 Dick E.: A-556 Dickerson E.: B-0692 Dicle O.: A-441 Diederichsen A.: CTiR 1 Dieckmeyer M.: B-0485 Diehl S.: B-0739, B-0836 Diekhoff T.: B-0067 Dietrich A.: B-0983 Dietrich C.F.: A-677 Dietrich O.: B-0965 Dietzel F.: B-0334, B-0335 Dietzel M.: B-0220, B-0757, B-1126 Diez Y.: B-1137, B-1138 Dijkhoff R.: B-1165 Dijkstra H.: B-0609, B-0610 Dilks P.: B-0018 Dillmann R.: B-0764 Dimai H.-P.: B-1146 Dimitrakopoulou-Strauss A.: B-0668 Dinapoli N.: A-670, B-1361 Ding C.: B-0723 Ding J.: B-0857 Ding N.: B-1327 Dinkel J.: A-348, B-0315, B-0989 Diogo R.: B-0906

www.myESR.org

List of Authors & Co-Authors

Discalzi A.: B-0541, B-0542 Dittrich S.: B-0614 Divenuto I.: B-1176 Divis P.: B-1101 Djekic J.: B-0181 Djuraeva N.: B-1305 Djurdjevic T.: B-0499 Djuric-Stefanovic A.: B-0214 Do T.D.: B-0865 Docema M.: CTiR 2 Dodd J.D.: A-383 Doellinger F.: B-1212 Doeswijk G.: B-0936 Dogru E.: B-0885 Dohan A.: B-0094, B-1169 Dolenc Groselj L.: B-0886 Dolgun A.: B-0726 Dombrovsky V.: B-0063 Domingues R.T.: B-0486 Dominguez E.: B-0311 Donatelli G.: B-1345 Donati F.: B-0209 Donati O.: B-1289 Donati O.F.: B-0698 Dong J.: B-0240 Dong Y.: B-0095, B-1228, B-1269 Doniselli F.: B-0199 Doniselli F.M.: B-0447, B-1143 Donnelly P.: B-1080 Donoghue V.: A-789 Donoso L.: A-218, A-221, A-255, A-725 Doran S.: B-1258 Dörfler A.: A-480, B-0283, B-0284 Doriguzzi Breatta A.: B-0541, B-0542 Dormagen J.B.: B-0211 Dörr F.: B-1004 Dorrius M.D.: B-0609, B-0610 D’Orsi C.J.: B-1131 Dósa E.: B-0261 Dosal Bañuelos J.D.: B-0413 Doshi A.: B-1197 Doss A.X.: B-0553 d’Othee B.J.: B-0615 Dougados M.: B-0071 Downey K.: A-036, B-1258 Drago S.: B-0770 Drago S.G.: B-0774, B-0775 Drapé J.-L.: B-1191 Dresen E.: B-1141 Dresen R.: B-1038, B-1323 Dreyhaupt J.: B-0883 Drieghe B.: B-0675 Drieling D.: B-0527 Driesser I.: B-1203 Drobni Z.: B-0788 Drobni Z.D.: B-0179 Dromain C.: B-1061, B-1121 Duan X.: B-0025 Dubach-Schwizer S.: B-1134 Dubay D.: B-0998 Düber C.: B-0412 Dubruel P.: B-0514 Duchesne N.: B-0021 Duclos A.: B-1169 Ducou le Pointe H.: A-019

www.myESR.org

Ducreux D.: B-0162 Dudea S.: A-525 Dueber C.: B-0455 Due-Tonnessen P.: K-07 Duffy S.: B-1136 Duffy S.W.: A-549, B-1127 Dugot-Senant N.: B-0932 Duh Q.-Y.: B-0364 Duhamel A.: B-0590, B-0987 Duijm L.E.M.: B-0925 Duman F.: B-0885 Duman T.: B-0885 Dumontiel S.: B-1258 Dumortier J.: B-1088 Dunant A.: B-1061, B-1121 Dunlop D.: B-0643 Dupuis-Girod S.: B-0117 Duran C.: A-676 Durán J.P.: B-0851 Durand A.: B-0367 Durando M.: B-1130 Durhan G.: B-1328 Duric N.: B-1117 Durmaz E.: B-1024 Dutertre A.: B-0298 Dutova I.N.: B-0552 Duymus M.: B-0171 Dwarkasing R.S.: B-0408 Dziadziuszko K.: B-0183 Dzoic Dominkovic M.: B-0474

E Ebdon-Jackson S.: A-484, A-486 Ebeling Barbier C.: B-0996 Eberhardt K.: A-362 Eberhardt R.: B-1214 Eberli D.: B-0698 Eckerbom P.: B-0575 Eckstein F.: B-0555 Eckstein H.-H.: B-1158 Edens M.A.: B-0954 Edlund R.: B-1181 Edward R.: B-0356 Egan A.M.: B-1017 Egashira R.: B-0586, B-1368 Ehret N.: B-0614 Eiber M.: B-0341 Eichinger M.: B-0315, B-1214 Eichler K.: B-0130 Eickelberg O.: B-0671 Eickhoff C.: B-1341 Eickhoff S.: B-1341 Eickhoff S.B.: B-1342 Eigentler T.: B-0039, B-0297 Eijsvoogel N.G.: B-0791 Eikendal A.L.M.: B-0060, B-0768 Eissa A.E.: B-1065 Ekenbäck C.: B-0749 Ekhlasi G.: B-0035 El Ghazaly H.: B-0294 El Hachemi M.: B-0181 El Kassas H.H.N.: B-0612, B-1279 El Messeidy D.: B-1257 EL Mozy W.: B-0050 El Saeidi S.: B-0050

El Tohamy M.F.: B-1135 El Waraki M.S.: B-1001 El-Azab M.S.: B-0663 Eldawoody H.F.: B-1050 El-Diasty M.T.: B-0579 El-Diasty T.A.: B-0579 Elewaut D.: B-0069 Elias M.: B-0353 Elias S.N.: B-0825 Elibol O.: B-1199 Eliezer M.: B-0721 Elizalde A.: B-1128, B-1129 Elkhamary S.M.: B-0158 Ellermann A.: B-0711 Ellis J.: B-0692 El-Maadawy S.M.: B-0888 Elmokadem A.H.: B-0647, B-0652, B-0822 El-Morsy A.E.-M.E.: B-1050 ElRefaei M.A.: B-1089 El-Serougy L.G.: B-1050 Elstob A.: B-0365 ElTohamy M.: B-1089 Emad Y.: B-1183 Emami H.: B-0787 Emberton M.: B-0948 Emerich L.: B-0809 Emrich T.: B-0455 Enblad P.: B-0203 Engelborghs S.: A-771 Engelen S.: B-0776 Engelke C.: B-1003 England A.: A-788, B-0307, B-1008, B-1208, B-1243, B-1244 Engström G.: CTiR 1 Engvall J.: CTiR 1 Enk A.: B-1003 Enlund A.-L.: B-0714 Eraslan C.: B-0085 Erb M.: B-0593 Erb-Eigner K.: B-0159 Ergen F.B.: B-0270 Ergün Y.: B-1328 Ermacora D.: B-1140 Eroglu A.: B-0625 Eroshenko O.: B-0063 Ertel N.: B-0544 Ertl L.M.: B-0794 Ertl-Wagner B.: A-360, A-501, A-749, B-0396, B-0793, B-0965, B-0968, B-1110, B-1114 Escalona-Huerta C.: B-0413 Eschbach R.: B-0931 Eschbach R.S.: B-0934 Escher A.: B-0230, B-0235 Espejo J.J.: B-0536 Espinoza-Boireau S.: A-738 Esposito A.: B-0031, B-0251, B-0256, B-0343, B-0626, B-0629, B-0638, B-0779, B-0781, B-1028, B-1074, B-1145 Esposito F.: B-1130 Esposito R.: B-0389 Esteban L.: B-0355 Esteves B.: B-0870 Esteves C.: B-1048 Estner H.: B-1315

Final Programme | ECR 2016

349

List of Authors & Co-Authors

Etievant J.: B-0117 Euler A.: B-0302, B-0304, B-0570, B-1288 Evans A.: A-641, B-0427, B-0526 Evans D.: B-0928 Evans R.: B-0737 Ewertsen C.: B-1321 Exner S.: B-0130 Exposito D.: B-0072 Ezhova R.: B-1164, B-1347

F Fabbro E.: B-0272 Facal de Castro F.: B-0641 Facchetti L.: B-0549, B-0551, B-1319, B-1320 Faccinato A.: A-542 Fadel S.H.: B-0808 Fadzli F.: B-0083 Faeghi F.: B-1113 Fahrleitner-Pammer A.: B-1146 Fainardi E.: B-0813, B-0964 Faivre J.-B.: B-0370, B-0581, B-0590, B-0987 Faker E.: B-1257 Falaschi F.: B-0209 Faletti C.: A-690 Faletti R.: B-0053 Falkner F.: B-0704 Falkowski A.L.: B-0076 Fallenberg E.M.: A-704, B-0926, B-1135 Falvey E.: B-0644 Fan L.: B-0682, B-0847 Fanelli F.: K-18 Fanning N.: B-0795 Fanti S.: B-1231 Faquir T.: B-0345 Farag M.: B-0764 Farahat A.: B-0612, B-1279 Farahat A.A.-K.: B-0808 Farchione A.: B-0677, B-1361 Farghaly H.R.S.: B-0509 Farina D.: A-523, A-568, A-611, B-0249 Farouk R.: B-1257 Farras Roca L.: B-1225 Farrell C.: B-1204 Fasciano M.: B-1130 Fassa-Ashrafpoor G.: A-598 Fassbender K.: B-0972 Faure M.: A-566 Favre I.: B-0500 Feeley L.: B-1021 Feger S.: B-0383, B-0460 Fei X.-C.: B-0529, B-1031, B-1033 Fejer B.: B-0061 Felber S.: B-0398, B-0399 Fele R.M.: B-0333 Fellah L.: B-1283 Felli V.: B-0255 Felson D.T.: B-0548 Fendler W.P.: B-0997 Fenelon C.: B-0782 Feng C.: B-0268, B-0269 Feng L.: B-0059 Feola T.: B-0454 Ferda J.: A-659, B-0508 Ferencik M.: B-0744

350

ECR 2016 | Final Programme

Fernandes P.: B-1245 Fernandez L.: B-0982 Fernandez Leon A.: B-1053 Fernandez-Bayó J.: A-135, A-581 Fernández-Real J.M.: B-1271 Ferraioli G.: B-1085 Ferrante Z.: B-0241, B-1238 Ferrari F.: B-1100, B-1226 Ferreira H.A.: B-0603, B-0703, B-0753 Ferrero G.: B-0272 Ferretti A.: B-0389 Ferretti G.: B-1363 Ferretti G.R.: A-059, B-1358 Ferron S.: B-0298 Fesl G.: B-0794 Feuchtner G.: A-115, A-201, B-0740 Feuerriegel G.: B-0549 Feydy A.: B-0071, B-1191, B-1195 Fichtner S.: B-1315 Fiedler A.: B-0895 Fieselmann A.: B-0670 Figiel J.: B-0258 Fijalkowska J.: B-0183 Fijalkowski M.: B-0183 Filice C.: B-1085 Filippiadis D.: B-0127, B-0330 Filli L.: B-1190 Finer N.: A-279 Finetto G.: B-0054 Fink C.: B-0313, B-1043 Finkenstaedt T.: B-0554 Fioole-Bruining A.: B-0225 Fior D.: B-0774, B-0835, B-1173, B-1196 Fiorelli A.: B-1314 Fiorina P.: B-0160 Fiorino C.: B-0779 Firetto M.C.: B-0525 Fischer A.: B-0314, B-1045 Fischer M.A.: B-0640, B-1190 Fischer N.: B-0564 Fischer S.: B-0878, B-1178, B-1222 Fischer T.: A-394 Fischer U.: B-0014, B-0218, B-0222 Fishman E.K.: B-0956 Fiz F.: B-0272 Flach P.: B-0438 Flaherty K.T.: B-0512 Flanigan D.: B-0556 Flechsig P.: B-0865 Fleischmann C.: B-0673 Fletcher A.: B-1218 Floeth F.W.: B-0901 Flohr T.: B-0508 Flohr T.G.: B-1349 Flores P.: B-0868 Floss T.: B-1161 Fodero G.: B-0366 Fodor P.: B-0306 Fohlen A.: B-1049 Föhr P.: B-0547 Foldyna B.: B-0853 Foley S.: B-0346, B-0352, B-0710, B-1122, B-1248 Foley S.J.: A-287, A-489, B-0708 Fonio P.: B-0541, B-0542, B-0858, B-1130

Fonteyne V.: A-105 Forment Navarro M.: B-0602 Formenti A.: B-0480 Formoso F.J.D.: B-0243 Fornari A.: B-0829 Forrai G.: A-243, A-597, CTiR 2 Forschner A.: B-0023 Forslin Y.: B-0196 Forsting M.: B-0068, B-0197, B-0507, B-0667, B-0903, B-0905, B-1058, B-1201, B-1307 Forstner R.: A-380 Fossaceca R.: B-1176, B-1375 Fouad R.M.K.: B-1066 Fournier L.: B-0097, K-37 Fournier L.S.: A-152 Fox E.: B-1170 Fox M.J.: B-0897, B-1385 Fracasso G.: B-0932 Fraga P.: B-0311, B-1292 Fraile E.: B-1292 Fraile Moreno E.: B-0311 Franchi P.: B-0677, B-0679, B-1361 Franchi-Abella S.: A-320 Francione G.: B-0958 Francis S.: B-0575 Franck C.: B-1202 Franckenberg S.: B-0640 Franco A.: B-0521 Francois C.J.: B-0322 Francone M.: A-114, B-0454, B-1314 Frangi A.: A-600 Frau J.: B-1108 Frauenfelder G.: B-0465, B-0518, B-0674 Frauenfelder T.: A-166, B-0846, B-1134 Fredrikson S.: B-0196 Freitag M.T.: B-0668 Frel M.: B-0275, B-0911, B-0914 Freling N.J.M.: A-737 Frellesen C.: B-0967 Fretellier N.: B-0201 Freyhardt P.: B-0621 Fridell K.: A-409 Friedensohn L.: B-0115 Friera Reyes A.: B-1096 Fries P.: B-0619, B-1002 Frigg A.: B-1186 Frija G.: A-017, A-078, A-483, A-487, A-731, A-783 Fritz F.: B-1047, B-1352 Fritz J.: B-0956, B-1188 Froemming A.: B-0706 Fröhlich J.: B-1388 Fromageau J.: B-1117 Fronda M.: B-0541, B-0542 Frosini D.: B-1345 Frulio N.: B-1223 Frulloni L.: B-0004, B-0005 Frush D.P.: A-084 Fu L.: B-1329 Fuchsjäger M.H.: A-642, B-0052, B-0257 Fuentealba A.: B-0851 Fujii K.: B-0223, B-0531, B-1277 Fujikawa T.: B-1039 Fujinaga Y.: B-0841

www.myESR.org

List of Authors & Co-Authors

Fujisawa Y.: B-0106, B-0684, B-0685 Fujita A.: B-0841 Fukui T.: B-0216 Fukuyama A.: B-0479 Fukuyama N.: B-0382 Fuld M.K.: B-0956 Fulford J.: B-0709 Fuller S.: B-0175, B-0263 Fuller S.R.: B-0174, B-0456, B-0785, B-1072 Funk E.M.: B-1013 Furman Y.: B-1032 Furman-Haran E.: B-0602 Fusaro M.: B-0745 Fusco F.: B-0824 Fütterer J.J.: A-104, A-741

G Gaa T.: B-1161 Gaaß T.: B-0989 Gaballa G.: B-0579 Gabbert H.E.: B-0334 Gaber A.: B-0087 Gabr A.: B-0563 Gabr A.M.: B-1001 Gabriele P.: B-0848 Gac P.: B-0062, B-0064, B-0771 Gaikwad S.: B-0084 Gaillard S.: B-1088 Gaillot K.: B-1115 Gaini N.: B-0140 Gainor J.F.: B-0512 Galant C.: B-1283 Galaska D.: B-0183 Galaska R.: B-0183 Galastri L.: B-0943 Galatoire O.: B-0157 Galban C.J.: B-0433, B-0439 Galbiati A.: B-1375 Galea N.: B-0454, B-1314 Galema T.: B-0743 Galia M.: B-0658 Galiè N.: B-0111 Gallesio C.: B-0053 Gallo T.: B-0566 Galobardes J.: B-0311 Galsman I.: B-1347 Gálvez García S.: B-0683 Galvez Gonzalez E.: B-0126 Galy-Fauroux I.: B-0097 Galzerano G.: B-1172 Gamboa P.: B-0711 Gamondes D.: B-0117 Gandhi L.: B-0512 Gandini G.: B-0053, B-0541, B-0542, B-0858, B-1130 Gandy S.: B-0748 Ganeshan B.: B-0094 Gangemi E.: B-0823 Gangi A.: A-413, A-479, A-619, A-774, B-0323, B-0442, B-1213 Ganslandt O.: B-0401 Gao J.: B-0101, B-0240, B-0583, B-1042, B-1285 Gao J.B.: B-0572, B-0599, B-0600, B-0733, B-0734, B-0735

www.myESR.org

Gao R.: B-1090 Gao Y.: B-0736 Garami Z.: B-0613 Garbe C.: B-0297 Garcia Barquin P.: B-1306, B-1312, B-1313 García de Pereda De Blas V.: B-0520 Garcia F.: B-0521 Garcia Oliver E.: B-0602 Garcia-Barquin P.: B-1129 García-Hidalgo Y.: B-0355 Garcia-Marti G.: B-0701 García-Peña M.P.: A-071 Gardarsdottir M.: A-274, A-386 Gardavaud F.: B-0104 Gareer S.: B-0612 Gareer S.W.Y.: B-1279 Garg A.: B-0084, B-0372 Gargalas S.: B-0796 Gariani J.: B-0588 Garibotto V.: A-428 Garnon J.: B-0323 Garnov N.: B-0983, B-1144 Garske-Roman U.: B-0996 Gasbarrini A.: B-0999 Gascho D.: B-0438 Gassenmaier S.: B-0719 Gatta R.: B-1361 Gaudiano C.: B-1233 Gaudino S.: B-0164 Gaunt T.C.: B-0487 Gavazzi E.: B-0249 Gavelli G.: B-0434, B-0435, B-0437, B-0515 Gavio L.L.S.: B-0486 Gavrilovic V.: B-1101 Gawlitza J.F.M.: B-0309 Gawlitza M.: B-0902, B-0906 Gazzera C.: B-0542, B-0858 Gebauer B.: B-0621, B-1003 Gee A.H.: B-0912, B-1147 Gee M.: B-0450 Geenen R.W.F.: B-0036 Geiger J.: B-0368 Geijer H.: B-0957 Geijer M.: B-0850, B-0957 Geisbüsch P.: B-1210 Geisler T.: CTiR 2 Gelderblom M.: B-0634 Geldof M.: B-1287 Genchellac H.: B-0140 Geneidi E.: B-0087 Geneidi E.A.S.: B-1054 Geng D.: B-0288 Gennarelli A.: B-0255 Gennari A.G.: B-0778 Gennaro G.: A-358 Geoghegan T.: B-1376 Georg D.: B-0944 Gepalova Y.: B-1267 Geraldo Roig L.: B-0027 Germain-Genevois C.: B-0932 Gersing A.: B-0398, B-0399, B-0551, B-0643 Gersing A.S.: B-0549, B-0557, B-0913, B-1193 Gervais D.: B-0450

Geurts J.J.G.: B-1105 Gevenois P.A.: B-0347 Ghaye B.: A-096, A-190 Ghekiere O.: B-0181 Ghemigian K.: B-0744 Ghiatas A.: B-1261 Ghomadi S.: B-0665 Ghosh Dastidar A.: B-0254 Ghoshhajra B.: CTiR 2 Ghunaim H.: B-1357 Giacobbe A.: CTiR 2 Giancotti A.: B-0894 Giannelli M.: B-0425 Giannini V.: CTiR 2 Giannotta M.: B-0111 Giannotti N.: B-0352 Gibaud B.: A-329 Gibson G.: B-0672 Giepmans W.: B-0239 Giesel F.L.: A-645 Giganti F.: B-0031, B-0291, B-0343, B-0626, B-0629, B-0948, B-1028 Giganti M.: B-0137, B-0241, B-0813, B-0834, B-0964, B-1238 Giggens R.: B-0961 Gigoni R.: B-0209 Gil B.-M.: B-0756 Gil Sierra A.: B-0126 Gilbert F.J.: A-089, A-145, A-344, B-1127, B-1136, CTiR 2 Gillies R.: B-0510 Gilligan P.: A-171, B-1247 Gilliland L.: B-1131 Gilson W.D.: B-1188 Gimeno A.: B-1271 Ginocchi V.: B-0922 Ginocchio M.I.: B-0465 Giordano A.V.: B-1100 Giordano J.: B-0581 Girard F.: A-648 Girardi V.: A-024 Giraudo C.: B-0070, B-0300, B-0660 Girometti R.: B-0605 Giugliano F.M.: B-1057 Giuliani L.: B-0354 Giuliani M.: B-0020 Giurazza F.: B-0518, B-0620, B-0674, B-1057 Given M.: B-0266, B-0267 Gizewski E.: B-0960 Gizewski E.R.: B-0499 Glastonbury C.M.: B-0364 Glavas R.: B-0714 Gleditsch J.: B-0008 Gleeson F.: A-349 Gleeson F.V.: B-0436 Glehen O.: B-1169 Glenn S.I.: B-1011 Glikstein R.: B-1192 Glöckler M.: B-0614 Glodny B.: B-0499 Glotov A.: B-0592, B-1264 Glüer C.-C.: B-0493 Gned D.: B-0030, B-0829 Gockner T.: B-0865

Final Programme | ECR 2016

351

List of Authors & Co-Authors

Godbert Y.: B-0298 Godt J.C.: B-0211 Goebel J.: B-0411, B-1150, B-1152, B-1153, B-1316 Goei D.: B-0852 Goh V.J.: A-183, A-518, A-753 Gökce S.: B-0769 Golay X.: A-293 Golding S.J.: A-499 Goldman D.A.: B-1063 Gołębiowski M.: B-0113, B-0952 Golfieri R.: B-1231, B-1233, B-1242 Goligher J.: B-0928 Goliszek S.: B-0113 Golja A.: B-1380 Golsari A.: B-0634 Gomez Ansón B.: B-1053 Gomez B.: B-0560, B-0657 Gommers S.: B-1064 Gonçalves D.: B-1048 Gontchar A.: B-0800 Goo J.M.: B-0623, B-1363 Gooding M.J.: B-0436 Goorts B.: B-0224, B-1276, B-1281 Goosens V.: B-0661 Gordon A.: B-1275 Gordon A.C.: B-0193 Gormeli C.A.: B-0591 Gosnell J.E.: B-0364 Götestrand S.: B-0957 Gotlieb M.: B-0226 Goto M.: B-0223, B-0531, B-1277 Goto Y.: B-1309 Gottardi D.: B-0659 Gottfried K.: B-0368 Gottlieb P.A.: B-0360 Gottschalk A.: CTiR 1 Gourtsoyianni S.: A-663 Gourtsoyiannis N.: A-219 Goussia A.: B-1059 Gout O.: B-0363 Gouveia N.: B-1146 Grabherr S.: B-0362 Grabsch H.: B-0244, B-0245 Grainger A.J.: A-630 Gramer B.M.: B-0378 Grams A.E.: B-0499 Granata G.: B-0393 Granberg D.: B-0996 Granberg T.: B-0196 Grande Icarán D.: B-0358 Granell Moreno E.: B-1053 Granhus T.: B-1382 Graser A.: A-423 Grass M.: B-0622, B-1353 Grassedonio E.: B-0658 Grassi R.: A-578 Grassi Zamora C.: B-1225 Grasso R.F.: B-0325 Gratama J.W.: B-0789 Gratama J.-W.C.: B-0114 Gratz M.: B-1150, B-1152 Gray E.: A-227 Greenberg D.: B-0686 Greenberg S.: B-0116

352

ECR 2016 | Final Programme

Gregor J.: B-0979 Gregori J.: B-1138 Gregori L.: B-0404, B-0501, B-0802 Gregori L.M.: B-0687 Grehan J.M.: B-0142 Greiser A.: B-0052 Grenacher L.: A-264, A-267, B-1352 Grenier N.: A-211, A-249, A-607, B-0932 Grenier P.A.: A-624, K-28 Grévent D.: B-0163 Griebel J.: A-485 Grieser C.: B-0621 Griffiths M.: B-0924 Grigoriadis S.: B-0127, B-0330 Grimm J.: B-0362 Grimm R.: B-0312, B-0706 Grinstaff M.W.: B-0013 Grippo C.: B-0790 Grisar J.: B-0070 Gristina L.: B-0016, B-0760, B-1069 Groenewald W.: B-0173 Gromov A.: B-0826 Gromova E.: B-1340 Groppo E.: B-0813, B-0964 Großhennig A.: B-1367 Grosso M.: B-1371 Grothoff M.: B-0462 Grover S.B.: B-0761 Gruber G.M.: B-0077 Gruber-Rouh T.: B-0467, B-0470, B-0725 Grueneisen J.: B-0560, B-0656, B-0657, B-0903, B-0905, B-1036, B-1058 Grünig E.: B-0313, B-1043 Grunwald I.Q.: B-0972 Gschwendtner M.: A-635 Gu Y.J.: B-1070 Guan Y.: B-0847 Guaricci A.I.: B-0377, B-0742, B-1075 Guarnieri G.L.: B-0620 Guberina N.: B-0068, B-0507, B-1201, B-1307 Gubern-Mérida A.: B-0426, B-0527, B-0921, B-1071, B-1137 Gückel B.: B-0023 Guclu B.: B-1199 Gudziol V.: B-0559 Gueckel B.: B-0664 Guennoc A.M.: B-1115 Guerin N.: B-0123 Guérin P.: B-1151 Guermazi A.: B-0548, B-0639 Guernieri M.: B-0103 Guerquin-Kern J.-L.: B-0201 Guerrini S.: B-1172 Guglielmi G.: A-460 Guglielmo M.: B-0377, B-0742, B-1075, B-1076 Guidi M.: B-0958 Guillaud O.: B-1088 Guimaraes J.: B-0549 Gulabi D.: B-1199 Güler F.: B-0939 Güler H.A.: B-0161 Güllmar D.: B-0895 Günbey H.P.: B-0082

Gündogdu B.: B-0598 Gundogdu Secen O.: B-0066 Gungor G.: B-0171 Guni E.: B-1000 Gunnlaugsson E.: B-0957 Günther M.: B-1138 Guo C.: B-0134 Guo Y.: B-0025 Gur E.: B-1199 Gür S.G.: B-0490 Gürel S.: B-0490 Gürer E.I.: B-1024 Gutberlet M.: A-275, A-448, A-546, B-0462, B-0853 Gutzeit A.: B-1041, B-1325, B-1388 Guyomarc’h Delassale B.: B-1151 Guzzardi G.: B-1176, B-1375 Gyebnár G.: B-0079, B-0080

H H.N S.: B-0042 Ha H.K.: B-0040 Ha K.-Y.: B-0806 Haack M.: B-0719 Haage P.: A-490 Haaring C.: B-0060, B-0768 Haas M.: B-0697, B-0945 Haasters F.: B-1182 Habereder T.: B-0931 Habets J.: B-1078 Habib Geryes B.: B-1227 Habib L.A.: B-1054 Habib N.: B-0540 Hachulla-Lemaire A.-L.: B-0588 Hackenbroch M.: B-0167 Hacker U.: B-1144 Hacking N.: B-1369, B-1370 Hadad Y.: B-0116 Hadaschik B.A.: A-162 Hadley L.C.: B-1012 Haensig M.: B-0853 Hafskjold L.: B-0148 Haftner T.: B-1146 Hagar A.: B-0862 Hagelstein C.: B-0373 Hahn H.K.: A-224 Hahn M.: B-1068 Hahnloser D.: B-0247 Haigh I.: B-1278 Hajnal J.: B-0897 Hajnal J.V.: B-1385 Håkansson C.: B-0397 Hakkert M.: B-1383 Hakumäki J.: A-389 Hakyemez B.: B-0327 Hales P.: A-180 Halıcıoğlu S.: B-0490 Haliloglu M.: A-069 Halimi P.: B-0320 Hall N.: B-0374 Haller B.: B-0341 Haller S.: A-427 Halvorsen B.: CTiR 1 Hamagandi P.: B-1192 Hambardzumyan A.: B-0170

www.myESR.org

List of Authors & Co-Authors

Hamed M.F.: B-0544 Hameed D.A.: B-1034 Hamm B.: A-161, A-695, B-0067, B-0621, B-0690, B-0697, B-0945, B-1174 Hammerstingl R.: B-0467, B-1222 Hammoud S.: B-1191 Hamze B.: B-0809 Han D.K.: B-0876 Han G.: B-1272, B-1295 Han H.: B-0755 Han H.Y.: B-1025 Han J.K.: B-0011, B-0090, B-0410, B-0415, B-0838, B-0842, B-1263, B-1297 Han J.S.: B-0156 Han N.H.: B-0645, B-0646 Han N.Y.: B-0108, B-0131, B-0573, B-1232 Han Na L.: B-1215 Han S.: B-1038, B-1141 Han Y.: B-0510 Hanafy M.M.H.H.: B-1066 Handlechner L.: B-0147 Hansell D.: B-0112, B-0586, B-0587, B-1368 Hansell P.: B-0575 Hansen D.: B-0181 Hansen J.: B-1047, B-1348, B-1352 Hansson M.: CTiR 1 Hansson O.: B-0397, B-0969 Hao X.: B-0970 Haouin K.: B-0986 Hara M.: B-0495 Hara T.: B-0615 Harata N.: B-0688 Harkness E.F.: B-1136 Harmening C.: B-0401 Harms S.: CTiR 2 Harris G.J.: B-0512 Harris R.: A-367 Harsaker V.: B-0345, B-1382 Harth M.: B-0725, B-1222 Hartley T.: B-0442 Hartmann I.: A-028 Hartung D.: B-0939 Hartvig Sode A.: K-11 Has A.C.: B-0082 Hasegawa D.: B-0807 Hashemi Taheri A.P.: B-0035 Hashim F.: B-0196 Hattori A.: B-0431 Hatw A.: B-1257 Haubenreisser H.: B-0580, B-1161 Haug A.-K.: B-0564 Hauge I.H.R.: B-1119 Hausegger K.: B-0973 Hausmann D.: B-0141 Haustermans K.: B-1323 Havla L.: B-0965 Hayashi D.: B-0548 He J.-R.: B-1031 He Y.: B-0141, B-1327 He Z.: B-0505 Hebestreit H.: B-0314 Heck O.: B-0500, B-0971 Hedman M.: B-0786 Heerink W.J.: B-0863 Heidari H.: B-1107

www.myESR.org

Heikkinen S.: B-1155 Heilmaier C.: B-0306, B-0310, B-1250 Heilmeier U.: B-0551 Heinemann V.: B-0189, B-1322 Heinz G.: B-0283, B-0284, B-1240 Heinz M.: B-0617 Heinzel A.: B-0375 Heinz-Peer G.: A-199 Heiss P.: B-1299 Helal M.: B-0612, B-1279 Helbich T.H.: B-0758, B-1259, K-27, B-0428, B-0944, B-1116, CTiR 2 Held U.: B-0438 Hélénon O.: A-528, A-805 Helfen T.: B-1182 Hellawell G.: B-0700, B-0947 Hellbach K.: B-0671 Helle M.: B-0666 Helley D.: B-0097 Hellmich M.: B-0295, B-0493 Hellström M.: A-239, B-0578, K-06 Helmberger T.K.: A-699 Hempel J.-M.: B-0907 Henareh L.: B-0749 Hendel T.: B-0667 Hendriks B.H.: B-0225 Hendriks B.M.F.: B-0473, B-0791, B-1040 Hendrikse J.: B-0650 Henes F.O.: B-0361, B-0550, B-0642 Hengl C.: B-1035 Henkes H.: B-0401 Henner A.: B-0151, B-0585, B-0866 Hennermann J.: B-0769 Hensen B.: B-1367 Hensen B.J.U.: B-0939 Hentschel H.: B-0492 Henzler T.: B-0373, B-0580, B-0739, B-0836, B-1161 Herazo-Bustos C.: B-0202 Herberich S.: B-1110 Herholz K.: A-773 Herlihy D.: B-0644 Hermann K.-G.: B-0067 Hermann S.: B-0067 Hermans J.J.: B-0188 Hernández-Argüello M.D.: B-0344 Hernández-Argüello M.D.D.: B-0702 Hernandez-Martinez A.: B-0413 Hernández-Muñiz S.: B-1046 Hernando D.: B-0982 Hernigou A.-C.: B-0320 Herold C.J.: A-144, K-16 Herregods N.: B-0069 Herrmann K.: B-0899 Herth F.: B-0315 Hervieu V.: B-1088 Herzen J.: B-0547, B-1149 Herzog D.: B-1212 Hesse N.: B-0189, B-1322 Hetterich H.: B-1149 Heudel P.E.: B-0123 Heusch P.: B-0099, B-0560, B-0656, B-0657, B-0901, B-1036, B-1058 Heussel C.P.: A-237, B-0315, B-0433, B-0439, B-0513, B-1214, B-1216

Heußer T.: B-0668, B-0669 Heverhagen J.T.: B-1035 Heywang-Köbrunner S.H.: A-550 Hibat-Allah S.: B-0162 Hidaka K.: B-1377 Higashigaito K.: B-0176, B-0519, B-1289 Highnam R.: B-1119 Hijaz T.: B-1343 Hilgendorff A.: B-0671 Hill A.: B-0119 Hill C.: B-0924 Hillergård K.: A-406 Hillman B.J.: A-067 Hinen S.: B-0174 Hinestroza M.F.N.: B-0243 Hinrichs J.: B-0978, B-1094 Hinrichs J.B.: B-1044 Hirani N.: B-1218 Hirata S.: B-0466 Hirner-Eppeneder H.: B-0931, B-0933, B-0934 Hirsch A.: B-0013 Hirsch J.: B-0667 Hirschmann M.T.: B-0076 Hirtler D.: B-0368 Hjemly H.H.: A-405 Hladuvka J.: B-1146 Hlavacek A.: B-0452 Ho C.: B-1131 Ho G.: B-1133 Ho H.S.: B-0359 Hocquelet A.: B-1223 Hodi F.S.: B-0512 Hodler J.: A-363 Hoefer I.E.: B-0060, B-0768 Hoeffel C.: B-0094 Hoeper M.M.: B-1044 Hoff S.R.: A-388 Hoffmann K.: B-0088 Hoffmann Nunes R.: B-0198, B-0200 Hoffmann R.: B-0861 Hoffmann T.: B-0883 Hoffmann U.: B-0744, B-0787, CTiR 2 Hoffstaedter F.: B-1341, B-1342 Hofmann F.: B-1322 Hofmann F.O.: B-0189 Hofmann Gonzalez F.: B-0413 Hofmann M.: B-0478, B-1224 Hofmann P.C.: B-1349 Hofmann W.J.: B-1175 Hofvind S.: B-0148, B-1119 Hogan P.: B-1007 Hogg P.: B-0307, B-0345, B-0353, B-0711, B-0716, B-1119, B-1208 Höglund P.: B-0850 Hogue J.-C.: B-0021 Hohl M.: B-0619 Hohlfeld R.: B-1110 Hoischen J.: B-1316 Holbrook A.: B-1131 Holch J.: B-0189, B-1322 Holden A.: B-0260 Holm T.: A-613 Hölmich P.: B-0639 Holmin S.: A-596

Final Programme | ECR 2016

353

List of Authors & Co-Authors

Holtedahl J.E.: B-0211 Holtman G.A.: B-0290 Holwein C.: B-1184 Holzapfel K.: B-0341, B-0517 Homampour S.: B-0109 Honarmand A.: B-0647 Honda H.: A-570 Hong D.: B-0576 Hong N.: B-0504 Hong Y.: B-0440 Hongo N.: B-1372 Hope T.A.: B-0364 Hopkins S.J.: B-0709 Hoppe H.: A-110 Horch R.E.: B-0259 Horcsik D.: B-0179 Horehledova B.: B-0791 Hori M.: B-0979 Hornung A.: B-0312 Hornung M.: B-1300 Horsch A.D.: B-0496 Horta M.: A-037 Horta R.G.: B-0486 Horváth A.: B-0285 Horváth B.: B-0457 Hoste P.: CTiR 1 Hosten N.: B-0006, B-0981, B-0984, B-1299 Hou P.: B-0102, B-0477 Houssami N.: CTiR 2 Houston G.: B-0748 Hov J.R.: B-0008 Howard M.L.: B-0145 Howarth N.: B-0347 Howells T.: B-0203 Howes A.: B-0353 Hricak H.: A-223, A-476 Hripun I.: B-0063 Hruska L.: B-0239 Hu A.-N.: B-0962 Hua X.: B-0584 Huang J.: B-0024 Huang L.: B-0445, B-0449 Huang S.: B-0445, B-0449 Huber A.: B-1158 Huber R.: B-0990 Hubertus P.: B-0979 Hübner J.: B-0006 Hücümenoğlu S.: B-1328 Hudak A.: B-1144 Hudson J.M.: B-0187 Huebner R.-H.: B-1212 Huegli R.W.: B-0076 Hughes A.: B-0648 Hughes M.C.: B-1063 Hughes N.M.: B-0024, B-1021 Huisman T.A.G.M.: A-750 Hummelink S.: B-1139 Hummler S.: B-0513 Humphreys H.: A-251 Humphries P.D.: A-494 Hung M.L.B.: B-0321 Hunink M.G.M.: A-068, A-257, B-0232, B-0237, B-0743 Hunold P.: A-216, B-1301 Hunter A.: B-0741

354

ECR 2016 | Final Programme

Hunter K.: B-0018 Hüper K.: B-0939 Hupkens B.J.P.: B-1160 Hurley M.C.: B-0647, B-0652 Hurst R.W.: B-0801 Husarik D.: B-0176 Hüsers K.: B-0877, B-0878 Hutchinson B.: B-1017 Hutt A.: B-0370 Hüttl A.: B-0261 Hüttl K.: B-0261 Huyskens J.: A-566 Huysse W.: A-076 Hwang C.M.: B-0755 Hwang S.B.: B-0798 Hwang S.S.: B-0207 Hwang S.T.: B-0573

I Iacconi C.: B-0425 Iafrate F.: B-0238 Iafrate S.: B-1226 Iannessi F.: B-0687 Iannicelli E.: B-0958, B-1142 Ianniello S.: B-0522 Iannitti M.: B-0238 Ichikawa S.: B-0466 Ichikawa T.: B-0615 Ichikawa Y.: B-0807, B-1309 Ichisaka S.: B-0495 Idee J.-M.: B-0201 Ienzi R.: B-0533 Iezzi R.: A-295, B-0999 Ikramov A.: B-1305 Iles S.E.: B-1120, B-1125 Ilgner J.: B-0722, B-0724 Ilhan H.: B-0997 Ilic D.: B-1378 Illomei G.: B-1108 Imai T.: B-0223, B-0531, B-1277 Imam H.M.K.: B-0091, B-0563, B-1034 Imbriaco M.: B-0453, B-0824 Imhoff A.B.: B-1184 Imhof-Tas M.: B-0535 Inagaki T.: B-0216 Inal M.: B-0161 Incesu L.: B-0082 Indesteege I.: B-0543 Inecikli M.F.: B-0327 Ingemansson R.: B-0850 Ingrisch M.: B-1110 Innocenti E.: B-1076 Inokawa H.: B-0106 Inoue M.: B-0216, B-1171 Introna T.: B-0421, B-1067, B-1256 Ioan I.: B-0923, B-1123 Iori M.: B-0922 Iotti V.: B-0922, B-1062 Ip J.: B-1133 Ippolito D.: B-0092, B-0096, B-0299, B-0441, B-0448, B-0662, B-0767, B-0770, B-0774, B-0775, B-0805, B-0835, B-1030, B-1084, B-1173, B-1196 Iranzo V.: A-439 Isaac S.: B-1169

Isabelle M.: B-0181 Isfort P.: B-0864 Ishibashi R.: B-0405 Ishida K.: B-1039 Ishida M.: B-0807, B-1309 Ishiguchi T.: B-0223, B-0531, B-1277 Ishii A.: B-0405 Isidori A.: B-0941 Iskra A.: B-1381 Islam S.: B-0185 Ismail A.: B-1095 Isoda H.: B-0479 Isogai J.: B-0688 Ito N.: B-0864 Itou C.: B-0615 Ittermann T.: B-0667 Ittrich H.: B-0478, B-1224, B-1353 Ivanac G.: B-0474 Ivanac K.: B-0474 Iwase K.: B-0431 Izhaky D.: B-0226 Izlakar J.: B-1380 Izzo R.: B-1057

J Jackson A.: A-291 Jackson D.M.: B-0729 Jackson S.A.: A-507 Jacob J.: B-0112, B-0586, B-0587, B-1368 Jacobi V.: B-0432, B-0483 Jacobs C.: B-1362 Jacobson J.A.: B-0076 Jacomet P.-V.: B-0153 Jacquier A.: A-217 Jäger D.: A-266 Jager E.A.: B-0568 Jager G.J.: B-0929 Jäger H.R.: A-185, A-481 Jäger R.: B-0823 Jager R.H.: B-0648 Jahn K.: B-0396 Jahoda J.: B-0239 Jain A.: B-0013 Jain P.: B-0761 Jain S.K.: B-0761 Jakab A.: B-0077 Jakobs T.F.: A-046 Jambi L.K.: B-0033 James K.: B-0795 Jamieson S.: B-0387 Jang H.: B-1239 Jang J.: B-0645, B-0646 Jang J.H.: B-0651 Jang J.K.: B-1360 Jang K.M.: B-0597 Jang M.: B-0530 Jang S.: B-1297 Jang S.W.: B-0172 Jang Y.R.: B-0090 Jankauskas A.: A-052 Jankowski A.: B-1358 Jannone M.: B-1028 Jans L.: A-076, B-0069 Jansen O.: B-0666 Janssen H.: B-0793, B-0820, B-0968

www.myESR.org

List of Authors & Co-Authors

Jansson K.: B-0714 Jaremko J.: B-0069 Jaschke W.R.: A-412, B-0273 Jaspers K.: B-0609, B-0610 Jazwiec P.: B-0062, B-0064 Je B.-K.: B-0576 Jech R.: B-1198 Jee W.-H.: B-0804, B-0806, B-0917 Jeevanandham B.: B-1333 Jegonday M.-A.: B-1049 Jengojan S.: B-0278, B-0279 Jenkins W.: B-1218 Jennings G.: B-0001, B-0003 Jensen C.: B-1153 Jentzsch T.: B-0438 Jeon H.J.: B-0464, B-1331 Jeon S.K.: B-1263 Jeong C.Y.: B-0010 Jeong S.-Y.: B-0884 Jeong W.K.: B-0839 Jerebko A.K.: B-0670 Jermendy A.: B-0179 Jermendy A.L.: B-0747, B-0766 Jermendy G.: B-0179 Jernberg T.: CTiR 1 Jeung M.-Y.: B-0582, B-0986 Ji Q.: B-0595 Ji Z.-B.: B-1228 Jia G.: B-0825, B-0833 Jia W.R.: B-0529, B-1031, B-1033 Jianbo G.: B-0992 Jiang X.: B-0445, B-0449 Jiang Y.: B-0240, B-0268, B-0269, B-0504, B-0962 Jiang Y.-J.: B-1269 Jiang Z.: B-1029 Jiao J.: B-0484, B-0577, B-1236 Jimenez R.: B-0521 Jiménez-Fonseca P.: B-1046 Jimenez-Juan L.: B-0109 Jin G.Y.: B-0221 Jin W.: B-0073 Jin Y.: B-0752 Jin Z.: B-1177 Jin Z.Y.: B-1093 Jin Z.-Y.: B-0177, B-0571, B-0739, B-0836, B-1235, B-1265, B-1266, B-1268 Jing X.: B-0857 Jingu K.: B-0055 Jinzaki M.: B-1171 Jjubisavljevic S.: B-1109 Jobst B.: B-1211 Jochelson M.S.: B-1063 Johannesen G.: B-0008 John U.: B-0895 Johnson K.M.: B-0322, B-1099 Johnson R.: B-1188 Johnsson M.: B-0397 Jonas E.: A-064 Jones J.: B-0796 Jones J.F.X.: B-1376 Jonkman L.E.: B-1105 Joo I.: B-0415, B-0842, B-1263, B-1297 Jordan E.: A-442 Jorge J.: B-0716

www.myESR.org

Joseph G.B.: B-0643 Ju X.: B-1029 Juarez Garcia M.: B-0124 Jugpal T.S.: B-0372 Jun H.Y.: B-1092 Jung C.: B-0478, B-1224 Jung D.C.: B-1239 Jung E.M.: B-0475, B-1026, B-1300 Jung H.K.: B-0015 Jung J.-Y.: B-0804, B-0806, B-0917 Jung S.C.: B-0654, B-0817 Jung S.E.: B-0339, B-0738 Jung S.I.: B-0464, B-1331 Jung S.L.: B-0558, B-0646, B-0651 Jung S.-L.: B-0645 Jungmann P.M.: B-0547, B-1184 Jurado-Gómez M.C.: B-1020 Juras V.: B-0491

K Kaasalainen T.: B-1155 Kabaalioğlu A.: B-1024 Kachelrieß M.: A-098, B-0668, B-0669, B-0673 Kachenoura N.: B-0763 Kadir T.: B-0436 Kadoya M.: B-0841 Kadoya N.: B-0055 Kaeding C.: B-0556 Kagawa K.: B-0731 Kahkouee S.: B-0856 Kahn C.E.: B-0236 Kahn J.: B-1174 Kahn T.: B-0074, B-0902, B-0906, B-0983, B-1144 Kahraman A.S.: B-0591 Kahraman B.: B-0591 Kainberger F.: A-374, B-0070 Kainz B.: B-1385 Kaiser A.: B-1070 Kaiser C.: B-1070 Kaiser C.G.: B-0757 Kalcan S.: B-0694 Kalenderian A.-C.: B-0128, B-0329 Kalia V.: B-0956, B-1188 Kälin P.: B-0640 Kalina I.: B-0471 Kalinin D.: B-0592, B-1264 Kallenbach K.: B-0764 Kamal R.M.: B-1257 Kaminaga S.: B-1364 Kamiya M.: B-0479 Kampmann C.: B-0769 Kamusella P.: B-0616 Kanana N.: B-0472, B-0680 Kanao S.: B-0216 Kandel S.: B-1204 Kane T.: B-0353 Kang B.C.: B-0138 Kang B.J.: B-0606, B-0756 Kang C.H.: B-0918 Kang E.-J.: B-0182 Kang H.J.: B-0604 Kang J.W.: B-0349 Kang M.: B-0406

Kang T.W.: B-0597 Kantarci M.: B-0598, B-1081 Kanz K.-G.: B-0517 Kao K.: B-0424 Kapetas P.: B-0423, B-0757, B-0758, B-1116, B-1259 Kaplan J.A.: B-0013 Kaposi P.N.: B-0471 Kappelle L.J.: B-0496 Kapustin V.: B-0826 Kara M.: B-0002 Karaban I.: B-1338 Karabulut N.: A-469, B-0598 Karaca L.: B-0598, B-1081 Karady J.: B-0179, B-0747 Karalok I.: B-1187 Karaman C.Z.: A-736 Karampinos D.C.: B-0485, B-0547 Karanikas G.: B-0300, B-0660 Karantanas A.H.: A-459 Karcaaltincaba M.: A-130 Karczmar G.: B-0429 Karenovics W.: B-0588 Karila Cohen P.: B-0633 Karimi M.A.: B-0856 Karkoshka T.: B-0063 Karlas T.: B-0983 Karmazanovsky G.: B-0592, B-0732, B-1264, B-1267 Karmazanovsky G.G.: B-0624 Karnabatidis D.: B-0618 Karolyi M.: B-0747 Karpenko A.K.: B-0552 Karpenko M.: B-1340 Karssemeijer N.: A-226, B-0527, B-0535, B-0921, B-1071, B-1355 Kartalis N.: B-1270 Karunyam B.: B-1370 Karwoski R.: B-0112, B-0587, B-1368 Kasprian G.: B-0077 Kassarjian A.: A-077 Kataeva G.: B-1340 Kato T.: B-0431 Katsanos K.: A-477 Katulska K.: A-123 Kauczor H.-U.: A-588, A-626, B-0313, B-0315, B-0433, B-0439, B-0513, B-0667, B-0764, B-0865, B-1043, B-1047, B-1210, B-1211, B-1214, B-1216, B-1348, B-1352 Kaufmann S.: B-0664 Kaul M.G.: B-0478, B-0550, B-1224 Kaup M.: B-0877 Kavcic P.: B-0886 Kawai H.: B-1051 Kawamitsu H.: B-0731 Kawashima A.: B-0706 Kawooya M.G.: A-083 Kayan M.: B-0002 Kaza R.: B-0692 Kazmierczak P.: B-0296, B-0933 Kazmierczak P.M.: B-0931, B-0934 Kelekis A.: B-0127, B-0330 Kelekis N.: B-0127, B-0330 Keller J.: B-1198 Keller S.: B-0007, B-0634

Final Programme | ECR 2016

355

List of Authors & Co-Authors

Kelly B.: K-35 Kelly B.S.: B-1019 Kelly J.F.: B-1119 Kelly P.: B-0352 Kelten C.: B-1280 Kemper J.: B-1132 Kendler D.: B-0027 Keohane D.: B-0644 Kerber J.: B-0740 Kerckhoffs K.: B-0496 Kerl J.M.: B-1077 Kerl M.: B-0186 Kerl M.J.: B-0213 Kersten E.: B-0244, B-0245 Kessels A.G.H.: B-0191, B-0192 Kessler D.E.: B-0861 Keupers M.: B-1357 Keyzer F.D.: B-1141 Khaled W.: B-0037 Khalid M.: B-0013 Khan F.: B-0748 Kharat A.: B-1293 Khashoggi K.: B-0708 Khomenko J.: B-1340 Khoo J.L.S.: B-0799 Khouatra C.: B-0117 Khung S.: B-0590, B-0987 Kianirad Y.: B-1343 Kickingereder P.: B-0282 Kidikas H.: B-0816 Kido T.: B-0382 Kiechl S.: B-0499 Kiessling F.M.A.: A-365 Kietselaer B.L.J.H.: B-0473, B-0791 Kilander L.: B-0388 Kilburn-Toppin F.: A-026 Kilickesmez Ö.N.: B-1280 Kilsdonk I.D.: B-1105 Kim A.Y.: B-0040 Kim B.: B-0221, B-0409, B-0416, B-0463 Kim B.R.: B-0406, B-1284 Kim B.S.: B-0651 Kim B.-S.: B-0645, B-0646 Kim D.J.: B-0576 Kim E.Y.: B-0594 Kim G.C.: B-1324 Kim G.M.: B-1102 Kim H.: B-1318 Kim H.A.: B-0207 Kim H.C.: B-1025 Kim H.J.: B-0040, B-1073, B-1154, B-1324 Kim H.-J.: B-0530 Kim H.O.: B-0010 Kim H.R.: B-0676 Kim H.S.: B-0654, B-0817 Kim H.W.: B-0884 Kim I.-O.: B-0169, B-0172 Kim J.: B-0409, B-1102 Kim J.E.: B-0010, B-0838 Kim J.H.: B-0090, B-0839 Kim J.K.: B-0187 Kim J.M.: B-0414 Kim J.S.: B-0073 Kim J.W.: B-0601, B-0653, B-0837, B-0975 Kim J.Y.: B-0604, B-0884

356

ECR 2016 | Final Programme

Kim K.: B-0755 Kim K.A.: B-0207, B-0208, B-0601, B-0837 Kim K.W.: B-1025 Kim M.D.: B-1102 Kim M.J.: B-0108, B-0131, B-0573, B-1232 Kim M.Y.: B-0676, B-0678, B-0681, B-1073, B-1154, B-1215, B-1360 Kim N.: B-1366 Kim R.: B-0287 Kim S.: B-0406, B-0558, B-0756, B-1272, B-1295 Kim S.H.: B-0011, B-0463, B-0597, B-1234 Kim S.J.: B-0015, B-0207, B-0654, B-0817 Kim S.K.: B-0349 Kim S.M.: B-0530, B-1073, B-1154 Kim S.T.: B-0090 Kim S.Y.: B-1102, B-1234 Kim T.: B-0979 Kim T.H.: B-0011, B-0169, B-0180, B-1234 Kim T.-H.: B-1092 Kim W.H.: B-1324 Kim W.S.: B-0169, B-0172 Kim Y.D.: B-0653 Kim Y.J.: B-0169, B-0464, B-0755, B-1025, B-1331 Kim Y.K.: B-0839 Kim Y.P.: B-1073, B-1154 Kim Y.S.: B-0798 Kim Y.T.: B-1363 Kinkel K.: A-128, A-402 Kinner S.: B-0165, B-0411, B-1036, B-1301, B-1316 Kirkham A.: B-0948 Kishida Y.: B-0316, B-0319, B-0655, B-0684, B-0685 Kiss M.: A-765 Kiss O.: B-0248 Kitagawa K.: B-0384, B-0385, B-0807, B-1309 Kitakawa K. : CTiR 2 Kitis O.: B-0085 Kitrou P.M.: B-0618 Kitslaar P.: B-0744 Kitzler H.H.: B-0559 Kiyosue H.: B-0405, B-1372 Kızıldağ B.: B-0065, B-0066, B-0637 Kjaer A.: A-515, A-754 Kjelle E.: B-0148 Klang E.: B-0472, B-0680, B-0686 Klauser A.: A-156, B-0273, B-0740, B-0960 Klauß M.: B-1047, B-1352 Klausz R.: B-1354 Klaver R.: B-1105 Kleiker M.: B-0716 Klemm T.: B-0853 Klengel A.: B-0074 Klengel S.: B-0074 Klimaj Z.: B-0079, B-0080 Klinder T.: A-032 Kljucevsek D.: A-495 Klode J.: B-0908 Kloeckner R.: A-538, B-0412, B-0907 Klompenhouwer E.G.: B-0925 Klos A.: B-0939 Klose H.: B-0855

Kloth C.: B-0039, B-0297 Kløw N.-E.: B-0211 Klug D.: B-1175 Kluge S.: B-0855 Kluijfhout W.P.: B-0364 Klumpp B.: B-0039, B-0297 Knapp K.M.: B-0709 Knaudt J.: B-1070 Knaup M.: B-0673 Knauth M.: A-039 Knebel F.: A-113 Kneidinger N.: B-0229 Kniepeiss D.: B-0417 Knoflach M.: B-0499 Knopp M.: B-0833 Knopp M.U.: B-0556 Knopp M.V.: B-0028, B-0029, B-0374, B-0556, B-0825 Knopp T.: B-0478, B-1224 Knuuti J.: A-009, A-449, CTiR 1 Ko K.H.: B-0015 Kobashi Y.: B-1189 Kobayashi Y.: B-0194 Koceva I.: B-1380 Koch G.: B-0323 Koch S.: B-1003 Kochhar R.: B-1167 Kock M.: B-0852 Kock M.C.J.M.: B-0012 Kockelkoren R.: B-0650 Koek D.H.: B-0650 Koell M.: B-1047 Kogler M.: B-0910 Koh D.-M.: A-085, A-339, B-0185, B-1258, B-1325 Koh M.: B-0854 Koh S.H.: B-0528 Kohler R.: A-143 Koikkalainen J.: A-601 Koizumi J.: B-0615 Kok H.K.: B-0267 Kok M.: B-0473, B-0791, B-1040 Kokan M.: B-0495 Kokosi M.: B-1368 Kokovic T.: B-1378 Kolahdoozan S.: B-0035 Koletzko L.: B-0229 Kollmann C.: B-0534 Kolokythas O.: B-0554 Kolossvary M.: B-0179, B-0747, B-0766, B-0788 Komori Y.: B-0479 Kömür B.: B-1199 Kondratyev E.: B-0732 Konen E.: B-0472, B-0680, B-0686 Kong E.: B-0596 Konietzke P.: B-0433, B-0439 Konijnenberg M.: B-0936 Kono A.: B-0731, CTiR 2 Konovalov P.: B-0800 Koo H.J.: B-0349, B-0676, B-0681, B-1360 Koo H.-S.: B-0073 Koo J.: B-0645 Kooi M.E.: B-0056 Kooijman H.: B-0007, B-0058, B-0485

www.myESR.org

List of Authors & Co-Authors

Kooijman-Kurfuerst H.: B-0634 Kook S.H.: B-0754 Kool D.R.: A-496 Kool W.: B-0036 Koole M.: B-1141 Koopman M.: B-0995 Koops A.: B-0622 Körber A.: B-0068 Kording F.: B-0007 Koren A.: B-0886 Korhonen M.: B-0786 Koritnik B.: B-0886 Korkmaz M.F.: B-0270 Korkusuz F.: B-0274 Körner E.: B-0292 Kornreif C.: B-0273 Kors J.A.: B-0232 Körsmeier K.: B-0909 Korta Gómez I.: B-0358 Korutz A.W.: B-1343 Korzeniowski K.: B-1374 Koşar P.: B-1328 Koshurnikov D.: B-0826 Koskas P.: B-0153 Koskinen S.K.: B-0689, B-0691 Kosma V.-M.: B-1118 Kosta P.: B-1059 Koster I.: B-0852 Köstler H.: B-0314, B-1045 Kosugi T.: B-0479 Kotb H.T.: B-0808 Kotb M.: B-0663 Kotter E.: A-013 Koudstaal P.: B-0400 Koumarianos D.: A-650 Kousaka J.: B-0223, B-0531, B-1277 Kovac J.D.: B-0214 Kovač V.: B-0317 Kovács A.: B-0766 Koyama H.: B-0316, B-0319, B-0655, B-0684, B-0685 Kozák L.R.: B-0079, B-0080 Kozerke S.: A-276, A-420 Kracke T.: B-1367 Kraff O.: B-0909 Krainik A.: A-292, B-0500, B-0971 Kramer H.: B-0088, B-0982, B-1099, B-1315 Kramer J.: A-458, A-564 Krämer S.: B-0295 Krauss B.: B-1349 Kravchick S.: B-0827 Krazinski A.W.: B-1203 Krdzalic J.: B-0776 Kreitner K.F.: B-0412 Kreitner K.-F.: A-629, B-0455 Kremser C.: B-0273, B-0960 Kress B.: CTiR 1 Krestan C.R.: A-462 Krestin G.: B-0743 Krestin G.P.: A-148, A-454 Kretzschmar M.: B-0643 Kreuter M.: B-0315 Krick S.: B-0907 Kristoffersen L.: B-0345 Kristoffersen Wiberg M.: B-0390

www.myESR.org

Kristoffersen-Wiberg M.: B-0196 Kristofferzon M.-L.: B-0814 Kroczek E.: B-0690 Kroiss A.: B-0027 Kroiss E.: B-1026 Kromrey M.-L.: B-0006, B-0981, B-0984, B-1299 Kronnerwetter C.: B-0491 Kroon W.: B-0114 Kröpil P.: B-0044, B-0099, B-0394, B-0545 Krotenkova I.: B-1111 Krotenkova M.: B-1111 Kruck S.: B-0704 Krug B.: B-0295, B-0493 Krych A.J.: B-0557 Ku M.C.: B-0562 Ku Y.M.: B-0038 Kubik-Huch R.A.: A-235, A-452, A-637 Kubo T.: B-0405 Kudryavtseva E.: B-0895 Kuestner T.: B-0593 Kuganesan A.: B-0737 Kuhl C.: B-0375, B-0722, B-0864 Kuhl C.K.: A-090, B-0724 Kuhl C.K.K.: A-457 Kühn A.L.: B-0972 Kuhn F.P.: B-1191, B-1195 Kühn J.-P.: B-0006, B-0981, B-0984, B-1299 Kuhnigk J.-M.: B-1212 Kuijer P.P.F.M.: B-1179 Kuijpers D.: B-0789 Kukkes T.: B-1016 Kukkola K.: B-0233 Kulkarni K.: B-0429 Kullberg J.: B-0388 Kumar Gg S.: B-1262 Kumar J.: B-0372 Kümpfel T.: B-1110, B-1114 Kündel M.: B-0312 Kunst D.: B-0727 Kuntner-Hannes C.: A-364 Kuntz J.: B-0673 Kunz A.S.: B-0314, B-1045 Kunz M.: B-0794 Kunz W.G.: B-0793, B-0965 Kupcs K.: B-0816 Kupka M.: B-0361 Kuplevatsky V.: B-0830, B-0831 Kurfürst M.: B-0574, B-0993 Kurobe Y.: B-0807 Kurozumi M.: B-0841 Kurra V.: B-0512 Kurre W.: B-0398, B-0399, B-0401 Kurucz P.: B-0401 Kus S.: B-0848, B-1140 Kushner D.C.: A-290 Kussmaul J.: B-1135 Kuzmiak C.M.: B-0755 Kvyatkovskaya E.: B-0831 Kwak H.S.: B-0798 Kwee R.: B-0056 Kwee R.M.: B-0930 Kwon H.: B-0416, B-1284 Kwon H.Y.: B-0138 Kwon S.H.: B-0546

Kwon S.O.: B-0876

l la Fougère C.: B-0023, B-0664, B-0904 La Fuente J.M.: B-0703 La Grutta L.: B-0658 La Marra A.: B-0324, B-0331, B-0332, B-0959 La torre L.E.: B-0745 Laader A.: B-1301 Läänelaid Z.: B-1016 Labani A.: B-0582, B-0986 Labori K.J.: B-0211 Labus S.: B-1351 Lacoste B.: B-1283 Laenen A.: B-0543 Lafitte F.: B-0153 Lagalla R.: B-0658 Laghi A.: A-003, A-513, B-0780, B-0783, B-0941, B-1142 Lahaye M.: B-0244, B-0245 Lahaye M.J.: B-1166 Lahkim M.: B-0367 Lai A.Y.T.: B-0799 Lai B.M.H.: B-0799 Laissy J.P.: B-0633 Lajarín Cano L.: B-1112 Lalji U.: B-1064 Laloo F.: B-0069 Lam M.: B-0995 Lam S.: B-1133 Lam T.: B-1133 Lam W.: B-1133 Lambert B.: B-0320 Lambert L.: B-0239 Lambert M.: B-0748 Lambertova A.: B-0239 Lambregts D.: B-0244, B-0245, B-0776, B-1165 Lambregts D.M.: A-341, A-665 Lambregts D.M.J.: B-0191, B-0192, B-1160, B-1163, B-1166, B-1168 Lammers J.-W.J.: B-0488, B-1365 Lamot U.: B-1106 Lamparski K.: B-1374 Lanca L.: B-0716 Landgraeber S.: B-0909 Landoni C.: B-1030 Lane N.: B-0551 Lane S.: B-0143 Lang W.: B-0259, B-0262, B-0617 Langner S.: A-056 Langs G.: B-0077 Laniado M.: A-662, B-0559 Lannsjö M.: B-0203 Lantuejoul S.: B-1358 Lanza E.: B-0325 Lanzman R.: B-0545 Lanzman R.S.: B-0099, B-0394 Lapidus G.: B-1181 Laporte S.: B-1195 Laqmani A.: B-0574, B-0855, B-0993 Lardenoije S.: B-0921 Laredo J.D.: B-0809 Largo Flores P.: B-1096

Final Programme | ECR 2016

357

List of Authors & Co-Authors

Larici A.R.: A-215, A-759, B-0677, B-0679, B-1361 Lario C.: B-0566, B-0659 Larkman N.: B-1278 Larrue V.: B-0818 Larson A.C.: B-0193 Larsson E.-M.B.: A-672, B-0388, B-0814 Larsson I.-M.: B-0814 Larvie M.: B-0390 Lätt J.: B-1055 Lattanzi R.: B-0404, B-0501, B-0687, B-0802 Lau C.-S.: B-0784 Lau C.-Y.: B-0086 Lau K.K.: B-0729 Lau K.K.-P.: B-0737 Lau S.M.: B-0988 Lau V.: B-1133 Lauenstein T.C.: B-0411, B-0900, B-1301 Laule M.: B-0383 Launay N.: B-1195 Lauren H.: B-0882 Laurent F.: B-1358 Laurent L.: B-0308 Lauretti D.L.: B-0093 Lauritzen C.: B-1321 Lause S.: B-0396 Lauvin M.A.: B-1115 Lavin P.T.: B-0217 Lawaczeck R.: B-0159 Lawson R.: B-0353 Lawton C.B.: B-0254 Lazic L.: B-0214 Lazik A.: B-0909 Łazowska-Przeorek I.: B-0893 Le Pennec V.: B-1049 Le Pimpec-Barthes F.: B-0320 Le Touze D.: B-1151 Leach M.O.: B-1258 Leale G.: B-1176 Leander P.: B-0730 Leber A.: B-0378 Lechel U.: B-0373 Lecler A.: B-0153, B-0157, B-0363, B-1121 Leconte I.: B-1283 LeCoultre R.: B-1286 Lederlin M.: B-1216, B-1358 Ledger A.: B-1117 Lee B.-F.: B-0940 Lee C.H.: B-0208, B-0601, B-0837, B-1363 Lee C.-H.: B-0975 Lee Christoffersen C.: B-0730 Lee D.H.: B-0654, B-0817, B-0838, B-0842, B-1297 Lee D.Y.: B-1102 Lee E.S.: B-1263 Lee G.M.: B-1092 Lee H.: B-0156 Lee H.A.: B-0215 Lee H.J.: B-0208, B-0601, B-0837 Lee H.N.: B-0676, B-0681 Lee I.J.: B-0854 Lee J.: B-0180, B-0182, B-0406, B-0416, B-0427, B-0440, B-0526, B-0601, B-0837, B-0876, B-1284

358

ECR 2016 | Final Programme

Lee J.B.: B-0676, B-1360 Lee J.H.: B-1023, B-1092 Lee J.-H.: B-0839 Lee J.M.: A-063, B-0208, B-0409, B-0410, B-0415, B-0651, B-0838, B-0842, B-1025, B-1263, B-1297, K-33 Lee J.S.: B-0040, B-0415 Lee J.S.Z.: B-0227 Lee K.: B-0528, B-0645 Lee K.B.: B-0011, B-0410 Lee K.W.: B-0918 Lee M.: B-0266, B-0267, B-1318 Lee M.A.: B-1324 Lee M.H.: B-0918 Lee M.J.: A-492 Lee N.: B-1272, B-1295 Lee N.J.: B-0654, B-0817 Lee R.: B-0321 Lee R.W.: B-0918 Lee S.: A-278, B-0416, B-0646, B-0651, B-0913, B-1284 Lee S.-C.: B-1154 Lee S.E.: B-0627 Lee S.H.: B-0396, B-0576 Lee S.I.: B-0512 Lee S.-K.: B-0395, B-0653, B-1337 Lee S.L.: B-0038 Lee S.M.: B-0415, B-1324, B-1366 Lee S.W.: B-0349 Lee S.-Y.: B-0806 Lee T.F.: B-0799 Lee W.K.: B-0395, B-0653, B-1337 Lee Y.: B-0156 Lee Y.H.: B-0215, B-1092 Leemans A.: A-107 Leenders G.J.L.H.: B-0340 Lees J.E.: B-0033 Lefere P.: A-240 Lefèvre-Colau M.-M.: B-1191, B-1195 Legou F.: B-0104 Lehmkuhl L.: B-0853 Lehn C.: B-0028 Lehner S.: B-0997 Lehnert T.: B-0470, B-0877, B-0976 Lehotska V.: B-1255 Lei J.: B-1093 Lei P.: B-0484, B-0577, B-1236 Leicher-Düber A.: B-0412 Leidenberger T.A.U.: B-0764 Leidner B.: A-497 Leiner T.: A-300, A-422, B-0060, B-0765, B-0768, B-0787, B-1365 Leitgeb N.: A-173 Lell M.: A-001, A-253, B-0879, B-0880, CTiR 2 Lemmens K.: B-0920 Lemmerling M.: A-609 Lemos A.A.: B-0525 Leni D.: B-1196 León C.A.: B-0243 Leon P.: B-0699 Leone M.B.: B-0111 Leonhardt H.: B-0559 Lepida A.: B-0618 Leporcq B.: A-542

Leporq B.: B-0977, B-1088 Lerch M.M.: B-0984 Leschka S.: CTiR 1 Lester M.: B-1343 Lesyuk O.: B-0713, B-0873, B-1006, B-1386 Letellier A.: B-1049 Leunen K.: B-1037 Leung J.: B-1133 Leung L.: B-0988 Leung W.K.W.: B-0799 Leuschner G.: B-0229 Leutz P.: B-1216 Lev M.: B-0390 Lewington V.: A-426 Lewis S.: B-0143, B-0741 Ley S.: B-0313, B-1043 Leyes M.: A-693 Li H.: B-0966 Li J.: B-1243 Li K.: B-0935 Li L.: B-1042 Li N.: B-1330 Li Q.: B-0510 Li T.: B-0992 Li W.: B-0193 Li X.: B-0089, B-0445, B-0449, B-0773 Li X.B.: B-0289, B-1052, B-1056 Li X.-T.: B-1317 Li Y.: B-0773, B-0938, B-0966 Li Z.: B-0445, B-0449 Lian Y.: B-0240 Liapin V.M.: B-0898 Liasis N.: A-010 Lieba-Samal D.: B-0278, B-0279 Lightfoot C.B.: B-1120, B-1125 Liguori C.: B-0518 Lilic G.: B-0214 Lim A.: B-1275 Lim C.: B-0182 Lim K.-S.: B-0083, B-0086 Lim S.: B-0678, B-0681 Lim S.M.: B-0395, B-0653, B-1337 Lima F.R.A.: B-1141 Lin C.E.: B-0424 Lin J.: B-0445, B-0449, B-0966 Lind L.: B-0388, CTiR 1 Linda A.: A-793, B-0605 Lindberg E.: CTiR 1 Lindberg O.: B-0397 Lindberg P.: B-1195 Linder N.: B-0983, B-1144 Lindner T.: B-0666, B-0690 Lindvall H.: B-0730 Linglart A.: B-0367 Link T.: B-0643 Link T.M.: B-0549, B-0551, B-0557, B-0913 Linov L.: B-0827 Linsenhoff L.: B-0361 Linsenmaier U.: A-306 Linz D.: B-0619 Liss P.: B-0575 Lissandrin R.: B-1085 Lista A.: B-0772 Lisý J.: B-0728 Littleford R.: B-0748

www.myESR.org

List of Authors & Co-Authors

Litton J.-E.: A-324 Littvay L.: B-0061 Liu H.: B-1093 Liu J.: B-0135, B-1042, B-1285 Liu J.-H.: B-0784 Liu J.-M.: B-0177 Liu L.: B-1162 Liu S.: B-0682, B-0847 Liu T.: B-0744 Liu W.: B-1268 Liu X.: B-0504 Liu Y.: A-271, B-0391, B-0504, B-0510 Liuzzi R.: B-0824 Ljuhar D.: B-1146 Ljuhar R.: B-1146 Llopis E.: A-628 Lo G.: B-0988 Lo Goh G.: B-0321 Lo S.S.W.: B-0799 Lobbes M.: B-0420, B-1064, CTiR 2 Lobbes M.B.I.: B-0224, B-1276, B-1281 Loberg C.: B-0375, B-0722, B-0724 Lobo M.L.: A-070 Lodato L.: B-0533 Loeuille D.: B-0071 Loewe C.: A-007, A-298, A-547, A-770 Logager V.: A-742 Lohezic M.: B-1385 Lohöfer F.: B-0547 Lohrke J.: B-0195 Lokar K.: B-1381 Lombardi S.: B-0096, B-0441, B-0448, B-0770 Lombardo F.: B-0819 Lombardo S.: B-0536 Lomovtseva K.K.: B-0592 Longman C.: B-0759 Longo N.: B-0824 Longo R.: B-1140 Loo C.E.: B-0225 Loo K.: B-1319, B-1320 Loose R.: B-1000 Loose R.W.R.: A-654 Lopci E.: A-429 Lopes A.M.A.: B-0486, B-0635 Lopes Dias J.: A-311 Lopez B.: B-0672 Lorca Chapa J.: B-1260 Lorenc T.: B-0952 Loreni G.: B-1005 Lorente M.F.: B-0521 Lorenzoni G.: B-0093 Lorusso F.: B-0468 Losio C.: B-0608, B-1273, CTiR 2 Loss M.: B-1300 Lötjönen J.: A-601 Lotte R.: B-0320 Lotz J.: B-0014, B-0218, B-0222 Loureiro J.: B-0603, B-0753 Louwman M.W.: B-0925 Løvblad K.-O.: A-718 Löve A.: B-0957 Lowe J.: B-1007 Loxley N.: B-0672 Lozano Martinez A.: B-1053

www.myESR.org

Lu A.: B-0316 Lu C.-L.: B-1083 Lu M.: B-0744 Lu Q.: B-1083 Lu X.: B-0723, B-0736 Lu Y.: B-0288 Lubbers M.M.: B-0743 Lubinus F.G.: A-779 Lucarelli N.M.: B-0631 Lucarini S.: B-0943 Lucatelli P.: B-0061, B-0537 Lucchini R.: B-0923 Luciani A.: B-0104 Lucidarme O.: B-0699 Ludes C.: B-0985, B-0986 Ludwikowska J.: B-0911, B-0914 Luecke C.: B-0853 Luedtke C.W.: B-0616 Luijten P.R.: B-1105 Lund G.: B-0049 Lund G.K.: B-0382, B-1156 Lundén M.: A-408 Lunder A.K.: B-0008 Luo X.: B-0963 Luo Y.: B-1083 Lupusoru R.: B-1086, B-1087 Lurie D.J.: A-713 Lütje S.: B-0900 Lv P.: B-0101 Lv P.J.: B-0572 Lyadov V.: B-1296

M M.Ali R.M.K.: B-0307 Ma B.: B-0557 Ma F.H.: B-0132 Maas M.: A-500, A-512, A-627, B-0191, B-0192, B-0776, B-0954, B-1160, B-1163, B-1165, B-1166, B-1168, B-1179 Maataoui A.: B-0357 Maccarone M.: B-0389 MacDonald S.: A-296 Macera A.: B-0566 Maciag R.: B-1374 Mack M.G.: A-505, A-589, A-612 Mackay S.: B-0143 MacNee W.: B-1213 Macron L.: B-0381 Madani G.: A-002 Maderthaner R.: B-1079 Maderwald S.: B-1150, B-1152, B-1153 Madrid J.M.: B-0702, B-1128, B-1129, B-1306, B-1313 Maes J.: B-0803 Maestre H.: B-0521 Maffi P.: B-0160 Magdy A.M.: B-0840 Magerkurth O.: B-0076 Maggini E.: B-0532 Magnussen R.: B-0556 Magometschnigg H.: B-0428 Mahajan M.: B-0423 Maher B.: B-1369, B-1370 Mahfoud F.: B-0619 Mahlke C.: B-0981, B-0984

Mahmood U.: B-0450, B-1350 Mahmoud E.M.M.: B-0567 Mahmoudi S.: B-0967 Mahnken A.H.: B-0258, B-1035, B-1349 Mainenti P.P.: B-0465 Maintz D.: B-0047, B-0048, B-0167, B-0295, B-0953 Maiocchi L.: B-1085 Mair K.: B-1354 Maisano F.: B-0176 Majer M.: B-0821 Majumdar S.: B-0557, B-0913 Mak K.-F.: B-0784 Makowski M.R.: A-008, A-186 Makynen A.: B-0233 Malagari K.: A-304 Malago R.: B-0054 Malamateniou C.: A-284, A-560, B-0897, B-1385 Malavasi S.: B-0437 Malavaud B.A.: B-0337 Malavé Dos Santos A.M.: B-1138 Malcolm P.: B-0980 Maldur V.: B-0532 Malekzadeh R.: B-0035 Maleux G.: B-0543 Mali W.P.T.M.: B-0650, B-1082 Mallarajapatna G.: B-0042 Mallat Z.: B-0763 Malmquist T.: B-0957 Malmqvist K.: B-0749 Malta B.: B-0241 Maly Sundgren P.C.: A-177, A-202, A-376, A-437 Mami F.: B-0856 Mamisch-Saupe N.: B-1186 Mañas-Garcia A.: B-0701 Mancini A.: B-0045, B-1311 Mancuso E.: B-0532 Mancuso V.: B-1060 Mandal A.: B-0761 Manfredi M.: B-0829 Manfredi R.: A-535, A-722, B-0004, B-0005 Mang T.: A-241 Manganaro L.: B-0168, B-0894, B-0896, B-1334 Mangiarotti M.: B-0874 Mangili G.: B-1028 Mangin P.: B-0362 Mangino D.A.: B-1063 Mangold S.: B-0174, B-0175, B-0263, B-0264, B-0452, B-0456, B-0783, B-0785, B-1072 Mani N.B.S.: B-0539 Maniawski P.: B-0029 Manikis G.C.: B-1270 Manka R.: A-679, CTiR 2 Mann M.J.: B-1008 Mann R.: B-0527, B-0535 Mann R.M.: B-0022, B-0217, B-0426, B-0921, B-1071, CTiR 2 Mannelli L.: B-1350 Manninger M.: B-0052, B-0257 Manos D.: B-1206 Mansueto G.: B-1103

Final Programme | ECR 2016

359

List of Authors & Co-Authors

Manyonda I.: A-683 Mao F.: B-0095, B-1228 Marano R.: A-200, B-0790 Maras Ozdemir Z.: B-0270 Marathu K.K.: B-0043 Marcel S.: B-0855 Marchetti A.: B-0139 Marchionni E.: B-0168 Marco S.: B-0201 Marcon M.: B-0220, B-0423 Marcus R.: B-0292, CTiR 1 Marcy P.-Y.: K-02 Mardanshahi Z.: B-1113 Mare R.: B-1086, B-1087 Maresky H.S.: B-0360 Maria Grazia R.: B-1273 Mariani D.: B-0881 Mariani S.: B-0324, B-0331, B-0332, B-0959 Marias K.: B-1270 Marin A.: B-1213, B-1218 Marincek B.: A-721 Marincu B.-N.: B-0197 Marini C.: B-0425 Marino M.A.: B-0220, B-0423, B-0757 Marino M.-A.: B-0428 Marino M.A.A.: B-0758, B-1259 Mariscotti G.: B-1130 Markali B.: B-0716 Marklund N.: B-0203 Marmuse J.P.: B-0633 Maroldi R.: A-074, A-204, B-0249 Maroof S.: B-0305 Marosi G.: B-0788 Marques M.: B-1014 Marra P.: B-0626, B-0629, B-1145, B-1298 Marrosu M.: B-1108 Marsecano C.: B-0255, B-0326 Marshall N.W.: B-1356 Marten-Engelke K.: A-470 Martens D.: B-0402 Martens E.: B-1356 Martens J.P.J.: B-0765 Martens M.: B-1165 Martí R.: B-1137, B-1138 Martí-Bonmatí L.: A-157, A-543, B-0701, B-1112 Martin S.: B-0967 Martin S.P.: B-0588 Martin S.S.: B-0432, B-0483, B-1178 Martìn Suàrez S.: B-0111 Martín V.S.: B-0243 Martinelli P.: B-0465 Martínez C.: B-0443 Martinez Gamarra C.: B-1282 Martinez R.: B-0401 Martinez Rubio C.: B-1260 Martinez Torrens F.: B-1225 Martínez-de-la-Haza D.: B-1046 Martini K.: B-0846 Martins S.R.R.: B-1384 Martinsen A.C.T.: B-0105 Martinuk T.: B-0750 Martirosian P.: B-0593, B-0704 Martola J.: B-0196, B-0390 Martucci M.: B-0164

360

ECR 2016 | Final Programme

Martus P.: B-0023, B-0383, B-0664 Martynov P.: B-0233 Maruno M.: B-1372 Marwitz L.: B-0990 Mas A.: B-0521 Masarwah A.N.J.: B-1118 Mascarenhas J.G.C.: B-1384 Mascarini L.: B-0742 Maschek S.: B-0555 Masciocchi C.: B-0045, B-0255, B-0324, B-0331, B-0332, B-0959, B-1100, B-1226, B-1311, B-1361 Masi R.: B-0045, B-0255, B-1311 Masmejean E.: B-0276 Massaroni C.: B-0674 Massmann A.: B-1002, B-1104, B-1229 Mastier C.: B-0128, B-0329 Masulovic D.: B-0214 Matapathi U.: B-0043 Matchin Y.: B-0750 Matheoud R.: B-0392 Mathieu M.-C.: B-1061 Mathoulin Pelissier S.: B-0298 Mathys C.: B-0402, B-1341, B-1342 Matínez-Miravete P.: B-1128 Matoori S.: B-1325, B-1388 Matos C.: A-061, A-159 Matosevic B.: B-0499 Matouskova T.: B-0508 Matsumoto S.: B-1372 Matsunobu Y.: B-0430 Matthews A.: B-0442 Mattila J.: A-601 Mattsson S.: A-391 Mauf S.: B-0438 Mauge L.: B-0097 Maurea S.: B-0465 Maurer M.H.: B-0621, B-0690 Maurer T.: B-0341 Mauri G.: B-0120, B-0122, B-0125 Maurizi Enrici M.: B-0369 Maurovich Horvat P.: B-0061 Maurovich-Horvat P.: B-0179, B-0744, B-0747, B-0766, B-0788 Mavrovi E.: B-0123, B-0128, B-0329 May M.: B-0879 May M.S.: B-0880 May R.: B-0402 Mayer J.: A-030 Mayer P.: B-1047 Mayerhoefer M.: B-0300, B-0660 Mayerle J.: B-0984 Mayor A.: B-0306 Mayr A.: B-0740 Mayr D.: B-1149 Mayrhofer M.T.: A-325 Mayrhofer T.: B-0744, B-0787 Mazioti A.: B-0127, B-0330 Mazouni C.: B-1061 Mazur G.: B-0062, B-0064, B-0771 Mazza E.: B-0291 Mazzei F.G.: B-1172 Mazzei M.A.: B-1172 Mazzeo S.: B-0121 Mazzetti S.: CTiR 2

Mazzocco C.: B-0932 Mazzoni L.N.: B-0943 Mazzotta D.: B-0425 Mbalisike E.: B-0862 Mc Guire V.: B-1247 Mc Nulty J.: B-0143, B-1247 McCavert M.: B-0266 McCulloch C.E.: B-0551, B-0643 McEntee M.F.: B-1119 McGrath C.: A-714 McGrath F.: B-0266 McHugh K.: A-521 McKnight L.: A-438 McKnight W.: B-0033 McNulty J.: A-557, A-559, B-0146, B-0352, B-1252 Meakin J.R.: B-0709 Mearadji B.: B-0451 Medici M.: B-1358 Meel-van den Abeelen A.S.S.: B-0022 Meera P.: B-0561 Meeuwis C.: B-0217 Mehrez H.: B-0109 Meier M.: B-0939 Meijer A.: B-0727 Meijering L.: B-0589 Meijs M.F.L.: B-1078 Meinel F.: B-1203 Meinel F.G.: B-0229, B-0386, B-0671, B-0746, B-0793 Meister A.: B-0342 Mejdoubi M.: B-0821 Mekis N.: A-763, B-1248, B-1380, B-1381 Melamud K.: B-0693 Meliadò G.: B-1253, B-1254 Melis L.: B-0333 Meloni G.B.: B-0254, B-0538 Melzig C.: B-0313, B-0865, B-1043 Menassel B.: B-1169 Menchi I.: B-0943 Mendes E.: B-0514 Mengel E.: B-0769 Menicagli L.: B-0923 Menovsky T.: B-0403 Mensel B.: B-0981 Mentzel H.-J.: B-0895 Menu Y.: A-317, A-435 Menzilcioglu M.S.: B-0171 Mercer C.E.: A-352 Meriot P.: B-0720 Merkel A.: B-0281 Merkely B.: B-0179, B-0248, B-0457, B-0747, B-0766, B-0788 Merkle E.M.: B-1286 Merlino B.: B-0790 Mershina E.: B-1296, B-1310 Mertelmeier T.: B-0670 Merzoug V.: B-0367 Mesrar J.: B-0665 Messa A.: B-1117 Messias N.: B-0717 Messina C.: B-1143 Messiou C.: B-1335 Metaxa L.: B-0018 Metin Y.: B-0694

www.myESR.org

List of Authors & Co-Authors

Metkees M.K.: B-0087 Metsälä E.: B-1009 Metschke M.: B-0855 Metzenmacher M.: B-0657 Meuli R.: B-0247, B-0362, B-0977, B-1286 Meyer A.: B-0259, B-0262, B-0986 Meyer B.: B-1094 Meyer B.C.: B-1044 Meyer E.: B-0986 Meyer M.: B-0580 Meyer-Baese A.: B-1116 Miccoli A.: B-1100, B-1226 Miccoli P.: B-0121 Michaud K.: B-0362 Michelini G.: B-0255 Michell M.J.: B-0928 Michels G.: B-0047, B-0048 Michielsen K.: B-1038, B-1357 Michielsen K.L.M.: B-1037 Michoux N.: B-1283 Mickley H.: CTiR 1 Midiri M.: B-0658 Miederer M.: B-0907 Miele V.: A-121, B-0522 Miese F.: B-0044 Miettunen K.: B-1009 Miglāne E.: B-0816 Miglietta S.: B-0941 Migliorisi C.: B-0772 Mihl C.: B-0473, B-1040 Mikhaylova E.: B-0889 Miki Y.: A-572 Mikšík L.: B-0728 Mikulis D.: A-294 Mildenberger P.: A-259, A-585, A-734 Miligkos D.: B-1370 Milles J.: B-0954 Millor M.: B-1129 Milosevic Z.: B-0419 Milot L.: B-0187 Milukhina I.: B-1340 Milwidsky A.: B-0116 Min C.-K.: B-0806 Minthon L.: B-0397, B-0969 Miraglia F.: B-0393 Mirminachi B.: B-0035 Mirón Mombiela R.: B-0641 Mirsadraee S.: B-1213, B-1218 Misery L.: B-0665 Mitropolskii N.: B-0233 Mitrovic M.: B-0214 Mittler J.: B-0412 Miyazaki M.: B-0316, B-0319 Miyazaki T.: B-0688 Miyoshi T.: B-0872 Mizandari M.: B-0540 Mizzi A.: B-0149 Mnif N.: B-0046, B-1308 Moccetti M.: B-0874 Mochizuki T.: B-0382 Mochula O.: B-0461 Modestino F.: B-1231 Mogami T.: B-1189 Mohamad M.T.: B-0243 Mohamed Hoesein F.A.A.: B-0488

www.myESR.org

Mohamed R.E.-E.-D.: B-1001 Mohanty H.: B-0042 Mohanty H.S.: B-1262 Möhlenbruch M.: B-0497 Mohr F.W.: B-0853 Mok W.: B-1258 Molinari F.: A-167 Möller T.: B-1291 Molloy M.: B-0644 Molnár A.Á.: B-0766, B-0788 Monaco C.G.: B-0120 Monetti F.: B-0016 Montalto C.: B-0241 Montauban van Swijndregt A.: B-0451 Montealegre Angarita A.C.: B-0124 Monteiro M.: B-0350 Montemezzi S.: B-0832, B-1253, B-1254 Montet X.: A-181, A-795, B-0588 Monti L.: B-0890 Montorsi F.: B-0343 Montorsi P.: B-0480 Moon J.H.: B-0528 Moon J.Y.: B-0597 Moon K.C.: B-1234 Moon S.M.: B-0015 Moore C.: B-0948 Mor E.: B-0226 Mora J.A.: B-0202 Moraitis N.: B-1205 Morán Hevia M.: B-0683 Morana G.: A-510, B-0745 Morawska K.: B-0514 Morden J.: B-1275 Moreira J.: B-1014 Morel J.: B-0928 Moreno P.: B-0641 Moretti M.: B-0425 Morgan P.S.: B-0149 Morgan R.: A-768 Morgunov M.: B-0063 Mori H.: B-0405, B-1372 Mori N.: B-0429 Morillo A.: A-782 Morishita J.: B-0430, B-0431 Moritz K.: B-1114 Moriyasu F.: B-0194 Morlando M.: B-0465 Morley N.: B-0118 Morozov S.: A-580 Morozova S.: B-1111 Morris E.A.: B-1063, B-1274 Morrish O.: A-357 Morrison W.B.: B-1180 Morsbach F.: B-0519, B-0570 Morscher S.: B-0908 Morse J.: B-0145 Mortazavi A.: B-0833 Moschetta M.: B-0421, B-0631, B-1067, B-1256 Mosconi C.: B-1231, B-1242 Moser M.: B-0931, B-0934 Moskovic E.: B-1335 Moskowitz C.S.: B-1063 Mosso E.: B-0053 Mostbeck G.H.: A-047, A-333

Mota R.M.V.: B-0486 Motara H.: B-0387 Motosugi U.: B-0206, B-0322, B-0466, B-0982, B-1099 Mottaghy F.: B-0375 Mottaghy F.M.: B-0056, B-0224, B-1276 Motton M.: B-0832 Mou T.: B-0024 Mouri Y.: B-0223, B-0531, B-1277 Mouridsen K.: B-0282 Mousa A.E.: B-1050 Moussa E.M.: B-1034 Mousseaux E.: B-0763 Moustafa A.S.: B-0544, B-0998 Mozer P.: B-0699 Mraity H.A.A.B.: B-1208 Mrakic Sposta F.: A-430 Mubarak F.: B-0649 Mueller A.-C.: B-0664 Mueller D.: B-0570 Mueller J.: B-0429 Muellerleile K.: B-1156 Mueller-Lisse U.: B-0342, B-0990 Mueller-Lisse U.L.: B-0342 Muellner A.: B-1274 Muenzel T.: B-0455 Mühlfeld C.: B-0052 Muir K.: B-0118 Mukund A.: B-0009 Mulè A.: B-0658 Mulé S.: B-0094 Muley T.: B-0513, B-1214 Mulla V.: B-0042 Mullan D.: B-1167 Mullen S.: B-1247 Müller A.: B-0619, B-1088 Müller H.: B-0417 Müller M.: B-0853 Müller-Eschner M.: B-0764 Müller-Forell W.: B-0769 Münch J.: B-0049 Munoz del Rio A.: B-0206 Muñoz Ruiz A.L.: B-0683 Muraglia S.: CTiR 1 Murakami T.: A-573, B-0106 Murashima S.: B-0807 Murchison J.: B-0118, B-1213 Murphy F.J.: B-1379 Murphy J.: B-0795 Murphy P.: B-0024 Murray T.: B-0266 Mus R.D.: B-0426 Muscogiuri G.: B-0369, B-0452, B-0456 Mushtaq S.: B-0377, B-0742, B-1075, B-1076 Mussen E.: B-1037 Mustonen P.: B-0786 Mutanen L.: B-0233 Muthurangu V.: A-421 Mutlu I.N.: B-1280 Muto G.: CTiR 2 Muto M.: A-359, B-0620, B-1057 Mutschler C.: B-0276 Muuronen A.T.: B-0786 Mylanus E.: B-0727 Myles J.: B-1127

Final Programme | ECR 2016

361

List of Authors & Co-Authors

N Na H.-S.: B-0864 Nabil H.: B-0133 Nadrljanski M.: B-0419 Naganawa S.: B-0479, B-1051 Nagasawa N.: B-0384, B-0385 Nagata M.: B-1309 Nagel H.D.: B-0993 Nagel H.-D.: B-0574 Nagel H.W.: B-0026 Naggara O.: B-1227 Nagle S.: B-0206 Nagle S.K.: B-0322 Naguib N.: B-1004 Naguib N.N.N.: B-0467, B-0470, B-0725, B-0860 Naguib N.N.N.N.: B-0129 Nagy A.: B-1373 Nagy E.: B-1373 Nair A.: B-0112, B-0586, B-0587, B-1217 Nair A.V.: B-0561 Nair T.: B-0440 Nakagawa T.: B-0688 Nakajima Y.: B-0055 Nakamori S.: B-1309 Nakamura Y.: B-0431 Nakane T.: B-1051 Nakano S.: B-0223, B-0531, B-1277 Nakatsuka S.: B-1171 Nakayama R.: B-0807 Nandikoor S.: B-0042, B-1262 Nanni C.: B-1231 Nanni I.: B-0137 Nanz D.: B-0640, B-0698, B-1190 Nappi C.: B-0453 Narbuts Z.: B-1022 Nardo L.: B-0913, B-1319, B-1320 Nas Ö.F.: B-0327 Nasatti A.: B-0092, B-0805 Nasr H.A.: B-0509 Nassenstein K.: B-0507, B-1150, B-1152, B-1153, B-1201, B-1307, B-1316, B-1351 Natale L.: A-680 Nattenmüller J.: B-0513 Natwa M.: B-0374 Nau E.: B-0153 Nava Tomás E.: B-0683 Navarra F.: B-0687 Navas C.: B-0202 Navichenka A.: B-0800 Navin P.: B-1017 Nazer P.K.: B-0561 Nazeri M.: B-1107 Nazli M.A.: B-0219, B-1280 Nchimi A.: B-0181 Nechaev V.: B-0849 Nederveen A.: B-1148 Nederveen A.J.: B-1091 Neff K.W.: B-0373 Negård A.: B-0008 Negi N.: B-0106, B-0731 Negrelli R.: B-0004, B-0005 Nehrer S.: B-1146 Nekolla S.G.: A-323

362

ECR 2016 | Final Programme

Nelassov N.: B-0063 Nelemans P.: B-1064 Nelemans P.J.: B-1281 Nemes B.: B-0261 Nensa F.: B-1058, B-1150, B-1152, B-1153, B-1307, B-1316 Nerad E.: B-0244, B-0245 Nerestyuk Y.I.: B-1267 Neri E.: A-014 Nestle U.: A-671 Neuhaus V.: B-0295 Neuhaus V.-F.: B-0953 Neuwelt E.: B-0285 Neuwirth J.: K-25 Nevalainen M.T.: B-1180 Nevitt M.C.: B-0548, B-0549, B-0551, B-0643 Newby D.E.: B-0741 Newell M.: B-1131 Ng A.H.: B-0033 Ng M.-Y.: B-0784 Nganga E.C.: B-0481 Nguyen H.: B-0825 Nguyen H.T.: B-0833 Nguyen-Kim T.D.L.: B-0438 Niccoli A.A.: B-0631 Nichelatti M.: B-0772 Nicholson P.: B-0795 Nicolai E.: B-0453 Nicoletti R.: B-0291 Nicolucci A.: B-1140 Nieboer K.H.: A-498 Niederstadt T.: B-0398, B-0399 Nielsen M.B.: B-1321 Nieman K.: B-0743, CTiR 2 Niessen W.J.: A-605 Nieuwenhuijzen G.: B-0420 Nieuwenhuis E.R.: B-0380 Nievelstein R.A.J.: A-445 Niezen A.: B-0743 Nightingale J.M.: B-1379 Nightingale P.: B-0716 Niiniviita H.: B-0882, B-1207 Nijholt W.: B-0711 Nikiforaki K.: B-1270 Nikitovic M.: B-0419 Niklas C.: B-1104 Nikolaou K.: A-273, B-0023, B-0039, B-0175, B-0263, B-0292, B-0297, B-0312, B-0593, B-0664, B-0704, B-0861, B-0904, B-1068, CTiR 2 Nikolic T.: B-0214 Nikseresht A.: B-1107 Nilsson A.: A-120 Nilsson M.: B-0730 Nio C.Y.: B-0444 Nishii T.: B-0731 Nissan N.: B-0602 Nitrosi A.: B-0922, B-1062 Nitzsche S.: B-0853 Niu J.: B-0548 Nobel M.: B-0228 Nobili E.: B-0480 Nobre R.R.: B-0486, B-0635 Nobusawa H.: B-1039

Noferini L.: B-0943 Nogueira L.: B-0603, B-0703, B-0753 Nonnekens J.: B-0936 Noordmans J.P.D.: B-0036 Noppe N.: B-0661 Nordemar D.: B-0810 Nørgaard B.: CTiR 1 Nörenberg D.: B-0088 Norman B.: B-1146 Nosenzo F.: B-0760 Notohamiprodjo M.: B-0292, B-0312, B-0593, B-0704 Notohamiprodjo S.: B-1149 Nour-Eldin N.-E.: B-0129, B-0130, B-0357, B-0725, B-0860 Nour-Eldin N.-E.A.: B-0467, B-0470, B-1178 Nova Vaca D.: B-1225 Nozawa Y.: B-1189 Nummela M.T.: B-0689 Nunes R.G.: B-0603, B-0753 Nunez D.: A-308 Nuñez Marín F.: B-1053 Nunziata A.: B-0293 Nutting A.C.: B-0452 Nuyts J.: B-1357 Nyberg L.: A-109 Nyhsen C.: A-248, A-502 Nyman R.: B-0996

O O’ Brien F.: B-0338 O’ Hora L.: B-1170 O’ Regan K.: B-0338 O’ Donohoe M.: B-1170 O’Leary D.: B-1122 Obadia M.: B-0363 Obdeijn I.-M.: CTiR 2 Öberg J.: B-0810 Oberholzer K.: B-0455 Oberndorfer S.: B-0283, B-0284 Obodov V.: B-0154 Obolonczyk L.: B-1027 Ocak G.A.: B-1024 Occhipinti M.: A-644, B-0677, B-0679 O’Connor M.: B-0346, B-0710 Oechsner M.: B-1045 Offermans J.: B-0867 Offiah A.C.: K-09 O’flynn E.: B-1117 O’Flynn E.A.M.: B-1258 Ognard J.: B-0665, B-0949 Ogul H.: B-0598, B-0625, B-1081 Ogur M.G.: B-0082 Oguro S.: B-1171 Oh D.K.: B-0812 Oh J.: B-0416, B-1284 Oh S.J.: B-0576 Oh S.W.: B-0395, B-1337 Oh S.Y.: B-1366 Oh Y.T.: B-1239 Ohana M.: B-0582, B-0986 Ohno Y.: B-0106, B-0316, B-0319, B-0655, B-0684, B-0685, B-1364 O’Hora L.: B-0867, B-1247 Oikari S.: B-1118

www.myESR.org

List of Authors & Co-Authors

Oikarinen H.: B-0585 Oikonomou A.: A-707 Okada H.: B-0872 Okazaki T.: B-1364 O’Keeffe S.: B-0018, B-0759 Oleaga Zufiría L.: A-785 O’Leary D.: A-710, B-1012 Oliva G.: B-0422, B-0881 Oliveira M.V.L.: B-0868 Oliver Goldaracena J.M.: B-1282 Oliver T.B.: B-0916 Oliveri A.: B-0347 Olsson K.: B-1044 Olusoga T.: B-0387 Omelchenko O.: B-1338, B-1344 Omori M.: B-0466 on behalf of CENTER-TBI Participants&Investigators.: B-0204 Onatsu J.: B-0786 O’Neill D.C.: B-0644 O’Neill J.E.: B-1389 O’Neill S.B.: B-0644 Ong M.: B-0867 Onishi H.: B-0466, B-0979 Onofrj V.: B-0393 Onu M.: B-1339 Onur M.R.: B-0274 Oosterbroek J.: B-0568 Oral A.: B-0085 Ordás I.: B-0446 O’Regan K.N.: B-0024 O’Reilly M.K.: B-1376 Orhan Metin N.: B-0694 Origgi D.: B-0103 Orlandi D.: B-0271 Orlando A.A.M.: B-0533 Örnberg G.: A-410 Örnek K.: B-0161 Örnek N.: B-0161 Orsenigo E.: B-0291, B-0629 Orsi F.: A-117, B-0125 Orsi M.: B-0881 Orsi M.A.: B-0422 Orsini E.: B-0299 Orsini E.B.: B-0662 Ortega M.I.R.: B-0350 Ortiz-Pérez J.T.: A-299 Ossadnik C.: B-0492 Ost P.: B-0942 Østergaard L.: B-0282 Östgren C.J.: CTiR 1 Osuga K.: B-1377 O’Sullivan F.: B-0024 Ota H.: B-0055, B-0110 Otani K.: B-0988 Othman A.: B-0292, B-0297, B-0704 Othman A.E.: B-0039 Otsubo K.: B-0479 Ottonello C.: B-0354 Oudkerk M.: A-447, B-0376, B-0380, B-0386, B-0488, B-0609, B-0610, B-0789, B-0863, B-1362 Ouhlous M.: B-0743 Ourednicek P.: B-0239 Oustwani C.S.: B-1343

www.myESR.org

Ouyang R.: B-0051 Ouyang R.Z.: B-0253 Owens C.: A-081, A-791 Owman T.: A-708 Oyen R.H.: A-051, A-210, A-332 Ozdemir O.: B-0694 Ozdemir Z.M.: B-0591 Ozgen Mocan B.: B-0726 Ozgokce M.: B-0625 Ozkan O.: B-1099 Ozolins A.: B-1022 Öztek M.A.: B-1024 Öztürk F.: B-0885 Ozturk K.: B-0190

P Ramachandran P.V.: B-0561 Paalimäki-Paakki K.: B-0151, B-0866 Pacciardi F.: B-0209 Pacho R.: B-0893 Padhani A.R.: A-396, A-696, B-0700, B-0947 Padrón M.: A-689 Padroni M.: B-0813 Padula C.: B-0344 Paek M.Y.: B-0806 Pagonidis K.: B-1205 Pahn G.: B-1047, B-1348, B-1352 Paias P.: B-0351 Palásthy Z.: B-1373 Palazzini M.: B-0111 Palczewski P.: B-0113, B-0952 Palfrey R.M.: B-0709 Palkó A.: A-193, A-195, A-382, A-744, A-787, B-1373 Palm F.: B-0575 Palmisano A.: B-0251, B-0256, B-0779, B-0781, B-1028, B-1074, B-1273 Palmqvist S.: B-0397, B-0969 Palumbo F.: B-0348 Palussiere J.: B-0298, B-0325 Pameijer F.A.: A-522, B-0568 Pampaloni M.H.: B-0364, B-1319, B-1320 Pan J.: B-0505, B-0511 Panahi B.: B-0129, B-0860 Panajotu A.: B-0747 Panci S.: B-1170 Panebianco L.: B-0045, B-1311 Panebianco V.: A-102, A-697, B-0946 Panés J.: B-0446 Panfili M.: B-0081 Panizo C.: B-0969 Panizza P.: B-0608, B-1273 Pannatier M.: B-0247 Pannekoek-Hekman M.: B-1179 Pans S.: B-0661 Pantrangam P.: B-0043 Panzeri M.M.: B-0608, B-1273 Paoli M.: B-0045, B-1311 Paolini M.: B-0990 Papadimatos P.: B-0618 Papadopoulos D.: B-1242 Papanikolaou N.: A-158, A-340, A-666, B-1270 Paprottka K.J.: B-0997

Paprottka P.M.: B-0997 Parakh A.: B-0302, B-0304, B-0570, B-1288 Paravasthu M.: B-1204 Pardo J.: B-0344, B-0702 Parenti G.C.C.: B-0137 Pargewar S.: B-0009 Parizel P.M.: A-269, A-482, A-566, B-0204, B-0205, B-0403, B-0803, B-1287 Park A.: B-0562 Park B.J.: B-0108, B-0131, B-0573, B-1232 Park C.: B-1272 Park C.H.: B-0180 Park C.M.: B-0208, B-0601, B-0623, B-0837, B-0975, B-1363 Park D.: B-1023 Park G.E.: B-0806 Park H.C.: B-0839 Park H.J.: B-0040, B-1263, B-1366 Park H.S.: B-0464, B-1331 Park J.: B-0182, B-0842, B-1263 Park J.E.: B-1023 Park J.-E.: B-0169 Park J.S.: B-0073, B-1324 Park J.Y.: B-0415, B-0842 Park S.B.: B-0569 Park S.H.: B-0040, B-1239 Park S.I.: B-1102 Park S.J.: B-0623 Park S.-J.: B-1073 Park S.Y.: B-0073, B-0207, B-1025, B-1239 Park Y.S.: B-0208, B-0601, B-0837, B-0975 Parkar A.P.: A-263, A-764, B-0075 Parkkonen J.: B-0786 Parlier C.: B-0809 Parthipun A.: B-0365 Partington K.: B-0961, B-1387 Partovi S.: B-0313, B-1043 Parziale G.: B-1176 Pascual I.: B-0344, B-0702 Pasquali R.: B-1242 Pasquier H.: B-0104 Passari A.: B-0137 Passoni P.: B-0779, B-0781 Passot G.: B-1169 Pastor C.: B-0977 Pastorelli L.: B-0447 Patak M.A.: A-050 Patel C.: B-0387 Patel D.: B-0119 Patriarca L.: B-0959, B-1311 Patro S.: B-1192 Patrolecco F.: B-0020 Patsoura S.: B-0818 Pattacini P.: B-0922, B-1062 Patti C.: B-0658 Pattyn E.: B-0942 Paul N.: B-0109 Paulo G.: A-417, A-561, B-0348, B-0870, B-1245, B-1248 Pavel M.: B-0041 Pavlicek W.: B-0303 Pavlovic - Stankovic D.: B-0419 Pawha P.: B-1197 Payet C.: B-1169 Peacock C.: B-0928

Final Programme | ECR 2016

363

List of Authors & Co-Authors

Peck D.: A-652 Pecorelli N.: B-0184 Pedicini V.: B-0325 Pediconi F.: A-246, A-756, B-0532, CTiR 2 Pedraza S.: B-0498, B-0502, B-0503, B-1271 Pedrazzini F.: B-1371 Peeters R.: A-172 Peetrons P.: A-021 Pegoretti K.: B-0897 Peireira P.L.: B-0865 Peix M.: B-0123 Pekarovic D.: A-766 Pekel G.: B-0155 Pelage J.-P.: B-1049 Peldschus K.: B-1219 Pelgrim G.J.: B-0376, B-0380, B-0386 Pellegrin A.: B-1101 Peltonen J.: B-1155 Peng W.: B-1029 Peng W.J.: B-1070 Peng Z.M.J.H.C.S.-T.F.: B-0032 Pennycooke K.: B-0267 Pepi M.: B-0377, B-0480, B-0742, B-1075, B-1076 Pereira A.: B-0870 Pereira C.: B-1387 Pereira J.G.: B-1048 Pereira P.L.: A-118 Perez Aguilera S.: B-0328 Perez J.: B-0521 Perez M.E.: B-0536 Perez R.: B-0701 Pérez-Jeldres T.: B-0446 Pérez-Tejada J.C.: B-1020 Perinetti M.: B-0760 Perisinakis K.: B-1205 Perkins A.C.: B-0033 Perkuhn M.: B-1165, B-1166 Perret T.: B-0971 Perri M.: B-0326 Pershina E.: B-0462, B-1310 Persson A.: A-011 Persson M.: CTiR 1 Perucchini E.: B-0525 Perugin Bernardi S.: B-0271 Pescatori L.C.: B-0120, B-0447, B-1143 Pesente S.: B-1140 Petracchini M.: B-0566, B-0659, B-0829 Petralia G.: B-0700, B-0705, B-0947, B-0950 Petrash E.: B-0889 Petres A.: B-1378 Petrides N.: B-0948 Petrillo A.: B-0293 Petrini M.: B-0252, B-0459 Petros F.G.: B-0825 Petrov D.: B-1357 Petrover D.: B-0809 Petrozza V.: B-0941 Petullà M.: B-1076 Peynircioglu B.: A-189 Pfannenberg C.: B-0023, B-0039, B-0664, B-0904 Pfeiffer F.: B-0671

364

ECR 2016 | Final Programme

Pfirrmann C.W.A.: B-0915 Pham M.: B-0497 Philippens M.E.: B-0568 Phyu S.M.: B-0937 Pianykh O.: B-0234, B-1290 Picard C.: B-0763 Picart H.: B-0157 Picchia S.: B-0780 Piccini D.: B-0452 Piccolo C.L.: A-121, B-0522 Pichi A.: B-0238 Pickup L.C.: B-0436 Pieber K.: B-0491 Piemonti L.: B-0160 Pienkowska J.: B-0183 Pietras J.: B-0500, B-0971 Pignataro P.: B-0468, B-0631 Pijnapel R.M.: B-0610 Pijnappel R.M.: A-213, B-0217, B-0609, B-1064 Pillai A.: B-0387 Pilleul F.: B-0123, B-0128 Piludu F.: B-0393 Pimentel Silva R.: B-0620, B-1057 Pina Insausti L.J.: A-345 Pina L.: B-1128, B-1129 Pinault S.: B-0021 Pingitore A.: B-0366 Pinheiro J.P.: B-0150, B-0152, B-0713, B-0717, B-0869, B-0873, B-1006, B-1246, B-1251 Pinilla R.: B-0350 Pinker-Domenig K.: A-229, B-0428, B-0758, B-0944, B-1116, B-1259, K-34, CTiR 2 Pinto D.: B-0152 Pinto dos Santos D.: A-399, B-0412 Pinto N.M.: B-1010, B-1249, B-1386 Pipková R.: B-0728 Piraner M.: B-1131 Pirnazarov M.: B-1305 Pisani Mainini A.: B-0122, B-0923, B-1123 Piskun B.: B-0800 Pitcher R.D.: B-0173 Pivec C.: B-0278, B-0279 Pizarro A.: B-0851 Pizzolato R.: B-0476 Pizzuti A.: B-0168 Placido R.: B-1220 Plakhotina N.: B-1194 Plank F.: B-0740 Planken R.N.: B-0792, B-1148, B-1179 Plasencia-Martínez J.M.: B-1046 Plass A.: B-0176 Platz Batista da Silva N.: B-1300 Platzek I.: B-0559 Platzgummer H.: B-0278, B-0279 Plesinac - Karapandzic V.: B-0419 Plodeck V.: B-0559 Ploumen E.H.: B-1281 Plum J.: B-0229 Pobozy T.: B-0275 Podgorska J.: A-005, B-0893 Podobnik G.: A-354 Podvratnik M.: B-1381 Poellinger A.: B-1212

Poeppel T.: B-1058 Poerio A.: B-1233 Pofi R.: B-0454 Pohar K.: B-0833 Poiares B.: B-0870 Poillucci G.: B-0476 Poiraudeau S.: B-1195 Pokieser P.: A-503 Polanec S.: B-0944 Polkowski C.: B-0994 Pomianowska A.: B-0911, B-0914 Pompe E.: B-0488 Pomschar A.: B-0396, B-1114 Ponhold L.: B-1240 Pons E.: B-0232, B-0237 Ponsiglione A.: B-0453 Ponsioen C.I.J.: B-0451 Pontillo Contillo B.: B-0121 Pontone G.: A-321, B-0377, B-0480, B-0742, B-1075, B-1076 Poole K.E.S.: B-0912, B-1147 Poole Z.: B-0175 Pop C.M.: B-0315 Popescu A.: B-1086, B-1087 Popolizio T.: B-0326 Popova Y.: B-1354 Pöppel T.: B-0068 Poreba M.: B-0062, B-0771 Poreba R.: B-0062, B-0064, B-0771 Poretti D.: B-0325 Porta N.: B-0941 Portalez D.: B-0337 Portelli J.: A-443 Portelli J.L.: B-1252 Posa A.: B-0999 Post H.: B-0052, B-0257 Potreck A.: B-0497 Potretzke T.: B-0206 Pottecher P.: B-0809 Pouwels P.J.W.: B-1105 Pozzi Mucelli R.: B-0004, B-0005, B-0054, B-0136, B-0819, B-1103 Pozzi-Mucelli R.: A-508 Prasse A.: B-1367 Prayer D.: A-639, B-0077 Preibsch H.: B-1068 Preinbergs M.: B-0816 Prenen H.: B-0543 Presilla S.: B-0874 Previtali S.: B-0638 Prevoo W.: A-617 Prevrhal S.: B-1353 Price A.: B-0897, B-1385 Pricolo P.: B-0705, B-0950 Priedītis P.: B-1018, B-1022 Prieto Fernández A.: B-0683 Priola A.M.: B-0030 Priola S.M.: B-0030 Priovolos D.: B-1261 Procter A.J.: B-0980 Profili S.: B-0538 Prokop M.: A-599, B-1362 Pronin I.N.: A-178 Prosch H.: A-165 Prothmann S.: B-0398, B-0399

www.myESR.org

List of Authors & Co-Authors

Pruijssers S.R.: B-0192 Pruszczyk P.: B-0113 Pu T.: B-0059 Pucci S.: B-1233 Puchner A.: B-0070 Puchner S.: B-0744 Puech P.: A-740 Pueyo J.: B-1306, B-1313 Pueyo J.C.: B-1312 Puget S.: B-0163 Puglia M.: B-0453 Puglielli E.: B-0404, B-0501, B-0802 Puglielli E.G.: B-0687 Pugliese F.: B-0386, CTiR 2 Puig J.: B-0498, B-0502, B-0503, B-1271 Pulido M.: B-0298 Pullens P.: B-0204 Puppato M.: B-1101 Purdie C.: B-0427, B-0526 Purz S.: B-0902, B-0906 Pusceddu C.: B-0333 Puylaert C.A.J.: B-0444 Pyatigorskaya N.: A-504

Q Qi W.: B-0504 Qian T.: B-0134 Qian W.-L.: B-0268, B-0269 Qiang J.W.: B-0132 Qiao Z.: B-0166 Quaia E.: A-004, B-0778, B-0848 Quarchioni S.: B-0331 Quarta Colosso G.: B-1142 Quattrocchio G.: B-1220 Quentin M.: B-0334, B-0335 Querques G.: B-0092, B-0096, B-0835 Quick H.: B-0903, B-0905 Quick H.H.: A-100, B-1150, B-1152 Quilez A.: B-1312 Quinn E.K.: B-0548 Quinn-Laurin V.: B-0021 Quitzke A.: B-0550, B-0642 Qurashi A.A.: B-0708 Qureshi M.M.: B-0013

R Ra Y.: B-0038 Raaijmakers C.P.: B-0568 Raatschen H.-J.: B-0978 Rabe K.F.: B-1219 Rabelo B.C.S.: B-0486, B-0635 Rabenalt R.: B-0334, B-0335 Radbruch A.: A-336, B-0282 Radema S.: B-0188 Raderer M.: B-0300, B-0660 Radmard A.R.: B-0035 Radunski U.K.: B-1156 Radzina M.: B-0816, B-1018, B-1022 Rafallah A.E.: B-0808 Ragab Y.: B-1183 Rageth C.: B-1134 Ragg J.C.: B-0762 Raghunath S.: B-0112, B-0587, B-1368 Raguwaran A.: B-1230 Rahim R.: B-0928

www.myESR.org

Rahmat K.: B-0083, B-0086 Rahmouni A.: B-0104 Rai A.: B-1214 Raimondi E.: B-0241, B-0813, B-0834, B-0964, B-1238 Rainer P.: B-1079 Rainford L.: B-0867, B-1122, B-1170, B-1247, B-1248, B-1252 Rainford L.A.: B-0142, B-0708 Raininko R.: B-0203, B-0814 Raiola G.: B-0366 Raithel E.: B-1188 Rajagopalan S.: B-0112, B-0586, B-0587 Rajan Mj G.: B-1262 Rajesh S.: B-0009 Rajgopal D.: B-0611 Ramalho J.: B-0198, B-0200 Ramalho M.: B-0198, B-0200 Raman S.R.: B-0956 Ramasundara S.: B-1127 Rames J.: B-0785 Ramirez D.: B-0851 Ramli N.: B-0083, B-0086 Ramos I.: B-0603, B-0753, B-1014 Rampoldi A.: B-0772 Rand T.: A-631 Rank C.M.: B-0668, B-0669 Rankine J.: A-565 Ranschaert E.R.: A-015, A-136 Rao N.: B-0365 Rao P.: B-0323 Rao S.-X.: B-0191 Raouf A.: B-0516 Raposo N.: B-0818 Raskin S.: B-0472, B-0680 Rasper M.: B-0378, B-1158 Rasschaert M.: B-0201 Rastelli M.: B-1005 Raszkowski A.: B-1382 Ratib O.: A-012, A-137, A-730, A-733 Ratti F.: B-1298 Rauda M.: B-1018 Raudner M.: B-0491 Rauen P.: B-0864 Rauneker T.: B-0883 Rauova K.: B-1255 Rauscher I.: B-0341 Ravaioli S.: B-1062 Ravelli S.: B-0343 Ray-Coquard I.: B-0123 Raza S.A.: B-1120, B-1125 Razek A.A.K.A.: B-1050 Raziorrouh B.: B-0229 Rebelo C.: B-1251 Rebsamen S.: B-0165 Reda W.: B-0087 Redden D.: B-0998 Reddy R.: B-0429 Reddy S.: B-0042, B-0119 Redheuil A.: B-0763 Reeder S.: B-0165 Reeder S.B.: B-0206, B-0322, B-0982, B-1099 Reekers J.A.: A-331, A-701 Reeps C.: B-1158

Reetz K.: B-1341 Refaat M.: B-1089 Regent B.: B-0183 Regge D.: A-242, A-579, CTiR 2 Regier M.: B-0550, B-0574, B-0642, B-0993, B-1353 Regnard N.-E.: B-1191 Regus S.: B-0617 Reh C.: B-0258 Rehwald W.G.: B-0456 Reichkendler M.: B-0910 Reid J.H.: B-0118 Reijnierse M.: A-153, B-0071 Reimer R.: B-1224 Reinboldt M.: B-0411 Reinstrup P.: B-0850 Reis C.: A-353 Reis C.S.D.: B-0345 Reiser M.F.: B-0058, B-0229, B-0296, B-0342, B-0671, B-0777, B-0793, B-0931, B-0933, B-0934, B-0965, B-0968, B-0989, B-0990, B-0997, B-1110, B-1114, B-1182, K-29 Reiter G.: B-0052, B-0257 Reiter U.: B-0052, B-0257 Reith W.: B-0398, B-0399 Rella L.: B-0421, B-1067, B-1256 Rella R.: B-0020 Remedios D.: A-686 Rempp H.: B-0861 Remy C.: B-0971 Rémy J.: B-0370, B-0581, B-0590, B-0987 Rémy-Jardin M.: A-093, A-184, A-467, B-0370, B-0581, B-0590, B-0987 Ren Q.: B-0494 Renard Pena R.: A-805 Renard-Penna R.: B-0699 Rendon Villa M.: B-0124 Renehan A.G.: B-1167 Reneman L.: A-040 Renger B.: B-1354 Rengier F.: A-633, B-0313, B-0764, B-1043 Rengo M.: A-281, B-0780, B-0941, B-1142 Renne J.: B-1044 Renz D.: B-0895 Renzulli M.: B-1231 Reponen J.: A-134, B-0233 Restrepo R.: A-780 Revel D.: B-0117 Revel M.-P.: A-745 Reymond E.: B-1358 Reznek R.H.: A-222 Rheinheimer S.: B-0258 Ribeiro A.M.: B-0351, B-0717, B-1010, B-1386 Ribeiro E.: B-0703 Ribeiro E.J.S.: B-0635 Ribeiro J.: B-0873 Ribeiro L.P.: B-0150, B-0152, B-0351, B-0717, B-0869, B-0873, B-1006, B-1010, B-1015, B-1246, B-1249, B-1251, B-1386 Ribeiro M.M.C.P.: B-1384, B-1389 Ricart Selma V.: B-0602 Riccabona M.: A-140 Ricci P.: A-368, B-0532 Ricciuti G.: B-0537

Final Programme | ECR 2016

365

List of Authors & Co-Authors

Richioud B.: B-0128, B-0329 Richter F.: B-0460 Richter G.M.: B-1348 Richter J.A.: B-0344, B-0702 Richter V.: B-1068 Rickaby S.J.: B-0231 Ricke J.: A-414 Riddell A.: B-0185 Riddell A.M.: K-05 Riechelmann H.: B-0564 Riederer S.: B-0706 Riedl C.: B-1350 Riedl D.: B-0564 Rief M.: B-0383, B-0460 Riegler G.: B-0278, B-0279 Riehm S.: B-0720 Riffel P.: B-0141 Righi D.: B-0541, B-0542 Riklund K.: A-425, A-667, A-726 Rimola J.: B-0446 Rinaldi P.: B-0020 Ring N.: B-0186, B-0213 Ringe K.I.: B-0978 Ringel F.: B-1193 Ringelstein A.: B-0507, B-1201 Rist C.: B-0296 Risy Y.: B-0902 Ritter C.O.: B-1045 Riva F.: B-0252 Riva I.: B-1123 Riva L.: B-0767 Riva S.: B-1375 Rivera C.: B-0320 Riviere D.: B-0188 Rizzati R.: B-0241, B-0834, B-1238 Rizzetto M.: B-0053 Robador L.O.: B-0243 Robben S.G.F.: A-319, A-792, B-0228 Robella M.: B-1220 Robert P.: B-0201 Robinson L.: B-0924, B-1379 Robinson P.: A-719 Robinson S.: A-073 Robinson T.E.: B-0433, B-0439 Robson K.J.: B-0672 Robson M.E.: B-1063 Roca Navarro M.J.: B-1282 Roccatello D.: B-1220 Roccia S.: B-0366 Rock B.: B-0720 Rockall A.G.: A-212 Rodeo S.A.: B-0557 Rodighiero M.: B-0608 Roditi G.: B-0741 Rodrigues A.: B-1146 Rodrigues I.: B-0713 Rodrigues J.C.L.: B-0254 Rodrigues S.: B-0150, B-0152, B-0869, B-0873, B-1246, B-1249, B-1251 Rodriguez Laval V.: B-0041 Rodriguez M.Á.S.: B-0243 Rodríguez S.: B-0446 Rodríguez-Fraile M.: B-0702 Rodriquez-Spiteri N.: B-1128 Rodt T.: B-0266

366

ECR 2016 | Final Programme

Roedl J.B.: B-1180 Roemer F.W.: B-0548, B-0555, B-0639 Roenisch N.: B-0074 Roethke M.C.: A-103 Rogalla P.: B-1204 Röhle R.: B-0460 Rohr K.: B-0313, B-1043 Roiati S.: B-0501, B-0687 Roldan-Alzate A.: B-1099 Rollven E.: A-511 Roloff A.-M.: B-1299 Romani F.: B-0772 Romani M.: B-0020 Romano A.: B-1060 Romano L.: B-0518 Romanycheva E.: B-1032 Romberg J.: B-0368 Rominger A.: B-0296, B-0933, B-0997 Rompel O.: B-0614 Ronot M.: A-509, A-542 Roobol M.J.: B-0336, B-0340 Roodenburg-Kooij H.S.: B-0012 Ros Mendoza L.H.: A-400, A-660 Ros P.R.: A-220, A-398 Roschin D.: B-0830, B-0831 Rosen B.: B-0450 Rosenbaum C.: B-0995 Rosenbaum-Krumme S.: B-0901 Rosengren A.: CTiR 1 Rossel N.: B-0851 Rossi A.: A-138, A-593, A-748 Rossi Espagnet M.C.: B-1060 Rossi F.: B-0016 Rossi P.: B-0890 Rossini P.M.: B-0393 Rössler K.: B-0281, B-0283, B-0284 Rostovtseva T.: B-1164, B-1347 Rota C.: B-0377, B-1075 Rother U.: B-0259, B-0262 Rottenkolber M.: B-1203 Rotzinger R.: B-0621 Rotzinger R.A.: B-1174 Roumiguie M.: B-0337 Roupret M.: B-0699 Rousset P.: B-1169 Routledge E.: B-1385 Roux P.: B-0363 Rovere Querini P.: B-0638 Rovira-Canellas A.: A-174, A-656 Rowinski O.: B-1374 Rowley H.: B-0165 Rowley H.A.: A-230, A-232 Roy C.: B-0582, B-0986 Rozendaal M.C.: B-0012 Rozhkova Z.: B-1338 Rozhkova Z.Z.: B-1344 Rübben H.: B-0900 Rubbert C.: B-0044, B-0402, B-1342 Ruberto E.: B-0164 Rubertsson S.: B-0814 Rubtsov R.: B-1214 Ruchkin D.V.: B-0624 Rück A.: B-0749 Ruda F.: B-0874 Rudas G.: B-0079, B-0080

Ruder T.: B-0438 Rudolph J.: B-1158 Ruers T.J.: B-0225 Ruff C.: B-0312 Rühaak J.: B-1362 Ruhlmann V.: B-0560, B-0656, B-0657, B-1036 Rummeny E.: B-1158 Rummeny E.J.: B-0485, B-0517, B-0547, B-1184 Rundstein A.: B-0226 Runge J.H.: B-1091 Runge V.: A-334 Runge V.M.: B-1289 Ruschke S.: B-0485 Russell G.: B-0387 Russo E.: B-1076 Russo F.: CTiR 2 Russo R.: B-0164 Rutherford M.: B-0897 Rutherford M.A.: B-1385 Rutigliano C.: B-0790 Rutten M.: B-0527 Rutten M.J.C.M.: A-777, B-0929 Ryan E.: B-0267 Ryan J.: B-1122 Rydelius A.: B-1055 Ryoo I.: B-0562 Ryu J.H.: B-1092 Ryu K.N.: B-0073 Ryzhkova D.V.: A-620

S Sá Pinto A.: B-1048 Saad M.A.M.: B-0840 Saam T.: B-0058, B-0768, B-1149 Saar M.: B-1104 Sabel B.O.T.: B-0229 Sabet A.: B-0068 Sablayrolles J.-L.: B-0381 Sabri O.: B-0902, B-0906 Sacchetto D.: CTiR 2 Saccomandi P.: B-0674 Saddekni S.: B-0998 Sade R.: B-0598, B-1081 Sadik J.-C.: B-0157, B-0363 Sadovnik O.: B-0115 Sadow C.A.: B-0512 Saering D.: B-1156 Safak K.Y.: B-1199 Safina M.: B-0533 Sagaydak O.: B-0750 Sahani D.: B-0450 Sahin N.: B-0591 Saif T.: B-0028 Saifi S.: B-0277 Saito K.: B-0194 Saito M.: B-0055 Sakai Y.: B-0431 Sakane M.: B-0979 Sakuma H.: B-0384, B-0385, B-0807, B-1309 Sala E.: A-035, A-453, A-638 Sala G.: B-0054 Sala S.: B-0251

www.myESR.org

List of Authors & Co-Authors

Salahi R.: B-1107 Salame H.: B-0347 Salamon J.: B-0478, B-1224 Salazer-ferrer P.: B-0109 Saldari M.: B-0168, B-0894, B-0896, B-1334 Salehian Nik E.: B-0035 Salem M.A.A.A.: B-0057 Salerno A.: B-0626, B-0629 Saletti A.: B-0813, B-0964 Salgado R.: A-055 Salice S.: B-0389 Saliou G.: B-1227 Sallemi C.: B-1298 Salsano M.: B-0890 Saltybaeva N.: B-1200, B-1209 Salut C.: B-1223 Salvatori F.M.: B-0537 Samaan M.A.: B-0913 Sanabria A.B.: B-0536 Sánchez García S.: B-0683 Sánchez-González M.: B-1046 Sandomenico F.: B-0293 Sandrasegaran K.: B-0001, B-0003 Sandström M.: B-0996 Sanguedolce F.: B-0700, B-0947 Sano K.: B-0466 Sanson S.: B-0337 Santangelo C.: B-0790 Santangelo T.: B-0370 Santangelo T.P.: B-0369 Santini C.: B-0514 Santoni M.: B-0238 Santos E.: B-1249 Santos J.: A-285, B-0348, B-0870, B-1245, B-1248 Santos J.R.: B-1246 Santos R.A.M.: B-0712 Sanz Díaz J.: B-0683 Sanz-Requena R.: B-0701 Saranovic D.: B-0214 Sardanelli F.: A-256, A-551, B-0120, B-0122, B-0199, B-0252, B-0447, B-0459, B-0923, B-1123, B-1143,CTiR 2 Sarıca M.A.: B-0065, B-0066, B-0637 Sarin S.K.: B-0009 Säring D.: B-0049 Sarisoy H.T.: A-440 Sarkadi H.: B-0261 Sarry El Din A.M.: B-0087 Sartoris R.: B-0271 Sarwar J.J.: B-1119 Sasaguri S.: B-1039 Sasiadek M.: A-361, A-595 Satchithananda K.: B-0928 Saturnino P.P.: B-0518 Saukko E.: B-0882 Savatovsky J.: B-0363 Savci G.: B-0190 Savino G.: B-0790 Saviolo C.: B-0659 Savlovskis J.: B-0816 Sawicki L.: B-0903, B-0905 Sawicki L.M.: B-0560, B-0656, B-0901, B-1036 Sayani R.: B-0516

www.myESR.org

Scaglione M.: A-049 Scarabello M.: B-0252 Scardapane A.: B-0468, B-0631 Scaringi C.: B-1060 Scarsbrook A.: B-0387 Scevola G.: B-1005 Schaarschmidt B.: B-0900, B-0903, B-0905, B-1036 Schaarschmidt B.M.: B-0560, B-0656, B-0657, B-0901 Schaarschmidt F.: B-0047, B-0048 Schabath M.: B-0510 Schacht D.: B-0429 Schadmand-Fischer S.: B-0907 Schaefer-Prokop C.M.: A-094, A-206, A-208, A-769, B-0850, B-1362 Schäfer J.: A-520 Schaffellner S.: B-0417 Schaller G.: B-1125 Schaller G.H.: B-1120 Schaudinn A.: B-0983, B-1144 Schavemaker M.: B-1281 Scheer F.: B-0616 Schegerer A.: B-0373 Schemuth H.P.: B-1150, B-1152, B-1153, B-1316 Schena E.: B-0674 Schenal G.: B-0832 Scherr D.: B-0257 Scherr M.: B-0342 Schertz M.: B-0276, B-0821 Schiani E.: B-0608 Schiavone M.V.: B-1084 Schiebler M.L.: B-0322 Schilham A.M.: B-1365 Schilham A.M.R.: B-0765 Schillaci G.: B-0061 Schillebeeckx J.: A-582 Schima W.: A-086 Schimmöller L.: B-0334, B-0335 Schindera S.: B-0230, B-0302, B-0304, B-0570, B-1288 Schindera S.T.: A-034, B-1286 Schinner R.: B-0229 Schipke J.: B-0052 Schittenhelm J.: B-0286 Schlaefer A.: B-1353 Schlamann M.: B-1058 Schlattmann P.: CTiR 1 Schleich C.: B-0099, B-0394 Schlembach D.: B-0895 Schlemmer H.-P.: A-163, A-739, B-0282, B-0668, B-0669 Schlett C.: B-0865 Schlett C.L.: B-0667 Schleußner E.: B-0895 Schlöricke E.: B-0616 Schlosser T.: B-0507, B-1150, B-1152, B-1153, B-1201, B-1307 Schmaranzer E.: B-0910 Schmaranzer F.: B-0910 Schmid A.: B-0262, B-0617 Schmid J.: B-1079 Schmidt B.: B-0508, B-1349 Schmidt D.: B-0730 Schmidt H.: B-0904

Schmidt M.: B-1117 Schmidt S.: B-0247, B-0977 Schmidt T.: B-0622 Schmidt-Holtz J.: B-0574, B-0993 Schmitt A.J.: B-0648 Schmitz D.: B-0955 Schmitzberger F.: B-0926, B-1135 Schmuschkowitsch H.: B-0926 Schnackenburg B.: B-0048 Schnapauff D.: B-0621 Schneider G.: A-446, B-0619, B-1002, B-1230 Schneider G.K.: B-1104, B-1229 Schneider M.: B-0931, B-0934, B-1110 Schneider P.: B-0260 Schneider U.: B-0895 Schnerr R.S.: B-0191, B-0192 Schniepp R.: B-0396 Schnitzler A.: B-1341, B-1342 Schoen G.: B-0642 Schoepf U.J.: B-0174, B-0175, B-0263, B-0264, B-0380, B-0386, B-0452, B-0456, B-0746, B-0783, B-0785, B-1072, B-1178, B-1203, CTiR 2 Schöfer F.: B-1354 Schöllnast H.: B-0417 Scholten E.T.: B-1362 Scholtz J.-E.: B-0483, B-0877, B-0878, B-0967, B-1178 Scholz O.: B-0926 Schönberg S.O.: A-146, A-411, B-0141, B-0373, B-0580, B-0739, B-0836, B-1070, B-1161 Schönenberger E.: B-0383, B-0460 Schoots I.G.: B-0336, B-0340 Schopphoven S.: B-1355 Schosseler F.: B-0514 Schouman-Claeys E.: A-475 Schraml C.: B-0593, B-0904 Schramm C.: B-0007 Schreckenberger M.: B-0907 Schreiter V.: B-1212 Schreuder F.: B-0056 Schreutelkamp I.L.: B-0930 Schroeder T.H.: B-0695, B-1219 Schubert E.C.: B-0517 Schubert T.B.: B-0165 Schuele S.-C.: B-0664 Schueller-Weidekamm C.: B-0070 Schuknecht B.F.: A-524 Schüle S.-C.: B-0023, B-0904 Schuler T.: B-0007 Schuller Arteaga M.A.: B-0358 Schultze Kool L.J.: B-1139 Schulz A.: B-0211 Schulz C.J.: B-1210 Schütz T.: B-0983 Schwaab J.: B-1138 Schwaiger B.: B-0398, B-0399 Schwaiger B.J.: B-0549, B-0551, B-0557, B-0643, B-0913, B-1193 Schwaiger M.: B-0341 Schwartz D.: B-0285 Schwarz B.A.: B-1192 Schwarz F.: B-1114

Final Programme | ECR 2016

367

List of Authors & Co-Authors

Schweitzer W.: B-0438 Schwenzer N.: B-0664, B-0904 Schwenzer N.F.: B-0593 Sciveres G.: B-0881 Sconfienza L.M.: A-023, B-0120, B-0122, B-0447, B-1143 Scott P.: B-0672 Scragg B.: B-0924 Scrivo A.: B-0139 Sebuodegaard S.: B-0148 Secchi A.: B-0160 Secchi F.: B-0252, B-0459 Sechopoulos I.: A-356, B-1131, B-1355 Secinaro A.: B-0369 Secondini L.: B-0760 Sedlaczek O.L.: A-760 Sedlmair M.: B-0508, B-1349 Sehner S.: B-0993 Seidel R.: B-0955, B-1002 Seif H.M.A.H.: B-0091 Seifeldein G.S.: B-0091, B-1034 Seifert I.: B-1153 Seith F.F.: B-0904 Seitz D.F.: B-1132 Seker F.: B-0497 Seki S.: B-0316, B-0319, B-0655, B-0684, B-0685 Sekiguchi T.: B-0615 Sellars M.: A-674 Sellors J.: A-127 Semelka R.C.: B-0198, B-0200 Sempoux C.: B-0977 Senage T.: B-1151 Sencer S.: A-297 Senese R.: B-1057 Senn D.: B-0300, B-0660 Sennaroglu L.: B-0726 Senol A.: B-0002 Seo D.K.: B-0349 Seo H.S.: B-0156 Seo J.B.: B-1366 Seo J.Y.: B-0755, B-1025 Seol H.Y.: B-0562 Serafini G.: B-0272 Seraydarmansour O.: B-0875 Serena J.: B-0502 Serhan J.: B-0442 Serin M.: B-0469 Serner A.: B-0639 Serra C.: B-0139 Serres X.: B-0124 Serša I.: B-0317 Servadio Y.: B-0226 Sessa B.: B-0522 Setacci C.: B-1172 Setacci F.: B-1172 Sethi G.R.: B-0372 Settles M.: B-1158 Setz-Pels W.: B-0925 Sevastyanov V.: B-1032 Sevcenco S.: B-1240 Severac F.: B-0986 Sevimli S.: B-1081 Sevryukov D.: B-0889 Seyfer P.: B-1035

368

ECR 2016 | Final Programme

Sghedoni R.: B-1062 Shady M.: B-0133 Shafik M.: B-0050 Shah A.: B-0741, B-1293 Shah D.: B-0078 Shah Z.: B-0825, B-0833 Shahbazkhani B.: B-0035 Shaibani A.: B-0652 Shaibania A.: B-0647 Shakirin G.: B-1165, B-1166 Shalmon A.: B-0226 Shams S.: B-0196, B-0390 Sharma A.K.: B-0210, B-0797 Sharma N.: B-0210, B-1217, B-1278 Sharma N.S.: B-0797 Sharma S.: B-1332 Sharma S.D.: B-0982 Sharp P.: A-390 Shchegolev A.I.: B-0898 Sheahan P.: B-1021 Sheehan M.: B-0267 Sheehy N.: B-0782 Shek K.: B-0288 Shen G.: B-0577 Shen K.-W.: B-0529, B-1033 Shen W.T.: B-0364 Sherazi F.: B-0647, B-0822 Sheth D.: B-0429 Shi J.: B-0301 Shi J.-N.: B-0529, B-1033 Shi S.: B-0059 Shigeyama S.: B-0872 Shimizu Y.: B-0430 Shin D.R.: B-0918 Shin H.-O.: B-1367 Shin H.S.: B-0562 Shin K.M.: B-1324 Shin M.: B-1102 Shin N.-Y.: B-0395, B-0653, B-1337 Shin W.: B-1102 Shirai M.: B-0216 Shires G.: B-0924 Shirodkar K.: B-0042, B-1262 Shirokorad V.: B-0826 Shmueli H.: B-0115 Shotar E.: B-0163 Shrainer I.: B-1296 Shukla G.: B-0084 Sibileau E.: B-0809 Siciliano G.: B-1345 Sick H.: B-0721 Sidhu P.S.: A-673 Siegmann-Luz K. : CTiR 2 Siemer S.: B-1104 Siemund R.: B-0850 Siesling S.: B-0420 Signori A.: B-1069 Sijens P.E.: B-0609, B-0610 Silva V.M.: B-1014 Silva Y.: B-0502 Silvera J.: B-0276 Silvestri E.: B-0271 Silvestri S.: B-0541 Sim K.C.: B-0108, B-0131, B-1232 Simoncini M.: B-0354

Simone M.: B-0834 Simonetti A.: B-0890 Simuni T.: B-1343 Sindel T.: B-1024 Singh M.B.: B-0084 Sinitsyn V.E.: B-1296, B-1310, K-15 Sinkus R.: B-1091 Sinn L.: B-1133 Sinn M.: B-1156 Sipilä O.: B-1155 Sirli R.: B-1086, B-1087 Sironi S.: B-0092, B-0096, B-0299, B-0441, B-0448, B-0662, B-0767, B-0770, B-0774, B-0775, B-0805, B-0835, B-1030, B-1084, B-1173 Siva A.: B-0028 Sivit C.J.: A-307 Sivrioglu A.K.: B-1326 Skaane P.: A-703 Skardelly M.: B-0286 Sklair M.: B-0680 Sklair-Levy M.: B-0226 Sklinda K.: B-0275 Skornitzke S.: B-1047, B-1348, B-1352 Skorpil M.: B-0810, B-1181 Skrobisz- Balandowska K.: B-1027 Slim N.: B-0779, B-0781 Sluimer J.: B-0056 Slump C.H.: B-0954 Slump K.: B-0376 Slump K.H.: B-0380 Slynarski K.: B-0275 Smadja J.: B-1061 Smakic A.: B-0739, B-0836 Smaldone F.: B-1100, B-1226 Smedby Ö.: B-0714 Smeets D.: B-0205 Smets A.M.J.B.: A-519 Smidt M.: B-1064 Smidt M.L.: B-0224, B-1276, B-1281 Smirnova A.: B-1194 Smirnova E.: B-1164 Smith L.: B-0648 Smith T.A.D.: B-0937 Smits L.P.: B-1091 Smits M.: A-231, A-233, A-658 Söderberg M.: B-0730 Söderberg S.: CTiR 1 Soens J.: B-1357 Soglia G.: B-0890 Sögner P.: B-1291 Sohaib A.: B-1325 Soikher E.: B-0115, B-0116 Soikkeli M.: B-1155 Sokhi H.: B-0700, B-0947 Solana Tubau G.: B-1225 Solbiati A.: B-0377, B-1075 Solbiati L.A.: A-048 Solcia M.: B-0772 Solheim E.: B-0075 Soligo E.: B-0392 Solmaz Tuncer A.: B-0490 Solorzano J.L.: B-0344, B-0702 Solyanik O.: B-1367 Šomen J.: B-1381

www.myESR.org

List of Authors & Co-Authors

Sommer B.: B-0281 Sommer C.M.: A-618, B-0865, B-1348 Sommer G.: A-464 Sommer N.: B-1182 Sommer N.N.: B-0058 Sommer W.: B-0719, B-0777, B-0997, B-1322 Sommer W.H.: B-0058, B-0189, B-0793, B-0820, B-0965, B-0968, B-1182 Son Y.: B-0806 Soncin E.: B-0542 Song B.: B-1090 Song J.S.: B-0594, B-0676 Song J.W.: B-1366 Song K.D.: B-0597 Song S.: B-0839 Song Y.: B-0250, B-0812 Sorantin E.: A-286, A-444 Sortino D.: B-1371 Sosna J.: K-19 Sotgia B.: B-0333 Soto J.: B-0693 Soto J.A.: A-205, A-207 Sotoudeh M.: B-0035 Sourbron S.: B-1110 Sousa P.: B-0717, B-0869, B-1246, B-1249, B-1251 Sousa P.F.: A-112 Sousa P.J.: B-1384 Souvatzoglou M.: B-0341 Souverijns G.: B-1037 Souza R.B.: B-0913 Soylu A.R.: B-0274 Soylu E.: B-0190 Sozzi C.: B-1103 Spasic N.: B-0419 Spearman J.V.: B-1203 Sperga M.: B-1018 Spezia L.: B-1103 Spezzacatene A.: B-0476 Spiga S.: B-0299, B-0662, B-0770 Spijkerboer A.: B-0451 Spiliopoulos S.: B-0330, B-0618 Spiliopoulos S.C.: A-192 Spinelli L.: B-0453 Spinicci G.: B-1108 Spink C.: B-0622, B-1353 Spira D.: A-018 Spitzweg C.: B-0296 Splendiani A.: B-0326 Spliethoff J.W.: B-0225 Sponza M.: B-1101 Sporea I.: B-1086, B-1087 Sportoletti C.: B-0139 Spronk P.E.: B-0114 Stäb D.: B-0314 Stabile Ianora A.A.: B-0421, B-0468, B-0631, B-1067, B-1256 Stadlbauer A.: B-0281, B-0283, B-0284 Staebler A.: B-1068 Staffa R.: B-0260 Ståhlbrandt H.: A-384 Stajgis M.: A-552 Stalder A.F.: B-0257 Stancombe K.: B-0345

www.myESR.org

Stanton M.T.: B-0715 Stanzione A.: B-0824 Starc T.: B-0867, B-1248 Stark-Paulsen T.: B-0357 Stauber R.: B-0417 Staudacher C.: B-0031 Stazi M.A.: B-0061 Stecco A.: B-0392 Steens S.: B-0727 Steffen I.: B-0041, B-0690 Stehning C.: B-0048, B-0049 Stein Hodgins J.: B-0924 Steinbach L.S.: B-0551 Steinberg D.: CTiR 2 Steinbrener J.: B-0670 Steins M.: B-0513 Stelzeneder D.: B-0491 Stenman C.: B-0714 Stenzel E.: B-0507 Stepanovs K.: B-1018 Sterzing F.: A-268 Stetkarova I.: B-1198 Steurer J.: B-0554 Steuwe A.: B-1210 Stichelbaut N.: CTiR 1 Stijnen M.: B-0376 Stiller B.: B-0368 Stiller W.: A-016, B-0865, B-1047, B-1210, B-1348, B-1352 Stocker G.: B-1144 Stoeckle M.: B-1104 Stoecklein S.: B-0396 Stoffels I.: B-0908 Stojakovic T.: B-1079 Stojanov D.: B-1109, B-1302 Stojanovic I.: B-1109 Stojanovic S.: A-576, B-1378 Stoker J.: B-0444, B-0451, B-0792, B-1091 Stork A.: B-1132 Stoupis C.: A-724, K-20 Stowe J.G.: B-0146 Sträter A.: B-1158 Stray-Pedersen A.: B-0105 Strecker R.: B-0486, B-0635 Streekstra G.J.: B-0954 Streitparth F.: B-0621, B-0690, B-1174 Štrekelj U.: B-1380 Streuber A.: B-0230, B-0235 Strobbe L.J.A.: B-0925 Stroebel M.: B-1072 Stroeder J.: B-0619, B-1230 Stroszczynski C.: B-0475, B-1026, B-1300 Struikmans H.: B-0420 Štrumfa I.: B-1018, B-1022 Struthers A.D.: B-0748 Stubenrauch A.: B-0263 Stumpp P.: B-0074, B-0902, B-0906 Suaris T.: B-0018, B-0759 Subasic I.: B-0575 Succio G.: B-0760 Sucha D.: B-0765, B-1078, B-1082 Sudah M.: B-1118 Sudarski S.: B-1161 Südmeyer M.: B-1341, B-1342 Sudoł-Szopińska I.: A-154

Suehiro E.: B-0731 Sugihara N.: B-0106, B-0684, B-0685, B-1364 Sugimoto K.: B-0194 Sugimura K.: B-0106, B-0110, B-0316, B-0319, B-0655, B-0684, B-0685, B-0731, B-1364 Sugita K.: B-0405 Sugrue G.: B-1376 Suh D.C.: B-0654, B-0817 Suh I.: B-0364 Suh S.: B-0562 Suhai F.I.: B-0248, B-0457 Sukhikh G.T.: B-0898 Sullivan R.J.: B-0512 Summers P.: B-0705, B-0950 Sun C.: B-0445, B-0449 Sun H.: B-0571, B-1235, B-1265, B-1266, B-1268 Sun J.: B-0980 Sun K.: CTiR 1 Sun Y.-S.: B-1317 Sun Z.-Y.: B-1265, B-1266 Sundgren P.C.: B-1055 Sundström J.: CTiR 1 Sung D.J.: B-0108, B-0131, B-0573, B-1232 Sung J.S.: B-1063 Sung Y.S.: B-1360 Sunnadkal R.: B-0043 Suntharalingam S.: B-0507, B-0903, B-0905, B-1201, B-1351 Suranyi P.: B-0452, B-0456 Surekha B.: B-0009 Šurlan Popovič K.: B-0317, B-1106 Susani M.: B-0944 Sutela A.: B-1118 Sutter R.: B-0915 Sutton E.J.: B-1274 Suzuki S.: B-0872 Suzuki T.: B-0495 Svensson A.: B-0749 Sverzellati N.: A-238 Swerdlow A.: B-1117 Swift S.: A-381 Sworczak K.: B-1027 Sydo N.: B-0248 Syha R.: B-0297 Symersky P.: B-1078, B-1082 Syrgiamiotis V.: A-350 Szapiro D.: B-0442 Szczepura K.: B-1008, B-1243 Szczerbo-Trojanowska M.: A-698 Szilveszter B.: B-0787, B-0788 Szima Mármarosi E.: B-0457 Szucs-Farkas Z.: B-0570 Szurowska E.: B-0183

T Tabacco G.: B-0054 Taberner Bonastre M.T.: B-1260 Taberner López E.: B-1260 Tacchetti C.: B-1145 Tack D.: A-794, B-0347 Tadros D.: B-0934 Taeymans Y.: B-0675

Final Programme | ECR 2016

369

List of Authors & Co-Authors

Tagliabue E.: B-0705, B-0950 Tagliaferri B.: B-0881 Tagliafico A.: B-0016, B-0760, B-1069 Tagliafico G.: B-1069 Taha H.: B-0083 Tahir E.: B-0049, B-0382, B-1156 Tahon F.: B-0500 Taibbi A.: B-0533 Taina M.: B-0786 Tajikawa T.: B-1377 Takács T.: B-1373 Takagi H.: B-0110 Takahashi K.: B-0431 Takahashi S.: B-0731 Takase K.: B-0055, B-0110 Takx R.A.P.: B-0787 Tal S.: B-0360 Talakic E.: B-0417 Talei Franzesi C.: B-0092, B-0096, B-0299, B-0441, B-0448, B-0662, B-0774, B-0775, B-0805, B-0835, B-1030, B-1084 Talei Franzesi C.R.G.L.: B-0767, B-0770, B-1173 Tali E.T.: A-057, A-176 Talwar A.: B-0436 Tam H.: B-0185 Tamborino C.: B-0813 Tamura M.: B-1171 Tan C.H.: B-0489, B-1241 Tan T.: B-0527 Tanabe Y.: B-0382 Tanboga I.H.: B-1081 Tanenbaum L.N.: B-1197 Tang K.Y.K.: B-0799 Tang L.: B-1031 Tanis W.: B-1078 Tanoue S.: B-0405, B-1372 Tantawy H.I.: B-1135 Tanyildizi Y.: B-0769 Taoka T.: A-574, B-1051 Tarantino L.: B-0843, B-0844, B-0845 Tarantino P.: B-0844 Tardáguila G.: B-0443 Tardivon A.: A-058 Tarella C.: B-0659 Tarnoki A.D.: B-0061, B-0179 Tarnoki D.L.: B-0061, B-0766 Taron J.: B-0593 Tartaro A.: B-0389 Tas S.: B-0274 Tatsumi M.: B-0979 Taupitz M.: B-0159 Tavanti F.: B-1060 Tavares A.: B-1218 Tavares F.: B-0150 Tavera Bahillo I.: B-0520 Tawfik S.A.: B-1065 Tay L.: B-0489 Taylor S.A.: A-006, A-160 Tecame M.: B-0620 Tecl A.: B-0580 Telegrafo M.: B-0421, B-0631, B-1067, B-1256 Terada M.: B-0479 Terceño M.: B-0502 Terhaard C.H.: B-0568

370

ECR 2016 | Final Programme

Terpstra A.: B-1179 Terraz S.: A-539 Tervonen O.: B-0585 Tesche C.: B-0174, B-0783, B-0785, B-1072 Tessa C.: A-187 Tetsuka R.: B-0223, B-0531, B-1277 Tezgah E.: B-1150 Tezza M.: B-0054 Thaher F.: B-0401 Thalhammer A.: B-1222 Thali M.J.: B-0438 Thanaratnam P.: B-0267 Thapar S.: B-0009 Thawait G.K.: B-1188 the German National Cohort.: B-0667 Theilig D.: B-1212 Thenint M.-A.: B-0323 Theodosiadou V.: B-0618 Theruvath A.: B-0455 Thevenin F.: B-0071 Theysohn J.: B-1201 Theysohn J.M.: B-0909 Thian Y.: B-1325 Thiéfin G.: B-0094 Thiel C.: B-0039 Thierens H.: B-0920 Thierfelder K.: B-0820 Thierfelder K.M.: B-0793, B-0965, B-0968, B-1203 Thiesse P.: B-0329 Thijssen J.M.: B-0022 Thoeny H.C.: A-087, A-606, A-806 Thomas C.: B-0044, B-0099, B-0394, B-0545 Thomassin-Naggara I.: A-038 Thomsen C.: B-1212 Thomsen F.: B-0493 Thorborg K.: B-0639 Thorelius L.: B-0714 Thorenz A.: B-0939 Thorwarth W.T.: A-289 Thunberg P.: B-1013 Thurnher M.M.: A-567, A-594 Thway K.: B-1335 Tian J.: B-0970 Tielbeek J.A.W.: B-0444 Till V.: B-1378 Tilli M.: B-0834, B-1238 Timmermans L.: B-0920 Timmis A.: B-0741 Timonen M.: B-1155 Tinelli C.: B-1085 Tirāne M.: B-1018 Tirkes T.: B-0001, B-0003 Tiryaki M.: B-1199 Tissot V.: B-0949 Titelbaum N.: B-1197 Tjan-Heijnen V.: B-0420 Tjan-Heijnen V.C.G.: B-0925 Tkachev A.: B-1194 Todica A.: B-0933 Toffart A.-C.: B-1358 Toi M.: B-0216 Tok S.: B-0554 Tol J.L.: B-0639

Toledo L.S.: B-0243 Tolonen A.: A-601 Tomà P.: B-0369, B-0890 Tomás Cucarella J.: B-1112 Tomiyama N.: A-575, B-0979 Toms A.: B-0487, B-0980 Tondelli G.: B-1062 Tonetti L.: B-0679 Tonkopi E.: B-1206 Tontini G.: B-0447 Tootell A.: B-0307 Tootle A.: B-1243 Topilsky Y.: B-0115, B-0116 Topopolsky R.: B-0827 Torén K.: CTiR 1 Torii M.: B-0216 Tornvall P.: B-0749 Törnwall O.: A-327 Torre G.: B-0890 Torres C.: B-1192 Torresin A.: A-169, A-784 Tosetti M.: A-712, B-1345 Tosto S.: B-0016, B-1069 Tot T.: A-092 Toth A.: B-0248, B-0457, B-0471 Tóth K.: B-0613 Touraine S.: B-0809 Touska P.: B-0365 Tramontini C.: B-0202 Tran Dong K.: B-0162 Trattenero C.: B-0441 Trattnig S.: A-150, A-270, B-0491 Trauth M.: B-1211 Tredan O.: B-0123 Treece G.M.: B-0912, B-1147 Treitl K.M.: B-0058 Trenti R.: B-1170 Treutlein M.: B-0048 Trezzi M.: B-0369 Trianni A.: A-393, A-651 Tribunella A.: B-0566, B-0829 Trilla E.: B-0124 Trillaud H.: B-1223 Trimboli R.M.: B-0923, CTiR 2 Trinci M.: A-121, B-0522 Tripathi M.: B-0084 Trojanowska A.: A-590 Truong J.: B-0235 Trzasko J.: B-0706 Tsai K.: B-1319, B-1320 Tsai W.: B-0424 Tsapaki V.: A-097, K-10 Tse H.-F.: B-0784 Tseng C.-C.: B-0937 Tsetis D.K.: A-632 Tsougos I.: A-715 Tsoumakidou G.: B-0323 Tsuboyama T.: B-0979 Tsuchimochi H.: B-0216 Tsuchiya K.: B-0429, B-0495 Tsuruda K.: B-1125 Tsuruda K.M.: B-1120 Tuan A.S.: B-0801 Tucker L.: B-1127, B-1136 Tufman A.: B-0990

www.myESR.org

List of Authors & Co-Authors

Tuhamy Y.M.: B-1065 Tumanova U.N.: B-0898 Tunay Bayrakcı V.: B-0270 Tuncel S.A.: B-0140 Tung Y.: B-0359 Tuñón M.: B-0355 Turini F.M.: B-0093 Turkeli M.: B-0598 Turmezei T.D.: B-0912, B-1147 Turowski B.: B-0402, B-1341, B-1342 Turtulici G.: B-0271 Tutein Nolthenius C.J.: B-0451 Tuthill E.: B-1170 Tutton S.: B-0127 Tveit K.: B-0008 Tyurin I.E.: A-027 Tzedakis A.: B-1205

U Uberoi R.: A-191, A-370, A-634 Uder M.: B-0617, B-0879, B-0880 Udondo González del Tánago M.: B-0358 Ueda K.: B-0841 Uehara T.: B-0841 Ueno Y.: B-0106, B-0731 Ugurluer G.: B-0469 Ukai T.: B-0872 Ukkola L.: B-0585 Ulbrich E.J.: B-0640, B-1190 Ulcigrai V.: B-0778 Ullrich T.: B-0335 Ulrich D.J.O.: B-1139 Ulrich N.H.: B-0554 Ulusoy L.: B-1187 Ulyte A.: B-0286 Umer A.: A-601 Umetani K.: B-0216 Umezawa R.: B-0055 Umul A.: B-0002 Umutlu L.: A-044, A-757, B-0197, B-0656, B-0657, B-0901, B-0903, B-0905, B-1036, B-1058 Ünal Daphan B.: B-0161 Ünlü M.E.: B-0140 Uno M.: B-1309 Unterhumer G.: B-0147 Ünverdi H.: B-1328 Uprimny C.: B-0027 Urbach H.: A-108 Urbani L.: B-0209 Ure C.: B-0924 Urhemaa T.: A-601 Uriza F.: A-781 Url C.: B-0564 Ussov W.: B-0461

V Vacirca F.: B-1196 Vacondio R.: B-0922, B-1062 Vago H.: B-0248, B-0457 Vakil P.: B-0822 Valcseva É.: B-0471 Valdora F.: B-0016, B-1069 Valentini V.: A-432, A-668, B-1361 Valentino L.: B-0389

www.myESR.org

Valentino M.: B-0137 Valeri A.: B-0949 Valero L.: B-0201 Valette P.-J.: B-1088, B-1169 van Aerde M.: B-0789 van Beek E.J.H.: B-0118 van Beek E.J.R.: A-095, A-465, A-678, B-0741, B-1213, B-1218 van Beers B.: B-0977 Van Beers B.E.: A-542 Van Binnebeek S.: B-1323 van Bommel R.M.G.: B-0925 Van Cutsem E.: B-1323 van Dalen T.: B-0420 van Dam L.: B-0408 van de Pol D.: B-1179 van den Berg J.W.K.: B-0589 van den Berg R.: B-0071 Van den Bosch F.: B-0069 van den Bosch H.: B-0244 van den Bosch H.C.M.: B-0245 van den Bosch M.: B-0995 van den Brink R.B.A.: B-1078 van den Hauwe L.: A-566, B-0205 van den Heuvel A.F.M.: B-0400 van den Hoven A.: B-0995 Van Den Wyngaert T.: A-566 van der Aalst C.M.: B-0789 Van der Geest R.: B-0380 van der Geest R.J.: B-0060, B-0768 van der Harst P.: CTiR 2 van der Heide U.: A-669 van der Heijde D.: B-0071 van der Hoorn A.: B-0290 van der Laak J.: A-228 van der Lugt A.: A-125, A-326, B-0400 van der Sande M.E.: B-1160 van der Schaaf I.C.: B-0496 van der Valk P.: B-0852 van der Werf H.W.: B-0400 van der Woude H.-J.: A-312 van der Zaag-Loonen H.J.: B-0114 van der Zijden T.: A-717, B-0403, B-0803 van Dijken B.R.J.: B-0290 Van Eendenburg C.: B-0498 van Engen R.E.: B-1355 van Geenen E.: B-0188 van Gent D.: B-0936 van Gerwen M.: B-0716 Van Gils C.: A-225 van Gils L.: B-0400 van Gils M.: A-601 van Ginneken B.: B-1362, B-1363 Van Goethem J.: A-566, K-30, CTiR 2 van Goethem M.: B-1064 Van Gompel G.: B-0107 van Griethuysen J.: B-0776 van Hamersvelt R.W.: B-0765, B-1365 van Hecke W.: B-0650 van Heeswijk M.M.: B-1160, B-1163, B-1166, B-1168 Van Herck K.: B-0920 van Herwerden L.A.: B-1078, B-1082 van Kesteren F.: B-0792, B-1148 van Laar P.J.: B-0290

van Laarhoven K.: B-0188 van Loveren M.: B-0225 van Mieghem N.M.: B-0400 van Nijnatten T.J.A.: B-1276, B-1281 Van Ongeval C.: B-0920, B-1357 van Ooij P.: B-1148 van Ooijen P.M.A.: B-0789 van Oostenbrugge R.: B-0056 van Osch J.A.C.: B-0954 van Raamt F.: B-0114 van Rein I.L.: B-0345 Van Steen A.: B-0920, B-1357 Van Tuijl S.: B-0376 Van Veluw S.J.: B-1105 Van Westen D.: B-0397, B-0969 van Wissen M.S.O.: B-0930 van Zanten M.: B-0188 van Zelst J.: B-0527, B-0535, B-1137, B-1138 van Zelst J.C.M.: B-0022 van Zwam W.: A-716 Vanags A.: B-1022 Vande Berg B.: K-03 Vande Vyvere T.: B-0205 Vandecaveye V.: A-342, B-1037, B-1038, B-1141, B-1323 Vandemeulebroucke J.: B-0212 Vandenbroucke F.: B-0212 Vanderschueren G.: A-313 Vandulek C.: A-489 Vanel D.: A-461 Vanhoenacker F.: A-076 Vanhoenacker F.M.H.M.: A-313 Vanhoenacker P.: B-0181 Vanni E.: B-0053 Vanninen R.: B-0786, B-1118 Vanovcanova L.: B-1255 Vanslembrouck R.: B-1037 Vanwetswinkel S.: B-1064, B-1281 Várallyay C.: B-0285 Varano G.M.: B-0125 Várbíró S.: B-0471 Varela C.: B-0443 Varga Z.: B-1134 Varga-Szemes A.: B-0174, B-0175, B-0263, B-0264, B-0452, B-0456, B-0783, B-0785, B-1072 Vargha A.: A-687 Varjonen E.A.: B-0691 Varkas G.: B-0069 Varlet P.: B-0163 Varma R.K.: B-0539 Varma S.: A-602 Varona-Porres D.: B-1046 Varoquaux D.-A.: A-569 Varrassi M.: B-0326 Vasilevska Nikodinovska V.: A-260 Vasilyev S.: B-1164 Vasin D.: B-0214 Vasudevan T.: B-0260 Vatn M.: B-0008 Vaudagna C.E.: B-0482 Vawda Z.: B-0173 Vaz G.: B-0329 Vázquez E.: A-751 Vecchi M.: B-0447

Final Programme | ECR 2016

371

List of Authors & Co-Authors

Vecchio F.: B-0393 Vecsey-Nagy M.: B-0788 Veekmans P.: B-0930 Végh E.M.: B-0261 Veillon F.: B-0720, B-0721, K-17 Veiss A.: B-0816 Veit-Haibach P.: A-614 Vejborg I.: A-385 Velarde Pedraza A.: B-0126 Velardo D.: B-0638 Veldhoen S.: B-0314, B-1045 Veldkamp W.J.H.: B-1355 Velickaite V.: B-0388 Veliou K.: B-1261 Vellucci V.: B-0045, B-0255, B-1311 Velthuis B.K.: B-0496 Veltman J.: B-0217, CTiR 2 Veltri A.: B-0030, B-0829, B-0858 Venderink W.: B-0727 Venkatasamy A.: B-0720, B-0721 Venneri M.: B-0941 Venstermans C.: A-566 Ventikos Y.: A-604 Venturini E.: B-1028 Venturini M.: B-0160, B-1298 Venuti G.: B-0254 Verbist B.: A-203, A-608 Verburg F.: B-0375 Verdolotti T.: B-0164 Verdun F.R.: B-1286 Vergote I.: B-0543, B-1037, B-1141 Verhaar H.J.J.: B-0488 Verheij J.: B-1091 Verheyden J.: B-0204 Verhoef C.: B-0191 Verkooijen H.: B-0995 Verón Sánchez A.: B-1282 Verschakelen J.A.: A-147 Verslype C.: B-0543, B-1323 Verstraete K.: A-076, A-563, B-0069, CTiR 1 Vicennati V.: B-1242 Vicente Quílez M.: B-0683 Videira A.R.R.: B-1384 Vieira I.F.: B-1141 Vieira J.: B-1015 Vieira T.S.: B-1048 Vierhapper M.: B-0278, B-0279 Viermetz M.: B-0547 Vietti E.: B-0659 Vignale D.: B-0256 Viguier A.: B-0818 Vikestad K.G.: B-0148 Viktil E.: B-0008 Vilanova J.C.: A-694, B-0019, K-26 Vilar J.: A-434, A-436 Vilela P.: K-14 Vilgrain V.: A-272, A-397, A-542 Villalón M.: B-0019 Villanueva A.: B-0443 Villarejo T.: B-0311 Villeirs G.M.: A-395, B-0942 Vimercati A.: B-1196 Vinci V.: B-0168, B-0894, B-0896, B-1334 Vindfeld S.: B-0075 Vink A.: B-0650

372

ECR 2016 | Final Programme

Vinnicombe S.J.: A-755, B-0427, B-0526 Vinurel N.: B-0117 Virgilio M.: B-0354 Virgolini I.J.: B-0027 Virtanen J.: B-1207 Vishnevskaya A.V.: B-0624 Visser J.J.: B-0237 Visser P.: B-0852 Vit A.: B-1101 Viteri Jusue A.: B-0358 Vivancos Costaleite K.: B-1096 Vivoda Tomšič M.: B-0317 Vlahos J.: A-214 Vlassenbroek A.: B-0954 Vliegenthart R.: A-322, A-545, B-0376, B-0380, B-0386, B-0789, B-0863, CTiR 2 Vock P.: A-079 Voest E.E.: A-752 Voevodin S.M.: B-0898 Vogel-Claussen J.: A-168 Vogl T.: B-0467, B-0725 Vogl T.J.: B-0129, B-0130, B-0186, B-0213, B-0264, B-0357, B-0432, B-0470, B-0483, B-0746, B-0860, B-0862, B-0877, B-0878, B-0967, B-0976, B-0994, B-1003, B-1004, B-1077, B-1178, B-1222 Vogl W.-D.: B-0428, B-1116 Vogt L.: B-0984 Vojinovic S.: B-1109 Völgyes D.: B-0105 Volle G.: B-0363 Volterrani L.: B-1172 vom Scheidt A.: B-0478, B-1224 von Baumgarten L.: B-0820, B-0968 von Below C.M.: B-0951 von Falck C.: B-0978, B-1044, B-1094 von Fintel E.: B-0014, B-0218, B-0222 von Guggenberg E.: B-0027 Vonder M.: B-0789 Vonken E.-J.P.: B-1365 Vöö S.: B-0224, B-1276 Vöö S.A.: B-0056 Voogd A.: B-0420 Voogd A.C.: B-0925 Voormolen M.: B-0403, B-0803 Vora M.P.: B-1346 Vorobiev S.: B-0063 Vorobyov N.: B-0830 Voropaev V.: B-1296 Vörös E.: B-0613 Voros S.: B-0766 Vorster L.: B-0711 Vos A.: B-0650 Voss S.: B-0953 Vreemann S.: B-0426, B-0921, B-1071 Vriens I.: B-0420 Vriens M.R.: B-0364 Vujnovic S.: B-1302

W Waade G.G.: B-1119 Waage J.E.R.: A-664 Wacker F.: B-0939, B-0978, B-1003, B-1044, B-1094, B-1367

Wafaie A.M.: B-0663 Wagenvoort A.M.: B-0036 Wahlund L.-O.: B-0390 Wakili R.: B-1315 Walecki J.: A-175, A-375, B-0911, B-0914 Walen S.: B-0589 Wallin E.: B-0814 Walsh D.: A-532 Walsh S.: B-0587 Walsh S.L.F.: B-0112, B-0586 Walther M.: CTiR 1 Wang D.-B.: B-1031 Wang F.: B-0857 Wang H.: B-0240, B-0268, B-0269, B-0510 Wang J.: B-0634 Wang L.-J.: B-0523 Wang M.: B-0599, B-0600 Wang P.: B-0736 Wang Q.: B-0001, B-0003, B-0723, B-1093 Wang R.: B-0746 Wang S.: B-0583, B-1274 Wang W.: B-0095 Wang W.-P.: B-1031, B-1228, B-1269 Wang X.: B-0577, B-0739, B-0836, B-1093, B-1177, B-1236, B-1265, B-1266, B-1268 Wang Y.: B-0177, B-0628, B-0682, B-0857 Wang Y.L.: B-0289, B-0847, B-1052, B-1056 Wang Y.-N.: B-0177 Wang Z.: B-0134, B-0135, B-0391 Ward A.M.: B-0715 Warin-Fresse K.: B-1151 Warmerdam N.C.: B-0345 Warringa N.: B-0589 Wasan R.: B-0928 Wasserman M.: B-0693 Watson M.: B-1185 Watson T.: B-1012 Wattjes M.P.: B-1105 Waugh S.: B-0427 Webber N.: B-1149 Weber C.: B-0492, B-0695, B-1219 Weber M.: B-0070, B-0300, B-0660, B-1116 Weber M.-A.: A-372 Weber R.J.P.: B-0925 Weckbach S.: A-126 Wee S.H.: B-0215 Wegjan E.: B-1132 Wei L.: B-0833 Wei W.: B-0556 Weibrecht M.: B-1165, B-1166 Weijers G.: B-0022 Weinheimer O.: B-0433, B-0439, B-1211, B-1216 Weinmann A.: B-0412 Weinrich J.: B-0049 Weir A.: B-0639 Weirich G.: B-0341 Weir-McCall J.: B-0748 Weis C.: B-0764 Weis J.: B-0575 Weis M.: B-0373 Weishaupt D.: B-0306, B-0310, B-1250 Weiss C.: A-282 Weiß J.: B-0312, B-0593, B-0704, B-0861 Welker L.: B-1219

www.myESR.org

List of Authors & Co-Authors

Well L.: B-0049 Wellenberg R.H.H.: B-0954 Wells A.: B-0112, B-0586, B-0587, B-1368 Welsch G.H.: B-0642 Weng A.M.: B-0314, B-1045 Wengert G.: B-1259 Wengert G.J.: B-0428, B-0758, B-1116 Wenkel E.: CTiR 2 Wenter V.: B-0296 Wergeland C.: B-0345 Werncke T.: B-1094, B-1367 Werner J.: A-265 Werring D.: B-0823 Wessalowski R.: B-0545 Westbrook C.: B-0149 Westenberg J.J.M.: B-0060 Westenend P.J.: B-0012 Westhofen M.: B-0722 Westman E.: B-0388 Weston M.: A-236 Wetscherek A.: B-0669 Wetter A.: B-0507, B-0560, B-0656, B-0900, B-1201, B-1351 Weyer H.: B-0483 White P.: B-0143, B-0672 Wichman J.L.: B-0746 Wichmann J.: B-0175, B-0263 Wichmann J.L.: B-0174, B-0264, B-0380, B-0386, B-0483, B-0783, B-0785, B-0877, B-0878, B-0967, B-0976, B-1077, B-1178, B-1222, B-1349 Wick A.: B-0282 Wick W.: B-0282 Widmann G.: B-0564 Wieben O.: B-1099 Wiedenmann B.: B-0041 Wiegerinck E.M.A.: B-0792 Wielema M.: B-0609, B-0610 Wielpütz M.: B-1211, B-1214 Wielpütz M.O.: B-0433, B-0439, B-0513, B-1216 Vienna J.: B-1156 Wienbeck S.: B-0014, B-0218, B-0222 Wieners G.: B-0621, B-0690 Wiersma J.: B-0589 Wierts R.: B-0056 Wiesinger B.: B-1068 Wiesinger I.: B-0475, B-1026 Wieske V.: CTiR 1 Wietek B.M.: B-1068 Wijesuriya S.: B-0928 Wikström J.: B-0203 Wildberger J.E.: B-0224, B-0473, B-0791, B-1040, B-1064, B-1276 Wildgruber M.: B-0547 Wildner S.: B-0534 Wilkmann C.: B-0864 Willaime J.M.Y.: B-0436 Willemink M.J.: B-1365 Willems S.M.: B-0568 Willemssen F.E.J.A.: B-0408 Willer K.: B-0671 Williams M.C.: B-0118, B-0741 Willinek W.: B-1003 Willner M.: B-1149

www.myESR.org

Wilms G.: B-0205 Wilson D.J.: A-776, B-0280, B-1185 Wilson I.: B-1370 Windhager R.: B-0491 Winklhofer S.: B-0554 Winter-Warnars G.A.: B-0225 Winzer K.-J.: B-0926 Wirth C.: B-0314 Wirth S.: A-553 Wirth W.: B-0555 Wiśniewska M.: B-0113 Wissgott C.: B-0260, B-0616 Wnuk E.: B-1374 Wochner R.: B-0513 Wohlgemuth W.A.: B-0475 Woitek R.: B-0423, B-0757, B-0758, B-1116, B-1259 Wojcik D.: B-0952 Wojtaszek M.: B-1374 Wolf F.: K-01 Wolfrum C.: B-0026 Wollersheim L.W.L.M.: B-1148 Wolsztynski E.: B-0024 Won J.Y.: B-1102 Wong K.: B-1133 Wong O.: B-0737 Wong P.C.: B-0359 Wong R.: B-0988 Wong S.C.: B-0973 Wong Y.-C.: B-0523 Woo E.K.: B-0227 Woo S.M.: B-1234 Woodley H.: A-318 Woods T.: B-0644 Wörtler K.: B-1184, K-24 Wörz S.: B-0313, B-1043 Wozniak M.: A-746 Wray J.: B-0924 Wright C.L.: B-0029 Wu C.-H.: B-0523 Wu H.: B-0584 Wu J.: B-0628 Wu L.: B-0051 Wu L.M.: B-0253 Wu Y.-W.: B-1241 Wuest W.: B-0879 Wulff A.: B-0953 Würstlin S.: B-1348 Wüst W.: B-0880 Wuthrick E.: B-0029 Wyse G.: B-0795

X Xia Y.: B-0847 Xiao L.: B-0359 Xiao Y.: B-0505, B-0511 Xiao Y.-D.: B-0974 Xu C.: B-0584 Xu H.: B-0676, B-0681, B-1360 Xu J.: B-0051, B-0584, B-1093 Xu J.-M.: B-0268, B-0269 Xu J.R.: B-0253 Xu Y.: B-0098 Xue H.: B-1177, B-1327 Xue H.D.: B-1093

Xue H.-D.: B-0571, B-0739, B-0836, B-1235, B-1265, B-1266, B-1268 Xydis V.: B-1059

Y Yagami K.: B-0872 Yagci R.: B-0155 Yaguchi A.: B-1364 Yamada A.: B-0841, B-1309 Yamada Y.: B-1171 Yamagata H.: B-0655 Yamamoto S.: B-1039 Yamamura J.: B-0007, B-0382, B-0634 Yamashita M.: B-0495 Yamazaki A.: B-0384, B-0385 Yamazoe S.: B-1189 Yan J.: B-0992 Yan X.: B-0289, B-1052, B-1056 Yang D.H.: B-0250 Yang Q.: B-0624 Yang Y.: B-0970 Yang Y.X.: B-0489 Yardimci A.H.: B-1280 Yaroshenko A.: B-0671 Yassin M.: B-0472, B-0680 Yavaşi Ö.: B-0694 Yavuz A.: B-0625 Yazar F.M.: B-0065 Ye Y.: B-0628 Ye Z.: B-0089, B-0510, B-0773 Yeap P.M.: B-0427, B-0526, B-0916 Yegin G.: B-1356 Yehya M.A.M.: B-0567 Yeniceri O.: B-1326 Yeo A.: B-0489 Yeon E.: B-0636 Yevich S.: B-0858 Yew S.: B-0489 Yi Y.: B-0177 Yilmaz E.: B-0140 Yilmaz E.U.T.A.A.K.C.T.: B-0318 Yilmaz K.: B-0155 Yılmaz O.: B-0002 Yilmaz S.: B-0085, B-0274, B-0591 Yim Y.: B-0464, B-1331 Yin B.: B-0288 Yin L.: B-0970 Yinn R.: B-0185 Yiu K.-H.: B-0784 Yoneyama Y.: B-0479 Yong Q.: B-0059 Yonggao Z.: B-0992 Yoo J.L.: B-0975 Yoo R.-E.: B-1363 Yoon J.: B-0546 Yoon J.H.: B-0410, B-0842, B-1297 Yoon K.H.: B-0215 Yoon K.-H.: B-1092 Yoon Y.C.: B-0812 Yoshikawa T.: B-0106, B-0316, B-0319, B-0684, B-0685, B-1364 You C.: B-1070 You S.H.: B-0573 You Y.: B-1093 Youn I.: B-0754

Final Programme | ECR 2016

373

List of Authors & Co-Authors

Yousry T.A.: A-106, A-337, A-655 Youssef A.: B-0567 Youssef A.: B-0356 Youssef A.A.Y.: B-1066 Youssif O.Z.: B-1065 Yperzeele L.: B-0403, B-0803 Yu B.: B-1029 Yu C.: B-1330 Yu J.I.: B-0839 Yu M.: B-0584 Yu M.H.: B-0464, B-1331 Yu S.: B-0265 Yuan H.: B-0391 Yuan J.: B-0059 Yuen C.T.: B-0321 Yuen M.K.: B-0359 Yui M.: B-0316, B-0319 Yun B.L.: B-0530 Yurttutan N.: B-0065, B-0066, B-0171, B-0637 Yutaka N.: B-0134

Z Zabala Landa R.M.: B-0358 Zackrisson S.: A-351, A-387, A-702 Zagoria R.J.: A-194, A-196 Zakharova M.: B-1111 Zamboni G.: A-661, B-0819 Zanca F.: A-653, B-1287 Zanetti G.: A-066 Zanetti M.: A-371, A-562, A-720, B-1186 Zangos S.: B-0130, B-0467, B-0470, B-0862, B-0976, B-1004, B-1222 Zantedeschi L.: B-0832 Zarb F.: B-0718 Zarnowski J.: B-0549 Zauner Jakubik M.: B-0328 Zdešar U.: A-766, B-1381 Zeccolini F.: B-1057 Zech C.J.: A-315 Zechlinski J.: B-0127 Zedan M.H.: B-0612, B-1279 Zefov V.N.: B-0888 Zeller T.: B-0260 Zeng X.: B-0391 Zerlauth J.-B.: B-0362 Zerolo A.: A-692 Zerunian M.: B-0780 Zhang C.: B-0628 Zhang D.: B-1177 Zhang F.: B-0584 Zhang G.: B-0938 Zhang G.F.: B-0132 Zhang G.-M.-Y.: B-0571, B-1235 Zhang H.: B-0134 Zhang J.: B-0028, B-0029, B-0374 Zhang K.: B-0089 Zhang L.: B-0059 Zhang M.: B-0504 Zhang X.: B-0970 Zhang X.-L.: B-0095 Zhang Y.: B-0265, B-0584, B-0628 Zhang Z.: B-0193, B-0445, B-0449, B-0938 Zhang Z.-L.: B-0991 Zhao J.: B-0289, B-1052, B-1056

374

ECR 2016 | Final Programme

Zhao Q.: B-1274 Zheng D.: B-0511 Zheng L.: B-0193, B-0938 Zheng X.: B-0511 Zhou D.-J.: B-0268, B-0269 Zhou J.: B-0963 Zhou Y.: B-0733, B-0734, B-0735 Zhu B.: B-0962 Zhu L.: B-1265, B-1266, B-1268 Žibert J.: B-1380, B-1381 Zidan D.Z.: B-0294 Zidi A.: B-0046, B-1308 Ziegeler K.: B-0067 Ziemlewicz T.: B-0206 Zijlstra I.A.J.: B-0407 Zikou A.: B-1059 Zimlichman E.: B-0686 Zimmer C.: B-1193 Zimmermann E.: B-0460 Zimmermann M.: B-0281, B-0283, B-0284 Zini C.: B-0537, B-0941 Zins M.: B-0037 Zinsser D.: B-0292 Ziv-Baran T.: B-0115, B-0116 Złotorowicz M.: B-0911, B-0914 Zmuda M.: B-0157 Zoga A.C.: B-1180 Zolda P.: A-455 Zompatori M.: B-0111, B-0139 Zonnenberg B.: B-0995 Zou W.: B-0847 Zuber N.: B-0306, B-0310, B-1250 Zugaro L.: B-0324, B-0331, B-0332 Zuiani C.: B-0220, B-0605, CTiR 2 Zulina T.: B-1305 Zurera L.J.: B-0536 Zvěřina E.: B-0728 Zykov O.: B-0154 Zynger D.: B-0825, B-0833

www.myESR.org

LIST OF M O D E R ATO R S

375

List of Moderators

A Abeyakoon O.: SS 1416 Adam E.J.: MIR 2 Agadakos E.: SS 314 Akata D.: SS 1001b Akhan O.: SS 609 Akchurina E.: SS 701c Alberich-Bayarri A.: SS 1805 Albrecht T.: SS 1009 Alkadhi H.: E3 1226c Allen, Jr. B.: ACR Allen S.: SS 202 Anderson S.E.: SS 1010b Arenson R.: CTiR 1, CTiR 2 Arkhipova I.: SS 1014 Artigas J.M.: SS 717 Athanasiou A.: RC 102 Aviram G.: SS 704 Ayuso C.: SS 216b

B Balassy C.: SS 312 Bali M.A.: SS 216a Balleyguier C.S.: SS 302 Bamberg F.: SS 203a Bargalló N.: SS 211a Bargellini I.: SS 1815 Basta-Nikolic M.: TF 1 Battisti S.: SS 1816 Beardmore C.: SS 714 Beets-Tan R.G.H.: E3 1726b Bell J.K.: MIR 3 Bellin M.-F.: SS 607b Bérczi V.: SS 1909 Bernardi D.: RC 1602 Bernathova M.: SS 1402b Berritto D.: TF 1 Beyer T.: EF 1 Bharadwaz A.: SS 1809 Bhatia K.S.S.: SS 1408 Bick U.: SS 1805 Bickelhaupt S.: SS 605 Bilbao J.I.: E3 1226a, SS 1515 Biondi A.: SS 311c Blomqvist L.K.: E3 1218, SS 1816 Bojanovic A.L.J.: SS 615 Bonekamp D.: SS 707 Borges A.: SS 608 Bos D.: SS 1411a Bouchareb Y.: SS 713 Boudabbous S.: SS 1010a Bougias B.: SS 1914 Brandão S.: SS 1014 Bremerich J.: E3 1520, ESR/ESMRMB Brisbois D.: SS 1003 Brkljačić B.: SS 602b Broncano J.: SS 303a Brountzos E.: SS 1815 Buls N.: SS 313 Buruian M.: SS 1011b

C Cademartiri F.: SS 203b Calli C.: SS 1411a

376

ECR 2016 | Final Programme

Camps Herrero J.: E3 24A, E3 24B, E3 24C, E3 24D, E3 24E Carbonetti F.: SS 617 Carrafiello G.: SS 209 Caseiro-Alves F.: SS 1501 Cesar R.: SS 1904 Chatziioannou S.: SS 206 Choi B.I.: SS 201a Ciet P.: SS 304 Ciraj-Bjelac O.: SS 313 Claudon M.: ESR/EFSUMB/ESPR Coche E.E.J.G.: SS 204 Coenegrachts K.: SS 1401 Conte G.: SS 308 Contegiacomo A.: SS 1015 Cotten A.: RC 1210, SS 1410 Cowan N.C.: SS 707 Crocetti L.: SS 1001b Cunha T.M.: E3 922 Curvo-Semedo L.: SS 1001a Czerny C.: SS 308

D Damilakis J.: EF 1 Danielsen E.R.: ESR/ESMRMB de Bruijne M.: SS 605 de Bucourt M.: SS 315 de las Heras Gala H.: SS 1913 de Roos A.: SS 303a Dewey M.: CTiR 1, CTiR 2 Di Matteo M.: SS 1002 Diamantopoulos A.: SS 309 Domingo A.: SS 602b Dondelinger R.F.: SS 1409 Donoso L.: EM 1, EM 2, EM 3, ESOR Dore R.: SS 203a Dormagen J.B.: SS 617 Dromain C.: SS 1902b Dudás I.: SS 1901b Due-Tønnessen P.: RC 111

E Ekberg O.: SS 701b Esen G.: RC 1502 Esposito A.: SS 1903

F Faggioni L.: SS 305 Falini A.: SS 311a Fallenberg E.M.: SS 1902a Fanelli F.: SS 715 Feuchtner G.: SS 203b Fischbach R.: SS 303b Fohlen A.: SS 216a Forrai G.: SS 1902a Fournier L.S.: SS 1916 Franchi-Abella S.: E3 1226b Francone M.: SS 303b Freling N.J.M.: RC 808 Frija G.: EuroSafe 2 Frühwald-Pallamar J.: RC 1308 Fuchsjäger M.H.: SS 302 Fütterer J.J.: E3 1022

G Garðarsdóttir M.: EM 1 Garnon J.: SS 1009 Geith T.: SS 1010b Gibaud B.: SS 305 Gillard J.H.: SS 1411b Glaveckaite S.: SS 1415 Gogbashian A.: SS 1916 Gourtsoyianni S.: SS 601b Gourtsoyiannis N.: ESOR Gramer B.M.: SS 213 Gruszczynska K.: SS 703 Guglielmi G.: SS 610a Gulino P.: SS 212

H Haage P.: SS 1015 Hagen G.: EM 1 Haider L.: SS 1911 Hamm B.: MIR 1 Hanelore H.: SS 211b Heinz-Peer G.: SS 1807 Helbich T.H.: RC 106 Helmberger T.K.: E3 1518 Hemke R.: SS 210 Henner A.: SS 1414 Henzler T.: SS 1404 Hermans R.: RC 508 Herneth A.M.: SS 1006 Herzog C.: SS 1903 Hirsch W.: RC 412 Hoeffel C.: SS 601b Hogg P.H.: SS 214 Honda H.: EM 2 Howarth N.: E3 25A, E3 25B, E3 25C, E3 25D, E3 25E Huzjan Korunić R.: SS 1807

I Issever A.S.: SS 610a

J Jahnen A.: SS 213 Jargiello T.: RC 815 Jon E.: SS 704 Junker D.: SS 1407

K Karabulut N.: ESR/ERS Karantanas A.H.: SS 1810 Karnabatidis D.: RC 415 Kasatkina E.: SS 301a Kasprian G.: SS 1012 Kau T.: SS 1011a Kauczor H.-U.: ACR Kelekis A.D.: SS 1809 Kerl J.M.: SS 1003 Kienzl-Palma D.: SS 1804 Kirova-Nedialkova G.I.: E3 1220 Klumpp B.: SS 1416 Knogler T.: SS 1802 Koerte I.: SS 211a Koff D.A.: MIR 2 Koh D.-M.: E3 1618 Kösling S.: SS 708

www.myESR.org

List of Moderators

Koutalonis M.: SS 1813 Krokidis M.: SS 1909 Kuhelj D.: SS 609 Kucheruk O.V.: SS 216b Kuhn F.P.: SS 311a

L Lambregts D.M.: SS 316 Lammers T.: SS 206 Lamot U.: SS 711 Lang K.: SS 714 Leander P.: SS 701a Lee J.M.: SS 1901a Lefere P.: E3 1318 Lehéricy S.: SS 1911 Leidecker C.: RC 1614 Ley S.: ESR/ERS Linsenmaier U.: RC 417 Loewe C.: E3 920 Logager V.: E3 822 Looby S.: SS 1411b Loose R.W.R.: SS 1813 Lopes Dias J.: SS 607b Løvblad K.-O.: SS 1511 Lubinus F.G.: EM 3

M Madureira A.J.B.S.: SS 603 Maintz D.: SS 1503 Maksimović R.: SS 301b Malagari K.: SS 1804 Malone D.E.: SS 601a Mang T.: SS 301b Mann R.M.: E3 1726c Marcia S.: SS 309 Markiet K.: SS 708 Masselli G.: SS 1907 Mayer J.: SS 1004 Mazzei M.A.: SS 701b Meissnitzer M.: SS 307 Merhemic Z.: SS 711 Meyer M.: SS 603 Mildenberger P.: MIR 3 Miletić D.: SS 1414 Molinari F.: SS 604 Morgan R.: RC 915 Morozov S.: MIR 1 Morozova S.: SS 1811 Mousseaux E.: E3 1620 Mrakic Sposta F.: SS 717 Mueller-Lisse U.G.: SS 207

N Neri E.: PC 9a Nielsen K.R.: EM 1 Nikolic O.: SS 607a Noebauer-Huhmann I.-M.: SS 210

O Oei E.H.G.: SS 610b Ortiz-Pérez J.T.: SS 315 Otero-García M.M.: E3 722 Oudeman J.: SS 710 Owens C.: ESR/EFSUMB/ESPR

www.myESR.org

P

T

Pagonidis K.: SS 1803 Palkó A.: MC 528, MC 628, MC 728, MC 828 Panebianco V.: SS 616 Panizza P.: SS 1902b Papaioannou G.: SS 1012 Parkar A.P.: RC 904 Pasterk M.: PC 9a Pediconi F.: SS 702 Peetrons P.: SS 310 Perez Rodrigo S.: SS 1402a Pershina E.: SS 1503 Persson A.: RC 1504 Pijnappel R.: RC 1302, SS 1402a Pina Insausti L.J.: SS 1402b Plumb A.: SS 1001a Politi L.S.: SS 208 Prayer D.: SS 212 Puzakov K.B.: SS 1907 Pyatigorskaya N.: SS 311b Pyra K.: SS 607a

Tack D.: SS 1404 Tali E.T.: RC 1511 Taylor A.M.: RC 512 Taylor Z.A.: EIBIR 4 Thibault F.: SS 702 Thierfelder K.M.: SS 611 Thoeny H.C.: E3 622 Thomassin-Naggara I.: SS 602a Tomà P.: RC 1312 Trattnig S.: SS 610b Traykova N.I.: SS 1008 Trojanowska A.: E3 1726a Tsalafoutas I.A.: SS 1913 Tsapaki V.: EF 2 Tsetis D.K.: SS 715 Tsitskari M.: SS 209

R Rainford L.: EuroSafe 1 Raissaki M.: RC 912 Rand T.: SS 615 Raupach R.: SS 713 Regier M.: E3 1626, SS 1904 Reiter M.: SS 215 Riddell A.M.: SS 301a Riklund K.: EM 1, EM 2, EM 3, ESR/ESHI Ringl H.: SS 701c Roditi G.: RC 403 Rodríguez P.: SS 601a Rodt T.: SS 208 Rohde S.: RC 1611 Rørvik J.: SS 1016 Rostovtseva T.: SS 1011b

S Sachs A.: SS 1810 Salvador R.: SS 1905 Santos J.: RC 1614 Schaarschmidt B.M.: SS 616 Schemuth H.P.: SS 311c Schmid-Tannwald C.: SS 1409 Schulz-Wendtland R.: SS 1502 Sconfienza L.M.: SS 310 Selim A.: SS 1802 Sellors J.: PS 427 Sever A.: SS 602a Sharp P.: EF 2 Silva M.: SS 604 Skrobisz-Balandowska K.: SS 201b Sohaib A.: SS 316 Sommer W.H.: SS 1016 Sorantin E.: SS 314 Sosna J.: SS 716 Spirovski M.: SS 1901a Ståhlbrandt H.: EM 1, SS 1814 Steens S.: SS 608 Stern E.J.: SS 1004 Szabó E.: SS 1914

Turkay R.: SS 207

V Van Beers B.E.: SS 201b van Buchem M.A.: SS 311b Van der Lugt A.: SS 215 van der Molen A.J.: SS 1401 Van Goethem J.: SS 1811 van Ooijen P.M.A.: SS 1905 Van Westen D.: E3 1726d Vanninen R.L.: EM 1 Varoquaux D.-A.: RC 408 Venancio J.: E3 522 Venkatesh S.K.: SS 1501 Vernooij M.: RC 1211 Vilanova J.C.: SS 1407 Vilela P.: SS 611 Vorwerk D.: SS 1901b

W Walker-Samuel S.: SS 1406 Wängler B.: SS 1406 Weber M.-A.: RC 410 Weckbach S.: PS 427 Westwood T.D.: SS 716 Wibmer A.: SS 701a Widmann G.: SS 1008 Wilson D.J.: SS 710 Wirth S.: RC 117 Woitek R.: SS 1511 Wörtler K.: SS 1010a

Y Yazici Z.: SS 312

Z Zagoria R.J.: MC 528, MC 628, MC 728, MC 828 Zamboni G.: SS 201a Zarb F.: SS 1814 Zlatareva D.: RC 1311

Final Programme | ECR 2016

377

vienna march 1–5 the flower gardens of radiology the annual meeting of

myESR.org The ECR is the annual meeting of the European Society of Radiology